Disruption	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
SCL	NN	compound	I-DNA
locus	NN	nmod	I-DNA
by	IN	case	O
``	``	punct	O
illegitimate	JJ	amod	O
''	''	punct	O
V-	NN	compound	O
(	-LRB-	punct	O
D	NN	compound	O
)	-RRB-	punct	O
-J	NN	nummod	O
recombinase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

A	DT	det	O
fusion	NN	compound	B-DNA
complementary	JJ	amod	I-DNA
DNA	NN	nsubj	I-DNA
in	IN	case	O
the	DT	det	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
HSB-2	NN	nmod	I-cell_line
elucidates	VBZ	ROOT	O
a	DT	det	O
provocative	JJ	amod	O
mechanism	NN	dobj	O
for	IN	case	O
the	DT	det	O
disruption	NN	nmod	O
of	IN	case	O
the	DT	det	O
putative	JJ	amod	O
hematopoietic	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
SCL	NN	dep	B-protein
.	.	punct	O

The	DT	det	O
fusion	NN	compound	B-DNA
cDNA	NN	nsubj	I-DNA
results	VBZ	ROOT	O
from	IN	case	O
an	DT	det	O
interstitial	JJ	amod	O
deletion	NN	nmod	O
between	IN	case	O
a	DT	det	O
previously	RB	advmod	O
unknown	JJ	amod	B-DNA
locus	NN	nmod	I-DNA
,	,	punct	O
SIL	NN	appos	B-DNA
(	-LRB-	punct	O
SCL	NN	compound	B-DNA
interrupting	NN	compound	I-DNA
locus	NN	appos	I-DNA
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
5	CD	nummod	B-DNA
'	''	punct	I-DNA
untranslated	JJ	amod	I-DNA
region	NN	conj	I-DNA
of	IN	case	O
SCL	NN	nmod	B-protein
.	.	punct	O

Similar	JJ	advmod	O
to	TO	prep	O
1	CD	pobj	O
;	:	punct	O
14	CD	nummod	O
translocations	NNS	dep	O
,	,	punct	O
this	DT	det	O
deletion	NN	nsubj	O
disrupts	VBZ	ROOT	O
the	DT	det	O
SCL	NN	compound	B-DNA
5	CD	nummod	I-DNA
'	``	punct	I-DNA
regulatory	JJ	amod	I-DNA
region	NN	dobj	I-DNA
.	.	punct	O

This	DT	det	O
event	NN	nsubjpass	O
is	VBZ	auxpass	O
probably	RB	advmod	O
mediated	VBN	ROOT	O
by	IN	case	O
V-	NN	compound	O
(	-LRB-	punct	O
D	NN	appos	O
)	-RRB-	punct	O
-J	NN	nummod	O
recombinase	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
although	IN	mark	O
neither	DT	det	O
locus	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
immunoglobulin	NN	advcl	B-protein
or	CC	cc	O
a	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	conj	I-protein
.	.	punct	O

Two	CD	nummod	O
other	JJ	amod	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubj	I-cell_line
,	,	punct	O
CEM	NN	appos	B-cell_line
and	CC	cc	O
RPMI	NN	conj	B-cell_line
8402	CD	nummod	I-cell_line
,	,	punct	O
have	VBP	ROOT	O
essentially	RB	advmod	O
identical	JJ	amod	O
deletions	NNS	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
,	,	punct	O
growth-affecting	JJ	amod	B-DNA
genes	NNS	nsubj	I-DNA
other	JJ	amod	O
than	IN	dep	O
immune	JJ	amod	B-protein
receptors	NNS	conj	I-protein
risk	VBP	ROOT	O
rearrangements	NNS	dobj	O
.	.	punct	O

Thyroid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptors	NNS	nsubj	I-protein
form	VBP	ROOT	O
distinct	JJ	amod	O
nuclear	JJ	amod	B-protein
protein-dependent	JJ	amod	I-protein
and	CC	cc	I-protein
independent	JJ	conj	I-protein
complexes	NNS	dobj	I-protein
with	IN	case	O
a	DT	det	O
thyroid	NN	compound	B-DNA
hormone	NN	compound	I-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
recombinant	JJ	amod	B-protein
thyroid	NN	compound	I-protein
hormone	NN	compound	I-protein
receptors	NNS	conj	I-protein
(	-LRB-	punct	O
TRs	NNS	appos	B-protein
)	-RRB-	punct	O
to	TO	case	O
the	DT	det	O
palindromic	JJ	amod	B-DNA
thyroid	NN	compound	I-DNA
hormone	NN	compound	I-DNA
responsive	JJ	amod	I-DNA
element	NN	nmod	I-DNA
AGGTCATGACCT	NN	dep	O
(	-LRB-	punct	O
TREp	NN	appos	B-DNA
)	-RRB-	punct	O
using	VBG	acl	O
a	DT	det	O
gel	NN	compound	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

Four	CD	nummod	O
specific	JJ	amod	O
protein-DNA	JJ	amod	B-protein
complexes	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
detected	VBN	ROOT	O
after	IN	case	O
incubation	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
(	-LRB-	punct	O
NE	NNS	appos	O
)	-RRB-	punct	O
from	IN	case	O
T3-responsive	JJ	amod	B-cell_line
pituitary	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
GH3	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
a	DT	det	O
TREp-containing	JJ	amod	B-DNA
DNA	NN	compound	I-DNA
fragment	NN	nmod	I-DNA
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
compared	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
TREp	NN	compound	B-DNA
binding	NN	nmod	O
of	IN	case	O
reticulocyte	NN	compound	B-protein
lysate-synthesized	JJ	amod	I-protein
TRs	NNS	nmod	I-protein
.	.	punct	O

TR	NN	compound	B-protein
alpha	NN	nsubj	I-protein
1	CD	nummod	I-protein
and	CC	cc	O
TR	NN	compound	B-protein
beta	NN	conj	I-protein
2	CD	nummod	I-protein
each	DT	dep	O
formed	VBD	ROOT	O
a	DT	det	O
single	JJ	amod	O
major	JJ	amod	O
TR	NN	compound	B-protein
:	:	punct	I-protein
TREp	NN	compound	I-protein
complex	NN	dobj	I-protein
which	WDT	nsubj	O
comigrated	VBD	acl:relcl	O
with	IN	case	O
the	DT	det	O
least	RBS	advmod	O
retarded	VBN	amod	O
complex	NN	nmod	O
formed	VBN	acl	O
by	IN	case	O
GH3	NN	compound	O
NE	NNS	nmod	O
,	,	punct	O
while	IN	mark	O
TR	NN	compound	B-protein
beta	NN	nsubj	I-protein
1	CD	nummod	I-protein
formed	VBD	advcl	O
multiple	JJ	amod	O
complexes	NNS	dobj	O
suggesting	VBG	acl	O
that	IN	mark	O
it	PRP	nsubj	O
can	MD	aux	O
bind	VB	ccomp	O
to	TO	case	O
TREp	NN	nmod	B-DNA
as	IN	case	O
an	DT	det	O
oligomer	NN	nmod	B-protein
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
coincubation	NN	nsubj	O
of	IN	case	O
35S-TR	NN	compound	B-protein
alpha	NN	nmod	I-protein
1	CD	nummod	I-protein
,	,	punct	O
GH3	NN	compound	O
NE	NNS	conj	O
,	,	punct	O
and	CC	cc	O
unlabeled	JJ	amod	O
TREp	NN	conj	B-DNA
resulted	VBD	ROOT	O
in	IN	case	O
not	RB	neg	O
only	RB	cc:preconj	O
the	DT	det	O
35S-TR	NN	compound	B-protein
:	:	punct	I-protein
TREp	NN	compound	I-protein
complex	NN	nmod	I-protein
,	,	punct	O
but	CC	cc	O
in	IN	case	O
two	CD	nummod	O
additional	JJ	amod	O
more	RBR	advmod	O
greatly	RB	advmod	O
retarded	VBN	amod	O
complexes	NNS	conj	O
containing	VBG	acl	O
35S-TR	NN	compound	B-protein
alpha	NN	dobj	I-protein
1	CD	nummod	I-protein
and	CC	cc	O
comigrating	VBG	conj	O
with	IN	case	O
those	DT	nmod	O
formed	VBN	acl	O
by	IN	case	O
GH3	NN	compound	O
extract	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

Incubation	NN	nsubj	O
of	IN	case	O
each	DT	nmod	O
of	IN	case	O
the	DT	det	O
TRs	NNS	nmod	B-protein
with	IN	case	O
NE	NNS	nmod	O
from	IN	case	O
COS-7	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
which	WDT	nsubj	O
do	VBP	aux	O
not	RB	neg	O
possess	VB	acl:relcl	O
sufficient	JJ	amod	O
endogenous	JJ	amod	O
TRs	NNS	dobj	B-protein
to	TO	mark	O
mediate	VB	xcomp	O
T3-responses	NNS	dobj	O
,	,	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
a	DT	det	O
new	JJ	amod	O
,	,	punct	O
more	RBR	advmod	O
greatly	RB	advmod	B-protein
shifted	VBN	amod	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
,	,	punct	O
heat	NN	compound	O
labile	JJ	amod	O
activity	NN	nsubj	O
which	WDT	nsubj	O
altered	VBD	acl:relcl	O
mobility	NN	dobj	O
of	IN	case	O
the	DT	det	O
TR	NN	compound	B-protein
:	:	punct	I-protein
TRE	NN	compound	I-protein
complex	NN	nmod	I-protein
was	VBD	cop	O
also	RB	advmod	O
present	JJ	ROOT	O
in	IN	case	O
NE	NNS	nmod	O
from	IN	case	O
T3-unresponsive	JJ	amod	B-cell_line
JEG-3	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

At	IN	case	O
high	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
NE	NN	nmod	O
,	,	punct	O
all	DT	nsubj	O
of	IN	case	O
the	DT	det	O
TR	NN	nmod	B-protein
bound	VBN	ROOT	O
to	TO	case	O
TREp	NN	nmod	B-DNA
was	VBD	auxpass	O
more	RBR	advmod	O
greatly	RB	advmod	O
retarded	VBN	conj	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
NE	NN	nmod	O
.	.	punct	O

Truncation	NN	nsubj	O
of	IN	case	O
TR	NN	compound	B-protein
alpha	NN	nmod	I-protein
1	CD	nummod	I-protein
at	IN	case	O
amino	NN	compound	B-protein
acid	NN	nmod	I-protein
210	CD	nummod	I-protein
prevented	VBD	ROOT	O
additional	JJ	amod	O
complex	NN	compound	O
formation	NN	dobj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
NE	NNS	nmod	O
without	IN	mark	O
affecting	VBG	advcl	O
DNA	NN	compound	O
binding	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
carboxyl-terminus	NN	nsubj	B-protein
of	IN	case	O
the	DT	det	O
TRs	NNS	nmod	B-protein
is	VBZ	cop	O
essential	JJ	ccomp	O
for	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Cell-specific	JJ	amod	O
differences	NNS	ROOT	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
of	IN	case	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	nmod	I-DNA
and	CC	cc	I-DNA
beta	NN	compound	I-DNA
interferon	NN	compound	I-DNA
promoters	NNS	conj	I-DNA
by	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	nmod	I-protein
.	.	punct	O

Three	CD	nummod	O
aspects	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
involvement	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
HIV	NN	appos	O
)	-RRB-	punct	O
pathogenesis	NN	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
.	.	punct	O

Tumor	NN	compound	B-RNA
necrosis	NN	compound	I-RNA
factor	NN	compound	I-RNA
alpha	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
TNF-alpha	NN	appos	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	compound	I-RNA
production	NN	nsubjpass	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
by	IN	case	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
amplification	NN	nmod	O
in	IN	case	O
monocytic	JJ	amod	B-cell_line
U937	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
in	IN	case	O
a	DT	det	O
chronically	RB	advmod	B-cell_line
HIV	NN	compound	I-cell_line
infected	JJ	amod	I-cell_line
U937	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
(	-LRB-	punct	O
U9-IIIB	NN	appos	B-cell_line
)	-RRB-	punct	O
.	.	punct	O

TNF-alpha	NN	compound	B-RNA
RNA	NN	nsubj	I-RNA
was	VBD	cop	O
undetectable	JJ	ROOT	O
in	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
whereas	IN	dep	O
a	DT	det	O
low	JJ	amod	O
constitutive	JJ	amod	O
level	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	parataxis	O
in	IN	case	O
U9-IIIB	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Paramyxovirus	NN	compound	O
infection	NN	nsubj	O
induced	VBD	ROOT	O
a	DT	det	O
5-	CD	compound	O
to	TO	dep	O
10-fold	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
steady-state	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
TNF-alpha	NN	compound	B-RNA
RNA	NN	nmod	I-RNA
in	IN	case	O
U9-IIIB	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
compared	VBN	case	O
with	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HIV-infected	JJ	amod	B-cell_line
monocytic	JJ	amod	I-cell_line
cells	NNS	nsubj	I-cell_line
produced	VBD	ccomp	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
than	IN	mark	O
did	VBD	advcl	O
normal	JJ	amod	O
cells	NNS	nsubj	O
after	IN	case	O
a	DT	det	O
secondary	JJ	amod	O
virus	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
on	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
transient	JJ	amod	O
expression	NN	compound	O
assays	NNS	nmod	O
using	VBG	acl	O
reporter	NN	compound	B-DNA
chloramphenicol	NN	compound	I-DNA
acetyltransferase	NN	compound	I-DNA
plasmids	NNS	dobj	I-DNA
linked	VBN	acl	O
to	TO	case	O
regulatory	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
from	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
beta	NN	compound	B-DNA
interferon	NN	compound	I-DNA
promoter	NN	conj	I-DNA
.	.	punct	O

In	IN	case	O
U937	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
Jurkat	NN	compound	I-cell_line
T	NN	compound	I-cell_line
lymphoid	JJ	amod	I-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
the	DT	det	O
inducibility	NN	nsubj	O
of	IN	case	O
the	DT	det	O
different	JJ	amod	O
hybrid	NN	compound	B-DNA
promoters	NNS	nmod	I-DNA
by	IN	case	O
TNF-alpha	NN	nmod	B-protein
or	CC	cc	O
phorbol	NN	compound	O
ester	NN	conj	O
varied	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
cell	NN	compound	O
type-	NN	amod	O
and	CC	cc	O
promoter	NN	nmod:npmod	O
context-specific	JJ	conj	O
manner	NN	nmod	O
;	:	punct	O
the	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
gene	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-DNA
B-containing	JJ	amod	I-DNA
plasmids	NNS	nmod	I-DNA
correlated	VBD	parataxis	O
directly	RB	advmod	O
with	IN	case	O
induction	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
DNA-binding	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
intact	JJ	amod	O
beta	NN	compound	B-DNA
interferon	NN	compound	I-DNA
promoter	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
only	RB	advmod	O
weakly	RB	advmod	O
stimulated	VBN	advcl	O
by	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
or	CC	cc	O
TNF-alpha	NN	conj	B-protein
,	,	punct	O
multimers	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
PRDII	NN	compound	B-DNA
NF-kappa	NN	compound	I-DNA
B-binding	JJ	amod	I-DNA
domain	NN	nmod	I-DNA
were	VBD	cop	O
inducible	JJ	ROOT	O
by	IN	case	O
both	DT	det	O
agents	NNS	nmod	O
.	.	punct	O

TNF-alpha	NN	nsubj	B-protein
was	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
increase	VB	xcomp	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
TNF-alpha	NN	nsubj	B-protein
did	VBD	aux	O
not	RB	neg	O
induce	VB	conj	O
the	DT	det	O
HIV	NN	compound	B-DNA
LTR	NN	dobj	I-DNA
above	IN	case	O
a	DT	det	O
constitutive	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
activity	NN	nmod	O
.	.	punct	O

This	DT	det	O
level	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
-independent	JJ	amod	O
activity	NN	nmod	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
sufficient	JJ	xcomp	O
for	IN	case	O
virus	NN	compound	O
multiplication	NN	nmod	O
,	,	punct	O
since	IN	mark	O
TNF-alpha	NN	compound	B-protein
treatment	NN	nsubj	O
had	VBD	advcl	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
kinetics	NNS	nmod	O
of	IN	case	O
de	FW	amod	O
novo	FW	dep	O
HIV	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
infection	NN	nmod	O
and	CC	cc	O
viral	JJ	amod	B-RNA
RNA	NN	compound	I-RNA
production	NN	conj	O
in	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
TNF-alpha	NN	nsubj	B-protein
dramatically	RB	advmod	O
enhanced	VBD	ROOT	O
the	DT	det	O
spread	NN	dobj	O
of	IN	case	O
HIV-1	NN	nmod	O
through	IN	case	O
the	DT	det	O
cell	NN	compound	O
population	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
viral	JJ	amod	B-RNA
RNA	NN	compound	I-RNA
synthesis	NN	conj	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
HIV-1	NN	compound	O
multiplication	NN	nsubjpass	O
was	VBD	auxpass	O
stimulated	VBN	ccomp	O
by	IN	case	O
TNF-alpha	NN	compound	B-protein
treatment	NN	nmod	O
.	.	punct	O

Functional	JJ	amod	O
analysis	NN	ROOT	O
of	IN	case	O
cis-linked	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
sequences	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
HLA	NN	compound	B-DNA
DRA	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
by	IN	case	O
transcription	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Two	CD	nummod	O
consensus	NN	compound	O
sequences	NNS	nsubjpass	O
,	,	punct	O
called	VBN	acl	O
X	NN	compound	B-DNA
and	CC	cc	I-DNA
Y	NN	conj	I-DNA
boxes	NNS	xcomp	I-DNA
,	,	punct	O
capable	JJ	amod	O
of	IN	mark	O
binding	VBG	advcl	O
nuclear	JJ	amod	B-protein
proteins	NNS	dobj	I-protein
and	CC	cc	O
regulating	VBG	conj	O
expression	NN	dobj	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
have	VBP	aux	O
been	VBN	auxpass	O
defined	VBN	ROOT	O
within	IN	case	O
the	DT	det	O
immediate	JJ	amod	O
upstream	JJ	amod	O
region	NN	nmod	O
of	IN	case	O
major	JJ	amod	B-DNA
histocompatibility	NN	compound	I-DNA
complex	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
MHC	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

Unlike	IN	case	O
other	JJ	amod	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
promoters	NNS	nmod	I-DNA
,	,	punct	O
the	DT	det	O
HLA-DR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
DRA	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	nsubj	I-DNA
also	RB	advmod	O
contains	VBZ	ROOT	O
one	CD	nummod	O
element	NN	dobj	O
identical	JJ	amod	O
to	TO	case	O
the	DT	det	O
``	``	punct	B-DNA
octamer	NN	compound	I-DNA
''	''	punct	I-DNA
motif	NN	nmod	I-DNA
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
variable	JJ	amod	I-DNA
region	NN	compound	I-DNA
promoters	NNS	nmod	I-DNA
that	WDT	nsubj	O
is	VBZ	cop	O
responsible	JJ	acl:relcl	O
for	IN	case	O
B	NN	nmod:npmod	O
cell-specific	JJ	amod	O
transcription	NN	nmod	O
.	.	punct	O

This	DT	det	O
``	``	punct	O
octamer	NN	nsubj	B-DNA
``	''	punct	O
in	IN	case	O
the	DT	dep	O
context	NN	dep	O
of	IN	case	O
DRA	NN	nmod	B-protein
appears	VBZ	ROOT	O
capable	JJ	xcomp	O
of	IN	mark	O
binding	VBG	advcl	O
both	CC	cc:preconj	O
the	DT	det	O
ubiquitous	JJ	dobj	B-protein
(	-LRB-	punct	O
OTF-1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
lymphoid-specific	JJ	conj	B-protein
(	-LRB-	punct	I-protein
OTF-2	NN	appos	I-protein
)	-RRB-	punct	I-protein
``	``	punct	I-protein
octamer	NN	compound	I-protein
''	''	punct	I-protein
binding	NN	compound	I-protein
proteins	NNS	dep	I-protein
,	,	punct	O
but	CC	cc	O
at	IN	case	O
least	JJS	nmod:npmod	O
one	CD	nummod	O
other	JJ	amod	O
distinct	JJ	amod	O
``	``	punct	B-protein
octamer	NN	compound	I-protein
''	''	punct	I-protein
complex	NN	nsubjpass	I-protein
was	VBD	auxpass	O
found	VBN	conj	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
characterize	VB	advcl	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
cis-acting	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
developed	VBN	ROOT	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
system	NN	dobj	O
in	IN	case	O
which	WDT	nmod	O
a	DT	det	O
DRA	NN	compound	B-DNA
promoter	NN	compound	I-DNA
construct	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
transcribed	VBN	acl:relcl	O
more	RBR	advmod	O
efficiently	RB	advmod	O
in	IN	case	O
extracts	NNS	nmod	O
from	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
than	IN	case	O
in	IN	case	O
extracts	NNS	nmod	O
from	IN	case	O
class	NN	compound	B-cell_line
II-negative	JJ	amod	I-cell_line
HeLa	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

5	CD	nummod	O
'	``	punct	O
deletion	NN	compound	O
constructs	NNS	nsubj	O
which	WDT	nsubj	O
lacked	VBD	acl:relcl	O
the	DT	det	O
Y	NN	compound	B-DNA
box	NN	dobj	I-DNA
,	,	punct	O
but	CC	cc	O
retained	VBD	ROOT	O
the	DT	det	O
``	``	punct	B-DNA
octamer	NN	compound	I-DNA
''	''	punct	I-DNA
motif	NN	dobj	I-DNA
and	CC	cc	O
TATA	NN	compound	B-DNA
box	NN	conj	I-DNA
were	VBD	cop	O
completely	RB	advmod	O
inactive	JJ	conj	O
,	,	punct	O
and	CC	cc	O
internal	JJ	amod	O
deletion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Y	NN	compound	B-DNA
box	NN	nmod	I-DNA
reduced	VBD	conj	O
transcription	NN	dobj	O
by	IN	case	O
95	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
supercoiled	JJ	amod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
linear	JJ	conj	O
templates	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
differences	NNS	dobj	O
in	IN	case	O
transcription	NN	compound	O
efficiencies	NNS	nmod	O
from	IN	case	O
templates	NNS	nmod	O
lacking	VBG	acl	O
or	CC	cc	O
disrupting	VBG	conj	O
the	DT	det	O
X	NN	compound	B-DNA
consensus	NN	compound	I-DNA
element	NN	dobj	I-DNA
that	WDT	nsubj	O
reflect	VBP	acl:relcl	O
effects	NNS	dobj	O
of	IN	case	O
random	JJ	amod	O
replacement	NN	nmod	O
of	IN	case	O
X	NN	compound	B-DNA
box	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
in	IN	case	O
transient	JJ	amod	O
expression	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

Demonstration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
complete	JJ	amod	O
dependence	NN	nmod	O
on	IN	case	O
the	DT	det	O
Y	NN	compound	B-DNA
box	NN	nmod	I-DNA
in	IN	case	O
this	DT	det	O
system	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
,	,	punct	O
despite	IN	case	O
its	PRP$	nmod:poss	O
demonstrated	VBN	amod	O
importance	NN	nmod	O
in	IN	case	O
the	DT	det	O
DRA	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
the	DT	det	O
DRA	NN	compound	B-DNA
``	``	punct	I-DNA
octamer	NN	nsubj	I-DNA
''	''	punct	I-DNA
does	VBZ	aux	O
not	RB	neg	O
utilize	VB	ccomp	O
OTF-2	NNP	dobj	B-protein
in	IN	case	O
a	DT	det	O
manner	NN	nmod	O
analogous	JJ	amod	O
to	TO	case	O
immunoglobulin	NN	compound	B-DNA
promoters	NNS	nmod	I-DNA
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Lipopolysaccharide	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
monocyte/macrophage-specific	JJ	amod	O
stimulator	NN	ROOT	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
expression	NN	nmod	O
.	.	punct	O

Lipopolysaccharide	NN	nsubj	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
potently	RB	advmod	O
stimulates	VBZ	ROOT	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1-long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
HIV-1-LTR	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
CAT	NN	compound	I-DNA
constructs	NNS	dobj	I-DNA
transfected	VBN	acl	O
into	IN	case	O
monocyte/macrophage-like	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
but	CC	cc	O
not	RB	cc	O
a	DT	det	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
.	.	punct	O

This	DT	det	O
effect	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
through	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
LPS	NN	nsubj	O
induces	VBZ	ccomp	O
a	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
indistinguishable	JJ	amod	O
from	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
U937	NN	nmod	B-cell_line
and	CC	cc	O
THP-1	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

LPS	NN	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
dramatically	RB	advmod	O
increase	VB	xcomp	O
HIV-1	NN	compound	O
production	NN	dobj	O
from	IN	case	O
a	DT	det	O
chronically	RB	advmod	B-cell_line
infected	JJ	amod	I-cell_line
monocyte/macrophage-like	JJ	amod	I-cell_line
cloned	VBN	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
U1	NN	appos	B-cell_line
,	,	punct	O
which	WDT	nsubj	O
produces	VBZ	acl:relcl	O
very	RB	advmod	O
low	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
HIV-1	NN	nmod	O
at	IN	case	O
baseline	NN	nmod	O
.	.	punct	O

The	DT	det	O
stimulation	NN	nsubj	O
of	IN	case	O
viral	JJ	amod	O
production	NN	nmod	O
from	IN	case	O
this	DT	det	O
cell	NN	compound	O
line	NN	nmod	O
occurs	VBZ	ROOT	O
only	RB	advmod	O
if	IN	mark	O
these	DT	det	O
cells	NNS	nsubjpass	O
are	VBP	auxpass	O
treated	VBN	advcl	O
with	IN	case	O
granulocyte/macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
GM-CSF	NN	appos	B-protein
)	-RRB-	punct	O
before	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
LPS	NN	nmod	O
.	.	punct	O

This	DT	det	O
stimulation	NN	nsubjpass	O
of	IN	case	O
HIV-1	NN	compound	O
production	NN	nmod	O
is	VBZ	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
HIV-1	NN	compound	B-RNA
RNA	NN	nmod	I-RNA
and	CC	cc	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

LPS	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
able	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
HIV-1	NN	compound	O
production	NN	dobj	O
in	IN	case	O
a	DT	det	O
cloned	VBN	amod	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
LPS	NN	nmod	O
on	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
occurs	VBZ	ROOT	O
at	IN	case	O
picogram	NN	nmod	O
per	IN	case	O
milliliter	NN	compound	O
concentrations	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
be	VB	cop	O
clinically	RB	advmod	O
significant	JJ	conj	O
in	IN	mark	O
understanding	VBG	advcl	O
the	DT	det	O
variability	NN	dobj	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
history	NN	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

Steroid	NN	compound	O
dose	NN	compound	O
sparing	NN	ROOT	O
:	:	punct	O
pharmacodynamic	JJ	amod	O
responses	NNS	dep	O
to	TO	case	O
single	JJ	amod	O
versus	CC	cc	O
divided	JJ	conj	O
doses	NNS	nmod	O
of	IN	case	O
methylprednisolone	NN	nmod	O
in	IN	case	O
man	NN	nmod	O
.	.	punct	O

Inhibitory	JJ	amod	O
drug	NN	compound	O
interactions	NNS	nsubj	O
affecting	VBG	acl	O
the	DT	det	O
metabolism	NN	dobj	O
of	IN	case	O
methylprednisolone	NN	nmod	O
(	-LRB-	punct	O
MP	NN	appos	O
)	-RRB-	punct	O
may	MD	aux	O
produce	VB	ROOT	O
either	CC	cc:preconj	O
steroid	NN	compound	O
sparing	NN	dobj	O
or	CC	cc	O
adverse	JJ	amod	O
effects	NNS	conj	O
partly	RB	advmod	O
by	IN	mark	O
increasing	VBG	advcl	O
the	DT	det	O
exposure	NN	compound	O
time	NN	dobj	O
to	TO	case	O
the	DT	det	O
steroid	NN	nmod	O
.	.	punct	O

This	DT	det	O
phenomenon	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
mimicked	VBN	ROOT	O
by	IN	mark	O
administering	VBG	advcl	O
MP	NN	dobj	O
in	IN	case	O
divided	JJ	amod	O
doses	NNS	nmod	O
.	.	punct	O

Two	CD	nummod	O
types	NNS	nsubjpass	O
of	IN	case	O
responses	NNS	nmod	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
after	IN	case	O
a	DT	det	O
single	JJ	amod	O
MP	NN	compound	O
dose	NN	nmod	O
(	-LRB-	punct	O
40	CD	compound	O
mg	NN	nummod	O
bolus	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
divided	JJ	amod	O
regimen	NNS	conj	O
(	-LRB-	punct	O
20	CD	compound	O
mg	NN	nummod	O
bolus	NN	dep	O
and	CC	cc	O
a	DT	det	O
5	CD	compound	O
mg	NN	nummod	O
bolus	NN	conj	O
8	CD	nummod	O
hours	NNS	npadvmod	O
later	RB	advmod	O
)	-RRB-	punct	O
in	IN	case	O
six	CD	nummod	O
healthy	JJ	amod	O
male	JJ	amod	O
volunteers	NNS	nmod	O
.	.	punct	O

The	DT	det	O
suppression	NN	nsubj	O
of	IN	case	O
basophils	NNS	nmod	B-cell_type
measured	VBN	ROOT	O
as	IN	case	O
whole	JJ	amod	O
blood	NN	compound	O
histamine	NN	nmod	O
and	CC	cc	O
plasma	NN	compound	O
cortisol	NN	compound	O
concentrations	NNS	conj	O
was	VBD	auxpass	O
assessed	VBN	conj	O
during	IN	case	O
32	CD	nummod	O
hours	NNS	nmod	O
.	.	punct	O

The	DT	det	O
37.5	CD	compound	O
%	NN	compound	O
reduction	NN	nsubj	O
in	IN	case	O
dose	NN	nmod	O
produced	VBD	ROOT	O
a	DT	det	O
23	CD	nummod	O
%	NN	compound	O
overall	RB	amod	O
decreased	VBN	amod	O
blood	NN	compound	O
histamine	NN	compound	O
response	NN	dobj	O
.	.	punct	O

A	DT	det	O
pharmacodynamic	JJ	amod	O
model	NN	nsubj	O
for	IN	case	O
basophil	NN	compound	O
cell	NN	compound	O
distribution	NN	nmod	O
to	TO	nmod	O
and	CC	cc	O
from	IN	case	O
an	DT	det	O
extravascular	JJ	amod	O
compartment	NN	nmod	O
describes	VBZ	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
MP	NN	nmod	O
after	IN	case	O
both	DT	det	O
regimens	NNS	nmod	O
.	.	punct	O

A	DT	det	O
slower	JJR	amod	O
initial	JJ	amod	O
decline	NN	nsubj	O
in	IN	case	O
blood	NN	compound	O
histamine	NN	nmod	O
after	IN	case	O
the	DT	det	O
divided	JJ	amod	O
regimen	NNS	nmod	O
may	MD	aux	O
be	VB	cop	O
related	JJ	ROOT	O
to	TO	case	O
incomplete	JJ	amod	O
suppression	NN	nmod	O
of	IN	case	O
basophil	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
return	NN	nmod	O
to	TO	case	O
blood	NN	nmod	O
.	.	punct	O

The	DT	det	O
50	CD	compound	O
%	NN	amod	O
inhibitory	JJ	amod	O
concentrations	NNS	nsubj	O
of	IN	case	O
MP	NN	nmod	O
of	IN	case	O
about	RB	advmod	O
5	CD	nummod	O
ng/ml	NN	nmod	O
were	VBD	cop	O
similar	JJ	ROOT	O
for	IN	case	O
both	DT	det	O
regimens	NNS	nmod	O
.	.	punct	O

The	DT	det	O
decline	NN	nsubj	O
and	CC	cc	O
return	NN	conj	O
of	IN	case	O
cortisol	NN	compound	O
concentrations	NNS	nmod	O
were	VBD	cop	O
similar	JJ	ROOT	O
between	IN	case	O
MP	NN	compound	O
treatments	NNS	nmod	O
with	IN	case	O
suppression	NN	nmod	O
continuing	VBG	acl	O
for	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
.	.	punct	O

The	DT	det	O
50	CD	compound	O
%	NN	amod	O
inhibitory	JJ	amod	O
concentrations	NNS	nsubj	O
of	IN	case	O
MP	NN	compound	O
values	NNS	nmod	O
for	IN	case	O
adrenal	JJ	amod	O
suppression	NN	nmod	O
were	VBD	cop	O
about	RB	advmod	O
1	CD	nummod	O
ng/ml	NN	ROOT	O
.	.	punct	O

Pharmacodynamic	JJ	amod	O
modeling	NN	nsubj	O
is	VBZ	cop	O
useful	JJ	ROOT	O
in	IN	mark	O
quantitating	VBG	advcl	O
corticosteroid	NN	compound	O
responses	NNS	dobj	O
and	CC	cc	O
generally	RB	advmod	O
predicted	VBD	conj	O
the	DT	det	O
``	``	punct	O
dose-sparing	JJ	amod	O
''	''	punct	O
effects	NNS	dobj	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
achieved	VBN	acl:relcl	O
by	IN	mark	O
prolonging	VBG	advcl	O
MP	NN	compound	O
plasma	NN	compound	O
concentrations	NNS	dobj	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
supports	VBZ	ROOT	O
previous	JJ	amod	O
clinical	JJ	amod	O
observations	NNS	dobj	O
that	IN	mark	O
patients	NNS	nsubj	O
may	MD	aux	O
require	VB	acl:relcl	O
morning	NN	dobj	O
through	IN	case	O
evening	NN	compound	O
exposure	NN	nmod	O
to	TO	case	O
MP	NN	nmod	O
to	TO	mark	O
optimize	VB	xcomp	O
efficacy	NN	dobj	O
while	IN	mark	O
adrenal	JJ	amod	O
suppression	NN	nsubjpass	O
is	VBZ	aux	O
being	VBG	auxpass	O
minimized	VBN	advcl	O
.	.	punct	O

1	LS	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D2	NN	compound	O
production	NN	ROOT	O
by	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
alveolar	JJ	amod	B-cell_type
macrophages	NNS	conj	I-cell_type
recovered	VBN	acl	O
by	IN	case	O
lavage	NN	nmod	O
from	IN	case	O
normocalcemic	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
tuberculosis	NN	nmod	O
.	.	punct	O

To	TO	mark	O
compare	VB	advcl	O
extra-renal	JJ	amod	O
1	CD	dep	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
production	NN	dobj	O
in	IN	case	O
different	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
granulomatous	JJ	amod	O
disease	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
identify	VB	conj	O
the	DT	det	O
cell	NN	compound	O
types	NNS	dobj	O
responsible	JJ	amod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
evaluated	VBN	ROOT	O
the	DT	det	O
conversion	NN	dobj	O
of	IN	case	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
D3	NN	nmod	O
in	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
by	IN	case	O
uncultured	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
recovered	VBN	acl	O
by	IN	case	O
bronchoalveolar	JJ	amod	O
lavage	NN	nmod	O
and	CC	cc	O
blood	NN	compound	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
from	IN	case	O
normocalcemic	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
sarcoidosis	NN	nmod	O
and	CC	cc	O
tuberculosis	NN	conj	O
.	.	punct	O

1	LS	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubjpass	O
was	VBD	auxpass	O
produced	VBN	ROOT	O
both	CC	advmod	O
by	IN	case	O
lavage	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
12/12	CD	nummod	O
tuberculosis	NN	compound	O
patients	NNS	dep	O
,	,	punct	O
2/6	CD	cc	O
sarcoidosis	NN	compound	O
patients	NNS	conj	O
)	-RRB-	punct	O
and	CC	cc	O
blood	NN	compound	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
(	-LRB-	punct	O
3/5	CD	nummod	O
tuberculosis	NN	compound	O
patients	NNS	dep	O
,	,	punct	O
0/3	CD	nummod	O
sarcoidosis	NN	compound	O
patients	NNS	appos	O
)	-RRB-	punct	O
from	IN	case	O
patients	NNS	nmod	O
but	CC	cc	O
not	RB	cc	O
controls	NNS	conj	O
,	,	punct	O
but	CC	cc	O
significantly	RB	advmod	O
greater	JJR	amod	O
amounts	NNS	nsubjpass	O
were	VBD	auxpass	O
produced	VBN	conj	O
by	IN	case	O
lavage	NN	compound	O
cells	NNS	nmod	O
from	IN	case	O
tuberculosis	NN	compound	O
patients	NNS	nmod	O
than	IN	case	O
those	DT	nmod	O
of	IN	case	O
sarcoidosis	NN	compound	O
patients	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

1	LS	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
production	NN	nsubj	O
by	IN	case	O
lavage	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
tuberculosis	NN	compound	O
patients	NNS	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
CD8+	JJ	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
present	JJ	amod	O
but	CC	cc	O
not	RB	cc	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	conj	O
.	.	punct	O

T	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
appeared	VBD	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
source	NN	xcomp	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
production	NN	nmod	O
,	,	punct	O
since	IN	mark	O
purified	VBN	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
from	IN	case	O
all	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
tuberculosis	NN	nmod	O
produced	VBD	advcl	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	dobj	O
,	,	punct	O
and	CC	cc	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
production	NN	nsubj	O
by	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
correlated	VBD	advcl	O
closely	RB	advmod	O
with	IN	case	O
that	DT	nmod	O
produced	VBN	acl	O
by	IN	case	O
unseparated	JJ	amod	O
lavage	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Because	IN	mark	O
1	CD	pobj	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
can	MD	aux	O
improve	VB	advcl	O
the	DT	det	O
capacity	NN	dobj	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
to	TO	mark	O
kill	VB	acl	O
mycobacteria	NNS	dobj	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
conclusion	NN	dobj	O
that	IN	mark	O
macrophage-lymphocyte	JJ	amod	O
interactions	NNS	nsubj	O
,	,	punct	O
mediated	VBN	acl	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
by	IN	case	O
1	CD	pobj	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
,	,	punct	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
component	NN	ccomp	O
of	IN	case	O
a	DT	det	O
successful	JJ	amod	O
antituberculous	JJ	amod	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Megakaryocytic	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
erythrocytic	JJ	conj	I-cell_line
lineages	NNS	nsubj	I-cell_line
share	VBP	ROOT	O
specific	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
.	.	punct	O

Erythroid-specific	JJ	amod	B-DNA
genes	NNS	nsubj	I-DNA
contain	VBP	ROOT	O
binding	VBG	amod	O
sites	NNS	dobj	O
for	IN	case	O
NF-E1	NN	nmod	B-protein
(	-LRB-	punct	O
also	RB	advmod	O
called	VBN	dep	O
GF-1	NN	xcomp	B-protein
and	CC	cc	O
Eryf-1	NN	conj	B-protein
;	:	punct	O
refs	NNS	xcomp	O
1-3	CD	nummod	O
respectively	RB	advmod	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
principal	JJ	amod	O
DNA-binding	JJ	amod	B-protein
protein	NN	dobj	I-protein
of	IN	case	O
the	DT	det	O
erythrocytic	JJ	amod	B-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

NF-E1	NN	compound	B-protein
expression	NN	nsubj	O
seems	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
restricted	JJ	xcomp	O
to	TO	case	O
the	DT	det	O
erythrocytic	JJ	amod	B-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
(	-LRB-	punct	O
if	IN	mark	O
not	RB	neg	O
identical	JJ	conj	O
)	-RRB-	punct	O
protein	NN	nsubjpass	O
is	VBZ	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
a	DT	det	O
human	JJ	amod	B-cell_line
megakaryocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
and	CC	cc	O
purified	VBN	amod	B-cell_line
human	JJ	amod	I-cell_line
megakaryocytes	NNS	conj	I-cell_line
;	:	punct	O
it	PRP	nsubj	O
binds	VBZ	parataxis	O
to	TO	case	O
promoter	NN	compound	B-DNA
regions	NNS	nmod	I-DNA
of	IN	case	O
two	CD	nummod	O
megakaryocytic-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
binding	VBG	amod	O
sites	NNS	nsubj	O
and	CC	cc	O
partial	JJ	amod	O
proteolysis	NN	compound	O
profile	NN	conj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
are	VBP	cop	O
indistinguishable	JJ	ROOT	O
from	IN	case	O
those	DT	nmod	O
of	IN	case	O
the	DT	det	O
erythroid	JJ	amod	B-protein
protein	NN	nmod	I-protein
;	:	punct	O
also	RB	advmod	O
,	,	punct	O
NF-E1	NN	compound	B-RNA
messenger	NN	compound	I-RNA
RNA	NN	nsubj	I-RNA
is	VBZ	cop	O
the	DT	det	O
same	JJ	amod	O
size	NN	dep	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
megakaryocytic	JJ	nmod	B-cell_line
and	CC	cc	I-cell_line
erythroid	JJ	conj	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dep	I-cell_line
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
point	NN	compound	O
mutations	NNS	nsubj	O
that	WDT	nsubj	O
abolish	VBP	acl:relcl	O
binding	NN	dobj	O
of	IN	case	O
NF-E1	NN	nmod	B-protein
result	VBP	ROOT	O
in	IN	case	O
a	DT	det	O
70	CD	compound	O
%	NN	amod	O
decrease	NN	nmod	O
in	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
a	DT	det	O
megakaryocytic-specific	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
find	VBP	ROOT	O
that	IN	mark	O
NF-E2	NN	nsubj	B-protein
,	,	punct	O
another	DT	det	O
trans-acting	JJ	amod	B-protein
factor	NN	appos	I-protein
of	IN	case	O
the	DT	det	O
erythrocytic	JJ	amod	B-cell_type
lineage	NN	nmod	I-cell_type
,	,	punct	O
is	VBZ	cop	O
present	JJ	ccomp	O
in	IN	case	O
megakaryocytes	NNS	nmod	B-cell_line
.	.	punct	O

Transcriptional	JJ	amod	O
effects	NNS	nsubjpass	O
in	IN	case	O
both	DT	det	O
lineages	NNS	nmod	O
might	MD	aux	O
then	RB	advmod	O
be	VB	auxpass	O
mediated	VBN	ROOT	O
in	IN	case	O
part	NN	nmod	O
by	IN	case	O
the	DT	det	O
same	JJ	amod	O
specific	JJ	amod	O
trans-acting	JJ	amod	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
strengthen	VBP	ROOT	O
the	DT	det	O
idea	NN	dobj	O
of	IN	case	O
a	DT	det	O
close	JJ	amod	O
association	NN	nmod	O
between	IN	case	O
the	DT	det	O
erythrocytic	JJ	nmod	B-cell_line
and	CC	cc	I-cell_line
the	DT	det	I-cell_line
megakaryocytic	JJ	amod	I-cell_line
lineages	NNS	dep	I-cell_line
and	CC	cc	O
could	MD	aux	O
also	RB	advmod	O
explain	VB	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
markers	NNS	nmod	O
specific	JJ	amod	O
to	TO	case	O
the	DT	det	O
erythrocytic	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
megakaryocytic	JJ	conj	I-cell_type
lineages	NNS	nmod	I-cell_type
in	IN	case	O
most	JJS	amod	O
erythroblastic	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
megakaryoblastic	JJ	conj	I-cell_line
permanent	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Transcriptional	JJ	amod	O
down-regulation	NN	ROOT	O
of	IN	case	O
c-myc	NN	compound	B-DNA
expression	NN	nmod	O
by	IN	case	O
protein	NN	compound	O
synthesis-dependent	JJ	amod	O
and	CC	cc	O
-independent	JJ	conj	O
pathways	NNS	nmod	O
in	IN	case	O
a	DT	det	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
lymphoblastic	JJ	amod	I-cell_line
tumor	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
lymphoblastic	JJ	amod	I-cell_line
tumor	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
Molt4	NN	compound	B-RNA
c-myc	NN	compound	I-RNA
mRNA	NN	nsubjpass	I-RNA
and	CC	cc	O
protein	NN	compound	O
expression	NN	conj	O
is	VBZ	auxpass	O
down-regulated	VBN	ccomp	O
after	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
dimethyl	JJ	amod	O
sulfoxide	NN	nmod	O
,	,	punct	O
to	TO	case	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	nmod	O
,	,	punct	O
or	CC	cc	O
to	TO	case	O
the	DT	det	O
calcium	NN	compound	O
ionophore	NN	compound	O
A23187	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
raises	VBZ	acl:relcl	O
the	DT	det	O
intracellular	JJ	amod	O
calcium	NN	compound	O
concentration	NN	dobj	O
.	.	punct	O

A	DT	det	O
block	NN	nsubj	O
to	TO	case	O
RNA	NN	compound	O
elongation	NN	nmod	O
is	VBZ	cop	O
largely	RB	advmod	O
responsible	JJ	ROOT	O
for	IN	case	O
decreased	VBN	amod	O
c-myc	NN	compound	B-DNA
transcription	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
negative	JJ	amod	O
regulation	NN	nsubj	O
by	IN	case	O
dimethyl	JJ	amod	O
sulfoxide	NN	nmod	O
takes	VBZ	advcl	O
place	NN	dobj	O
even	RB	advmod	O
when	WRB	advmod	O
protein	NN	compound	O
synthesis	NN	nsubjpass	O
is	VBZ	auxpass	O
inhibited	VBN	advcl	O
by	IN	case	O
cycloheximide	NN	nmod	O
,	,	punct	O
the	DT	det	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	compound	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
blocked	VBN	ROOT	O
to	TO	case	O
some	DT	det	O
extent	NN	nmod	O
only	RB	advmod	O
by	IN	case	O
cycloheximide	NN	nmod	O
.	.	punct	O

The	DT	det	O
calcium	NN	compound	O
ionophore-induced	JJ	amod	O
c-myc	NN	compound	B-DNA
suppression	NN	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
strictly	RB	advmod	O
requires	VBZ	ROOT	O
de	FW	amod	O
novo	FW	dep	O
protein	NN	compound	O
synthesis	NN	dobj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
two	CD	nummod	O
different	JJ	amod	O
negative	JJ	amod	O
regulatory	JJ	amod	O
pathways	NNS	nsubjpass	O
are	VBP	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
c-myc	NN	compound	B-DNA
regulation	NN	nmod	O
:	:	punct	O
one	CD	dep	O
which	WDT	nsubj	O
is	VBZ	cop	O
independent	JJ	acl:relcl	O
and	CC	cc	O
one	CD	conj	O
which	WDT	nsubj	O
depends	VBZ	acl:relcl	O
on	IN	case	O
de	FW	amod	O
novo	FW	dep	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
latter	JJ	amod	O
one	CD	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
by	IN	case	O
a	DT	det	O
rapidly	RB	advmod	O
calcium-dependent	JJ	amod	B-protein
induced	VBN	amod	I-protein
gene	NN	compound	I-protein
product	NN	nmod	I-protein
.	.	punct	O

Oestrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
ER	NN	appos	B-protein
)	-RRB-	punct	O
analysis	NN	ROOT	O
in	IN	case	O
B-cell	NN	compound	O
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukemia	NN	nmod	O
:	:	punct	O
correlation	NN	dep	O
of	IN	case	O
biochemical	JJ	amod	O
and	CC	cc	O
immunocytochemical	JJ	conj	O
methods	NNS	nmod	O
.	.	punct	O

Oestrogen	NN	compound	B-protein
receptors	NNS	nsubj	I-protein
(	-LRB-	punct	O
ER	NN	appos	B-protein
)	-RRB-	punct	O
are	VBP	cop	O
present	JJ	ROOT	O
in	IN	case	O
neoplastic	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
have	VBP	aux	O
been	VBN	auxpass	O
considered	VBN	conj	O
a	DT	det	O
physiological	JJ	amod	O
marker	NN	dobj	O
of	IN	case	O
growth	NN	compound	O
rate	NN	nmod	O
or	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Tamoxifen	NN	nsubjpass	O
,	,	punct	O
an	DT	det	O
oestrogen	NN	compound	O
antagonist	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
given	VBN	ROOT	O
in	IN	case	O
some	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
CLL	NN	nmod	O
and	CC	cc	O
Hodgkin	NN	nmod:poss	O
's	POS	case	O
disease	NN	conj	O
,	,	punct	O
with	IN	case	O
dramatic	JJ	amod	O
response	NN	nmod	O
in	IN	case	O
single	JJ	amod	O
cases	NNS	nmod	O
.	.	punct	O

Until	IN	case	O
now	RB	advmod	O
,	,	punct	O
ER	NN	compound	B-protein
status	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
assessed	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
steroid	NN	compound	O
binding	NN	compound	O
assay	NN	dobj	O
(	-LRB-	punct	O
SBA	NN	appos	O
)	-RRB-	punct	O
which	WDT	nsubj	O
has	VBZ	acl:relcl	O
many	JJ	amod	O
inherent	JJ	amod	O
problems	NNS	dobj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
the	DT	det	O
development	NN	nsubjpass	O
of	IN	case	O
monoclonal	JJ	amod	O
antibodies	NNS	nmod	O
directed	VBN	acl	O
against	IN	case	O
ER	NN	nmod	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
applied	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
study	NN	nmod	O
of	IN	case	O
breast	NN	compound	O
carcinomas	NNS	nmod	O
and	CC	cc	O
results	NNS	nsubj	O
obtained	VBN	acl	O
show	VBP	conj	O
good	JJ	amod	O
correlation	NN	dobj	O
with	IN	case	O
the	DT	det	O
quantitative	JJ	amod	O
SBA	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
studied	VBD	ROOT	O
49	CD	nummod	O
cases	NNS	dobj	O
of	IN	case	O
B-cell	NN	compound	O
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
CLL	NN	appos	O
)	-RRB-	punct	O
using	VBG	advcl	O
immunostaining	NN	dobj	O
of	IN	case	O
cytospin	NN	compound	O
preparations	NNS	nmod	O
.	.	punct	O

In	IN	case	O
30	CD	nmod	O
of	IN	case	O
these	DT	det	O
cases	NNS	nmod	O
ER	NN	compound	B-protein
enzyme	NN	compound	O
immunoassay	NN	nsubjpass	O
(	-LRB-	punct	O
ER	NN	compound	B-protein
-EIA	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
performed	VBN	ROOT	O
.	.	punct	O

Cultured	VBN	amod	B-cell_line
MCF-7	NN	compound	I-cell_line
cells	NNS	nsubjpass	I-cell_line
,	,	punct	O
derived	VBN	acl	O
from	IN	case	O
a	DT	det	O
pleural	JJ	amod	O
effusion	NN	nmod	O
of	IN	case	O
a	DT	det	O
breast	NN	compound	O
cancer	NN	compound	O
patient	NN	nmod	O
,	,	punct	O
known	VBN	acl	O
to	TO	mark	O
contain	VB	xcomp	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
ER	NN	nmod	B-protein
were	VBD	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
positive	JJ	amod	O
control	NN	nmod	O
(	-LRB-	punct	O
40-48	CD	nummod	O
%	NN	compound	O
ER	NN	compound	B-cell_type
positive	JJ	amod	I-cell_type
cells	NNS	dep	I-cell_type
by	IN	case	O
immunocytochemistry	NN	nmod	O
;	:	punct	O
200	CD	nummod	O
fmol/mg	NN	compound	O
protein	NN	dep	O
by	IN	case	O
EIA	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

All	DT	nsubj	O
of	IN	case	O
the	DT	det	O
CLL	NN	compound	O
cases	NNS	nmod	O
except	IN	case	O
two	CD	nmod	O
(	-LRB-	punct	O
96	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
were	VBD	cop	O
negative	JJ	ROOT	O
for	IN	case	O
ER	NN	nmod	B-protein
(	-LRB-	punct	O
less	JJR	advmod	O
than	IN	mwe	O
1	CD	nummod	O
%	NN	amod	O
staining	NN	dep	O
;	:	punct	O
less	JJR	amod	O
than	IN	case	O
4	CD	compound	O
fmol/mg	NN	amod	O
protein	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
positive	JJ	amod	O
cases	NNS	nsubj	O
expressed	VBD	ROOT	O
granular	JJ	amod	O
ER	NN	compound	B-protein
staining	NN	dobj	O
over	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
(	-LRB-	punct	O
9.2	CD	nummod	O
and	CC	cc	O
12.1	CD	conj	O
%	NN	compound	O
positive	JJ	amod	O
cells	NNS	conj	O
)	-RRB-	punct	O
and	CC	cc	O
were	VBD	cop	O
positive	JJ	conj	O
by	IN	case	O
EIA	NN	nmod	O
and	CC	cc	O
SBA	NN	conj	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
(	-LRB-	punct	O
i	LS	dep	O
)	-RRB-	punct	O
patients	NNS	nsubj	O
with	IN	case	O
CLL	NN	nmod	O
rarely	RB	advmod	O
express	VBP	ccomp	O
ER	NN	dobj	B-protein
and	CC	cc	O
(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
immunocytochemical	JJ	amod	O
staining	NN	nsubj	O
of	IN	case	O
cytospin	NN	compound	O
preparations	NNS	nmod	O
is	VBZ	cop	O
a	DT	det	O
valid	JJ	amod	O
technique	NN	conj	O
for	IN	case	O
the	DT	det	O
measurement	NN	nmod	O
of	IN	case	O
ER	NN	nmod	B-protein
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	ROOT	O
of	IN	prep	O
interest	NN	pobj	O
that	IN	mark	O
one	CD	nsubjpass	O
of	IN	case	O
the	DT	det	O
positive	JJ	amod	O
cases	NNS	nmod	O
was	VBD	auxpass	O
diagnosed	VBN	ccomp	O
as	IN	case	O
CLL	NN	nmod	O
with	IN	case	O
Richter	NN	nmod:poss	O
's	POS	case	O
transformation	NN	nmod	O
confirming	VBG	acl	O
earlier	JJR	amod	O
findings	NNS	dobj	O
.	.	punct	O

Type-II	JJ	amod	B-protein
estrogen	NN	compound	I-protein
binding	NN	compound	I-protein
sites	NNS	ROOT	I-protein
in	IN	case	O
a	DT	det	O
lymphoblastoid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
and	CC	cc	O
growth-inhibitory	JJ	amod	O
effect	NN	conj	O
of	IN	case	O
estrogen	NN	nmod	O
,	,	punct	O
anti-estrogen	NN	conj	O
and	CC	cc	O
bioflavonoids	NNS	conj	O
.	.	punct	O

Type-II	JJ	amod	B-protein
estrogen-binding	JJ	amod	I-protein
sites	NNS	nsubjpass	I-protein
(	-LRB-	punct	O
type-II	JJ	amod	B-protein
EBS	NNS	appos	I-protein
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
lymphoblastoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
IM-9	NN	nmod	B-cell_line
using	VBG	xcomp	O
a	DT	det	O
whole-cell	JJ	amod	O
assay	NN	dobj	O
with	IN	case	O
(	-LRB-	punct	O
6	CD	intj	O
,	,	punct	O
7-3H	NN	appos	O
)	-RRB-	punct	O
estradiol	NN	compound	O
(	-LRB-	punct	O
3H-E2	NN	nmod	O
)	-RRB-	punct	O
as	IN	case	O
tracer	NN	nmod	O
.	.	punct	O

Competition	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
anti-estrogen	JJ	amod	O
tamoxifen	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
flavonoids	NNS	compound	O
quercetin	NN	conj	O
and	CC	cc	O
rutin	NN	conj	O
competed	VBD	ccomp	O
for	IN	case	O
(	-LRB-	punct	O
3H	NN	intj	O
)	-RRB-	punct	O
-E2	CD	compound	O
binding	VBG	nmod	O
to	TO	case	O
type-II	JJ	amod	B-protein
EBS	NNS	nmod	I-protein
.	.	punct	O

Growth	NN	compound	O
experiments	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
diethylstilbestrol	NN	compound	O
(	-LRB-	punct	O
DES	NN	appos	O
)	-RRB-	punct	O
tamoxifen	NN	nsubj	O
(	-LRB-	punct	O
TAM	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
quercetin	NN	conj	O
and	CC	cc	O
rutin	NN	conj	O
exerted	VBD	ccomp	O
a	DT	det	O
reversible	JJ	amod	O
dose-dependent	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
in	IN	case	O
the	DT	det	O
range	NN	nmod	O
of	IN	case	O
concentrations	NNS	nmod	O
between	IN	case	O
10	CD	nummod	O
nM	NN	nmod	O
and	CC	cc	O
10	CD	nummod	O
microM	NN	conj	O
.	.	punct	O

The	DT	det	O
relative	JJ	amod	O
binding	NN	compound	O
affinity	NN	nsubj	O
of	IN	case	O
quercetin	NN	nmod	O
,	,	punct	O
rutin	NN	conj	O
,	,	punct	O
DES	NN	conj	O
and	CC	cc	O
TAM	NN	conj	O
for	IN	case	O
type-II	JJ	amod	B-protein
EBS	NNS	nmod	I-protein
correlated	VBD	ROOT	O
well	RB	advmod	O
with	IN	case	O
their	PRP$	nmod:poss	O
potency	NN	nmod	O
as	IN	case	O
cell	NN	compound	O
growth	NN	compound	O
inhibitors	NNS	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
hesperidin	NN	nsubj	O
,	,	punct	O
a	DT	det	O
flavonoid	NN	appos	O
which	WDT	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
bind	VB	acl:relcl	O
to	TO	case	O
type-II	JJ	amod	B-protein
EBS	NNS	nmod	I-protein
,	,	punct	O
was	VBD	cop	O
ineffective	JJ	ROOT	O
in	IN	mark	O
inhibiting	VBG	advcl	O
cell	NN	compound	O
growth	NN	dobj	O
.	.	punct	O

Cell-cycle	JJ	amod	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
growth-inhibitory	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
DES	NN	nmod	O
,	,	punct	O
TAM	NN	conj	O
or	CC	cc	O
quercetin	NN	conj	O
was	VBD	cop	O
due	JJ	ccomp	O
to	TO	case	O
a	DT	det	O
blocking	NN	amod	O
effect	NN	nmod	O
in	IN	case	O
the	DT	det	O
G0-G1	JJ	compound	O
phases	NNS	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
high	JJ	amod	O
estrogen	NN	nsubj	O
and	CC	cc	O
anti-estrogen	JJ	conj	O
concentrations	NNS	dep	O
and	CC	cc	O
flavonoids	NNS	conj	O
may	MD	aux	O
regulate	VB	ccomp	O
IM-9	NN	compound	B-cell_line
cell	NN	compound	O
growth	NN	dobj	O
through	IN	case	O
a	DT	det	O
common	JJ	amod	O
mechanism	NN	nmod	O
involving	VBG	acl	O
a	DT	det	O
binding	VBG	amod	O
interaction	NN	dobj	O
with	IN	case	O
type-II	JJ	amod	B-protein
EBS	NNS	nmod	I-protein
.	.	punct	O

[	-LRB-	punct	O
Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
bronchial	JJ	amod	O
asthma	NN	nmod	O
]	-RRB-	punct	O

Quantitation	NN	nsubjpass	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
GCR	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
study	NN	conj	O
of	IN	case	O
their	PRP$	nmod:poss	O
affinity	NN	nmod	O
for	IN	case	O
glucocorticosteroids	NNS	nmod	O
(	-LRB-	punct	O
GCS	NNS	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
made	VBN	ROOT	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
of	IN	case	O
bronchial	JJ	amod	O
asthma	NN	compound	O
(	-LRB-	punct	O
BA	NN	appos	O
)	-RRB-	punct	O
patients	NNS	nmod	O
in	IN	case	O
consideration	NN	nmod	O
of	IN	case	O
GCR	NN	compound	B-protein
treatment	NN	nmod	O
and	CC	cc	O
serum	NN	compound	O
levels	NNS	conj	O
of	IN	case	O
endogenous	JJ	amod	O
cortisol	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
stated	VBN	ROOT	O
that	IN	mark	O
GCR	NN	nsubj	B-protein
of	IN	case	O
healthy	JJ	amod	O
controls	NNS	nmod	O
and	CC	cc	O
GCS-untreated	JJ	amod	O
patients	NNS	conj	O
outnumbered	VBD	ccomp	O
those	DT	dobj	O
of	IN	case	O
cortisol-dependent	JJ	amod	O
BA	NN	compound	O
patients	NNS	nmod	O
on	IN	case	O
hormone	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

Following	VBG	case	O
discontinuation	NN	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	O
drugs	NNS	compound	O
GCR	NN	compound	B-protein
count	NN	nmod	O
in	IN	case	O
cortisol-dependent	JJ	amod	O
BA	NN	nmod	O
tends	VBZ	ROOT	O
to	TO	mark	O
rise	VB	xcomp	O
.	.	punct	O

Endogenous	JJ	amod	O
cortisol	NN	nsubj	O
has	VBZ	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
GCR	NN	compound	B-protein
level	NN	nmod	O
estimated	VBN	acl	O
by	IN	case	O
3H-triamcinolone	NN	compound	O
acetonide	NN	nmod	O
.	.	punct	O

Two	CD	nummod	O
glucocorticoid	NN	compound	B-protein
binding	NN	compound	I-protein
sites	NNS	ROOT	I-protein
on	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Glucocorticoids	NNS	nsubjpass	O
are	VBP	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
a	DT	det	O
lytic	JJ	amod	O
effect	NN	dobj	O
in	IN	case	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
via	IN	case	O
interactions	NNS	nmod	O
with	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Cortisol	NN	nsubj	O
and	CC	cc	O
various	JJ	amod	O
synthetic	JJ	amod	O
glucocorticoids	NNS	conj	O
bind	VBP	ROOT	O
to	TO	case	O
the	DT	det	O
GR	NN	nmod	B-protein
with	IN	case	O
one-site	JJ	amod	O
kinetics	NNS	nmod	O
.	.	punct	O

Cortivazol	NN	nsubj	O
(	-LRB-	punct	O
CVZ	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
unique	JJ	amod	O
,	,	punct	O
high	JJ	amod	O
potency	NN	compound	O
synthetic	JJ	amod	O
glucocorticoid	NN	ROOT	O
,	,	punct	O
which	WDT	nsubj	O
has	VBZ	acl:relcl	O
a	DT	det	O
phenylpyrazol	JJ	dobj	O
fused	VBN	acl	O
to	TO	case	O
the	DT	det	O
A-ring	NN	nmod	O
of	IN	case	O
the	DT	det	O
steroid	NN	compound	O
nucleus	NN	nmod	O
and	CC	cc	O
displays	VBZ	conj	O
binding	NN	dobj	O
consistent	JJ	amod	O
with	IN	case	O
two	CD	nummod	O
or	CC	cc	O
more	JJR	conj	O
sites	NNS	nmod	O
in	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
from	IN	case	O
CEM	NN	compound	B-cell_line
C7	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
a	DT	det	O
human	JJ	amod	B-cell_line
acute	JJ	amod	I-cell_line
lymphoblastic	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
lower	JJR	amod	O
affinity	NN	compound	O
class	NN	nsubj	O
of	IN	case	O
sites	NNS	nmod	O
are	VBP	cop	O
similar	JJ	ccomp	O
in	IN	case	O
affinity	NN	nmod	O
and	CC	cc	O
site	NN	compound	O
molarity	NN	conj	O
to	TO	case	O
those	DT	nmod	O
recognized	VBN	acl	O
by	IN	case	O
dexamethasone	NN	nmod	O
.	.	punct	O

The	DT	det	O
higher	JJR	amod	O
affinity	NN	compound	O
sites	NNS	nsubj	O
bind	VBP	ROOT	O
CVZ	NN	dobj	O
with	IN	case	O
20-	CD	nmod:npmod	O
to	TO	dep	O
50-fold	RB	advmod	O
greater	JJR	amod	O
affinity	NN	nmod	O
,	,	punct	O
consistent	JJ	advcl	O
with	IN	case	O
CVZ	NN	nmod:poss	O
's	POS	case	O
enhanced	VBN	amod	O
biological	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

In	IN	case	O
mutant	JJ	amod	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
resistant	JJ	amod	O
to	TO	case	O
the	DT	det	O
lytic	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
,	,	punct	O
CVZ	NN	nsubj	O
both	CC	cc:preconj	O
lyses	VBZ	ROOT	O
the	DT	det	O
cells	NNS	dobj	O
and	CC	cc	O
recognizes	VBZ	conj	O
a	DT	det	O
single	JJ	amod	O
class	NN	dobj	O
of	IN	case	O
sites	NNS	nmod	O
similar	JJ	amod	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
affinity	NN	compound	O
site	NN	nmod	O
in	IN	case	O
CEM	NN	compound	B-cell_line
C7	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
carried	VBN	ROOT	O
out	RP	prt	O
experiments	NNS	dobj	O
to	TO	mark	O
define	VB	xcomp	O
the	DT	det	O
nature	NN	dobj	O
of	IN	case	O
the	DT	det	O
higher	JJR	amod	B-protein
affinity	NN	compound	I-protein
CVZ	NN	compound	I-protein
binding	NN	compound	I-protein
site	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
:	:	punct	O
1	LS	dep	O
)	-RRB-	punct	O
CVZ	NN	nsubj	O
has	VBZ	ccomp	O
more	JJR	advmod	O
than	IN	mwe	O
one	CD	nummod	O
binding	VBG	amod	O
site	NN	dobj	O
in	IN	case	O
a	DT	det	O
second	JJ	amod	O
,	,	punct	O
independent	JJ	dep	O
,	,	punct	O
B-cell	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
IM-9	NN	appos	B-cell_line
;	:	punct	O
2	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
antiglucocorticoid	JJ	amod	O
RU	NN	nsubj	O
38486	CD	nummod	O
is	VBZ	cop	O
able	JJ	conj	O
to	TO	mark	O
block	VB	xcomp	O
both	CC	cc:preconj	O
CVZ	NN	nmod:poss	O
's	POS	case	O
higher	JJR	amod	O
and	CC	cc	O
lower	JJR	conj	O
affinity	NN	compound	O
sites	NNS	dobj	O
;	:	punct	O
3	LS	dep	O
)	-RRB-	punct	O
all	DT	nsubj	O
of	IN	case	O
CVZ	NN	nmod:poss	B-protein
's	POS	case	I-protein
binding	VBG	amod	I-protein
sites	NNS	nmod	I-protein
are	VBP	cop	O
on	IN	case	O
a	DT	det	O
protein	NN	parataxis	O
immunologically	RB	advmod	O
indistinguishable	JJ	amod	O
from	IN	case	O
the	DT	det	O
human	JJ	amod	O
GR	NN	nmod	B-protein
;	:	punct	O
and	CC	cc	O
4	LS	conj	O
)	-RRB-	punct	O
freshly	RB	advmod	O
isolated	VBN	amod	O
clones	NNS	nsubj	O
of	IN	case	O
CVZ-resistant	JJ	amod	O
cells	NNS	nmod	O
have	VBP	aux	O
lost	VBN	conj	O
all	DT	det	O
binding	VBG	amod	O
sites	NNS	dobj	O
for	IN	case	O
CVZ	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
CVZ	NN	nsubj	O
is	VBZ	aux	O
recognizing	VBG	ccomp	O
two	CD	nummod	O
glucocorticoid	NN	compound	B-protein
binding	NN	compound	I-protein
sites	NNS	dobj	I-protein
on	IN	case	O
the	DT	det	O
human	JJ	amod	O
GR	NN	nmod	B-protein
or	CC	cc	O
a	DT	det	O
protein	NN	conj	O
very	RB	advmod	O
similar	JJ	amod	O
to	IN	case	O
it	PRP	nmod	O
.	.	punct	O

Retroviral	JJ	amod	O
mediated	VBN	amod	O
transfer	NN	ROOT	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
exogenous	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
primary	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
assaying	VBG	acl	O
for	IN	case	O
a	DT	det	O
viral	JJ	amod	O
transactivator	NN	compound	B-protein
activity	NN	nmod	O
in	IN	case	O
normal	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
malignant	JJ	conj	I-cell_type
cells	NNS	dep	I-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
the	DT	det	O
use	NN	dobj	O
of	IN	case	O
recombinant	JJ	amod	O
retroviruses	NNS	nmod	O
to	TO	mark	O
characterize	VB	acl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
an	DT	det	O
exogenous	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
primary	JJ	amod	O
cells	NNS	nmod	O
obtained	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
lymphoproliferative	JJ	amod	O
disorders	NNS	nmod	O
.	.	punct	O

The	DT	det	O
infection	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cultured	VBN	amod	O
and	CC	cc	O
primary	JJ	conj	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
a	DT	det	O
recombinant	JJ	amod	O
retrovirus	NN	nmod	O
containing	VBG	acl	O
a	DT	det	O
histone	NN	compound	B-DNA
promoter-driven	JJ	amod	I-DNA
beta-galactosidase	NN	compound	I-DNA
gene	NN	dobj	I-DNA
is	VBZ	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
result	VB	xcomp	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
beta-galactosidase	NN	nmod	B-protein
in	IN	case	O
50	CD	nummod	O
%	NN	nmod	O
to	TO	dep	O
100	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
infection	NN	nsubj	O
with	IN	case	O
a	DT	det	O
recombinant	JJ	amod	O
retrovirus	NN	nmod	O
containing	VBG	acl	O
the	DT	det	O
beta-galactosidase	NN	compound	B-DNA
gene	NN	dobj	I-DNA
with	IN	case	O
an	DT	det	O
adenovirus	NN	compound	B-DNA
E2	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
results	VBZ	ROOT	O
in	IN	case	O
beta-galactosidase	NN	compound	B-protein
activity	NN	nmod	O
in	IN	case	O
a	DT	det	O
limited	JJ	amod	O
number	NN	nmod	O
of	IN	case	O
cultured	VBN	amod	B-cell_line
and	CC	cc	O
primary	JJ	conj	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
adenovirus	NN	compound	B-DNA
E2	NN	compound	I-DNA
promoter	NN	nsubjpass	I-DNA
has	VBZ	aux	O
been	VBN	auxpass	O
well	RB	advmod	O
characterized	VBN	advcl	O
and	CC	cc	O
is	VBZ	auxpass	O
known	VBN	conj	O
to	TO	mark	O
be	VB	auxpass	O
regulated	VBN	xcomp	O
by	IN	case	O
transactivators	NNS	nmod	B-protein
encoded	VBN	acl	O
by	IN	case	O
many	JJ	amod	O
viruses	NNS	nmod	O
,	,	punct	O
the	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
promoter	NN	nmod	O
in	IN	case	O
specific	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
is	VBZ	auxpass	O
discussed	VBN	ROOT	O
in	IN	case	O
reference	NN	dep	O
to	TO	case	O
both	CC	cc:preconj	O
the	DT	det	O
biology	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	nmod	O
and	CC	cc	O
the	DT	det	O
possible	JJ	amod	O
presence	NN	conj	O
of	IN	case	O
as	RB	advmod	O
yet	RB	advmod	O
undetected	JJ	amod	O
viral	JJ	amod	B-protein
gene	NN	compound	I-protein
products	NNS	nmod	I-protein
.	.	punct	O

[	-LRB-	punct	O
The	DT	det	O
effect	NN	ROOT	O
of	IN	case	O
24	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
(	-LRB-	punct	O
dioxyvit	NN	appos	O
)	-RRB-	punct	O
on	IN	case	O
Ca	NN	compound	O
metabolism	NN	nmod	O
and	CC	cc	O
immune	JJ	amod	O
status	NN	conj	O
during	IN	case	O
chronic	JJ	amod	O
kidney	NN	compound	O
failure	NN	nmod	O
]	-RRB-	punct	O

Active	JJ	amod	O
metabolite	NN	nsubjpass	O
of	IN	case	O
vitamin	NN	compound	O
D3	NN	nmod	O
,	,	punct	O
24R	NN	conj	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	appos	O
(	-LRB-	punct	O
dioxyvit	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
used	VBN	ROOT	O
at	IN	case	O
a	DT	det	O
daily	JJ	amod	O
dose	NN	nmod	O
of	IN	case	O
100	CD	nummod	O
micrograms	NNS	nmod	O
in	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
children	NNS	nmod	O
affected	VBN	acl	O
with	IN	case	O
tubulointerstitial	JJ	compound	O
disease	NN	nmod	O
of	IN	case	O
kidney	NN	nmod	O
and	CC	cc	O
with	IN	case	O
chronic	JJ	amod	O
glomerulonephritis	NN	conj	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
kidney	NN	compound	O
insufficiency	NN	nmod	O
.	.	punct	O

The	DT	det	O
drug	NN	nsubj	O
exhibited	VBD	ROOT	O
distinct	JJ	amod	O
normalizing	NN	amod	O
effect	NN	dobj	O
on	IN	case	O
patterns	NNS	nmod	O
of	IN	case	O
calcium	NN	compound	O
metabolism	NN	nmod	O
:	:	punct	O
increase	NN	dep	O
of	IN	case	O
total	JJ	nmod	O
and	CC	cc	O
ionized	VBN	conj	O
Ca2+	NN	dep	O
and	CC	cc	O
of	IN	case	O
25-OHD	NN	conj	O
,	,	punct	O
decrease	NN	advcl	O
in	IN	case	O
concentration	NN	nmod	O
of	IN	case	O
parath	NN	compound	O
hormone	NN	nmod	O
and	CC	cc	O
osteocalcine	NN	conj	O
in	IN	case	O
blood	NN	compound	O
serum	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
on	IN	case	O
immunological	JJ	amod	O
parameters	NNS	conj	O
:	:	punct	O
restoration	NN	dep	O
of	IN	case	O
decreased	VBN	amod	O
content	NN	nmod	O
of	IN	case	O
T-	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
0-lymphocytes	NNS	conj	I-cell_type
.	.	punct	O

Concentration	NN	nsubjpass	O
of	IN	case	O
receptors	NNS	nmod	O
of	IN	case	O
hormonal	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
minimal	JJ	xcomp	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
chronic	JJ	amod	O
kidney	NN	compound	O
insufficiency	NN	nmod	O
,	,	punct	O
while	IN	mark	O
their	PRP$	nmod:poss	O
expression	NN	nsubjpass	O
,	,	punct	O
after	IN	case	O
the	DT	det	O
dioxyvit	NN	compound	O
action	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	advcl	O
only	RB	advmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
glomerulonephritis	NN	nmod	O
.	.	punct	O

Specific	JJ	amod	O
calcitropic	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
dioxyvit	NN	nmod	O
with	IN	case	O
simultaneous	JJ	amod	O
correction	NN	nmod	O
of	IN	case	O
vitamin	NN	compound	O
D	NN	compound	O
deficiency	NN	nmod	O
were	VBD	cop	O
apparently	RB	advmod	O
responsible	JJ	ROOT	O
for	IN	case	O
high	JJ	amod	O
efficacy	NN	nmod	O
of	IN	case	O
the	DT	det	O
drug	NN	nmod	O
in	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
calcium	NN	compound	O
metabolism	NN	nmod	O
and	CC	cc	O
immunity	NN	compound	O
impairments	NNS	conj	O
in	IN	case	O
children	NNS	nmod	O
with	IN	case	O
renal	JJ	amod	O
deteriorations	NNS	nmod	O
at	IN	case	O
the	DT	det	O
step	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	O
kidney	NN	compound	O
insufficiency	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
HLA	NN	compound	B-protein
antigens	NNS	conj	I-protein
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
Cushing	NN	nmod:poss	O
's	POS	case	O
syndrome	NN	nmod	O
]	-RRB-	punct	O

Lymphocytic	JJ	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
in	IN	case	O
114	CD	nummod	O
patients	NNS	nmod	O
suffering	VBG	acl	O
from	IN	case	O
Icenko-Cushing	NN	nmod:poss	O
's	POS	case	O
syndrome	NN	nmod	O
.	.	punct	O

Incidence	NN	nsubjpass	O
of	IN	case	O
HLA	NN	compound	B-protein
antigens	NNS	nmod	I-protein
was	VBD	auxpass	O
determined	VBN	ROOT	O
in	IN	case	O
94	CD	nmod	O
of	IN	case	O
them	PRP	nmod	O
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
rise	NN	nsubj	O
of	IN	case	O
A10	NN	nmod	B-protein
and	CC	cc	O
B27	NN	conj	B-protein
antigen	NN	compound	I-protein
incidence	NN	dep	O
compared	VBN	case	O
to	TO	case	O
that	DT	nmod	O
in	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
allows	VBZ	ROOT	O
these	DT	det	O
antigens	NNS	nsubjpass	O
to	TO	mark	O
be	VB	auxpass	O
considered	VBN	ccomp	O
genetic	JJ	amod	O
markers	NNS	dobj	O
of	IN	case	O
Icenko-Cushing	NN	nmod:poss	O
's	POS	case	O
syndrome	NN	nmod	O
.	.	punct	O

The	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
are	VBP	cop	O
lower	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
both	CC	cc:preconj	O
in	IN	case	O
the	DT	det	O
active	JJ	amod	O
stage	NN	nmod	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
and	CC	cc	O
following	VBG	case	O
bilateral	JJ	amod	O
total	JJ	amod	O
adrenalectomy	NN	conj	O
.	.	punct	O

The	DT	det	O
patients	NNS	nsubj	O
carrying	VBG	acl	O
B27	NN	compound	B-protein
antigen	NN	dobj	I-protein
had	VBD	ROOT	O
lymphocytic	JJ	amod	O
receptor	NN	compound	O
concentrations	NNS	dobj	O
under	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
such	JJ	nmod	O
in	IN	case	O
patients	NNS	nmod	O
free	JJ	amod	O
of	IN	case	O
the	DT	det	O
antigen	NN	compound	O
carriage	NN	nmod	O
.	.	punct	O

Antigen	NN	compound	B-protein
B27	NN	nsubj	I-protein
seems	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
cause	NN	xcomp	O
of	IN	case	O
lower	JJR	amod	O
levels	NNS	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
blood	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
1	CD	compound	O
alpha	NN	compound	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
on	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
chronic	JJ	amod	I-cell_line
myelogenous	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
RWLeu-4	NN	dep	B-cell_line
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
1	CD	compound	O
alpha	NN	compound	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
(	-LRB-	punct	O
VD3	NN	appos	O
)	-RRB-	punct	O
on	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
,	,	punct	O
and	CC	cc	O
macromolecular	JJ	amod	O
synthesis	NN	conj	O
in	IN	case	O
the	DT	det	O
new	JJ	amod	O
Philadelphia	NN	nmod:npmod	B-cell_line
chromosome-positive	JJ	amod	I-cell_line
chronic	JJ	amod	I-cell_line
myelogenous	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
RWLeu-4	NN	appos	B-cell_line
,	,	punct	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

Binding	NN	ROOT	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
VD3	NN	nsubj	O
was	VBD	cop	O
saturable	JJ	nmod	O
,	,	punct	O
with	IN	case	O
approximately	RB	advmod	O
2000-3000	CD	nummod	O
sites/cell	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
half-maximal	JJ	amod	O
binding	NN	conj	O
occurring	VBG	acl	O
at	IN	case	O
0.21-0.33	CD	nummod	O
nM	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
RWLeu-4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
VD3	NN	nmod	O
induced	VBD	ROOT	O
24R-hydroxylase	NN	compound	B-protein
activity	NN	dobj	O
,	,	punct	O
a	DT	det	O
marker	NN	dobj	O
of	IN	case	O
vitamin	NN	compound	O
D3	NN	compound	O
responsiveness	NN	nmod	O
in	IN	case	O
many	JJ	amod	O
tissues	NNS	nmod	O
.	.	punct	O

Exposure	NN	nsubj	O
of	IN	case	O
RWLeu-4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
to	TO	case	O
VD3	NN	nmod	O
also	RB	advmod	O
inhibited	VBD	ROOT	O
proliferation	NN	dobj	O
and	CC	cc	O
DNA	NN	compound	O
synthesis	NN	conj	O
with	IN	case	O
a	DT	det	O
50	CD	compound	O
%	NN	amod	O
effective	JJ	amod	O
dose	NN	nmod	O
of	IN	case	O
3.5-10	CD	nummod	O
nM	NN	nmod	O
within	IN	case	O
72	CD	nummod	O
h	NN	nmod	O
;	:	punct	O
in	IN	case	O
addition	NN	nmod	O
,	,	punct	O
protein	NN	compound	O
and	CC	cc	O
RNA	NN	compound	O
synthesis	NN	nsubjpass	O
were	VBD	auxpass	O
inhibited	VBN	parataxis	O
by	IN	case	O
VD3	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Exposure	NN	nsubj	O
of	IN	case	O
RWLeu-4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
to	TO	case	O
5	CD	compound	O
nM	NN	amod	O
VD3	NN	nmod	O
for	IN	case	O
72	CD	nummod	O
h	NN	nmod	O
caused	VBD	ROOT	O
50	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
to	TO	mark	O
differentiate	VB	xcomp	O
into	IN	case	O
macrophage/monocyte	JJ	compound	B-cell_type
type	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
as	IN	mark	O
judged	VBN	advcl	O
by	IN	case	O
nitroblue	JJ	amod	O
tetrazolium	NN	compound	O
staining	NN	nmod	O
and	CC	cc	O
adherence	NN	conj	O
to	TO	case	O
plastic	NN	nmod	O
.	.	punct	O

Progressive	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
maturation-specific	JJ	amod	I-protein
antigens	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
monocyte/macrophage	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
RWLeu-4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
VD3	NN	nmod	O
for	IN	case	O
24	CD	compound	O
to	TO	dep	O
72	CD	nummod	O
h	NN	nmod	O
at	IN	case	O
doses	NNS	nmod	O
that	WDT	nsubj	O
inhibited	VBD	acl:relcl	O
cellular	JJ	amod	O
proliferation	NN	dobj	O
.	.	punct	O

c-myc	NN	compound	B-RNA
RNA	NN	nsubj	I-RNA
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
constitutively	RB	advmod	O
expressed	VBN	acl:relcl	O
in	IN	case	O
RWLeu-4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
increased	VBD	ROOT	O
after	IN	case	O
0.5	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
50	CD	compound	O
nM	NN	amod	O
VD3	NN	nmod	O
and	CC	cc	O
then	RB	advmod	O
rapidly	RB	advmod	O
decreased	VBD	conj	O
to	TO	case	O
barely	RB	advmod	O
detectable	JJ	amod	O
levels	NNS	nmod	O
after	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
tyrosine	NN	compound	O
kinase	NN	compound	O
activity	NN	nsubjpass	O
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
p210bcr-abl	NN	compound	B-protein
oncogene	NN	compound	I-protein
product	NN	nmod	I-protein
was	VBD	auxpass	O
decreased	VBN	ROOT	O
approximately	RB	advmod	O
50	CD	nummod	O
%	NN	dobj	O
by	IN	case	O
VD3	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Because	IN	case	O
of	IN	mwe	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
a	DT	det	O
functional	JJ	amod	O
receptor-effector	JJ	amod	O
system	NN	nmod	O
for	IN	case	O
VD3	NN	nmod	O
and	CC	cc	O
multiple	JJ	amod	O
biological	JJ	amod	O
responses	NNS	conj	O
to	TO	case	O
the	DT	det	O
hormone	NN	nmod	O
,	,	punct	O
these	DT	det	O
cells	NNS	nsubj	O
provide	VBP	ROOT	O
a	DT	det	O
unique	JJ	amod	O
model	NN	compound	O
system	NN	dobj	O
with	IN	case	O
which	WDT	nmod	O
to	TO	mark	O
probe	VB	acl:relcl	O
the	DT	det	O
specific	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
VD3	NN	nmod	O
on	IN	case	O
cell	NN	nmod	O
growth	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
in	IN	case	O
chronic	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

A	DT	det	O
new	JJ	amod	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
leucine	NN	compound	B-protein
zipper	NN	compound	I-protein
class	NN	nmod	I-protein
of	IN	case	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
HLA	NN	compound	B-DNA
DR	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Several	JJ	amod	O
mutants	NNS	nsubj	O
derived	VBN	acl	O
from	IN	case	O
transformed	VBN	amod	B-cell_line
human	JJ	amod	I-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
are	VBP	cop	O
defective	JJ	ROOT	O
in	IN	mark	O
expressing	VBG	advcl	O
major	JJ	amod	B-DNA
histocompatibility	NN	compound	I-DNA
complex	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
MHC	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
genes	NNS	dobj	I-DNA
.	.	punct	O

The	DT	det	O
failure	NN	nsubjpass	O
to	TO	mark	O
express	VB	acl	O
a	DT	det	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
gene	NN	dobj	I-DNA
in	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
one	CD	nummod	O
such	JJ	amod	O
mutant	JJ	amod	B-cell_line
line	NN	nmod	I-cell_line
has	VBZ	aux	O
been	VBN	auxpass	O
mapped	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
MHC	NN	compound	B-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
X	NN	compound	I-DNA
box	NN	nmod	I-DNA
,	,	punct	O
a	DT	det	O
conserved	VBN	amod	B-DNA
transcriptional	JJ	amod	I-DNA
element	NN	appos	I-DNA
in	IN	case	O
the	DT	det	O
promoter	NN	compound	B-DNA
region	NN	nmod	I-DNA
.	.	punct	O

A	DT	det	O
complementary	JJ	amod	B-DNA
DNA	NN	nsubjpass	I-DNA
encoding	VBG	acl	O
a	DT	det	O
DNA-binding	JJ	amod	B-protein
protein	NN	dobj	I-protein
(	-LRB-	punct	O
human	JJ	amod	B-protein
X	NN	compound	I-protein
box	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	dep	I-protein
,	,	punct	O
hXBP-1	NN	appos	B-protein
)	-RRB-	punct	O
whose	WP$	nmod:poss	O
target	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
human	JJ	amod	B-DNA
DR	NN	compound	I-DNA
alpha	NN	compound	I-DNA
X	NN	compound	I-DNA
box	NN	dep	I-DNA
and	CC	cc	O
the	DT	det	O
3	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
region	NN	conj	I-DNA
has	VBZ	aux	O
now	RB	advmod	O
been	VBN	auxpass	O
cloned	VBN	ROOT	O
.	.	punct	O

This	DT	det	O
complementary	JJ	amod	B-DNA
DNA	NN	nsubj	I-DNA
encoded	VBD	ROOT	O
a	DT	det	O
protein	NN	dobj	O
with	IN	case	O
structural	JJ	amod	O
similarities	NNS	nmod	O
to	TO	case	O
the	DT	det	O
c-jun	NN	compound	B-protein
proto-oncogene	NN	compound	I-protein
product	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
target	NN	compound	O
sequence	NN	nsubj	O
was	VBD	cop	O
closely	RB	advmod	O
related	JJ	conj	O
to	TO	case	O
the	DT	det	O
palindromic	JJ	amod	B-DNA
target	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
of	IN	case	O
c-jun	NN	nmod	B-DNA
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hXBP-1	NN	compound	B-DNA
DNA	NN	compound	I-DNA
target	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
decreased	VBD	ROOT	O
DR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
hXBP-1	NN	compound	B-protein
protein	NN	nsubj	I-protein
acts	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Pseudohypoaldosteronism	NN	ROOT	O
in	IN	case	O
eight	CD	nummod	O
families	NNS	nmod	O
:	:	punct	O
different	JJ	amod	O
forms	NNS	nsubj	O
of	IN	case	O
inheritance	NN	nmod	O
are	VBP	cop	O
evidence	NN	dep	O
for	IN	case	O
various	JJ	amod	O
genetic	JJ	amod	O
defects	NNS	nmod	O
.	.	punct	O

Pseudohypoaldosteronism	NN	nsubj	O
is	VBZ	ROOT	O
a	DT	det	O
rare	JJ	amod	O
hereditary	JJ	amod	O
disorder	NN	attr	O
presenting	VBG	acl	O
in	IN	case	O
early	JJ	amod	O
infancy	NN	nmod	O
with	IN	case	O
renal	JJ	amod	O
salt	NN	compound	O
loss	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
hyponatremia	NN	nmod	O
and	CC	cc	O
hyperkalemia	NN	conj	O
despite	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
plasma	NN	compound	O
aldosterone	NN	nmod	O
.	.	punct	O

The	DT	det	O
patients	NNS	nsubj	O
are	VBP	cop	O
insensitive	JJ	ROOT	O
to	TO	case	O
mineralocorticoids	NNS	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
sodium	NN	compound	O
supplementation	NN	nsubj	O
is	VBZ	cop	O
able	JJ	parataxis	O
to	TO	mark	O
correct	VB	xcomp	O
electrolyte	NN	compound	O
abnormalities	NNS	dobj	O
.	.	punct	O

Absent	JJ	nsubjpass	O
or	CC	cc	O
greatly	RB	advmod	O
diminished	VBN	conj	O
type	NN	compound	O
I	CD	nummod	B-protein
aldosterone	NN	compound	I-protein
receptors	NNS	dep	I-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leucocytes	NNS	nmod	I-cell_type
have	VBP	aux	O
been	VBN	auxpass	O
recently	RB	advmod	O
demonstrated	VBN	ROOT	O
and	CC	cc	O
explain	VB	conj	O
the	DT	det	O
lack	NN	dobj	O
of	IN	case	O
response	NN	nmod	O
to	TO	case	O
mineralocorticoids	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
the	DT	det	O
mode	NN	dobj	O
of	IN	case	O
inheritance	NN	nmod	O
in	IN	case	O
eight	CD	nummod	O
families	NNS	nmod	O
with	IN	case	O
a	DT	det	O
total	NN	nmod	O
of	IN	case	O
nine	CD	nummod	O
patients	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
evidence	NN	nsubj	O
for	IN	case	O
an	DT	det	O
autosomal	JJ	amod	O
recessive	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
inheritance	NN	nmod	O
in	IN	case	O
four	CD	nummod	O
families	NNS	nmod	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
other	JJ	amod	O
four	CD	nummod	O
families	NNS	nsubj	O
appeared	VBD	advcl	O
to	TO	mark	O
have	VB	xcomp	O
an	DT	det	O
autosomal	JJ	amod	O
dominant	JJ	amod	O
mode	NN	dobj	O
of	IN	case	O
transmission	NN	nmod	O
.	.	punct	O

In	IN	case	O
three	CD	nummod	O
families	NNS	nmod	O
the	DT	det	O
autosomal	JJ	amod	O
recessive	JJ	amod	O
form	NN	nsubjpass	O
was	VBD	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
normal	JJ	amod	B-protein
receptor	NN	nmod	I-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
hormone	NN	compound	O
data	NNS	conj	O
in	IN	case	O
both	DT	det	O
parents	NNS	nmod	O
,	,	punct	O
while	IN	mark	O
in	IN	case	O
one	CD	nummod	O
family	NN	compound	O
receptor	NN	compound	O
levels	NNS	nsubjpass	O
in	IN	case	O
both	DT	det	O
parents	NNS	nmod	O
were	VBD	auxpass	O
greatly	RB	advmod	O
reduced	VBN	advcl	O
,	,	punct	O
but	CC	cc	O
hormone	NN	compound	O
levels	NNS	nsubj	O
were	VBD	cop	O
normal	JJ	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
four	CD	nummod	O
families	NNS	nmod	O
with	IN	case	O
an	DT	det	O
autosomal	JJ	amod	O
dominant	JJ	amod	O
mode	NN	nmod	O
of	IN	case	O
transmission	NN	nmod	O
there	EX	expl	O
was	VBD	cop	O
always	RB	advmod	O
one	CD	nummod	O
parent	NN	ROOT	O
with	IN	case	O
reduced	VBN	amod	O
receptor	NN	compound	O
binding	NN	nmod	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leucocytes	NNS	nmod	I-cell_type
and	CC	cc	O
elevated	JJ	amod	O
serum	NN	compound	O
hormone	NN	compound	O
levels	NNS	conj	O
.	.	punct	O

These	DT	det	O
parents	NNS	nsubj	O
were	VBD	ROOT	O
entirely	RB	advmod	O
asymptomatic	JJ	acomp	O
.	.	punct	O

In	IN	case	O
an	DT	det	O
extended	VBN	amod	O
family	NN	nmod	O
we	PRP	nsubj	O
were	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
an	DT	det	O
aunt	NN	dobj	O
and	CC	cc	O
her	PRP$	nmod:poss	O
newborn	JJ	amod	O
daughter	NN	conj	O
,	,	punct	O
who	WP	nsubjpass	O
were	VBD	auxpass	O
both	DT	cc:preconj	O
also	RB	advmod	O
biochemically	RB	advmod	O
affected	VBN	acl:relcl	O
but	CC	cc	O
clinically	RB	advmod	O
asymptomatic	JJ	conj	O
.	.	punct	O

It	PRP	nsubj	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
appears	VBZ	ROOT	O
that	IN	mark	O
this	DT	det	O
dual	JJ	amod	O
pattern	NN	nsubj	O
of	IN	case	O
genetic	JJ	amod	O
transmission	NN	nmod	O
may	MD	aux	O
indicate	VB	ccomp	O
differing	VBG	amod	O
genetic	JJ	amod	O
defects	NNS	dobj	O
which	WDT	nsubj	O
cause	VBP	acl:relcl	O
the	DT	det	O
same	JJ	amod	O
clinical	JJ	amod	O
picture	NN	dobj	O
of	IN	case	O
pseudohypoaldosteronism	NN	nmod	O
.	.	punct	O

Perceived	VBN	amod	O
social	JJ	amod	O
support	NN	ROOT	O
and	CC	cc	O
tumor	NN	compound	O
estrogen/progesterone	NN	compound	B-protein
receptor	NN	compound	I-protein
status	NN	conj	O
as	IN	case	O
predictors	NNS	nmod	O
of	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
activity	NN	nmod	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

This	DT	det	O
report	NN	nsubjpass	O
is	VBZ	auxpass	O
concerned	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
prediction	NN	nmod	O
of	IN	case	O
natural	JJ	amod	O
killer	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
NK	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cell	NN	compound	I-cell_type
activity	NN	nmod	O
in	IN	case	O
61	CD	nummod	O
Stage	NN	compound	O
I	CD	dep	O
and	CC	cc	O
II	CD	conj	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
,	,	punct	O
between	IN	case	O
the	DT	det	O
ages	NNS	nmod	O
of	IN	case	O
25	CD	nmod	O
and	CC	cc	O
70	CD	conj	O
,	,	punct	O
who	WP	nsubjpass	O
were	VBD	auxpass	O
accrued	VBN	acl:relcl	O
to	TO	case	O
this	DT	det	O
project	NN	nmod	O
.	.	punct	O

All	DT	dep	O
baseline	NN	compound	O
interview	NN	nsubjpass	O
and	CC	cc	O
testing	NN	compound	O
data	NNS	conj	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
either	CC	cc:preconj	O
just	RB	advmod	O
before	IN	case	O
patients	NNS	nsubjpass	O
were	VBD	auxpass	O
discharged	VBN	advcl	O
from	IN	case	O
the	DT	det	O
hospital	NN	nmod	O
,	,	punct	O
or	CC	cc	O
at	IN	case	O
their	PRP$	nmod:poss	O
first	JJ	amod	O
outpatient	JJ	amod	O
visit	NN	conj	O
,	,	punct	O
within	IN	case	O
two	CD	nummod	O
weeks	NNS	nmod	O
of	IN	prep	O
discharge	NN	pobj	O
.	.	punct	O

A	DT	det	O
major	JJ	amod	O
interest	NN	nsubj	O
of	IN	case	O
this	DT	det	O
project	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
predictive	JJ	amod	O
value	NN	ROOT	O
of	IN	case	O
perceived	VBN	amod	O
social	JJ	amod	O
support	NN	nmod	O
,	,	punct	O
as	IN	case	O
a	DT	det	O
potential	JJ	amod	O
``	``	punct	O
stress	NN	compound	O
''	''	punct	O
buffer	NN	nmod	O
,	,	punct	O
related	JJ	amod	O
to	TO	case	O
NK	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
main	JJ	amod	O
model	NN	nmod	O
reported	VBN	acl	O
here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
significant	JJ	amod	O
amount	NN	nsubjpass	O
of	IN	case	O
NK	NN	compound	O
activity	NN	compound	O
variance	NN	nmod	O
could	MD	aux	O
be	VB	auxpass	O
explained	VBN	ccomp	O
by	IN	case	O
five	CD	nummod	O
variables	NNS	nmod	O
.	.	punct	O

Higher	JJR	amod	O
NK	NN	compound	O
activity	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
predicted	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
perception	NN	nmod	O
of	IN	case	O
high	JJ	amod	O
quality	NN	compound	O
emotional	JJ	amod	O
support	NN	nmod	O
from	IN	case	O
a	DT	det	O
spouse	NN	nmod	O
or	CC	cc	O
intimate	JJ	amod	O
other	JJ	conj	O
,	,	punct	O
perceived	VBN	amod	O
social	JJ	amod	O
support	NN	conj	O
from	IN	case	O
the	DT	det	O
patient	NN	nmod:poss	O
's	POS	case	O
physician	NN	nmod	O
,	,	punct	O
estrogen	NN	nmod:npmod	B-protein
receptor	NN	nmod:npmod	I-protein
-negative	JJ	amod	O
tumor	NN	compound	O
status	NN	conj	O
,	,	punct	O
having	VBG	advcl	O
an	DT	det	O
excisional	JJ	amod	O
biopsy	NN	dobj	O
as	IN	case	O
surgical	JJ	amod	O
treatment	NN	nmod	O
,	,	punct	O
and	CC	cc	O
actively	RB	advmod	O
seeking	VBG	conj	O
social	JJ	amod	O
support	NN	dobj	O
as	IN	case	O
a	DT	det	O
major	JJ	amod	O
coping	NN	compound	O
strategy	NN	nmod	O
(	-LRB-	punct	O
R2	NN	dep	O
=	JJ	amod	O
0.33	CD	dobj	O
,	,	punct	O
F	NN	conj	O
(	-LRB-	punct	O
5	CD	nummod	O
,	,	punct	O
55	CD	appos	O
)	-RRB-	punct	O
=	JJ	amod	O
5.5	CD	dobj	O
,	,	punct	O
p	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.0004	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Findings	NNS	nsubjpass	O
are	VBP	auxpass	O
discussed	VBN	ROOT	O
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
host	NN	compound	O
interaction	NN	nmod	O
with	IN	case	O
tumor	NN	compound	O
endocrine	JJ	amod	O
status	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
role	NN	conj	O
that	WDT	mark	O
social	JJ	amod	O
support	NN	nsubj	O
might	MD	aux	O
play	VB	ccomp	O
in	IN	prep	O
modulating	VBG	pcomp	O
such	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

[	-LRB-	punct	O
Estrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	ROOT	O
of	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
systemic	JJ	amod	O
lupus	NN	compound	O
erythematosus	NN	nmod	O
]	-RRB-	punct	O

ER	NN	compound	O
content	NN	nsubjpass	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
of	IN	case	O
peripheral	JJ	amod	O
blood	NN	nmod	O
from	IN	case	O
27	CD	nummod	O
SLE	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
20	CD	nummod	O
healthy	JJ	amod	O
controls	NNS	conj	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
dextran-coated	JJ	amod	O
charcoal	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

ER	NN	compound	B-protein
content	NN	nsubjpass	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
of	IN	case	O
each	DT	det	O
sample	NN	nmod	O
was	VBD	auxpass	O
expressed	VBN	ROOT	O
by	IN	case	O
both	CC	cc:preconj	O
fmol/mg	NN	nmod	O
of	IN	case	O
lymphocyte	NN	compound	B-protein
cytosolic	JJ	amod	I-protein
protein	NN	nmod	I-protein
and	CC	cc	O
fmol/micrograms	NN	conj	O
of	IN	case	O
lymphocyte	NN	compound	B-DNA
DNA	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
there	EX	expl	O
was	VBD	ccomp	O
no	DT	neg	O
significant	JJ	amod	O
difference	NN	nsubj	O
between	IN	case	O
the	DT	det	O
ER	NN	compound	B-protein
content	NN	nmod	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
from	IN	case	O
the	DT	det	O
controls	NNS	nmod	O
and	CC	cc	O
that	IN	conj	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
SLE	NN	nmod	O
.	.	punct	O

But	CC	cc	O
the	DT	det	O
logarithmic	JJ	amod	O
mean	NN	nsubj	O
of	IN	case	O
ER	NN	compound	B-protein
content	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
,	,	punct	O
expressed	VBN	acl	O
by	IN	case	O
fmol/mg	NN	nmod	O
of	IN	case	O
cytosolic	JJ	amod	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
in	IN	case	O
14	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
active	JJ	amod	O
SLE	NN	nmod	O
(	-LRB-	punct	O
0.9356	CD	dep	O
+/-	CC	cc	O
0.31	CD	conj	O
)	-RRB-	punct	O
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
13	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
inactive	JJ	amod	O
SLE	NN	nmod	O
(	-LRB-	punct	O
0.2979	CD	dep	O
+/-	CC	cc	O
0.23	CD	conj	O
,	,	punct	O
P	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
controls	NNS	conj	O
(	-LRB-	punct	O
0.6204	CD	dep	O
+/-	CC	cc	O
0.52	CD	conj	O
,	,	punct	O
P	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
normal	JJ	amod	O
upper	JJ	amod	O
limit	NN	nsubj	O
of	IN	case	O
ER	NN	compound	B-protein
content	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
,	,	punct	O
expressed	VBN	acl	O
by	IN	case	O
fmol/micrograms	NN	nmod	O
of	IN	case	O
DNA	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
0.136	CD	ROOT	O
.	.	punct	O

The	DT	det	O
elevated	JJ	amod	O
rate	NN	nsubj	O
of	IN	case	O
ER	NN	compound	B-protein
content	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
in	IN	case	O
14	CD	nummod	O
active	JJ	amod	O
SLE	NN	nmod	O
(	-LRB-	punct	O
92.9	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
also	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
quieiescent	JJ	amod	O
patients	NNS	nmod	O
(	-LRB-	punct	O
23.1	CD	nummod	O
%	NN	dep	O
,	,	punct	O
P	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
controls	NNS	conj	O
(	-LRB-	punct	O
10	CD	nummod	O
%	NN	dep	O
,	,	punct	O
P	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
elevated	JJ	amod	O
level	NN	nsubjpass	O
of	IN	case	O
ER	NN	compound	B-protein
content	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
related	JJ	xcomp	O
to	TO	case	O
the	DT	det	O
positive	JJ	amod	O
antidsDNA	JJ	amod	B-protein
antibody	NN	nmod	I-protein
and	CC	cc	O
hypocomplementemia	NN	conj	O
.	.	punct	O

An	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
globin	NN	compound	B-DNA
gene	NN	compound	I-DNA
switching	NN	compound	O
model	NN	ROOT	O
based	VBN	case	O
on	IN	case	O
differentiated	VBN	amod	B-cell_type
embryonic	JJ	amod	I-cell_type
stem	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
used	VBD	ROOT	O
mouse	NN	compound	B-cell_type
embryonic	JJ	amod	I-cell_type
stem	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
ES	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	dobj	I-cell_type
to	TO	mark	O
study	VB	advcl	O
globin	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
and	CC	cc	O
switching	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
ES-derived	JJ	amod	B-cell_type
embryoid	JJ	amod	I-cell_type
bodies	NNS	nsubj	I-cell_type
express	VBP	ccomp	O
the	DT	det	O
full	JJ	amod	O
complement	NN	dobj	O
of	IN	case	O
mouse	NN	compound	B-DNA
embryonic	JJ	amod	I-DNA
globin	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
correct	JJ	amod	O
temporal	JJ	amod	O
order	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
on	IN	case	O
further	JJ	amod	O
differentiation	NN	nmod	O
,	,	punct	O
a	DT	det	O
switch	NN	nsubj	O
occurs	VBZ	conj	O
to	TO	case	O
the	DT	det	O
fetal/adult	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
erythroid-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
NF-E1	NN	nsubjpass	B-protein
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
expressed	VBN	xcomp	O
coordinately	RB	advmod	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
globin	NN	nmod	B-protein
in	IN	case	O
embryoid	JJ	amod	B-cell_type
bodies	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
from	IN	case	O
these	DT	det	O
experiments	NNS	nmod	O
that	WDT	mark	O
the	DT	det	O
ES	NN	compound	O
cell	NN	compound	O
system	NN	nsubj	O
provides	VBZ	ccomp	O
a	DT	det	O
good	JJ	amod	O
model	NN	dobj	O
to	TO	mark	O
study	VB	acl	O
hematopoietic	JJ	amod	O
development	NN	dobj	O
.	.	punct	O

When	WRB	advmod	O
the	DT	det	O
human	JJ	amod	B-DNA
epsilon-	NN	preconj	I-DNA
or	CC	cc	I-DNA
beta-globin	NN	conj	I-DNA
genes	NNS	nsubjpass	I-DNA
driven	VBN	acl	O
by	IN	case	O
the	DT	det	O
dominant	JJ	amod	B-DNA
control	NN	compound	I-DNA
region	NN	nmod	I-DNA
(	-LRB-	punct	O
DCR	NN	appos	B-DNA
)	-RRB-	punct	O
are	VBP	auxpass	O
introduced	VBN	advcl	O
into	IN	case	O
this	DT	det	O
system	NN	nmod	O
,	,	punct	O
the	DT	det	O
human	JJ	amod	B-DNA
epsilon-globin	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
beta-globin	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
is	VBZ	auxpass	O
not	RB	neg	O
deregulated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
the	DT	det	O
DCR	NN	nmod	B-DNA
and	CC	cc	O
is	VBZ	auxpass	O
expressed	VBN	conj	O
strictly	RB	advmod	O
as	IN	case	O
an	DT	det	O
embryonic	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
from	IN	case	O
this	DT	nmod	O
that	IN	mark	O
the	DT	det	O
epsilon-globin	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
not	RB	neg	O
regulated	VBN	ccomp	O
by	IN	case	O
competition	NN	nmod	O
with	IN	case	O
other	JJ	amod	O
genes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
beta-globin	NN	compound	I-DNA
locus	NN	nmod	I-DNA
.	.	punct	O

Cloning	NN	ROOT	O
of	IN	case	O
a	DT	det	O
mitogen-inducible	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
encoding	VBG	acl	O
a	DT	det	O
kappa	NN	compound	B-protein
B	NN	compound	I-protein
DNA-binding	JJ	amod	I-protein
protein	NN	dobj	I-protein
with	IN	case	O
homology	NN	nmod	O
to	TO	case	O
the	DT	det	O
rel	NN	compound	B-DNA
oncogene	NN	nmod	I-DNA
and	CC	cc	O
to	TO	case	O
cell-cycle	JJ	amod	B-DNA
motifs	NNS	conj	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
cloned	VBN	ROOT	O
and	CC	cc	O
characterized	VBN	conj	O
a	DT	det	O
mitogen-inducible	JJ	amod	B-DNA
gene	NN	dobj	I-DNA
isolated	VBN	acl	O
from	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubj	O
predicts	VBZ	acl:relcl	O
a	DT	det	O
protein	NN	dobj	O
of	IN	case	O
968	CD	nummod	B-protein
amino	NN	compound	I-protein
acids	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
amino-terminal	JJ	amod	B-protein
domain	NN	nsubj	I-protein
has	VBZ	ROOT	O
regions	NNS	dobj	O
homologous	JJ	amod	O
to	TO	case	O
the	DT	det	O
oncogene	NN	compound	B-DNA
rel	NN	nmod	I-DNA
and	CC	cc	O
to	TO	case	O
the	DT	det	O
developmentally	RB	advmod	O
important	JJ	amod	O
gene	NN	compound	O
dorsal	NN	conj	B-DNA
of	IN	case	O
Drosophila	FW	nmod	O
.	.	punct	O

The	DT	det	O
carboxy-terminal	JJ	amod	B-protein
domain	NN	nsubj	I-protein
contains	VBZ	ROOT	O
repeat	NN	compound	O
structures	NNS	dobj	O
found	VBN	acl	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
proteins	NNS	nmod	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
cell-cycle	JJ	amod	O
control	NN	nmod	O
of	IN	case	O
yeast	NN	nmod	O
and	CC	cc	O
in	IN	case	O
tissue	NN	compound	O
differentiation	NN	conj	O
in	IN	case	O
Drosophila	FW	nmod	O
and	CC	cc	O
Ceanorhabditis	FW	compound	O
elegans	FW	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
the	DT	det	O
putative	JJ	amod	B-DNA
human	JJ	amod	I-DNA
oncogene	NN	compound	I-DNA
bcl-3	NN	conj	I-DNA
and	CC	cc	O
in	IN	case	O
the	DT	det	O
ankyrin	NN	compound	B-protein
protein	NN	conj	I-protein
.	.	punct	O

A	DT	det	O
truncated	JJ	amod	O
form	NN	nsubj	O
of	IN	case	O
the	DT	det	O
product	NN	nmod	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
translated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
is	VBZ	cop	O
a	DT	det	O
DNA-binding	JJ	amod	B-protein
protein	NN	ROOT	I-protein
which	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
specifically	RB	advmod	O
with	IN	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
found	VBN	acl	O
in	IN	case	O
many	JJ	amod	O
inducible	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
including	VBG	case	O
the	DT	det	O
enhancer	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
.	.	punct	O

This	DT	det	O
gene	NN	nsubj	O
is	VBZ	ROOT	O
yet	RB	advmod	O
another	DT	attr	O
in	IN	case	O
a	DT	det	O
growing	VBG	amod	O
list	NN	nmod	O
of	IN	case	O
important	JJ	amod	O
regulatory	JJ	amod	O
molecules	NNS	nmod	O
whose	WP$	nmod:poss	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
transcriptionally	RB	advmod	O
induced	VBN	acl:relcl	O
upon	IN	case	O
cellular	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

Extrarenal	JJ	amod	O
receptor-effector-mechanisms	NNS	ROOT	O
for	IN	case	O
aldosterone	NN	nmod	O
:	:	punct	O
the	DT	det	O
sequence	NN	dep	O
of	IN	case	O
effects	NNS	nmod	O
on	IN	case	O
the	DT	det	O
cellular	JJ	amod	O
electrolyte	NN	compound	O
transport	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
their	PRP$	nmod:poss	O
implications	NNS	conj	O
for	IN	case	O
disorders	NNS	nmod	O
of	IN	case	O
the	DT	det	O
water	NN	nmod	O
and	CC	cc	O
electrolyte	NN	conj	O
balances	NNS	dep	O
.	.	punct	O

High	JJ	amod	O
affinity	NN	compound	O
aldosterone	NN	compound	O
binding	NN	compound	O
sites	NNS	nsubjpass	O
have	VBP	aux	O
not	RB	neg	O
only	RB	advmod	O
been	VBN	auxpass	O
described	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
classic	JJ	amod	O
target	NN	compound	O
tissues	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
renal	JJ	amod	O
tubules	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
in	IN	case	O
non-classic	JJ	amod	O
target	NN	compound	O
tissues	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
hippocampus	NN	nmod	O
,	,	punct	O
mammary	JJ	amod	O
gland	NN	conj	O
,	,	punct	O
endothelial	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
and	CC	cc	O
,	,	punct	O
recently	RB	advmod	O
,	,	punct	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	dobj	I-cell_type
.	.	punct	O

An	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
effect	NN	nsubjpass	O
of	IN	case	O
aldosterone	NN	nmod	O
on	IN	case	O
intracellular	JJ	amod	O
sodium	NN	nmod	O
,	,	punct	O
potassium	NN	conj	O
and	CC	cc	O
calcium	NN	conj	O
concentrations	NNS	dep	O
and	CC	cc	O
cell	NN	compound	O
volume	NN	conj	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
aldosterone	NN	nmod	O
,	,	punct	O
the	DT	det	O
intracellular	JJ	amod	O
Na+	NN	nsubj	O
,	,	punct	O
K+	NN	conj	O
and	CC	cc	O
Ca2+	NN	conj	O
concentrations	NNS	dep	O
and	CC	cc	O
the	DT	det	O
cell	NN	compound	O
volume	NN	conj	O
decreased	VBD	ROOT	O
significantly	RB	advmod	O
,	,	punct	O
but	CC	cc	O
remained	VBD	conj	O
constant	JJ	xcomp	O
when	WRB	advmod	O
aldosterone	NN	nsubjpass	O
(	-LRB-	punct	O
1.4	CD	nummod	O
nmol/l	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
added	VBN	advcl	O
to	TO	case	O
the	DT	det	O
incubation	NN	compound	O
medium	NN	nmod	O
.	.	punct	O

These	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
aldosterone	NN	nmod	O
were	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
aldosterone	NN	compound	O
antagonist	NN	compound	O
canrenone	NN	nmod	O
(	-LRB-	punct	O
140	CD	nummod	O
nmol/l	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
sodium/proton	JJ	amod	B-protein
exchanger	NN	nsubjpass	I-protein
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
membrane	NN	nmod	O
could	MD	aux	O
be	VB	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
primary	JJ	amod	O
target	NN	nmod	O
of	IN	case	O
the	DT	det	O
aldosterone	NN	compound	O
action	NN	nmod	O
,	,	punct	O
possibly	RB	advmod	O
non-genomically	RB	advmod	O
mediated	VBN	acl	O
through	IN	case	O
membrane	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
significance	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
model	NN	nmod	O
was	VBD	auxpass	O
underlined	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
demonstration	NN	nmod	O
of	IN	case	O
absent	JJ	nmod	O
or	CC	cc	O
a	DT	det	O
decreased	VBN	amod	O
number	NN	conj	O
of	IN	case	O
mineralocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
the	DT	det	O
lack	NN	conj	O
of	IN	case	O
electrolyte	NN	compound	O
response	NN	nmod	O
to	TO	case	O
aldosterone	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
pseudohypoaldosteronism	NN	nmod	O
and	CC	cc	O
aldosteronism	NN	conj	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
an	DT	det	O
abnormal	JJ	amod	O
effector	NN	compound	O
mechanism	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
demonstrated	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
from	IN	case	O
essential	JJ	amod	O
hypertensives	NNS	nmod	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
are	VBP	cop	O
the	DT	det	O
first	JJ	ROOT	O
to	TO	mark	O
demonstrate	VB	xcomp	O
the	DT	det	O
significance	NN	dobj	O
of	IN	case	O
extrarenal	JJ	amod	B-protein
,	,	punct	I-protein
nonepithelial	JJ	dep	I-protein
mineralocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
the	DT	det	O
related	JJ	amod	O
effector	NN	compound	O
mechanism	NN	conj	O
in	IN	case	O
different	JJ	amod	O
disorders	NNS	nmod	O
of	IN	case	O
the	DT	dep	O
water	NN	nmod	O
and	CC	cc	O
electrolyte	NN	conj	O
balance	NN	dep	O
in	IN	case	O
man	NN	nmod	O
.	.	punct	O

Immunohistochemical	JJ	amod	O
study	NN	ROOT	O
of	IN	case	O
steroid	NN	compound	O
hormones	NNS	nmod	O
and	CC	cc	O
an	DT	det	O
estrogen	NN	compound	O
binding	NN	compound	O
assay	NN	conj	O
in	IN	case	O
malignant	JJ	amod	B-cell_type
soft	JJ	amod	I-cell_type
tissue	NN	compound	I-cell_type
tumors	NNS	nmod	I-cell_type
.	.	punct	O

Immunohistochemically	RB	advmod	O
,	,	punct	O
the	DT	det	O
immunoreaction	NN	nsubjpass	O
against	IN	case	O
5	CD	nummod	O
steroid	NN	compound	O
hormone	NN	compound	O
anti-sera	NNS	nmod	O
(	-LRB-	punct	O
estradiol	NN	dep	O
,	,	punct	O
estriol	NN	conj	O
,	,	punct	O
cortisol	NN	conj	O
,	,	punct	O
progesterone	NN	conj	O
and	CC	cc	O
testosterone	NN	conj	O
)	-RRB-	punct	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
39	CD	nummod	O
cases	NNS	nmod	O
with	IN	case	O
the	DT	det	O
malignant	JJ	amod	B-cell_type
soft	JJ	amod	I-cell_type
tissue	NN	compound	I-cell_type
tumors	NNS	nmod	I-cell_type
(	-LRB-	punct	O
fibrosarcoma	NN	dep	O
:	:	punct	O
8	CD	dep	O
,	,	punct	O
malignant	JJ	amod	O
fibrous	JJ	amod	O
histiocytoma	NN	appos	O
:	:	punct	O
6	CD	dep	O
,	,	punct	O
rhabdomyosarcoma	NN	appos	O
:	:	punct	O
10	CD	dep	O
,	,	punct	O
leiomyosarcoma	NN	appos	O
:	:	punct	O
10	CD	dep	O
,	,	punct	O
liposarcoma	NN	appos	O
:	:	punct	O
5	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Seventeen	CD	nummod	O
cases	NNS	nsubj	O
revealed	VBD	ROOT	O
distinct	JJ	amod	O
immunostaining	NN	dobj	O
against	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
1	CD	nmod	O
of	IN	case	O
the	DT	det	O
5	CD	nummod	O
steroid	NN	compound	O
hormones	NNS	nmod	O
.	.	punct	O

Immunostained	VBN	amod	B-cell_type
tumor	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
more	RBR	advmod	O
frequently	RB	advmod	O
distributed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
area	NN	nmod	O
where	WRB	advmod	O
tumor	NN	compound	O
cell	NN	compound	O
infiltration	NN	nsubj	O
was	VBD	cop	O
more	RBR	advmod	O
invasive	JJ	acl:relcl	O
.	.	punct	O

The	DT	det	O
majority	NN	nsubj	O
of	IN	case	O
the	DT	det	O
positive	JJ	amod	O
cases	NNS	nmod	O
occurred	VBD	ROOT	O
in	IN	case	O
female	JJ	amod	O
cases	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
existence	NN	nsubjpass	O
of	IN	case	O
estrogen	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
estrogen	NN	compound	O
binding	NN	compound	O
activity	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
histochemically	RB	advmod	O
in	IN	case	O
39	CD	nummod	O
cases	NNS	nmod	O
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	conj	O
in	IN	case	O
8	CD	nmod	O
.	.	punct	O

We	PRP	nsubj	O
concluded	VBD	ROOT	O
that	IN	mark	O
steroid	NN	compound	O
hormones	NNS	nsubj	O
might	MD	aux	O
be	VB	cop	O
closely	RB	advmod	O
related	JJ	ccomp	O
to	TO	case	O
tumor	NN	compound	O
cell	NN	compound	O
infiltration	NN	nmod	O
of	IN	case	O
some	DT	det	O
malignant	JJ	amod	B-cell_type
soft	JJ	amod	I-cell_type
tissue	NN	compound	I-cell_type
tumors	NNS	nmod	I-cell_type
.	.	punct	O

Involvement	NN	ROOT	O
of	IN	case	O
cyclic	JJ	amod	B-protein
AMP-dependent	JJ	amod	I-protein
protein	NN	compound	I-protein
kinases	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nmod	O
for	IN	case	O
interleukin-1	NN	nmod	B-protein
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
a	DT	det	O
highly	RB	advmod	O
specific	JJ	amod	O
protein	NN	compound	O
inhibitor	NN	nmod	O
for	IN	case	O
cyclic	JJ	amod	B-protein
AMP-dependent	JJ	amod	I-protein
protein	NN	compound	I-protein
kinases	NNS	nmod	I-protein
in	IN	case	O
interleukin-1	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
IL-1	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
-responsive	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
blocked	VBD	ROOT	O
IL-1-induced	JJ	amod	B-DNA
gene	NN	compound	I-DNA
transcription	NN	dobj	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
driven	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
immunoglobulin	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
or	CC	cc	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	conj	I-DNA
.	.	punct	O

This	DT	det	O
inhibitor	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
protein	NN	nmod:npmod	B-protein
kinase	NN	nmod:npmod	I-protein
C	NN	nmod:npmod	I-protein
-mediated	JJ	amod	O
gene	NN	compound	O
transcription	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
cyclic	JJ	amod	B-protein
AMP-dependent	JJ	amod	I-protein
protein	NN	compound	I-protein
kinases	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nmod	O
for	IN	case	O
IL-1	NN	nmod	B-protein
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
responsive	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
types	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
Epstein-Barr	JJ	amod	B-DNA
virus	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
EBV	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
ORI1yt	NN	compound	I-DNA
enhancer	NN	nsubj	I-DNA
is	VBZ	cop	O
not	RB	neg	O
B-cell	NN	nmod:npmod	O
specific	JJ	ROOT	O
and	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
respond	VB	conj	O
synergistically	RB	advmod	O
to	TO	case	O
the	DT	det	O
EBV	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
R	NN	dep	I-protein
and	CC	cc	I-protein
Z	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
Epstein-Barr	JJ	amod	B-DNA
virus	NN	compound	I-DNA
DR	NN	compound	I-DNA
promoter	NN	nsubj	I-DNA
is	VBZ	cop	O
located	JJ	ROOT	O
upstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
PstI	NN	compound	B-DNA
repeats	NNS	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
in	IN	case	O
addition	NN	conj	O
to	TO	case	O
the	DT	det	O
TATA	NN	compound	B-DNA
box	NN	nmod	I-DNA
,	,	punct	O
it	PRP	nsubj	O
contains	VBZ	parataxis	O
an	DT	det	O
upstream	JJ	amod	B-DNA
region	NN	dobj	I-DNA
(	-LRB-	punct	O
positions	NNS	dep	O
-69	CD	compound	O
to	TO	dep	O
-220	CD	dep	O
)	-RRB-	punct	O
responsive	JJ	amod	O
to	TO	case	O
EB1	NN	nmod	B-protein
(	-LRB-	punct	I-protein
Z	NN	appos	I-protein
)	-RRB-	punct	I-protein
(	-LRB-	punct	O
the	DT	det	O
BZLF1-encoded	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	appos	I-protein
)	-RRB-	punct	O
and	CC	cc	O
an	DT	det	O
enhancer	NN	conj	B-DNA
with	IN	case	O
two	CD	nummod	O
functionally	RB	advmod	O
distinct	JJ	amod	O
domains	NNS	nmod	O
,	,	punct	O
A	NN	appos	O
and	CC	cc	O
B	NN	conj	B-DNA
.	.	punct	O

Domain	NN	compound	B-DNA
B	NN	nsubjpass	I-DNA
has	VBZ	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
B-cell-specific	JJ	amod	B-DNA
EB1-responsive	JJ	amod	I-DNA
element	NN	nmod	I-DNA
(	-LRB-	punct	O
P.M.Lieberman	NNP	dep	O
,	,	punct	O
J.M.Hardwick	NNP	conj	O
,	,	punct	O
and	CC	cc	O
S.D.Hayward	NNP	conj	O
,	,	punct	O
J.Virol.63	NNP	appos	O
:	:	punct	O
3040-3050	CD	dep	O
,	,	punct	O
1989	CD	amod	O
)	-RRB-	punct	O
activated	VBN	acl	O
synergistically	RB	advmod	O
by	IN	case	O
EB1	NN	nmod	B-protein
and	CC	cc	O
R	NN	conj	B-protein
,	,	punct	O
an	DT	det	O
EBV	NN	compound	B-protein
early	JJ	amod	I-protein
product	NN	appos	I-protein
encoded	VBN	acl	O
by	IN	case	O
the	DT	det	O
open	JJ	amod	B-DNA
reading	NN	compound	I-DNA
frame	NN	compound	I-DNA
BRLF1	NN	nmod	I-DNA
(	-LRB-	punct	O
M.A.	NNP	compound	O
Cox	NNP	dep	O
,	,	punct	O
J.Leahy	NNP	conj	O
,	,	punct	O
and	CC	cc	O
J.M.Hardwick	NNP	conj	O
,	,	punct	O
J.Virol.64	NNP	appos	O
:	:	punct	O
313-321	CD	dep	O
,	,	punct	O
1990	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
domain	NN	compound	B-DNA
B	NN	nsubj	I-DNA
is	VBZ	cop	O
an	DT	det	O
R-responsive	JJ	amod	B-DNA
element	NN	ccomp	I-DNA
in	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
is	VBZ	cop	O
therefore	RB	advmod	O
not	RB	neg	O
an	DT	det	O
EB1-responsive	JJ	amod	B-DNA
B-cell-specific	JJ	amod	I-DNA
element	NN	conj	I-DNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
an	DT	det	O
EB1-binding	JJ	amod	B-DNA
site	NN	nsubj	I-DNA
(	-LRB-	punct	O
ZRE-B	NN	appos	B-DNA
)	-RRB-	punct	O
located	JJ	amod	O
within	IN	case	O
the	DT	det	O
R-responsive	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
region	NN	nmod	I-DNA
.	.	punct	O

ZRE-B	NN	nsubjpass	B-DNA
can	MD	aux	O
be	VB	auxpass	O
deleted	VBN	ROOT	O
without	IN	mark	O
affecting	VBG	advcl	O
the	DT	det	O
R-dependent	JJ	amod	O
enhancer	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
no	DT	neg	O
cooperation	NN	nsubj	O
or	CC	cc	O
synergy	NN	conj	O
between	IN	case	O
R	NN	nmod	B-protein
and	CC	cc	O
EB1	NN	conj	B-protein
when	WRB	advmod	O
activating	VBG	advcl	O
the	DT	det	O
B	NN	compound	B-DNA
domain	NN	dobj	I-DNA
(	-LRB-	punct	O
ZRE-B	NN	dep	B-DNA
plus	CC	cc	O
the	DT	det	O
R-responsive	JJ	amod	B-DNA
element	NN	conj	I-DNA
)	-RRB-	punct	O
positioned	JJ	conj	O
as	IN	case	O
an	DT	det	O
enhancer	NN	nmod	B-DNA
.	.	punct	O

ZRE-B	NN	nsubj	B-DNA
is	VBZ	cop	O
therefore	RB	advmod	O
not	RB	neg	O
part	NN	ROOT	O
of	IN	case	O
the	DT	det	O
R-	NN	compound	B-DNA
inducible	JJ	amod	I-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
tested	VBN	ROOT	O
several	JJ	amod	O
subregions	NNS	dobj	O
of	IN	case	O
the	DT	det	O
DR	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
B	NN	compound	B-DNA
domain	NN	nmod	I-DNA
,	,	punct	O
either	CC	appos	O
alone	RB	advmod	O
or	CC	cc	O
in	IN	case	O
combination	NN	conj	O
,	,	punct	O
for	IN	case	O
their	PRP$	nmod:poss	O
capacity	NN	nmod	O
to	TO	mark	O
transmit	VB	acl	O
the	DT	det	O
R-activating	JJ	amod	O
signal	NN	dobj	O
to	TO	case	O
the	DT	det	O
rabbit	NN	compound	B-DNA
beta-globin	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
R-responsive	JJ	amod	B-DNA
element	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
composed	VBN	ccomp	O
of	IN	case	O
four	CD	nummod	O
protoenhancers	NNS	nmod	B-DNA
that	WDT	nsubj	O
span	VBP	acl:relcl	O
the	DT	det	O
whole	JJ	amod	O
B	NN	compound	B-DNA
domain	NN	dobj	I-DNA
.	.	punct	O

These	DT	det	O
protoenhancers	NNS	nsubj	B-DNA
alone	RB	advmod	O
are	VBP	cop	O
weakly	JJ	ROOT	O
or	CC	cc	O
not	RB	conj	O
responsive	JJ	conj	O
to	TO	case	O
R	NN	nmod	B-protein
.	.	punct	O

One	CD	nsubj	O
of	IN	prep	O
the	DT	det	O
protoenhancers	NNS	pobj	B-DNA
contains	VBZ	ROOT	O
the	DT	det	O
overlapping	VBG	amod	B-DNA
palindromes	NNS	dobj	I-DNA
5'-TTGTCCcgtGGACAAaTGTCC-3'	NN	dep	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
one	CD	nummod	O
palindrome	NN	nsubj	B-DNA
,	,	punct	O
either	CC	appos	O
alone	RB	advmod	O
or	CC	cc	O
duplicated	JJ	conj	O
,	,	punct	O
or	CC	cc	O
the	DT	det	O
overlapping	VBG	amod	B-DNA
palindromes	NNS	conj	I-DNA
did	VBD	aux	O
not	RB	neg	O
respond	VB	ROOT	O
to	TO	case	O
R	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	O
3	CD	nummod	B-protein
,	,	punct	I-protein
5	CD	conj	I-protein
,	,	punct	I-protein
3'-triiodothyronine	NN	amod	I-protein
receptors	NNS	ROOT	I-protein
(	-LRB-	punct	O
T3R	NN	appos	B-protein
)	-RRB-	punct	O
of	IN	case	O
circulating	VBG	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
hyper-	JJ	nmod	O
and	CC	cc	O
hypothyroidism	NN	conj	O
and	CC	cc	O
nonthyroidal	JJ	amod	O
diseases	NNS	conj	O
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
implications	NNS	nsubjpass	O
of	IN	case	O
nuclear	JJ	amod	O
T3R	NN	compound	B-protein
alterations	NNS	nmod	O
of	IN	case	O
circulating	VBG	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
hyperthyroidism	NN	nmod	O
,	,	punct	O
hypothyroidism	NN	conj	O
and	CC	cc	O
nonthyroidal	JJ	amod	O
diseases	NNS	conj	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

Nuclear	JJ	amod	O
T3R	NN	nsubjpass	B-protein
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
radio-ligand	JJ	amod	O
binding	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
in	IN	case	O
hyper-	JJ	nmod	O
and	CC	cc	O
hypothyroid	JJ	conj	O
patients	NNS	dep	O
the	DT	det	O
nuclear	JJ	amod	O
affinity	NN	nsubj	O
(	-LRB-	punct	O
Ka	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
T3	NN	nmod	O
was	VBD	cop	O
similar	JJ	ccomp	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
.	.	punct	O

In	IN	case	O
hyperthyroidism	NN	nmod	O
nuclear	JJ	amod	O
T3	NN	compound	O
maximal	JJ	amod	O
binding	NN	compound	O
capacity	NN	dobj	O
(	-LRB-	punct	O
MBC	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
unaltered	JJ	ROOT	O
,	,	punct	O
whereas	IN	dep	O
in	IN	case	O
hypothyroidism	NN	nmod	O
the	DT	det	O
MBC	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
increased	VBN	parataxis	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
diabetes	NN	compound	O
mellitus	NN	nmod	O
,	,	punct	O
chronic	JJ	amod	O
renal	JJ	amod	O
failure	NN	conj	O
and	CC	cc	O
hepatic	JJ	amod	O
cirrhosis	NN	conj	O
,	,	punct	O
the	DT	det	O
nuclear	JJ	amod	B-protein
T3R	NN	compound	I-protein
MBC	NN	nsubj	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
was	VBD	cop	O
about	RB	advmod	O
1.5-1.6	CD	compound	O
times	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
normal	JJ	amod	O
controls	NNS	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
there	EX	expl	O
existed	VBD	ccomp	O
hormonal	JJ	amod	O
regulation	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
T3R	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
up-regulation	NN	nsubjpass	O
was	VBD	auxpass	O
seen	VBN	conj	O
in	IN	case	O
hypothyroidism	NN	nmod	O
and	CC	cc	O
low	JJ	amod	O
T3	NN	compound	O
syndrome	NN	conj	O
.	.	punct	O

Lymphocyte	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubj	I-cell_line
from	IN	case	O
vitamin	NN	compound	O
D-dependent	JJ	amod	O
rickets	NN	compound	O
type	NN	nmod	O
II	CD	nummod	O
show	VBP	ROOT	O
functional	JJ	amod	O
defects	NNS	dobj	O
in	IN	case	O
the	DT	det	O
1	CD	compound	B-protein
alpha	NN	compound	I-protein
,	,	punct	I-protein
25-dihydroxyvitamin	NN	compound	I-protein
D3	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Lymphocyte	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
established	VBN	ROOT	O
from	IN	case	O
five	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
vitamin	NN	compound	O
D-dependent	JJ	amod	O
rickets	NN	nmod	O
,	,	punct	O
type	NN	appos	O
II	CD	nummod	O
(	-LRB-	punct	O
VDDR-II	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
lines	NNS	nsubjpass	O
were	VBD	auxpass	O
established	VBN	ROOT	O
by	IN	case	O
infection	NN	nmod	O
with	IN	case	O
human	JJ	amod	O
T-lymphotrophic	JJ	amod	O
virus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
(	-LRB-	punct	O
HTLV-I	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Binding	NN	nsubjpass	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
1	CD	nummod	O
alpha	NN	compound	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
(	-LRB-	punct	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	appos	O
)	-RRB-	punct	O
to	TO	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
in	IN	case	O
these	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
was	VBD	auxpass	O
compared	VBN	ROOT	O
to	TO	case	O
binding	NN	amod	O
studies	NNS	nmod	O
using	VBG	acl	O
a	DT	det	O
T-lymphocyte	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	dobj	I-cell_line
(	-LRB-	punct	O
S-LB1	NN	appos	B-cell_line
)	-RRB-	punct	O
from	IN	case	O
a	DT	det	O
normal	JJ	amod	O
individual	NN	nmod	O
.	.	punct	O

The	DT	det	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
receptor	NN	nsubj	O
of	IN	case	O
S-LB1	NN	nmod	B-cell_line
was	VBD	cop	O
comparable	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
well-characterized	JJ	amod	O
chick	NN	nmod:npmod	B-protein
intestinal	JJ	amod	I-protein
1	CD	nummod	I-protein
,	,	punct	I-protein
25	CD	nummod	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptor	NN	nmod	I-protein
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
ligand	NN	compound	O
binding	NN	compound	O
affinity	NN	nmod	O
and	CC	cc	O
capacity	NN	conj	O
,	,	punct	O
its	PRP$	nmod:poss	O
mobility	NN	conj	O
on	IN	case	O
5-20	CD	nummod	O
%	NN	amod	O
sucrose	NN	compound	O
gradients	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
adsorption	NN	conj	O
to	TO	dep	O
and	CC	cc	O
elution	NN	compound	O
properties	NNS	conj	O
from	IN	case	O
DNA-cellulose	NN	nmod	O
.	.	punct	O

Three	CD	nummod	O
cell	NN	compound	B-cell_line
lines	NNS	nsubj	I-cell_line
established	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
VDDR-II	NN	nmod	O
(	-LRB-	punct	O
Rh-	NN	compound	O
VDR	NN	dep	B-protein
,	,	punct	O
Sh-	NN	compound	O
VDR	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Ab-	NN	compound	O
VDR	NN	conj	B-protein
)	-RRB-	punct	O
showed	VBD	ROOT	O
no	DT	neg	O
specific	JJ	amod	O
binding	NN	dobj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	nmod	O
to	TO	case	O
a	DT	det	O
receptor	NN	nmod	B-protein
and	CC	cc	O
treatment	NN	conj	O
of	IN	case	O
the	DT	det	O
cultured	VBN	amod	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
stimulate	VB	conj	O
production	NN	dobj	O
of	IN	case	O
24	CD	nummod	O
,	,	punct	O
25-dihydroxy-vitamin	JJ	amod	O
D3	NN	nmod	O
(	-LRB-	punct	O
24	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
response	NN	appos	O
which	WDT	nsubj	O
is	VBZ	cop	O
diagnostic	JJ	acl:relcl	O
of	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
a	DT	det	O
functional	JJ	amod	B-protein
1	CD	dep	I-protein
,	,	punct	I-protein
25	CD	nummod	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
a	DT	det	O
fourth	JJ	amod	O
cell	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
A1-VDR	NN	nsubj	B-cell_line
,	,	punct	O
the	DT	det	O
receptor	NN	nsubj	O
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
had	VBD	ROOT	O
a	DT	det	O
low	JJ	amod	O
binding	NN	compound	O
capacity	NN	dobj	O
and	CC	cc	O
25	CD	nummod	B-protein
(	-LRB-	punct	I-protein
OH	NN	appos	I-protein
)	-RRB-	punct	I-protein
D3-24-hydroxylase	NN	compound	I-protein
activity	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
detectable	JJ	conj	O
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
24	CD	nummod	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
synthesis	NN	nmod	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
fifth	JJ	amod	O
cell	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
designated	VBN	acl	O
Ro-VDR	NN	xcomp	B-cell_line
,	,	punct	O
although	IN	mark	O
the	DT	det	O
sensitivity	NN	nsubj	O
to	TO	case	O
hormone	NN	compound	O
treatment	NN	nmod	O
was	VBD	cop	O
lower	JJR	advcl	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
control	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
from	IN	case	O
a	DT	det	O
normal	JJ	amod	O
donor	NN	nmod	O
.	.	punct	O

The	DT	det	O
capacity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	B-protein
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
was	VBD	cop	O
low	JJ	ROOT	O
in	IN	case	O
Ro-VDR	NN	nmod	B-cell_line
.	.	punct	O

In	IN	case	O
all	DT	det	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
where	WRB	advmod	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
binding	NN	nsubj	O
to	TO	case	O
a	DT	det	O
receptor	NN	nmod	B-protein
was	VBD	cop	O
detectable	JJ	ROOT	O
,	,	punct	O
the	DT	det	O
receptor	NN	nsubj	B-protein
had	VBD	parataxis	O
the	DT	det	O
typical	JJ	amod	O
sedimentation	NN	compound	O
coefficient	NN	dobj	O
of	IN	case	O
3.7	CD	nummod	O
S	NN	nmod	O
on	IN	case	O
sucrose	NN	compound	O
density	NN	compound	O
gradient	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Binding	NN	nsubjpass	O
and	CC	cc	O
elution	NN	conj	O
properties	NNS	dep	O
to	TO	case	O
DNA-cellulose	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
differed	VBD	ROOT	O
from	IN	case	O
normal	JJ	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
Ro-VDR	NN	nmod	B-cell_line
and	CC	cc	O
A1-VDR	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
where	WRB	advmod	O
elution	NN	nsubj	O
from	IN	case	O
DNA-cellulose	NN	nmod	O
occurred	VBD	ccomp	O
at	IN	case	O
a	DT	det	O
lower	JJR	amod	O
salt	NN	compound	O
concentration	NN	nmod	O
than	IN	mark	O
is	VBZ	cop	O
typical	JJ	advcl	O
of	IN	case	O
the	DT	det	O
1	CD	nummod	B-protein
,	,	punct	I-protein
25	CD	conj	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

While	IN	mark	O
Ro-VDR	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
showed	VBD	advcl	O
typical	JJ	amod	O
nuclear	JJ	amod	O
localization	NN	dobj	O
of	IN	case	O
the	DT	det	O
unoccupied	JJ	amod	B-protein
1	CD	dep	I-protein
,	,	punct	I-protein
25	CD	nummod	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptor	NN	nmod	I-protein
,	,	punct	O
neither	CC	cc:preconj	O
the	DT	det	O
unoccupied	JJ	nsubjpass	O
nor	CC	cc	O
the	DT	det	O
occupied	JJ	amod	O
receptor	NN	conj	B-protein
from	IN	case	O
A1-VDR	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
completely	RB	advmod	O
localized	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
series	NN	nmod	O
of	IN	case	O
functional	JJ	amod	O
studies	NNS	nmod	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
modulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
the	DT	det	O
mRNAs	NNS	nmod	B-RNA
coding	VBG	acl	O
for	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
c-myc	NN	compound	B-DNA
oncogene	NN	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
growth	NN	compound	O
factor	NN	conj	O
known	VBN	acl	O
as	IN	case	O
granulocyte-monocyte	JJ	compound	O
colony	NN	compound	O
stimulating	NN	compound	O
activity	NN	nmod	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
correlated	VBD	ccomp	O
with	IN	case	O
the	DT	det	O
1	CD	nummod	B-protein
,	,	punct	I-protein
25	CD	conj	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptor	NN	compound	I-protein
status	NN	nmod	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Use	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
will	MD	aux	O
facilitate	VB	ROOT	O
further	JJ	amod	O
study	NN	dobj	O
of	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
defect	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
receptor	NN	nmod	B-protein
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
in	IN	case	O
vitamin	NN	compound	O
D-dependent	JJ	amod	O
rickets	NN	compound	O
type	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
will	MD	aux	O
allow	VB	conj	O
a	DT	det	O
correlation	NN	dobj	O
with	IN	case	O
impairment	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	O
functions	NNS	nmod	O
.	.	punct	O

Transcriptional	JJ	amod	O
and	CC	cc	O
post-transcriptional	JJ	conj	O
regulation	NN	ROOT	O
of	IN	case	O
c-jun	NN	compound	B-DNA
expression	NN	nmod	O
during	IN	case	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_line
myeloid	JJ	amod	I-cell_line
leukemic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

AP-1	NN	nsubj	B-protein
,	,	punct	O
the	DT	det	O
polypeptide	NN	compound	O
product	NN	appos	O
of	IN	case	O
c-jun	NN	nmod	B-DNA
,	,	punct	O
recognizes	VBZ	ROOT	O
and	CC	cc	O
binds	VBZ	conj	O
to	TO	case	O
specific	JJ	amod	O
DNA	NN	compound	O
sequences	NNS	nmod	O
and	CC	cc	O
stimulates	VBZ	conj	O
transcription	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	B-DNA
responsive	JJ	amod	O
to	TO	case	O
certain	JJ	amod	O
growth	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
phorbol	NN	compound	O
esters	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
12-O-tetradecanoylphorbol-13-acetate	NN	nmod	O
(	-LRB-	punct	O
TPA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
TPA	NN	nmod	O
on	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
c-jun	NN	compound	B-DNA
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
during	IN	case	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Low	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
c-jun	NN	compound	B-RNA
transcripts	NNS	nmod	I-RNA
were	VBD	cop	O
detectable	JJ	ROOT	O
in	IN	case	O
untreated	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
leukemic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
increased	VBD	conj	O
significantly	RB	advmod	O
by	IN	case	O
6	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
and	CC	cc	O
reached	VBD	conj	O
near	IN	case	O
maximal	JJ	amod	O
levels	NNS	nmod	O
by	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
32	CD	compound	O
nM	NN	amod	O
TPA	NN	nmod	O
.	.	punct	O

Similar	JJ	amod	O
kinetics	NNS	nsubjpass	O
of	IN	case	O
c-jun	NN	compound	B-DNA
induction	NN	nmod	O
by	IN	case	O
TPA	NN	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_line
U-937	NN	nmod	I-cell_line
and	CC	cc	O
THP-1	NN	compound	B-cell_line
monocytic	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

Similar	JJ	amod	O
findings	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
bryostatin	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
10	CD	nummod	O
nM	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
another	DT	det	O
activator	NN	appos	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
and	CC	cc	O
inducer	NN	conj	O
of	IN	case	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nsubj	O
(	-LRB-	punct	O
0.5	CD	nummod	O
microM	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
structurally	RB	advmod	O
distinct	JJ	amod	O
agent	NN	appos	O
which	WDT	nsubj	O
also	RB	advmod	O
induces	VBZ	acl:relcl	O
HL-60	NN	compound	O
monocytic	JJ	amod	O
differentiation	NN	dobj	O
,	,	punct	O
increased	VBD	ROOT	O
c-jun	NN	compound	B-DNA
expression	NN	dobj	O
.	.	punct	O

TPA	NN	compound	O
treatment	NN	nsubjpass	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
cycloheximide	NN	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
superinduction	NN	nmod	O
of	IN	case	O
c-jun	NN	compound	B-DNA
transcripts	NNS	nmod	O
.	.	punct	O

Run-on	JJ	amod	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
detectable	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
c-jun	NN	compound	B-DNA
gene	NN	compound	O
transcription	NN	nmod	O
in	IN	case	O
untreated	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
exposure	NN	nsubj	O
to	TO	case	O
TPA	NN	nmod	O
increases	VBZ	conj	O
this	DT	det	O
rate	NN	dobj	O
3.3-fold	RB	advmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
both	CC	cc:preconj	O
TPA	NN	nmod	O
and	CC	cc	O
cycloheximide	NN	conj	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
rates	NNS	nmod	O
of	IN	case	O
c-jun	NN	compound	B-DNA
transcription	NN	nmod	O
.	.	punct	O

The	DT	det	O
half-life	NN	nsubj	O
of	IN	case	O
c-jun	NN	compound	B-RNA
RNA	NN	nmod	I-RNA
as	IN	mark	O
determined	VBN	acl	O
by	IN	mark	O
treating	VBG	advcl	O
HL-60	NN	compound	B-cell_line
cells	NNS	dobj	I-cell_line
with	IN	case	O
TPA	NN	nmod	O
and	CC	cc	O
actinomycin	NN	compound	O
D	NN	conj	O
was	VBD	cop	O
30	CD	nummod	O
min	NN	ROOT	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
half-life	NN	nsubj	O
of	IN	case	O
c-jun	NN	compound	B-RNA
RNA	NN	nmod	I-RNA
in	IN	case	O
TPA-treated	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
exposed	VBN	acl	O
to	TO	case	O
cycloheximide	NN	nmod	O
and	CC	cc	O
actinomycin	NN	compound	O
D	NN	conj	O
was	VBD	cop	O
greater	JJR	ROOT	O
than	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
increase	NN	nsubjpass	O
in	IN	case	O
c-jun	NN	compound	B-RNA
RNA	NN	nmod	I-RNA
observed	VBN	acl	O
during	IN	case	O
TPA-induced	JJ	amod	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
both	CC	cc:preconj	O
transcriptional	JJ	amod	O
and	CC	cc	O
post-transcriptional	JJ	conj	O
mechanisms	NNS	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Hormonal	JJ	amod	O
interactions	NNS	ROOT	O
and	CC	cc	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	conj	I-protein
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
the	DT	det	O
nephrotic	JJ	amod	O
syndrome	NN	nmod	O
]	-RRB-	punct	O

As	RB	mark	O
many	JJ	amod	O
as	IN	quantmod	O
27	CD	nummod	O
children	NNS	nsubjpass	O
aged	JJ	amod	O
6	CD	compound	O
to	TO	dep	O
15	CD	nummod	O
years	NNS	dep	O
with	IN	prep	O
morphologically	RB	advmod	O
verified	VBN	amod	O
nephropathies	NNS	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
.	.	punct	O

Four	CD	nummod	O
variants	NNS	nsubjpass	O
of	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
thyroid	NN	compound	O
status	NN	nmod	O
,	,	punct	O
characteristic	JJ	amod	O
of	IN	case	O
children	NNS	nmod	O
with	IN	case	O
different	JJ	amod	O
variants	NNS	nmod	O
of	IN	case	O
nephrotic	JJ	amod	O
syndrome	NN	nmod	O
were	VBD	auxpass	O
distinguished	VBN	ROOT	O
:	:	punct	O
1	LS	dep	O
)	-RRB-	punct	O
biochemical	JJ	amod	O
signs	NNS	dep	O
of	IN	case	O
primary	JJ	amod	O
hypothyroidism	NN	nmod	O
,	,	punct	O
2	LS	dep	O
)	-RRB-	punct	O
biochemical	JJ	amod	O
signs	NNS	conj	O
of	IN	case	O
secondary	JJ	amod	O
hypothyroidism	NN	nmod	O
,	,	punct	O
3	LS	dep	O
)	-RRB-	punct	O
low	JJ	amod	O
content	NN	appos	O
of	IN	case	O
T3	NN	nmod	O
,	,	punct	O
4	LS	dep	O
)	-RRB-	punct	O
dysfunction	NN	dep	O
of	IN	case	O
the	DT	det	O
hypophyseal	NN	amod	O
and	CC	cc	O
thyroid	NN	conj	O
system	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
shown	VBN	ROOT	O
that	IN	dobj	O
the	DT	det	O
low	JJ	amod	O
level	NN	intj	O
of	IN	case	O
steroid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
thyroid	NN	compound	O
hormones	NNS	appos	O
that	IN	mark	O
the	DT	det	O
low	JJ	amod	O
level	NN	nsubj	O
of	IN	case	O
steroid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
thyroid	NN	compound	O
hormones	NNS	conj	O
(	-LRB-	punct	O
T3	NN	dep	O
and	CC	cc	O
T4	NN	conj	O
)	-RRB-	punct	O
and	CC	cc	O
cortisol	NN	conj	O
is	VBZ	cop	O
typical	JJ	ccomp	O
of	IN	case	O
children	NNS	nmod	O
with	IN	case	O
the	DT	det	O
signs	NNS	nmod	O
of	IN	case	O
renal	JJ	amod	O
dysplasia	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
assumed	VBN	ROOT	O
that	IN	mark	O
superaddition	NN	nsubj	O
under	IN	case	O
such	JJ	amod	O
conditions	NNS	nmod	O
of	IN	case	O
immune	JJ	amod	O
glomerulopathy	NN	nmod	O
(	-LRB-	punct	O
glomerulonephritis	NN	dep	O
and	CC	cc	O
nephrotic	JJ	amod	O
syndrome	NN	conj	O
)	-RRB-	punct	O
gives	VBZ	ccomp	O
rise	NN	dobj	O
to	TO	case	O
the	DT	det	O
resistance	NN	nmod	O
to	TO	case	O
the	DT	det	O
treatment	NN	nmod	O
with	IN	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

Lymphoid	JJ	amod	O
specific	JJ	amod	O
gene	NN	compound	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
adenovirus	NN	compound	B-DNA
early	JJ	amod	I-DNA
region	NN	compound	I-DNA
3	CD	nummod	I-DNA
promoter	NN	nmod	I-DNA
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
binding	NN	compound	I-DNA
motifs	NNS	nmod	I-DNA
.	.	punct	O

A	DT	det	O
primary	JJ	amod	O
site	NN	nsubj	O
of	IN	case	O
infection	NN	nmod	O
by	IN	case	O
human	JJ	amod	O
adenoviruses	NNS	nmod	O
is	VBZ	cop	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	ROOT	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
analysis	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
viral	JJ	amod	B-DNA
control	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
cellular	JJ	amod	B-protein
factors	NNS	conj	I-protein
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
adenoviral	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
adenovirus	NN	compound	B-protein
early	JJ	amod	I-protein
region	NN	compound	I-protein
3	CD	nummod	I-protein
(	-LRB-	punct	I-protein
ES	NN	compound	I-protein
)	-RRB-	punct	I-protein
gene	NN	compound	I-protein
products	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
maintenance	NN	nmod	O
of	IN	case	O
viral	JJ	amod	O
persistence	NN	nmod	O
by	IN	mark	O
complexing	VBG	advcl	O
with	IN	case	O
the	DT	det	O
class	NN	compound	B-protein
I	CD	nummod	I-protein
MHC	NN	compound	I-protein
antigens	NNS	nmod	I-protein
,	,	punct	O
thus	RB	advmod	O
preventing	VBG	advcl	O
their	PRP$	nmod:poss	O
cell	NN	compound	O
surface	NN	compound	O
expression	NN	dobj	O
with	IN	case	O
a	DT	det	O
resultant	JJ	amod	O
decrease	NN	nmod	O
in	IN	case	O
host	NN	compound	O
immunologic	JJ	amod	O
destruction	NN	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
different	JJ	amod	O
cellular	JJ	amod	B-protein
factors	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
E3	NN	compound	O
regulation	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
both	CC	cc:preconj	O
DNA	NN	compound	O
binding	NN	nsubjpass	O
and	CC	cc	O
transfection	NN	compound	O
analysis	NN	conj	O
with	IN	case	O
the	DT	det	O
E3	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
both	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
detected	VBD	ROOT	O
two	CD	nummod	O
novel	JJ	amod	B-DNA
domains	NNS	dobj	I-DNA
referred	VBN	acl	O
to	TO	nmod	O
as	IN	case	O
L1	NN	nmod	B-DNA
and	CC	cc	O
L2	NN	conj	B-DNA
with	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
lymphoid	JJ	nmod	O
but	CC	cc	O
not	RB	cc	O
HeLa	NN	conj	O
extracts	NNS	dep	O
.	.	punct	O

Each	DT	nsubj	O
of	IN	case	O
these	DT	det	O
domains	NNS	nmod	O
possessed	VBD	ROOT	O
strong	JJ	amod	O
homology	NN	dobj	O
to	TO	case	O
motifs	NNS	nmod	O
previously	RB	advmod	O
found	VBN	acl	O
to	TO	mark	O
bind	VB	xcomp	O
the	DT	det	O
cellular	JJ	amod	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	I-protein
B	NN	dobj	I-protein
.	.	punct	O

Transfections	NNS	nsubj	O
of	IN	case	O
E3	NN	compound	B-DNA
constructs	NNS	nmod	I-DNA
linked	VBN	acl	O
to	TO	case	O
the	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
gene	NN	nmod	I-DNA
revealed	VBD	ROOT	O
that	IN	mark	O
mutagenesis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
distal	JJ	amod	B-DNA
NF-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
motif	NN	nmod	I-DNA
(	-LRB-	punct	O
L2	NN	appos	B-DNA
)	-RRB-	punct	O
had	VBD	ccomp	O
minimal	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
promoter	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
but	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
dramatic	JJ	amod	O
decreases	NNS	nmod	O
in	IN	case	O
expression	NN	nmod	O
by	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
mutagenesis	NN	nsubj	O
of	IN	case	O
proximal	JJ	amod	B-DNA
NF-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
motif	NN	nmod	I-DNA
(	-LRB-	punct	O
L1	NN	appos	B-DNA
)	-RRB-	punct	O
had	VBD	ROOT	O
minimal	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
but	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
a	DT	det	O
small	JJ	amod	O
,	,	punct	O
but	CC	cc	O
reproducible	JJ	conj	O
,	,	punct	O
increase	NN	nmod	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
when	WRB	advmod	O
coupled	VBN	advcl	O
to	TO	case	O
the	DT	det	O
L2	NN	compound	B-DNA
mutation	NN	nmod	O
.	.	punct	O

Reversing	VBG	csubj	O
the	DT	det	O
position	NN	dobj	O
and	CC	cc	O
subsequent	JJ	amod	O
mutagenesis	NN	conj	O
of	IN	case	O
the	DT	dep	O
L1	NN	nmod	B-DNA
and	CC	cc	O
L2	NN	conj	B-DNA
domains	NNS	dep	I-DNA
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
primary	JJ	amod	B-DNA
sequence	NN	nsubj	I-DNA
of	IN	case	O
these	DT	det	O
motifs	NNS	nmod	O
rather	RB	cc	O
than	IN	mwe	O
their	PRP$	nmod:poss	O
position	NN	conj	O
in	IN	case	O
the	DT	det	O
E3	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
was	VBD	cop	O
critical	JJ	ccomp	O
for	IN	mark	O
regulating	VBG	advcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
defensin	NN	compound	B-protein
resistance	NN	compound	O
phenotypes	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
phoP	NN	compound	B-DNA
virulence	NN	compound	I-DNA
regulon	NN	nmod	I-DNA
of	IN	case	O
Salmonella	FW	compound	O
typhimurium	FW	nmod	O
.	.	punct	O

The	DT	det	O
defensin	NN	compound	B-protein
sensitivities	NNS	nsubjpass	O
of	IN	case	O
Salmonella	FW	compound	O
typhimurium	FW	compound	O
strains	NNS	nmod	O
with	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
phoP/phoQ	NN	compound	B-DNA
two-component	JJ	amod	I-DNA
virulence	NN	compound	I-DNA
regulon	NN	nmod	I-DNA
were	VBD	auxpass	O
tested	VBN	ROOT	O
by	IN	mark	O
using	VBG	advcl	O
purified	VBN	amod	B-protein
defensins	NNS	dobj	I-protein
NP-1	NN	dep	B-protein
and	CC	cc	O
NP-2	NN	conj	B-protein
.	.	punct	O

Strains	NNS	nsubj	O
with	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
either	CC	det	O
gene	NN	nmod	O
of	IN	case	O
the	DT	det	O
regulatory	JJ	amod	B-DNA
pair	NN	nmod	I-DNA
(	-LRB-	punct	O
phoP	NN	compound	B-DNA
[	-LRB-	punct	O
transcriptional	JJ	amod	B-DNA
activator	NN	dep	I-DNA
]	-RRB-	punct	O
or	CC	cc	O
phoQ	NN	compound	B-DNA
[	-LRB-	punct	O
membrane	NN	compound	B-protein
sensor	NN	compound	I-protein
kinase	NN	conj	I-protein
]	-RRB-	punct	O
)	-RRB-	punct	O
had	VBD	aux	O
increased	VBN	ROOT	O
sensitivities	NNS	dobj	O
to	TO	case	O
defensin	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
predicted	VBN	amod	O
periplasmic	JJ	amod	B-protein
domain	NN	nsubj	I-protein
of	IN	case	O
the	DT	det	O
PhoQ	NN	compound	B-protein
protein	NN	nmod	I-protein
contained	VBD	ROOT	O
a	DT	det	O
markedly	RB	advmod	O
anionic	JJ	amod	O
domain	NN	dobj	O
that	WDT	nsubj	O
could	MD	aux	O
interact	VB	acl:relcl	O
with	IN	case	O
cationic	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
that	DT	nsubj	O
could	MD	aux	O
be	VB	cop	O
responsible	JJ	conj	O
for	IN	case	O
resistance	NN	nmod	O
to	TO	case	O
defensin	NN	nmod	B-protein
.	.	punct	O

Because	IN	mark	O
insertion	NN	compound	O
mutations	NNS	nsubj	O
in	IN	case	O
phoP	NN	nmod	B-DNA
are	VBP	cop	O
polar	JJ	advcl	O
on	IN	case	O
phoQ	NN	nmod	B-DNA
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
strains	NNS	dobj	O
that	WDT	nsubj	O
expressed	VBD	acl:relcl	O
the	DT	det	O
PhoQ	NN	compound	B-protein
protein	NN	dobj	I-protein
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
PhoP	NN	nmod	B-protein
to	TO	mark	O
test	VB	advcl	O
whether	IN	mark	O
resistance	NN	nsubj	O
to	TO	case	O
defensin	NN	nmod	O
requires	VBZ	ccomp	O
only	RB	advmod	O
the	DT	det	O
phoQ	NN	compound	B-protein
gene	NN	compound	I-protein
product	NN	dobj	I-protein
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
resistance	NN	nsubj	O
to	TO	case	O
defensin	NN	nmod	O
requires	VBZ	ccomp	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
both	DT	det	O
components	NNS	nmod	O
of	IN	case	O
this	DT	det	O
regulatory	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
because	IN	mark	O
strains	NNS	nsubj	O
expressing	VBG	acl	O
PhoQ	NN	dobj	B-protein
without	IN	case	O
PhoP	NN	nmod	B-protein
were	VBD	cop	O
still	RB	advmod	O
markedly	RB	advmod	O
sensitive	JJ	advcl	O
to	TO	case	O
defensins	NNS	nmod	B-protein
.	.	punct	O

This	DT	nsubj	O
implied	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
pag	NN	compound	B-protein
(	-LRB-	punct	I-protein
phoP-activated	JJ	amod	I-protein
gene	NN	compound	I-protein
)	-RRB-	punct	I-protein
product	NN	nsubj	I-protein
is	VBZ	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
defensin	NN	compound	B-protein
resistance	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
tested	VBD	ROOT	O
for	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
defensins	NNS	nmod	B-protein
NP-1	NN	dep	B-protein
,	,	punct	O
NP-5	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
HNP-1	NN	conj	B-protein
to	TO	mark	O
activate	VB	acl	O
pag	NN	compound	B-DNA
expression	NN	dobj	O
and	CC	cc	O
found	VBD	conj	O
that	IN	mark	O
these	DT	det	O
peptides	NNS	nsubj	O
have	VBP	ccomp	O
no	DT	neg	O
effect	NN	dobj	O
.	.	punct	O

Defensin	NN	compound	O
resistance	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
the	DT	det	O
only	JJ	amod	O
virulence	NN	compound	O
characteristic	NN	ROOT	O
controlled	VBN	acl	O
by	IN	case	O
the	DT	det	O
PhoP-PhoQ	JJ	amod	B-protein
regulon	NN	nmod	I-protein
because	IN	mark	O
mutations	NNS	nsubj	O
in	IN	case	O
pagC	NN	nmod	B-DNA
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
ones	NNS	conj	O
in	IN	case	O
the	DT	det	O
phoP	NN	compound	B-DNA
locus	NN	nmod	I-DNA
that	WDT	nsubj	O
resulted	VBD	acl:relcl	O
in	IN	case	O
constitutive	JJ	amod	O
pag	NN	compound	B-DNA
activation	NN	nmod	O
(	-LRB-	punct	O
phenotype	NN	compound	O
PhoPc	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
had	VBD	advcl	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
defensin	NN	compound	B-protein
resistance	NN	nmod	O
,	,	punct	O
even	RB	advmod	O
though	IN	mark	O
they	PRP	nsubj	O
rendered	VBD	advcl	O
the	DT	det	O
organism	NN	compound	O
avirulent	JJ	xcomp	O
and	CC	cc	O
deficient	JJ	conj	O
in	IN	case	O
survival	NN	nmod	O
within	IN	case	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
virulence	NN	compound	O
defect	NN	nsubjpass	O
conferred	VBN	acl	O
by	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
phoP	NN	compound	B-DNA
-phoQ	CD	nummod	B-DNA
two-component	JJ	amod	O
regulatory	JJ	amod	O
system	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
completely	RB	advmod	O
explained	VBN	ROOT	O
by	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
resistance	NN	nmod	O
to	TO	case	O
cationic	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
involves	VBZ	conj	O
the	DT	det	O
control	NN	dobj	O
of	IN	case	O
other	JJ	amod	O
proteins	NNS	nmod	O
necessary	JJ	amod	O
for	IN	case	O
S.	FW	compound	O
typhimurium	FW	compound	O
survival	NN	nmod	O
within	IN	case	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
clone	NN	nmod	I-cell_line
with	IN	case	O
anti-CD3	NN	nmod	B-protein
or	CC	cc	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	conj	I-protein
induces	VBZ	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
translocation	NN	dobj	O
but	CC	cc	O
not	RB	cc	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
1	CD	nummod	O
enhancer-dependent	JJ	amod	O
transcription	NN	conj	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
transiently	RB	advmod	O
transfected	VBN	amod	O
expression	NN	compound	O
vectors	NNS	nmod	O
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
HIV	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
its	PRP$	nmod:poss	O
enhancer	NN	compound	B-DNA
sequence	NN	conj	I-DNA
and	CC	cc	O
the	DT	det	O
translocation	NN	conj	O
of	IN	case	O
the	DT	det	O
HIV	NN	compound	B-protein
enhancer-binding	JJ	amod	I-protein
protein	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
two	CD	nummod	O
human	JJ	amod	O
T-cell	NN	compound	B-cell_line
clones	NNS	nmod	I-cell_line
stimulated	VBN	acl	O
through	IN	case	O
their	PRP$	nmod:poss	O
T-cell	NN	compound	B-protein
receptor	NN	compound	I-protein
complex	NN	nmod	I-protein
or	CC	cc	O
by	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	conj	I-protein
or	CC	cc	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
a	DT	det	O
dissociation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
translocation	NN	nmod	O
from	IN	case	O
transactivation	NN	nmod	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
HIV	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
or	CC	cc	O
the	DT	det	O
HIV	NN	compound	B-DNA
enhancer	NN	conj	I-DNA
.	.	punct	O

Interleukin	NN	nsubj	B-protein
2	CD	nummod	I-protein
induced	VBD	amod	O
proliferation	NN	ROOT	O
but	CC	cc	O
not	RB	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
translocation	NN	conj	O
or	CC	cc	O
LTR	NN	compound	B-DNA
transactivation	NN	conj	O
.	.	punct	O

Phorbol	NN	compound	O
ester	NN	nsubj	O
or	CC	cc	O
specific	JJ	amod	O
antigen	NN	compound	O
recognition	NN	conj	O
induced	VBD	ROOT	O
HIV	NN	compound	B-DNA
LTR	NN	compound	I-DNA
transactivation	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
stimulation	NN	nsubj	O
with	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	nmod	I-protein
or	CC	cc	O
antibody	NN	conj	O
to	TO	case	O
CD3	NN	nmod	B-protein
did	VBD	parataxis	O
not	RB	neg	O
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
latter	JJ	amod	O
signals	NNS	nsubj	O
were	VBD	cop	O
nevertheless	RB	advmod	O
able	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
translocation	NN	dobj	O
with	IN	case	O
a	DT	det	O
pattern	NN	nmod	O
in	IN	case	O
the	DT	det	O
band-shift	JJ	amod	O
assay	NN	nmod	O
indistinguishable	JJ	amod	O
from	IN	case	O
that	DT	nmod	O
observed	VBN	acl	O
using	VBG	xcomp	O
phorbol	NN	compound	O
ester	NN	dobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
finding	NN	nsubj	O
that	IN	mark	O
induction	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
by	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	nmod	I-protein
or	CC	cc	O
antibody	NN	conj	B-protein
to	TO	case	I-protein
CD3	NN	nmod	I-protein
is	VBZ	cop	O
not	RB	neg	O
sufficient	JJ	ccomp	O
to	TO	mark	O
induce	VB	xcomp	O
HIV	NN	compound	B-DNA
enhancer	NN	nmod:npmod	I-DNA
-dependent	JJ	amod	O
transcription	NN	dobj	O
in	IN	case	O
cloned	VBN	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
contrasts	VBZ	ROOT	O
with	IN	case	O
results	NNS	nmod	O
obtained	VBN	acl	O
in	IN	case	O
most	JJS	amod	O
lymphoblastoid	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
indicates	VBZ	conj	O
that	IN	mark	O
normal	JJ	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
differ	VBP	ccomp	O
from	IN	case	O
tumoral	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
requirements	NNS	nmod	O
for	IN	case	O
HIV	NN	compound	B-DNA
LTR	NN	compound	I-DNA
activation	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
events	NNS	nsubj	O
linked	VBN	acl	O
to	TO	case	O
T-cell	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
translocation	NN	nmod	O
per	FW	compound	O
se	FW	nmod	O
,	,	punct	O
induce	VBP	ccomp	O
functional	JJ	amod	O
interactions	NNS	dobj	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
complex	NN	nmod	I-protein
with	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

Decreased	VBN	amod	O
concentration	NN	ROOT	O
of	IN	case	O
1	CD	nummod	B-protein
,	,	punct	I-protein
25-dihydroxyvitamin	NN	dep	I-protein
D3	NN	compound	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
X-linked	JJ	amod	O
hypophosphatemic	JJ	amod	O
rickets	NN	nmod	O
:	:	punct	O
effect	NN	dep	O
of	IN	case	O
phosphate	NN	compound	O
supplementation	NN	nmod	O
.	.	punct	O

Abnormal	JJ	amod	O
renal	JJ	amod	O
tubular	JJ	amod	O
phosphate	NN	compound	O
transport	NN	nsubjpass	O
is	VBZ	auxpass	O
considered	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
primary	JJ	amod	O
defect	NN	xcomp	O
in	IN	case	O
X-linked	JJ	amod	O
hypophosphatemic	JJ	amod	O
rickets	NN	nmod	O
(	-LRB-	punct	O
XLH	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
resistance	NN	nsubjpass	O
to	TO	case	O
vitamin	NN	compound	O
D	NN	compound	O
treatment	NN	nmod	O
in	IN	case	O
XLH	NN	nmod	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
hypophosphatemia	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

Since	IN	mark	O
most	JJS	nsubjpass	O
of	IN	case	O
the	DT	det	O
actions	NNS	nmod	O
of	IN	case	O
vitamin	NN	compound	O
D	NN	nmod	O
are	VBP	auxpass	O
mediated	VBN	advcl	O
by	IN	case	O
its	PRP$	nmod:poss	O
receptors	NNS	nmod	O
(	-LRB-	punct	O
VDR	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
abnormalities	NNS	nsubjpass	O
of	IN	case	O
VDR	NN	nmod	B-protein
have	VBP	aux	O
been	VBN	auxpass	O
postulated	VBN	ROOT	O
in	IN	case	O
XLH	NN	nmod	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
investigate	VB	advcl	O
this	DT	det	O
possibility	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
measured	VBD	ROOT	O
the	DT	det	O
concentration	NN	dobj	O
of	IN	case	O
VDR	NN	nmod	B-protein
in	IN	case	O
PHA-activated	JJ	amod	B-cell_line
peripheral	JJ	amod	I-cell_line
mononuclear	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
from	IN	case	O
10	CD	nummod	O
XLH	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

Patients	NNS	nsubj	O
without	IN	case	O
phosphate	NN	compound	O
supplementation	NN	nmod	O
showed	VBD	ROOT	O
significantly	RB	advmod	O
lower	JJR	amod	O
concentration	NN	dobj	O
(	-LRB-	punct	O
21.7	CD	intj	O
+/-	CC	cc	O
5.1	CD	conj	O
fmol/mg	NN	compound	O
protein	NN	conj	O
,	,	punct	O
mean	NN	appos	O
+/-	CC	cc	O
SEM	NN	conj	O
)	-RRB-	punct	O
compared	VBN	case	O
to	TO	case	O
the	DT	det	O
normal	JJ	amod	O
controls	NNS	advcl	O
(	-LRB-	punct	O
60.7	CD	dep	O
+/-	CC	cc	O
4.0	CD	conj	O
)	-RRB-	punct	O
.	.	punct	O

On	IN	prep	O
the	DT	det	O
contrary	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
difference	NN	nsubj	O
between	IN	case	O
the	DT	det	O
phosphate-supplemented	JJ	amod	O
patients	NNS	nmod	O
(	-LRB-	punct	O
58.3	CD	dep	O
+/-	CC	cc	O
2.7	CD	conj	O
)	-RRB-	punct	O
and	CC	cc	O
controls	NNS	conj	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
positive	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
VDR	NN	compound	B-protein
concentration	NN	nmod	O
and	CC	cc	O
serum	NN	compound	O
phosphate	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.05	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
two	CD	nummod	O
patients	NNS	nmod	O
,	,	punct	O
VDR	NN	nsubjpass	B-protein
was	VBD	auxpass	O
increased	VBN	ROOT	O
after	IN	case	O
daily	JJ	amod	O
phosphate	NN	compound	O
supplementation	NN	nsubjpass	O
was	VBD	auxpass	O
started	VBN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
decreased	VBN	amod	O
concentration	NN	nsubj	O
of	IN	case	O
VDR	NN	nmod	B-protein
secondary	JJ	amod	O
to	TO	case	O
persistent	JJ	amod	O
hypophosphatemia	NN	nmod	O
is	VBZ	cop	O
one	CD	ccomp	O
of	IN	case	O
the	DT	det	O
causes	NNS	nmod	O
of	IN	case	O
vitamin	NN	compound	O
D	NN	compound	O
resistance	NN	nmod	O
in	IN	case	O
XLH	NN	nmod	O
.	.	punct	O

Two	CD	nummod	O
distinct	JJ	amod	O
forms	NNS	ROOT	O
of	IN	case	O
active	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
CREB	NN	nmod	I-protein
(	-LRB-	punct	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Mammalian	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
express	VBP	ROOT	O
two	CD	nummod	O
distinct	JJ	amod	O
forms	NNS	dobj	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
CREB	NN	nmod	I-protein
(	-LRB-	punct	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	appos	I-protein
)	-RRB-	punct	O
that	WDT	nsubj	O
are	VBP	cop	O
apparently	RB	advmod	O
the	DT	det	O
products	NNS	acl:relcl	O
of	IN	case	O
alternative	JJ	amod	O
splicing	NN	nmod	O
of	IN	case	O
the	DT	det	O
CREB	NN	compound	B-RNA
gene	NN	compound	I-RNA
transcript	NN	nmod	I-RNA
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
proteins	NNS	nsubj	O
differ	VBP	ROOT	O
by	IN	case	O
a	DT	det	O
14-amino	NN	compound	B-protein
acid	NN	compound	I-protein
serine-rich	JJ	amod	I-protein
insertion	NN	nmod	I-protein
present	JJ	amod	O
in	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
CREB	NN	compound	B-protein
isoforms	NNS	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
both	DT	det	O
CREB	NN	compound	B-protein
isoforms	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
many	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
types	NNS	nmod	I-cell_type
and	CC	cc	O
mammalian	JJ	amod	O
species	NNS	conj	O
.	.	punct	O

Both	DT	nsubj	O
encode	VBP	ROOT	O
proteins	NNS	dobj	O
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
specifically	RB	advmod	O
to	TO	case	O
a	DT	det	O
cAMP	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
in	FW	compound	I-DNA
vitro	FW	advmod	I-DNA
.	.	punct	O

As	IN	mark	O
expected	VBN	advcl	O
for	IN	case	O
proteins	NNS	nmod	O
of	IN	case	O
this	DT	det	O
class	NN	nmod	O
,	,	punct	O
the	DT	det	O
CREB	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
bind	VBP	ROOT	O
DNA	NN	dobj	O
as	IN	case	O
dimers	NNS	nmod	O
.	.	punct	O

Both	DT	det	O
proteins	NNS	nsubj	O
impart	VBP	ROOT	O
cAMP-regulated	JJ	amod	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
to	TO	case	O
a	DT	det	O
heterologous	JJ	amod	B-DNA
DNA-binding	JJ	amod	I-DNA
domain	NN	nmod	I-DNA
,	,	punct	O
showing	VBG	advcl	O
that	IN	mark	O
cAMP	NN	nsubj	O
directly	RB	advmod	O
modulates	VBZ	ccomp	O
the	DT	det	O
transcriptional	JJ	amod	O
stimulatory	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
CREB	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
multiple	JJ	amod	O
CREB	NN	compound	B-protein
isoforms	NNS	nmod	I-protein
with	IN	case	O
identical	JJ	amod	O
DNA-binding	JJ	amod	O
specificities	NNS	nmod	O
but	CC	cc	O
differences	NNS	conj	O
in	IN	case	O
the	DT	det	O
presumed	JJ	amod	O
regulatory	JJ	amod	B-protein
domain	NN	nmod	I-protein
raises	VBZ	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
CREB	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
may	MD	aux	O
be	VB	cop	O
able	JJ	ccomp	O
to	TO	mark	O
integrate	VB	xcomp	O
distinct	JJ	amod	O
regulatory	JJ	amod	O
signals	NNS	dobj	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

Human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
vpr	NN	compound	O
product	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
virion-associated	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
protein	NN	ROOT	I-protein
.	.	punct	O

The	DT	det	O
vpr	NN	compound	B-protein
product	NN	nsubj	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
acts	VBZ	ROOT	O
in	IN	case	O
trans	NN	nmod	O
to	TO	mark	O
accelerate	VB	xcomp	O
virus	NN	compound	O
replication	NN	dobj	O
and	CC	cc	O
cytopathic	JJ	amod	O
effect	NN	conj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
HIV-1	NN	compound	O
viral	JJ	amod	O
particle	NN	nsubj	O
contains	VBZ	ccomp	O
multiple	JJ	amod	O
copies	NNS	dobj	O
of	IN	case	O
the	DT	det	O
vpr	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
vpr	NN	compound	B-protein
product	NN	nsubj	I-protein
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
regulatory	JJ	amod	O
protein	NN	ROOT	O
of	IN	case	O
HIV-1	NN	nmod	O
to	TO	mark	O
be	VB	auxpass	O
found	VBN	acl	O
in	IN	case	O
the	DT	det	O
virus	NN	compound	O
particle	NN	nmod	O
.	.	punct	O

This	DT	det	O
observation	NN	nsubj	O
raises	VBZ	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
vpr	NN	nsubj	B-DNA
acts	VBZ	ccomp	O
to	TO	mark	O
facilitate	VB	xcomp	O
the	DT	det	O
early	JJ	amod	O
steps	NNS	dobj	O
of	IN	case	O
infection	NN	nmod	O
before	IN	mark	O
de	FW	amod	O
novo	FW	dep	O
viral	JJ	amod	O
protein	NN	compound	O
synthesis	NN	nsubj	O
occurs	VBZ	advcl	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
B-cell	NN	compound	B-protein
lineage-specific	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	ROOT	I-protein
present	JJ	amod	O
at	IN	case	O
early	JJ	amod	O
but	CC	cc	O
not	RB	cc	O
late	JJ	conj	O
stages	NNS	nmod	O
of	IN	case	O
differentiation	NN	nmod	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
B-cell-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nsubjpass	I-protein
,	,	punct	O
BSAP	NN	appos	B-protein
,	,	punct	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
mammalian	JJ	amod	B-protein
homolog	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
sea	NN	compound	B-protein
urchin	NN	compound	I-protein
protein	NN	nmod	I-protein
TSAP	NN	dep	B-protein
,	,	punct	O
which	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
the	DT	det	O
promoters	NNS	nmod	B-DNA
of	IN	case	O
four	CD	nummod	O
tissue-specific	JJ	amod	B-DNA
late	JJ	amod	I-DNA
histone	NN	nmod	I-DNA
H2A-2	NN	dep	I-DNA
and	CC	cc	I-DNA
H2B-2	NN	conj	I-DNA
genes	NNS	dep	I-DNA
.	.	punct	O

As	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
mobility-shift	NN	amod	O
,	,	punct	O
methylation	NN	compound	O
interference	NN	conj	O
,	,	punct	O
and	CC	cc	O
mutational	JJ	amod	O
analyses	NNS	nmod	O
,	,	punct	O
the	DT	det	O
mammalian	JJ	amod	B-protein
protein	NN	compound	I-protein
BSAP	NN	nsubj	B-protein
recognizes	VBZ	ROOT	O
all	DT	det	O
four	CD	nummod	O
sea	NN	compound	B-DNA
urchin	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
in	IN	case	O
a	DT	det	O
manner	NN	nmod	O
indistinguishable	JJ	amod	O
from	IN	case	O
TSAP	NN	nmod	B-protein
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
two	CD	nummod	O
proteins	NNS	nsubj	O
differ	VBP	parataxis	O
in	IN	case	O
molecular	JJ	amod	O
weight	NN	nmod	O
.	.	punct	O

BSAP	NN	nsubj	B-protein
is	VBZ	cop	O
exclusively	RB	advmod	O
restricted	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
B-cell	NN	compound	O
lineage	NN	nmod	O
of	IN	case	O
lymphoid	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Its	PRP$	nmod:poss	O
expression	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
activated	VBN	xcomp	O
during	IN	case	O
pro-B-cell	JJ	amod	O
development	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
abundant	JJ	conj	O
at	IN	case	O
the	DT	dep	O
pre-B-	JJ	nmod	O
and	CC	cc	O
mature	JJ	amod	O
B-cell	NN	compound	O
stages	NNS	conj	O
,	,	punct	O
but	CC	cc	O
is	VBZ	cop	O
absent	JJ	conj	O
in	IN	case	O
terminally	RB	advmod	B-cell_type
differentiated	VBN	amod	I-cell_type
plasma	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
BSAP	NN	nsubj	B-protein
is	VBZ	cop	O
clearly	RB	advmod	O
a	DT	det	O
B-cell-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	ROOT	I-protein
,	,	punct	O
as	IN	case	O
a	DT	det	O
wild-type	JJ	nmod	B-DNA
but	CC	cc	O
not	RB	cc	O
a	DT	det	O
mutant	JJ	amod	B-DNA
TSAP-binding	JJ	amod	I-DNA
site	NN	dep	I-DNA
of	IN	case	O
the	DT	det	O
sea	NN	compound	O
urchin	NN	compound	O
functions	NNS	nmod	O
only	RB	advmod	O
in	IN	case	O
transfected	VBN	amod	B-cell_line
B	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
as	IN	case	O
an	DT	det	O
upstream	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Competition	NN	compound	O
experiments	NNS	nsubj	O
did	VBD	aux	O
not	RB	neg	O
reveal	VB	ROOT	O
any	DT	det	O
high-affinity	JJ	amod	B-DNA
binding	VBG	compound	I-DNA
site	NN	dobj	I-DNA
for	IN	case	O
BSAP	NN	nmod	B-protein
in	IN	case	O
known	JJ	amod	O
regulatory	JJ	amod	B-DNA
regions	NNS	nmod	I-DNA
of	IN	case	O
immunoglobulin	NN	nmod	B-DNA
and	CC	cc	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
major	JJ	amod	I-DNA
histocompatibility	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
MHC	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
genes	NNS	conj	I-DNA
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
BSAP	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
regulator	NN	ccomp	O
of	IN	case	O
a	DT	det	O
different	JJ	amod	O
set	NN	nmod	O
of	IN	case	O
B-lymphoid-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Octamer	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	ROOT	I-protein
and	CC	cc	O
the	DT	det	O
cell	NN	compound	B-DNA
type-specificity	NN	conj	I-DNA
of	IN	case	I-DNA
immunoglobulin	NN	compound	I-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

Antibodies	NNS	nsubjpass	B-protein
are	VBP	auxpass	O
produced	VBN	ROOT	O
exclusively	RB	advmod	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
antibody-encoding	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
Ig	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
genes	NNS	appos	I-DNA
,	,	punct	O
is	VBZ	aux	O
also	RB	advmod	O
restricted	JJ	ROOT	O
to	TO	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
octamer	NN	compound	B-DNA
sequence	NN	compound	I-DNA
ATGCAAAT	NN	nsubj	O
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
promoter	NN	nmod	B-DNA
and	CC	cc	O
the	DT	det	O
enhancer	NN	conj	B-DNA
of	IN	case	O
Ig	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
plays	VBZ	conj	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
its	PRP$	nmod:poss	O
tissue-specific	JJ	amod	O
expression	NN	nmod	O
.	.	punct	O

This	DT	det	O
sequence	NN	compound	B-DNA
motif	NN	nsubj	I-DNA
is	VBZ	cop	O
a	DT	det	O
binding	VBG	amod	O
site	NN	ROOT	O
for	IN	case	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
the	DT	det	O
so-called	JJ	amod	O
octamer	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	appos	I-protein
(	-LRB-	punct	O
Oct	NN	dep	B-protein
or	CC	cc	O
OTF	NN	compound	B-protein
factors	NNS	conj	I-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
Oct-1	NN	compound	B-protein
protein	NN	nsubj	I-protein
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
all	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
analyzed	VBN	acl	O
so	RB	advmod	O
far	RB	advmod	O
,	,	punct	O
whereas	IN	mark	O
Oct-2A	NN	nsubjpass	B-protein
and	CC	cc	O
Oct-2B	NN	conj	B-protein
are	VBP	auxpass	O
found	VBN	advcl	O
mainly	RB	advmod	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

All	DT	det	O
three	CD	nummod	O
proteins	NNS	nsubj	O
show	VBP	ROOT	O
the	DT	det	O
same	JJ	amod	O
sequence	NN	compound	O
specificity	NN	dobj	O
and	CC	cc	O
binding	NN	compound	O
affinity	NN	conj	O
.	.	punct	O

It	PRP	nsubj	O
appears	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
B	NN	nmod:npmod	O
cell-specific	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
Ig	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
by	IN	case	O
cell	NN	nmod:npmod	O
type-specific	JJ	amod	B-protein
Oct	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
there	EX	expl	O
are	VBP	conj	O
both	CC	cc:preconj	O
quantitative	JJ	amod	O
and	CC	cc	O
qualitative	JJ	conj	O
differences	NNS	nsubj	O
between	IN	case	O
Oct-1	NN	nmod	B-protein
and	CC	cc	O
Oct-2	NN	conj	B-protein
factors	NNS	dep	I-protein
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
a	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
other	JJ	amod	O
octamer	NN	compound	B-protein
factor	NN	compound	I-protein
variants	NNS	nmod	I-protein
were	VBD	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O

Many	JJ	nsubjpass	O
of	IN	case	O
these	DT	nmod	O
may	MD	aux	O
be	VB	auxpass	O
created	VBN	ROOT	O
by	IN	case	O
alternative	JJ	amod	O
splicing	NN	nmod	O
of	IN	case	O
a	DT	det	O
primary	JJ	amod	B-RNA
transcript	NN	nmod	I-RNA
of	IN	case	O
one	CD	nummod	O
Oct	NN	compound	O
factor	NN	compound	O
gene	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
serve	VB	conj	O
a	DT	det	O
specific	JJ	amod	O
function	NN	dobj	O
in	IN	case	O
the	DT	det	O
fine	JJ	amod	O
tuning	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

A	DT	det	O
factor	NN	nsubj	O
known	VBN	acl	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
endogenous	JJ	amod	B-DNA
Ig	NN	compound	I-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
only	RB	advmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
is	VBZ	cop	O
a	DT	det	O
ubiquitously	RB	advmod	B-protein
active	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	ROOT	I-protein
.	.	punct	O

The	DT	det	O
transcriptional	JJ	amod	B-DNA
enhancer	NN	nsubj	I-DNA
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
first	JJ	amod	O
intron	NN	nmod	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
constant	JJ	amod	I-DNA
region	NN	nmod	I-DNA
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
determinant	NN	ROOT	O
of	IN	case	O
B-cell-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Like	IN	case	O
other	JJ	amod	O
enhancers	NNS	nmod	B-DNA
,	,	punct	O
the	DT	det	O
Ig	NN	compound	B-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
enhancer	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
several	JJ	amod	O
short	JJ	amod	O
sequence	NN	compound	B-DNA
motifs	NNS	dobj	I-DNA
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	dobj	I-protein
.	.	punct	O

Each	DT	det	O
binding	VBG	compound	B-DNA
site	NN	nsubj	I-DNA
contributes	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
overall	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
enhancer	NN	nmod	B-DNA
,	,	punct	O
however	RB	advmod	O
no	DT	neg	O
single	JJ	amod	O
element	NN	nsubj	O
seems	VBZ	parataxis	O
absolutely	RB	advmod	O
required	VBN	xcomp	O
for	IN	case	O
activity	NN	nmod	O
.	.	punct	O

For	IN	case	O
a	DT	det	O
better	JJR	amod	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
Ig	NN	compound	B-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
enhancer	NN	compound	I-DNA
components	NNS	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
cloned	VBN	ROOT	O
and	CC	cc	O
analyzed	VBN	conj	O
individual	JJ	amod	O
sequence	NN	compound	B-DNA
elements	NNS	dobj	I-DNA
.	.	punct	O

We	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
factor	NN	nsubj	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
E3	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
motif	NN	nmod	I-DNA
,	,	punct	O
CATGTGGC	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
ubiquitous	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	ccomp	I-protein
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
an	DT	det	O
active	JJ	amod	O
form	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
non-B	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
where	WRB	advmod	O
it	PRP	nsubj	O
can	MD	aux	O
mediate	VB	acl:relcl	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
despite	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
activate	VB	acl	O
transcription	NN	dobj	O
of	IN	case	O
a	DT	det	O
transfected	VBN	amod	B-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
the	DT	det	O
factor	NN	nsubj	O
is	VBZ	cop	O
apparently	RB	advmod	O
unable	JJ	ROOT	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
the	DT	det	O
endogenous	JJ	amod	B-DNA
Ig	NN	compound	I-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
non-lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
In	IN	case	O
previous	JJ	amod	O
experiments	NNS	nmod	O
by	IN	case	O
others	NNS	nmod	O
,	,	punct	O
the	DT	det	O
characteristic	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
footprint	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
factor	NN	nmod	O
,	,	punct	O
designated	VBN	acl	O
NF-muE3	NN	xcomp	B-protein
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	parataxis	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
non-B	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

From	IN	case	O
this	DT	nmod	O
and	CC	cc	O
other	JJ	amod	O
findings	NNS	conj	O
the	DT	det	O
picture	NN	nsubj	O
emerges	VBZ	ROOT	O
that	IN	mark	O
there	EX	expl	O
are	VBP	ccomp	O
at	IN	case	O
least	JJS	nmod:npmod	O
three	CD	nummod	O
categories	NNS	nsubj	O
of	IN	case	O
factors	NNS	nmod	O
which	WDT	nsubj	O
mediate	VBP	acl:relcl	O
cell-type-specific	JJ	amod	O
transcription	NN	dobj	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
:	:	punct	O
(	-LRB-	punct	O
a	LS	det	O
)	-RRB-	punct	O
cell-specific	JJ	amod	B-protein
factors	NNS	dep	I-protein
such	JJ	case	O
as	IN	mwe	O
Oct-2A	NN	nmod	B-protein
and	CC	cc	O
Oct-2B	NN	conj	B-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
not	RB	neg	O
expressed	VBN	acl:relcl	O
in	IN	case	O
most	JJS	amod	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
:	:	punct	O
(	-LRB-	punct	O
b	LS	dep	O
)	-RRB-	punct	O
ubiquitous	JJ	amod	B-protein
factors	NNS	dep	I-protein
such	JJ	case	O
as	IN	mwe	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
that	WDT	nsubj	O
are	VBP	cop	O
constitutively	RB	advmod	O
active	JJ	acl:relcl	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
are	VBP	auxpass	O
sequestered	VBN	conj	O
in	IN	case	O
an	DT	det	O
inactive	JJ	amod	O
form	NN	nmod	O
in	IN	case	O
other	JJ	amod	O
cells	NNS	nmod	O
;	:	punct	O
(	-LRB-	punct	O
c	LS	dep	O
)	-RRB-	punct	O
ubiquitously	RB	advmod	B-protein
active	JJ	amod	I-protein
factors	NNS	dep	I-protein
,	,	punct	O
exemplified	VBN	acl	O
by	IN	case	O
the	DT	det	O
one	CD	nummod	O
binding	VBG	nmod	O
to	TO	case	O
the	DT	det	O
E3	NN	compound	B-DNA
sequence	NN	compound	I-DNA
motif	NN	nmod	I-DNA
.	.	punct	O

This	DT	det	O
factor	NN	nsubj	O
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
an	DT	det	O
active	JJ	amod	O
form	NN	nmod	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
types	NNS	nmod	O
but	CC	cc	O
is	VBZ	cop	O
apparently	RB	advmod	O
unable	JJ	conj	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
the	DT	det	O
endogenous	JJ	amod	B-DNA
Ig	NN	compound	I-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
non-B	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
perhaps	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
a	DT	det	O
non-permissive	JJ	amod	O
chromatin	NN	compound	B-DNA
structure	NN	nmod	O
of	IN	case	O
the	DT	det	O
Ig	NN	compound	B-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
locus	NN	nmod	I-DNA
.	.	punct	O

[	-LRB-	punct	O
Endocrine	JJ	amod	O
status	NN	compound	O
changes	NNS	ROOT	O
in	IN	case	O
children	NNS	nmod	O
with	IN	case	O
bronchial	JJ	amod	O
asthma	NN	nmod	O
]	-RRB-	punct	O

A	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
made	VBN	ROOT	O
of	IN	case	O
adrenocortical	JJ	amod	O
function	NN	nmod	O
by	IN	mark	O
measuring	VBG	advcl	O
blood	NN	compound	O
plasma	NN	compound	O
cortisol	NN	compound	O
concentration	NN	dobj	O
and	CC	cc	O
amount	NN	conj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
thyroid	NN	compound	O
function	NN	conj	O
by	IN	mark	O
measuring	VBG	advcl	O
blood	NN	compound	O
plasma	NN	compound	O
triidothyronine	NN	dobj	O
and	CC	cc	O
thyroxine	NN	compound	O
concentration	NN	conj	O
in	IN	case	O
58	CD	nummod	O
bronchial	JJ	amod	O
asthma	NN	compound	O
children	NNS	nmod	O
aged	JJ	amod	O
1	CD	compound	O
to	TO	dep	O
14	CD	nummod	O
years	NNS	dep	O
.	.	punct	O

The	DT	det	O
authors	NNS	nsubj	O
revealed	VBD	ROOT	O
alterations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
functional	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
indicated	VBN	amod	O
endocrine	JJ	amod	O
glands	NNS	nmod	O
depending	VBG	case	O
on	IN	case	O
the	DT	det	O
intensity	NN	nmod	O
of	IN	case	O
bronchial	JJ	amod	O
patency	NN	compound	O
disorders	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
nature	NN	conj	O
of	IN	case	O
the	DT	det	O
therapeutic	JJ	amod	O
measures	NNS	nmod	O
carried	VBN	acl	O
out	RP	prt	O
.	.	punct	O

TAR	NN	compound	B-DNA
independent	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
in	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod:npmod	O
stimulated	JJ	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Multiple	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	nsubjpass	I-DNA
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
HIV	NN	compound	B-DNA
LTR	NN	appos	I-DNA
)	-RRB-	punct	O
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
HIV	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Previous	JJ	amod	O
transfection	NN	compound	O
studies	NNS	nsubj	O
of	IN	case	O
HIV	NN	compound	B-DNA
LTR	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
linked	VBN	acl	O
to	TO	case	O
the	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
gene	NN	nmod	I-DNA
indicated	VBD	ROOT	O
that	IN	mark	O
multiple	JJ	amod	O
regulatory	JJ	amod	B-DNA
regions	NNS	nsubj	I-DNA
including	VBG	case	O
the	DT	det	O
enhancer	NN	nmod	B-DNA
,	,	punct	O
SP1	NN	conj	B-DNA
,	,	punct	O
TATA	NN	conj	B-DNA
and	CC	cc	O
TAR	NN	compound	B-DNA
regions	NNS	conj	I-DNA
were	VBD	cop	O
important	JJ	ccomp	O
for	IN	case	O
HIV	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

To	TO	mark	O
characterize	VB	advcl	O
these	DT	det	O
regulatory	JJ	amod	B-DNA
elements	NNS	dobj	I-DNA
further	RBR	advmod	O
,	,	punct	O
mutations	NNS	nsubjpass	O
in	IN	case	O
these	DT	det	O
regions	NNS	nmod	O
were	VBD	auxpass	O
inserted	VBN	ROOT	O
into	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
5	CD	nummod	O
'	''	punct	O
and	CC	cc	O
3	CD	conj	O
'	``	punct	O
HIV	NN	compound	B-DNA
LTRs	NNS	dobj	I-DNA
and	CC	cc	O
infectious	JJ	amod	O
proviral	JJ	amod	O
constructs	NNS	nsubjpass	O
were	VBD	auxpass	O
assembled	VBN	conj	O
.	.	punct	O

These	DT	det	O
constructs	NNS	nsubjpass	O
were	VBD	auxpass	O
transfected	VBN	ROOT	O
into	IN	case	O
either	CC	cc:preconj	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
Jurkat	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
or	CC	cc	O
U937	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
in	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
presence	NN	nmod	O
and	CC	cc	O
absence	NN	conj	O
of	IN	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
which	WDT	nsubjpass	O
have	VBP	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
demonstrated	VBN	acl:relcl	O
to	TO	mark	O
activate	VB	xcomp	O
HIV	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Viral	JJ	amod	O
gene	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
assayed	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
p24	NN	compound	B-protein
gag	NN	compound	I-protein
protein	NN	nmod	I-protein
released	VBN	acl	O
from	IN	case	O
cultures	NNS	nmod	O
transfected	VBN	acl	O
with	IN	case	O
the	DT	det	O
proviral	JJ	amod	O
constructs	NNS	nmod	O
.	.	punct	O

Results	NNS	nsubj	O
in	IN	case	O
all	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
mutations	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
SP1	NN	nmod	B-DNA
,	,	punct	O
TATA	NN	conj	B-DNA
and	CC	cc	O
the	DT	det	O
TAR	NN	conj	O
loop	NN	dep	O
and	CC	cc	O
stem	NN	compound	O
secondary	JJ	amod	O
structure	NN	conj	O
resulted	VBD	ccomp	O
in	IN	case	O
marked	JJ	amod	O
decreases	NNS	nmod	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
while	IN	mark	O
mutations	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
enhancer	NN	compound	B-DNA
motif	NN	nmod	I-DNA
or	CC	cc	O
TAR	NN	compound	B-DNA
primary	JJ	amod	I-DNA
sequence	NN	conj	I-DNA
resulted	VBD	advcl	O
in	IN	case	O
only	RB	advmod	O
slight	JJ	amod	O
decreases	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
viruses	NNS	nsubj	O
containing	VBG	acl	O
mutations	NNS	dobj	O
in	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
TAR	NN	compound	B-DNA
loop	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
or	CC	cc	O
stem	NN	compound	O
secondary	JJ	amod	O
structure	NN	conj	O
which	WDT	nsubj	O
were	VBD	cop	O
very	RB	advmod	O
defective	JJ	acl:relcl	O
for	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
untreated	JJ	amod	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
gave	VBD	ROOT	O
nearly	RB	advmod	O
wild-type	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
phorbol	NN	compound	B-cell_line
ester-treated	JJ	amod	I-cell_line
Jurkat	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
phorbol	NN	nmod:npmod	B-cell_line
ester-treated	JJ	amod	I-cell_line
HeLa	NN	conj	I-cell_line
or	CC	cc	O
U937	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

High	JJ	amod	O
level	NN	compound	O
gene	NN	compound	O
expression	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
TAR	NN	compound	B-DNA
mutant	JJ	amod	I-DNA
constructs	NNS	nmod	I-DNA
in	IN	case	O
phorbol	NN	compound	B-cell_line
ester-treated	JJ	amod	I-cell_line
Jurkat	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
eliminated	VBN	ROOT	O
by	IN	case	O
second	JJ	amod	O
site	NN	compound	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
enhancer	NN	compound	B-DNA
region	NN	nmod	I-DNA
or	CC	cc	O
by	IN	case	O
disruption	NN	conj	O
of	IN	case	O
the	DT	det	O
tat	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

A	DT	det	O
case	NN	ROOT	O
of	IN	case	O
hypersensitivity	NN	nmod	O
to	TO	case	O
thyroid	NN	compound	O
hormones	NNS	nmod	O
with	IN	case	O
normally	RB	advmod	O
functioning	VBG	amod	O
thyroid	NN	compound	O
gland	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
nuclear	JJ	amod	O
triiodothyronine	NN	compound	B-protein
receptors	NNS	conj	I-protein
.	.	punct	O

A	DT	det	O
52-year-old	JJ	amod	O
male	JJ	nsubj	O
presented	VBD	ROOT	O
himself	PRP	dobj	O
with	IN	case	O
tachycardia	NN	compound	O
crises	NNS	nmod	O
which	WDT	nsubj	O
appeared	VBD	acl:relcl	O
first	RB	advmod	O
during	IN	case	O
childhood	NN	nmod	O
,	,	punct	O
increased	VBD	conj	O
in	IN	case	O
frequency	NN	nmod	O
without	IN	case	O
goiter	NN	nmod	O
or	CC	cc	O
exophthalmos	NN	conj	O
.	.	punct	O

Cardiac	JJ	amod	O
and	CC	cc	O
adrenergic	JJ	conj	O
diseases	NNS	nsubjpass	O
were	VBD	auxpass	O
excluded	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
thyroid	NN	compound	O
function	NN	nsubj	O
was	VBD	cop	O
normal	JJ	ROOT	O
regarding	VBG	case	O
T4	NN	nmod	O
,	,	punct	O
free	JJ	amod	O
T4	NN	conj	O
and	CC	cc	O
T3	NN	conj	O
,	,	punct	O
TBG	NN	conj	O
,	,	punct	O
radioiodine	NN	compound	O
uptake	NN	conj	O
,	,	punct	O
TSH	NN	appos	O
and	CC	cc	O
T3	NN	conj	O
suppressibility	NN	dep	O
;	:	punct	O
however	RB	advmod	O
the	DT	det	O
TSH	NN	compound	O
response	NN	nsubjpass	O
to	TO	case	O
TRH	NN	nmod	O
was	VBD	auxpass	O
decreased	VBN	parataxis	O
.	.	punct	O

The	DT	det	O
lymphocyte	NN	compound	B-protein
nuclear	JJ	amod	I-protein
T3	NN	compound	I-protein
receptor	NN	nsubjpass	I-protein
was	VBD	auxpass	O
found	VBN	ROOT	O
with	IN	case	O
an	DT	det	O
affinity	NN	nmod	O
close	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
normal	JJ	amod	O
volunteers	NNS	nmod	O
(	-LRB-	punct	O
Ka	NN	appos	O
:	:	punct	O
1.42	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
10	CD	dep	O
)	-RRB-	punct	O
M-1	NN	dep	O
vs	CC	cc	O
1.95	CD	nummod	O
+/-	CC	cc	O
0.35	CD	conj	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
10	CD	dep	O
)	-RRB-	punct	O
M-1	NN	conj	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
binding	NN	compound	O
capacity	NN	nsubj	O
markedly	RB	advmod	O
increased	VBD	conj	O
(	-LRB-	punct	O
9.9	CD	nummod	O
vs	CC	cc	O
3.7	CD	conj	O
+/-	CC	cc	O
0.4	CD	conj	O
fmol	NN	compound	O
T3/100	JJ	compound	O
micrograms	NNS	compound	O
DNA	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

Pindolol	NN	nsubj	O
was	VBD	cop	O
inefficient	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
dysrhythmia	NN	nmod	O
which	WDT	nsubj	O
disappeared	VBD	acl:relcl	O
with	IN	case	O
carbimazole	NN	nmod	O
and	CC	cc	O
relapsed	VBD	conj	O
after	IN	case	O
withdrawal	NN	nmod	O
of	IN	case	O
the	DT	det	O
antithyroid	JJ	amod	O
drug	NN	nmod	O
.	.	punct	O

Under	IN	case	O
carbimazole	NN	nmod	O
,	,	punct	O
the	DT	det	O
plasma	NN	compound	O
T4	NN	nsubj	O
markedly	RB	advmod	O
decreased	VBD	ROOT	O
(	-LRB-	punct	O
27.7	CD	nummod	O
+/-	CC	cc	O
3.6	CD	conj	O
nmol/l	NN	dep	O
)	-RRB-	punct	O
but	CC	cc	O
the	DT	det	O
patient	NN	nsubj	O
remained	VBD	conj	O
euthyroid	JJ	xcomp	O
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
course	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
laboratory	NN	amod	O
data	NNS	conj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
tachycardia	NN	compound	O
crises	NNS	nsubj	O
are	VBP	cop	O
the	DT	det	O
consequence	NN	ccomp	O
of	IN	case	O
a	DT	det	O
hypersensitivity	NN	nmod	O
of	IN	case	O
the	DT	det	O
heart	NN	nmod	O
to	TO	case	O
thyroid	NN	compound	O
hormones	NNS	nmod	O
,	,	punct	O
associated	VBN	acl	O
with	IN	case	O
an	DT	det	O
increased	VBN	amod	O
number	NN	nmod	O
of	IN	case	O
T3	NN	compound	B-protein
nuclear	JJ	amod	I-protein
receptor	NN	compound	I-protein
sites	NNS	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Induction	NN	ROOT	O
of	IN	case	O
immediate	JJ	amod	B-DNA
early	JJ	amod	I-DNA
response	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
by	IN	case	O
macrophage	NN	compound	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	nmod	I-protein
in	IN	case	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
group	NN	nsubjpass	O
of	IN	case	O
coordinately	RB	advmod	O
induced	VBN	amod	O
protooncogenes	NNS	nmod	B-DNA
,	,	punct	O
cytoskeletal	JJ	conj	B-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
extracellular	JJ	amod	I-DNA
matrix	NN	compound	I-DNA
genes	NNS	conj	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
termed	VBN	ROOT	O
immediate	JJ	amod	B-DNA
early	JJ	amod	I-DNA
response	NN	compound	I-DNA
genes	NNS	xcomp	I-DNA
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
induction	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	conj	O
with	IN	case	O
growth	NN	nmod:npmod	B-protein
factor	NN	nmod:npmod	I-protein
-stimulated	JJ	amod	O
cell	NN	compound	O
proliferation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
by	IN	case	O
macrophage-CSF	NN	nmod	B-protein
(	-LRB-	punct	O
M-CSF	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
that	WDT	nsubj	O
do	VBP	aux	O
not	RB	neg	O
proliferate	VB	acl:relcl	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
M-CSF	NN	nmod	B-protein
but	CC	cc	O
require	VBP	conj	O
the	DT	det	O
factor	NN	dobj	O
for	IN	case	O
optimal	JJ	amod	O
cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

Normal	JJ	amod	O
human	JJ	amod	B-cell_type
monocytes	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
isolated	VBN	ROOT	O
,	,	punct	O
carefully	RB	advmod	O
washed	VBN	conj	O
,	,	punct	O
and	CC	cc	O
incubated	VBN	conj	O
for	IN	case	O
36	CD	compound	O
to	TO	dep	O
48	CD	nummod	O
h	NN	nmod	O
in	IN	case	O
fetal	JJ	amod	O
bovine	JJ	amod	O
serum-containing	JJ	amod	O
medium	NN	nmod	O
.	.	punct	O

At	IN	case	O
the	DT	det	O
end	NN	nmod	O
of	IN	case	O
this	DT	det	O
incubation	NN	nmod	O
the	DT	det	O
resting	VBG	amod	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	ROOT	O
with	IN	case	O
M-CSF	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
RNA	NN	nsubjpass	O
was	VBD	auxpass	O
isolated	VBN	conj	O
for	IN	case	O
analysis	NN	nmod	O
by	IN	case	O
Northern	NN	compound	O
blotting	NN	nmod	O
.	.	punct	O

RNA	NN	nsubj	O
from	IN	case	O
control	JJ	amod	O
resting	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
contained	VBD	ROOT	O
low	JJ	dobj	O
to	TO	case	O
undetectable	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
c-jun	NN	nmod	B-RNA
,	,	punct	O
fibronectin	NN	compound	B-RNA
receptor	NN	conj	I-RNA
,	,	punct	O
and	CC	cc	O
actin	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
.	.	punct	O

Within	IN	case	O
15	CD	compound	O
to	TO	dep	O
30	CD	nummod	O
min	NN	nmod	O
of	IN	case	O
addition	NN	nmod	O
of	IN	case	O
M-CSF	NN	nmod	B-protein
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
dramatic	JJ	amod	O
coordinate	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
.	.	punct	O

The	DT	det	O
c-jun	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nsubj	O
was	VBD	cop	O
very	RB	advmod	O
transient	JJ	ROOT	O
and	CC	cc	O
was	VBD	cop	O
not	RB	neg	O
detectable	JJ	conj	O
by	IN	case	O
60	CD	nummod	O
min	NN	nmod	O
after	IN	case	O
M-CSF	NN	compound	B-protein
addition	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
actin	NN	nmod	B-RNA
and	CC	cc	I-RNA
fibronectin	NN	compound	I-RNA
receptor	NN	compound	I-RNA
mRNA	NN	conj	I-RNA
was	VBD	cop	O
more	RBR	advmod	O
sustained	JJ	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
remained	VBD	conj	O
elevated	JJ	xcomp	O
at	IN	case	O
24	CD	compound	O
to	TO	dep	O
48	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
M-CSF	NN	compound	B-protein
addition	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
observed	VBD	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
the	DT	det	O
myelomonocytic	JJ	amod	B-DNA
specific	JJ	amod	I-DNA
tyrosine	NN	compound	I-DNA
kinase	NN	compound	I-DNA
hck	NN	compound	I-DNA
gene	NN	nmod	I-DNA
simultaneously	RB	advmod	O
with	IN	case	O
the	DT	det	O
other	JJ	amod	O
immediate	JJ	amod	B-DNA
early	JJ	amod	I-DNA
response	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
protein	NN	compound	O
synthesis	NN	compound	O
inhibitor	NN	compound	O
cycloheximide	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
block	VB	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
any	DT	nmod	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
fact	NN	nmod	O
,	,	punct	O
super-induced	VBD	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
c-jun	NN	nmod	B-DNA
and	CC	cc	O
hck	NN	conj	B-DNA
.	.	punct	O

Nuclear	JJ	amod	O
run	NN	ROOT	O
on	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
c-jun	NN	nmod	B-DNA
,	,	punct	O
hck	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
actin	NN	compound	B-DNA
genes	NNS	conj	I-DNA
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
in	IN	case	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
monocytes	NNS	nmod	I-cell_type
M-CSF	NN	dep	B-protein
induces	VBZ	ROOT	O
immediate	JJ	amod	B-DNA
early	JJ	amod	I-DNA
response	NN	compound	I-DNA
genes	NNS	dobj	I-DNA
without	IN	mark	O
inducing	VBG	advcl	O
cell	NN	compound	O
proliferation	NN	dobj	O
.	.	punct	O

These	DT	det	O
genes	NNS	nsubj	O
may	MD	aux	O
then	RB	advmod	O
play	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
altering	VBG	advcl	O
the	DT	det	O
physiologic	JJ	amod	O
status	NN	dobj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
CSF	NN	nmod	B-protein
.	.	punct	O

Inducible	JJ	amod	O
nuclear	JJ	amod	B-protein
factor	NN	nsubjpass	I-protein
binding	VBG	acl	O
to	TO	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
can	MD	aux	O
be	VB	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
in	IN	case	O
a	DT	det	O
signal-dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Cyclosporin	NN	compound	O
A	NN	nsubjpass	O
(	-LRB-	punct	O
CsA	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
exert	VB	xcomp	O
its	PRP$	nmod:poss	O
immunosuppressive	JJ	amod	O
effects	NNS	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
distinct	JJ	amod	O
set	NN	nmod	O
of	IN	case	O
lymphokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
which	WDT	nsubjpass	O
are	VBP	auxpass	O
induced	VBN	acl:relcl	O
upon	IN	case	O
T-cell	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
among	IN	case	O
them	PRP	nmod	O
the	DT	det	O
gene	NN	dobj	O
coding	VBG	acl	O
for	IN	case	O
interleukin-2	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
HIV	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
partially	RB	advmod	O
suppressed	VBN	ROOT	O
.	.	punct	O

To	TO	mark	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
suppression	NN	dobj	O
by	IN	case	O
CsA	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
this	DT	det	O
drug	NN	nmod	O
on	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
formation	NN	nsubjpass	O
of	IN	case	O
two	CD	nummod	O
distinct	JJ	amod	O
mitogen-inducible	JJ	amod	B-protein
DNA-binding	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
,	,	punct	O
the	DT	det	O
kappa	NN	compound	B-protein
B	NN	compound	I-protein
complex	NN	appos	I-protein
within	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
NFAT-1	NN	compound	B-protein
complex	NN	conj	I-protein
within	IN	case	O
the	DT	det	O
interleukin-2	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
,	,	punct	O
is	VBZ	auxpass	O
inhibited	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
CsA	NN	nmod	O
.	.	punct	O

The	DT	det	O
kappa	NN	compound	O
B-binding	JJ	amod	O
activity	NN	nsubjpass	O
with	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
is	VBZ	auxpass	O
inhibited	VBN	ROOT	O
only	RB	advmod	O
if	IN	mark	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	advcl	O
via	IN	case	O
the	DT	det	O
mitogen	NN	compound	B-protein
phytohemagglutinin	NN	nmod	B-protein
whereas	IN	mark	O
phorbol	NN	nmod:npmod	O
myristate	NN	nmod:npmod	O
acetate-mediated	JJ	amod	O
activation	NN	nsubj	O
is	VBZ	cop	O
completely	RB	advmod	O
insensitive	JJ	advcl	O
to	TO	case	O
the	DT	det	O
drug	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
a	DT	det	O
model	NN	dobj	O
in	IN	case	O
which	WDT	nmod	O
functionally	RB	advmod	O
indistinguishable	JJ	amod	O
kappa	NN	compound	B-protein
B	NN	compound	I-protein
complexes	NNS	nsubjpass	I-protein
can	MD	aux	O
be	VB	auxpass	O
activated	VBN	acl:relcl	O
via	IN	case	O
two	CD	nummod	O
separate	JJ	amod	O
pathways	NNS	nmod	O
of	IN	case	O
signal	NN	compound	O
transduction	NN	nmod	O
distinguishable	JJ	amod	O
by	IN	case	O
CsA	NN	nmod	O
.	.	punct	O

Purification	NN	ROOT	O
of	IN	case	O
TCF-1	NN	compound	B-protein
alpha	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
T-cell-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	appos	I-protein
that	WDT	nsubj	O
activates	VBZ	acl:relcl	O
the	DT	det	O
T-cell	NN	compound	B-DNA
receptor	NN	compound	I-DNA
C	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	compound	I-DNA
enhancer	NN	dobj	I-DNA
in	IN	case	O
a	DT	det	O
context-dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

The	DT	det	O
differentiation	NN	nsubjpass	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
into	IN	case	O
functionally	RB	advmod	O
diverse	JJ	amod	O
subpopulations	NNS	nmod	O
is	VBZ	auxpass	O
controlled	VBN	ROOT	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
and	CC	cc	O
silencing	NN	conj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	parataxis	O
in	IN	case	O
detail	NN	nmod	O
about	IN	case	O
the	DT	det	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
influence	VBP	acl:relcl	O
this	DT	det	O
developmental	JJ	amod	O
process	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
purified	VBN	ROOT	O
a	DT	det	O
new	JJ	amod	O
T-cell-specific	JJ	amod	B-protein
factor	NN	dobj	I-protein
,	,	punct	O
TCF-1	NN	compound	B-protein
alpha	NN	appos	I-protein
,	,	punct	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
encoding	VBG	acl	O
a	DT	det	O
major	JJ	amod	O
component	NN	dobj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
T-cell	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
TCR	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

TCF-1	NN	compound	B-protein
alpha	NN	nsubjpass	I-protein
,	,	punct	O
originally	RB	advmod	O
identified	VBN	acl	O
and	CC	cc	O
purified	VBN	conj	O
through	IN	case	O
its	PRP$	nmod:poss	O
binding	VBG	amod	O
sites	NNS	nmod	O
on	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
the	DT	det	O
TCR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
and	CC	cc	O
to	TO	case	O
promoters	NNS	conj	B-DNA
for	IN	case	O
several	JJ	amod	O
genes	NNS	nmod	B-DNA
expressed	VBN	acl	O
at	IN	case	O
significantly	RB	advmod	O
earlier	JJR	amod	O
stages	NNS	nmod	O
of	IN	case	O
T-cell	NN	compound	O
development	NN	nmod	O
than	IN	case	O
the	DT	det	O
TCR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
(	-LRB-	punct	O
e.g.	FW	dep	O
,	,	punct	O
p56lck	NN	dep	B-DNA
and	CC	cc	O
CD3	NN	compound	B-DNA
delta	NN	conj	I-DNA
)	-RRB-	punct	O
.	.	punct	O

Sequences	NNS	nsubjpass	O
related	JJ	amod	O
to	TO	case	O
the	DT	det	O
TCF-1	NN	compound	B-DNA
alpha	NN	compound	I-DNA
binding	NN	compound	I-DNA
motif	NN	nmod	I-DNA
(	-LRB-	punct	O
5'-GGCACCCTTTGA-3	NN	appos	O
'	''	punct	O
)	-RRB-	punct	O
are	VBP	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
TCR	NN	compound	I-DNA
delta	NN	compound	I-DNA
(	-LRB-	punct	O
and	CC	cc	O
possibly	RB	advmod	O
TCR	NN	compound	B-DNA
beta	NN	conj	I-DNA
)	-RRB-	punct	O
enhancers	NNS	nmod	B-DNA
.	.	punct	O

Southwestern	NN	nsubj	O
and	CC	cc	O
gel	NN	compound	O
renaturation	NN	compound	O
experiments	NNS	conj	O
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
purified	VBN	amod	O
protein	NN	compound	O
fractions	NNS	nmod	O
revealed	VBD	ROOT	O
that	IN	mark	O
TCF-1	NN	compound	B-protein
alpha	NN	compound	I-protein
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
derived	VBN	ccomp	O
from	IN	case	O
a	DT	det	O
family	NN	nmod	O
of	IN	case	O
57-	CD	nummod	B-protein
to	TO	dep	I-protein
53-kD	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
abundantly	RB	advmod	O
expressed	VBN	acl:relcl	O
in	IN	case	O
mature	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
immature	JJ	conj	I-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
(	-LRB-	punct	O
Jurkat	NN	dep	B-cell_line
,	,	punct	O
CCRF-CEM	NN	appos	B-cell_line
)	-RRB-	punct	O
and	CC	cc	O
not	RB	neg	O
in	IN	case	O
mature	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
(	-LRB-	punct	O
JY	NN	dep	B-cell_line
,	,	punct	O
Namalwa	NN	appos	B-cell_line
)	-RRB-	punct	O
or	CC	cc	O
nonlymphoid	JJ	amod	B-cell_line
(	-LRB-	punct	I-cell_line
HeLa	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

A	DT	det	O
small	JJ	amod	O
95-bp	JJ	amod	O
fragment	NN	nsubj	O
of	IN	case	O
the	DT	det	O
TCR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
control	NN	compound	I-DNA
region	NN	nmod	I-DNA
that	WDT	nsubj	O
contains	VBZ	acl:relcl	O
the	DT	det	O
TCF-1	NN	compound	B-DNA
alpha	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
juxtaposed	VBD	acl	O
between	IN	case	O
a	DT	det	O
cAMP-response	JJ	amod	B-DNA
element	NN	nmod	I-DNA
(	-LRB-	punct	O
the	DT	det	O
CRE	NN	dep	B-DNA
or	CC	cc	O
T	NN	compound	B-DNA
alpha	NN	compound	I-DNA
1	CD	nummod	I-DNA
motif	NN	conj	I-DNA
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
binding	VBG	amod	B-DNA
site	NN	conj	I-DNA
for	IN	case	O
a	DT	det	O
distinct	JJ	amod	O
lymphoid-specific	JJ	amod	B-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
TCF-2	NN	compound	B-protein
alpha	NN	appos	I-protein
)	-RRB-	punct	O
behaved	VBD	ROOT	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
T-cell-specific	JJ	amod	B-DNA
enhancer	NN	nmod	I-DNA
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Tandem	JJ	amod	O
copies	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
enhancer	NN	nmod	O
functioned	VBD	ROOT	O
synergistically	RB	advmod	O
in	IN	case	O
mature	JJ	amod	B-cell_line
(	-LRB-	punct	I-cell_line
Jurkat	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
resting	VBG	amod	O
and	CC	cc	O
activated	VBN	conj	O
immature	JJ	amod	B-cell_line
(	-LRB-	punct	I-cell_line
CCRF-CEM	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
TCF-1	NN	compound	B-DNA
alpha	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
diminished	VBD	ROOT	O
enhancer	NN	compound	O
activity	NN	dobj	O
and	CC	cc	O
disrupted	VBD	conj	O
the	DT	det	O
synergism	NN	dobj	O
observed	VBN	acl	O
in	FW	compound	O
vivo	FW	advmod	O
between	IN	case	O
tandem	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
repeats	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
TCF-1	NN	compound	B-DNA
alpha	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
also	RB	advmod	O
required	VBN	ROOT	O
for	IN	case	O
TCR	NN	compound	B-protein
alpha	NN	compound	O
enhancer	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
transcriptionally	RB	advmod	O
active	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
Jurkat	NN	nmod	B-cell_line
but	CC	cc	O
not	RB	cc	O
HeLa	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
confirming	VBG	xcomp	O
that	IN	mark	O
TCF-1	NN	compound	B-protein
alpha	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
T-cell-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	ccomp	I-protein
.	.	punct	O

Curiously	RB	advmod	O
,	,	punct	O
the	DT	det	O
TCF-1	NN	compound	B-protein
alpha	NN	compound	I-protein
binding	NN	compound	O
element	NN	nsubj	O
was	VBD	cop	O
inactive	JJ	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
when	WRB	advmod	O
removed	VBN	advcl	O
from	IN	case	O
its	PRP$	nmod:poss	O
neighboring	JJ	amod	O
elements	NNS	nmod	O
on	IN	case	O
the	DT	det	O
TCR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
and	CC	cc	O
positioned	JJ	conj	O
in	IN	case	O
one	CD	nummod	O
or	CC	cc	O
more	JJR	conj	O
copies	NNS	nmod	O
upstream	RB	advmod	O
of	IN	case	O
a	DT	det	O
heterologous	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	nsubj	O
of	IN	case	O
TCF-1	NN	compound	B-protein
alpha	NN	nmod	I-protein
appears	VBZ	ROOT	O
to	TO	mark	O
depend	VB	xcomp	O
on	IN	case	O
the	DT	dep	O
TCF-2	NN	compound	B-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
T	NN	compound	B-protein
alpha	NN	compound	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
CREB	NN	compound	B-protein
)	-RRB-	punct	O
transcription	NN	compound	B-protein
factors	NNS	dep	I-protein
and	CC	cc	O
the	DT	det	O
context	NN	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
binding	VBG	amod	O
site	NN	nmod	O
within	IN	case	O
the	DT	det	O
TCR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

Tandem	JJ	amod	B-DNA
AP-1-binding	JJ	amod	I-DNA
sites	NNS	ROOT	I-DNA
within	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
beta-globin	NN	compound	I-DNA
dominant	JJ	amod	I-DNA
control	NN	compound	I-DNA
region	NN	compound	I-DNA
function	VBP	nmod	O
as	IN	case	O
an	DT	det	O
inducible	JJ	amod	B-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
powerful	JJ	amod	O
enhancer	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
mapped	VBN	ROOT	O
to	TO	case	O
an	DT	det	O
18-bp	JJ	amod	B-DNA
DNA	NN	compound	I-DNA
segment	NN	nmod	I-DNA
located	JJ	amod	O
11	CD	nummod	O
kb	NN	nmod	O
5	CD	nummod	O
'	''	punct	O
to	TO	case	O
the	DT	det	O
human	JJ	amod	B-DNA
epsilon-globin	NN	compound	I-DNA
gene	NN	nmod	I-DNA
within	IN	case	O
the	DT	det	O
dominant	JJ	amod	B-DNA
control	NN	nmod	I-DNA
or	CC	cc	O
locus-activating	JJ	amod	B-DNA
region	NN	conj	I-DNA
.	.	punct	O

This	DT	det	O
enhancer	NN	nsubj	B-DNA
is	VBZ	cop	O
inducible	JJ	ROOT	O
in	IN	case	O
K562	NN	compound	B-cell_line
human	JJ	amod	I-cell_line
erythroleukemia	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
increasing	VBG	advcl	O
linked	VBN	amod	O
gamma-globin	NN	compound	B-DNA
promoter	NN	compound	I-DNA
/luciferase	NN	compound	B-protein
gene	NN	compound	O
expression	NN	dobj	O
to	TO	case	O
170-fold	RB	nmod	O
over	IN	case	O
an	DT	det	O
enhancerless	JJ	compound	B-DNA
construct	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
enhancer	NN	nsubj	B-DNA
consists	VBZ	ROOT	O
of	IN	case	O
tandem	JJ	amod	B-DNA
AP-1-binding	JJ	amod	I-DNA
sites	NNS	nmod	I-DNA
,	,	punct	O
phased	JJ	conj	O
10	CD	nummod	O
bp	NN	nmod:npmod	O
apart	RB	advmod	O
,	,	punct	O
which	WDT	nsubj	O
are	VBP	auxpass	O
both	DT	dep	O
required	VBN	conj	O
for	IN	case	O
full	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

DNA-protein	JJ	amod	O
binding	NN	compound	O
assays	NNS	nsubj	O
with	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
induced	VBN	amod	O
cells	NNS	nmod	O
demonstrate	VBP	ROOT	O
a	DT	det	O
high	JJ	amod	B-protein
molecular	JJ	amod	I-protein
weight	NN	compound	I-protein
complex	NN	dobj	I-protein
on	IN	case	O
the	DT	det	O
enhancer	NN	nmod	B-DNA
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
complex	NN	nmod	O
also	RB	advmod	O
requires	VBZ	ROOT	O
both	DT	cc:preconj	O
AP-1	NN	compound	B-DNA
sites	NNS	dobj	I-DNA
and	CC	cc	O
correlates	VBZ	conj	O
with	IN	case	O
maximal	JJ	amod	O
enhancer	NN	compound	B-DNA
activity	NN	nmod	O
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
enhancer	NN	nmod	B-DNA
may	MD	aux	O
have	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
increase	NN	nmod	O
in	IN	case	O
globin	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
that	WDT	nsubj	O
characterizes	VBZ	acl:relcl	O
erythroid	JJ	amod	O
maturation	NN	dobj	O
.	.	punct	O

Enhancer	NN	compound	O
activity	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
binding	NN	nmod	O
of	IN	case	O
a	DT	det	O
complex	NN	nmod	O
of	IN	case	O
proteins	NNS	nmod	O
from	IN	case	O
the	DT	det	O
jun	NN	compound	B-DNA
and	CC	cc	I-DNA
fos	NN	conj	I-DNA
families	NNS	nmod	I-DNA
to	TO	case	O
tandem	JJ	amod	B-DNA
AP-1	NN	compound	I-DNA
consensus	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	B-protein
factor	NN	nmod	I-protein
that	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
an	DT	det	O
immunoglobulin	NN	compound	B-DNA
heavy-chain	NN	amod	I-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
stimulates	VBZ	conj	O
transcription	NN	dobj	O
in	IN	case	O
conjunction	NN	nmod	O
with	IN	case	O
the	DT	det	O
lymphoid	JJ	amod	B-protein
cell-specific	JJ	amod	I-protein
factor	NN	nmod	I-protein
OTF2	NN	dep	B-protein
.	.	punct	O

The	DT	det	O
tissue-specific	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
MOPC	NN	compound	B-DNA
141	CD	nummod	I-DNA
immunoglobulin	NN	compound	I-DNA
heavy-chain	JJ	amod	I-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
studied	VBN	ROOT	O
by	IN	mark	O
using	VBG	advcl	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	dobj	O
.	.	punct	O

B-cell-specific	JJ	amod	O
transcription	NN	nsubj	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
was	VBD	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
octamer	NN	compound	B-DNA
element	NN	compound	I-DNA
5'-ATGCAAAG-3	NN	nmod	O
'	''	punct	O
,	,	punct	O
located	JJ	xcomp	O
in	IN	case	O
the	DT	det	O
upstream	JJ	amod	B-DNA
region	NN	nmod	I-DNA
of	IN	case	O
this	DT	det	O
promoter	NN	nmod	B-DNA
and	CC	cc	O
in	IN	case	O
the	DT	det	O
promoters	NNS	conj	B-DNA
of	IN	case	O
all	DT	det	O
other	JJ	amod	O
immunoglobulin	NN	nmod	B-DNA
heavy-	JJ	amod	I-DNA
and	CC	cc	I-DNA
light-chain	JJ	conj	I-DNA
genes	NNS	dep	I-DNA
.	.	punct	O

The	DT	det	O
interaction	NN	nsubjpass	O
of	IN	case	O
purified	VBN	amod	O
octamer	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
1	CD	dep	O
and	CC	cc	O
2	CD	conj	O
(	-LRB-	punct	O
OTF1	NN	dep	B-protein
and	CC	cc	O
OTF2	NN	conj	B-protein
)	-RRB-	punct	O
with	IN	case	O
the	DT	det	O
MOPC	NN	compound	B-DNA
141	CD	nummod	I-DNA
promoter	NN	nmod	I-DNA
was	VBD	auxpass	O
studied	VBN	ROOT	O
by	IN	mark	O
using	VBG	advcl	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	dobj	O
and	CC	cc	O
DNase	NN	compound	B-protein
I	CD	nummod	I-protein
footprinting	NN	conj	O
.	.	punct	O

Purified	VBN	amod	O
OTF1	NN	nsubj	B-protein
from	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
OTF1	NN	conj	B-protein
and	CC	cc	O
OTF2	NN	conj	B-protein
from	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
bound	VBD	ROOT	O
to	TO	case	O
identical	JJ	amod	O
sequences	NNS	nmod	O
within	IN	case	O
the	DT	det	O
heavy-chain	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
OTF	NN	compound	O
interactions	NNS	nsubj	O
we	PRP	nsubj	O
observed	VBD	acl:relcl	O
extended	VBD	ROOT	O
over	IN	case	O
the	DT	det	O
heptamer	NN	compound	B-DNA
element	NN	compound	I-DNA
5'-CTCAGGA-3	NN	nmod	O
'	''	punct	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubj	O
seems	VBZ	conj	O
likely	JJ	xcomp	O
that	IN	mark	O
the	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
purified	VBN	amod	B-protein
factors	NNS	nmod	I-protein
involves	VBZ	ccomp	O
cooperation	NN	dobj	O
between	IN	case	O
octamer	NN	compound	B-DNA
and	CC	cc	I-DNA
heptamer	NN	conj	I-DNA
sites	NNS	nmod	I-DNA
in	IN	case	O
this	DT	det	O
promoter	NN	nmod	B-DNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
these	DT	det	O
elements	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
a	DT	det	O
second	JJ	amod	O
regulatory	JJ	amod	B-DNA
element	NN	dobj	I-DNA
,	,	punct	O
the	DT	det	O
N	NN	compound	B-DNA
element	NN	appos	I-DNA
with	IN	case	O
the	DT	det	O
sequence	NN	compound	O
5'-GGAACCTCCCCC-3'	NN	nmod	O
.	.	punct	O

The	DT	det	O
N	NN	compound	B-DNA
element	NN	nsubj	I-DNA
could	MD	aux	O
independently	RB	advmod	O
mediate	VB	ROOT	O
low	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
transcription	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
B-cell	NN	nmod	O
and	CC	cc	O
HeLa-cell	JJ	conj	O
extracts	NNS	dep	O
,	,	punct	O
and	CC	cc	O
,	,	punct	O
in	IN	case	O
conjunction	NN	nmod	O
with	IN	case	O
the	DT	det	O
octamer	NN	compound	B-DNA
element	NN	nmod	I-DNA
,	,	punct	O
it	PRP	nsubj	O
can	MD	aux	O
promote	VB	conj	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
transcription	NN	nmod	O
in	IN	case	O
B-cell	NN	compound	O
extracts	NNS	nmod	O
.	.	punct	O

The	DT	det	O
N	NN	compound	B-DNA
element	NN	nsubj	I-DNA
bound	VBD	ROOT	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	dobj	I-protein
,	,	punct	O
NTF	NN	appos	B-protein
,	,	punct	O
that	WDT	nsubj	O
is	VBZ	cop	O
ubiquitous	JJ	acl:relcl	O
in	IN	case	O
cell-type	JJ	amod	O
distribution	NN	nmod	O
,	,	punct	O
and	CC	cc	O
NTF	NN	nsubj	B-protein
was	VBD	cop	O
distinct	JJ	conj	O
from	IN	case	O
any	DT	nmod	O
of	IN	case	O
the	DT	det	O
previously	RB	advmod	B-protein
described	VBN	amod	I-protein
proteins	NNS	nmod	I-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
to	TO	case	O
similar	JJ	amod	O
sequences	NNS	nmod	O
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
these	DT	det	O
results	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
NTF	NN	compound	B-protein
and	CC	cc	O
OTF2	NN	conj	B-protein
interactions	NNS	nsubj	O
(	-LRB-	punct	O
both	CC	cc:preconj	O
with	IN	case	O
their	PRP$	nmod:poss	O
cognate	JJ	amod	B-DNA
DNA	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
and	CC	cc	O
possibly	RB	advmod	O
at	IN	case	O
the	DT	det	O
protein-protein	JJ	amod	O
level	NN	conj	O
)	-RRB-	punct	O
may	MD	aux	O
be	VB	cop	O
critical	JJ	ccomp	O
to	TO	case	O
B-cell-specific	JJ	amod	O
expression	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
these	DT	det	O
interactions	NNS	nsubj	O
provide	VBP	conj	O
additional	JJ	amod	O
pathways	NNS	dobj	O
for	IN	mark	O
regulating	VBG	acl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

NF-kappa	NN	compound	B-protein
B	NN	ROOT	I-protein
as	IN	case	O
inducible	JJ	amod	O
transcriptional	JJ	amod	B-protein
activator	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
granulocyte-macrophage	JJ	amod	B-DNA
colony-stimulating	JJ	amod	I-DNA
factor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
encoding	VBG	acl	O
the	DT	det	O
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	dobj	I-protein
(	-LRB-	punct	O
GM-CSF	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
upon	IN	case	O
activation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
phytohemagglutinin	NN	nmod	B-protein
and	CC	cc	O
active	JJ	amod	O
phorbolester	NN	conj	O
and	CC	cc	O
upon	IN	case	O
expression	NN	conj	O
of	IN	case	O
tax1	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
transactivating	VBG	amod	B-protein
protein	NN	appos	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
.	.	punct	O

The	DT	det	O
same	JJ	amod	O
agents	NNS	nsubj	O
induce	VBP	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
the	DT	det	O
interleukin-2	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha-chain	NN	nmod	I-DNA
and	CC	cc	I-DNA
interleukin-2	NN	conj	I-DNA
genes	NNS	dep	I-DNA
,	,	punct	O
depending	VBG	case	O
on	IN	case	O
promoter	NN	compound	B-DNA
elements	NNS	nmod	I-DNA
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
the	DT	det	O
inducible	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	dep	I-protein
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
(	-LRB-	punct	O
or	CC	cc	O
an	DT	det	O
NF-kappa	NN	compound	B-protein
B-like	JJ	amod	I-protein
factor	NN	conj	I-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
therefore	RB	advmod	O
tested	VBD	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
also	RB	advmod	O
regulated	VBN	ccomp	O
by	IN	case	O
a	DT	det	O
cognate	JJ	amod	O
motif	NN	nmod	O
for	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
.	.	punct	O

A	DT	det	O
recent	JJ	amod	O
functional	JJ	amod	O
analysis	NN	nsubj	O
by	IN	case	O
Miyatake	NNP	nmod	O
et	FW	dep	O
al.	FW	dep	O
(	-LRB-	punct	O
S.	NNP	compound	O
Miyatake	NNP	dep	O
,	,	punct	O
M.	NNP	compound	O
Seiki	NNP	conj	O
,	,	punct	O
M.	NNP	compound	O
Yoshida	NNP	conj	O
,	,	punct	O
and	CC	cc	O
K.	NNP	compound	O
Arai	NNP	conj	O
,	,	punct	O
Mol.	NNP	compound	O
Cell.	NNP	compound	O
Biol.	NNP	appos	O
8	CD	nummod	O
:	:	punct	O
5581-5587	CD	dep	O
,	,	punct	O
1988	CD	amod	O
)	-RRB-	punct	O
described	VBD	ROOT	O
a	DT	det	O
short	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
region	NN	dobj	I-DNA
in	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
gene	NN	nmod	I-DNA
that	WDT	nsubj	O
conferred	VBD	acl:relcl	O
strong	JJ	amod	O
inducibility	NN	dobj	O
by	IN	case	O
T-cell-activating	JJ	amod	O
signals	NNS	nmod	O
and	CC	cc	O
tax1	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
NF-kappa	NN	compound	B-DNA
B-binding	JJ	amod	I-DNA
motifs	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
identified	VBN	conj	O
.	.	punct	O

Using	VBG	advcl	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
binding	NN	dobj	O
of	IN	case	O
purified	VBN	amod	O
human	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
activated	VBN	acl	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
to	TO	case	O
an	DT	det	O
oligonucleotide	NN	nmod	O
comprising	VBG	acl	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	compound	I-DNA
element	NN	dobj	I-DNA
responsible	JJ	amod	O
for	IN	mark	O
mediating	VBG	advcl	O
responsiveness	NN	dobj	O
to	TO	case	O
T-cell-activating	JJ	amod	O
signals	NNS	nmod	O
and	CC	cc	O
tax1	NN	conj	B-protein
.	.	punct	O

As	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
a	DT	det	O
methylation	NN	compound	O
interference	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
oligonucleotide	NN	compound	O
competition	NN	compound	O
experiments	NNS	conj	O
,	,	punct	O
purified	VBN	amod	O
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
binds	VBZ	ROOT	O
at	IN	case	O
positions	NNS	nmod	B-DNA
-82	CD	nummod	I-DNA
to	TO	dep	I-DNA
-91	CD	nummod	I-DNA
(	-LRB-	punct	O
GGGAACTACC	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	compound	I-DNA
sequence	NN	nmod	O
with	IN	case	O
an	DT	det	O
affinity	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
with	IN	case	O
which	WDT	nmod	O
it	PRP	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
biologically	RB	advmod	B-DNA
functional	JJ	amod	I-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
motif	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
beta	NN	compound	B-DNA
interferon	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
(	-LRB-	punct	O
GGGAAATTCC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Two	CD	nummod	O
kappa	NN	compound	B-DNA
B-like	JJ	amod	I-DNA
motifs	NNS	nsubjpass	I-DNA
at	IN	case	O
positions	NNS	nmod	B-DNA
-98	CD	nummod	I-DNA
to	TO	dep	I-DNA
-108	CD	nummod	I-DNA
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
were	VBD	auxpass	O
also	RB	advmod	O
recognized	VBN	ROOT	O
but	CC	cc	O
with	IN	conj	O
much	RB	advmod	O
lower	JJR	amod	O
affinities	NNS	pobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
strong	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
gene	NN	nmod	I-DNA
following	VBG	case	O
T-cell	NN	compound	O
activation	NN	nmod	O
is	VBZ	auxpass	O
controlled	VBN	ccomp	O
by	IN	case	O
binding	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
to	TO	case	O
a	DT	det	O
high-affinity	JJ	amod	B-DNA
binding	VBG	compound	I-DNA
site	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
mitogenic	JJ	amod	O
agents	NNS	nmod	O
upon	IN	case	O
glucocorticoid	NN	compound	O
action	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
tonsillar	JJ	amod	I-cell_type
T-lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
treatment	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_type
tonsillar	NN	amod	I-cell_type
T-lymphocytes	NNS	nmod	I-cell_type
with	IN	case	O
4-phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
about	RB	advmod	O
two	CD	nummod	O
fold	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
number	NN	nmod	O
,	,	punct	O
without	IN	case	O
any	DT	det	O
significant	JJ	amod	O
change	NN	nmod	O
in	IN	case	O
the	DT	det	O
receptor	NN	compound	O
affinity	NN	nmod	O
.	.	punct	O

This	DT	det	O
increase	NN	nsubj	O
disappeared	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
cycloheximide	NN	nmod	O
.	.	punct	O

Alone	RB	advmod	O
,	,	punct	O
PMA	NN	nsubj	O
and	CC	cc	O
calcium	NN	compound	O
ionophore	NN	compound	O
A23187	NN	conj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
,	,	punct	O
but	CC	cc	O
together	RB	advmod	O
stimulated	VBD	conj	O
,	,	punct	O
like	IN	case	O
phytohaemagglutinin	NN	nmod	B-protein
(	-LRB-	punct	O
PHA	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
leucine	NN	dobj	O
and	CC	cc	O
,	,	punct	O
in	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
thymidine	NN	compound	O
incorporation	NN	nmod	O
.	.	punct	O

PMA	NN	nsubj	O
enhanced	VBD	ROOT	O
slightly	RB	advmod	O
the	DT	det	O
stimulatory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
PHA	NN	nmod	B-protein
.	.	punct	O

Alone	RB	advmod	O
,	,	punct	O
these	DT	det	O
agents	NNS	nsubj	O
failed	VBD	ROOT	O
to	TO	mark	O
alter	VB	xcomp	O
the	DT	det	O
suppressive	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
dexamethasone	NN	nmod	O
on	IN	case	O
thymidine	NN	nmod	O
and	CC	cc	O
leucine	NN	conj	O
incorporation	NN	dep	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
PMA-A23187	JJ	compound	O
and	CC	cc	O
PMA	NN	conj	O
-PHA	CD	conj	B-protein
combinations	NNS	nsubj	O
appeared	VBD	parataxis	O
to	TO	mark	O
antagonize	VB	xcomp	O
the	DT	det	O
suppression	NN	dobj	O
by	IN	case	O
dexamethasone	NN	nmod	O
.	.	punct	O

To	TO	aux	O
be	VB	ROOT	O
or	CC	cc	O
not	RB	neg	O
to	TO	aux	O
be	VB	conj	O
a	DT	det	O
responder	NN	attr	O
in	IN	case	O
T-cell	NN	compound	O
responses	NNS	nmod	O
:	:	punct	O
ubiquitous	JJ	amod	O
oligopeptides	NNS	dep	O
in	IN	case	O
all	DT	det	O
proteins	NNS	nmod	O
.	.	punct	O

Amino	NN	compound	O
acid	NN	compound	O
sequences	NNS	nsubj	O
of	IN	case	O
all	DT	det	O
proteins	NNS	nmod	O
are	VBP	cop	O
essays	NNS	ROOT	O
written	VBN	acl	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
language	NN	nmod	O
.	.	punct	O

Accordingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
same	JJ	amod	O
set	NN	nsubj	O
of	IN	prep	O
words	NNS	pobj	O
and	CC	cc	O
phrases	NNS	conj	O
(	-LRB-	punct	O
oligopeptides	NNS	appos	O
)	-RRB-	punct	O
appear	VBP	ROOT	O
in	IN	case	O
totally	RB	advmod	O
unrelated	JJ	amod	O
proteins	NNS	nmod	O
.	.	punct	O

The	DT	det	O
reason	NN	nsubjpass	O
that	IN	mark	O
only	RB	advmod	O
certain	JJ	amod	O
individuals	NNS	nsubj	O
of	IN	case	O
particular	JJ	amod	O
major	JJ	amod	B-protein
histocompatibility	NN	compound	I-protein
complex	NN	compound	I-protein
(	-LRB-	punct	I-protein
MHC	NN	compound	I-protein
)	-RRB-	punct	I-protein
haplotypes	NNS	nmod	I-protein
can	MD	aux	O
mount	VB	relcl	O
T-cell	NN	compound	O
responses	NNS	dobj	O
against	IN	case	O
a	DT	det	O
given	JJ	amod	O
antigen	NN	nmod	O
of	IN	case	O
pathogens	NNS	nmod	O
is	VBZ	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
fact	NN	nmod	O
that	IN	mark	O
T-cell	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
designed	VBN	ccomp	O
to	TO	mark	O
recognize	VB	xcomp	O
18-20	CD	nummod	O
residue-long	JJ	amod	O
peptide	NN	compound	O
fragments	NNS	dobj	O
sandwiched	JJ	acl	O
between	IN	case	O
two	CD	nummod	O
alpha-helices	NNS	nmod	B-protein
of	IN	case	O
class	NN	nmod	B-protein
I	CD	nummod	I-protein
or	CC	cc	O
class	NN	compound	O
II	CD	nummod	O
MHC	NN	compound	O
molecules	NNS	conj	O
.	.	punct	O

At	IN	case	O
this	DT	det	O
range	NN	nmod	O
of	IN	case	O
peptide	NN	compound	O
lengths	NNS	nmod	O
,	,	punct	O
most	JJS	nsubj	O
would	MD	aux	O
appear	VB	ROOT	O
as	IN	prep	O
self	NN	pobj	O
,	,	punct	O
while	IN	mark	O
nonselfness	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
remainders	NNS	nmod	O
are	VBP	auxpass	O
destined	VBN	advcl	O
to	TO	aux	O
be	VB	xcomp	O
quite	RB	advmod	O
ambiguous	JJ	acomp	O
,	,	punct	O
hence	RB	advmod	O
creating	VBG	advcl	O
responders	NNS	dobj	O
and	CC	cc	O
nonresponders	NNS	conj	O
.	.	punct	O

Two	CD	nummod	O
distinct	JJ	amod	O
signal	NN	compound	O
transmission	NN	compound	O
pathways	NNS	nsubjpass	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
are	VBP	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
complexes	NNS	nmod	O
formed	VBN	acl	O
between	IN	case	O
an	DT	det	O
immunophilin	NN	nmod	B-protein
and	CC	cc	O
either	CC	cc:preconj	O
FK506	NN	conj	O
or	CC	cc	O
rapamycin	NN	conj	O
.	.	punct	O

Proliferation	NN	nsubjpass	O
and	CC	cc	O
immunologic	JJ	amod	O
function	NN	conj	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
are	VBP	auxpass	O
initiated	VBN	ROOT	O
by	IN	case	O
signals	NNS	nmod	O
from	IN	case	O
the	DT	det	O
antigen	NN	compound	B-protein
receptor	NN	nmod	I-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
inhibited	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
immunosuppressant	JJ	amod	O
FK506	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
its	PRP$	nmod:poss	O
structural	JJ	amod	O
analog	NN	conj	O
,	,	punct	O
rapamycin	NN	appos	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
IL-2	NN	compound	B-protein
)	-RRB-	punct	O
-induced	JJ	amod	O
signals	NNS	nsubjpass	O
are	VBP	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
rapamycin	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
FK506	NN	conj	O
.	.	punct	O

Remarkably	RB	advmod	O
,	,	punct	O
these	DT	det	O
two	CD	nummod	O
drugs	NNS	nsubj	O
inhibit	VBP	ROOT	O
each	DT	det	O
other	JJ	amod	O
's	POS	case	O
actions	NNS	dobj	O
,	,	punct	O
raising	VBG	advcl	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
both	DT	nsubj	O
act	VBP	ccomp	O
by	IN	case	O
means	NNS	nmod	O
of	IN	case	O
a	DT	det	O
common	JJ	amod	O
immunophilin	NN	nmod	B-protein
(	-LRB-	punct	O
immunosuppressant	JJ	amod	B-protein
binding	NN	compound	I-protein
protein	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
dissociation	NN	compound	O
constant	NN	nsubj	O
of	IN	case	O
rapamycin	NN	nmod	O
to	TO	case	O
the	DT	det	O
FK506	NN	compound	B-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
FKBP	NN	dep	B-protein
(	-LRB-	punct	O
Kd	NN	dep	O
=	JJ	amod	O
0.2	CD	nummod	O
nM	NN	dep	O
)	-RRB-	punct	O
is	VBZ	cop	O
close	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
dissociation	NN	compound	O
constant	NN	nmod	O
of	IN	case	O
FK506	NN	nmod	O
to	TO	case	O
FKBP	NN	nmod	B-protein
(	-LRB-	punct	O
Kd	NN	dep	O
=	JJ	amod	O
0.4	CD	nummod	O
nM	NN	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
to	TO	case	O
their	PRP$	nmod:poss	O
effective	JJ	amod	O
biologic	JJ	amod	O
inhibitory	JJ	amod	O
concentrations	NNS	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
an	DT	det	O
excess	NN	nsubjpass	O
of	IN	case	O
rapamycin	NN	nmod	O
is	VBZ	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
revert	VB	xcomp	O
FK506-mediated	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
IL-2	NN	compound	B-protein
production	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
transcriptional	JJ	amod	O
activation	NN	conj	O
of	IN	case	O
NF-AT	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
T-cell-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	appos	I-protein
necessary	JJ	amod	O
for	IN	case	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
activation	NN	nmod	O
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
an	DT	det	O
excess	NN	nsubjpass	O
of	IN	case	O
FK506	NN	nmod	O
is	VBZ	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
revert	VB	xcomp	O
rapamycin-mediated	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
IL-2	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
proliferation	NN	nmod	O
.	.	punct	O

The	DT	det	O
drug	NN	compound	O
concentrations	NNS	nsubjpass	O
required	VBN	acl	O
for	IN	case	O
antagonism	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
relative	JJ	amod	O
affinity	NN	nmod	O
of	IN	case	O
the	DT	det	O
drugs	NNS	nmod	O
to	TO	dep	O
,	,	punct	O
and	CC	cc	O
by	IN	case	O
the	DT	det	O
abundance	NN	conj	O
of	IN	prep	O
,	,	punct	O
the	DT	det	O
immunophilin	NN	appos	B-protein
FKBP	NN	dep	B-protein
.	.	punct	O

FKBP	NN	nsubjpass	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
catalyze	VB	xcomp	O
the	DT	det	O
interconversion	NN	dobj	O
of	IN	case	O
the	DT	det	O
cis-	JJ	nmod	O
and	CC	cc	O
trans-rotamers	NNS	conj	O
of	IN	case	O
the	DT	det	O
peptidyl-prolyl	JJ	amod	B-protein
amide	NN	compound	I-protein
bond	NN	nmod	I-protein
of	IN	case	O
peptide	NN	compound	O
substrates	NNS	nmod	O
;	:	punct	O
here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	parataxis	O
that	IN	mark	O
rapamycin	NN	nsubj	O
,	,	punct	O
like	IN	case	O
FK506	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	ccomp	O
of	IN	case	O
the	DT	det	O
rotamase	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
FKBP	NN	nmod	B-protein
(	-LRB-	punct	O
Ki	NN	dep	O
=	JJ	amod	O
0.2	CD	nummod	O
nM	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

Neither	CC	cc:preconj	O
FKBP	NN	compound	B-protein
binding	NN	nsubj	O
nor	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
rotamase	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
FKBP	NN	nmod	B-protein
alone	RB	advmod	O
is	VBZ	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
explain	VB	xcomp	O
the	DT	det	O
biologic	JJ	amod	O
actions	NNS	dobj	O
of	IN	case	O
these	DT	det	O
drugs	NNS	nmod	O
.	.	punct	O

Rather	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
immunophilin	NN	nsubj	B-protein
bound	VBN	csubj	O
to	TO	case	O
FK506	NN	nmod	O
interferes	VBZ	ccomp	O
with	IN	case	O
antigen	NN	nmod:npmod	B-protein
receptor	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
signals	NNS	nmod	O
,	,	punct	O
while	IN	mark	O
rapamycin	NN	nsubj	O
bound	VBN	csubj	O
to	TO	case	O
the	DT	det	O
immunophilin	NN	nmod	B-protein
interferes	VBZ	advcl	O
with	IN	case	O
IL-2	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
signals	NNS	nmod	O
.	.	punct	O

Adherence-dependent	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
human	JJ	amod	B-RNA
monocyte	NN	compound	I-RNA
PDGF	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
B	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	nmod	I-RNA
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
increases	NNS	nmod	O
in	IN	case	O
c-fos	NN	nmod	B-RNA
,	,	punct	I-RNA
c-jun	NN	conj	I-RNA
,	,	punct	I-RNA
and	CC	cc	I-RNA
EGR2	NN	conj	I-RNA
mRNA	NN	dep	I-RNA
.	.	punct	O

Adherence	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
initial	JJ	amod	O
step	NN	ROOT	O
in	IN	case	O
the	DT	det	O
transition	NN	nmod	O
of	IN	case	O
a	DT	det	O
circulating	VBG	amod	B-cell_type
monocyte	NN	nmod	I-cell_type
to	TO	case	O
a	DT	det	O
tissue	NN	compound	B-cell_type
macrophage	NN	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
differentiation	NN	nsubjpass	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
augmented	JJ	amod	O
capacity	NN	nmod	O
to	TO	mark	O
generate	VB	acl	O
growth	NN	compound	B-protein
factors	NNS	dobj	I-protein
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
adherence	NN	nsubj	O
itself	PRP	dep	O
might	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
trigger	NN	ccomp	O
for	IN	case	O
a	DT	det	O
sequence	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
activation	NN	nmod	O
culminating	VBG	acl	O
in	IN	case	O
cells	NNS	nmod	O
with	IN	case	O
increased	VBN	amod	O
mRNA	NN	nmod	B-RNA
encoding	VBG	acl	O
profibrotic	JJ	amod	O
growth	NN	compound	B-protein
factors	NNS	dobj	I-protein
such	JJ	case	O
as	IN	mwe	O
platelet-derived	JJ	amod	B-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
B	NN	compound	I-protein
subunit	NN	nmod	I-protein
(	-LRB-	punct	O
PDGF	NN	compound	B-protein
[	-LRB-	punct	I-protein
B	NN	appos	I-protein
]	-RRB-	punct	I-protein
)	-RRB-	punct	O
and	CC	cc	O
transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor-beta	NN	conj	I-protein
(	-LRB-	punct	O
TGF-beta	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

After	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
adherence	NN	nmod	O
,	,	punct	O
human	JJ	amod	O
monocytes	NNS	nsubj	O
had	VBD	ROOT	O
a	DT	det	O
biphasic	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
PDGF	NN	compound	B-RNA
(	-LRB-	punct	I-RNA
B	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	nmod	I-RNA
with	IN	case	O
peaks	NNS	nmod	O
at	IN	case	O
6	CD	nummod	O
h	NN	nmod	O
and	CC	cc	O
13	CD	nummod	O
d	NN	conj	O
.	.	punct	O

No	DT	neg	O
increase	NN	nsubjpass	O
in	IN	case	O
TGF-beta	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
6-h	JJ	amod	O
increase	NN	nsubj	O
in	IN	case	O
PDGF	NN	compound	B-RNA
(	-LRB-	punct	I-RNA
B	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	nmod	I-RNA
was	VBD	cop	O
adherence	NN	nmod:npmod	O
dependent	JJ	ROOT	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
addition	NN	conj	O
,	,	punct	O
was	VBD	auxpass	O
abrogated	VBN	conj	O
when	WRB	advmod	O
the	DT	det	O
cytoskeletal	JJ	amod	O
integrity	NN	nsubjpass	O
was	VBD	auxpass	O
compromised	VBN	advcl	O
by	IN	case	O
cytochalasin	NN	compound	O
D	NN	nmod	O
.	.	punct	O

The	DT	det	O
6-h	JJ	amod	O
increase	NN	nsubj	O
in	IN	case	O
PDGF	NN	compound	B-RNA
(	-LRB-	punct	I-RNA
B	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	nmod	I-RNA
was	VBD	cop	O
unaltered	JJ	ROOT	O
by	IN	case	O
adherence	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
the	DT	det	O
monocyte	NN	compound	O
stimulus	NN	compound	O
lipopolysaccharide	NN	nmod	O
.	.	punct	O

Adherence	NN	nsubj	O
to	TO	case	O
either	CC	cc:preconj	O
fibronectin	NN	nmod	O
or	CC	cc	O
collagen-coated	JJ	amod	O
plastic	NN	conj	O
had	VBD	ROOT	O
little	JJ	amod	O
consistent	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
PDGF	NN	compound	B-RNA
(	-LRB-	punct	I-RNA
B	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	compound	I-RNA
accumulation	NN	nmod	O
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
PDGF	NN	compound	B-RNA
(	-LRB-	punct	I-RNA
B	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	nsubjpass	I-RNA
observed	VBN	acl	O
in	IN	case	O
adherent	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
increases	NNS	nmod	O
in	IN	case	O
mRNAs	NNS	nmod	B-RNA
of	IN	case	O
the	DT	det	O
early	JJ	amod	B-DNA
growth	NN	compound	I-DNA
response	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
c-fos	NN	dep	B-DNA
(	-LRB-	punct	O
maximal	JJ	dep	O
at	IN	case	O
20	CD	nummod	O
min	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
c-jun	NN	conj	O
,	,	punct	O
and	CC	cc	O
EGR2	NN	conj	O
(	-LRB-	punct	O
maximal	JJ	dep	O
at	IN	case	O
6-24	CD	nummod	O
h	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
increase	NN	nsubjpass	O
in	IN	case	O
c-jun	NN	nmod	O
and	CC	cc	O
EGR2	NN	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
c-fos	NN	conj	B-DNA
,	,	punct	O
mRNA	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
abrogated	VBN	ROOT	O
by	IN	case	O
cytochalasin	NN	compound	O
D	NN	nmod	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
adherence	NN	nsubj	O
results	VBZ	ccomp	O
in	IN	case	O
increases	NNS	nmod	O
of	IN	case	O
c-fos	NN	nmod	B-RNA
,	,	punct	I-RNA
c-jun	NN	conj	I-RNA
,	,	punct	I-RNA
EGR2	NN	conj	I-RNA
,	,	punct	I-RNA
and	CC	cc	I-RNA
PDGF	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
B	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	conj	I-RNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
increases	NNS	nsubj	O
in	IN	case	O
c-jun	NN	nmod	B-DNA
,	,	punct	O
EGR2	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
PDGF	NN	conj	B-protein
(	-LRB-	punct	I-protein
B	NN	appos	I-protein
)	-RRB-	punct	I-protein
may	MD	aux	O
depend	VB	ROOT	O
on	IN	case	O
cytoskeletal	JJ	amod	O
rearrangement	NN	nmod	O
.	.	punct	O

Modulation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
events	NNS	nmod	O
at	IN	case	O
the	DT	det	O
time	NN	nmod	O
of	IN	case	O
adherence	NN	nmod	O
offers	VBZ	ROOT	O
a	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
differential	JJ	amod	O
priming	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
may	MD	aux	O
be	VB	auxpass	O
accomplished	VBN	acl:relcl	O
.	.	punct	O

Single	JJ	amod	O
cell	NN	compound	O
assay	NN	nsubj	O
of	IN	case	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
reveals	VBZ	ROOT	O
a	DT	det	O
threshold	NN	dobj	O
in	IN	case	O
transcription	NN	nmod	O
activated	VBN	acl	O
by	IN	case	O
signals	NNS	nmod	O
emanating	VBG	acl	O
from	IN	case	O
the	DT	det	O
T-cell	NN	compound	B-protein
antigen	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
through	IN	case	O
their	PRP$	nmod:poss	O
antigen	NN	compound	B-protein
receptor	NN	nmod	I-protein
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
including	VBG	case	O
NF-AT	NN	nmod	B-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
involved	VBN	acl:relcl	O
in	IN	mark	O
regulating	VBG	advcl	O
genes	NNS	dobj	O
required	VBN	acl	O
for	IN	case	O
immunologic	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
a	DT	det	O
single	JJ	amod	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
in	IN	case	O
individual	JJ	amod	B-cell_type
viable	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
applied	VBN	ROOT	O
an	DT	det	O
assay	NN	dobj	O
that	WDT	nsubj	O
uses	VBZ	acl:relcl	O
the	DT	det	O
fluorescence-activated	JJ	amod	O
cell	NN	compound	O
sorter	NN	dobj	O
to	TO	mark	O
quantitate	VB	xcomp	O
beta-galactosidase	NN	dobj	B-protein
(	-LRB-	punct	O
beta-gal	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
analyzed	VBN	ROOT	O
the	DT	det	O
distribution	NN	dobj	O
of	IN	case	O
NF-AT	NN	compound	B-protein
transcriptional	JJ	amod	O
activity	NN	nmod	O
among	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
undergoing	VBG	acl	O
activation	NN	dobj	O
by	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
construct	NN	dobj	O
in	IN	case	O
which	WDT	nmod	O
three	CD	nummod	O
tandem	JJ	amod	O
copies	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
NF-AT-binding	JJ	amod	B-DNA
site	NN	nmod	I-DNA
directs	VBZ	acl:relcl	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
lacZ	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Unexpectedly	RB	advmod	O
,	,	punct	O
stimulation	NN	nsubj	O
of	IN	case	O
cloned	VBN	amod	B-cell_line
stably	RB	advmod	I-cell_line
transfected	VBN	amod	I-cell_line
Jurkat	NN	compound	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
bimodal	JJ	amod	O
pattern	NN	nmod	O
of	IN	case	O
beta-gal	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
which	WDT	nmod	O
some	DT	det	O
cells	NNS	nsubj	O
express	VBP	acl:relcl	O
no	DT	neg	O
beta-gal	NN	dobj	B-protein
and	CC	cc	O
others	NNS	nsubj	O
express	VBP	conj	O
high	JJ	amod	O
levels	NNS	dobj	O
.	.	punct	O

This	DT	det	O
expression	NN	compound	O
pattern	NN	nsubjpass	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
accounted	VBN	ROOT	O
for	IN	case	O
by	IN	case	O
cell-cycle	JJ	amod	O
position	NN	nmod	O
or	CC	cc	O
heritable	JJ	amod	O
variation	NN	conj	O
.	.	punct	O

Further	JJ	advmod	O
results	NNS	nsubj	O
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
beta-gal	NN	compound	B-protein
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
correlated	VBN	acl:relcl	O
with	IN	case	O
NF-AT	NN	compound	B-protein
-binding	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
concentration	NN	nsubj	O
of	IN	case	O
NF-AT	NN	nmod	B-protein
must	MD	aux	O
exceed	VB	ccomp	O
a	DT	det	O
critical	JJ	amod	O
threshold	NN	dobj	O
before	IN	mark	O
transcription	NN	nsubj	O
initiates	VBZ	nmod	O
.	.	punct	O

This	DT	det	O
threshold	NN	nsubj	O
likely	RB	advmod	O
reflects	VBZ	ROOT	O
the	DT	det	O
NF-AT	NN	compound	B-protein
concentration-dependent	JJ	amod	O
assembly	NN	dobj	O
of	IN	case	O
transcription	NN	compound	B-protein
complexes	NNS	nmod	I-protein
at	IN	case	O
the	DT	det	O
promoter	NN	nmod	B-DNA
.	.	punct	O

Similar	JJ	amod	O
constructs	NNS	nsubj	O
controlled	VBN	acl	O
by	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
or	CC	cc	O
the	DT	det	O
entire	JJ	amod	O
interleukin-2	NN	compound	B-DNA
enhancer	NN	conj	I-DNA
show	VBP	ROOT	O
bimodal	JJ	amod	O
expression	NN	compound	O
patterns	NNS	dobj	O
during	IN	case	O
induction	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
thresholds	NNS	nsubj	O
set	VBN	acl	O
by	IN	case	O
the	DT	det	O
concentration	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
common	JJ	amod	O
property	NN	ccomp	O
of	IN	case	O
inducible	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
Epstein-Barr	JJ	amod	B-DNA
virus	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
EBV	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
BMRF1	NN	compound	I-DNA
promoter	NN	nsubjpass	I-DNA
for	IN	case	O
early	JJ	amod	B-protein
antigen	NN	nmod	I-protein
(	-LRB-	punct	O
EA-D	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
EBV	NN	compound	B-protein
transactivators	NNS	nmod	I-protein
,	,	punct	O
BRLF1	NN	appos	B-protein
and	CC	cc	O
BZLF1	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
a	DT	det	O
cell-specific	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

The	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
early	JJ	amod	I-protein
antigen	NN	compound	I-protein
diffuse	NN	compound	I-protein
component	NN	nsubj	I-protein
(	-LRB-	punct	O
EA-D	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	B-DNA
DNA	NN	compound	I-DNA
polymerase	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
suppressed	VBN	conj	O
during	IN	case	O
latent	JJ	amod	O
infection	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
promoter	NN	nmod	B-DNA
(	-LRB-	punct	O
BMRF1	NN	appos	B-DNA
)	-RRB-	punct	O
for	IN	case	O
this	DT	det	O
early	JJ	amod	O
gene	NN	nmod	O
by	IN	mark	O
studying	VBG	advcl	O
its	PRP$	nmod:poss	O
responsiveness	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
to	TO	case	O
two	CD	nummod	O
immediate-early	JJ	amod	B-protein
viral	JJ	amod	I-protein
transactivators	NNS	nmod	I-protein
,	,	punct	O
BZLF1	NN	appos	B-protein
(	-LRB-	punct	O
Z	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
BRLF1	NN	conj	B-protein
(	-LRB-	punct	O
R	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
focusing	VBG	advcl	O
on	IN	case	O
the	DT	det	O
differences	NNS	nmod	O
in	IN	case	O
response	NN	nmod	O
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
epithelial	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

In	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
Z	NN	nsubj	B-protein
or	CC	cc	O
R	NN	conj	B-protein
alone	RB	advmod	O
produced	VBD	ROOT	O
only	RB	advmod	O
small	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
EA-D	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
both	DT	det	O
transactivators	NNS	nsubj	B-protein
together	RB	advmod	O
produced	VBD	parataxis	O
a	DT	det	O
large	JJ	amod	O
stimulatory	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

In	IN	case	O
epithelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
the	DT	det	O
Z	NN	compound	B-protein
transactivator	NN	nsubj	I-protein
alone	RB	advmod	O
produced	VBD	ROOT	O
maximal	JJ	amod	O
stimulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
EA-D	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
;	:	punct	O
the	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
R	NN	nmod	B-protein
and	CC	cc	O
Z	NN	conj	B-protein
together	RB	advmod	O
was	VBD	cop	O
no	DT	neg	O
greater	JJR	parataxis	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
Z	NN	nmod	B-protein
alone	RB	advmod	O
.	.	punct	O

Deletional	JJ	amod	O
analysis	NN	nsubj	O
and	CC	cc	O
site-directed	JJ	amod	O
mutagenesis	NN	conj	O
of	IN	case	O
the	DT	det	O
EA-D	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
demonstrated	VBD	ROOT	O
that	IN	mark	O
in	IN	case	O
epithelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
the	DT	det	O
potential	JJ	amod	O
AP-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	nsubj	I-DNA
plays	VBZ	ccomp	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
Z	NN	compound	B-protein
responsiveness	NN	nmod	O
,	,	punct	O
although	IN	mark	O
sequences	NNS	nsubj	O
further	RB	advmod	O
upstream	JJ	advmod	O
are	VBP	cop	O
also	RB	advmod	O
important	JJ	advcl	O
.	.	punct	O

In	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
only	RB	advmod	O
the	DT	det	O
upstream	JJ	amod	B-DNA
sequences	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
transactivation	NN	nmod	O
by	IN	case	O
the	DT	det	O
Z/R	NN	compound	B-protein
combination	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
AP-1	NN	compound	B-protein
site	NN	nsubj	I-protein
is	VBZ	cop	O
dispensable	JJ	conj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
EA-D	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
BMRF1	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	compound	I-DNA
regulation	NN	nsubj	O
by	IN	case	O
Z	NN	nmod	B-protein
and	CC	cc	O
R	NN	conj	B-protein
is	VBZ	cop	O
cell	NN	nmod:npmod	O
type	NN	nmod:npmod	O
specific	JJ	ccomp	O
and	CC	cc	O
appears	VBZ	conj	O
to	TO	mark	O
involve	VB	xcomp	O
different	JJ	amod	O
mechanisms	NNS	dobj	O
in	IN	case	O
each	DT	det	O
cell	NN	compound	O
type	NN	nmod	O
.	.	punct	O

Complementary	JJ	amod	B-DNA
DNA	NN	ROOT	I-DNA
encoding	VBG	acl	O
the	DT	det	O
human	JJ	amod	B-protein
T-cell	NN	compound	I-protein
FK506-binding	JJ	amod	I-protein
protein	NN	dobj	I-protein
,	,	punct	O
a	DT	det	O
peptidylprolyl	JJ	amod	B-protein
cis-trans	JJ	amod	I-protein
isomerase	NN	appos	I-protein
distinct	JJ	amod	O
from	IN	case	O
cyclophilin	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
recently	RB	advmod	O
discovered	VBN	amod	O
macrolide	NN	nsubjpass	O
FK506	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
potent	JJ	amod	O
immunosuppressive	JJ	amod	O
activity	NN	dobj	O
at	IN	case	O
concentrations	NNS	nmod	O
100-fold	RB	advmod	O
lower	JJR	amod	O
than	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
,	,	punct	O
a	DT	det	O
cyclic	JJ	amod	O
undecapeptide	NN	appos	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
used	VBN	acl:relcl	O
to	TO	mark	O
prevent	VB	xcomp	O
rejection	NN	dobj	O
after	IN	case	O
transplantation	NN	nmod	O
of	IN	case	O
bone	NN	compound	O
marrow	NN	nmod	O
and	CC	cc	O
organs	NNS	conj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
kidney	NN	nmod	O
,	,	punct	O
heart	NN	conj	O
,	,	punct	O
and	CC	cc	O
liver	NN	conj	O
.	.	punct	O

After	IN	mark	O
the	DT	det	O
recent	JJ	amod	O
discovery	NN	pobj	O
that	IN	mark	O
the	DT	det	O
cyclosporin	NN	compound	B-protein
A-binding	JJ	amod	I-protein
protein	NN	compound	I-protein
cyclophilin	NN	nsubj	B-protein
is	VBZ	cop	O
identical	JJ	ccomp	O
to	TO	case	O
peptidylprolyl	JJ	amod	B-protein
cis-trans	JJ	amod	I-protein
isomerase	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
cellular	JJ	amod	B-protein
binding	NN	compound	I-protein
protein	NN	nsubjpass	I-protein
for	IN	case	O
FK506	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
distinct	JJ	xcomp	O
from	IN	case	O
cyclophilin	NN	nmod	B-protein
but	CC	cc	O
to	TO	mark	O
have	VB	conj	O
the	DT	det	O
same	JJ	amod	O
enzymatic	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
isolated	VBD	ROOT	O
a	DT	det	O
cDNA	NN	dobj	B-DNA
coding	VBG	acl	O
for	IN	case	O
FK506-binding	JJ	amod	O
protein	NN	nmod	O
(	-LRB-	punct	O
FKBP	NN	appos	B-protein
)	-RRB-	punct	O
from	IN	case	O
human	JJ	amod	O
peripheral	JJ	amod	O
blood	NN	compound	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	mark	O
using	VBG	advcl	O
mixed	JJ	amod	O
20-mer	JJ	amod	O
oligonucleotide	NN	compound	O
probes	NNS	dobj	O
synthesized	VBN	acl	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
the	DT	det	O
sequence	NN	nmod	O
,	,	punct	O
Glu-Asp-Gly-Lys-Lys-Phe-Asp	NN	appos	O
,	,	punct	O
reported	VBN	acl	O
for	IN	case	O
bovine	JJ	amod	B-protein
FKBP	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
DNA	NN	nsubj	O
isolated	VBN	acl	O
contained	VBD	ROOT	O
an	DT	det	O
open	JJ	amod	O
reading	NN	compound	O
frame	NN	dobj	O
encoding	VBG	acl	O
108	CD	nummod	O
amino	NN	compound	O
acid	NN	compound	O
residues	NNS	dobj	O
.	.	punct	O

The	DT	det	O
first	JJ	amod	O
40	CD	nummod	O
residues	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
deduced	VBN	amod	O
amino	NN	compound	O
acid	NN	compound	O
sequence	NN	nmod	O
were	VBD	cop	O
identical	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
the	DT	det	O
reported	VBN	amod	O
amino-terminal	JJ	amod	O
sequence	NN	nmod	O
of	IN	case	O
bovine	JJ	amod	O
FKBP	NN	nmod	B-protein
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
DNA	NN	compound	O
sequence	NN	nsubj	O
isolated	VBN	acl	O
represents	VBZ	ccomp	O
the	DT	det	O
gene	NN	dobj	O
coding	VBG	acl	O
for	IN	case	O
FKBP	NN	nmod	B-protein
.	.	punct	O

Computer-assisted	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
deduced	VBN	amod	O
amino	NN	compound	O
acid	NN	compound	O
sequence	NN	nmod	O
indicates	VBZ	ROOT	O
that	IN	mark	O
FKBP	NN	nsubj	B-protein
exhibits	VBZ	ccomp	O
no	DT	neg	O
internal	JJ	amod	O
homology	NN	dobj	O
and	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
have	VB	conj	O
significant	JJ	amod	O
sequence	NN	compound	O
similarity	NN	dobj	O
to	TO	case	O
any	DT	det	O
other	JJ	amod	O
amino	NN	compound	O
acid	NN	compound	O
sequences	NNS	nmod	O
of	IN	case	O
known	JJ	amod	O
proteins	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
cyclophilin	NN	nmod	B-protein
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
two	CD	nummod	O
catalytically	RB	advmod	O
similar	JJ	amod	O
proteins	NNS	nsubj	O
,	,	punct	O
cyclophilin	NN	appos	B-protein
and	CC	cc	O
FKBP	NN	conj	B-protein
,	,	punct	O
evolved	VBD	ccomp	O
independently	RB	advmod	O
.	.	punct	O

In	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
mRNA	NN	compound	B-RNA
species	NNS	nsubjpass	I-RNA
of	IN	case	O
approximately	RB	advmod	O
1.8	CD	nummod	O
kilobases	NNS	nmod	O
that	WDT	nsubj	O
hybridized	VBD	acl:relcl	O
with	IN	case	O
human	JJ	amod	B-DNA
FKBP	NN	compound	I-DNA
cDNA	NN	nmod	I-DNA
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
poly	NN	compound	B-RNA
(	-LRB-	punct	I-RNA
A	NN	nmod	I-RNA
)	-RRB-	punct	I-RNA
+	CC	cc	I-RNA
RNAs	NNS	conj	I-RNA
from	IN	case	O
brain	NN	nmod	O
,	,	punct	O
lung	NN	conj	O
,	,	punct	O
liver	NN	conj	O
,	,	punct	O
and	CC	cc	O
placental	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
and	CC	cc	O
leukocytes	NNS	conj	B-cell_type
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
leukemic	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	nmod	O
and	CC	cc	O
ionomycin	NN	conj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
FKBP	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Southern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-DNA
genomic	JJ	amod	I-DNA
DNA	NN	nmod	I-DNA
digested	VBN	acl	O
with	IN	case	O
different	JJ	amod	O
restriction	NN	compound	B-protein
enzymes	NNS	nmod	I-protein
suggests	VBZ	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
only	RB	advmod	O
a	DT	det	O
few	JJ	amod	O
copies	NNS	nmod	O
of	IN	case	O
the	DT	det	O
DNA	NN	compound	O
sequence	NN	nmod	O
encoding	VBG	acl	O
FKBP	NN	dobj	B-protein
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
in	IN	prep	O
contrast	NN	pobj	O
to	TO	prep	O
the	DT	det	O
result	NN	pobj	O
that	IN	mark	O
as	RB	advmod	O
many	JJ	amod	O
as	IN	quantmod	O
20	CD	nummod	O
copies	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
cyclophilin	NN	compound	B-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
possible	JJ	amod	O
pseudogenes	NNS	conj	O
may	MD	aux	O
be	VB	cop	O
present	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
mammalian	JJ	amod	B-DNA
genome	NN	nmod	I-DNA
.	.	punct	O

Involvement	NN	ROOT	O
of	IN	case	O
a	DT	det	O
second	JJ	amod	O
lymphoid-specific	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
element	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
heavy-chain	JJ	amod	I-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
enhancer	NN	compound	B-DNA
elements	NNS	nsubj	I-DNA
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
the	DT	det	O
highly	RB	advmod	O
conserved	VBN	amod	O
octamer	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
OCTA	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-nucleotide	JJ	amod	I-DNA
motif	NN	nmod	I-DNA
are	VBP	cop	O
important	JJ	ccomp	O
for	IN	case	O
lymphoid-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
heavy-chain	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IgH	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	mark	O
mutating	VBG	acl	O
the	DT	det	O
binding	VBG	amod	B-DNA
site	NN	dobj	I-DNA
for	IN	case	O
a	DT	det	O
putative	JJ	amod	B-protein
additional	JJ	amod	I-protein
lymphoid-specific	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
designated	VBN	acl	O
NF-microB	NN	xcomp	B-protein
,	,	punct	O
in	IN	case	O
the	DT	det	O
murine	JJ	amod	B-DNA
IgH	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
NF-microB-binding	JJ	amod	B-DNA
site	NN	nsubj	I-DNA
plays	VBZ	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
,	,	punct	O
because	IN	mark	O
mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
microB	NN	compound	O
DNA	NN	compound	O
motif	NN	nmod	O
decreased	VBD	advcl	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
B-cell	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
nonlymphoid	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

This	DT	det	O
effect	NN	nsubj	O
was	VBD	cop	O
comparable	JJ	ROOT	O
to	TO	nmod	O
or	CC	cc	O
even	RB	advmod	O
stronger	JJR	conj	O
than	IN	case	O
the	DT	det	O
effect	NN	nmod	O
of	IN	case	O
a	DT	det	O
mutation	NN	nmod	O
in	IN	case	O
the	DT	det	O
OCTA	NN	compound	B-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
combined	JJ	amod	O
mutation	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
microB	NN	nmod	B-DNA
and	CC	cc	O
OCTA	NN	compound	B-DNA
sites	NNS	conj	I-DNA
further	RBR	advmod	O
reduced	VBD	ROOT	O
enhancer	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
alteration	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	dep	O
microB	NN	nmod	B-DNA
or	CC	cc	O
E3	NN	compound	B-DNA
site	NN	conj	I-DNA
in	IN	case	O
a	DT	det	O
70-base-pair	JJ	amod	B-DNA
fragment	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
that	WDT	nsubj	O
lacks	VBZ	acl:relcl	O
the	DT	det	O
binding	VBG	amod	O
site	NN	dobj	O
for	IN	case	O
OCTA	NN	nmod	O
abolished	VBD	ROOT	O
enhancer	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
completely	RB	advmod	O
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
a	DT	det	O
multimer	NN	nsubj	O
of	IN	case	O
the	DT	det	O
microB	NN	compound	B-DNA
motif	NN	nmod	I-DNA
alone	RB	advmod	O
showed	VBD	ROOT	O
no	DT	neg	O
enhancer	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

DNase	NN	compound	O
footprinting	NN	compound	O
analysis	NN	nsubj	O
corroborated	VBD	ROOT	O
the	DT	det	O
functional	JJ	amod	O
data	NNS	dobj	O
showing	VBG	acl	O
that	IN	mark	O
a	DT	det	O
lymphoid-specific	JJ	amod	B-protein
protein	NN	nsubj	I-protein
binds	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
microB	NN	compound	B-DNA
DNA	NN	compound	I-DNA
motif	NN	nmod	I-DNA
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
microB	NN	compound	B-DNA
element	NN	nsubj	I-DNA
is	VBZ	cop	O
a	DT	det	O
new	JJ	amod	O
crucial	JJ	amod	O
element	NN	ccomp	O
important	JJ	amod	O
for	IN	case	O
lymphoid-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
IgH	NN	compound	O
gene	NN	nmod	O
but	CC	cc	O
that	IN	mark	O
interaction	NN	nsubj	O
with	IN	case	O
another	DT	det	O
enhancer	NN	compound	B-DNA
element	NN	nmod	I-DNA
is	VBZ	cop	O
essential	JJ	conj	O
for	IN	case	O
its	PRP$	nmod:poss	O
activity	NN	nmod	O
.	.	punct	O

Stimulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
2	CD	nummod	O
(	-LRB-	punct	O
HIV-2	NN	appos	O
)	-RRB-	punct	O
gene	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
the	DT	det	O
cytomegalovirus	NN	nmod	O
and	CC	cc	O
HIV-2	NN	compound	B-DNA
transactivator	NN	compound	I-DNA
gene	NN	conj	I-DNA
.	.	punct	O

Human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nsubj	O
(	-LRB-	punct	O
HIV	NN	appos	O
)	-RRB-	punct	O
often	RB	advmod	O
causes	VBZ	ROOT	O
latent	JJ	amod	O
infection	NN	dobj	O
.	.	punct	O

Transactivation	NN	nsubjpass	O
by	IN	case	O
some	DT	det	O
DNA	NN	compound	O
viruses	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	mark	O
inducing	VBG	advcl	O
HIV-1	NN	compound	O
replication	NN	dobj	O
and	CC	cc	O
pathogenesis	NN	conj	O
.	.	punct	O

The	DT	det	O
transactivator	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
IE-2	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nsubj	I-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
cytomegalovirus	NN	nmod	O
(	-LRB-	punct	O
CMV	NN	appos	O
)	-RRB-	punct	O
can	MD	aux	O
enhance	VB	ROOT	O
HIV-2	NN	dobj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
HIV-1	NN	compound	O
gene	NN	compound	O
expression	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

This	DT	det	O
inducer	NN	nsubj	O
can	MD	aux	O
act	VB	ROOT	O
in	IN	case	O
concert	NN	dep	O
with	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
tat	NN	compound	I-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
T-cell	NN	compound	O
activation	NN	conj	O
in	IN	mark	O
enhancing	VBG	advcl	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
CD4+	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

While	IN	mark	O
the	DT	dep	O
HIV-2	NN	nsubj	O
and	CC	cc	O
HIV-1	NN	compound	B-DNA
tat	NN	compound	I-DNA
genes	NNS	conj	I-DNA
and	CC	cc	O
T-cell	NN	compound	B-protein
activators	NNS	conj	I-protein
apparently	RB	advmod	O
employ	VBP	advcl	O
independent	JJ	amod	O
modes	NNS	dobj	O
of	IN	case	O
action	NN	nmod	O
,	,	punct	O
the	DT	det	O
CMV	NN	compound	B-DNA
transactivator	NN	nsubj	I-DNA
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
tat	NN	nmod	I-DNA
or	CC	cc	O
T-cell	NN	compound	B-protein
activators	NNS	conj	I-protein
may	MD	aux	O
employ	VB	ROOT	O
a	DT	det	O
gene	NN	compound	O
activation	NN	compound	O
pathway	NN	dobj	O
with	IN	case	O
some	DT	det	O
common	JJ	nmod	O
and	CC	cc	O
some	DT	det	O
distinct	JJ	amod	O
components	NNS	conj	O
.	.	punct	O

Both	CC	cc:preconj	O
HIV-2	NN	nsubj	O
and	CC	cc	O
CMV	NN	compound	B-DNA
transactivators	NNS	conj	I-DNA
enhance	VBP	ROOT	O
HIV-2	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
by	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
involving	VBG	acl	O
transcript	NN	compound	O
initiation	NN	dobj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
elongation	NN	conj	O
,	,	punct	O
with	IN	case	O
CMV	NN	compound	B-DNA
transactivator	NN	nmod	I-DNA
affecting	VBG	acl	O
elongation	NN	dobj	O
more	JJR	advmod	O
than	IN	prep	O
the	DT	det	O
initiation	NN	pobj	O
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
proportion	NN	nsubj	O
of	IN	case	O
transcripts	NNS	nmod	B-RNA
appear	VBP	ROOT	O
to	TO	mark	O
terminate	VB	xcomp	O
prematurely	RB	advmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
transactivators	NNS	nmod	B-protein
.	.	punct	O

Deletion	NN	compound	O
mutation	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
element	NN	nsubj	O
that	WDT	nsubj	O
responds	VBZ	acl:relcl	O
to	TO	case	O
CMV	NN	compound	O
transactivation	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
CD4+	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
is	VBZ	cop	O
either	CC	cc:preconj	O
a	DT	det	O
diffuse	JJ	amod	O
one	CD	ccomp	O
or	CC	cc	O
located	JJ	conj	O
downstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Quantitative	JJ	amod	O
immunohistochemical	JJ	amod	O
analysis	NN	ROOT	O
of	IN	case	O
mononuclear	JJ	amod	B-cell_type
infiltrates	NNS	nmod	I-cell_type
in	IN	case	O
breast	NN	compound	O
carcinomas	NNS	nmod	O
--	:	punct	O
correlation	NN	dep	O
with	IN	case	O
tumour	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

Inflammatory	JJ	amod	B-cell_type
infiltrates	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
analysed	VBN	ROOT	O
in	IN	case	O
tissue	NN	compound	O
sections	NNS	nmod	O
of	IN	case	O
76	CD	nummod	O
breast	NN	compound	O
carcinomas	NNS	nmod	O
by	IN	mark	O
counting	VBG	advcl	O
the	DT	det	O
percentage	NN	dobj	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
,	,	punct	O
IgA+	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
IgG+	JJ	conj	I-cell_type
plasma	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
with	IN	case	O
their	PRP$	nmod:poss	O
subpopulations	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
by	IN	mark	O
measuring	VBG	conj	O
postcapillary	JJ	amod	O
venules	NNS	dobj	O
(	-LRB-	punct	O
PCVs	NNS	appos	O
,	,	punct	O
found	VBN	acl	O
in	IN	case	O
12	CD	nummod	O
cases	NNS	nmod	O
)	-RRB-	punct	O
within	IN	case	O
the	DT	det	O
infiltrates	NNS	nmod	O
.	.	punct	O

These	DT	det	O
parameters	NNS	nsubjpass	O
were	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
nuclear	JJ	amod	O
grade	NN	nmod	O
and	CC	cc	O
biochemically	RB	advmod	O
determined	VBN	amod	O
hormone	NN	compound	O
receptor	NN	compound	O
status	NN	conj	O
,	,	punct	O
known	JJ	amod	O
markers	NNS	appos	O
of	IN	case	O
tumour	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

A	DT	det	O
direct	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
extent	NN	nmod	O
of	IN	case	O
inflammation	NN	nmod	O
and	CC	cc	O
nuclear	JJ	amod	O
grade	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.0001	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
an	DT	det	O
inverse	JJ	amod	O
correlation	NN	conj	O
between	IN	case	O
inflammation	NN	nmod	O
and	CC	cc	O
oestrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
OR	NN	appos	B-protein
)	-RRB-	punct	O
positivity	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.05	CD	nmod	O
)	-RRB-	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inflammation	NN	conj	O
and	CC	cc	O
progesterone	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
PR	NN	appos	B-protein
)	-RRB-	punct	O
positivity	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.05	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
percentage	NN	nsubj	O
of	IN	case	O
the	DT	det	O
OKT8+	JJ	amod	B-cell_line
suppressor/cytotoxic	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
increased	VBD	ROOT	O
when	WRB	advmod	O
the	DT	det	O
inflammation	NN	nsubj	O
expanded	VBN	advcl	O
from	IN	case	O
scanty	JJ	nmod	O
to	TO	mark	O
moderate	JJ	xcomp	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.02	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
diameter	NN	nsubj	O
of	IN	case	O
the	DT	det	O
PCVs	NNS	nmod	O
also	RB	advmod	O
increased	VBD	ROOT	O
with	IN	case	O
increasing	VBG	amod	O
inflammatory	JJ	amod	O
infiltrate	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.02	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
a	DT	det	O
direct	JJ	amod	O
correlation	NN	nsubj	O
exists	VBZ	ROOT	O
between	IN	case	O
the	DT	det	O
diameter	NN	nmod	O
of	IN	case	O
the	DT	det	O
PCVs	NNS	nmod	O
and	CC	cc	O
both	CC	cc:preconj	O
the	DT	det	O
percentage	NN	conj	O
of	IN	case	O
the	DT	det	O
OKT8+	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.04	CD	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
Leu-7+	JJ	amod	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.03	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Reactivity	NN	ROOT	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_line
to	TO	case	O
a	DT	det	O
progesterone	NN	compound	B-protein
receptor-specific	JJ	amod	I-protein
monoclonal	JJ	amod	I-protein
antibody	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
present	VBP	ROOT	O
evidence	NN	dobj	O
for	IN	case	O
reactivity	NN	nmod	O
of	IN	case	O
pregnancy	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
nonpregnancy	NN	compound	B-cell_type
lymphocytes	NNS	conj	I-cell_type
,	,	punct	O
with	IN	case	O
the	DT	det	O
progesterone	NN	nmod:npmod	B-protein
receptor-specific	JJ	amod	I-protein
monoclonal	JJ	amod	I-protein
antibody	NN	compound	I-protein
mPRI	NN	nmod	B-protein
.	.	punct	O

Using	VBG	advcl	O
an	DT	det	O
avidin	NN	compound	B-protein
-biotin	NN	compound	B-protein
peroxidase	NN	compound	I-protein
detection	NN	compound	O
system	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
a	DT	det	O
nuclear	JJ	amod	O
staining	NN	dobj	O
in	IN	case	O
14.6	CD	nummod	O
+/-	CC	cc	O
3.7	CD	conj	O
%	NN	nmod	O
(	-LRB-	punct	O
mean	NN	dep	O
+/-	CC	cc	O
SEM	NN	conj	O
,	,	punct	O
N	NN	nsubj	O
=	JJ	appos	O
27	CD	dep	O
)	-RRB-	punct	O
of	IN	case	O
pregnancy	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
while	IN	mark	O
only	RB	advmod	O
0.47	CD	nummod	O
+/-	CC	cc	O
0.33	CD	conj	O
%	NN	nsubj	O
(	-LRB-	punct	O
mean	NN	dep	O
+/-	CC	cc	O
SEM	NN	conj	O
,	,	punct	O
N	NN	appos	O
=	JJ	amod	O
15	CD	dep	O
)	-RRB-	punct	O
of	IN	case	O
nonpregnancy	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
reacted	VBD	advcl	O
with	IN	case	O
the	DT	det	O
antibody	NN	nmod	O
.	.	punct	O

To	TO	mark	O
characterize	VB	advcl	O
the	DT	det	O
receptor-bearing	JJ	amod	O
subset	NN	dobj	O
,	,	punct	O
CD8+	JJ	conj	B-cell_line
and	CC	cc	I-cell_line
CD4+	JJ	conj	I-cell_line
cells	NNS	conj	I-cell_line
were	VBD	auxpass	O
depleted	VBN	ROOT	O
by	IN	case	O
complement-dependent	JJ	amod	O
lysis	NN	nmod	O
.	.	punct	O

Depletion	NN	nsubjpass	O
of	IN	case	O
CD8+	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
62	CD	nummod	O
+/-	CC	cc	O
18	CD	conj	O
%	NN	amod	O
loss	NN	nmod	O
of	IN	case	O
progesterone	NN	compound	B-cell_line
receptor-bearing	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
while	IN	mark	O
depletion	NN	nsubj	O
of	IN	case	O
CD4+	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
resulted	VBD	advcl	O
in	IN	case	O
a	DT	det	O
twofold	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
positively	RB	advmod	O
staining	VBG	amod	O
lymphocytes	NNS	nmod	B-cell_line
.	.	punct	O

In	IN	case	O
nonpregnancy	NN	compound	B-cell_line
lymphocytes	NNS	nmod	I-cell_line
a	DT	det	O
3-day	JJ	amod	O
PHA	NN	compound	B-protein
treatment	NN	nsubj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
allogeneic	JJ	amod	O
stimulation	NN	conj	O
,	,	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
receptor-containing	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
pregnancy	NN	nsubj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
nonpregnancy	NN	conj	O
,	,	punct	O
lymphocytes	NNS	nsubj	B-cell_line
contain	VBP	ccomp	O
progesterone	NN	compound	B-protein
binding	NN	compound	I-protein
structures	NNS	dobj	I-protein
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
these	DT	nsubj	O
are	VBP	cop	O
inducible	JJ	conj	O
by	IN	case	O
mitogenic	JJ	nmod	O
or	CC	cc	O
alloantigenic	JJ	conj	O
stimuli	NNS	dep	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-cell_line
CD4	NN	compound	I-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

Interaction	NN	nsubj	O
of	IN	case	O
fibronectin	NN	nmod	B-protein
with	IN	case	O
VLA-5	NN	compound	B-protein
receptor	NN	nmod	I-protein
on	IN	case	O
CD4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
induces	VBZ	ROOT	O
the	DT	det	O
AP-1	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	dobj	I-protein
.	.	punct	O

Fibronectin	NN	nsubj	B-protein
synergized	VBD	ROOT	O
with	IN	case	O
anti-CD3	JJ	amod	B-protein
antibody	NN	nmod	I-protein
to	TO	mark	O
promote	VB	xcomp	O
CD4	NN	compound	B-protein
cell	NN	compound	O
proliferation	NN	dobj	O
in	IN	case	O
a	DT	det	O
serum-free	JJ	amod	O
culture	NN	compound	O
system	NN	nmod	O
whereas	IN	mark	O
no	DT	neg	O
proliferation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	advcl	O
when	WRB	advmod	O
CD4	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
cultured	VBN	advcl	O
with	IN	case	O
anti-CD3	NN	nmod	B-protein
alone	RB	advmod	O
or	CC	cc	O
fibronectin	NN	conj	B-protein
alone	RB	advmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
anti-CD29	JJ	amod	B-protein
(	-LRB-	punct	O
integrin	NN	compound	B-protein
beta	NN	dep	I-protein
1	CD	nummod	I-protein
)	-RRB-	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
anti-VLA-5	JJ	conj	B-protein
(	-LRB-	punct	O
human	JJ	amod	B-protein
fibronectin	NN	compound	I-protein
receptor	NN	appos	I-protein
)	-RRB-	punct	O
antibodies	NNS	nsubj	O
blocked	VBD	ROOT	O
this	DT	det	O
CD4	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
activation	NN	dobj	O
in	IN	case	O
this	DT	det	O
system	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
anti-CD3	NN	nsubj	B-protein
alone	RB	advmod	O
or	CC	cc	O
fibronectin	NN	conj	B-protein
alone	RB	advmod	O
can	MD	aux	O
not	RB	neg	O
induce	VB	advcl	O
IL-2	NN	compound	B-protein
message	NN	dobj	O
by	IN	case	O
CD4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
the	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
anti-CD3	NN	nmod	B-protein
plus	CC	cc	O
fibronectin	NN	conj	B-protein
induced	VBD	ROOT	O
IL-2	NN	compound	B-protein
message	NN	dobj	O
by	IN	case	O
CD4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
an	DT	det	O
analysis	NN	nmod	O
of	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	nmod	O
by	IN	case	O
which	WDT	nmod	O
IL-2	NN	compound	B-protein
message	NN	nsubjpass	O
was	VBD	auxpass	O
generated	VBN	acl:relcl	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
fibronectin	NN	compound	B-protein
-VLA-5	NN	compound	O
fibronectin	NN	compound	B-protein
receptor	NN	compound	I-protein
interaction	NN	nsubj	O
may	MD	aux	O
contribute	VB	ccomp	O
an	DT	det	O
independent	JJ	amod	O
signal	NN	dobj	O
distinct	JJ	amod	O
from	IN	case	O
the	DT	det	O
CD3	NN	compound	B-protein
pathway	NN	nmod	O
of	IN	case	O
activation	NN	nmod	O
by	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
an	DT	det	O
AP-1	NN	compound	B-protein
transcriptional	JJ	amod	I-protein
factor	NN	nmod	I-protein
.	.	punct	O

Thus	RB	advmod	O
the	DT	det	O
VLA-5	NN	compound	B-protein
fibronectin	NN	compound	I-protein
receptor	NN	nsubj	I-protein
on	IN	case	O
CD4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
can	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
complementary	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
CD3	NN	nmod:npmod	B-protein
-	:	punct	O
TCR	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
signal	NN	compound	O
transduction	NN	nmod	O
through	IN	case	O
its	PRP$	nmod:poss	O
interaction	NN	nmod	O
with	IN	case	O
fibronectin	NN	nmod	B-protein
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
on	IN	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
in	IN	case	O
Alzheimer	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
.	.	punct	O

Several	JJ	amod	O
lines	NNS	nsubj	O
of	IN	case	O
evidence	NN	nmod	O
suggest	VBP	ROOT	O
disturbances	NNS	dobj	O
of	IN	case	O
the	DT	det	O
hypothalamic-pituitary-adrenal	JJ	amod	O
(	-LRB-	punct	O
HPA	JJ	dep	O
)	-RRB-	punct	O
system	NN	nmod	O
in	IN	case	O
Alzheimer	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
(	-LRB-	punct	O
AD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
an	DT	det	O
exploration	NN	nmod	O
of	IN	case	O
the	DT	det	O
potential	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	O
receptor	NN	nmod	O
(	-LRB-	punct	O
GR	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
AD	NN	nmod	O
,	,	punct	O
GR	NN	compound	O
density	NN	conj	O
and	CC	cc	O
affinity	NN	conj	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
on	IN	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
of	IN	case	O
12	CD	nummod	O
AD	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
12	CD	nummod	O
healthy	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

GR	NN	compound	O
binding	NN	compound	O
characteristics	NNS	nsubj	O
did	VBD	aux	O
not	RB	neg	O
differ	VB	ROOT	O
between	IN	case	O
patients	NNS	nmod	O
and	CC	cc	O
controls	NNS	conj	O
or	CC	cc	O
between	IN	case	O
patients	NNS	conj	O
subdivided	VBN	acl	O
according	VBG	case	O
to	TO	case	O
diagnosis	NN	nmod	O
or	CC	cc	O
associated	VBN	amod	O
clinical	JJ	amod	O
features	NNS	conj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
abnormalities	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
HPA	JJ	amod	O
system	NN	nmod	O
in	IN	case	O
AD	NN	nmod	O
are	VBP	cop	O
not	RB	neg	O
related	JJ	ccomp	O
to	TO	case	O
a	DT	det	O
GR	NN	compound	B-protein
deficiency	NN	nmod	O
.	.	punct	O

Oncogene	NN	compound	O
amplification	NN	nsubj	O
correlates	VBZ	ROOT	O
with	IN	case	O
dense	JJ	amod	O
lymphocyte	NN	compound	O
infiltration	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
breast	NN	compound	O
cancers	NNS	nmod	O
:	:	punct	O
a	DT	det	O
role	NN	dep	O
for	IN	case	O
hematopoietic	JJ	amod	B-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
release	NN	nmod	O
by	IN	case	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
?	.	punct	O

One	CD	nummod	O
hundred	CD	cc	O
six	CD	nummod	O
primary	JJ	amod	O
breast	NN	compound	O
cancer	NN	compound	O
samples	NNS	nsubjpass	O
were	VBD	auxpass	O
analysed	VBN	ROOT	O
for	IN	case	O
c-erbB2	NN	nmod	O
,	,	punct	O
int-2	NN	conj	O
,	,	punct	O
and	CC	cc	O
c-myc	NN	conj	O
gene	NN	compound	O
amplification	NN	dep	O
.	.	punct	O

Surgically	RB	advmod	O
confirmed	VBN	amod	O
nodal	JJ	amod	O
involvement	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
42	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

Level	NN	nsubjpass	O
of	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
by	IN	case	O
Southern	NN	nmod	O
and/or	CC	cc	O
slot	NN	conj	O
blot	NN	compound	O
techniques	NNS	dep	O
.	.	punct	O

Amplified	VBN	amod	O
c-erbB2	NN	compound	B-DNA
gene	NN	compound	I-DNA
sequences	NNS	nsubj	I-DNA
were	VBD	cop	O
present	JJ	ROOT	O
in	IN	case	O
21.5	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
all	DT	det	O
samples	NNS	nmod	O
.	.	punct	O

Int-2	NN	nsubjpass	B-DNA
was	VBD	auxpass	O
amplified	VBN	ROOT	O
in	IN	case	O
13.1	CD	nummod	O
%	NN	nmod	O
and	CC	cc	O
c-myc	NN	nsubjpass	B-DNA
was	VBD	auxpass	O
amplified	VBN	conj	O
in	IN	case	O
10.3	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
non-parametric	JJ	amod	O
test	NN	nmod	O
(	-LRB-	punct	O
Kruskal-Wallis	NN	appos	O
)	-RRB-	punct	O
a	DT	det	O
strong	JJ	amod	O
negative	JJ	amod	O
association	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
c-erbB2	NN	compound	B-DNA
amplification	NN	nmod	O
and	CC	cc	O
absence	NN	conj	O
of	IN	case	O
estrogen	NN	compound	O
receptor	NN	compound	O
(	-LRB-	punct	O
ER	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.0009	CD	dep	O
)	-RRB-	punct	O
or	CC	cc	O
progesterone	NN	compound	B-protein
receptor	NN	conj	I-protein
(	-LRB-	punct	O
PR	NN	appos	B-protein
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.011	CD	dep	O
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O

No	DT	det	O
correlations	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
all	DT	amod	O
or	CC	cc	O
high	JJ	conj	O
levels	NNS	nmod	O
of	IN	case	O
amplification	NN	nmod	O
of	IN	case	O
each	DT	det	O
oncogene	NN	nmod	O
separately	RB	advmod	O
or	CC	cc	O
combined	VBN	conj	O
with	IN	case	O
T	NN	nmod	O
,	,	punct	O
N	NN	conj	O
,	,	punct	O
grade	NN	conj	O
,	,	punct	O
multifocality	NN	conj	O
of	IN	case	O
tumor	NN	nmod	O
,	,	punct	O
or	CC	cc	O
associated	VBN	amod	O
carcinoma	NN	conj	O
in	FW	compound	O
situ	FW	advmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
trend	NN	attr	O
approaching	VBG	acl	O
statistical	JJ	amod	O
significance	NN	dobj	O
for	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
c-erbB2	NN	compound	B-DNA
amplifications	NNS	nmod	O
to	TO	mark	O
have	VB	acl	O
positive	JJ	amod	O
lymph	NN	compound	O
nodes	NNS	dobj	O
at	IN	case	O
surgery	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0.09	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
somewhat	RB	advmod	O
surprising	JJ	amod	O
finding	NN	nsubj	O
however	RB	advmod	O
was	VBD	ROOT	O
a	DT	det	O
very	RB	advmod	O
strong	JJ	amod	O
association	NN	nsubj	O
between	IN	case	O
oncogene	NN	compound	B-DNA
amplification	NN	nmod	O
and	CC	cc	O
dense	JJ	amod	O
lymphocyte	NN	compound	O
infiltration	NN	conj	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O
This	DT	det	O
correlation	NN	nsubj	O
is	VBZ	cop	O
even	RB	advmod	O
stronger	JJR	ROOT	O
when	WRB	advmod	O
only	RB	advmod	O
high	JJ	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
amplification	NN	nmod	O
are	VBP	auxpass	O
considered	VBN	advcl	O
,	,	punct	O
either	CC	nmod	O
for	IN	case	O
each	DT	det	O
oncogene	NN	nmod	O
separately	RB	advmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.0048	CD	dep	O
)	-RRB-	punct	O
or	CC	cc	O
in	IN	case	O
combination	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.0007	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
malignant	JJ	amod	O
cell	NN	compound	O
cytokine	NN	compound	B-protein
production	NN	nsubj	O
may	MD	aux	O
help	VB	ccomp	O
explain	VB	xcomp	O
this	DT	det	O
observation	NN	dobj	O
.	.	punct	O

Suppression	NN	ROOT	O
of	IN	case	O
signals	NNS	nmod	O
required	VBN	acl	O
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
in	IN	case	O
cells	NNS	nmod	O
constitutively	RB	advmod	O
expressing	VBG	acl	O
the	DT	det	O
HTLV-I	NN	compound	B-protein
Tax	NN	compound	I-protein
protein	NN	dobj	I-protein
.	.	punct	O

Transient	JJ	amod	O
short-term	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Tax	NN	compound	B-protein
protein	NN	nmod	I-protein
of	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type-I	NN	nmod	O
(	-LRB-	punct	O
HTLV-I	NN	appos	O
)	-RRB-	punct	O
leads	VBZ	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
pleiotropic	JJ	amod	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
findings	NNS	nmod	O
obtained	VBN	acl	O
with	IN	case	O
transient	JJ	amod	O
expression	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
marked	JJ	amod	O
accumulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
of	IN	case	O
Namalwa	NN	compound	B-cell_line
B	NN	compound	I-cell_line
lymphoid	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
which	WDT	nsubj	O
constitutively	RB	advmod	O
express	VBP	acl:relcl	O
Tax	NN	dobj	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
following	VBG	case	O
long-term	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
Tax	NN	nmod	B-protein
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
both	CC	cc:preconj	O
mitogens	NNS	nmod	O
and	CC	cc	O
cytokines	NNS	conj	B-protein
to	TO	mark	O
activate	VB	acl	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
was	VBD	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
constitutively	RB	advmod	O
expressing	VBG	acl	O
Tax	NN	dobj	B-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
other	JJ	amod	O
mitogen-inducible	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
Fos	NN	nmod	B-protein
and	CC	cc	O
Jun	NN	conj	B-protein
,	,	punct	O
was	VBD	cop	O
unaffected	JJ	ROOT	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
depending	VBG	case	O
on	IN	case	O
the	DT	det	O
cellular	JJ	amod	O
environment	NN	nmod	O
,	,	punct	O
the	DT	dep	O
short-	JJ	nsubj	O
and	CC	cc	O
long-term	JJ	conj	O
effects	NNS	dep	O
of	IN	case	O
Tax	NN	compound	B-protein
expression	NN	nmod	O
can	MD	aux	O
be	VB	cop	O
quite	RB	advmod	O
different	JJ	ROOT	O
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
one	CD	nummod	O
function	NN	nsubj	O
of	IN	case	O
Tax	NN	nmod	B-protein
in	IN	case	O
cells	NNS	nmod	O
infected	VBN	acl	O
with	IN	case	O
HTLV-I	NN	nmod	O
might	MD	aux	O
involve	VB	ROOT	O
cell-type-specific	JJ	amod	O
suppression	NN	dobj	O
,	,	punct	O
as	IN	mark	O
opposed	VBN	advcl	O
to	TO	case	O
activation	NN	nmod	O
,	,	punct	O
of	IN	case	O
distinct	JJ	amod	O
signal	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

The	DT	det	O
cells	NNS	compound	O
lines	NNS	nsubj	O
described	VBN	acl	O
here	RB	advmod	O
should	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
delineation	NN	nmod	O
of	IN	case	O
signaling	NN	compound	O
pathways	NNS	nmod	O
utilized	VBN	acl	O
in	IN	case	O
the	DT	det	O
selective	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Interferon-gamma	NN	ROOT	B-protein
and	CC	cc	O
the	DT	det	O
sexual	JJ	amod	O
dimorphism	NN	conj	O
of	IN	case	O
autoimmunity	NN	nmod	O
.	.	punct	O

The	DT	det	O
sexual	JJ	amod	O
difference	NN	nsubj	O
in	IN	case	O
the	DT	det	O
incidence	NN	nmod	O
of	IN	case	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
has	VBZ	aux	O
remained	VBN	ROOT	O
an	DT	det	O
enigma	NN	dobj	O
for	IN	case	O
many	JJ	amod	O
years	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
examination	NN	nmod	O
of	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
autoimmunity	NN	nmod	O
in	IN	case	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
,	,	punct	O
evidence	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
obtained	VBN	ROOT	O
further	RB	advmod	O
implicating	VBG	xcomp	O
the	DT	det	O
lymphokine	NN	compound	B-protein
interferon-gamma	NN	dobj	B-protein
in	IN	case	O
the	DT	det	O
etiology	NN	nmod	O
of	IN	case	O
autoimmunity	NN	nmod	O
.	.	punct	O

Sex	NN	compound	O
steroid	NN	compound	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
this	DT	det	O
molecule	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
other	JJ	amod	O
cytokines	NNS	conj	B-protein
,	,	punct	O
may	MD	aux	O
help	VB	ROOT	O
explain	VB	xcomp	O
the	DT	det	O
gender-specific	JJ	amod	O
differences	NNS	dobj	O
in	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
including	VBG	case	O
autoimmunity	NN	nmod	O
.	.	punct	O

Cloning	NN	ROOT	O
of	IN	case	O
a	DT	det	O
transcriptionally	RB	advmod	B-protein
active	JJ	amod	I-protein
human	JJ	amod	I-protein
TATA	NN	compound	I-protein
binding	NN	compound	I-protein
factor	NN	nmod	I-protein
.	.	punct	O

Transcription	NN	compound	B-protein
factor	NN	compound	I-protein
IID	NN	nsubj	I-protein
(	-LRB-	punct	O
TFIID	NN	appos	B-protein
)	-RRB-	punct	O
binds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
TATA	NN	compound	B-DNA
box	NN	compound	I-DNA
promoter	NN	compound	I-DNA
element	NN	nmod	I-DNA
and	CC	cc	O
regulates	VBZ	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
most	JJS	advmod	O
eukaryotic	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
transcribed	VBN	acl	O
by	IN	case	O
RNA	NN	compound	B-protein
polymerase	NN	nmod	I-protein
II	CD	nummod	I-protein
.	.	punct	O

Complementary	JJ	amod	B-DNA
DNA	NN	nsubjpass	I-DNA
(	-LRB-	punct	O
cDNA	NN	appos	B-DNA
)	-RRB-	punct	O
encoding	VBG	acl	O
a	DT	det	O
human	JJ	amod	B-protein
TFIID	NN	compound	I-protein
protein	NN	dobj	I-protein
has	VBZ	aux	O
been	VBN	auxpass	O
cloned	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-protein
TFIID	NN	compound	I-protein
polypeptide	NN	nsubj	I-protein
has	VBZ	ROOT	O
339	CD	nummod	O
amino	NN	compound	O
acids	NNS	dobj	O
and	CC	cc	O
a	DT	det	O
molecular	JJ	amod	O
size	NN	conj	O
of	IN	case	O
37	CD	nummod	O
,	,	punct	O
745	CD	nummod	O
daltons	NNS	nmod	O
.	.	punct	O

The	DT	det	O
carboxyl-terminal	JJ	amod	B-protein
181	CD	nummod	I-protein
amino	NN	compound	I-protein
acids	NNS	nsubj	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
TFIID	NN	compound	I-protein
protein	NN	nmod	I-protein
shares	VBZ	ROOT	O
80	CD	nummod	O
%	NN	compound	O
identity	NN	dobj	O
with	IN	case	O
the	DT	det	O
TFIID	NN	compound	B-protein
protein	NN	nmod	O
from	IN	case	O
Saccharomyces	FW	compound	O
cerevisiae	FW	nmod	O
.	.	punct	O

The	DT	det	O
amino	NN	compound	B-protein
terminus	NN	nsubj	I-protein
contains	VBZ	ROOT	O
an	DT	det	O
unusual	JJ	amod	O
repeat	NN	dobj	O
of	IN	case	O
38	CD	nummod	O
consecutive	JJ	amod	O
glutamine	NN	compound	O
residues	NNS	nmod	O
and	CC	cc	O
an	DT	det	O
X-Thr-Pro	NN	compound	B-protein
repeat	NN	conj	I-protein
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
DNA	NN	nmod	O
in	IN	case	O
reticulocyte	NN	compound	O
lysates	NNS	nmod	O
or	CC	cc	O
in	IN	case	O
Escherichia	FW	compound	O
coli	FW	conj	O
yielded	VBD	ROOT	O
a	DT	det	O
protein	NN	dobj	O
that	WDT	nsubj	O
was	VBD	cop	O
competent	JJ	acl:relcl	O
for	IN	case	O
both	CC	cc:preconj	O
DNA	NN	compound	O
binding	NN	nmod	O
and	CC	cc	O
transcription	NN	compound	O
activation	NN	conj	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
T-cell	NN	compound	B-protein
trans-activator	NN	ROOT	I-protein
that	WDT	nsubj	O
recognizes	VBZ	acl:relcl	O
a	DT	det	O
phorbol	NN	compound	B-DNA
ester-inducible	JJ	amod	I-DNA
element	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
interleukin-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
interleukin	NN	compound	B-DNA
2	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
IL-2	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
recognized	VBN	ROOT	O
by	IN	case	O
several	JJ	amod	O
cell-type-specific	JJ	nmod	B-protein
and	CC	cc	I-protein
ubiquitous	JJ	conj	I-protein
transcriptional	JJ	amod	I-protein
regulators	NNS	dep	I-protein
that	WDT	nsubj	O
integrate	VBP	acl:relcl	O
information	NN	dobj	O
transmitted	VBN	acl	O
by	IN	case	O
various	JJ	amod	O
signaling	NN	compound	O
systems	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
IL-2	NN	compound	B-protein
production	NN	nmod	O
and	CC	cc	O
T-cell	NN	compound	B-cell_type
activation	NN	conj	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
combination	NN	dobj	O
of	IN	case	O
transfection	NN	nmod	O
,	,	punct	O
protein-DNA	JJ	amod	O
binding	NN	conj	O
,	,	punct	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	compound	O
methods	NNS	conj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
discovered	VBN	ROOT	O
the	DT	det	O
novel	JJ	amod	B-protein
T-cell-specific	JJ	amod	I-protein
transcriptional	JJ	amod	I-protein
activator	NN	dobj	I-protein
TCF-1	NN	dep	B-protein
(	-LRB-	punct	O
for	IN	case	O
T-Cell	NN	compound	B-protein
Factor-1	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
recognizes	VBZ	dep	O
a	DT	det	O
T-cell-specific	JJ	amod	B-DNA
response	NN	compound	I-DNA
element	NN	dobj	I-DNA
(	-LRB-	punct	O
TCE	NN	appos	B-DNA
)	-RRB-	punct	O
located	JJ	amod	O
within	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
TCE	NN	nsubj	B-DNA
is	VBZ	cop	O
similar	JJ	advcl	O
in	IN	case	O
sequence	NN	nmod	O
to	TO	case	O
a	DT	det	O
consensus	NN	compound	B-DNA
NF	NN	compound	I-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
site	NN	nmod	I-DNA
,	,	punct	O
several	JJ	amod	O
criteria	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
TCF-1	NN	nsubj	B-protein
is	VBZ	cop	O
distinct	JJ	ccomp	O
from	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
like	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
,	,	punct	O
TCF-1	NN	compound	B-protein
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
and	CC	cc	O
other	JJ	amod	O
T-cell	NN	compound	O
activators	NNS	conj	O
.	.	punct	O

Risk	NN	compound	O
factors	NNS	ROOT	O
for	IN	case	O
breast	NN	compound	O
recurrence	NN	nmod	O
in	IN	case	O
premenopausal	JJ	nmod	O
and	CC	cc	O
postmenopausal	JJ	conj	O
patients	NNS	dep	O
with	IN	case	O
ductal	JJ	amod	O
cancers	NNS	nmod	O
treated	VBN	acl	O
by	IN	case	O
conservation	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

Risk	NN	compound	O
factors	NNS	nsubjpass	O
for	IN	case	O
local	JJ	amod	O
failure	NN	nmod	O
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
for	IN	case	O
496	CD	nummod	O
clinical	JJ	amod	O
Stage	NN	compound	O
I-II	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
infiltrating	VBG	amod	O
ductal	JJ	amod	O
carcinomas	NNS	nmod	O
(	-LRB-	punct	O
median	NN	amod	O
follow-up	NN	dep	O
,	,	punct	O
71	CD	nummod	O
months	NNS	appos	O
)	-RRB-	punct	O
treated	VBN	acl	O
by	IN	case	O
conservative	JJ	amod	O
surgery	NN	nmod	O
and	CC	cc	O
radiotherapy	NN	conj	O
.	.	punct	O

Monofactorial	JJ	amod	O
analysis	NN	nsubj	O
identified	VBD	ROOT	O
the	DT	det	O
following	JJ	amod	O
factors	NNS	nsubjpass	O
to	TO	mark	O
be	VB	auxpass	O
correlated	VBN	ccomp	O
with	IN	case	O
increased	VBN	amod	O
risk	NN	nmod	O
:	:	punct	O
moderate/marked	JJ	amod	O
mononuclear	JJ	amod	O
cell	NN	compound	O
reaction	NN	dep	O
(	-LRB-	punct	O
MCR	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
high	JJ	amod	O
histologic	JJ	amod	O
grade	NN	conj	O
(	-LRB-	punct	O
G	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
extensive	JJ	amod	O
intraductal	JJ	amod	O
component	NN	conj	O
(	-LRB-	punct	O
EIC	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
tumor	NN	compound	O
necrosis	NN	conj	O
,	,	punct	O
macroscopic	JJ	amod	O
multiplicity	NN	conj	O
,	,	punct	O
estrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
negativity	NN	conj	O
,	,	punct	O
anatomic	JJ	amod	O
tumor	NN	compound	O
size	NN	conj	O
,	,	punct	O
age	NN	appos	O
younger	JJR	amod	O
than	IN	case	O
40	CD	nummod	O
years	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	O
invasion	NN	conj	O
.	.	punct	O

Only	RB	advmod	O
MCR	NN	nsubj	O
,	,	punct	O
G	NN	conj	O
,	,	punct	O
and	CC	cc	O
EIC	NN	conj	O
proved	VBD	ROOT	O
significant	JJ	xcomp	O
in	IN	case	O
Cox	NN	compound	O
multivariate	JJ	amod	O
analysis	NN	nmod	O
.	.	punct	O

These	DT	det	O
risk	NN	compound	O
factors	NNS	nsubj	O
were	VBD	cop	O
highly	RB	advmod	O
age	NN	nmod:npmod	O
dependent	JJ	ROOT	O
,	,	punct	O
with	IN	case	O
EIC	NN	nsubj	O
markedly	RB	advmod	O
more	RBR	advmod	O
prevalent	JJ	advcl	O
in	IN	case	O
women	NNS	nmod	O
younger	JJR	amod	O
than	IN	case	O
50	CD	nmod	O
,	,	punct	O
MCR	NN	conj	O
and	CC	cc	O
G	NN	conj	O
in	IN	case	O
women	NNS	nmod	O
younger	JJR	amod	O
than	IN	case	O
40	CD	nmod	O
.	.	punct	O

Separate	JJ	compound	O
Cox	NN	compound	O
analysis	NN	nsubj	O
for	IN	case	O
premenopausal	JJ	amod	O
patients	NNS	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
MCR/EIC	NN	nsubj	O
determined	VBD	ccomp	O
risk	NN	dobj	O
independent	JJ	amod	O
of	IN	case	O
resection	NN	compound	O
margins	NNS	nmod	O
:	:	punct	O
tumors	NNS	nsubj	O
with	IN	case	O
MCR	NN	nmod	O
had	VBD	parataxis	O
a	DT	det	O
28	CD	nummod	O
%	NN	dobj	O
,	,	punct	O
and	CC	cc	O
with	IN	case	O
EIC	NN	conj	O
a	DT	det	O
22	CD	compound	O
%	NN	amod	O
probability	NN	dep	O
of	IN	mark	O
recurring	VBG	acl	O
locally	RB	advmod	O
by	IN	prep	O
5	CD	nummod	O
years	NNS	pobj	O
.	.	punct	O

Premenopausal	JJ	amod	O
patients	NNS	nsubj	O
with	IN	case	O
neither	DT	det	O
risk	NN	compound	O
factor	NN	nmod	O
had	VBD	ROOT	O
a	DT	det	O
very	RB	advmod	O
low	JJ	amod	O
failure	NN	compound	O
rate	NN	dobj	O
(	-LRB-	punct	O
2.6	CD	nummod	O
%	NN	dep	O
at	IN	case	O
5	CD	nummod	O
years	NNS	nmod	O
)	-RRB-	punct	O
,	,	punct	O
regardless	RB	advmod	O
of	IN	case	O
age	NN	nmod	O
.	.	punct	O

For	IN	case	O
postmenopausal	JJ	amod	O
patients	NNS	compound	O
risk	NN	nsubjpass	O
of	IN	case	O
breast	NN	compound	O
recurrence	NN	nmod	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
both	CC	dep	O
by	IN	case	O
adequacy	NN	nmod	O
of	IN	case	O
resection	NN	compound	O
margins	NNS	nmod	O
and	CC	cc	O
grade	NN	conj	O
,	,	punct	O
with	IN	case	O
a	DT	det	O
high	JJ	amod	O
local	JJ	amod	O
failure	NN	compound	O
rate	NN	nmod	O
for	IN	case	O
patients	NNS	nmod	O
having	VBG	acl	O
G3	NN	compound	O
tumors	NNS	dobj	O
with	IN	case	O
positive	JJ	nmod	O
or	CC	cc	O
indeterminate	JJ	conj	O
margins	NNS	dep	O
(	-LRB-	punct	O
31	CD	nummod	O
%	NN	dep	O
at	IN	case	O
5	CD	nummod	O
years	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
authors	NNS	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
microscopic	JJ	amod	O
examination	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
only	JJ	advmod	O
useful	JJ	amod	O
tool	NN	nsubj	O
for	IN	mark	O
assessing	VBG	acl	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
local	JJ	amod	O
failure	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
quite	RB	advmod	O
low	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
majority	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
breast	NN	compound	O
conservation	NN	nmod	O
.	.	punct	O

High-risk	JJ	amod	O
patients	NNS	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
recognized	VBN	ROOT	O
morphologically	RB	advmod	O
.	.	punct	O

The	DT	det	O
age	NN	compound	O
dependence	NN	nsubj	O
of	IN	case	O
morphologic	JJ	amod	O
risk	NN	compound	O
factors	NNS	nmod	O
appears	VBZ	ROOT	O
to	TO	mark	O
explain	VB	xcomp	O
the	DT	det	O
high	JJ	amod	O
local	JJ	amod	O
failure	NN	compound	O
rate	NN	dobj	O
seen	VBN	acl	O
in	IN	case	O
patients	NNS	nmod	O
younger	JJR	amod	O
than	IN	case	O
40	CD	nmod	O
.	.	punct	O

Tax	NN	nmod:npmod	B-protein
-independent	JJ	amod	O
binding	NN	ROOT	O
of	IN	case	O
multiple	JJ	amod	O
cellular	JJ	amod	B-protein
factors	NNS	nmod	I-protein
to	TO	case	O
Tax-response	JJ	amod	B-DNA
element	NN	compound	I-DNA
DNA	NN	nmod	I-DNA
of	IN	case	O
HTLV-I	NN	nmod	O
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-DNA
T-cell	NN	compound	I-DNA
leukemia	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
I	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
HTLV-I	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
three	CD	nummod	O
copies	NNS	dobj	O
of	IN	case	O
imperfect	JJ	compound	O
repeats	NNS	nmod	O
of	IN	case	O
a	DT	det	O
21-base	JJ	amod	O
pair	NN	compound	O
sequence	NN	nmod	O
designated	VBN	acl	O
here	RB	advmod	O
as	IN	case	O
TRE	NN	nmod	B-DNA
(	-LRB-	punct	O
Tax-response	JJ	amod	B-DNA
element	NN	appos	I-DNA
)	-RRB-	punct	O
that	WDT	nsubj	O
is	VBZ	cop	O
responsive	JJ	acl:relcl	O
to	TO	case	O
the	DT	det	O
virally	RB	advmod	B-protein
encoded	VBN	amod	I-protein
transactivator	NN	compound	I-protein
protein	NN	compound	I-protein
Tax	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
and	CC	cc	O
separated	VBN	conj	O
four	CD	nummod	O
nuclear	JJ	amod	B-protein
proteins	NNS	dobj	I-protein
from	IN	case	O
C81-66-45	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
an	DT	det	O
HTLV-I	NN	compound	B-cell_line
immortalized	JJ	amod	I-cell_line
Tax-expressing	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
T-lymphocyte	NN	compound	I-cell_line
line	NN	appos	I-cell_line
(	-LRB-	punct	O
Salahuddin	NNP	dep	O
et	FW	dep	O
al.	FW	dep	O
,	,	punct	O
1983	CD	amod	O
)	-RRB-	punct	O
,	,	punct	O
that	WDT	nsubj	O
interact	VBP	ccomp	O
with	IN	case	O
the	DT	det	O
TRE-DNA	NN	nmod	B-DNA
,	,	punct	O
none	NN	nsubj	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	cop	O
identical	JJ	parataxis	O
with	IN	case	O
the	DT	det	O
Tax-protein	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
proteins	NNS	nsubj	O
identified	VBN	acl	O
have	VBP	ROOT	O
molecular	JJ	amod	O
weights	NNS	dobj	O
of	IN	case	O
about	RB	advmod	O
32	CD	nummod	O
,	,	punct	O
36	CD	compound	O
to	TO	dep	O
42	CD	conj	O
,	,	punct	O
50	CD	conj	O
and	CC	cc	O
110	CD	conj	O
kD	NN	nmod	O
.	.	punct	O

Four	CD	nummod	O
different	JJ	amod	O
methods	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
identify	VB	xcomp	O
the	DT	det	O
proteins	NNS	dobj	O
.	.	punct	O

First	RB	advmod	O
,	,	punct	O
from	IN	case	O
different	JJ	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
three	CD	nummod	O
or	CC	cc	O
all	DT	conj	O
four	CD	nsubjpass	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
were	VBD	auxpass	O
specifically	RB	advmod	O
cross-linked	VBN	ROOT	O
by	IN	case	O
UV	NN	compound	O
irradiation	NN	nmod	O
to	TO	case	O
the	DT	det	O
radioactively	RB	advmod	O
labeled	VBN	amod	O
TRE-DNA	NN	compound	B-DNA
fragment	NN	nmod	I-DNA
.	.	punct	O

Second	RB	advmod	O
,	,	punct	O
TRE-DNA	NN	compound	B-protein
binding	NN	compound	I-protein
proteins	NNS	ROOT	I-protein
sedimented	VBD	acl	O
through	IN	case	O
a	DT	det	O
glycerol	NN	compound	O
density	NN	compound	O
gradient	NN	nmod	O
at	IN	case	O
rates	NNS	nmod	O
corresponding	VBG	acl	O
to	TO	case	O
proteins	NNS	nmod	O
of	IN	case	O
native	JJ	amod	O
molecular	JJ	amod	O
weights	NNS	nmod	O
of	IN	case	O
35	CD	compound	O
to	TO	dep	O
50	CD	nummod	O
kD	NN	nmod	O
and	CC	cc	O
110	CD	nummod	O
kD	NN	conj	O
.	.	punct	O

Third	RB	advmod	O
,	,	punct	O
only	RB	advmod	O
the	DT	det	O
50	CD	nummod	B-protein
kD	NN	compound	I-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
retained	VBN	ROOT	O
on	IN	case	O
a	DT	det	O
biotinylated	VBN	amod	O
DNA-streptavidin	NN	compound	O
matrix	NN	nmod	O
when	WRB	advmod	O
the	DT	det	O
DNA	NN	compound	O
fragment	NN	nsubj	O
contained	VBD	advcl	O
the	DT	det	O
TRE-DNA	NN	dobj	B-DNA
.	.	punct	O

Fourth	RB	advmod	O
,	,	punct	O
extensive	JJ	amod	O
purification	NN	nsubj	O
by	IN	case	O
several	JJ	amod	O
cycles	NNS	nmod	O
of	IN	case	O
TRE	NN	compound	B-DNA
-DNA	NN	compound	O
affinity	NN	compound	O
chromatography	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	dep	O
32	CD	nmod	B-protein
,	,	punct	I-protein
36	CD	compound	I-protein
to	TO	dep	I-protein
42	CD	conj	I-protein
and	CC	cc	I-protein
110	CD	conj	I-protein
kD	NN	conj	I-protein
proteins	NNS	dep	I-protein
and	CC	cc	O
to	TO	case	O
less	JJR	advmod	O
extent	NN	conj	O
the	DT	det	O
50	CD	nummod	B-protein
kD	NN	compound	I-protein
factor	NN	dep	I-protein
.	.	punct	O

Two	CD	nummod	O
abundant	JJ	amod	O
proteins	NNS	nsubjpass	O
of	IN	case	O
75	CD	nummod	O
and	CC	cc	O
80	CD	conj	O
kD	NN	nmod	O
were	VBD	auxpass	O
competed	VBN	ROOT	O
out	RP	advmod	O
by	IN	case	O
poly	NN	amod	O
[	-LRB-	punct	O
d	NN	nmod	O
(	-LRB-	punct	O
I-C	NN	appos	O
)	-RRB-	punct	O
]	-RRB-	punct	O
in	IN	case	O
all	DT	det	O
reactions	NNS	nmod	O
.	.	punct	O

The	DT	det	O
cAMP-response	JJ	amod	B-DNA
element	NN	compound	I-DNA
CRE	NN	nsubj	B-DNA
,	,	punct	O
TGACGTCA	NN	appos	O
,	,	punct	O
present	JJ	amod	O
in	IN	case	O
the	DT	det	O
21	CD	nummod	B-DNA
base-pair	NN	amod	I-DNA
sequence	NN	nmod	I-DNA
,	,	punct	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
essential	JJ	xcomp	O
for	IN	case	O
specific	JJ	amod	O
protein-	NN	amod	O
TRE	NN	compound	B-DNA
-DNA	CD	compound	O
interactions	NNS	nmod	O
because	IN	mark	O
mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
G	NN	nmod	O
's	NNS	case	O
destroys	VBZ	advcl	O
this	DT	det	O
complex	NN	dobj	O
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nsubjpass	I-protein
,	,	punct	O
CREB	NN	appos	B-protein
,	,	punct	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
protein-TRE-DNA	JJ	amod	B-protein
complex	NN	nmod	I-protein
and	CC	cc	O
in	IN	mark	O
mediating	VBG	advcl	O
the	DT	det	O
Tax	NN	compound	B-protein
response	NN	dobj	O
.	.	punct	O

Two	CD	nummod	O
distinct	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	ROOT	I-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
microE5/kappa	NN	compound	B-DNA
2	CD	nummod	I-DNA
motif	NN	dobj	I-DNA
.	.	punct	O

Activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	nmod	B-DNA
heavy	JJ	dep	I-DNA
and	CC	cc	I-DNA
kappa	NN	compound	I-DNA
light	JJ	amod	I-DNA
chain	NN	compound	I-DNA
gene	NN	compound	I-DNA
enhancers	NNS	dep	I-DNA
depends	VBZ	ROOT	O
on	IN	case	O
a	DT	det	O
complex	JJ	amod	O
interplay	NN	nmod	O
of	IN	case	O
ubiquitous	JJ	amod	B-protein
and	CC	cc	I-protein
developmentally	RB	advmod	I-protein
regulated	VBN	conj	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

Two	CD	nummod	O
complementary	JJ	amod	B-DNA
DNAs	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
isolated	VBN	ROOT	O
that	WDT	nsubj	O
encode	VBP	ccomp	O
proteins	NNS	dobj	O
,	,	punct	O
denoted	VBN	acl	O
ITF-1	NN	xcomp	B-protein
and	CC	cc	O
ITF-2	NN	conj	B-protein
,	,	punct	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
expressed	VBN	acl:relcl	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
types	NNS	nmod	O
and	CC	cc	O
bind	VBP	conj	O
the	DT	det	O
microE5/kappa	NN	compound	B-DNA
2	CD	nummod	I-DNA
motif	NN	dobj	I-DNA
found	VBN	acl	O
in	IN	case	O
both	CC	cc:preconj	O
heavy	JJ	amod	B-DNA
and	CC	cc	I-DNA
kappa	NN	conj	I-DNA
light	JJ	conj	I-DNA
chain	NN	compound	I-DNA
enhancers	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
complementary	JJ	amod	B-DNA
DNAs	NNS	nsubj	I-DNA
are	VBP	cop	O
the	DT	det	O
products	NNS	ROOT	O
of	IN	case	O
distinct	JJ	amod	O
genes	NNS	nmod	O
,	,	punct	O
yet	CC	cc	O
both	CC	cc:preconj	O
ITF-1	NN	nsubj	B-protein
and	CC	cc	O
ITF-2	NN	conj	B-protein
are	VBP	cop	O
structurally	RB	advmod	O
and	CC	advmod	O
functionally	RB	advmod	O
similar	JJ	conj	O
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
proteins	NNS	nsubj	O
interact	VBP	ROOT	O
with	IN	case	O
one	CD	nmod	O
another	DT	dep	O
through	IN	case	O
their	PRP$	nmod:poss	O
putative	JJ	amod	O
helix-loop-helix	JJ	amod	B-protein
motifs	NNS	nmod	I-protein
and	CC	cc	O
each	DT	nsubj	O
possesses	VBZ	conj	O
a	DT	det	O
distinct	JJ	amod	O
domain	NN	dobj	O
that	WDT	nsubj	O
dictates	VBZ	acl:relcl	O
transcription	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

Elevated	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
concentrations	NNS	ROOT	O
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
glucocorticoid	NN	compound	O
therapy	NN	nmod	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
atopic	JJ	amod	O
dermatitis	NN	nmod	O
.	.	punct	O

The	DT	det	O
number	NN	nsubjpass	O
and	CC	cc	O
affinity	NN	conj	O
of	IN	case	O
glucocorticoid	NN	compound	O
binding	NN	compound	O
sites	NNS	nmod	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
atopic	JJ	amod	O
dermatitis	NN	nmod	O
(	-LRB-	punct	O
AD	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
healthy	JJ	amod	O
controls	NNS	conj	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
under	IN	case	O
baseline	NN	compound	O
conditions	NNS	nmod	O
and	CC	cc	O
after	IN	case	O
a	DT	det	O
defined	VBN	amod	O
oral	JJ	amod	O
glucocorticoid	NN	compound	O
treatment	NN	conj	O
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
AD	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
15	CD	dep	O
)	-RRB-	punct	O
exhibited	VBD	ROOT	O
significantly	RB	advmod	O
more	JJR	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	dobj	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
per	IN	case	O
cell	NN	nmod	O
than	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
22	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
GR	NN	compound	B-protein
affinity	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
differ	VB	advcl	O
.	.	punct	O

Methylprednisolone	NN	compound	O
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
the	DT	det	O
GR	NN	compound	B-protein
sites	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
in	IN	case	O
the	DT	det	O
steroid-treated	JJ	amod	O
control	NN	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
10	CD	dep	O
)	-RRB-	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
patients	NNS	nmod	O
.	.	punct	O

The	DT	det	O
dissociation	NN	compound	O
constant	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
affected	VBN	ROOT	O
by	IN	case	O
methylprednisolone	NN	compound	O
treatment	NN	nmod	O
in	IN	case	O
either	DT	det	O
group	NN	nmod	O
.	.	punct	O

In	IN	case	O
view	NN	nmod	O
of	IN	case	O
the	DT	det	O
therapeutic	JJ	amod	O
efficiency	NN	nmod	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
in	IN	case	O
AD	NN	nmod	O
and	CC	cc	O
findings	NNS	conj	O
of	IN	case	O
abnormal	JJ	amod	O
cAMP	NN	nmod	O
and	CC	cc	O
cAMP-phosphodiesterase	NN	conj	O
activity	NN	dep	O
,	,	punct	O
the	DT	det	O
elevated	JJ	amod	O
GR	NN	compound	B-protein
concentrations	NNS	nsubj	O
in	IN	case	O
AD	NN	nmod	O
lend	VBP	ROOT	O
support	NN	dobj	O
to	TO	case	O
the	DT	det	O
hypothesis	NN	nmod	O
of	IN	case	O
a	DT	det	O
compensatory	JJ	amod	O
GR	NN	compound	B-protein
upregulation	NN	nmod	O
due	JJ	case	O
to	TO	case	O
an	DT	det	O
insufficient	JJ	amod	O
action	NN	nmod	O
of	IN	case	O
endogenous	JJ	amod	O
cortisol	NN	nmod	O
or	CC	cc	O
to	TO	case	O
altered	JJ	amod	O
cAMP-induced	JJ	amod	O
GR	NN	compound	B-protein
expression	NN	conj	O
.	.	punct	O

The	DT	det	O
actions	NNS	nsubj	O
of	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
and	CC	cc	O
FK506	NN	conj	O
suggest	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
step	NN	dobj	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Cyclosporin	NN	compound	O
A	NN	nsubj	O
and	CC	cc	O
FK506	NN	conj	O
are	VBP	cop	O
immunosuppressive	JJ	amod	O
compounds	NNS	ROOT	O
that	WDT	nsubj	O
have	VBP	acl:relcl	O
similar	JJ	amod	O
inhibitory	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
lymphokines	NNS	nmod	B-protein
produced	VBN	acl	O
by	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Despite	IN	case	O
their	PRP$	nmod:poss	O
similar	JJ	amod	O
effects	NNS	nmod	O
the	DT	det	O
drugs	NNS	nsubj	O
bind	VBP	ROOT	O
to	TO	case	O
two	CD	nummod	O
different	JJ	amod	O
cytosolic	JJ	amod	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
cyclophilin	NN	appos	B-protein
and	CC	cc	O
FKBP	NN	conj	B-protein
respectively	RB	advmod	O
,	,	punct	O
which	WDT	nsubj	O
raises	VBZ	acl:relcl	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
they	PRP	nsubj	O
have	VBP	ccomp	O
different	JJ	amod	O
modes	NNS	dobj	O
of	IN	case	O
action	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
constructs	NNS	dobj	O
in	IN	case	O
which	WDT	nmod	O
mRNA	NN	compound	B-RNA
production	NN	nsubjpass	O
controlled	VBN	acl	O
by	IN	case	O
a	DT	det	O
specific	JJ	amod	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
could	MD	aux	O
be	VB	auxpass	O
readily	RB	advmod	O
measured	VBN	acl:relcl	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
cyclosporin	NN	compound	O
A	NN	nsubj	O
and	CC	cc	O
FK506	NN	conj	O
completely	RB	advmod	O
inhibited	VBD	ccomp	O
transcription	NN	dobj	O
activated	VBN	acl	O
by	IN	case	O
NF-AT	NN	nmod	B-protein
,	,	punct	O
NFIL2	NN	compound	B-protein
A	NN	conj	I-protein
,	,	punct	O
NFIL2	NN	compound	B-protein
B	NN	conj	I-protein
and	CC	cc	O
partially	RB	advmod	O
inhibited	VBD	conj	O
transcription	NN	dobj	O
activated	VBN	acl	O
by	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

Cyclosporin	NN	compound	O
A	NN	nsubj	O
and	CC	cc	O
FK506	NN	conj	O
inhibited	VBD	ROOT	O
only	RB	advmod	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
that	WDT	nsubj	O
was	VBD	cop	O
dependent	JJ	acl:relcl	O
on	IN	case	O
Ca2+	NN	compound	O
mobilization	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
cyclosporin	NN	compound	O
A	NN	nsubj	O
and	CC	cc	O
FK506	NN	conj	O
did	VBD	aux	O
not	RB	neg	O
inhibit	VB	ROOT	O
Ca2+	NN	nmod:npmod	O
mobilization	NN	nmod:npmod	O
dependent	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
c-fos	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
indicating	VBG	advcl	O
that	IN	mark	O
only	RB	advmod	O
a	DT	det	O
subset	NN	nsubj	O
of	IN	case	O
signalling	NN	amod	O
pathways	NNS	nmod	O
regulated	VBN	acl	O
by	IN	case	O
Ca2+	NN	nmod	O
is	VBZ	cop	O
sensitive	JJ	ccomp	O
to	TO	case	O
these	DT	det	O
drugs	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
did	VBD	aux	O
not	RB	neg	O
observe	VB	ROOT	O
any	DT	det	O
qualitative	JJ	amod	O
differences	NNS	dobj	O
between	IN	case	O
the	DT	det	O
effect	NN	nmod	O
of	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
and	CC	cc	O
FK506	NN	conj	O
on	IN	case	O
six	CD	nummod	O
different	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
which	WDT	nsubj	O
suggests	VBZ	acl:relcl	O
that	IN	mark	O
these	DT	det	O
drugs	NNS	nsubj	O
may	MD	aux	O
interfere	VB	ccomp	O
with	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	O
Ca2+	NN	compound	O
dependent	JJ	amod	O
step	NN	nmod	O
that	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
several	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
.	.	punct	O

The	DT	det	O
internal	JJ	amod	O
methionine	NN	compound	O
codons	NNS	nsubjpass	O
of	IN	case	O
human	JJ	amod	B-DNA
T-cell	NN	compound	I-DNA
leukemia	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
II	CD	nummod	I-DNA
rex	NN	compound	I-DNA
gene	NN	nmod	I-DNA
are	VBP	auxpass	O
not	RB	neg	O
required	VBN	ROOT	O
for	IN	case	O
p24rex	NN	compound	B-protein
production	NN	nmod	O
or	CC	cc	O
virus	NN	compound	O
replication	NN	conj	O
and	CC	cc	O
transformation	NN	conj	O
.	.	punct	O

Human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
types	NNS	nsubj	O
I	CD	nummod	O
(	-LRB-	punct	O
HTLV-I	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
II	CD	conj	O
(	-LRB-	punct	O
HTLV-II	NN	appos	O
)	-RRB-	punct	O
have	VBP	ROOT	O
two	CD	nummod	O
nonstructural	JJ	amod	B-DNA
trans-acting	JJ	amod	I-DNA
regulatory	JJ	amod	I-DNA
genes	NNS	dobj	I-DNA
,	,	punct	O
tax	NN	appos	B-DNA
and	CC	cc	O
rex	NN	conj	B-DNA
,	,	punct	O
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
3	CD	nummod	B-DNA
'	``	punct	I-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
viral	JJ	amod	B-DNA
genome	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
tax	NN	compound	B-protein
gene	NN	compound	I-protein
product	NN	nsubj	I-protein
(	-LRB-	punct	O
HTLV-I	NN	compound	B-protein
p40tax	NN	dep	I-protein
and	CC	cc	O
HTLV-II	NN	compound	B-protein
p37tax	NN	conj	I-protein
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
transcriptional	JJ	amod	O
activator	NN	ROOT	O
of	IN	case	O
the	DT	det	O
viral	JJ	amod	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
rex	NN	compound	B-DNA
gene	NN	nsubj	I-DNA
encodes	VBZ	ROOT	O
two	CD	nummod	O
protein	NN	compound	O
products	NNS	dobj	O
,	,	punct	O
p27rex/p21rex	NN	appos	B-protein
and	CC	cc	O
p26rex/p24rex	NN	conj	B-protein
in	IN	case	O
HTLV-I	NN	nmod	O
and	CC	cc	O
HTLV-II	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Rex	NN	nsubj	B-protein
acts	VBZ	ROOT	O
posttranscriptionally	RB	advmod	O
to	TO	mark	O
facilitate	VB	xcomp	O
accumulation	NN	dobj	O
of	IN	case	O
full-length	JJ	amod	O
gag/pol	NN	nmod	B-protein
and	CC	cc	O
singly	RB	advmod	O
spliced	VBN	amod	O
env	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
of	IN	case	O
HTLV-infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
first	JJ	amod	O
ATG	NN	nsubj	O
of	IN	case	O
the	DT	det	O
rex	NN	compound	B-DNA
gene	NN	nmod	I-DNA
is	VBZ	cop	O
critical	JJ	ccomp	O
for	IN	case	O
Rex	NN	compound	B-protein
production	NN	nmod	O
and	CC	cc	O
function	NN	conj	O
.	.	punct	O

The	DT	det	O
importance	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
internal	JJ	amod	O
ATGs	NNS	nmod	O
to	TO	case	O
Rex	NN	compound	B-protein
function	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	FW	amod	O
vitro	FW	dep	O
mutagenesis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
HTLV-I	NN	compound	O
rex	NN	compound	B-DNA
gene	NN	nmod	I-DNA
has	VBZ	aux	O
provided	VBN	ROOT	O
indirect	JJ	amod	O
evidence	NN	dobj	O
which	WDT	nsubj	O
suggests	VBZ	acl:relcl	O
that	IN	mark	O
p21rex	NN	nsubj	B-protein
,	,	punct	O
and	CC	cc	O
by	IN	case	O
analogy	NN	compound	O
HTLV-II	NN	compound	O
p24rex	NN	conj	B-protein
,	,	punct	O
results	VBZ	ccomp	O
from	IN	case	O
initiation	NN	nmod	O
at	IN	case	O
an	DT	det	O
internal	JJ	amod	O
AUG	NN	nmod	O
of	IN	case	O
the	DT	det	O
tax/rex	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
an	DT	det	O
infectious	JJ	amod	O
molecular	JJ	amod	O
clone	NN	dobj	O
of	IN	case	O
HTLV-II	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
the	DT	det	O
internal	JJ	amod	O
ATGs	NNS	nmod	O
of	IN	case	O
the	DT	det	O
rex	NN	compound	B-DNA
gene	NN	nmod	I-DNA
on	IN	case	O
Rex	NN	compound	B-protein
protein	NN	compound	O
production	NN	nmod	O
and	CC	cc	O
function	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
p24rex	NN	nsubjpass	B-protein
of	IN	case	O
HTLV-II	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
initiated	VBN	ccomp	O
at	IN	case	O
an	DT	det	O
internal	JJ	amod	O
AUG	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
internal	JJ	amod	O
methionine	NN	compound	O
codons	NNS	nsubj	O
are	VBP	cop	O
not	RB	neg	O
crucial	JJ	conj	O
to	TO	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
the	DT	det	O
rex	NN	compound	B-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
,	,	punct	O
ultimately	RB	advmod	O
,	,	punct	O
the	DT	det	O
transforming	VBG	amod	O
properties	NNS	dobj	O
of	IN	case	O
the	DT	det	O
virus	NN	nmod	O
.	.	punct	O

Astrocytes	NNS	nsubj	B-cell_type
and	CC	cc	O
glioblastoma	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
express	VBP	ROOT	O
novel	JJ	amod	O
octamer-DNA	NN	compound	B-protein
binding	NN	compound	I-protein
proteins	NNS	dobj	I-protein
distinct	JJ	amod	O
from	IN	case	O
the	DT	det	O
ubiquitous	JJ	amod	B-protein
Oct-1	NN	nmod	I-protein
and	CC	cc	I-protein
B	NN	compound	I-protein
cell	NN	compound	I-protein
type	NN	compound	I-protein
Oct-2	NN	compound	I-protein
proteins	NNS	conj	I-protein
.	.	punct	O

The	DT	det	O
'octamer	NN	nmod:poss	B-DNA
'	POS	punct	I-DNA
sequence	NN	nsubj	I-DNA
,	,	punct	O
ATGCAAAT	NN	appos	O
or	CC	cc	O
its	PRP$	nmod:poss	O
complement	NN	compound	O
ATTTGCAT	NN	conj	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
key	JJ	amod	O
element	NN	ROOT	O
for	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
B-lymphocytes	NNS	nmod	B-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
number	NN	conj	O
of	IN	case	O
housekeeping	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
all	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

In	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
,	,	punct	O
the	DT	det	O
octamer-binding	JJ	amod	B-protein
protein	NN	nsubjpass	I-protein
Oct-2A	NN	dep	B-protein
and	CC	cc	O
variants	NNS	conj	O
thereof	RB	advmod	O
are	VBP	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
the	DT	det	O
B-cell	NN	compound	B-DNA
specific	JJ	amod	I-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
ubiquitous	JJ	amod	O
protein	NN	compound	O
Oct-1	NN	nsubj	O
seems	VBZ	advcl	O
to	TO	mark	O
control	VB	xcomp	O
general	JJ	amod	O
octamer	NN	nmod:npmod	B-DNA
site	NN	nmod:npmod	I-DNA
-dependent	JJ	amod	O
transcription	NN	dobj	O
.	.	punct	O

Various	JJ	amod	O
other	JJ	amod	O
genes	NNS	nsubj	O
,	,	punct	O
for	IN	case	O
example	NN	nmod	O
interleukin-1	NN	dep	B-DNA
and	CC	cc	I-DNA
MHC	NN	compound	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
genes	NNS	conj	I-DNA
,	,	punct	O
contain	VBP	ROOT	O
an	DT	det	O
octamer	NN	compound	B-DNA
sequence	NN	dobj	I-DNA
in	IN	case	O
the	DT	det	O
promoter	NN	nmod	B-DNA
and	CC	cc	O
are	VBP	auxpass	O
expressed	VBN	conj	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
immune	JJ	nmod	O
and	CC	cc	O
nervous	JJ	conj	O
systems	NNS	dep	O
.	.	punct	O

This	DT	nsubj	O
prompted	VBD	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
analyze	VB	xcomp	O
the	DT	det	O
octamer-binding	JJ	amod	B-protein
proteins	NNS	dobj	I-protein
in	IN	case	O
the	DT	det	O
latter	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

Using	VBG	ROOT	O
the	DT	det	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
at	IN	case	O
least	JJS	nmod:npmod	O
six	CD	nummod	O
novel	JJ	amod	O
octamer	NN	compound	B-protein
binding	NN	compound	I-protein
proteins	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
detected	VBN	parataxis	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
cultured	VBN	amod	B-cell_type
mouse	NN	compound	I-cell_type
astrocytes	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
proteins	NNS	nsubjpass	O
are	VBP	auxpass	O
differentially	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_line
glioblastoma	NN	nmod	I-cell_line
and	CC	cc	I-cell_line
neuroblastoma	NN	conj	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dep	I-cell_line
.	.	punct	O

The	DT	det	O
nervous	JJ	amod	B-protein
system-derived	JJ	amod	I-protein
(	-LRB-	punct	I-protein
N-Oct	NN	compound	I-protein
)	-RRB-	punct	I-protein
proteins	NNS	nsubj	I-protein
bound	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
octamer	NN	compound	B-DNA
DNA	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
in	IN	case	O
a	DT	det	O
manner	NN	nmod	O
which	WDT	nsubj	O
is	VBZ	cop	O
indistinguishable	JJ	acl:relcl	O
from	IN	case	O
the	DT	dep	O
Oct-1	NN	nmod	B-protein
and	CC	cc	O
Oct-2A	NN	conj	B-protein
proteins	NNS	dep	I-protein
.	.	punct	O

The	DT	det	O
relationship	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
N-Oct	NN	compound	B-protein
proteins	NNS	nmod	I-protein
to	TO	case	O
Oct-1	NN	nmod	B-protein
and	CC	cc	O
Oct-2A	NN	conj	B-protein
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
by	IN	case	O
proteolytic	JJ	amod	O
clipping	JJ	amod	O
bandshift	NN	compound	O
assays	NNS	nmod	O
and	CC	cc	O
by	IN	case	O
their	PRP$	nmod:poss	O
reactivity	NN	conj	O
towards	IN	case	O
antisera	NNS	nmod	O
raised	VBN	acl	O
against	IN	case	O
recombinant	JJ	amod	O
Oct-1	NN	nmod	B-protein
and	CC	cc	O
Oct-2A	NN	conj	B-protein
proteins	NNS	dep	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
these	DT	det	O
assays	NNS	nmod	O
,	,	punct	O
all	DT	det	O
N-Oct-factors	NNS	nsubjpass	B-protein
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
distinct	JJ	xcomp	O
from	IN	case	O
the	DT	det	O
ubiquitous	JJ	amod	B-protein
Oct-1	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
lymphoid-specific	JJ	amod	B-protein
Oct-2A	NN	compound	I-protein
proteins	NNS	conj	O
.	.	punct	O

In	IN	case	O
melanoma	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubj	O
contain	VBP	acl:relcl	O
the	DT	det	O
N-Oct-3	NN	compound	B-protein
factor	NN	dobj	I-protein
,	,	punct	O
a	DT	det	O
transfected	VBN	amod	O
lymphocyte-specific	JJ	amod	O
promoter	NN	nsubjpass	O
was	VBD	auxpass	O
neither	CC	cc:preconj	O
activated	VBN	ROOT	O
nor	CC	cc	O
was	VBD	auxpass	O
it	PRP	nsubjpass	O
repressed	VBN	conj	O
upon	IN	case	O
contransfection	NN	nmod	O
with	IN	case	O
an	DT	det	O
Oct-2A	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
therefore	RB	advmod	O
speculate	VBP	ROOT	O
that	IN	mark	O
N-Oct-3	NN	nsubj	B-protein
and	CC	cc	O
other	JJ	amod	O
N-Oct	NN	compound	B-protein
factors	NNS	conj	I-protein
have	VBP	ccomp	O
a	DT	det	O
specific	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
nervous	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Detection	NN	ROOT	O
in	IN	case	O
non-erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
a	DT	det	O
factor	NN	nmod	O
with	IN	case	O
the	DT	det	O
binding	NN	amod	O
characteristics	NNS	nmod	O
of	IN	case	O
the	DT	det	O
erythroid	JJ	amod	B-protein
cell	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
EF1	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
erythroid	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
erythroid	JJ	amod	B-protein
factor-1	NN	nsubj	I-protein
(	-LRB-	punct	O
EF1	NN	appos	B-protein
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
transcription	NN	nmod	O
of	IN	case	O
erythroid-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
a	DT	det	O
factor	NN	nmod	O
with	IN	case	O
the	DT	dep	O
mobility	NN	nmod	O
and	CC	cc	O
sequence-specific	JJ	amod	O
DNA-binding	JJ	amod	O
characteristics	NNS	conj	O
of	IN	case	O
EF1	NN	nmod	B-protein
at	IN	case	O
low	JJ	amod	O
abundance	NN	nmod	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
non-erythroid	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
types	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
first	JJ	amod	O
report	NN	attr	O
of	IN	case	O
an	DT	det	O
EF1	NN	compound	B-protein
-like	JJ	amod	O
activity	NN	nmod	O
in	IN	case	O
non-erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
indicates	VBZ	conj	O
that	IN	mark	O
this	DT	det	O
factor	NN	nsubj	O
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	B-DNA
expressed	VBN	acl	O
in	IN	case	O
such	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

Protein	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	compound	O
H-7	NN	nsubj	O
blocks	VBZ	ROOT	O
accumulation	NN	dobj	O
of	IN	case	O
unspliced	JJ	amod	B-RNA
mRNA	NN	nmod	I-RNA
of	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
(	-LRB-	punct	O
HTLV-I	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Rex	NN	nsubjpass	B-protein
,	,	punct	O
the	DT	det	O
post-transcriptional	JJ	amod	B-protein
regulator	NN	appos	I-protein
of	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
(	-LRB-	punct	O
HTLV-I	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
accumulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
unspliced	JJ	amod	B-RNA
viral	JJ	amod	I-RNA
gag-pol	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Rex	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
phosphoprotein	NN	ROOT	B-protein
found	VBN	acl	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
nucleolus	NN	nmod	O
,	,	punct	O
whose	WP$	nmod:poss	O
function	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
regulated	VBN	parataxis	O
by	IN	case	O
its	PRP$	nmod:poss	O
localization	NN	nmod	O
and	CC	cc	O
phosphorylation	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
phosphorylation	NN	nmod	O
on	IN	case	O
Rex	NN	compound	B-protein
function	NN	nmod	O
by	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
protein	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	dobj	O
,	,	punct	O
H-7	NN	compound	O
[	-LRB-	punct	O
1-	CD	compound	O
(	-LRB-	punct	O
5-isoquinolinyl-sulfonyl	JJ	appos	O
)	-RRB-	punct	O
-2-methylpiperazine	NN	appos	O
]	-RRB-	punct	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
an	DT	det	O
HTLV-I	NN	compound	B-cell_line
infected	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
with	IN	case	O
H-7	NN	nmod	O
blocked	VBD	ROOT	O
specifically	RB	advmod	O
accumulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
unspliced	JJ	amod	B-RNA
gag-pol	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
the	DT	det	O
decreased	VBN	amod	O
Gag	NN	compound	B-protein
protein	NN	compound	I-protein
synthesis	NN	nmod	O
that	WDT	nsubj	O
corresponds	VBZ	acl:relcl	O
with	IN	case	O
the	DT	det	O
decreased	VBN	amod	O
in	FW	amod	O
vivo	FW	dep	O
phosphorylation	NN	nmod	O
of	IN	case	O
Rex	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
other	JJ	amod	O
viral	JJ	amod	O
and	CC	cc	O
cellular	JJ	conj	O
products	NNS	nsubjpass	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
influenced	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
H-7	NN	nmod	O
used	VBN	acl	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
the	DT	det	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
Rex	NN	nmod	B-protein
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
viral	JJ	amod	O
RNA	NN	compound	O
partition	NN	nmod	O
of	IN	case	O
HTLV-I	NN	nmod	O
.	.	punct	O

Increased	VBN	amod	O
glucocorticoid	NN	compound	O
responsiveness	NN	ROOT	O
of	IN	case	O
CD4+	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
clonal	JJ	amod	I-cell_line
lines	NNS	nmod	I-cell_line
grown	VBN	acl	O
in	IN	case	O
serum-free	JJ	amod	O
media	NNS	nmod	O
.	.	punct	O

CEM-C7	NN	nsubjpass	B-cell_line
,	,	punct	O
a	DT	det	O
human	JJ	amod	B-cell_line
leukemic	JJ	amod	I-cell_line
CD4+	JJ	amod	I-cell_line
T-lymphocyte	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
and	CC	cc	O
three	CD	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
subclones	NNS	nmod	O
,	,	punct	O
CEM-4R4	NN	conj	B-cell_line
,	,	punct	O
CEM-3R43	NN	conj	B-cell_line
,	,	punct	O
and	CC	cc	O
ICR-27	NN	conj	B-cell_line
,	,	punct	O
previously	RB	advmod	O
cultured	VBN	acl	O
in	IN	case	O
a	DT	det	O
medium	NN	nmod	O
supplemented	VBN	acl	O
with	IN	case	O
5	CD	compound	O
to	TO	dep	O
10	CD	nummod	O
%	NN	dep	O
fetal	JJ	amod	O
bovine	JJ	amod	O
serum	NN	nmod	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
adapted	VBN	ROOT	O
to	TO	case	O
serum-free	JJ	amod	O
media	NNS	nmod	O
.	.	punct	O

The	DT	det	O
best	JJS	amod	O
medium	NN	nsubj	O
of	IN	case	O
those	DT	nmod	O
tested	VBN	acl	O
was	VBD	cop	O
RPMI	NN	ROOT	O
1640	CD	nummod	O
supplemented	VBN	acl	O
with	IN	case	O
5	CD	nummod	O
micrograms/ml	NNS	nmod	O
each	DT	det	O
transferrin	NN	dep	B-protein
and	CC	cc	O
insulin	NN	conj	B-protein
+	CC	cc	O
5	CD	conj	O
ng/ml	NN	compound	O
sodium	NN	compound	O
selenite	NN	conj	O
+/-	CC	cc	O
0.1	CD	compound	O
%	NN	amod	O
bovine	JJ	amod	B-protein
serum	NN	compound	I-protein
albumin	NN	conj	I-protein
.	.	punct	O

While	IN	mark	O
growing	VBG	advcl	O
either	CC	advmod	O
with	IN	prep	O
or	CC	cc	O
without	IN	conj	O
albumin	NN	dobj	O
,	,	punct	O
the	DT	det	O
several	JJ	amod	O
clonal	JJ	amod	B-cell_line
lines	NNS	nsubj	I-cell_line
of	IN	case	O
CEM	NN	compound	B-cell_line
cells	NNS	nmod	O
displayed	VBD	ROOT	O
growth	NN	dobj	O
similar	JJ	amod	O
to	TO	case	O
serum-supplemented	JJ	amod	O
cultures	NNS	nmod	O
.	.	punct	O

Cell	NN	compound	O
proliferation	NN	nsubjpass	O
of	IN	case	O
CEM-C7	NN	compound	B-cell_line
cells	NNS	nmod	O
cultured	VBN	acl	O
in	IN	case	O
both	DT	det	O
serum-free	JJ	amod	O
media	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
sustained	JJ	ROOT	O
for	IN	case	O
3	CD	nummod	O
mo	NN	nmod	O
.	.	punct	O

with	IN	case	O
culture	NN	compound	O
doubling	VBG	compound	O
times	NNS	ROOT	O
of	IN	case	O
about	RB	advmod	O
25	CD	nummod	O
h	NN	nmod	O
for	IN	case	O
both	CC	cc:preconj	O
serum-supplemented	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
serum-free	JJ	conj	I-cell_line
cultures	NNS	nmod	I-cell_line
(	-LRB-	punct	O
viability	NN	dep	O
greater	JJR	amod	O
than	IN	dep	O
or	CC	cc	O
equal	JJ	conj	O
to	TO	case	O
90	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Cell	NN	compound	O
morphology	NN	nsubj	O
remained	VBD	ROOT	O
essentially	RB	advmod	O
the	DT	det	O
same	JJ	advmod	O
in	IN	case	O
serum-free	JJ	nmod	O
or	CC	cc	O
serum	NN	conj	O
containing	VBG	conj	O
media	NNS	dobj	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
CD4	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
marker	NN	appos	O
for	IN	case	O
T-derived	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
was	VBD	cop	O
not	RB	neg	O
significantly	RB	advmod	O
different	JJ	ROOT	O
in	IN	case	O
serum-free	JJ	amod	O
medium	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
grown	VBN	advcl	O
in	IN	case	O
serum-free	JJ	amod	O
medium	NN	nmod	O
,	,	punct	O
CEM-C7	NN	compound	B-cell_line
cells	NNS	nsubj	O
exhibited	VBD	ROOT	O
increased	VBN	amod	O
steroid	NN	compound	O
responsiveness	NN	dobj	O
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
increased	VBN	amod	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
binding	NN	compound	O
sites	NNS	nmod	O
,	,	punct	O
increased	VBN	amod	O
induction	NN	dobj	O
of	IN	case	O
glutamine	NN	compound	B-protein
synthetase	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
cell	NN	compound	O
lysis	NN	conj	O
at	IN	case	O
lower	JJR	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
steroid	NN	nmod	O
.	.	punct	O

Receptor	NN	compound	O
mutant	JJ	amod	O
subclones	NNS	nsubj	O
of	IN	case	O
CEM-C7	NN	nmod	B-cell_line
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
proven	VBN	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
completely	RB	advmod	O
unresponsive	JJ	xcomp	O
to	TO	case	O
micromolar	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
when	WRB	advmod	O
grown	VBN	advcl	O
in	IN	case	O
serum-supplemented	JJ	amod	O
medium	NN	nmod	O
,	,	punct	O
become	VBP	ROOT	O
partially	RB	advmod	O
sensitive	JJ	xcomp	O
to	TO	case	O
the	DT	det	O
hormone	NN	nmod	O
after	IN	case	O
growth	NN	nmod	O
in	IN	case	O
defined	VBN	amod	O
medium	NN	nmod	O
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
sensitivity	NN	nsubj	O
of	IN	case	O
CEM-C7	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
its	PRP$	nmod:poss	O
subclones	NNS	conj	O
to	TO	case	O
dexamethasone	NN	nmod	O
in	IN	case	O
serum-free	JJ	amod	O
medium	NN	nmod	O
returned	VBD	ROOT	O
to	TO	case	O
previous	JJ	amod	O
levels	NNS	nmod	O
when	WRB	advmod	O
these	DT	det	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
recultured	VBN	advcl	O
in	IN	case	O
serum-containing	JJ	amod	O
medium	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
substances	NNS	nsubj	O
in	IN	case	O
serum	NN	nmod	O
influence	VBP	ccomp	O
steroid	NN	compound	O
effects	NNS	dobj	O
on	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
molecular	JJ	amod	O
details	NNS	nsubjpass	O
of	IN	case	O
glucocorticoid	NN	compound	O
hormone	NN	compound	O
action	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
pursued	VBN	conj	O
more	RBR	advmod	O
precisely	RB	advmod	O
in	IN	case	O
a	DT	det	O
clearly	RB	advmod	O
defined	VBN	amod	O
culture	NN	compound	O
medium	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
on	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
mononuclear	JJ	amod	I-cell_type
and	CC	cc	I-cell_type
polymorphonuclear	JJ	conj	I-cell_type
leucocytes	NNS	nmod	I-cell_type
:	:	punct	O
changes	NNS	dep	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
yang-deficiency	NN	nmod	O
]	-RRB-	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
former	JJ	amod	O
works	NNS	nmod	O
,	,	punct	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
(	-LRB-	punct	O
GCR	NN	appos	B-protein
)	-RRB-	punct	O
on	IN	case	O
peripheral	JJ	amod	B-cell_type
mixed	JJ	amod	I-cell_type
leucocytes	NNS	nmod	I-cell_type
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
Yang-deficiency	NN	nmod	O
were	VBD	auxpass	O
decreased	VBN	ccomp	O
.	.	punct	O

In	IN	prep	O
this	DT	det	O
work	NN	pobj	O
,	,	punct	O
the	DT	det	O
mixed	JJ	amod	B-cell_type
leucocytes	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
further	RB	advmod	O
separated	VBN	nmod	O
into	IN	case	O
mononuclear	JJ	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
MNL	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
and	CC	cc	I-cell_type
polymorphonuclear	JJ	amod	I-cell_type
(	-LRB-	punct	I-cell_type
PML	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
leucocytes	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
GCR	NN	nsubjpass	B-protein
were	VBD	auxpass	O
determined	VBN	ROOT	O
in	IN	case	O
each	DT	det	O
part	NN	nmod	O
of	IN	case	O
leucocytes	NNS	nmod	B-cell_type
.	.	punct	O

GCR	NN	nsubj	B-protein
on	IN	case	O
MNL	NN	nmod	B-cell_type
and	CC	cc	O
PML	NN	conj	B-cell_type
in	IN	case	O
6	CD	nummod	O
Yang	NN	compound	O
deficient	JJ	amod	O
patients	NNS	nmod	O
were	VBD	cop	O
3473	CD	ROOT	O
+/-	CC	cc	O
413	CD	conj	O
and	CC	cc	O
4433	CD	conj	O
+/-	CC	cc	O
651	CD	conj	O
sites/cell	NNS	dep	O
respectively	RB	advmod	O
,	,	punct	O
statistically	RB	advmod	O
significant	JJ	amod	O
from	IN	case	O
the	DT	det	O
normal	JJ	amod	O
control	NN	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
4462	CD	dep	O
+/-	CC	cc	O
962	CD	conj	O
and	CC	cc	O
5622	CD	conj	O
+/-	CC	cc	O
782	CD	conj	O
sites/cell	NNS	dep	O
respectively	RB	advmod	O
,	,	punct	O
P	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.05	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

GCR	NN	nsubjpass	B-protein
on	IN	case	O
MNL	NN	nmod	B-cell_type
,	,	punct	O
PML	NN	conj	B-cell_type
and	CC	cc	O
mixed	JJ	amod	B-cell_type
leucocytes	NNS	conj	I-cell_type
in	IN	case	O
5	CD	nummod	O
patients	NNS	nmod	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
simultaneously	RB	advmod	O
,	,	punct	O
and	CC	cc	O
all	DT	nsubj	O
lowered	VBD	conj	O
from	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
were	VBD	cop	O
3369	CD	ROOT	O
+/-	CC	cc	O
370	CD	conj	O
,	,	punct	O
4986	CD	conj	O
+/-	CC	cc	O
419	CD	conj	O
and	CC	cc	O
4524	CD	conj	O
+/-	CC	cc	O
852	CD	conj	O
sites/cell	NNS	dep	O
respectively	RB	advmod	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
lowest	JJS	amod	O
GCR	NN	nmod	B-protein
on	IN	case	O
MNL	NN	nmod	B-cell_type
and	CC	cc	O
highest	JJS	conj	O
on	IN	case	O
PML	NN	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
ubiquitous	JJ	amod	B-protein
octamer-binding	JJ	amod	I-protein
protein	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
is	VBZ	cop	O
sufficient	JJ	ROOT	O
for	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

All	DT	det	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nsubj	I-DNA
contain	VBP	ROOT	O
a	DT	det	O
conserved	VBN	amod	O
octanucleotide	NN	compound	B-DNA
promoter	NN	compound	I-DNA
element	NN	dobj	I-DNA
,	,	punct	O
ATGCAAAT	NN	appos	O
,	,	punct	O
which	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
for	IN	case	O
their	PRP$	nmod:poss	O
normal	JJ	amod	O
B-cell-specific	JJ	amod	O
transcription	NN	nmod	O
.	.	punct	O

Proteins	NNS	nsubjpass	O
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
this	DT	det	O
octamer	NN	dobj	O
have	VBP	aux	O
been	VBN	auxpass	O
purified	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
cDNAs	NNS	nsubjpass	B-DNA
encoding	VBG	acl	O
octamer-binding	JJ	amod	B-protein
proteins	NNS	dobj	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
cloned	VBN	conj	O
.	.	punct	O

Some	DT	nsubj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
(	-LRB-	punct	O
referred	VBN	dep	O
to	TO	nmod	O
as	IN	case	O
OTF-2	NN	nmod	B-protein
)	-RRB-	punct	O
are	VBP	cop	O
lymphoid	JJ	amod	O
specific	JJ	ROOT	O
,	,	punct	O
whereas	IN	dep	O
at	IN	case	O
least	JJS	nmod:npmod	O
one	CD	nummod	O
other	JJ	dep	O
,	,	punct	O
and	CC	cc	O
possibly	RB	advmod	O
more	JJR	conj	O
(	-LRB-	punct	O
referred	VBN	dep	O
to	TO	nmod	O
as	IN	case	O
OTF-1	NN	nmod	B-protein
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	auxpass	O
found	VBN	conj	O
ubiquitously	RB	advmod	O
in	IN	case	O
all	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

The	DT	det	O
exact	JJ	amod	O
role	NN	nsubj	O
of	IN	case	O
these	DT	det	O
different	JJ	amod	O
proteins	NNS	nmod	O
in	IN	mark	O
directing	VBG	acl	O
the	DT	det	O
tissue-specific	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
is	VBZ	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
two	CD	nummod	O
human	JJ	amod	B-cell_line
pre-B-cell	NN	compound	I-cell_line
lines	NNS	dobj	I-cell_line
that	WDT	nsubj	O
contain	VBP	acl:relcl	O
extremely	RB	advmod	O
low	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
OTF-2	NN	nmod	B-protein
yet	CC	advmod	O
still	RB	advmod	O
express	VBP	advcl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
steady-state	JJ	amod	B-RNA
immunoglobulin	NN	compound	I-RNA
heavy-chain	JJ	amod	I-RNA
mRNA	NN	nmod	I-RNA
in	FW	compound	O
vivo	FW	advmod	O
and	CC	cc	O
efficiently	RB	advmod	O
transcribe	VBP	conj	O
an	DT	det	O
immunoglobulin	NN	compound	B-DNA
gene	NN	dobj	I-DNA
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Addition	NN	ROOT	O
of	IN	case	O
a	DT	det	O
highly	RB	advmod	O
enriched	JJ	amod	O
preparation	NN	nmod	O
of	IN	case	O
OTF-1	NN	nmod	B-protein
made	VBN	acl	O
from	IN	case	O
one	CD	nmod	O
of	IN	case	O
these	DT	det	O
pre-B	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
or	CC	cc	O
from	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
specifically	RB	advmod	O
stimulated	VBD	acl	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	dobj	O
of	IN	case	O
an	DT	det	O
immunoglobulin	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
OFT-1	NN	nsubj	O
appeared	VBD	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
approximately	RB	advmod	O
the	DT	det	O
same	JJ	amod	O
transactivation	NN	compound	O
ability	NN	dobj	O
as	IN	case	O
OTF-2	NN	nmod	B-protein
when	WRB	advmod	O
normalized	VBN	advcl	O
for	IN	case	O
binding	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
OTF-1	NN	nsubj	B-protein
,	,	punct	O
without	IN	case	O
OTF-2	NN	nmod	B-protein
,	,	punct	O
is	VBZ	cop	O
sufficient	JJ	ccomp	O
for	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
that	IN	mark	O
OTF-2	NN	nsubj	B-protein
alone	RB	advmod	O
is	VBZ	cop	O
not	RB	neg	O
responsible	JJ	conj	O
for	IN	case	O
the	DT	det	O
B-cell-specific	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
aldosterone	NN	nmod	O
on	IN	case	O
intralymphocytic	JJ	amod	O
sodium	NN	nmod	O
and	CC	cc	O
potassium	NN	conj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
essential	JJ	amod	O
hypertension	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
binding	NN	nsubjpass	O
of	IN	case	O
aldosterone	NN	nmod	O
to	TO	case	O
mineralocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
on	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
HML	NNS	appos	B-cell_type
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
effects	NNS	conj	O
on	IN	case	O
the	DT	det	O
intracellular	JJ	amod	O
sodium	NN	compound	O
and	CC	cc	O
potassium	NN	conj	O
concentrations	NNS	nmod	O
of	IN	case	O
HML	NNS	nmod	B-cell_type
have	VBP	aux	O
already	RB	advmod	O
been	VBN	auxpass	O
described	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
paper	NN	nmod	O
this	DT	det	O
easily	RB	advmod	O
accessible	JJ	amod	O
human	JJ	amod	O
cell	NN	compound	O
model	NN	nsubjpass	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
13	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
essential	JJ	amod	O
hypertension	NN	nmod	O
.	.	punct	O

In	IN	case	O
only	RB	advmod	O
four	CD	nummod	O
patients	NNS	compound	O
sodium	NN	nsubj	O
in	IN	case	O
HML	NNS	nmod	B-cell_type
without	IN	case	O
incubation	NN	nmod	O
was	VBD	cop	O
elevated	JJ	ROOT	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
range	NN	nmod	O
for	IN	case	O
normal	JJ	amod	O
persons	NNS	nmod	O
.	.	punct	O

A	DT	det	O
decrease	NN	nsubj	O
of	IN	case	O
intracellular	JJ	amod	O
sodium	NN	nmod	O
or	CC	cc	O
potassium	NN	conj	O
occurred	VBD	ROOT	O
during	IN	case	O
incubation	NN	nmod	O
without	IN	case	O
aldosterone	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.02	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
1.4	CD	compound	O
nM	NN	amod	O
aldosterone	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
prevent	VB	ROOT	O
this	DT	det	O
loss	NN	dobj	O
of	IN	case	O
electrolytes	NNS	nmod	O
as	IN	mark	O
observed	VBN	advcl	O
in	IN	case	O
normal	JJ	amod	O
persons	NNS	nmod	O
.	.	punct	O

Plasma	NN	compound	B-protein
renin	NN	compound	I-protein
activity	NN	nsubjpass	O
and	CC	cc	O
aldosterone	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
electrolyte	NN	compound	O
response	NN	nmod	O
and	CC	cc	O
were	VBD	cop	O
within	IN	case	O
the	DT	det	O
normal	JJ	amod	O
limits	NNS	conj	O
.	.	punct	O

The	DT	det	O
number	NN	nsubj	O
of	IN	case	O
mineralocorticoid	NN	compound	B-protein
receptors	NNS	compound	I-protein
/cell	NN	nmod	O
were	VBD	cop	O
within	IN	ROOT	O
or	CC	cc	O
close	JJ	conj	O
to	TO	case	O
the	DT	det	O
normal	JJ	amod	O
range	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
9	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
independence	NN	nsubj	O
of	IN	case	O
intracellular	JJ	amod	O
electrolytes	NNS	nmod	O
from	IN	case	O
aldosterone	NN	nmod	O
despite	IN	case	O
a	DT	det	O
normal	JJ	amod	O
number	NN	nmod	O
of	IN	case	O
mineralocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
may	MD	aux	O
reflect	VB	ROOT	O
an	DT	det	O
impairment	NN	dobj	O
of	IN	case	O
the	DT	det	O
mineralocorticoid	NN	compound	O
effector	NN	compound	O
mechanism	NN	nmod	O
in	IN	case	O
the	DT	det	O
HML	NN	nmod	B-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
essential	JJ	amod	O
hypertension	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Differential	JJ	amod	O
diagnostic	JJ	amod	O
value	NN	ROOT	O
of	IN	case	O
receptors	NNS	nmod	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	amod	O
D3	NN	compound	O
(	-LRB-	punct	O
calcitriol	NN	appos	O
)	-RRB-	punct	O
determination	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
of	IN	case	O
children	NNS	nmod	O
with	IN	case	O
rickets	NN	nmod	O
and	CC	cc	O
rickets-like	JJ	amod	O
diseases	NNS	conj	O
]	-RRB-	punct	O

The	DT	det	O
authors	NNS	nsubj	O
provide	VBP	ROOT	O
the	DT	det	O
results	NNS	dobj	O
of	IN	mark	O
studying	VBG	acl	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	dobj	O
(	-LRB-	punct	O
calcitriol	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
of	IN	case	O
children	NNS	nmod	O
with	IN	case	O
rickets	NN	nmod	O
and	CC	cc	O
rickets-like	JJ	amod	O
diseases	NNS	conj	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
character	NN	nsubjpass	O
of	IN	case	O
their	PRP$	nmod:poss	O
expression	NN	nmod	O
under	IN	case	O
the	DT	det	O
influence	NN	nmod	O
of	IN	case	O
vitamin	NN	compound	O
D	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
with	IN	case	O
differential	JJ	amod	O
diagnostic	JJ	amod	O
purposes	NNS	nmod	O
in	IN	case	O
view	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
with	IN	case	O
double-stranded	JJ	amod	O
phosphorothioate	NN	compound	O
oligonucleotides	NNS	nmod	O
.	.	punct	O

Alteration	NN	nsubj	O
of	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
by	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
transcriptional	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
is	VBZ	cop	O
necessary	JJ	ROOT	O
for	IN	mark	O
determining	VBG	advcl	O
how	WRB	advmod	O
these	DT	det	O
factors	NNS	nsubj	O
participate	VBP	ccomp	O
in	IN	case	O
cellular	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

The	DT	det	O
functions	NNS	nsubjpass	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
can	MD	aux	O
be	VB	auxpass	O
antagonized	VBN	ROOT	O
by	IN	case	O
several	JJ	amod	O
methods	NNS	nmod	O
,	,	punct	O
each	DT	appos	O
with	IN	case	O
specific	JJ	amod	O
limitations	NNS	nmod	O
.	.	punct	O

Inhibition	NN	nsubjpass	O
of	IN	case	O
sequence-specific	JJ	amod	B-protein
DNA-binding	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
was	VBD	auxpass	O
achieved	VBN	ROOT	O
with	IN	case	O
double-stranded	JJ	amod	O
(	-LRB-	punct	O
ds	JJ	dep	O
)	-RRB-	punct	O
phosphorothioate	NN	compound	O
oligonucleotides	NNS	nmod	O
that	WDT	nsubj	O
contained	VBD	acl:relcl	O
octamer	NN	compound	B-DNA
or	CC	cc	I-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
consensus	NN	compound	I-DNA
sequences	NNS	dobj	I-DNA
.	.	punct	O

The	DT	det	O
phosphorothioate	NN	compound	O
oligonucleotides	NNS	nsubj	O
specifically	RB	advmod	O
bound	VBD	ROOT	O
either	CC	cc:preconj	O
octamer	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	dobj	I-protein
or	CC	cc	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappa	NN	compound	I-protein
B	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
modified	VBN	amod	O
oligonucleotides	NNS	nsubj	O
accumulated	VBD	acl	O
in	IN	case	O
cells	NNS	nmod	O
more	RBR	advmod	O
effectively	RB	ROOT	O
than	IN	case	O
standard	JJ	amod	O
ds	JJ	amod	O
oligonucleotides	NNS	nmod	O
and	CC	cc	O
modulated	VBD	amod	O
gene	NN	compound	O
expression	NN	conj	O
in	IN	case	O
a	DT	det	O
specific	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Octamer-dependent	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
reporter	NN	compound	B-DNA
plasmid	NN	nmod	I-DNA
or	CC	cc	O
NF-kappa	NN	nmod:npmod	B-protein
B	NN	nmod:npmod	I-protein
-dependent	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
HIV	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
enhancer	NN	nmod	I-DNA
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
when	WRB	advmod	O
the	DT	det	O
appropriate	JJ	amod	O
phosphorothioate	NN	compound	O
oligonucleotide	NN	nsubjpass	O
was	VBD	auxpass	O
added	VBN	advcl	O
to	TO	case	O
a	DT	det	O
transiently	RB	advmod	B-cell_line
transfected	VBN	amod	I-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Addition	NN	nsubj	O
of	IN	case	O
phosphorothioate	NN	compound	O
oligonucleotides	NNS	nmod	O
that	WDT	nsubj	O
contained	VBD	acl:relcl	O
the	DT	det	O
octamer	NN	compound	B-DNA
consensus	NN	dobj	I-DNA
to	TO	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
leukemia	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
inhibited	VBD	ROOT	O
interleukin-2	NN	compound	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
secretion	NN	dobj	O
to	TO	case	O
a	DT	det	O
degree	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
observed	VBN	acl	O
with	IN	case	O
a	DT	det	O
mutated	VBN	amod	B-DNA
octamer	NN	compound	I-DNA
site	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
ds	JJ	amod	O
phosphorothioate	NN	compound	O
oligonucleotides	NNS	nsubj	O
probably	RB	advmod	O
compete	VBP	ROOT	O
for	IN	case	O
binding	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
transcription	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
provide	VB	conj	O
anti-viral	JJ	amod	O
,	,	punct	O
immunosuppressive	JJ	conj	O
,	,	punct	O
or	CC	cc	O
other	JJ	amod	O
therapeutic	JJ	amod	O
effects	NNS	dobj	O
.	.	punct	O

[	-LRB-	punct	O
Effect	NN	ROOT	O
of	IN	case	O
the	DT	det	O
regimen	NN	nmod	O
of	IN	case	O
kidney-tonifying	JJ	nmod	O
and	CC	cc	O
qi-invigorating	JJ	conj	O
on	IN	case	O
aging	VBG	compound	O
changes	NNS	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
]	-RRB-	punct	O

The	DT	det	O
plasma	NN	compound	O
cortisol	NN	compound	O
concentration	NN	nsubjpass	O
and	CC	cc	O
the	DT	det	O
sites	NNS	conj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
GCR	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
peripheral	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
were	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
32	CD	nummod	O
healthy	JJ	amod	O
aged	JJ	dep	O
persons	NNS	nmod	O
and	CC	cc	O
13	CD	nummod	O
young	JJ	amod	O
adults	NNS	conj	O
.	.	punct	O

In	IN	case	O
animal	NN	compound	O
experiment	NN	nmod	O
,	,	punct	O
GCR	NN	nsubjpass	B-protein
of	IN	case	O
spleen	NN	compound	B-cell_type
lymphocytic	JJ	amod	I-cell_type
cell	NN	nmod	I-cell_type
was	VBD	auxpass	O
also	RB	advmod	O
measured	VBN	ROOT	O
in	IN	case	O
18	CD	nummod	O
aged	JJ	amod	O
rats	NNS	nmod	O
and	CC	cc	O
9	CD	nummod	O
young	JJ	amod	O
rats	NNS	conj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
GCR	NN	nsubj	B-protein
was	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	ccomp	O
in	IN	case	O
the	DT	det	O
aged	JJ	amod	O
persons	NNS	nmod	O
or	CC	cc	O
rats	NNS	conj	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
the	DT	det	O
young	JJ	nmod	O
while	IN	mark	O
the	DT	det	O
plasma	NN	compound	O
cortisol	NN	compound	O
level	NN	nsubj	O
did	VBD	aux	O
n't	RB	neg	O
change	VB	advcl	O
with	IN	case	O
aging	NN	nmod	O
.	.	punct	O

So	RB	advmod	O
we	PRP	nsubj	O
think	VBP	ROOT	O
that	IN	mark	O
GCR	NN	nsubj	B-protein
is	VBZ	cop	O
more	RBR	advmod	O
sensitive	JJ	ccomp	O
than	IN	case	O
the	DT	det	O
plasma	NN	compound	O
cortisol	NN	compound	O
level	NN	nmod	O
to	TO	mark	O
reflect	VB	xcomp	O
the	DT	det	O
aging	NN	compound	O
change	NN	dobj	O
of	IN	case	O
the	DT	det	O
adrenal	JJ	amod	O
cortex	NN	compound	O
function	NN	nmod	O
.	.	punct	O

After	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
regimen	NN	nmod	O
of	IN	case	O
Kidney-tonifying	JJ	nmod	O
and	CC	cc	O
Qi-invigorating	JJ	conj	O
,	,	punct	O
the	DT	det	O
GCR	NN	nsubjpass	B-protein
of	IN	case	O
the	DT	det	O
aged	JJ	amod	O
persons	NNS	nmod	O
and	CC	cc	O
rats	NNS	conj	O
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
this	DT	det	O
way	NN	nmod	O
,	,	punct	O
the	DT	det	O
function	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
aged	JJ	amod	O
adrenal	JJ	amod	O
cortex	NN	nmod	O
was	VBD	auxpass	O
improved	VBN	conj	O
.	.	punct	O

Interferon	NN	nsubj	O
affects	VBZ	ROOT	O
nuclear	JJ	amod	B-protein
proteins	NNS	dobj	I-protein
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
clinically	RB	advmod	O
sensitive	JJ	amod	O
chronic	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

Cytoplasmic	JJ	amod	O
protein	NN	compound	O
extracts	NNS	nsubj	O
from	IN	case	O
chronic	JJ	amod	B-cell_type
myelogenous	JJ	amod	I-cell_type
leukemia	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
CML	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
contained	VBD	ROOT	O
an	DT	det	O
activity	NN	dobj	O
that	WDT	nsubj	O
altered	VBD	acl:relcl	O
the	DT	det	O
electrophoretic	JJ	amod	O
mobility	NN	dobj	O
of	IN	case	O
complexes	NNS	nmod	O
formed	VBN	acl	O
between	IN	case	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
the	DT	det	O
transcriptional	JJ	amod	O
enhancers	NNS	conj	O
of	IN	case	O
interferon	NN	compound	O
(	-LRB-	punct	O
IFN	NN	compound	O
)	-RRB-	punct	O
-inducible	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

Exposure	NN	nsubj	O
of	IN	case	O
CML	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
IFN-alpha	NN	nmod	B-protein
diminished	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
CML	NN	compound	B-protein
cytoplasmic	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
on	IN	case	O
these	DT	det	O
nuclear	JJ	amod	B-protein
protein-DNA	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
clinical	JJ	amod	O
responsiveness	NN	nmod	O
to	TO	case	O
IFN-alpha	NN	nmod	B-protein
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
sensitivity	NN	nmod	O
to	TO	case	O
the	DT	det	O
IFN	NN	compound	B-protein
-induced	JJ	amod	O
change	NN	nmod	O
in	IN	case	O
the	DT	det	O
electrophoretic	JJ	amod	O
mobility	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
protein-DNA	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
action	NN	nsubjpass	O
of	IN	case	O
IFN-alpha	NN	nmod	B-protein
in	IN	case	O
CML	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
linked	VBN	ccomp	O
to	TO	case	O
a	DT	det	O
pathway	NN	nmod	O
that	WDT	nsubj	O
can	MD	aux	O
result	VB	acl:relcl	O
in	IN	case	O
posttranslational	JJ	amod	O
modification	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
nuclear	JJ	amod	I-protein
antigen	NN	nsubj	I-protein
2	CD	nummod	I-protein
transactivates	VBZ	ROOT	O
latent	JJ	amod	B-protein
membrane	NN	compound	I-protein
protein	NN	compound	I-protein
LMP1	NN	dobj	B-protein
.	.	punct	O

Several	JJ	amod	O
lines	NNS	nsubj	O
of	IN	case	O
evidence	NN	nmod	O
are	VBP	cop	O
compatible	JJ	ROOT	O
with	IN	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
(	-LRB-	punct	I-protein
EBV	NN	appos	I-protein
)	-RRB-	punct	I-protein
nuclear	JJ	amod	I-protein
antigen	NN	nsubj	I-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
EBNA-2	NN	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
leader	NN	compound	B-protein
protein	NN	conj	I-protein
(	-LRB-	punct	O
EBNA-LP	NN	appos	B-protein
)	-RRB-	punct	O
affects	VBZ	ccomp	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
EBV	NN	compound	B-protein
latent	JJ	amod	I-protein
infection	NN	compound	I-protein
membrane	NN	compound	I-protein
protein	NN	nmod	I-protein
LMP1	NN	dep	B-protein
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
demonstrate	VBP	ROOT	O
the	DT	det	O
following	NN	dobj	O
.	.	punct	O

(	-LRB-	punct	O
i	LS	dep	O
)	-RRB-	punct	O
Acute	JJ	amod	O
transfection	NN	nsubj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
EBNA-2	NN	nmod	B-protein
under	IN	case	O
control	NN	nmod	O
of	IN	case	O
simian	JJ	amod	B-DNA
virus	NN	nmod	I-DNA
40	CD	nummod	I-DNA
or	CC	cc	I-DNA
Moloney	NN	conj	I-DNA
murine	JJ	amod	I-DNA
leukemia	NN	compound	I-DNA
virus	NN	compound	I-DNA
promoters	NNS	dep	I-DNA
resulted	VBD	ROOT	O
in	IN	case	O
increased	VBN	amod	O
LMP1	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
P3HR-1-infected	JJ	amod	B-cell_line
Burkitt	NN	nmod:poss	I-cell_line
's	POS	case	I-cell_line
lymphoma	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
the	DT	det	O
P3HR-1	NN	conj	B-cell_line
or	CC	cc	O
Daudi	NN	conj	B-cell_line
cell	NN	compound	I-cell_line
line	NN	dep	I-cell_line
.	.	punct	O

(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
Transfection	NN	nsubj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
EBNA-LP	NN	nmod	B-protein
alone	RB	advmod	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
LMP1	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
act	VB	conj	O
synergistically	RB	advmod	O
with	IN	case	O
EBNA-2	NN	nmod	B-protein
to	TO	mark	O
affect	VB	xcomp	O
LMP1	NN	compound	B-protein
expression	NN	dobj	O
.	.	punct	O

(	-LRB-	punct	O
iii	LS	dep	O
)	-RRB-	punct	O
LMP1	NN	compound	B-protein
expression	NN	nsubjpass	O
in	IN	case	O
Daudi	NN	nmod	B-cell_line
and	CC	cc	O
P3HR-1-infected	JJ	amod	B-cell_line
cells	NNS	conj	I-cell_line
was	VBD	auxpass	O
controlled	VBN	ROOT	O
at	IN	case	O
the	DT	det	O
mRNA	NN	compound	B-RNA
level	NN	nmod	O
,	,	punct	O
and	CC	cc	O
EBNA-2	NN	compound	B-protein
expression	NN	nsubj	O
in	IN	case	O
Daudi	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
increased	VBD	conj	O
LMP1	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
.	.	punct	O

(	-LRB-	punct	O
iv	LS	dep	O
)	-RRB-	punct	O
No	DT	neg	O
other	JJ	amod	O
EBV	NN	compound	B-DNA
genes	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
EBNA-2	NN	compound	B-protein
transactivation	NN	nmod	O
of	IN	case	O
LMP1	NN	nmod	B-protein
since	IN	mark	O
cotransfection	NN	nsubj	O
of	IN	case	O
recombinant	JJ	amod	B-DNA
EBNA-2	NN	compound	I-DNA
expression	NN	compound	I-DNA
vectors	NNS	nmod	I-DNA
and	CC	cc	O
genomic	JJ	amod	O
LMP1	NN	compound	B-DNA
DNA	NN	compound	I-DNA
fragments	NNS	conj	I-DNA
enhanced	VBD	advcl	O
LMP1	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
the	DT	det	O
EBV-negative	JJ	amod	B-cell_line
B-lymphoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
BJAB	NN	dep	B-cell_line
,	,	punct	O
Louckes	NN	conj	B-cell_line
,	,	punct	O
and	CC	cc	O
BL30	NN	conj	B-cell_line
.	.	punct	O

(	-LRB-	punct	O
v	LS	dep	O
)	-RRB-	punct	O
An	DT	det	O
EBNA-2-responsive	JJ	amod	B-DNA
element	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
found	VBN	ROOT	O
within	IN	case	O
the	DT	det	O
-512	CD	compound	B-DNA
to	TO	dep	I-DNA
+40	CD	nummod	I-DNA
LMP1	NN	compound	I-DNA
DNA	NN	nmod	I-DNA
since	IN	mark	O
this	DT	det	O
DNA	NN	nsubjpass	O
linked	VBN	acl	O
to	TO	case	O
a	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
transactivated	VBN	advcl	O
by	IN	case	O
cotransfection	NN	nmod	O
with	IN	case	O
an	DT	det	O
EBNA-2	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
.	.	punct	O

(	-LRB-	punct	O
vi	LS	dep	O
)	-RRB-	punct	O
The	DT	det	O
EBV	NN	compound	O
type	NN	compound	O
2	CD	nummod	O
EBNA-2	NN	nsubj	B-protein
transactivated	VBD	ROOT	O
LMP1	NN	dobj	B-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
EBV	NN	compound	B-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
EBNA-2	NN	conj	I-protein
.	.	punct	O

(	-LRB-	punct	O
vii	LS	dep	O
)	-RRB-	punct	O
Two	CD	nummod	O
deletions	NNS	nsubj	O
within	IN	case	O
the	DT	det	O
EBNA-2	NN	compound	B-protein
gene	NN	nmod	O
which	WDT	nsubj	O
rendered	VBD	acl:relcl	O
EBV	NN	compound	O
transformation	NN	compound	O
incompetent	JJ	dobj	O
did	VBD	aux	O
not	RB	neg	O
transactivate	VB	ROOT	O
LMP1	NN	dobj	B-protein
,	,	punct	O
whereas	IN	dep	O
a	DT	det	O
transformation-competent	JJ	amod	B-DNA
EBNA-2	NN	compound	I-DNA
deletion	NN	compound	I-DNA
mutant	NN	nsubj	I-DNA
did	VBD	aux	O
transactivate	VB	parataxis	O
LMP1	NN	dobj	B-protein
.	.	punct	O

LMP1	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
effector	NN	ROOT	O
of	IN	case	O
B-lymphocyte	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
can	MD	aux	O
act	VB	conj	O
synergistically	RB	advmod	O
with	IN	case	O
EBNA-2	NN	nmod	B-protein
to	TO	mark	O
induce	VB	xcomp	O
cellular	JJ	amod	O
CD23	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
EBNA-2	NN	compound	B-protein
transactivation	NN	nsubj	O
of	IN	case	O
LMP1	NN	nmod	B-protein
amplifies	VBZ	ROOT	O
the	DT	det	O
biological	JJ	amod	O
impact	NN	dobj	O
of	IN	case	O
EBNA-2	NN	nmod	B-protein
and	CC	cc	O
underscores	VBZ	conj	O
its	PRP$	nmod:poss	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
EBV-induced	JJ	amod	O
growth	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
c-fos	NN	nmod	B-DNA
,	,	punct	O
c-jun	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
c-myc	NN	conj	B-DNA
genes	NNS	dep	I-DNA
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-DNA
protooncogenes	NNS	nmod	I-DNA
c-fos	NN	dep	B-DNA
,	,	punct	O
c-jun	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
c-myc	NN	conj	B-DNA
was	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Heat	NN	compound	O
shock	NN	nsubj	O
caused	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
c-fos	NN	compound	O
and	CC	cc	O
c-jun	NN	conj	O
mRNA	NN	compound	O
levels	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
decrease	NN	conj	O
in	IN	case	O
c-myc	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nmod	O
in	IN	case	O
pre-B	JJ	nmod	B-cell_line
(	-LRB-	punct	I-cell_line
Hyon	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
and	CC	cc	I-cell_line
T	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
DND-41	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
freshly	RB	advmod	O
isolated	VBN	amod	O
normal	JJ	amod	O
human	JJ	amod	O
thymocytes	NNS	conj	O
.	.	punct	O

The	DT	det	O
changes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
mRNA	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
these	DT	det	O
protooncogenes	NNS	nmod	B-DNA
in	IN	case	O
Hyon	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
were	VBD	auxpass	O
most	RBS	advmod	O
pronounced	JJ	ROOT	O
at	IN	case	O
42	CD	nummod	O
and	CC	cc	O
43	CD	conj	O
degrees	NNS	compound	O
C	NN	nmod	O
;	:	punct	O
kinetic	JJ	amod	O
analysis	NN	nsubj	O
demonstrated	VBD	parataxis	O
that	IN	mark	O
the	DT	det	O
changes	NNS	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
detected	VBN	ccomp	O
within	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
of	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
.	.	punct	O

Altered	JJ	amod	O
transcription	NN	nsubj	O
of	IN	case	O
c-fos	NN	nmod	B-DNA
and	CC	cc	O
c-myc	NN	conj	B-DNA
genes	NNS	dep	I-DNA
was	VBD	cop	O
the	DT	det	O
primary	JJ	amod	O
effect	NN	ROOT	O
of	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
.	.	punct	O

Secondarily	RB	advmod	O
,	,	punct	O
heat	NN	compound	O
shock	NN	nsubj	O
of	IN	case	O
Hyon	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
stabilized	VBD	ROOT	O
the	DT	det	O
c-myc	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
level	NN	dobj	O
by	IN	mark	O
increasing	VBG	advcl	O
its	PRP$	nmod:poss	O
half-life	NN	dobj	O
from	IN	case	O
24	CD	compound	O
to	TO	dep	O
45	CD	nummod	O
min	NN	nmod	O
.	.	punct	O

The	DT	det	O
overall	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
on	IN	case	O
c-myc	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
level	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
was	VBD	cop	O
a	DT	det	O
marked	JJ	amod	O
inhibition	NN	ROOT	O
of	IN	case	O
its	PRP$	nmod:poss	O
transcription	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
transcription	NN	nsubjpass	O
of	IN	case	O
nuclear	JJ	amod	B-DNA
protooncogenes	NNS	nmod	I-DNA
is	VBZ	auxpass	O
regulated	VBN	ccomp	O
by	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
indicating	VBG	acl	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
nuclear	JJ	amod	B-DNA
protooncogenes	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
stress	NN	compound	O
response	NN	nmod	O
of	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Mapping	NN	ROOT	O
of	IN	case	O
B-cell	NN	compound	B-protein
epitopes	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
hepatitis	NN	compound	I-protein
B	NN	compound	I-protein
virus	NN	compound	I-protein
X	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
immune	JJ	amod	O
response	NN	nsubjpass	O
to	TO	case	O
the	DT	det	O
X	NN	compound	B-protein
protein	NN	nmod	I-protein
of	IN	case	O
human	JJ	amod	O
hepatitis	NN	compound	O
B	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
HBV	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
by	IN	case	O
epitope	NN	compound	O
mapping	NN	nmod	O
by	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
set	NN	dobj	O
of	IN	case	O
MS2-HBx	NN	compound	B-protein
fusion	NN	compound	I-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
synthetic	JJ	amod	O
peptides	NNS	conj	O
.	.	punct	O

Antibodies	NNS	nsubj	O
in	IN	case	O
sera	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
and	CC	cc	O
chronic	JJ	conj	O
HBV	NN	compound	O
infection	NN	nmod	O
showed	VBD	ROOT	O
a	DT	det	O
multispecific	JJ	amod	O
immune	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Each	DT	det	O
serum	NN	nsubj	O
contained	VBD	ROOT	O
antibodies	NNS	dobj	B-protein
to	TO	case	O
a	DT	det	O
different	JJ	amod	O
set	NN	nmod	O
of	IN	case	O
epitopes	NNS	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
taken	VBN	acl:relcl	O
together	RB	advmod	O
cover	VBP	conj	O
most	JJS	dobj	O
of	IN	case	O
the	DT	det	O
HBx	NN	compound	B-protein
sequence	NN	nmod	I-protein
.	.	punct	O

Some	DT	nsubj	O
of	IN	case	O
the	DT	det	O
epitopes	NNS	nmod	O
were	VBD	cop	O
detectable	JJ	ROOT	O
only	RB	advmod	O
by	IN	mark	O
immunoblotting	VBG	advcl	O
with	IN	case	O
fusion	NN	compound	B-protein
proteins	NNS	nmod	I-protein
;	:	punct	O
others	NNS	nsubj	O
were	VBD	cop	O
detectable	JJ	parataxis	O
only	RB	advmod	O
by	IN	case	O
an	DT	det	O
enzyme-linked	JJ	amod	O
immunosorbent	JJ	amod	O
assay	NN	nmod	O
(	-LRB-	punct	O
ELISA	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
synthetic	JJ	amod	O
peptides	NNS	nmod	O
.	.	punct	O

The	DT	det	O
carboxy-terminal	JJ	amod	B-protein
half	NN	nsubjpass	I-protein
of	IN	case	O
the	DT	det	O
HBx	NN	compound	B-protein
protein	NN	nmod	I-protein
was	VBD	auxpass	O
preferentially	RB	advmod	O
recognized	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	B-protein
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
hepatitis	NN	nmod	O
and	CC	cc	O
contained	VBD	conj	O
a	DT	det	O
short	JJ	amod	O
immunodominant	JJ	amod	B-protein
antigenic	JJ	amod	I-protein
region	NN	dobj	I-protein
with	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
two	CD	nummod	O
major	JJ	amod	O
nonoverlapping	JJ	amod	B-protein
epitopes	NNS	nmod	I-protein
.	.	punct	O

Anti-	JJ	amod	O
HBx	NN	compound	B-protein
antibody	NN	compound	O
titers	NNS	nsubj	O
as	IN	mark	O
revealed	VBN	dep	O
by	IN	case	O
peptide	NN	compound	O
ELISAs	NNS	nmod	O
were	VBD	cop	O
highest	JJS	ROOT	O
and	CC	cc	O
most	RBS	advmod	O
frequent	JJ	conj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
hepatitis	NN	nmod	O
and	CC	cc	O
usually	RB	advmod	O
low	JJ	conj	O
in	IN	case	O
acutely	RB	advmod	O
infected	JJ	amod	O
patients	NNS	nmod	O
and	CC	cc	O
asymptomatic	JJ	amod	O
carriers	NNS	conj	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
a	DT	det	O
remarkable	JJ	amod	O
qualitative	JJ	amod	O
and	CC	cc	O
quantitative	JJ	conj	O
heterogeneity	NN	dobj	O
of	IN	case	O
the	DT	det	O
humoral	JJ	amod	O
HBx	NN	compound	B-protein
immune	JJ	amod	O
response	NN	nmod	O
which	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
monitored	VBN	acl:relcl	O
by	IN	case	O
HBx	NN	compound	B-protein
-specific	JJ	amod	O
peptide	NN	compound	O
ELISAs	NNS	nmod	O
.	.	punct	O

Such	JJ	amod	O
tests	NNS	nsubj	O
may	MD	aux	O
become	VB	ROOT	O
useful	JJ	amod	O
diagnostic	JJ	amod	O
tools	NNS	attr	O
.	.	punct	O

[	-LRB-	punct	O
The	DT	det	O
inhibitory	JJ	amod	O
effect	NN	ROOT	O
of	IN	case	O
hydrocortisone	NN	nmod	O
on	IN	case	O
the	DT	det	O
chemotactic	JJ	amod	O
migration	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
]	-RRB-	punct	O

Random	JJ	amod	O
migration	NN	nsubjpass	O
(	-LRB-	punct	O
RM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
chemotactic	JJ	amod	O
migration	NN	conj	O
(	-LRB-	punct	O
ChtM	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
human	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
to	TO	case	O
yeast	NN	compound	O
activated	JJ	amod	O
serum	NN	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
modified	VBN	amod	O
Boyden	NN	compound	O
chamber	NN	compound	O
method	NN	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
RM	NN	nsubj	O
and	CC	cc	O
ChtM	NN	conj	O
showed	VBD	ROOT	O
circadian	JJ	amod	O
rhythm	NN	dobj	O
.	.	punct	O

Leukocytes	NNS	nsubj	B-cell_type
migrated	VBD	ROOT	O
most	RBS	advmod	O
rapidly	RB	advmod	O
at	IN	prep	O
night	NN	pobj	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
between	IN	case	O
the	DT	det	O
peak	NN	nmod	O
(	-LRB-	punct	O
0	CD	nummod	O
:	:	punct	O
00	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
trough	NN	compound	O
values	NNS	conj	O
(	-LRB-	punct	O
8	CD	nummod	O
:	:	punct	O
00	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
RM	NN	nmod	O
and	CC	cc	O
ChtM	NN	conj	O
was	VBD	cop	O
significant	JJ	ROOT	O
statistically	RB	advmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.01	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

ChtM	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
hydrocortisone	NN	nmod	O
(	-LRB-	punct	O
F	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
physiological	JJ	amod	O
concentration	NN	nmod	O
(	-LRB-	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
-9	CD	dep	O
)	-RRB-	punct	O
-10	CD	nummod	O
(	-LRB-	punct	O
-7	CD	nummod	O
)	-RRB-	punct	O
mol/L	NN	appos	O
)	-RRB-	punct	O
which	WDT	nsubj	O
was	VBD	cop	O
dose-dependent	JJ	acl:relcl	O
and	CC	cc	O
completely	RB	advmod	O
antagonized	VBN	conj	O
by	IN	case	O
the	DT	det	O
competitive	JJ	amod	O
antagonist	NN	nmod	O
,	,	punct	O
RU38486	NN	appos	O
.	.	punct	O

The	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubj	O
was	VBD	cop	O
much	RB	advmod	O
more	RBR	advmod	O
evident	JJ	ROOT	O
with	IN	case	O
higher	JJR	amod	O
dose	NN	nmod	O
(	-LRB-	punct	O
more	JJR	dep	O
than	IN	dep	O
10	CD	nummod	O
(	-LRB-	punct	O
-5	CD	nummod	O
)	-RRB-	punct	O
mol/L	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
reversed	VBN	conj	O
by	IN	case	O
RU38486	NN	nmod	O
,	,	punct	O
but	CC	cc	O
only	RB	advmod	O
partially	RB	advmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
(	-LRB-	punct	O
GC	NN	appos	O
)	-RRB-	punct	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
physiological	JJ	amod	O
regulator	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
leukocytes	NNS	nmod	B-cell_type
and	CC	cc	O
its	PRP$	nmod:poss	O
inhibitory	JJ	amod	O
action	NN	conj	O
on	IN	case	O
ChtM	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
antiinflammatory	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
GC	NN	nmod	O
of	IN	case	O
pharmacological	JJ	amod	O
doses	NNS	nmod	O
.	.	punct	O

The	DT	det	O
action	NN	nsubjpass	O
of	IN	case	O
physiological	JJ	amod	O
and	CC	cc	O
pharmacological	JJ	conj	O
concentration	NN	nmod	O
of	IN	case	O
GC	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
low	JJ	amod	B-protein
affinity	NN	nmod:npmod	I-protein
specific	JJ	amod	I-protein
binding	VBG	amod	I-protein
sites	NNS	nmod	I-protein
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Heterogeneity	NN	ROOT	O
of	IN	case	O
antigen	NN	compound	B-protein
molecules	NNS	nmod	I-protein
recognized	VBN	acl	O
by	IN	case	O
anti-tax1	JJ	amod	B-protein
monoclonal	JJ	amod	I-protein
antibody	NN	nmod	I-protein
Lt-4	NN	dep	B-protein
in	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
bearing	VBG	acl	O
human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	dobj	O
I	CD	nummod	O
and	CC	cc	O
related	JJ	amod	O
retroviruses	NNS	conj	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	dobj	I-protein
,	,	punct	O
Lt-4	NN	appos	B-protein
,	,	punct	O
directed	VBN	acl	O
against	IN	case	O
human	JJ	amod	B-protein
T	NN	compound	I-protein
cell	NN	compound	I-protein
leukemia	NN	compound	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
I	CD	nummod	I-protein
(	-LRB-	punct	I-protein
HTLV-I	NN	compound	I-protein
)	-RRB-	punct	I-protein
trans-activator	NN	compound	I-protein
(	-LRB-	punct	I-protein
tax1	NN	compound	I-protein
)	-RRB-	punct	I-protein
antigen	NN	nmod	I-protein
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
tax1	NN	nmod	B-protein
and	CC	cc	O
related	JJ	amod	O
antigens	NNS	conj	B-protein
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
bearing	VBG	acl	O
HTLV-I	NN	dobj	O
and	CC	cc	O
related	JJ	amod	O
retroviruses	NNS	conj	O
,	,	punct	O
simian	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	appos	O
I	CD	nummod	O
(	-LRB-	punct	O
STLV-I	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
HTLV-II	NN	conj	O
,	,	punct	O
by	IN	case	O
immunofluorescence	NN	nmod	O
and	CC	cc	O
immunoblot	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

Lt-4	NN	nsubj	B-protein
reacted	VBD	ROOT	O
with	IN	case	O
all	DT	det	O
HTLV-I-bearing	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
tested	VBN	acl	O
and	CC	cc	O
five	CD	nummod	O
out	IN	dep	O
of	IN	case	O
eight	CD	nummod	O
simian	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
bearing	VBG	acl	O
STLV-I	NN	dobj	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
an	DT	det	O
HTLV-II-bearing	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
.	.	punct	O

Lt-4	NN	nsubj	B-protein
detected	VBD	ROOT	O
40	CD	nummod	O
kd	NN	compound	O
tax1	NN	compound	B-protein
antigen	NN	compound	I-protein
molecules	NNS	dobj	I-protein
in	IN	case	O
most	JJS	amod	O
HTLV-I-bearing	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
except	IN	case	O
one	CD	nummod	O
cell	NN	compound	O
line	NN	nmod	O
that	WDT	nsubj	O
expressed	VBD	acl:relcl	O
39	CD	nummod	B-protein
kd	NN	compound	I-protein
tax1	NN	compound	I-protein
antigen	NN	dobj	I-protein
.	.	punct	O

In	IN	case	O
the	DT	det	O
STLV-I-bearing	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
tax1-related	JJ	amod	B-protein
antigen	NN	compound	I-protein
molecules	NNS	nsubj	I-protein
detected	VBN	acl	O
by	IN	case	O
Lt-4	NN	nmod	B-protein
were	VBD	cop	O
heterogeneous	JJ	ROOT	O
,	,	punct	O
having	VBG	xcomp	O
molecular	JJ	amod	O
weights	NNS	dobj	O
in	IN	case	O
the	DT	det	O
range	NN	nmod	O
of	IN	case	O
36-41	CD	nummod	O
kd	NN	nmod	O
.	.	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
immunodeficiency	NN	compound	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
enhancer-binding	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
from	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
Jurkat	NN	nmod	B-cell_line
.	.	punct	O

The	DT	det	O
transcription	NN	nsubj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
under	IN	case	O
the	DT	det	O
control	NN	ROOT	O
of	IN	case	O
cellular	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
viral	JJ	amod	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
.	.	punct	O

Among	IN	case	O
the	DT	det	O
protein-binding	JJ	amod	O
regions	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
is	VBZ	cop	O
the	DT	det	O
transcription-enhancer	JJ	amod	B-DNA
region	NN	ROOT	I-DNA
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
at	IN	case	O
least	JJS	nmod:npmod	O
one	CD	nummod	O
inducible	JJ	nsubj	B-protein
,	,	punct	O
C1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
one	CD	nummod	O
constitutive	JJ	amod	B-protein
,	,	punct	I-protein
C2	NN	conj	I-protein
,	,	punct	I-protein
protein	NN	nsubj	I-protein
can	MD	aux	O
bind	VB	ccomp	O
to	TO	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
proteins	NNS	nsubj	O
differ	VBP	ROOT	O
in	IN	case	O
their	PRP$	nmod:poss	O
surface	NN	compound	O
charge	NN	nmod	O
,	,	punct	O
since	IN	mark	O
they	PRP	nsubj	O
are	VBP	cop	O
separable	JJ	advcl	O
by	IN	case	O
anion-exchange	JJ	amod	O
chromatography	NN	nmod	O
.	.	punct	O

Bivalent	JJ	amod	O
cations	NNS	nsubj	O
such	JJ	case	O
as	IN	mwe	O
Mg2+	NN	nmod	O
and	CC	cc	O
Zn2+	NN	conj	O
differentially	RB	advmod	O
affect	VBP	ROOT	O
their	PRP$	nmod:poss	O
binding	NN	dobj	O
to	TO	case	O
oligonucleotides	NNS	nmod	O
which	WDT	nsubj	O
contain	VBP	acl:relcl	O
the	DT	det	O
HIV-enhancer	NN	compound	B-DNA
domain	NN	dobj	I-DNA
.	.	punct	O

Both	CC	cc:preconj	O
C1	NN	nsubj	B-protein
and	CC	cc	O
C2	NN	conj	B-protein
proteins	NNS	dep	I-protein
also	RB	advmod	O
bind	VBP	ROOT	O
to	TO	case	O
a	DT	det	O
similar	JJ	amod	O
sequence	NN	nmod	O
found	VBN	acl	O
in	IN	case	O
the	DT	det	O
interleukin-2-receptor	NN	compound	B-DNA
alpha-subunit	NN	amod	I-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
inducible	JJ	amod	B-protein
C1	NN	compound	I-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
partially	RB	advmod	O
purified	VBN	ROOT	O
by	IN	case	O
three	CD	nummod	O
chromatographic	JJ	amod	O
steps	NNS	nmod	O
and	CC	cc	O
characterized	VBN	conj	O
by	IN	case	O
u.v.	NN	amod	O
cross-linking	NN	nmod	O
as	IN	case	O
a	DT	det	O
47	CD	nummod	B-protein
kDa	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

Differences	NNS	ROOT	O
in	IN	case	O
transcriptional	JJ	amod	B-DNA
enhancers	NNS	nmod	I-DNA
of	IN	case	O
HIV-1	NN	nmod	O
and	CC	cc	O
HIV-2	NN	conj	O
.	.	punct	O

Response	NN	ROOT	O
to	TO	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	compound	O
signals	NNS	nmod	O
.	.	punct	O

T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
HIV	NN	compound	O
replication	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
thought	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
one	CD	nummod	O
mechanism	NN	xcomp	O
leading	VBG	acl	O
to	TO	case	O
the	DT	det	O
conversion	NN	nmod	O
from	IN	case	O
latent	JJ	nmod	O
to	TO	case	O
active	JJ	amod	O
viral	JJ	amod	O
infection	NN	nmod	O
.	.	punct	O

In	IN	case	O
HIV-1	NN	nmod	O
,	,	punct	O
the	DT	det	O
sequences	NNS	nsubjpass	O
that	WDT	nsubj	O
respond	VBP	acl:relcl	O
to	TO	case	O
these	DT	det	O
signaling	NN	compound	O
events	NNS	nmod	O
are	VBP	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
and	CC	cc	O
comprise	VBP	conj	O
the	DT	det	O
transcriptional	JJ	amod	B-DNA
enhancer	NN	dobj	I-DNA
,	,	punct	O
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
two	CD	nummod	O
conserved	VBN	amod	B-DNA
binding	VBG	compound	I-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
corresponding	JJ	amod	O
region	NN	nsubj	O
in	IN	case	O
the	DT	det	O
second	JJ	amod	O
AIDS	NN	compound	O
retrovirus	NN	nmod	O
,	,	punct	O
HIV-2	NN	appos	O
,	,	punct	O
contains	VBZ	ROOT	O
a	DT	det	O
conserved	VBN	amod	O
and	CC	cc	O
a	DT	det	O
divergent	JJ	conj	O
NF	NN	compound	B-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	nsubj	I-DNA
responds	VBZ	ccomp	O
better	JJR	advmod	O
than	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
to	TO	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	compound	O
signals	NNS	nmod	O
.	.	punct	O

These	DT	det	O
qualitative	JJ	amod	O
differences	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
response	NN	nmod	O
to	TO	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
are	VBP	auxpass	O
reproduced	VBN	ROOT	O
not	RB	neg	O
only	RB	cc:preconj	O
when	WRB	advmod	O
HIV-1	NN	compound	B-DNA
or	CC	cc	I-DNA
HIV-2	NN	conj	I-DNA
enhancers	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
placed	VBN	advcl	O
upstream	RB	advmod	O
of	IN	case	O
a	DT	det	O
heterologous	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
but	CC	cc	O
also	RB	advmod	O
when	WRB	advmod	O
these	DT	det	O
enhancers	NNS	nsubjpass	B-DNA
are	VBP	auxpass	O
switched	VBN	conj	O
between	IN	case	O
their	PRP$	nmod:poss	O
respective	JJ	amod	O
LTR	NN	nmod	B-DNA
.	.	punct	O

In	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nsubj	I-protein
binds	VBZ	ROOT	O
to	TO	case	O
both	CC	det	O
conserved	VBN	amod	O
sites	NNS	nmod	O
in	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
transcriptional	JJ	amod	I-DNA
enhancer	NN	nmod	I-DNA
and	CC	cc	O
only	RB	advmod	O
to	TO	case	O
the	DT	det	O
single	JJ	amod	O
conserved	VBN	amod	O
site	NN	conj	O
in	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
transcriptional	JJ	amod	I-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

Instead	RB	advmod	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
,	,	punct	O
the	DT	det	O
activator	NN	compound	B-protein
protein	NN	nsubj	I-protein
3	CD	nummod	I-protein
binds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
divergent	JJ	amod	O
site	NN	nmod	O
in	IN	case	O
HIV-2	NN	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
HIV-1	NN	nsubjpass	O
and	CC	cc	O
HIV-2	NN	conj	O
are	VBP	auxpass	O
differentially	RB	advmod	O
regulated	VBN	ROOT	O
by	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	compound	O
signals	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
difference	NN	nsubj	O
may	MD	aux	O
account	VB	conj	O
for	IN	case	O
the	DT	det	O
longer	JJR	amod	O
period	NN	nmod	O
of	IN	case	O
viral	JJ	amod	O
latency	NN	nmod	O
observed	VBN	acl	O
with	IN	case	O
HIV-2	NN	nmod	O
than	IN	case	O
with	IN	case	O
HIV-1	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

NF-X2	NN	nsubj	B-protein
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
DRA	NN	compound	B-DNA
X2-box	NN	nmod	I-DNA
is	VBZ	cop	O
activator	NN	compound	B-protein
protein	NN	ROOT	I-protein
1	CD	nummod	I-protein
.	.	punct	O

Expression	NN	compound	O
cloning	NN	ROOT	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
.	.	punct	O

Human	JJ	amod	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
MHC	NN	compound	I-protein
Ag	NN	nsubj	I-protein
are	VBP	cop	O
a	DT	det	O
family	NN	ROOT	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
glycoproteins	NNS	nmod	I-protein
.	.	punct	O

Their	PRP$	nmod:poss	O
constitutive	JJ	amod	O
expression	NN	nsubjpass	O
is	VBZ	cop	O
limited	JJ	ROOT	O
to	TO	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
thymic	JJ	amod	B-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

In	IN	case	O
many	JJ	amod	O
other	JJ	amod	O
cells	NNS	nmod	O
their	PRP$	nmod:poss	O
expression	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
IFN-gamma	NN	nmod	B-protein
.	.	punct	O

Conserved	VBN	amod	O
upstream	JJ	amod	O
promoter	NN	compound	O
sequences	NNS	nsubj	O
regulate	VBP	ROOT	O
this	DT	det	O
tissue-specific	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

In	IN	case	O
the	DT	det	O
DRA	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
one	CD	nsubj	O
of	IN	case	O
these	DT	det	O
cis-acting	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
motifs	NNS	nmod	I-DNA
is	VBZ	cop	O
the	DT	det	O
X2-box	NN	ROOT	B-DNA
to	TO	case	O
which	WDT	nmod	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
X2	NN	nsubj	I-protein
(	-LRB-	punct	O
NF-X2	NN	appos	B-protein
)	-RRB-	punct	O
binds	VBZ	acl:relcl	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
present	VBP	ROOT	O
the	DT	det	O
isolation	NN	dobj	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
the	DT	det	O
full-length	JJ	amod	B-DNA
cDNA	NN	compound	I-DNA
clone	NN	nmod	I-DNA
encoding	VBG	acl	O
NF-X2	NN	dobj	B-protein
.	.	punct	O

This	DT	det	O
cDNA	NN	compound	B-DNA
clone	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
isolated	VBN	ROOT	O
by	IN	case	O
expression	NN	compound	O
cDNA	NN	compound	B-DNA
cloning	NN	nmod	O
,	,	punct	O
and	CC	cc	O
encodes	VBZ	conj	O
the	DT	det	O
human	JJ	amod	B-protein
c-Jun	NN	compound	I-protein
protein	NN	dobj	I-protein
,	,	punct	O
which	WDT	nsubj	O
together	RB	advmod	O
with	IN	case	O
c-Fos	NN	nmod	B-protein
forms	VBZ	acl:relcl	O
the	DT	det	O
heterodimeric	JJ	amod	B-protein
activator	NN	compound	I-protein
protein-1	NN	compound	I-protein
transcription	NN	compound	I-protein
complex	NN	dobj	I-protein
.	.	punct	O

Whereas	IN	mark	O
c-Fos/c-Jun	NN	compound	B-protein
heterodimers	NNS	nsubj	I-protein
do	VBP	aux	O
not	RB	neg	O
exist	VB	advcl	O
in	IN	case	O
B	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
they	PRP	nsubj	O
form	VBP	ROOT	O
and	CC	cc	O
bind	VBP	conj	O
to	TO	case	O
the	DT	det	O
X2-box	NN	nmod	B-DNA
in	IN	case	O
class	NN	compound	B-cell_line
II	CD	nummod	I-cell_line
nonexpressing	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
c-Fos/c-Jun	NN	compound	B-protein
heterodimers	NNS	nsubj	I-protein
might	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
repression	NN	nmod	O
of	IN	case	O
DRA	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

Synthesis	NN	ROOT	O
of	IN	case	O
4	CD	nummod	O
,	,	punct	O
19-disubstituted	JJ	amod	O
derivatives	NNS	nmod	O
of	IN	case	O
DOC	NN	nmod	O
.	.	punct	O

Radioreceptor	NN	compound	O
assay	NN	ROOT	O
of	IN	case	O
some	DT	det	O
corticosteroid	NN	compound	O
derivatives	NNS	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

Several	JJ	amod	O
new	JJ	amod	O
4	CD	dep	O
,	,	punct	O
19-substituted	JJ	dep	O
steroids	NNS	nsubjpass	O
and	CC	cc	O
previously	RB	advmod	O
synthesized	VBN	amod	O
corticosteroids	NNS	conj	O
were	VBD	auxpass	O
assayed	VBN	ROOT	O
for	IN	case	O
affinity	NN	nmod	O
to	TO	case	O
type	NN	compound	B-protein
1	CD	nummod	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

11	CD	nummod	O
beta	NN	nsubjpass	O
,	,	punct	O
19-epoxy-4	CD	conj	O
,	,	punct	O
21-dihydroxypregn-4-ene-3	NN	conj	O
,	,	punct	O
20-dione	NN	appos	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
hydrogenated	VBN	ROOT	O
with	IN	case	O
Pd-C	NN	nmod	O
to	TO	mark	O
yield	VB	xcomp	O
a	DT	det	O
mixture	NN	dobj	O
of	IN	case	O
all	DT	det	O
four	CD	nummod	O
dihydro	NN	compound	O
derivatives	NNS	nmod	O
5	CD	nummod	O
,	,	punct	O
accompanied	VBN	advcl	O
by	IN	case	O
4	CD	nummod	O
,	,	punct	O
21-diacetoxy-11	NN	compound	O
beta	NN	nmod	O
,	,	punct	O
19-epoxy-3-hydroxypregnan-20-one	NN	appos	O
(	-LRB-	punct	O
6	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
21-acetoxy-11	NN	compound	O
beta	NN	conj	O
,	,	punct	O
19-epoxy-4-hydroxypregnane-3	CD	conj	O
,	,	punct	O
20-dione	NN	conj	O
(	-LRB-	punct	O
7	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

With	IN	case	O
hot	JJ	amod	O
acetic	JJ	dep	O
+	CC	cc	O
p-toluenesulfonic	JJ	amod	O
acid	NN	nsubj	O
5	CD	nummod	O
underwent	VBD	ROOT	O
rearrangement	NN	dobj	O
to	TO	case	O
21-acetoxy-11	NN	compound	O
beta	NN	compound	O
,	,	punct	O
19-epoxypregn-5-ene-4	NN	conj	O
,	,	punct	O
20-dione	NN	conj	O
(	-LRB-	punct	O
8	CD	appos	O
)	-RRB-	punct	O
Pd-C	NN	compound	O
hydrogenation	NN	nmod	O
of	IN	case	O
3	CD	nummod	O
,	,	punct	O
21-diacetoxy-5	CD	compound	O
beta	NN	nmod	O
,	,	punct	O
19-cyclopregna-2	CD	conj	O
,	,	punct	O
9	CD	nummod	O
(	-LRB-	punct	O
11	CD	dep	O
)	-RRB-	punct	O
-diene-4	NNS	conj	O
,	,	punct	O
20-dione	NN	conj	O
(	-LRB-	punct	O
10	CD	appos	O
)	-RRB-	punct	O
gave	VBD	xcomp	O
3	CD	nummod	O
,	,	punct	O
21-diacetoxy-5	CD	compound	O
beta	NN	conj	O
,	,	punct	O
19-cyclopregn-5-ene-4	NN	conj	O
,	,	punct	O
20-dione	NN	dobj	O
(	-LRB-	punct	O
11	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	dep	O
9	CD	nummod	O
,	,	punct	O
11-dihydro	JJ	appos	O
derivative	NN	conj	O
of	IN	case	O
the	DT	det	O
latter	JJ	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
10	CD	nmod	O
with	IN	case	O
warm	JJ	amod	O
HCl	NN	nmod	O
furnished	JJ	ROOT	O
19-chloro-4	CD	dobj	O
,	,	punct	O
21-dihydroxypregna-4	CD	conj	O
,	,	punct	O
9	CD	compound	O
(	-LRB-	punct	O
11	CD	nummod	O
)	-RRB-	punct	O
-diene-3	CD	conj	O
,	,	punct	O
20-dione	NN	conj	O
(	-LRB-	punct	O
13	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Pd-C	NN	compound	O
hydrogenation	NN	nsubj	O
of	IN	case	O
its	PRP$	nmod:poss	O
diacetate	NN	nmod	O
14	CD	nummod	O
afforded	VBD	ROOT	O
the	DT	det	O
4	CD	nummod	O
,	,	punct	O
5-dihydro	JJ	dep	O
derivative	NN	dobj	O
18	CD	nummod	O
,	,	punct	O
19-chloro-21-acetoxypregn-9	CD	conj	O
(	-LRB-	punct	O
11	CD	nummod	O
)	-RRB-	punct	O
-en-20-one	NN	dep	O
(	-LRB-	punct	O
15	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
its	PRP$	nmod:poss	O
4-acetoxy	NN	amod	O
derivative	NN	appos	O
16	CD	nummod	O
and	CC	cc	O
the	DT	dep	O
3	CD	conj	O
,	,	punct	O
4-diacetoxy	JJ	amod	O
derivative	NN	appos	O
17	CD	nummod	O
.	.	punct	O

When	WRB	advmod	O
tested	VBN	advcl	O
in	IN	case	O
a	DT	det	O
radioreceptor	NN	compound	O
assay	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
the	DT	det	O
synthesized	VBN	amod	O
compounds	NNS	nsubj	O
showed	VBD	ROOT	O
only	RB	advmod	O
low	JJ	amod	O
relative	JJ	amod	O
binding	NN	compound	O
affinities	NNS	dobj	O
(	-LRB-	punct	O
RBA	NNS	appos	O
)	-RRB-	punct	O
to	TO	case	O
type	NN	compound	B-protein
1	CD	nummod	I-protein
receptor	NN	nmod	I-protein
,	,	punct	O
the	DT	det	O
highest	JJS	nsubj	O
being	VBG	cop	O
0.72	CD	nummod	O
%	NN	appos	O
for	IN	case	O
13	CD	nmod	O
(	-LRB-	punct	O
aldosterone	NN	appos	O
=	JJ	amod	O
100	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

For	IN	prep	O
comparison	NN	pobj	O
,	,	punct	O
other	JJ	amod	O
RBA	NNS	nsubj	O
in	IN	case	O
this	DT	det	O
system	NN	nmod	O
were	VBD	ROOT	O
:	:	punct	O
19-noraldosterone	NN	attr	O
,	,	punct	O
20	CD	nummod	O
%	NN	appos	O
;	:	punct	O
18-deoxyaldosterone	NN	conj	O
,	,	punct	O
5.8	CD	nummod	O
%	NN	appos	O
;	:	punct	O
18-deoxy-19-noraldosterone	NN	conj	O
,	,	punct	O
4.7	CD	nummod	O
%	NN	appos	O
;	:	punct	O
18	CD	nummod	O
,	,	punct	O
21-anhydroaldosterone	NN	conj	O
,	,	punct	O
0.37	CD	nummod	O
%	NN	appos	O
;	:	punct	O
17-isoaldosterone	NN	conj	O
,	,	punct	O
7.6	CD	nummod	O
%	NN	appos	O
and	CC	cc	O
apoaldosterone	NN	conj	O
,	,	punct	O
4.3	CD	nummod	O
%	NN	appos	O

Cell	NN	compound	O
type	NN	compound	O
specificity	NN	ROOT	O
and	CC	cc	O
activation	NN	compound	O
requirements	NNS	conj	O
for	IN	case	O
NFAT-1	NN	compound	B-protein
(	-LRB-	punct	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	case	O
activated	VBN	amod	B-cell_type
T-cells	NNS	appos	I-cell_type
)	-RRB-	punct	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
determined	VBN	acl	O
by	IN	case	O
a	DT	det	O
new	JJ	amod	O
method	NN	nmod	O
using	VBG	acl	O
transgenic	JJ	amod	O
mice	NNS	dobj	O
to	TO	mark	O
assay	VB	advcl	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
an	DT	det	O
individual	JJ	amod	O
nuclear	JJ	amod	B-protein
factor	NN	nmod	I-protein
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor	NN	nsubj	I-protein
of	IN	case	O
activated	VBN	amod	B-cell_type
T-cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
NFAT-1	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	ROOT	I-protein
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
considered	VBN	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
regulator	NN	xcomp	O
in	IN	case	O
early	JJ	amod	O
T-cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
developed	VBN	ROOT	O
a	DT	det	O
system	NN	dobj	O
to	TO	mark	O
monitor	VB	acl	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
NFAT-1	NN	nmod	B-protein
at	IN	case	O
the	DT	det	O
single	JJ	amod	O
cell	NN	compound	O
level	NN	nmod	O
in	IN	case	O
whole	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O

The	DT	det	O
system	NN	nsubjpass	O
is	VBZ	auxpass	O
based	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
an	DT	det	O
oligomerized	JJ	amod	O
NFAT-1	NN	compound	B-protein
binding	NN	compound	O
motif	NN	nmod	O
that	WDT	nsubj	O
directs	VBZ	acl:relcl	O
transcription	NN	dobj	B-protein
of	IN	case	I-protein
SV40	NN	compound	I-protein
T-antigen	NN	nmod	I-protein
in	IN	case	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

This	DT	det	O
report	NN	nsubj	O
represents	VBZ	ROOT	O
the	DT	det	O
first	JJ	amod	O
demonstration	NN	dobj	O
that	IN	mark	O
a	DT	det	O
multimerized	JJ	amod	O
short	JJ	amod	O
binding	VBG	compound	O
motif	NN	nsubj	O
can	MD	aux	O
function	VB	ccomp	O
appropriately	RB	advmod	O
in	IN	case	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

NFAT-1	NN	compound	B-protein
activity	NN	nsubjpass	O
had	VBD	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
confined	VBN	xcomp	O
to	TO	case	O
activated	VBN	amod	B-cell_type
T-lymphocytes	NNS	nmod	I-cell_type
upon	IN	case	O
release	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	B-cell_type
calcium	NN	nmod	I-cell_type
.	.	punct	O

By	IN	mark	O
targeting	VBG	advcl	O
NFAT-1	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
we	PRP	nsubj	O
discovered	VBD	ROOT	O
new	JJ	amod	O
sites	NNS	dobj	O
of	IN	case	O
NFAT-1	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

Besides	IN	case	O
in	IN	case	O
T-lymphocytes	NNS	nmod	B-cell_type
NFAT-1	NN	compound	B-protein
activity	NN	nsubjpass	O
could	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
T-lymphocyte-depleted	JJ	amod	B-cell_type
spleen	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
purified	VBN	amod	B-cell_type
B-lymphocytes	NNS	conj	I-cell_type
and	CC	cc	O
requires	VBZ	conj	O
agents	NNS	dobj	O
that	WDT	nsubj	O
both	CC	nsubj	O
release	VBP	acl:relcl	O
intracellular	JJ	amod	O
calcium	NN	dobj	O
and	CC	cc	O
activate	VBP	conj	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	dobj	I-protein
.	.	punct	O

A	DT	det	O
difference	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
time	NN	compound	O
course	NN	nmod	O
of	IN	case	O
appearance	NN	nmod	O
of	IN	case	O
NFAT-1	NN	compound	B-protein
activity	NN	nmod	O
between	IN	case	O
T-lymphocytes	NNS	nmod	B-cell_type
and	CC	cc	O
non-T-lymphocytes	NNS	conj	B-cell_type
was	VBD	auxpass	O
revealed	VBN	ROOT	O
.	.	punct	O

Constitutive	JJ	amod	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
small	JJ	amod	O
population	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
in	IN	case	O
the	DT	det	O
dermis	NN	nmod	O
and	CC	cc	O
some	DT	det	O
mice	NNS	nsubj	O
have	VBP	aux	O
developed	VBN	conj	O
skin	NN	compound	O
lesions	NNS	dobj	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
tissue	NN	compound	O
pattern	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
NFAT-1	NN	compound	B-protein
activity	NN	nmod	O
resembles	VBZ	ROOT	O
the	DT	det	O
expression	NN	compound	O
pattern	NN	dobj	O
described	VBN	acl	O
for	IN	case	O
HIV-LTR/tat	NN	compound	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
(	-LRB-	punct	O
Vogel	NNP	compound	O
,	,	punct	O
J.	NNP	dep	O
,	,	punct	O
Hinrichs	NNP	compound	O
,	,	punct	O
S.	NNP	appos	O
H.	NNP	conj	O
,	,	punct	O
Reynolds	NNP	compound	O
,	,	punct	O
R.	NNP	compound	O
K.	NNP	conj	O
,	,	punct	O
Luciw	NNP	compound	O
,	,	punct	O
P.	NNP	appos	O
A.	NNP	conj	O
,	,	punct	O
and	CC	cc	O
Jay	NNP	compound	O
,	,	punct	O
G.	NNP	conj	O
(	-LRB-	punct	O
1988	CD	dep	O
)	-RRB-	punct	O
Nature	NNP	dep	O
335	CD	nummod	O
,	,	punct	O
606-611	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
similarity	NN	nsubj	O
in	IN	case	O
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
fact	NN	conj	O
that	IN	mark	O
NFAT-1	NN	nsubjpass	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ccomp	O
to	TO	mark	O
bind	VB	xcomp	O
functional	JJ	amod	B-DNA
sequences	NNS	dobj	I-DNA
in	IN	case	O
HIV-LTR	NN	nmod	B-DNA
suggest	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
NFAT-1	NN	nmod	B-protein
in	IN	case	O
dermal	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIV-LTR	NN	nmod	B-DNA
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
T-cell	NN	compound	B-protein
protein	NN	ROOT	I-protein
which	WDT	nsubj	O
recognizes	VBZ	acl:relcl	O
a	DT	det	O
palindromic	JJ	amod	B-DNA
sequence	NN	dobj	I-DNA
in	IN	case	O
the	DT	det	O
negative	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
element	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
.	.	punct	O

Two	CD	nummod	O
major	JJ	amod	B-DNA
protein-binding	JJ	amod	I-DNA
sites	NNS	nsubjpass	I-DNA
within	IN	case	O
the	DT	det	O
negative	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
element	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1	CD	nummod	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O

One	CD	nsubj	O
(	-LRB-	punct	O
site	NN	compound	B-DNA
B	NN	appos	I-DNA
)	-RRB-	punct	O
contained	VBD	ROOT	O
a	DT	det	O
palindromic	JJ	amod	B-DNA
sequence	NN	dobj	I-DNA
with	IN	case	O
homology	NN	nmod	O
to	TO	case	O
steroid/thyroid	NN	compound	B-DNA
hormone	NN	compound	I-DNA
response	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
but	CC	cc	O
was	VBD	cop	O
distinct	JJ	conj	O
from	IN	case	O
previously	RB	advmod	O
described	VBN	amod	O
binding	VBG	amod	O
sites	NNS	nmod	O
of	IN	case	O
this	DT	det	O
class	NN	nmod	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
T-cell	NN	compound	B-protein
protein	NN	nsubj	I-protein
recognized	VBD	ROOT	O
the	DT	det	O
palindromic	JJ	amod	B-DNA
sequence	NN	dobj	I-DNA
within	IN	case	O
site	NN	compound	B-DNA
B	NN	nmod	I-DNA
and	CC	cc	O
also	RB	advmod	O
bound	VBD	conj	O
estrogen-	NN	dobj	B-DNA
or	CC	cc	I-DNA
thyroid	NN	compound	I-DNA
hormone-response	JJ	amod	I-DNA
elements	NNS	conj	I-DNA
with	IN	case	O
lower	JJR	amod	O
affinity	NN	nmod	O
.	.	punct	O

A	DT	det	O
7-base-pair	JJ	amod	O
mutation	NN	nsubj	O
in	IN	case	O
the	DT	det	O
site	NN	compound	B-DNA
B	NN	compound	I-DNA
palindrome	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
destroyed	VBD	acl:relcl	O
protein	NN	compound	O
binding	NN	dobj	O
,	,	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
increased	VBN	amod	O
expression	NN	nmod	O
from	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1	CD	nummod	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Progesterone	NN	compound	O
suppression	NN	nsubjpass	O
of	IN	case	O
pregnancy	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
not	RB	neg	O
mediated	VBN	ROOT	O
by	IN	case	O
glucocorticoid	NN	compound	O
effect	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
the	DT	det	O
suppressive	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
progesterone	NN	nmod	O
on	IN	case	O
pregnancy	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
specific	JJ	amod	O
progesterone	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
a	DT	det	O
competitive	JJ	amod	O
progesterone	NN	compound	O
antagonist	NN	nmod	O
(	-LRB-	punct	O
RU486	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
specific	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
blocker	NN	conj	O
(	-LRB-	punct	O
RU43044	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
tested	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
release	NN	nmod	O
of	IN	case	O
a	DT	det	O
blocking	VBG	amod	B-protein
factor	NN	nmod	I-protein
by	IN	case	O
progesterone-treated	JJ	amod	B-cell_line
pregnancy	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

RU	NN	nsubj	O
486	CD	nummod	O
tested	VBN	acl	O
at	IN	case	O
an	DT	det	O
equal	JJ	amod	O
concentration	NN	nmod	O
as	IN	case	O
progesterone	NN	nmod	O
significantly	RB	advmod	O
inhibited	VBD	ROOT	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
the	DT	det	O
blocking	NN	compound	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
while	IN	mark	O
RU	NN	nsubj	O
43044	CD	nummod	O
was	VBD	cop	O
without	IN	case	O
effect	NN	advcl	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
pregnancy	NN	nmod	O
,	,	punct	O
lymphocyte	NN	compound	O
progesterone	NN	nsubj	O
acts	VBZ	ccomp	O
on	IN	case	O
specific	JJ	amod	O
progesterone	NN	compound	B-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
glucocorticoid	NN	compound	B-protein
binding	NN	compound	I-protein
sites	NNS	conj	I-protein
are	VBP	auxpass	O
not	RB	neg	O
involved	VBN	conj	O
.	.	punct	O

The	DT	det	O
56-59-kilodalton	JJ	amod	B-protein
protein	NN	nsubj	I-protein
identified	VBN	acl	O
in	IN	case	O
untransformed	JJ	amod	B-protein
steroid	NN	compound	I-protein
receptor	NN	compound	I-protein
complexes	NNS	nmod	I-protein
is	VBZ	cop	O
a	DT	det	O
unique	JJ	amod	B-protein
protein	NN	ROOT	I-protein
that	WDT	nsubj	O
exists	VBZ	acl:relcl	O
in	IN	case	O
cytosol	NN	nmod	O
in	IN	case	O
a	DT	det	O
complex	NN	nmod	O
with	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
70-	CD	nmod	B-protein
and	CC	cc	I-protein
90-kilodalton	JJ	conj	I-protein
heat	NN	compound	I-protein
shock	NN	compound	I-protein
proteins	NNS	dep	I-protein
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
9S	NN	nsubj	B-protein
,	,	punct	O
untransformed	JJ	amod	B-protein
progestin	NN	conj	I-protein
,	,	punct	I-protein
estrogen	NN	conj	I-protein
,	,	punct	I-protein
androgen	NN	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	compound	I-protein
complexes	NNS	conj	I-protein
in	IN	case	O
rabbit	NN	nmod	O
uterine	NN	amod	O
and	CC	cc	O
liver	NN	conj	O
cytosols	NNS	conj	O
contain	VBP	ccomp	O
a	DT	det	O
59-kDa	JJ	amod	B-protein
protein	NN	dobj	I-protein
[	-LRB-	punct	O
Tai	NNP	compound	O
,	,	punct	O
P.K.	NNP	dep	O
,	,	punct	O
Maeda	NNP	compound	O
,	,	punct	O
Y.	NNP	conj	O
,	,	punct	O
Nakao	NNP	compound	O
,	,	punct	O
K.	NNP	conj	O
,	,	punct	O
Wakim	NNP	compound	O
,	,	punct	O
N.G.	NNP	conj	O
,	,	punct	O
Duhring	NNP	compound	O
,	,	punct	O
J.L.	NNP	conj	O
,	,	punct	O
&	CC	cc	O
Faber	NNP	compound	O
,	,	punct	O
L.E.	NNP	compound	O
(	-LRB-	punct	O
1986	CD	appos	O
)	-RRB-	punct	O
Biochemistry	NNP	conj	O
25	CD	nummod	O
,	,	punct	O
5269-5275	CD	nummod	O
]	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
work	NN	nmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	compound	I-protein
KN	NN	compound	I-protein
382/EC1	NN	nsubj	I-protein
raised	VBN	acl	O
against	IN	case	O
the	DT	det	O
rabbit	NN	compound	B-protein
59-kDa	JJ	amod	I-protein
protein	NN	nmod	I-protein
reacts	VBZ	ccomp	O
with	IN	case	O
9S	NN	nmod	B-protein
,	,	punct	O
untransformed	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	compound	I-protein
complexes	NNS	appos	I-protein
in	IN	case	O
cytosol	NN	nmod	O
prepared	VBN	acl	O
from	IN	case	O
human	JJ	amod	B-cell_line
IM-9	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
4S	NN	nmod:npmod	B-protein
salt-transformed	JJ	amod	I-protein
receptors	NNS	conj	I-protein
.	.	punct	O

The	DT	det	O
human	JJ	amod	O
protein	NN	nsubj	O
recognized	VBN	acl	O
by	IN	case	O
the	DT	det	O
EC1	NN	compound	B-protein
antibody	NN	nmod	I-protein
is	VBZ	cop	O
a	DT	det	O
56-kDa	JJ	amod	B-protein
protein	NN	ROOT	I-protein
(	-LRB-	punct	O
p56	NN	appos	B-protein
)	-RRB-	punct	O
of	IN	case	O
moderate	JJ	amod	O
abundance	NN	nmod	O
located	JJ	amod	O
predominantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
by	IN	case	O
indirect	JJ	amod	O
immunofluorescence	NN	nmod	O
.	.	punct	O

There	EX	expl	O
are	VBP	ROOT	O
at	IN	case	O
least	JJS	nmod:npmod	O
six	CD	nummod	O
isomorphs	NNS	nsubj	B-protein
of	IN	case	O
p56	NN	nmod	B-protein
by	IN	case	O
two-dimensional	JJ	amod	O
gel	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

N-Terminal	JJ	amod	O
sequencing	NN	nsubj	O
(	-LRB-	punct	O
20	CD	nummod	O
amino	NN	compound	O
acids	NNS	appos	O
)	-RRB-	punct	O
shows	VBZ	ROOT	O
that	IN	mark	O
p56	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
unique	JJ	amod	B-protein
human	JJ	amod	I-protein
protein	NN	ccomp	I-protein
.	.	punct	O

When	WRB	advmod	O
p56	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
immunoadsorbed	VBN	advcl	O
from	IN	case	O
IM-9	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
cytosol	NN	nmod	O
,	,	punct	O
both	CC	cc:preconj	O
the	DT	dep	O
70-	CD	nsubjpass	B-protein
and	CC	cc	I-protein
90-kDa	JJ	conj	I-protein
heat	NN	compound	I-protein
shock	NN	compound	I-protein
proteins	NNS	dep	I-protein
are	VBP	auxpass	O
coadsorbed	VBN	ROOT	O
in	IN	case	O
an	DT	det	O
immune-specific	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Neither	DT	det	O
heat	NN	compound	B-protein
shock	NN	compound	I-protein
protein	NN	nsubj	I-protein
reacts	VBZ	ROOT	O
directly	RB	advmod	O
with	IN	case	O
the	DT	det	O
EC1	NN	compound	B-protein
antibody	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
p56	NN	nsubj	B-protein
exists	VBZ	ccomp	O
in	IN	case	O
cytosol	NN	nmod	O
in	IN	case	O
a	DT	det	O
higher	JJR	amod	O
order	NN	compound	O
complex	NN	nmod	O
containing	VBG	acl	O
hsp70	NN	dobj	B-protein
and	CC	cc	O
hsp90	NN	conj	B-protein
,	,	punct	O
both	DT	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
in	IN	case	O
turn	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
untransformed	JJ	amod	B-protein
steroid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Sequence-specific	JJ	amod	O
DNA	NN	compound	O
binding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proto-oncoprotein	NN	compound	B-protein
ets-1	NN	nmod	B-protein
defines	VBZ	ROOT	O
a	DT	det	O
transcriptional	JJ	amod	B-DNA
activator	NN	compound	I-DNA
sequence	NN	dobj	I-DNA
within	IN	case	O
the	DT	det	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
Moloney	NN	compound	O
murine	JJ	amod	O
sarcoma	NN	compound	O
virus	NN	nmod	O
.	.	punct	O

The	DT	det	O
ets	NN	compound	B-DNA
proto-oncogene	NN	compound	I-DNA
family	NN	nsubj	I-DNA
is	VBZ	cop	O
a	DT	det	O
group	NN	ROOT	O
of	IN	case	O
sequence-related	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
whose	WP$	nmod:poss	O
normal	JJ	amod	O
cellular	JJ	amod	O
function	NN	nsubj	O
is	VBZ	cop	O
unknown	JJ	parataxis	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
study	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
murine	JJ	amod	O
retroviruses	NNS	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
discovered	VBN	ROOT	O
that	IN	mark	O
a	DT	det	O
member	NN	nsubj	O
of	IN	case	O
the	DT	det	O
ets	NN	compound	B-DNA
gene	NN	compound	I-DNA
family	NN	nmod	I-DNA
encodes	VBZ	ccomp	O
a	DT	det	O
sequence-specific	JJ	amod	B-protein
DNA-binding	JJ	amod	I-protein
protein	NN	dobj	I-protein
.	.	punct	O

A	DT	det	O
mouse	NN	compound	B-DNA
ets-1	NN	compound	I-DNA
cDNA	NN	compound	I-DNA
clone	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
obtained	VBN	ROOT	O
by	IN	mark	O
screening	VBG	advcl	O
a	DT	det	O
mouse	NN	compound	O
thymus	NN	compound	O
cDNA	NN	compound	O
expression	NN	compound	O
library	NN	dobj	O
with	IN	case	O
a	DT	det	O
double-stranded	JJ	amod	B-DNA
oligonucleotide	NN	compound	I-DNA
probe	NN	nmod	I-DNA
representing	VBG	acl	O
20	CD	nummod	O
bp	NN	dobj	O
of	IN	case	O
the	DT	det	O
Moloney	NN	compound	O
murine	JJ	amod	O
sarcoma	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
MSV	NN	appos	O
)	-RRB-	punct	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
cDNA	NN	compound	B-DNA
sequence	NN	nsubj	I-DNA
has	VBZ	ROOT	O
an	DT	det	O
813-bp	JJ	amod	B-DNA
open	JJ	amod	I-DNA
reading	NN	compound	I-DNA
frame	NN	dobj	I-DNA
(	-LRB-	punct	O
ORF	NN	appos	B-DNA
)	-RRB-	punct	O
whose	WP$	nmod:poss	O
predicted	VBN	amod	O
amino	NN	compound	O
acid	NN	compound	O
sequence	NN	nsubj	O
is	VBZ	cop	O
97.6	CD	nummod	O
%	NN	nmod:npmod	O
identical	JJ	amod	O
to	TO	case	O
the	DT	det	O
272	CD	nummod	B-protein
carboxy-terminal	JJ	amod	I-protein
amino	NN	compound	I-protein
acids	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
ets-1	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
ORF	NN	nsubjpass	B-DNA
was	VBD	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
bacteria	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
30-kD	JJ	amod	B-protein
protein	NN	compound	I-protein
product	NN	nsubjpass	I-protein
was	VBD	auxpass	O
shown	VBN	conj	O
to	TO	mark	O
bind	VB	xcomp	O
DNA	NN	dobj	O
in	IN	case	O
a	DT	det	O
sequence-specific	JJ	amod	O
manner	NN	nmod	O
by	IN	case	O
mobility-shift	JJ	amod	O
assays	NNS	nmod	O
,	,	punct	O
Southwestern	NN	compound	O
blot	NN	compound	O
analysis	NN	conj	O
,	,	punct	O
and	CC	cc	O
methylation	NN	compound	O
interference	NN	conj	O
.	.	punct	O

A	DT	det	O
mutant	JJ	amod	B-DNA
LTR	NN	nsubjpass	I-DNA
containing	VBG	acl	O
four	CD	nummod	O
base	NN	compound	O
pair	NN	compound	O
substitutions	NNS	dobj	O
in	IN	case	O
the	DT	det	O
ets-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
was	VBD	auxpass	O
constructed	VBN	ROOT	O
and	CC	cc	O
was	VBD	auxpass	O
shown	VBN	conj	O
to	TO	mark	O
have	VB	xcomp	O
reduced	VBN	amod	O
binding	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Transcriptional	JJ	amod	O
efficiency	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
MSV	NN	compound	B-DNA
LTR	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
containing	VBG	acl	O
this	DT	det	O
disrupted	VBN	amod	O
ets-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
was	VBD	auxpass	O
compared	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
a	DT	det	O
wild-type	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
mouse	NN	compound	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
and	CC	cc	O
15-	CD	compound	O
to	TO	dep	O
20-fold	JJ	amod	O
reduction	NN	nsubjpass	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
reporter	NN	compound	B-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
observed	VBN	conj	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
ets-1	NN	nsubj	B-protein
functions	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
activator	NN	nmod	O
of	IN	case	O
mammalian	JJ	amod	O
type-C	JJ	amod	O
retroviruses	NNS	nmod	O
and	CC	cc	O
speculate	VBP	conj	O
that	IN	mark	O
ets-related	JJ	amod	B-DNA
genes	NNS	nsubj	I-DNA
constitute	VBP	ccomp	O
a	DT	det	O
new	JJ	amod	O
group	NN	dobj	O
of	IN	case	O
eukaryotic	JJ	amod	B-protein
DNA-binding	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

Type	NN	compound	B-protein
II	CD	nummod	I-protein
estrogen	NN	compound	I-protein
binding	NN	compound	I-protein
sites	NNS	ROOT	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
variations	NNS	dep	O
during	IN	case	O
the	DT	det	O
menstrual	JJ	amod	O
cycle	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
contain	VBP	ccomp	O
type	NN	compound	O
II	CD	nummod	B-protein
estrogen	NN	compound	I-protein
binding	NN	compound	I-protein
sites	NNS	dobj	I-protein
(	-LRB-	punct	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
EBS	NNS	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
fluctuations	NNS	nsubjpass	O
of	IN	case	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
EBS	NNS	nmod	I-protein
during	IN	case	O
the	DT	det	O
menstrual	JJ	amod	O
cycle	NN	nmod	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
6	CD	nummod	O
normally	RB	advmod	O
menstruating	VBG	amod	O
women	NNS	nmod	O
.	.	punct	O

Approximately	RB	advmod	O
3	CD	nummod	O
times	NNS	nummod	O
higher	JJR	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
EBS	NNS	nmod	I-protein
were	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
periovulatory	JJ	amod	O
period	NN	nmod	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
both	CC	cc:preconj	O
follicular	JJ	amod	O
and	CC	cc	O
luteal	JJ	conj	O
phases	NNS	nmod	O
.	.	punct	O

In	IN	case	O
postmenopausal	JJ	amod	O
women	NNS	nmod	O
the	DT	det	O
mean	NN	amod	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
EBS	NNS	compound	I-protein
levels	NNS	nsubj	O
were	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
observed	VBN	acl	O
in	IN	case	O
the	DT	det	O
follicular	JJ	amod	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cycle	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
3	CD	nummod	O
postmenopausal	JJ	amod	O
patients	NNS	nmod	O
a	DT	det	O
short	JJ	amod	O
course	NN	nsubj	O
of	IN	case	O
estrogen	NN	nmod	O
or	CC	cc	O
tamoxifen	NN	conj	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
marked	JJ	amod	O
increase	NN	nmod	O
of	IN	case	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
EBS	NNS	compound	I-protein
levels	NNS	nmod	O
.	.	punct	O

Tamoxifen	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
compete	VB	xcomp	O
with	IN	case	O
17	CD	nummod	O
beta-estradiol	NN	nmod	O
for	IN	case	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
EBS	NNS	nmod	I-protein
in	IN	case	O
PBMC	NN	nmod	B-cell_type
,	,	punct	O
although	IN	mark	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	advcl	O
than	IN	case	O
diethylstilbestrol	NN	nmod	O
.	.	punct	O

Mononuclear	JJ	amod	B-cell_type
leukocyte	NN	compound	I-cell_type
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
binding	NN	compound	O
characteristics	NNS	ROOT	O
and	CC	cc	O
down-regulation	NN	conj	O
in	IN	case	O
major	JJ	amod	O
depression	NN	nmod	O
.	.	punct	O

Some	DT	det	O
patients	NNS	nsubj	O
with	IN	case	O
major	JJ	amod	O
depressive	JJ	amod	O
disorder	NN	nmod	O
(	-LRB-	punct	O
MDD	NN	appos	O
)	-RRB-	punct	O
have	VBP	ROOT	O
elevated	JJ	amod	O
plasma	NN	compound	O
cortisol	NN	compound	O
concentrations	NNS	dobj	O
and	CC	cc	O
show	VBP	conj	O
failure	NN	dobj	O
to	TO	mark	O
suppress	VB	acl	O
cortisol	NN	compound	O
secretion	NN	dobj	O
upon	IN	case	O
administration	NN	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
DEX	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
yet	CC	advmod	O
they	PRP	nsubj	O
do	VBP	aux	O
not	RB	neg	O
have	VB	conj	O
Cushingoid	JJ	amod	O
features	NNS	dobj	O
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
whether	IN	mark	O
this	DT	nsubj	O
represents	VBZ	ccomp	O
glucocorticoid	NN	compound	O
(	-LRB-	punct	O
GC	NN	appos	O
)	-RRB-	punct	O
resistance	NN	dobj	O
,	,	punct	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-DEX-binding	NN	amod	O
assays	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
measure	VB	xcomp	O
,	,	punct	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
the	DT	det	O
GC	NN	compound	B-protein
receptor	NN	compound	I-protein
affinity	NN	appos	O
(	-LRB-	punct	O
1/Kd	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
number	NN	conj	O
(	-LRB-	punct	O
Bmax	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
of	IN	case	O
11	CD	nummod	O
MDD	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
15	CD	nummod	O
control	JJ	amod	O
subjects	NNS	conj	O
.	.	punct	O

No	DT	neg	O
receptor	NN	compound	O
abnormalities	NNS	nsubjpass	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
MDD	NN	compound	O
group	NN	nmod	O
;	:	punct	O
thus	RB	advmod	O
any	DT	det	O
cellular	JJ	amod	O
defect	NN	dep	O
leading	VBG	acl	O
to	TO	case	O
a	DT	det	O
lack	NN	nmod	O
of	IN	case	O
responsiveness	NN	nmod	O
to	TO	case	O
GC	NN	nmod	O
in	IN	case	O
the	DT	det	O
MDD	NN	compound	O
patients	NNS	nmod	O
,	,	punct	O
if	IN	mark	O
present	JJ	advcl	O
,	,	punct	O
probably	RB	advmod	O
lies	VBZ	parataxis	O
beyond	IN	case	O
the	DT	det	O
initial	JJ	amod	O
receptor	NN	compound	O
binding	NN	nmod	O
.	.	punct	O

DEX	NN	nsubjpass	O
(	-LRB-	punct	O
1.0	CD	nummod	O
mg	NN	appos	O
orally	RB	advmod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
administered	VBN	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
in	FW	amod	O
vivo	FW	dep	B-protein
GC	NN	compound	I-protein
receptor	NN	compound	I-protein
down-regulation	NN	dobj	O
.	.	punct	O

Compared	VBN	case	O
to	TO	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
,	,	punct	O
fewer	JJR	amod	O
depressed	JJ	amod	O
subjects	NNS	nsubj	O
down-regulated	VBD	ROOT	O
Bmax	NN	dobj	O
after	IN	case	O
DEX	NN	nmod	O
.	.	punct	O

By	IN	case	O
paired	JJ	amod	O
t-test	NN	nmod	O
,	,	punct	O
Bmax	NN	nsubj	O
decreased	VBD	ROOT	O
significantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
the	DT	det	O
depressed	JJ	amod	O
group	NN	conj	O
.	.	punct	O

Receptor	NN	compound	O
number	NN	nsubj	O
on	IN	case	O
the	DT	det	O
control	JJ	compound	O
day	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
correlate	VB	ROOT	O
significantly	RB	advmod	O
with	IN	case	O
the	DT	det	O
degree	NN	nmod	O
of	IN	case	O
receptor	NN	compound	O
down-regulation	NN	nmod	O
,	,	punct	O
severity	NN	dobj	O
of	IN	case	O
depression	NN	nmod	O
or	CC	cc	O
cortisol	NN	compound	O
concentrations	NNS	conj	O
across	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
subjects	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
do	VBP	aux	O
not	RB	neg	O
lend	VB	ROOT	O
support	NN	dobj	O
to	TO	case	O
previous	JJ	amod	O
reports	NNS	nmod	O
suggesting	VBG	acl	O
that	IN	mark	O
GC	NN	compound	O
resistance	NN	nsubj	O
in	IN	case	O
MDD	NN	nmod	O
results	VBZ	ccomp	O
from	IN	case	O
a	DT	det	O
GC	NN	compound	O
receptor-binding	JJ	amod	O
abnormality	NN	nmod	O
,	,	punct	O
and	CC	cc	O
they	PRP	nsubj	O
emphasize	VBP	conj	O
the	DT	det	O
importance	NN	dobj	O
of	IN	mark	O
considering	VBG	acl	O
receptor	NN	compound	O
studies	NNS	dobj	O
in	IN	case	O
the	DT	det	O
context	NN	nmod	O
of	IN	case	O
GC-mediated	JJ	amod	O
cell	NN	compound	O
processes	NNS	nmod	O
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
identify	VB	advcl	O
the	DT	det	O
exact	JJ	amod	O
cellular	JJ	amod	O
defect	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
leading	VBG	acl	O
to	TO	case	O
GC	NN	compound	O
resistance	NN	nmod	O
.	.	punct	O

Ras-related	JJ	amod	B-protein
GTP-binding	JJ	amod	I-protein
proteins	NNS	ROOT	I-protein
and	CC	cc	O
leukocyte	NN	compound	B-cell_type
signal	NN	compound	O
transduction	NN	conj	O
.	.	punct	O

Many	JJ	amod	O
aspects	NNS	nsubjpass	O
of	IN	case	O
leukocyte	NN	compound	B-cell_type
function	NN	nmod	O
are	VBP	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
both	CC	cc:preconj	O
heterotrimeric	JJ	amod	B-protein
and	CC	cc	O
Ras-related	JJ	conj	B-protein
GTP-binding	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
but	CC	cc	O
there	EX	expl	O
is	VBZ	conj	O
little	JJ	amod	O
definite	JJ	compound	O
information	NN	nsubj	O
about	IN	case	O
their	PRP$	nmod:poss	O
roles	NNS	nmod	O
in	IN	case	O
the	DT	det	O
specialized	VBN	amod	O
processes	NNS	nmod	O
utilized	VBN	acl	O
by	IN	case	O
leukocytes	NNS	nmod	B-cell_type
for	IN	case	O
cell	NN	compound	O
killing	NN	nmod	O
.	.	punct	O

Recent	JJ	amod	O
progress	NN	nsubj	O
in	IN	mark	O
understanding	VBG	acl	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
phagocyte	NN	compound	B-protein
NADPH	NN	compound	I-protein
oxidase	NN	nmod	I-protein
by	IN	case	O
the	DT	det	O
Rac	NN	compound	B-protein
GTP-binding	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
provides	VBZ	ROOT	O
a	DT	det	O
basis	NN	dobj	O
for	IN	mark	O
defining	VBG	acl	O
the	DT	det	O
operational	JJ	amod	O
characteristics	NNS	dobj	O
of	IN	prep	O
one	CD	nummod	O
such	JJ	amod	O
phagocyte	NN	compound	O
system	NN	pobj	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
clear	JJ	ROOT	O
from	IN	case	O
various	JJ	amod	O
studies	NNS	nmod	O
that	IN	mark	O
the	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
NADPH	NN	compound	B-protein
oxidase	NN	nmod	I-protein
can	MD	aux	O
be	VB	auxpass	O
modulated	VBN	ccomp	O
through	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
GTP-GDP	NN	compound	O
state	NN	nmod	O
of	IN	case	O
Rac	NN	nmod	B-protein
.	.	punct	O

Proteins	NNS	nsubj	O
exist	VBP	ROOT	O
in	IN	case	O
leukocytes	NNS	nmod	B-cell_type
able	JJ	amod	O
to	TO	mark	O
modify	VB	xcomp	O
GTP-binding	JJ	amod	B-protein
protein	NN	compound	I-protein
function	NN	dobj	O
in	IN	case	O
this	DT	det	O
manner	NN	nmod	O
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
activity	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
regulated	VBN	conj	O
by	IN	case	O
signals	NNS	nmod	O
generated	VBN	acl	O
on	IN	case	O
phagocyte	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Proteins	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
Ras	NN	compound	B-protein
superfamily	NN	nmod	I-protein
are	VBP	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
phagocyte	NN	compound	O
functions	NNS	nmod	O
through	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
modulate	VB	acl	O
the	DT	det	O
assembly	NN	dobj	O
of	IN	case	O
actin	NN	compound	B-protein
filaments	NNS	nmod	I-protein
,	,	punct	O
direct	JJ	amod	O
vesicle	NN	compound	O
trafficking	NN	conj	O
and	CC	cc	O
fusion	NN	conj	O
,	,	punct	O
and	CC	cc	O
so	RB	advmod	O
forth	RB	advmod	O
.	.	punct	O

BSAP	NN	ROOT	B-protein
:	:	punct	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	appos	O
of	IN	case	O
B-cell	NN	compound	B-cell_type
development	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

B-cell-specific	JJ	amod	B-protein
activator	NN	compound	I-protein
protein	NN	nsubj	I-protein
(	-LRB-	punct	O
BSAP	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
recently	RB	advmod	O
identified	VBN	amod	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Pax-gene	NN	amod	B-DNA
family	NN	nmod	I-DNA
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
;	:	punct	O
in	IN	case	O
the	DT	det	O
lymphoid	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
BSAP	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
produced	VBN	parataxis	O
only	RB	advmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
Markus	NNP	compound	O
Neurath	NNP	nsubj	O
,	,	punct	O
Eckhard	NNP	compound	O
Stuber	NNP	conj	O
and	CC	cc	O
Warren	NNP	compound	O
Strober	NNP	conj	O
describe	VBP	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
structure	NN	dobj	O
of	IN	case	O
BSAP	NN	nmod	B-protein
and	CC	cc	O
focus	VBP	conj	O
on	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
to	TO	mark	O
regulate	VB	acl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
B-cell-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

They	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
BSAP	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
key	JJ	amod	B-protein
protein	NN	ccomp	I-protein
of	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
that	IN	mark	O
it	PRP	nsubj	O
not	RB	neg	O
only	RB	cc:preconj	O
influence	VBP	conj	O
B-cell	NN	compound	O
development	NN	dobj	O
but	CC	cc	O
also	RB	advmod	O
influences	VBZ	conj	O
the	DT	det	O
balance	NN	dobj	O
between	IN	case	O
B-cell	NN	compound	O
proliferation	NN	nmod	O
and	CC	cc	O
immunoglobulin	NN	compound	B-protein
secretion	NN	conj	O
at	IN	case	O
later	JJR	amod	O
stages	NNS	nmod	O
of	IN	case	O
B-cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

Down-regulation	NN	ROOT	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
protein	NN	compound	I-protein
levels	NNS	nmod	O
in	IN	case	O
activated	VBN	amod	O
human	JJ	amod	O
lymphocytes	NNS	nmod	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
[	-LRB-	punct	O
published	VBN	amod	O
erratum	NN	nsubj	O
appears	VBZ	dep	O
in	IN	case	O
Proc	NNP	compound	O
Natl	NNP	compound	O
Acad	NNP	compound	O
Sci	NNP	compound	O
U	NNP	compound	O
S	NNP	compound	O
A	NNP	compound	O
1996	CD	nummod	O
Jan	NNP	nmod	O
9	CD	nummod	O
;	:	punct	O
93	CD	nummod	O
(	-LRB-	punct	O
1	CD	appos	O
)	-RRB-	punct	O
:	:	punct	O
524	CD	nummod	O
]	-RRB-	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
[	-LRB-	punct	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
D3	NN	appos	O
]	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
steroid	NN	compound	O
hormone	NN	appos	O
with	IN	case	O
immunomodulating	JJ	amod	O
properties	NNS	nmod	O
,	,	punct	O
on	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
proteins	NNS	nmod	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
in	FW	amod	B-cell_line
vitro	FW	dep	I-cell_line
activated	VBN	amod	I-cell_line
normal	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Over	IN	case	O
a	DT	det	O
72-hr	JJ	amod	O
period	NN	nmod	O
of	IN	case	O
activation	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
50-kDa	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
,	,	punct	O
p50	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
precursor	NN	conj	O
,	,	punct	O
p105	NN	appos	B-protein
,	,	punct	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
progressively	RB	advmod	O
.	.	punct	O

When	WRB	advmod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
activated	VBN	advcl	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
,	,	punct	O
the	DT	det	O
levels	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
mature	JJ	amod	O
protein	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
its	PRP$	nmod:poss	O
precursor	NN	conj	O
were	VBD	auxpass	O
decreased	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hormone	NN	nmod	O
on	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
p50	NN	nmod	B-protein
was	VBD	cop	O
demonstrable	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
cytosolic	JJ	amod	O
and	CC	cc	O
nuclear	JJ	conj	O
compartments	NNS	nmod	O
;	:	punct	O
it	PRP	nsubj	O
required	VBD	parataxis	O
between	IN	case	O
4	CD	nummod	O
and	CC	cc	O
8	CD	conj	O
hr	NN	nmod	O
and	CC	cc	O
was	VBD	cop	O
specific	JJ	conj	O
,	,	punct	O
as	IN	mark	O
25-hydroxyvitamin	NN	compound	O
D3	NN	nsubj	O
and	CC	cc	O
24	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	conj	O
were	VBD	cop	O
ineffective	JJ	advcl	O
.	.	punct	O

Besides	IN	case	O
p50	NN	nmod	B-protein
,	,	punct	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
decreased	VBD	ROOT	O
the	DT	det	O
levels	NNS	dobj	O
of	IN	case	O
another	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
protein	NN	nmod	I-protein
,	,	punct	O
namely	RB	advmod	O
c-rel	NN	appos	B-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
decreased	VBD	ROOT	O
the	DT	det	O
abundance	NN	dobj	O
of	IN	case	O
a	DT	det	O
specific	JJ	amod	B-protein
DNA-protein	JJ	amod	I-protein
complex	NN	nmod	I-protein
formed	VBN	acl	O
upon	IN	case	O
incubation	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
activated	VBN	amod	O
lymphocytes	NNS	nmod	O
with	IN	case	O
a	DT	det	O
labeled	VBN	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
DNA	NN	compound	I-protein
binding	NN	compound	I-protein
motif	NN	nmod	I-protein
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
inhibited	VBD	ROOT	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
transiently	RB	advmod	O
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
construct	NN	nmod	B-DNA
containing	VBG	acl	O
four	CD	nummod	O
tandem	JJ	amod	B-DNA
repeats	NNS	dobj	I-DNA
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
binding	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
kappa	NN	compound	I-DNA
light	JJ	amod	I-DNA
chain	NN	compound	I-DNA
gene	NN	nmod	I-DNA
linked	VBN	acl	O
to	TO	case	O
the	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
demonstrate	VBP	ROOT	O
directly	RB	advmod	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
de	FW	amod	O
novo	FW	dep	O
synthesis	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
during	IN	case	O
human	JJ	amod	O
lymphocyte	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
this	DT	det	O
process	NN	nsubjpass	O
is	VBZ	auxpass	O
hormonally	RB	advmod	O
regulated	VBN	ccomp	O
.	.	punct	O

The	DT	det	O
myeloid	JJ	amod	B-DNA
zinc	NN	compound	I-DNA
finger	NN	compound	I-DNA
gene	NN	nsubj	I-DNA
,	,	punct	O
MZF-1	NN	appos	B-DNA
,	,	punct	O
regulates	VBZ	ROOT	O
the	DT	det	O
CD34	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

MZF-1	NN	nsubj	B-DNA
is	VBZ	cop	O
a	DT	det	O
C2H2	NN	compound	B-DNA
zinc	NN	compound	I-DNA
finger	NN	compound	I-DNA
gene	NN	ROOT	I-DNA
encoding	VBG	acl	O
a	DT	det	O
putative	JJ	amod	B-protein
transcriptional	JJ	amod	I-protein
regulator	NN	dobj	I-protein
of	IN	case	O
myeloid	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

The	DT	det	O
MZF-1	NN	compound	B-DNA
protein	NN	nsubj	O
contains	VBZ	ROOT	O
13	CD	nummod	O
C2H2	NN	compound	B-protein
zinc	NN	compound	I-protein
fingers	NNS	dobj	I-protein
arranged	VBN	acl	O
in	IN	case	O
bipartite	JJ	amod	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
domains	NNS	nmod	I-protein
containing	VBG	acl	O
zinc	NN	compound	B-protein
fingers	NNS	dobj	I-protein
through	IN	case	O
4	CD	nmod	O
and	CC	cc	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
carboxy-terminus	NN	nmod	B-protein
,	,	punct	O
5	CD	npadvmod	O
through	IN	case	O
13	CD	nmod	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
identified	VBD	ROOT	O
the	DT	det	O
DNA	NN	compound	B-DNA
consensus	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
recognized	VBN	acl	O
by	IN	case	O
the	DT	det	O
two	CD	nummod	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
domains	NNS	nmod	I-protein
.	.	punct	O

To	TO	mark	O
assess	VB	advcl	O
the	DT	det	O
transcription	NN	compound	O
regulatory	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
MZF-1	NN	nmod	B-DNA
,	,	punct	O
the	DT	det	O
full-length	JJ	amod	O
MZF-1	NN	compound	B-DNA
coding	NN	compound	O
region	NN	nsubjpass	O
was	VBD	auxpass	O
fused	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
yeast	NN	compound	B-protein
transactivator	NN	compound	I-protein
GAL4	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
expression	NN	compound	O
vector	NN	nsubjpass	O
was	VBD	auxpass	O
cotransfected	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyl	NN	compound	I-DNA
transferase	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CAT	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
regulated	VBN	acl	O
by	IN	case	O
the	DT	det	O
thymidine	NN	compound	B-DNA
kinase	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
containing	VBG	acl	O
GAL4	NN	compound	B-DNA
DNA	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
into	IN	case	O
NIH	NN	compound	B-cell_line
3T3	NN	nmod	I-cell_line
,	,	punct	O
293	CD	conj	B-cell_line
,	,	punct	O
K562	NN	conj	B-cell_line
,	,	punct	O
and	CC	cc	O
Jurkat	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

MZF-1	NN	nsubj	B-DNA
represses	VBZ	ROOT	O
CAT	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
via	IN	case	O
GAL4	NN	compound	B-protein
binding	NN	compound	O
sites	NNS	nmod	O
in	IN	case	O
the	DT	det	O
nonhematopoietic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
NIH	NN	compound	B-cell_line
3T3	NN	dep	I-cell_line
and	CC	cc	O
293	CD	conj	B-cell_line
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
MZF-1	NN	nsubj	B-DNA
activates	VBZ	ROOT	O
CAT	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
in	IN	case	O
the	DT	det	O
hematopoietic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
K562	NN	dep	B-cell_line
and	CC	cc	O
Jurkat	NN	conj	B-cell_line
.	.	punct	O

The	DT	det	O
MZF-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nsubj	I-DNA
are	VBP	cop	O
present	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
promoters	NNS	nmod	B-DNA
of	IN	case	O
several	JJ	amod	O
genes	NNS	nmod	B-DNA
expressed	VBN	acl	O
during	IN	case	O
myeloid	JJ	amod	O
differentiation	NN	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
CD34	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

MZF-1	NN	compound	B-DNA
transcriptional	JJ	amod	O
regulation	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
physiologically	RB	advmod	B-DNA
relevant	JJ	amod	I-DNA
promoter	NN	nmod	I-DNA
was	VBD	auxpass	O
assessed	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
hematopoietic	JJ	nmod	B-cell_line
and	CC	cc	O
nonhematopoietic	JJ	conj	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dep	I-cell_line
.	.	punct	O

Recombinant	JJ	amod	B-protein
MZF-1	NN	compound	I-protein
protein	NN	nsubj	I-protein
specifically	RB	advmod	O
binds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
consensus	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
CD34	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

MZF-1	NN	compound	B-DNA
expression	NN	compound	O
vectors	NNS	nsubjpass	O
were	VBD	auxpass	O
cotransfected	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
luciferase	NN	compound	B-DNA
reporter	NN	compound	I-DNA
plasmids	NNS	nmod	I-DNA
regulated	VBN	acl	O
by	IN	case	O
the	DT	det	O
CD34	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
into	IN	case	O
both	CC	cc:preconj	O
nonhematopoietic	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
hematopoietic	JJ	conj	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

As	IN	case	O
with	IN	case	O
the	DT	det	O
heterologous	JJ	amod	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
,	,	punct	O
MZF-1	NN	nsubj	B-DNA
represses	VBZ	ROOT	O
reporter	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
in	IN	case	O
nonhematopoietic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
activates	VBZ	conj	O
expression	NN	dobj	O
in	IN	case	O
hematopoietic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
CD34	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
hematopoietic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
intact	JJ	amod	O
MZF-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
cell	NN	nmod:npmod	O
type-specific	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
CD34	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
by	IN	case	O
MZF-1	NN	nmod	B-DNA
suggests	VBZ	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
tissue-specific	JJ	amod	O
regulators/adapters	NNS	nmod	O
or	CC	cc	O
differential	JJ	amod	O
MZF-1	NN	compound	B-DNA
modifications	NNS	conj	O
that	WDT	nsubj	O
determine	VBP	acl:relcl	O
MZF-1	NN	compound	B-DNA
transcriptional	JJ	amod	O
regulatory	JJ	amod	O
function	NN	dobj	O
.	.	punct	O

The	DT	det	O
murine	JJ	amod	O
BCL6	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
activated	VBN	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
as	IN	case	O
an	DT	det	O
immediate	JJ	amod	B-DNA
early	JJ	amod	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
chromosomal	JJ	amod	O
translocation	NN	nsubjpass	O
involving	VBG	acl	O
3q27	NN	dobj	B-DNA
is	VBZ	auxpass	O
often	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
B-cell	NN	compound	I-cell_type
lymphomas	NNS	nmod	I-cell_type
,	,	punct	O
especially	RB	advmod	O
diffuse	JJ	amod	O
lymphomas	NNS	nmod	O
with	IN	case	O
a	DT	det	O
large-cell	JJ	amod	O
component	NN	nmod	O
.	.	punct	O

The	DT	det	O
BCL6	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
has	VBZ	aux	O
been	VBN	auxpass	O
isolated	VBN	ROOT	O
from	IN	case	O
the	DT	det	O
chromosomal	JJ	amod	O
breakpoint	NN	nmod	O
in	IN	case	O
these	DT	det	O
lymphomas	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
cloned	VBD	ROOT	O
the	DT	det	O
murine	JJ	amod	B-DNA
BCL6	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
mBCL6	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
cDNA	NN	dobj	I-DNA
from	IN	case	O
the	DT	det	O
muscle	NN	compound	B-DNA
cDNA	NN	compound	I-DNA
library	NN	nmod	I-DNA
using	VBG	acl	O
the	DT	det	O
human	JJ	amod	B-DNA
BCL6	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
hBCL6	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
cDNA	NN	dobj	I-DNA
as	IN	case	O
a	DT	det	O
probe	NN	nmod	O
.	.	punct	O

The	DT	det	O
predicted	VBN	amod	O
amino	NN	compound	O
acid	NN	compound	O
sequence	NN	nsubj	O
was	VBD	cop	O
95	CD	nummod	O
%	NN	nmod:npmod	O
identical	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
hBCL6	NN	nmod	B-protein
.	.	punct	O

It	PRP	nsubj	O
contains	VBZ	ROOT	O
six	CD	nummod	O
repeats	NNS	dobj	O
of	IN	case	O
the	DT	det	O
Kruppel-like	JJ	amod	B-protein
zinc-finger	JJ	amod	I-protein
motif	NN	nmod	I-protein
that	WDT	nsubj	O
are	VBP	cop	O
completely	RB	advmod	O
identical	JJ	acl:relcl	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
hBCL6	NN	nmod	B-protein
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
BCL6	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
well	RB	advmod	O
conserved	VBN	ccomp	O
between	IN	case	O
humans	NNS	nmod	O
and	CC	cc	O
mice	NNS	conj	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
mBCL6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
ubiquitously	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
adult	JJ	amod	O
mouse	NN	compound	O
tissues	NNS	nmod	O
including	VBG	case	O
lymphatic	JJ	amod	O
organs	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
activated	VBN	acl	O
with	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
and	CC	cc	O
Ca2+	NN	compound	O
ionophore	NN	conj	O
within	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
after	IN	case	O
stimulation	NN	nmod	O
.	.	punct	O

This	DT	det	O
induction	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
inhibited	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
a	DT	det	O
protein	NN	compound	O
synthesis	NN	compound	O
inhibitor	NN	nmod	O
,	,	punct	O
cycloheximide	NN	appos	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
BCL6	NN	nsubj	B-protein
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
as	IN	case	O
an	DT	det	O
immediate	JJ	amod	O
early	JJ	amod	O
gene	NN	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
BSAP	NN	nmod	B-protein
(	-LRB-	punct	O
Pax-5	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
B-cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

The	DT	det	O
hierarchy	NN	nsubjpass	O
of	IN	case	O
transcriptional	JJ	amod	O
control	NN	nmod	O
in	IN	case	O
B-cell	NN	compound	O
development	NN	nmod	O
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
analyzed	VBN	ROOT	O
by	IN	case	O
targeted	VBN	amod	O
gene	NN	compound	O
inactivation	NN	nmod	O
in	IN	case	O
the	DT	det	O
mouse	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
manner	NN	nmod	O
,	,	punct	O
the	DT	det	O
paired	JJ	amod	B-DNA
box	NN	compound	I-DNA
containing	VBG	compound	I-DNA
gene	NN	compound	I-DNA
Pax-5	NN	nsubjpass	B-DNA
,	,	punct	O
encoding	VBG	acl	O
the	DT	det	O
B	NN	compound	B-protein
cell	NN	compound	I-protein
specific	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
BSAP	NN	dobj	B-protein
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
early	JJ	amod	O
B	NN	compound	O
lymphopoiesis	NN	nmod	O
.	.	punct	O

Other	JJ	amod	O
experimental	JJ	amod	O
strategies	NNS	nsubj	O
have	VBP	aux	O
implicated	VBN	ROOT	O
BSAP	NN	dobj	B-protein
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
isotype	NN	compound	O
switching	NN	conj	O
and	CC	cc	O
transcription	NN	conj	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-protein
heavy-chain	JJ	amod	I-protein
gene	NN	nmod	O
at	IN	case	O
late	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
B-cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

The	DT	det	O
DNA-binding	JJ	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
two	CD	nummod	B-protein
heat	NN	compound	I-protein
shock	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
HSF1	NN	appos	B-protein
and	CC	cc	O
HSF3	NN	conj	B-protein
,	,	punct	O
are	VBP	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
avian	JJ	amod	B-cell_line
erythroblast	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
HD6	NN	nmod	B-cell_line
.	.	punct	O

Avian	JJ	amod	O
cells	NNS	nsubj	O
express	VBP	ROOT	O
three	CD	nummod	O
heat	NN	compound	B-DNA
shock	NN	compound	I-DNA
transcription	NN	compound	I-DNA
factor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
HSF	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
genes	NNS	dobj	I-DNA
corresponding	VBG	acl	O
to	TO	case	O
a	DT	det	O
novel	JJ	amod	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
HSF3	NN	appos	B-protein
,	,	punct	O
and	CC	cc	O
homologs	NNS	conj	O
of	IN	case	O
mouse	NN	nmod	O
and	CC	cc	O
human	JJ	conj	O
HSF1	NN	dep	B-protein
and	CC	cc	O
HSF2	NN	conj	B-protein
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	dep	O
biochemical	JJ	nmod	O
and	CC	cc	O
cell	NN	nmod:npmod	O
biological	JJ	conj	O
properties	NNS	dep	O
of	IN	case	O
these	DT	det	O
HSFs	NNS	nmod	B-protein
reveals	VBZ	ROOT	O
that	IN	mark	O
HSF3	NN	nsubj	B-protein
has	VBZ	ccomp	O
properties	NNS	dobj	O
in	IN	case	O
common	JJ	nmod	O
with	IN	case	O
both	CC	cc:preconj	O
HSF1	NN	nmod	B-protein
and	CC	cc	O
HSF2	NN	conj	B-protein
and	CC	cc	O
yet	RB	advmod	O
has	VBZ	conj	O
features	NNS	dobj	O
which	WDT	nsubj	O
are	VBP	cop	O
distinct	JJ	acl:relcl	O
from	IN	case	O
both	DT	nmod	O
.	.	punct	O

HSF3	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
constitutively	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
erythroblast	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
HD6	NN	nmod	I-cell_line
,	,	punct	O
the	DT	det	O
lymphoblast	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
MSB	NN	appos	I-cell_line
,	,	punct	O
and	CC	cc	O
embryo	NN	compound	B-cell_line
fibroblasts	NNS	conj	I-cell_line
,	,	punct	O
and	CC	cc	O
yet	RB	advmod	O
its	PRP$	nmod:poss	O
DNA-binding	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	conj	O
only	RB	advmod	O
upon	IN	case	O
exposure	NN	nmod	O
of	IN	case	O
HD6	NN	compound	O
cells	NNS	nmod	O
to	TO	case	O
heat	NN	compound	O
shock	NN	nmod	O
.	.	punct	O

Acquisition	NN	nsubjpass	O
of	IN	case	O
HSF3	NN	compound	B-protein
DNA-binding	JJ	amod	O
activity	NN	nmod	O
in	IN	case	O
HD6	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
oligomerization	NN	nmod	O
from	IN	case	O
a	DT	det	O
non-DNA-binding	JJ	amod	B-protein
dimer	NN	nmod	I-protein
to	TO	case	O
a	DT	det	O
DNA-binding	JJ	amod	B-protein
trimer	NN	nmod	I-protein
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
on	IN	case	O
HSF1	NN	nmod	B-protein
is	VBZ	cop	O
oligomerization	NN	parataxis	O
of	IN	case	O
an	DT	det	O
inert	JJ	amod	B-protein
monomer	NN	nmod	I-protein
to	TO	case	O
a	DT	det	O
DNA-binding	JJ	amod	B-protein
trimer	NN	nmod	I-protein
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
HSF3	NN	compound	B-protein
DNA-binding	JJ	amod	O
activity	NN	nmod	O
is	VBZ	auxpass	O
delayed	VBN	ROOT	O
compared	VBN	case	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
HSF1	NN	nmod	B-protein
.	.	punct	O

As	IN	mark	O
occurs	VBZ	advcl	O
for	IN	case	O
HSF1	NN	nmod	B-protein
,	,	punct	O
heat	NN	compound	O
shock	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
translocation	NN	nmod	O
of	IN	case	O
HSF3	NN	nmod	B-protein
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

HSF	NN	nsubj	O
exhibits	VBZ	ROOT	O
the	DT	det	O
properties	NNS	dobj	O
of	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	B-protein
activator	NN	nmod	I-protein
,	,	punct	O
as	IN	mark	O
judged	VBN	advcl	O
from	IN	case	O
the	DT	det	O
stimulatory	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
transiently	RB	advmod	B-protein
overexpressed	VBN	amod	I-protein
HSF3	NN	nmod	I-protein
measured	VBN	acl	O
by	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
heat	NN	compound	B-DNA
shock	NN	compound	I-DNA
element-containing	JJ	amod	I-DNA
reporter	NN	compound	I-DNA
construct	NN	dobj	I-DNA
and	CC	cc	O
as	IN	advmod	O
independently	RB	advmod	O
assayed	VBN	conj	O
by	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
a	DT	det	O
chimeric	JJ	amod	B-protein
GAL4-HSF3	NN	compound	I-protein
protein	NN	nmod	I-protein
on	IN	case	O
a	DT	det	O
GAL4	NN	compound	B-DNA
reporter	NN	compound	I-DNA
construct	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
reveal	VBP	ROOT	O
that	IN	mark	O
HSF3	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
negatively	RB	advmod	O
regulated	VBN	ccomp	O
in	IN	case	O
avian	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
acquires	VBZ	conj	O
DNA-binding	JJ	amod	O
activity	NN	dobj	O
in	IN	case	O
certain	JJ	amod	O
cells	NNS	nmod	O
upon	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
.	.	punct	O

Direct	JJ	amod	O
demonstration	NN	ROOT	O
of	IN	case	O
NFATp	NN	compound	B-protein
dephosphorylation	NN	nmod	O
and	CC	cc	O
nuclear	JJ	amod	O
localization	NN	conj	O
in	IN	case	O
activated	VBN	amod	B-cell_line
HT-2	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
using	VBG	acl	O
a	DT	det	O
specific	JJ	amod	O
NFATp	NN	compound	B-protein
polyclonal	JJ	amod	I-protein
antibody	NN	dobj	I-protein
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nsubj	I-protein
(	-LRB-	punct	O
NFAT	NN	appos	B-protein
)	-RRB-	punct	O
regulates	VBZ	ROOT	O
transcription	NN	dobj	O
of	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-protein
genes	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
NFAT	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
stimulated	VBN	parataxis	O
following	VBG	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Several	JJ	amod	O
lines	NNS	nsubj	O
of	IN	case	O
evidence	NN	nmod	O
have	VBP	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
NFAT	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
substrate	NN	ccomp	O
for	IN	case	O
calcineurin	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
serine/threonine	NN	compound	B-protein
phosphatase	NN	appos	I-protein
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
polyclonal	JJ	amod	O
antibody	NN	dobj	O
to	TO	case	O
murine	JJ	amod	B-protein
NFATp	NN	nmod	I-protein
,	,	punct	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
various	JJ	amod	O
mouse	NN	compound	O
tissues	NNS	nmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
110-130-kDa	JJ	amod	O
NFATp	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
highly	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
thymus	NN	nmod	O
and	CC	cc	O
spleen	NN	conj	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
immunoprecipitated	VBN	amod	O
NFATp	NN	nmod	B-protein
from	IN	case	O
untreated	JJ	amod	O
HT-2	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
calcineurin	NN	nmod	B-protein
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
dephosphorylation	NN	nmod	O
of	IN	case	O
NFATp	NN	nmod	B-protein
,	,	punct	O
demonstrating	VBG	xcomp	O
that	IN	mark	O
NFATp	NN	nsubj	B-protein
is	VBZ	cop	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
substrate	NN	ccomp	O
for	IN	case	O
calcineurin	NN	nmod	B-protein
.	.	punct	O

NFATp	NN	nsubj	B-protein
immunoprecipitated	VBN	acl	O
from	IN	case	O
32P-labeled	JJ	amod	B-cell_line
HT-2	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
migrated	VBD	ROOT	O
as	IN	case	O
an	DT	det	O
approximately	RB	advmod	O
120-kDa	JJ	amod	O
protein	NN	nmod	O
that	WDT	nsubj	O
was	VBD	cop	O
localized	JJ	acl:relcl	O
to	TO	case	O
the	DT	det	O
cytosol	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
ionomycin	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
weight	NN	nmod	O
of	IN	case	O
NFATp	NN	nmod	B-protein
and	CC	cc	O
a	DT	det	O
loss	NN	conj	O
of	IN	case	O
32P	NN	nmod	O
,	,	punct	O
consistent	JJ	xcomp	O
with	IN	case	O
NFATp	NN	compound	B-protein
dephosphorylation	NN	nmod	O
.	.	punct	O

The	DT	det	O
dephosphorylation	NN	nsubjpass	O
of	IN	case	O
NFATp	NN	nmod	B-protein
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
localization	NN	nmod	O
of	IN	case	O
the	DT	det	O
protein	NN	nmod	O
to	TO	case	O
the	DT	det	O
nuclear	JJ	amod	O
fraction	NN	nmod	O
.	.	punct	O

Both	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
events	NNS	nmod	O
were	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
preincubation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
FK506	NN	nmod	O
,	,	punct	O
a	DT	det	O
calcineurin	NN	compound	B-protein
inhibitor	NN	appos	O
,	,	punct	O
consistent	JJ	advcl	O
with	IN	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
NFATp	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
calcineurin	NN	compound	B-protein
substrate	NN	ccomp	O
in	IN	case	O
cells	NNS	nmod	O
.	.	punct	O

Activation	NN	ROOT	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factors	NNS	nmod	I-protein
of	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
NFATp	NN	dep	B-protein
and	CC	cc	O
NFATc	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
human	JJ	amod	B-cell_type
natural	JJ	amod	I-cell_type
killer	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
regulation	NN	dep	O
upon	IN	case	O
CD16	NN	compound	B-protein
ligand	NN	compound	O
binding	NN	nmod	O
.	.	punct	O

The	DT	det	O
putative	JJ	amod	O
factors	NNS	nsubjpass	O
that	WDT	nsubj	O
couple	VBP	acl:relcl	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	dobj	O
from	IN	case	O
surface	NN	compound	O
receptors	NNS	nmod	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-protein
synthesis	NN	nmod	O
in	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NK	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
elucidated	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
NFATp	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
cyclosporin	NN	compound	B-protein
A	NN	compound	I-protein
(	-LRB-	punct	I-protein
CsA	NN	compound	I-protein
)	-RRB-	punct	I-protein
-sensitive	JJ	amod	I-protein
factor	NN	appos	I-protein
that	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
mediates	VBZ	ccomp	O
CD16	NN	compound	B-protein
-induced	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
cytokine	NN	compound	B-protein
genes	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
NK	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

CD16	NN	compound	B-protein
(	-LRB-	punct	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
RIIIA	NN	appos	I-protein
)	-RRB-	punct	O
-induced	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
cytokine	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
occurs	VBZ	ROOT	O
via	IN	case	O
a	DT	det	O
CsA-sensitive	JJ	amod	O
and	CC	cc	O
Ca	NN	conj	O
(	-LRB-	punct	O
2+	NN	amod	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
CD16	NN	compound	B-protein
ligands	NNS	nmod	O
induces	VBZ	ROOT	O
NFAT	NN	compound	B-protein
-like	JJ	amod	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
,	,	punct	O
as	IN	mark	O
detected	VBN	advcl	O
in	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

This	DT	nsubj	O
occurs	VBZ	ROOT	O
with	IN	case	O
fast	JJ	amod	O
kinetics	NNS	nmod	O
after	IN	case	O
stimulation	NN	nmod	O
,	,	punct	O
via	IN	case	O
a	DT	det	O
CsA-sensitive	JJ	amod	O
and	CC	cc	O
Ca	NN	conj	O
(	-LRB-	punct	O
2+	NN	dep	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
mechanism	NN	nmod	O
that	WDT	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
require	VB	acl:relcl	O
de	FW	amod	O
novo	FW	dep	O
protein	NN	compound	O
synthesis	NN	dobj	O
.	.	punct	O

NK	NN	compound	B-protein
cell	NN	compound	I-protein
NFAT	NN	nsubj	I-protein
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
of	IN	case	O
nonstimulated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
migrates	NNS	conj	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
upon	IN	case	O
stimulation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
can	MD	aux	O
associate	VB	conj	O
with	IN	case	O
AP-1	NN	nmod	B-protein
.	.	punct	O

Two	CD	nummod	O
distinct	JJ	amod	O
molecules	NNS	nsubjpass	O
,	,	punct	O
NFATp	NN	appos	B-protein
and	CC	cc	O
NFATc	NN	conj	B-protein
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
mediate	VB	xcomp	O
NFAT	NN	compound	B-protein
activity	NN	dobj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
of	IN	case	O
supershift	NN	compound	O
assays	NNS	nmod	O
using	VBG	acl	O
NFATp-	NN	dobj	B-protein
and	CC	cc	I-protein
NFATc-	JJ	conj	I-protein
specific	JJ	amod	I-protein
antibodies	NNS	dep	I-protein
indicate	VBP	ROOT	O
that	IN	mark	O
NK	NN	compound	O
cell	NN	compound	O
activation	NN	nsubj	O
early	RB	amod	O
after	IN	case	O
CD16	NN	compound	B-protein
ligand	NN	compound	O
binding	NN	nmod	O
involves	VBZ	ccomp	O
primarily	RB	advmod	O
,	,	punct	O
if	IN	mark	O
not	RB	neg	O
exclusively	RB	advmod	O
,	,	punct	O
NFATp	NN	nsubj	B-protein
,	,	punct	O
and	CC	cc	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
shows	VBZ	ccomp	O
that	IN	mark	O
this	DT	nsubj	O
has	VBZ	ccomp	O
the	DT	det	O
same	JJ	amod	O
electrophoretic	JJ	amod	O
mobility	NN	dobj	O
(	-LRB-	punct	O
approximately	RB	advmod	O
120	CD	nummod	O
kD	NN	appos	O
)	-RRB-	punct	O
as	IN	case	O
that	DT	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

NK	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
do	VBP	aux	O
not	RB	neg	O
express	VB	ROOT	O
NFATc	NN	dobj	B-protein
constitutively	RB	advmod	O
,	,	punct	O
but	CC	cc	O
NFATc	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
accumulation	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	conj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
within	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
CD16	NN	compound	O
ligands	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
supershift	NN	compound	O
assays	NNS	nsubj	O
using	VBG	acl	O
the	DT	det	O
available	JJ	amod	O
mAb	NN	dobj	B-protein
recognizing	VBG	acl	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
NFATc	NN	dobj	I-protein
revealed	VBD	ROOT	O
no	DT	neg	O
detectable	JJ	amod	O
NFATc	NN	compound	B-protein
protein	NN	dobj	O
in	IN	case	O
nuclear	JJ	amod	O
and	CC	cc	O
cytoplasmic	JJ	conj	O
extracts	NNS	nmod	O
from	IN	case	O
CD16-	JJ	nmod	O
or	CC	cc	O
phorbol	NN	nmod:npmod	B-cell_line
ester-stimulated	JJ	amod	I-cell_line
cells	NNS	dep	I-cell_line
at	IN	case	O
any	DT	det	O
time	NN	nmod	O
tested	VBN	acl	O
,	,	punct	O
up	IN	advmod	O
to	TO	dep	O
4	CD	nummod	O
h	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
direct	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
both	CC	cc:preconj	O
CsA-sensitive	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nsubjpass	I-protein
,	,	punct	O
NFATp	NN	appos	B-protein
and	CC	cc	O
NFATc	NN	conj	B-protein
,	,	punct	O
are	VBP	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
human	JJ	amod	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
their	PRP$	nmod:poss	O
activation	NN	nsubjpass	O
and/or	CC	cc	O
expression	NN	conj	O
can	MD	aux	O
be	VB	auxpass	O
regulated	VBN	conj	O
in	IN	case	O
primary	JJ	amod	O
cells	NNS	nmod	O
by	IN	case	O
a	DT	det	O
single	JJ	amod	O
stimulus	NN	nmod	O
,	,	punct	O
that	WDT	nsubj	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
case	NN	nmod	O
of	IN	case	O
CD16	NN	nmod	O
in	IN	case	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
results	VBZ	conj	O
in	IN	case	O
early	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
NFATp	NN	nmod	B-protein
and	CC	cc	O
subsequently	RB	advmod	O
induced	VBN	amod	O
expression	NN	conj	O
of	IN	case	O
NFATc	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Interleukin	NN	compound	O
2	CD	nummod	O
signaling	NN	nsubj	O
involves	VBZ	ROOT	O
the	DT	det	O
phosphorylation	NN	dobj	O
of	IN	case	O
Stat	NN	compound	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
important	JJ	amod	O
cytokines	NNS	nmod	B-protein
involved	VBN	acl	O
in	IN	case	O
immune	JJ	amod	O
response	NN	compound	O
regulation	NN	nmod	O
is	VBZ	cop	O
interleukin	NN	ROOT	O
2	CD	nummod	O
(	-LRB-	punct	O
IL-2	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
activator	NN	appos	O
of	IN	case	O
the	DT	dep	O
proliferation	NN	nmod	O
and	CC	cc	O
function	NN	conj	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubjpass	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
IL-2	NN	nmod	B-protein
are	VBP	auxpass	O
propagated	VBN	acl:relcl	O
within	IN	case	O
cells	NNS	nmod	O
are	VBP	auxpass	O
not	RB	neg	O
understood	VBN	ROOT	O
.	.	punct	O

While	IN	mark	O
the	DT	det	O
binding	NN	nsubjpass	O
of	IN	case	O
IL-2	NN	nmod	B-protein
to	TO	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
was	VBD	auxpass	O
recently	RB	advmod	O
shown	VBN	advcl	O
to	TO	mark	O
lead	VB	xcomp	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
kinases	NNS	nmod	B-protein
,	,	punct	O
Jak-1	NN	appos	B-protein
and	CC	cc	O
Jak-3	CD	conj	B-protein
,	,	punct	O
subsequent	JJ	amod	O
steps	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
that	WDT	nsubj	O
lead	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
genes	NNS	nmod	O
had	VBD	aux	O
not	RB	neg	O
been	VBN	auxpass	O
characterized	VBN	ROOT	O
.	.	punct	O

Since	IN	mark	O
many	JJ	amod	O
cytokines	NNS	nsubj	B-protein
that	WDT	nsubj	O
activate	VBP	acl:relcl	O
Jak	NN	compound	B-protein
kinases	NNS	dobj	I-protein
also	RB	advmod	O
lead	VBP	advcl	O
to	TO	case	O
the	DT	det	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Stat	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
the	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
IL-2	NN	nmod	B-protein
to	TO	mark	O
trigger	VB	acl	O
Stat	NN	compound	O
phosphorylation	NN	dobj	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
.	.	punct	O

Exposure	NN	nsubj	O
of	IN	case	O
activated	VBN	amod	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
or	CC	cc	O
of	IN	case	O
a	DT	det	O
natural	JJ	amod	B-cell_line
killer	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
(	-LRB-	punct	O
NKL	NN	appos	B-cell_line
)	-RRB-	punct	O
to	TO	case	O
IL-2	NN	nmod	B-protein
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
Stat1	NN	compound	B-protein
alpha	NN	nmod	I-protein
,	,	punct	O
Stat1	NN	compound	O
beta	NN	conj	O
,	,	punct	O
and	CC	cc	O
Stat3	NN	conj	B-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
of	IN	case	O
two	CD	nummod	O
Stat-related	JJ	amod	B-protein
proteins	NNS	conj	I-protein
,	,	punct	O
p94	NN	appos	B-protein
and	CC	cc	O
p95	NN	conj	B-protein
.	.	punct	O

p94	NN	nsubj	B-protein
and	CC	cc	O
p95	NN	conj	B-protein
share	VBP	ROOT	O
homology	NN	dobj	O
with	IN	case	O
Stat1	NN	nmod	B-protein
at	IN	case	O
the	DT	det	O
phosphorylation	NN	compound	B-protein
site	NN	nmod	I-protein
and	CC	cc	O
in	IN	case	O
the	DT	det	O
Src	NN	compound	B-protein
homology	NN	compound	I-protein
2	CD	nummod	I-protein
(	-LRB-	punct	I-protein
SH2	NN	compound	I-protein
)	-RRB-	punct	I-protein
domain	NN	conj	I-protein
,	,	punct	O
but	CC	cc	O
otherwise	RB	advmod	O
are	VBP	cop	O
immunologically	RB	advmod	O
distinct	JJ	conj	O
from	IN	case	O
Stat1	NN	nmod	B-protein
.	.	punct	O

These	DT	det	O
Stat	NN	compound	B-protein
proteins	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
translocate	VB	xcomp	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
and	CC	cc	O
to	TO	mark	O
bind	VB	conj	O
to	TO	case	O
a	DT	det	O
specific	JJ	amod	B-DNA
DNA	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
IL-2	NN	nsubj	B-protein
binding	VBG	acl	O
to	TO	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
may	MD	aux	O
activate	VB	acl:relcl	O
specific	JJ	amod	B-DNA
genes	NNS	dobj	I-DNA
involved	VBN	acl	O
in	IN	case	O
immune	JJ	amod	O
cell	NN	compound	O
function	NN	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
c-fos	NN	nmod	B-DNA
correlates	VBZ	ROOT	O
with	IN	case	O
IFN-alpha	NN	compound	B-protein
responsiveness	NN	nmod	O
in	IN	case	O
Philadelphia	NN	compound	O
chromosome	NN	compound	O
positive	JJ	amod	O
chronic	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
evaluates	NNS	ROOT	O
(	-LRB-	punct	O
i	LS	dep	O
)	-RRB-	punct	O
constitutive	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
oncogene	NN	compound	B-DNA
and	CC	cc	O
p53	NN	conj	B-RNA
transcripts	NNS	nmod	I-RNA
in	IN	case	O
chronic	JJ	amod	O
phase	NN	compound	O
CML	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
their	PRP$	nmod:poss	O
modulations	NNS	conj	O
subsequent	JJ	amod	O
to	TO	case	O
in	FW	amod	O
vivo	FW	dep	O
therapy	NN	nmod	O
with	IN	case	O
rIFN-alpha	NN	compound	B-protein
2c	NN	nmod	I-protein
.	.	punct	O

Peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nsubjpass	I-cell_type
(	-LRB-	punct	O
pbmc	NN	appos	B-cell_type
)	-RRB-	punct	O
and	CC	cc	O
bone	NN	compound	B-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
of	IN	case	O
26	CD	nummod	O
patients	NNS	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
for	IN	case	O
c-fos	NN	nmod	O
,	,	punct	O
c-myc	NN	conj	O
,	,	punct	O
p53	NN	conj	O
and	CC	cc	O
the	DT	det	O
hybrid	NN	compound	O
bcr/abl	NN	compound	O
mRNA	NN	compound	O
levels	NNS	conj	O
.	.	punct	O

Results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
(	-LRB-	punct	O
i	LS	dep	O
)	-RRB-	punct	O
constitutive	JJ	amod	O
c-fos	NN	compound	B-RNA
transcript	NN	compound	I-RNA
levels	NNS	nsubj	O
are	VBP	cop	O
significantly	RB	advmod	O
higher	JJR	ccomp	O
in	IN	case	O
patients	NNS	nmod	O
subsequently	RB	advmod	O
responding	VBG	acl	O
to	TO	case	O
IFN-alpha	NN	compound	B-protein
therapy	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
<	JJR	dep	O
0.01	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
positively	RB	advmod	O
correlated	VBD	conj	O
with	IN	case	O
the	DT	det	O
proportion	NN	nmod	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
0.6895	CD	dobj	O
,	,	punct	O
p	NN	dep	O
<	JJR	parataxis	O
0.01	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
negatively	RB	advmod	O
with	IN	case	O
the	DT	det	O
proportion	NN	conj	O
of	IN	case	O
immature	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
-0.568	NN	dobj	O
,	,	punct	O
p	NN	appos	O
<	JJR	amod	O
0.01	CD	nummod	O
)	-RRB-	punct	O
contained	VBN	advcl	O
in	IN	case	O
the	DT	det	O
pbmc	NN	amod	B-cell_type
preparations	NNS	nmod	O
tested	VBN	acl	O
,	,	punct	O
(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
constitutive	JJ	amod	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
hybrid	NN	compound	B-DNA
bcr/abl	NN	nmod	I-DNA
,	,	punct	O
c-myc	NN	conj	B-DNA
and	CC	cc	O
p53	NN	conj	B-DNA
are	VBP	auxpass	O
positively	RB	advmod	O
correlated	VBN	conj	O
with	IN	case	O
each	DT	det	O
other	JJ	nmod	O
,	,	punct	O
but	CC	cc	O
failed	VBD	conj	O
to	TO	mark	O
relate	VB	xcomp	O
to	TO	case	O
disease	NN	compound	O
parameters	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
(	-LRB-	punct	O
iii	LS	dep	O
)	-RRB-	punct	O
acute	JJ	amod	O
and	CC	cc	O
chronic	JJ	conj	O
in	FW	amod	O
vivo	FW	dep	O
exposure	NN	nsubjpass	O
to	TO	case	O
IFN-alpha	NN	nmod	B-protein
is	VBZ	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
upregulation	NN	nmod	O
of	IN	case	O
c-fos	NN	nmod	B-DNA
and	CC	cc	O
downregulation	NN	conj	O
of	IN	case	O
c-myc	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nmod	O
in	IN	case	O
responder	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

Menopause	NNP	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
blood	NN	compound	O
monocyte	NN	compound	O
number	NN	nmod	O
and	CC	cc	O
a	DT	det	O
relative	JJ	amod	O
decrease	NN	conj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
estrogen	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

PROBLEM	NN	ROOT	O
:	:	punct	O
The	DT	det	O
clinical	JJ	amod	O
significance	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
differential	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
estrogen	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
ER	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
was	VBD	auxpass	O
evaluated	VBN	dep	O
.	.	punct	O

METHOD	NN	ROOT	O
:	:	punct	O
Two	CD	nummod	O
color	NN	compound	O
flow	NN	compound	O
cytometry	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	dep	O
on	IN	case	O
peripheral	JJ	amod	O
blood	NN	compound	O
samples	NNS	nmod	O
of	IN	case	O
young	JJ	amod	O
and	CC	cc	O
postmenopausal	JJ	conj	O
females	NNS	nmod	O
and	CC	cc	O
postmenopausal	JJ	amod	O
females	NNS	conj	O
treated	VBN	acl	O
with	IN	case	O
estrogen	NN	compound	O
replacement	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
monocyte	NN	compound	O
and	CC	cc	O
lymphocyte	NN	conj	O
counts	NNS	nsubjpass	O
and	CC	cc	O
the	DT	det	O
blood	NN	compound	O
estrogen	NN	compound	O
levels	NNS	conj	O
of	IN	case	O
each	DT	det	O
patient	NN	nmod	O
were	VBD	auxpass	O
determine	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
During	IN	case	O
menopause	NN	nmod	O
there	EX	expl	O
is	VBZ	dep	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	nsubj	O
in	IN	case	O
the	DT	det	O
percentage	NN	nmod	O
of	IN	case	O
ER	NN	compound	B-cell_type
positive	JJ	amod	I-cell_type
monocytes	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
an	DT	det	O
increase	NN	conj	O
in	IN	case	O
blood	NN	compound	B-cell_type
monocyte	NN	compound	I-cell_type
number	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
declines	VBZ	acl:relcl	O
following	VBG	case	O
estrogen	NN	compound	O
replacement	NN	compound	O
therapy	NN	nmod	O
to	TO	case	O
values	NNS	nmod	O
of	IN	case	O
the	DT	det	O
young	JJ	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	dep	O
that	IN	mark	O
estrogen	NN	nsubj	O
modulates	VBZ	ccomp	O
the	DT	det	O
monocyte	NN	compound	B-cell_type
numbers	NNS	dobj	O
and	CC	cc	O
its	PRP$	nmod:poss	O
effects	NNS	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
mediated	VBN	conj	O
through	IN	case	O
the	DT	det	O
ER	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Staphylococcal	JJ	amod	B-protein
enterotoxins	NNS	nsubj	I-protein
modulate	VBP	ROOT	O
interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
receptor	NN	compound	I-protein
expression	NN	dobj	O
and	CC	cc	O
ligand-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	conj	O
of	IN	case	O
the	DT	det	O
Janus	NN	compound	B-protein
protein-tyrosine	NN	compound	I-protein
kinase	NN	nmod	I-protein
3	CD	nummod	I-protein
(	-LRB-	punct	O
Jak3	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
signal	NN	compound	B-protein
transducers	NNS	conj	I-protein
and	CC	cc	I-protein
activators	NNS	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
(	-LRB-	punct	O
Stat	NN	compound	B-protein
proteins	NNS	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Staphylococcal	JJ	amod	B-protein
enterotoxins	NNS	nsubj	I-protein
(	-LRB-	punct	O
SE	NN	appos	B-protein
)	-RRB-	punct	O
stimulate	VBP	ROOT	O
T	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
expressing	VBG	acl	O
the	DT	det	O
appropriate	JJ	amod	O
variable	JJ	amod	B-protein
region	NN	compound	I-protein
beta	NN	compound	I-protein
chain	NN	dobj	I-protein
of	IN	case	I-protein
(	-LRB-	punct	I-protein
V	NN	compound	I-protein
beta	NN	compound	I-protein
)	-RRB-	punct	I-protein
T-cell	NN	compound	I-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	conj	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

Depending	VBG	case	O
on	IN	case	O
costimulatory	JJ	amod	O
signals	NNS	nmod	O
,	,	punct	O
SE	NN	nsubj	B-protein
induce	VBP	ROOT	O
either	CC	cc:preconj	O
proliferation	NN	dobj	O
or	CC	cc	O
anergy	NN	conj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
SE	NN	nsubj	B-protein
can	MD	aux	O
induce	VB	ROOT	O
an	DT	det	O
interleukin-2	NN	compound	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
nonresponsive	JJ	amod	O
state	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
SE	NN	nsubj	B-protein
induce	VBP	ccomp	O
dynamic	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	dep	O
and	CC	cc	O
signal	NN	compound	O
transduction	NN	conj	O
through	IN	case	O
the	DT	dep	O
IL-2	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	I-protein
IL-2R	NN	compound	I-protein
)	-RRB-	punct	I-protein
beta	NN	nmod	I-protein
and	CC	cc	I-protein
gamma	NN	compound	I-protein
chains	NNS	conj	I-protein
(	-LRB-	punct	O
IL-2R	NN	compound	B-protein
beta	NN	dep	I-protein
and	CC	cc	O
IL-2R	NN	compound	B-protein
gamma	NN	conj	I-protein
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	B-cell_line
antigen-specific	JJ	amod	I-cell_line
CD4+	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
after	IN	case	O
4	CD	nummod	O
hr	NN	nmod	O
of	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
SEA	NN	nmod	B-protein
and	CC	cc	O
SEB	NN	conj	B-protein
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
IL-2R	NN	compound	B-protein
beta	NN	nmod	I-protein
was	VBD	auxpass	O
down-regulated	VBN	advcl	O
,	,	punct	O
IL-2R	NN	compound	B-protein
gamma	NN	nsubjpass	I-protein
was	VBD	auxpass	O
slightly	RB	advmod	O
up-regulated	VBN	ROOT	O
,	,	punct	O
while	IN	mark	O
IL-2R	NN	compound	B-protein
alpha	NN	nsubj	I-protein
remained	VBD	advcl	O
largely	RB	advmod	O
unaffected	JJ	xcomp	O
.	.	punct	O

The	DT	det	O
changes	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
composition	NN	nmod	O
of	IN	case	O
IL-2Rs	NNS	nmod	B-protein
were	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
IL-2	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
Janus	NN	compound	B-protein
protein-tyrosine	NN	compound	I-protein
kinase	NN	nmod	I-protein
3	CD	nummod	I-protein
(	-LRB-	punct	O
Jak3	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
signal	NN	compound	B-protein
transducers	NNS	conj	I-protein
and	CC	cc	I-protein
activators	NNS	conj	I-protein
of	IN	case	I-protein
transcription	NN	nmod	I-protein
called	VBN	acl	O
Stat3	NN	xcomp	B-protein
and	CC	cc	O
Stat5	NN	conj	B-protein
.	.	punct	O

In	IN	case	O
parallel	JJ	amod	O
experiments	NNS	nmod	O
,	,	punct	O
IL-2	NN	nmod:npmod	B-protein
-driven	JJ	amod	O
proliferation	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
significantly	RB	advmod	O
.	.	punct	O

After	IN	case	O
16	CD	nummod	O
hr	NN	nmod	O
of	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
SE	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
IL-2R	NN	compound	B-protein
beta	NN	nmod	I-protein
remained	VBD	ROOT	O
low	JJ	xcomp	O
,	,	punct	O
while	IN	mark	O
that	DT	nsubjpass	O
of	IN	case	O
IL2R	NN	compound	B-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
IL2R	NN	compound	B-protein
gamma	NN	conj	I-protein
was	VBD	auxpass	O
further	RB	advmod	O
up-regulated	VBN	advcl	O
,	,	punct	O
and	CC	cc	O
ligand-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
Jak3	NN	nmod	B-protein
and	CC	cc	O
Stat	NN	compound	B-protein
proteins	NNS	conj	I-protein
was	VBD	auxpass	O
partly	RB	advmod	O
normalized	VBN	conj	O
.	.	punct	O

Yet	RB	advmod	O
,	,	punct	O
IL-2	NN	nmod:npmod	B-protein
-driven	JJ	amod	O
proliferation	NN	nsubj	O
remained	VBD	ROOT	O
profoundly	RB	advmod	O
inhibited	VBD	xcomp	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
signaling	NN	compound	O
events	NNS	nsubjpass	O
other	JJ	amod	O
than	IN	case	O
Jak3	NN	compound	B-protein
/Stat	NN	compound	B-protein
activation	NN	nmod	O
had	VBD	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
changed	VBN	ccomp	O
following	VBG	case	O
SE	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
SE	NN	nsubj	B-protein
can	MD	aux	O
modulate	VB	ccomp	O
IL-2R	NN	compound	B-protein
expression	NN	dobj	O
and	CC	cc	O
signal	NN	compound	O
transduction	NN	conj	O
involving	VBG	acl	O
the	DT	det	O
Jak/Stat	NN	compound	B-protein
pathway	NN	dobj	O
in	IN	case	O
CD4+	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Constitutive	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	ROOT	O
,	,	punct	O
enhanced	VBN	amod	O
granulopoiesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
neonatal	JJ	amod	O
lethality	NN	conj	O
in	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod:npmod	I-protein
-deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Transcription	NN	compound	B-protein
factors	NNS	nsubjpass	I-protein
belonging	VBG	acl	O
to	TO	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
family	NN	nmod	I-protein
are	VBP	auxpass	O
controlled	VBN	ROOT	O
by	IN	case	O
inhibitory	JJ	amod	B-protein
I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
mainly	RB	advmod	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	appos	I-protein
and	CC	cc	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
beta	NN	conj	I-protein
.	.	punct	O

Apparently	RB	advmod	O
normal	JJ	advcl	O
at	IN	prep	O
birth	NN	pobj	O
,	,	punct	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	I-protein
-/-	JJ	compound	O
mice	NNS	nsubj	O
exhibit	VBP	ROOT	O
severe	JJ	amod	O
runting	NN	dobj	O
,	,	punct	O
skin	NN	compound	O
defects	NNS	conj	O
,	,	punct	O
and	CC	cc	O
extensive	JJ	amod	O
granulopoiesis	NN	conj	O
postnatally	RB	advmod	O
,	,	punct	O
typically	RB	advmod	O
dying	VBG	advcl	O
by	IN	case	O
8	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O

Hematopoietic	JJ	amod	O
tissues	NNS	nsubj	O
from	IN	case	O
these	DT	det	O
mice	NNS	nmod	O
display	VBP	ROOT	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
nuclear	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
mRNAs	NNS	conj	B-RNA
of	IN	case	O
some	DT	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
all	DT	conj	O
,	,	punct	O
genes	NNS	dobj	O
thought	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
regulated	VBN	xcomp	O
by	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
elevation	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
these	DT	det	O
phenotypic	JJ	amod	O
abnormalities	NNS	nmod	O
because	IN	mark	O
mice	NNS	nsubj	O
lacking	VBG	acl	O
both	CC	cc:preconj	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	dobj	I-protein
and	CC	cc	O
the	DT	det	O
p50	NN	compound	B-protein
subunit	NN	conj	I-protein
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
show	VBP	advcl	O
a	DT	det	O
dramatically	RB	advmod	O
delayed	VBN	amod	O
onset	NN	dobj	O
of	IN	case	O
abnormalities	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
I	NN	compound	B-cell_line
kappa	NN	compound	I-cell_line
B	NN	compound	I-cell_line
alpha-/-	JJ	amod	I-cell_line
embryonic	JJ	amod	I-cell_line
fibroblasts	NNS	nsubj	I-cell_line
show	VBP	ROOT	O
minimal	JJ	amod	O
constitutive	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	dobj	I-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
normal	JJ	amod	O
signal-dependent	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	conj	O
that	WDT	nsubj	O
is	VBZ	cop	O
concomitant	JJ	acl:relcl	O
with	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
beta	NN	compound	I-protein
degradation	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
I	NN	compound	O
kappa	NN	compound	O
b	NN	compound	O
beta	NN	nsubjpass	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	conj	I-protein
,	,	punct	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
the	DT	det	O
signal-dependent	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
fibroblasts	NNS	nmod	B-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
postinduction	NN	compound	O
repression	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
fibroblasts	NNS	nmod	B-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
define	VBP	ROOT	O
distinct	JJ	amod	O
roles	NNS	dobj	O
for	IN	case	O
the	DT	det	O
two	CD	nummod	O
forms	NNS	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
demonstrate	VBP	conj	O
the	DT	det	O
necessity	NN	dobj	O
for	IN	case	O
stringent	JJ	amod	O
control	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

Interleukin-7	NN	nsubj	B-protein
can	MD	aux	O
induce	VB	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
Jak	NN	nmod	B-protein
1	CD	nummod	I-protein
,	,	punct	O
Jak	NN	appos	B-protein
3	CD	nummod	I-protein
and	CC	cc	O
STAT	NN	compound	B-protein
5	CD	nummod	I-protein
proteins	NNS	conj	I-protein
in	IN	case	O
murine	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
activation	NN	nsubjpass	O
of	IN	case	O
Janus	NN	compound	B-protein
protein	NN	compound	I-protein
tyrosine	NN	compound	I-protein
kinases	NNS	nmod	I-protein
(	-LRB-	punct	O
Jak	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
STAT	NN	conj	B-protein
(	-LRB-	punct	I-protein
signal	NN	compound	I-protein
transducer	NN	dep	I-protein
and	CC	cc	I-protein
activator	NN	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
)	-RRB-	punct	I-protein
proteins	NNS	conj	I-protein
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
mechanism	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
cytokines	NNS	nmod	B-protein
.	.	punct	O

IL-7	NN	nsubjpass	B-protein
was	VBD	auxpass	O
observed	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
a	DT	det	O
rapid	JJ	amod	O
and	CC	cc	O
dose-dependent	JJ	conj	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
Jak	NN	nmod	B-protein
1	CD	nummod	I-protein
and	CC	cc	O
Jak	NN	conj	B-protein
3	CD	nummod	I-protein
and	CC	cc	O
concomitantly	RB	advmod	O
,	,	punct	O
the	DT	det	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
and	CC	cc	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	conj	O
of	IN	case	O
multiple	JJ	amod	O
STAT	NN	compound	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
STAT	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
utilized	VBN	acl	O
by	IN	case	O
IL-7	NN	nmod	B-protein
were	VBD	cop	O
identical	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
induced	VBN	acl	O
by	IN	case	O
IL-2	NN	nmod	B-protein
and	CC	cc	O
could	MD	aux	O
be	VB	auxpass	O
identified	VBN	conj	O
as	IN	case	O
various	JJ	amod	O
STAT	NN	compound	B-protein
5	CD	nummod	I-protein
isoforms	NNS	nmod	I-protein
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
Jak	NN	nmod	B-protein
1	CD	nummod	I-protein
and	CC	cc	I-protein
3	CD	conj	I-protein
,	,	punct	O
and	CC	cc	O
STAT	NN	compound	B-protein
5	CD	nummod	I-protein
activity	NN	conj	O
strongly	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
growth-promoting	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
IL-7	NN	nmod	B-protein
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
this	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
mechanism	NN	nsubj	O
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
IL-7	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
proliferation	NN	nmod	O
.	.	punct	O

Cytokine	NN	compound	B-protein
-modulating	JJ	amod	O
activity	NN	ROOT	O
of	IN	case	O
tepoxalin	NN	nmod	O
,	,	punct	O
a	DT	det	O
new	JJ	amod	O
potential	JJ	amod	O
antirheumatic	NN	appos	O
.	.	punct	O

Tepoxalin	NN	nsubj	O
is	VBZ	ROOT	O
a	DT	det	O
new	JJ	amod	O
dual	JJ	amod	O
cyclooxygenase/5-lipoxygenase	NN	compound	O
anti-inflammatory	JJ	amod	O
compound	NN	attr	O
currently	RB	advmod	O
under	IN	prep	O
clinical	JJ	amod	O
investigation	NN	pobj	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
possess	VB	xcomp	O
anti-inflammatory	JJ	amod	O
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
animal	NN	compound	O
models	NNS	nmod	O
and	CC	cc	O
more	RBR	advmod	O
recently	RB	advmod	O
to	TO	mark	O
inhibit	VB	xcomp	O
IL-2	NN	nmod:npmod	B-protein
induced	JJ	amod	O
signal	NN	compound	O
transduction	NN	dobj	O
.	.	punct	O

The	DT	det	O
current	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
conducted	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
cytokine	NN	dobj	B-protein
modulating	NN	acl	O
activity	NN	dobj	O
of	IN	case	O
tepoxalin	NN	nmod	O
and	CC	cc	O
the	DT	det	O
role	NN	conj	O
of	IN	case	O
iron	NN	nmod	O
in	IN	case	O
these	DT	det	O
effects	NNS	nmod	O
.	.	punct	O

In	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
stimulated	VBN	acl	O
with	IN	case	O
OKT3/PMA	NN	nmod	O
,	,	punct	O
tepoxalin	NN	nsubj	O
inhibited	VBD	ROOT	O
lymphocyte	NN	compound	B-cell_type
proliferation	NN	dobj	O
with	IN	case	O
an	DT	det	O
IC50	NN	nmod	O
of	IN	case	O
6	CD	nummod	O
microM	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibited	VBD	ROOT	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
LTB4	NN	nmod	B-protein
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	parataxis	O
0.5	CD	nummod	O
microM	NN	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
cytokines	NNS	conj	B-protein
IL-2	NN	dep	B-protein
,	,	punct	O
IL-6	NN	conj	B-protein
and	CC	cc	O
TNF	NN	compound	B-protein
alpha	NN	conj	I-protein
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	acl:relcl	O
10-12	CD	nummod	O
microM	NN	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Cytotoxicity	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
demonstrated	VBN	ROOT	O
at	IN	case	O
these	DT	det	O
concentrations	NNS	nmod	O
.	.	punct	O

Add-back	JJ	amod	O
experiments	NNS	nsubj	O
with	IN	case	O
either	DT	cc:preconj	O
cytokines	NNS	nmod	B-protein
(	-LRB-	punct	O
IL-2	NN	dep	B-protein
or	CC	cc	O
IL-6	NN	conj	B-protein
)	-RRB-	punct	O
,	,	punct	O
LTB4	NN	conj	B-protein
or	CC	cc	O
conditioned	JJ	amod	O
media	NNS	conj	O
failed	VBD	ROOT	O
to	TO	mark	O
restore	VB	xcomp	O
the	DT	det	O
proliferative	JJ	amod	O
response	NN	dobj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
tepoxalin	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
concurrent	JJ	amod	O
addition	NN	nsubj	O
of	IN	case	O
iron	NN	nmod	O
(	-LRB-	punct	O
in	IN	case	O
the	DT	det	O
form	NN	nmod	O
of	IN	case	O
ferrous	JJ	amod	O
or	CC	cc	O
ferric	JJ	conj	O
chloride	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
iron	NN	compound	O
salts	NNS	conj	O
)	-RRB-	punct	O
reversed	VBD	ROOT	O
the	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
proliferation	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
tepoxalin	NN	nmod	O
.	.	punct	O

Tepoxalin	NN	nsubj	O
also	RB	advmod	O
inhibits	VBZ	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	appos	I-protein
which	WDT	nsubj	O
acts	VBZ	acl:relcl	O
on	IN	case	O
several	JJ	amod	O
cytokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Tepoxalin	NN	nmod:poss	O
's	POS	case	O
effect	NN	nsubjpass	O
on	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
is	VBZ	auxpass	O
also	RB	advmod	O
reversed	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
iron	NN	compound	O
salts	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
action	NN	nsubj	O
of	IN	case	O
tepoxalin	NN	nmod	O
to	TO	mark	O
inhibit	VB	acl	O
proliferation	NN	dobj	O
in	IN	case	O
PBMC	NN	nmod	B-cell_type
may	MD	aux	O
be	VB	cop	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
its	PRP$	nmod:poss	O
ability	NN	ccomp	O
to	TO	mark	O
reduce	VB	acl	O
the	DT	det	O
amount	NN	dobj	O
of	IN	prep	O
available	JJ	amod	O
iron	NN	pobj	O
resulting	VBG	acl	O
in	IN	case	O
decreased	VBN	amod	O
activation	NN	nmod	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
subsequent	JJ	amod	O
inhibition	NN	conj	O
of	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
.	.	punct	O

N-	NN	nsubj	B-protein
and	CC	cc	I-protein
C-terminal	JJ	conj	I-protein
sequences	NNS	dep	I-protein
control	VBP	ROOT	O
degradation	NN	dobj	O
of	IN	case	O
MAD3/I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
inducers	NNS	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
.	.	punct	O

The	DT	det	O
proteolytic	JJ	amod	O
degradation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	B-protein
protein	NN	compound	I-protein
MAD3/I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
extracellular	JJ	amod	O
stimulation	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
prerequisite	JJ	amod	O
step	NN	ROOT	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-protein
I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	I-protein
protein	NN	nmod	I-protein
in	IN	case	O
stable	JJ	amod	O
transfectants	NNS	nmod	O
of	IN	case	O
mouse	NN	compound	B-cell_line
70Z/3	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
shows	VBZ	ROOT	O
that	IN	mark	O
,	,	punct	O
as	IN	case	O
for	IN	case	O
the	DT	det	O
endogenous	JJ	amod	O
murine	JJ	amod	O
protein	NN	nmod	O
,	,	punct	O
exogenous	JJ	amod	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
degraded	VBN	ccomp	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
inducers	NNS	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	nmod	O
or	CC	cc	O
lipopolysaccharide	NN	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
pretreatment	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
the	DT	det	O
proteasome	NN	compound	B-protein
inhibitor	NN	nmod	O
N-Ac-Leu-Leu-norleucinal	NN	dep	O
inhibits	VBZ	ROOT	O
this	DT	det	O
ligand-induced	JJ	amod	O
degradation	NN	dobj	O
and	CC	cc	O
,	,	punct	O
in	IN	case	O
agreement	NN	nmod	O
with	IN	case	O
previous	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
stabilizes	VBZ	conj	O
a	DT	det	O
hyperphosphorylated	JJ	amod	O
form	NN	dobj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

By	IN	mark	O
expressing	VBG	advcl	O
mutant	JJ	amod	O
forms	NNS	dobj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
protein	NN	nmod	O
in	IN	case	O
this	DT	det	O
cell	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
been	VBN	cop	O
able	JJ	ROOT	O
to	TO	mark	O
delineate	VB	xcomp	O
the	DT	det	O
sequences	NNS	dobj	O
responsible	JJ	amod	O
for	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
ligand-induced	JJ	amod	O
phosphorylation	NN	nmod	O
and	CC	cc	O
the	DT	det	O
degradation	NN	conj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
deletion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
C	NN	compound	B-protein
terminus	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	I-protein
molecule	NN	nmod	O
up	RB	advmod	O
to	TO	case	O
amino	NN	compound	B-protein
acid	NN	nmod	I-protein
279	CD	nummod	I-protein
abolishes	VBZ	ccomp	O
constitutive	JJ	amod	O
but	CC	cc	O
not	RB	cc	O
ligand-inducible	JJ	conj	O
phosphorylation	NN	dobj	O
and	CC	cc	O
inhibits	VBZ	conj	O
ligand-inducible	JJ	amod	O
degradation	NN	dobj	O
.	.	punct	O

Further	JJ	amod	O
analysis	NN	nsubj	O
reveals	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
inducible	JJ	amod	O
phosphorylation	NN	nsubj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
maps	VBZ	ccomp	O
to	TO	case	O
two	CD	nummod	O
serines	NNS	nmod	O
in	IN	case	O
the	DT	det	O
N	NN	compound	B-protein
terminus	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
protein	NN	nmod	O
(	-LRB-	punct	O
residues	NNS	dep	O
32	CD	nummod	O
and	CC	cc	O
36	CD	conj	O
)	-RRB-	punct	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
mutation	NN	nsubj	O
of	IN	case	O
either	DT	det	O
residue	NN	nmod	O
is	VBZ	cop	O
sufficient	JJ	conj	O
to	TO	mark	O
abolish	VB	xcomp	O
ligand-induced	JJ	amod	O
degradation	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
both	DT	det	O
residues	NNS	nsubjpass	O
must	MD	aux	O
be	VB	auxpass	O
mutated	VBN	parataxis	O
to	TO	mark	O
abolish	VB	xcomp	O
inducible	JJ	amod	O
phosphorylation	NN	dobj	O
of	IN	case	O
the	DT	det	O
protein	NN	nmod	O
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Microtubules	NNS	nsubj	B-protein
mediate	VBP	ROOT	O
cellular	JJ	amod	O
25-hydroxyvitamin	NN	compound	O
D3	NN	compound	O
trafficking	NN	dobj	O
and	CC	cc	O
the	DT	det	O
genomic	JJ	amod	O
response	NN	conj	O
to	TO	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
genomic	JJ	amod	O
actions	NNS	nsubjpass	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
(	-LRB-	punct	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	appos	O
)	-RRB-	punct	O
are	VBP	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
intracellular	JJ	amod	O
vitamin	NN	compound	B-protein
D	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
VDR	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Although	IN	mark	O
immunocytochemistry	NN	nsubj	O
has	VBZ	aux	O
shown	VBN	advcl	O
that	IN	mark	O
disruption	NN	nsubj	O
of	IN	case	O
microtubular	JJ	amod	O
assembly	NN	nmod	O
prevents	VBZ	ccomp	O
nuclear	JJ	amod	O
access	NN	dobj	O
of	IN	case	O
the	DT	det	O
sterol-VDR	JJ	compound	B-protein
complex	NN	nmod	I-protein
,	,	punct	O
the	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
microtubules	NNS	nmod	B-protein
in	IN	case	O
the	DT	det	O
response	NN	nmod	O
to	TO	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	dep	O
)	-RRB-	punct	O
2D3	NN	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
viable	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
examined	VBD	ROOT	O
this	DT	det	O
interaction	NN	dobj	O
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

Monocytes	NNS	nsubj	O
convert	VBP	ROOT	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
D3	NN	dobj	O
to	TO	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	nmod	O
and	CC	cc	O
to	TO	case	O
24-hydroxylated	JJ	amod	O
metabolites	NNS	conj	O
more	RBR	advmod	O
polar	JJ	advmod	O
than	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
.	.	punct	O

Microtubule	JJ	compound	O
disruption	NN	nsubj	O
totally	RB	advmod	O
abolished	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
exogenous	JJ	amod	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
to	TO	mark	O
suppress	VB	acl	O
its	PRP$	nmod:poss	O
own	JJ	amod	O
synthesis	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
24-hydroxylase	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
and	CC	cc	O
activity	NN	conj	O
,	,	punct	O
without	IN	mark	O
affecting	VBG	advcl	O
either	CC	cc:preconj	O
total	JJ	dobj	O
1	CD	dep	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
uptake	NN	dep	O
or	CC	cc	O
maximal	JJ	amod	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	compound	O
-VDR	NN	compound	B-protein
binding	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
intact	JJ	amod	O
microtubules	NNS	nsubj	B-protein
are	VBP	cop	O
essential	JJ	ROOT	O
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3-dependent	JJ	conj	O
modulation	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
microtubule	JJ	compound	B-protein
disruption	NN	nsubj	O
also	RB	advmod	O
decreased	VBD	ROOT	O
monocyte	NN	dobj	B-cell_type
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	compound	O
synthesis	NN	appos	O
,	,	punct	O
not	RB	neg	O
by	IN	mark	O
decreasing	VBG	acl	O
the	DT	det	O
Vmax	NN	dobj	O
of	IN	case	O
monocyte	NN	compound	B-protein
mitochondrial	JJ	amod	I-protein
1	CD	nummod	I-protein
alpha-hydroxylase	NN	nmod	I-protein
but	CC	cc	O
through	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
Km	NN	nmod	O
for	IN	case	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
D3	NN	compound	O
transport	NN	dobj	O
.	.	punct	O

Microtubule	JJ	compound	O
disruption	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
total	JJ	amod	O
cellular	JJ	amod	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
D3	NN	compound	O
uptake	NN	dobj	O
but	CC	cc	O
reduced	VBD	conj	O
its	PRP$	nmod:poss	O
intracellular	JJ	amod	O
trafficking	VBG	dobj	O
to	TO	case	O
the	DT	det	O
mitochondria	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
microtubules	NNS	nsubj	B-protein
participate	VBP	ROOT	O
in	IN	case	O
intracellular	JJ	amod	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
D3	NN	compound	O
transport	NN	nmod	O
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
integrity	NN	compound	O
determines	VBZ	conj	O
normal	JJ	amod	O
1	CD	dep	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
synthesis	NN	dep	O
.	.	punct	O

Relationship	NN	ROOT	O
between	IN	case	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
phosphorylation	NN	dep	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
Ca2+	NN	compound	O
transport	NN	nmod	O
in	IN	case	O
platelets	NNS	nmod	B-cell_type
:	:	punct	O
a	DT	det	O
new	JJ	amod	O
approach	NN	dep	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
interrelationship	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
messengers	NNS	nmod	O
Ca2+	NN	dep	O
and	CC	cc	O
cyclic	JJ	conj	O
AMP	NN	dep	O
in	IN	case	O
platelet	NN	compound	O
function	NN	nmod	O
is	VBZ	auxpass	O
well	RB	advmod	O
documented	VBN	advcl	O
,	,	punct	O
its	PRP$	nmod:poss	O
mechanism	NN	nsubj	O
of	IN	case	O
action	NN	nmod	O
still	RB	advmod	O
remains	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
established	VBN	xcomp	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
here	RB	advmod	O
the	DT	det	O
question	NN	dobj	O
of	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
platelet	NN	compound	B-protein
Ca	NN	compound	I-protein
(	-LRB-	punct	I-protein
2+	NN	appos	I-protein
)	-RRB-	punct	I-protein
-ATPases	NN	nmod	I-protein
by	IN	case	O
cyclic	JJ	amod	O
AMP	NN	nmod	O
through	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
using	VBG	acl	O
a	DT	det	O
pathological	JJ	amod	O
model	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
first	RB	advmod	O
found	VBD	ROOT	O
experimental	JJ	amod	O
conditions	NNS	dobj	O
where	WRB	advmod	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	dep	O
)	-RRB-	punct	O
-transport	NN	nsubj	O
by	IN	case	O
platelet	NN	compound	O
membrane	NN	compound	O
vesicles	NNS	nmod	O
appeared	VBD	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
dependent	JJ	xcomp	O
on	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

Then	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
platelets	NNS	dobj	B-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
congestive	JJ	amod	O
heart	NN	compound	O
failure	NN	nmod	O
for	IN	case	O
their	PRP$	nmod:poss	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
potential	JJ	amod	O
97	CD	nummod	B-protein
kDa	NN	compound	I-protein
Ca	NN	compound	I-protein
(	-LRB-	punct	I-protein
2+	NN	dep	I-protein
)	-RRB-	punct	I-protein
-ATPase	NN	compound	I-protein
target	NN	nmod	I-protein
of	IN	case	O
regulation	NN	nmod	O
through	IN	case	O
the	DT	det	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
phosphorylation	NN	conj	O
of	IN	case	O
the	DT	det	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
using	VBG	xcomp	O
the	DT	det	O
catalytic	JJ	amod	B-protein
subunit	NN	dobj	I-protein
of	IN	case	O
the	DT	det	O
cyclic	JJ	amod	B-protein
AMP-dependent	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
C.	NN	compound	B-protein
Sub	NN	appos	I-protein
.	.	punct	I-protein
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
first	JJ	amod	O
patients	NNS	nmod	O
studied	VBN	acl	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
modification	NN	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
97	CD	nummod	B-protein
kDa	NN	compound	I-protein
Ca	NN	compound	I-protein
(	-LRB-	punct	I-protein
2+	NN	dep	I-protein
)	-RRB-	punct	I-protein
-ATPase	NN	nmod	I-protein
by	IN	case	O
Western	NN	compound	O
blotting	NN	nmod	O
using	VBG	acl	O
the	DT	det	O
PL/IM	NN	compound	B-protein
430	CD	nummod	I-protein
monoclonal	JJ	amod	I-protein
antibody	NN	dobj	I-protein
which	WDT	nsubj	O
specifically	RB	advmod	O
recognized	VBD	acl:relcl	O
this	DT	det	O
isoform	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
Rap1	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
differentially	RB	advmod	O
phosphorylated	VBN	ROOT	O
when	WRB	advmod	O
using	VBG	advcl	O
15	CD	nummod	O
micrograms/ml	NNS	dobj	O
of	IN	case	O
the	DT	det	O
C.	NN	compound	B-protein
Sub	NN	nmod	I-protein
.	.	punct	I-protein

These	DT	det	O
results	NNS	nsubj	O
allowed	VBD	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
use	VB	xcomp	O
these	DT	det	O
pathological	JJ	amod	O
platelets	NNS	dobj	B-cell_type
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
regulation	NN	conj	O
of	IN	case	O
Ca2+	NN	compound	O
transport	NN	nmod	O
by	IN	mark	O
selecting	VBG	advcl	O
a	DT	det	O
patient	NN	dobj	O
with	IN	case	O
severe	JJ	amod	O
heart	NN	compound	O
failure	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
could	MD	aux	O
show	VB	ROOT	O
a	DT	det	O
decrease	NN	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
the	DT	det	O
phosphorylation	NN	conj	O
of	IN	case	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
and	CC	cc	O
demonstrate	VBP	conj	O
a	DT	det	O
lower	JJR	amod	O
effect	NN	dobj	O
of	IN	case	O
C.	NN	compound	B-protein
Sub	NN	nmod	I-protein
.	.	punct	I-protein
on	IN	case	O
Ca2+	NN	compound	O
transport	NN	ROOT	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
by	IN	mark	O
studying	VBG	advcl	O
a	DT	det	O
further	JJ	amod	O
series	NN	dobj	O
of	IN	case	O
patients	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
could	MD	aux	O
confirm	VB	ROOT	O
that	IN	mark	O
the	DT	det	O
decrease	NN	nsubj	O
in	IN	case	O
Rap1	NN	compound	B-protein
protein	NN	compound	I-protein
expression	NN	nmod	O
in	IN	case	O
heart	NN	compound	O
failure	NN	nmod	O
,	,	punct	O
whatever	WDT	det	O
its	PRP$	nmod:poss	O
extent	NN	appos	O
,	,	punct	O
was	VBD	cop	O
variable	JJ	ccomp	O
,	,	punct	O
and	CC	cc	O
could	MD	aux	O
strictly	RB	advmod	O
correlate	VB	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
with	IN	case	O
the	DT	det	O
stimulatory	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
C.	NN	compound	B-protein
Sub	NN	nmod	I-protein
.	.	punct	I-protein
on	IN	case	O
Ca2+	NN	compound	O
transport	NN	ROOT	O
.	.	punct	O

Besides	IN	case	O
the	DT	det	O
evidence	NN	nmod	O
for	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
in	IN	case	O
platelets	NNS	nmod	B-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
heart	NN	compound	O
failure	NN	nmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
constitute	VBP	ROOT	O
a	DT	det	O
new	JJ	amod	O
approach	NN	dobj	O
in	IN	case	O
favour	NN	nmod	O
of	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
platelet	NN	compound	O
Ca2+	NN	compound	O
transport	NN	nmod	O
through	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

An	DT	det	O
IRF-1	NN	compound	B-protein
-dependent	JJ	amod	O
pathway	NN	ROOT	O
of	IN	case	O
DNA	NN	compound	O
damage-induced	JJ	amod	O
apoptosis	NN	nmod	O
in	IN	case	O
mitogen-activated	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

Lymphocytes	NNS	nsubj	B-cell_line
are	VBP	cop	O
particularly	RB	advmod	O
susceptible	JJ	ROOT	O
to	TO	case	O
DNA	NN	nmod:npmod	O
damage-induced	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
a	DT	det	O
response	NN	dep	O
which	WDT	nsubj	O
may	MD	aux	O
serve	VB	acl:relcl	O
as	IN	case	O
a	DT	det	O
form	NN	nmod	O
of	IN	case	O
'altruistic	JJ	amod	O
suicide	NN	nmod	O
'	''	punct	O
to	TO	mark	O
counter	VB	xcomp	O
their	PRP$	nmod:poss	O
intrinsic	JJ	amod	O
high	JJ	amod	O
potential	NN	dobj	O
for	IN	case	O
mutation	NN	nmod	O
and	CC	cc	O
clonal	JJ	amod	O
expansion	NN	conj	O
.	.	punct	O

The	DT	det	O
tumour	NN	compound	B-protein
suppressor	NN	compound	I-protein
p53	NN	nsubjpass	I-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
regulate	VB	xcomp	O
this	DT	det	O
type	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
,	,	punct	O
but	CC	cc	O
an	DT	det	O
as	RB	advmod	O
yet	RB	advmod	O
unknown	JJ	dep	O
,	,	punct	O
p53	NN	compound	B-protein
-independent	JJ	amod	O
pathway	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
appears	VBZ	conj	O
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
same	JJ	amod	O
event	NN	dobj	O
in	IN	case	O
mitogen-activated	JJ	amod	B-cell_line
mature	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
DNA	NN	compound	O
damage-induced	JJ	amod	O
apoptosis	NN	dobj	O
in	IN	case	O
these	DT	det	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
is	VBZ	cop	O
dependent	JJ	ccomp	O
on	IN	case	O
the	DT	det	O
antioncogenic	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
interferon	NN	compound	I-protein
regulatory	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	B-protein
IRF	NN	nmod	I-protein
)	-RRB-	punct	I-protein
-1	CD	nummod	I-protein
.	.	punct	O

Thus	RB	advmod	O
two	CD	nummod	O
different	JJ	amod	O
anti-onco-genic	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nsubjpass	I-protein
,	,	punct	O
p53	NN	appos	B-protein
and	CC	cc	O
IRF-1	NN	conj	B-protein
,	,	punct	O
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
distinct	JJ	amod	O
apoptotic	JJ	amod	O
pathways	NNS	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
mitogen	NN	compound	O
induction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
interleukin-1	NN	compound	B-DNA
beta	NN	compound	I-DNA
converting	NN	compound	I-DNA
enzyme	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
ICE	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
a	DT	det	O
mammalian	JJ	amod	B-protein
homologue	NN	appos	I-protein
of	IN	case	O
the	DT	det	O
Caenorhabditis	NN	compound	B-DNA
elegans	NN	compound	I-DNA
cell	NN	compound	I-DNA
death	NN	compound	I-DNA
gene	NN	compound	I-DNA
ced-3	NN	nmod	B-DNA
,	,	punct	O
is	VBZ	cop	O
IRF-1	NN	nmod:npmod	B-protein
-dependent	JJ	ccomp	O
.	.	punct	O

Ectopic	JJ	amod	O
overexpression	NN	nsubj	O
of	IN	case	O
IRF-1	NN	nmod	B-protein
results	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
endogenous	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
for	IN	case	O
ICE	NN	nmod	B-protein
and	CC	cc	O
enhances	VBZ	conj	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	O
to	TO	case	O
radiation-induced	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Circadian	JJ	amod	O
rhythm	NN	ROOT	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
and	CC	cc	O
their	PRP$	nmod:poss	O
reactivity	NN	conj	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

1	LS	dep	O
)	-RRB-	punct	O
There	EX	expl	O
exists	VBZ	ROOT	O
a	DT	det	O
CR	NN	dobj	O
of	IN	case	O
GR	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
,	,	punct	O
PMN	NN	appos	B-cell_type
,	,	punct	O
and	CC	cc	O
monocytes	NNS	conj	B-cell_type
with	IN	case	O
the	DT	det	O
peak	NN	amod	O
values	NNS	nmod	O
from	IN	case	O
0400	CD	compound	O
to	TO	dep	O
0800	CD	nummod	O
hr	NN	nmod	O
and	CC	cc	O
the	DT	det	O
trough	NN	compound	O
values	NNS	conj	O
between	IN	case	O
2300	CD	nummod	O
and	CC	cc	O
0000	CD	conj	O
hr	NN	nmod	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
between	IN	case	O
them	PRP	nmod	O
was	VBD	cop	O
significant	JJ	ROOT	O
statistically	RB	advmod	O
.	.	punct	O

2	LS	dep	O
)	-RRB-	punct	O
The	DT	det	O
FI	NN	nsubj	O
of	IN	case	O
the	DT	det	O
chemotactic	JJ	amod	O
migration	NN	compound	O
rate	NN	nmod	O
of	IN	case	O
PMN	NN	nmod	B-cell_type
by	IN	case	O
cortisol	NN	nmod	O
also	RB	advmod	O
showed	VBD	ROOT	O
diurnal	JJ	amod	O
changes	NNS	dobj	O
which	WDT	nsubj	O
were	VBD	cop	O
synchronous	JJ	acl:relcl	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
GR	NN	nmod	B-protein
.	.	punct	O

This	DT	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
CR	NN	nsubj	O
of	IN	case	O
GR	NN	nmod	B-protein
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
functional	JJ	amod	O
significance	NN	ccomp	O
.	.	punct	O

3	LS	dep	O
)	-RRB-	punct	O
In	IN	case	O
Cushing	NN	nmod:poss	O
's	POS	case	O
syndrome	NN	nmod	O
,	,	punct	O
the	DT	det	O
CR	NN	nsubj	O
of	IN	case	O
GR	NN	nmod	B-protein
was	VBD	cop	O
normal	JJ	ROOT	O
in	IN	case	O
spite	NN	nmod	O
of	IN	case	O
the	DT	det	O
fact	NN	nmod	O
that	IN	mark	O
the	DT	det	O
CR	NN	nsubjpass	O
of	IN	case	O
plasma	NN	compound	O
cortisol	NN	nmod	O
was	VBD	auxpass	O
disturbed	VBN	ccomp	O
.	.	punct	O

This	DT	nsubj	O
indicates	VBZ	ROOT	O
the	DT	det	O
independency	NN	dobj	O
of	IN	case	O
the	DT	det	O
CR	NN	nmod	O
of	IN	case	O
GR	NN	nmod	B-protein
from	IN	case	O
that	DT	nmod	O
of	IN	case	O
cortisol	NN	nmod	O
.	.	punct	O

4	LS	dep	O
)	-RRB-	punct	O
In	IN	case	O
apoplexy	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
brain	NN	compound	O
ischemia	NN	nmod	O
,	,	punct	O
the	DT	det	O
CR	NN	nsubjpass	O
of	IN	case	O
GR	NN	nmod	B-protein
was	VBD	auxpass	O
abolished	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
basal	JJ	amod	O
lesions	NNS	nmod	O
but	CC	cc	O
preserved	VBN	conj	O
when	WRB	advmod	O
the	DT	det	O
lesions	NNS	nsubj	O
were	VBD	cop	O
located	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
cerebral	JJ	amod	O
cortex	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
strongly	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
main	JJ	amod	O
``	``	punct	O
circadian	JJ	amod	O
pacemaker	NN	nsubj	O
''	''	punct	O
of	IN	case	O
GR	NN	nmod	B-protein
is	VBZ	cop	O
located	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
basal	JJ	amod	O
brain	NN	nmod	O
,	,	punct	O
most	RBS	advmod	O
probably	RB	advmod	O
in	IN	case	O
the	DT	det	O
suprachiasmatic	JJ	amod	O
nuclei	NNS	nmod	O
as	IN	mark	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	advcl	O
for	IN	case	O
rodents	NNS	nmod	O
.	.	punct	O

B-lymphoblastoid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	ROOT	I-cell_line
from	IN	case	O
multiple	JJ	amod	O
sclerosis	NN	amod	O
patients	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
healthy	JJ	amod	O
control	NN	conj	O
producing	VBG	acl	O
a	DT	det	O
putative	JJ	amod	O
new	JJ	amod	O
human	JJ	amod	O
retrovirus	NN	dobj	O
and	CC	cc	O
Epstein-Barr	JJ	amod	O
virus	NN	conj	O
.	.	punct	O

On	IN	case	O
several	JJ	amod	O
occasions	NNS	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
observed	VBN	ROOT	O
retrovirus-like	JJ	amod	O
particles	NNS	dobj	O
(	-LRB-	punct	O
RVLPs	NNS	appos	O
)	-RRB-	punct	O
by	IN	case	O
transmission	NN	compound	O
electron	NN	compound	O
microscopy	NN	nmod	O
(	-LRB-	punct	O
EM	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
cultured	VBN	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
from	IN	case	O
a	DT	det	O
patient	NN	nmod	O
with	IN	case	O
MS	NN	nmod	O
.	.	punct	O

Later	RB	advmod	O
we	PRP	nsubj	O
established	VBD	ROOT	O
spontaneously	RB	advmod	O
formed	VBD	amod	O
B-lymphoblastoid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dobj	I-cell_line
(	-LRB-	punct	O
LCLs	NNS	appos	B-cell_line
)	-RRB-	punct	O
from	IN	case	O
a	DT	det	O
patient	NN	nmod	O
with	IN	case	O
an	DT	det	O
MS-like	JJ	amod	O
disease	NN	nmod	O
and	CC	cc	O
from	IN	case	O
another	DT	det	O
patient	NN	conj	O
with	IN	case	O
MS	NN	nmod	O
who	WP	nsubj	O
had	VBD	acl:relcl	O
a	DT	det	O
reactivated	VBN	amod	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
infection	NN	dobj	O
.	.	punct	O

Both	DT	det	O
LCLs	NNS	nsubjpass	B-cell_line
were	VBD	auxpass	O
found	VBN	ROOT	O
by	IN	case	O
EM	NN	nmod	O
to	TO	mark	O
produce	VB	xcomp	O
RVLP	NN	compound	O
and	CC	cc	O
EBV	NN	conj	O
particles	NNS	dobj	O
.	.	punct	O

Reverse	JJ	amod	O
transcriptase	NN	compound	O
(	-LRB-	punct	O
RT	NN	appos	O
)	-RRB-	punct	O
assays	NNS	nsubj	O
were	VBD	cop	O
positive	JJ	ROOT	O
in	IN	case	O
purified	VBN	amod	O
viral	JJ	amod	O
material	NN	nmod	O
from	IN	case	O
both	DT	det	O
LCLs	NNS	nmod	B-cell_line
.	.	punct	O

To	TO	mark	O
substantiate	VB	advcl	O
these	DT	det	O
findings	NNS	dobj	O
we	PRP	nsubj	O
initiated	VBD	ROOT	O
an	DT	det	O
intensified	VBN	amod	O
culturing	VBG	compound	O
procedure	NN	dobj	O
and	CC	cc	O
were	VBD	cop	O
able	JJ	conj	O
to	TO	mark	O
establish	VB	xcomp	O
LCLs	NNS	dobj	B-cell_line
from	IN	case	O
5	CD	nummod	O
out	IN	dep	O
of	IN	case	O
21	CD	nummod	O
consecutive	JJ	amod	O
MS	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
1	CD	nummod	O
out	IN	cc	O
of	IN	case	O
13	CD	nummod	O
consecutive	JJ	amod	O
healthy	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

All	DT	det	O
LCLs	NNS	nsubjpass	B-cell_line
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
produce	VB	xcomp	O
both	CC	cc:preconj	O
RVLP	NN	dobj	O
and	CC	cc	O
EBV	NN	conj	O
particles	NNS	dep	O
by	IN	case	O
EM	NN	nmod	O
.	.	punct	O

Whether	IN	mark	O
the	DT	det	O
putative	JJ	amod	O
new	JJ	amod	O
retrovirus	NN	nsubj	O
(	-LRB-	punct	O
es	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
EBV	NN	conj	O
have	VBP	advcl	O
any	DT	det	O
causal	JJ	amod	O
relationship	NN	dobj	O
to	TO	case	O
MS	NN	nmod	O
is	VBZ	auxpass	O
still	RB	advmod	O
not	RB	neg	O
known	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
findings	NNS	nsubj	O
support	VBP	conj	O
this	DT	det	O
possibility	NN	dobj	O
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
an	DT	det	O
ionomycin/cyclosporin	NN	compound	B-DNA
A-responsive	JJ	amod	I-DNA
element	NN	nmod	I-DNA
within	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
T	NN	compound	I-DNA
cell	NN	compound	I-DNA
receptor	NN	compound	I-DNA
gamma	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

Activation	NN	nsubj	O
through	IN	case	O
the	DT	det	O
Ca2+/	NN	amod	O
calcineurin	NN	compound	B-protein
pathway	NN	nmod	O
is	VBZ	cop	O
essential	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
transcription	NN	nmod	O
of	IN	case	O
many	JJ	amod	O
cytokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
conserved	VBN	amod	B-DNA
cis-acting	JJ	amod	I-DNA
sequence	NN	nsubjpass	I-DNA
,	,	punct	O
GGAAAA	NN	conj	O
,	,	punct	O
and	CC	cc	O
transcription	NN	compound	B-protein
factors	NNS	nsubjpass	I-protein
binding	VBG	acl	O
to	TO	case	O
this	DT	det	O
sequence	NN	nmod	O
are	VBP	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
response	NN	nmod	O
to	TO	case	O
increased	VBN	amod	O
intracellular	JJ	amod	O
Ca2+	NN	compound	O
concentrations	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
identification	NN	dobj	O
and	CC	cc	O
importance	NN	conj	O
of	IN	case	O
the	DT	det	O
same	JJ	amod	O
sequence	NN	nmod	O
in	IN	case	O
a	DT	det	O
non-cytokine	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
the	DT	det	O
human	JJ	amod	B-DNA
T	NN	compound	I-DNA
cell	NN	compound	I-DNA
receptor	NN	compound	I-DNA
gamma	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
TCRG	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
enhancer	NN	appos	I-DNA
.	.	punct	O

Results	NNS	nsubj	O
from	IN	case	O
site-directed	JJ	amod	O
mutations	NNS	nmod	O
and	CC	cc	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	conj	O
strongly	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
sequence	NN	nsubj	O
mediates	VBZ	ccomp	O
the	DT	det	O
ionomycin-induced	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
TCRG	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

Our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
provide	VBP	ROOT	O
an	DT	det	O
explanation	NN	dobj	O
for	IN	case	O
a	DT	det	O
previous	JJ	amod	O
observation	NN	nmod	O
that	IN	mark	O
TCRG	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nsubjpass	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
mRNA	NN	compound	O
levels	NNS	conj	O
for	IN	case	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
alpha	NN	nmod	I-protein
and	CC	cc	I-protein
-beta	NN	conj	I-protein
,	,	punct	O
are	VBP	auxpass	O
increased	VBN	ccomp	O
by	IN	case	O
ionomycin	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Coexpression	NN	ROOT	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B/Rel	NN	nmod	I-protein
and	CC	cc	O
Sp1	NN	conj	B-protein
transcription	NN	compound	B-protein
factors	NNS	dep	I-protein
in	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
1-induced	JJ	amod	O
,	,	punct	O
dendritic	JJ	dep	O
cell-T-cell	NN	compound	O
syncytia	NN	nmod	O
.	.	punct	O

Productive	JJ	amod	O
infection	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
typically	RB	advmod	O
requires	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
be	VB	auxpass	O
stimulated	VBN	ccomp	O
with	IN	case	O
antigens	NNS	nmod	O
or	CC	cc	O
mitogens	NNS	conj	O
.	.	punct	O

This	DT	det	O
requirement	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
attributed	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
synergizes	VBZ	acl:relcl	O
with	IN	case	O
the	DT	det	O
constitutive	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
Sp1	NN	nmod	B-protein
to	TO	mark	O
drive	VB	xcomp	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
vigorous	JJ	amod	O
replication	NN	nsubj	O
of	IN	case	O
HIV-1	NN	nmod	O
takes	VBZ	ccomp	O
place	NN	dobj	O
in	IN	case	O
nonactivated	JJ	amod	O
memory	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
after	IN	case	O
syncytium	NN	compound	O
formation	NN	nmod	O
with	IN	case	O
dendritic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
DCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
syncytia	NNS	nsubj	O
lack	VBP	ROOT	O
activated	VBN	amod	B-cell_type
cells	NNS	dobj	I-cell_type
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
an	DT	det	O
absence	NN	nmod	O
of	IN	case	O
staining	VBG	nmod	O
for	IN	case	O
Ki-67	NN	compound	O
cell	NN	compound	O
cycle	NN	compound	O
antigen	NN	nmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
and	CC	cc	O
activity	NN	conj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
Sp1	NN	conj	B-protein
were	VBD	auxpass	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
analyzed	VBN	ROOT	O
in	IN	case	O
isolated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
DCs	NNS	conj	B-cell_type
from	IN	case	O
humans	NNS	nmod	O
and	CC	cc	O
mice	NNS	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
immunolabeling	NN	dobj	O
,	,	punct	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	conj	O
,	,	punct	O
and	CC	cc	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	conj	O
and	CC	cc	O
supershift	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
lack	VBP	ROOT	O
active	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
but	CC	cc	O
express	VBP	conj	O
Sp1	NN	dobj	B-protein
as	IN	mark	O
expected	VBN	advcl	O
.	.	punct	O

DCs	NNS	nsubj	B-cell_type
express	VBP	ROOT	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
all	DT	det	O
known	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
and	CC	cc	O
Rel	NN	conj	B-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
with	IN	case	O
activity	NN	nmod	O
residing	VBG	acl	O
primarily	RB	advmod	O
within	IN	case	O
RelB	NN	nmod	B-protein
,	,	punct	O
p50	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p65	NN	conj	B-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
DCs	NNS	nsubj	B-cell_type
lack	VBP	ROOT	O
Sp1	NN	dobj	B-protein
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
explain	VB	acl:relcl	O
the	DT	det	O
failure	NN	dobj	O
of	IN	case	O
HIV-1	NN	nmod	O
to	TO	mark	O
replicate	VB	acl	O
in	IN	case	O
purified	VBN	amod	O
DCs	NNS	nmod	B-cell_type
.	.	punct	O

Coexpression	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
Sp1	NN	conj	B-protein
occurs	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
heterologous	JJ	amod	B-cell_type
DC-T-cell	NN	compound	I-cell_type
syncytia	NN	nmod	I-cell_type
that	WDT	nsubjpass	O
are	VBP	auxpass	O
induced	VBN	acl:relcl	O
by	IN	case	O
HIV-1	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
HIV-1-induced	JJ	amod	O
cell	NN	compound	O
fusion	NN	nsubj	O
brings	VBZ	ROOT	O
together	RB	advmod	O
factors	NNS	dobj	O
that	WDT	nsubj	O
upregulate	VBP	acl:relcl	O
virus	NN	compound	O
transcription	NN	dobj	O
.	.	punct	O

Since	IN	mark	O
DCs	NNS	nsubj	B-cell_type
and	CC	cc	O
memory	NN	conj	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
frequently	RB	advmod	O
traffic	VBP	advcl	O
together	RB	advmod	O
in	FW	compound	O
situ	FW	advmod	O
,	,	punct	O
these	DT	det	O
unusual	JJ	amod	O
heterologous	JJ	amod	B-cell_type
syncytia	NN	nsubj	I-cell_type
could	MD	aux	O
develop	VB	ROOT	O
in	IN	case	O
infected	JJ	amod	O
individuals	NNS	nmod	O
and	CC	cc	O
lead	VB	conj	O
to	TO	case	O
chronic	JJ	amod	O
HIV-1	NN	compound	O
replication	NN	nmod	O
without	IN	case	O
ostensible	JJ	amod	O
immune	JJ	amod	O
stimulation	NN	nmod	O
.	.	punct	O

Cupric	JJ	amod	O
ion	NN	nsubj	O
blocks	VBZ	ROOT	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
activation	NN	dobj	O
through	IN	mark	O
inhibiting	VBG	advcl	O
the	DT	det	O
signal-induced	JJ	amod	O
phosphorylation	NN	dobj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

A	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nsubjpass	I-protein
,	,	punct	O
which	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
various	JJ	amod	O
cellular	JJ	amod	O
genes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
immune	JJ	amod	O
responses	NNS	nmod	O
and	CC	cc	O
viral	JJ	amod	B-DNA
genes	NNS	conj	I-DNA
including	VBG	case	O
HIV	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
sequestered	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
as	IN	case	O
a	DT	det	O
complex	NN	nmod	O
with	IN	case	O
an	DT	det	O
inhibitory	JJ	amod	B-protein
protein	NN	compound	I-protein
I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

Various	JJ	amod	O
extracellular	JJ	amod	O
signals	NNS	nsubj	O
induce	VBP	ROOT	O
phosphorylation	NN	dobj	O
and	CC	cc	O
rapid	JJ	amod	O
degradation	NN	conj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
to	TO	mark	O
release	VB	advcl	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	dobj	I-protein
.	.	punct	O

Cu2+	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
induced	VBN	acl	O
by	IN	case	O
TNF-alpha	NN	nmod	B-protein
,	,	punct	O
TPA	NN	conj	O
,	,	punct	O
or	CC	cc	O
H2O2	NN	conj	O
.	.	punct	O

Deoxycholate	JJ	amod	O
treatment	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	O
extract	NN	nmod	O
prepared	VBN	acl	O
from	IN	case	O
cells	NNS	nmod	O
stimulated	VBN	acl	O
by	IN	case	O
TNF-alpha	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
Cu2+	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
release	NN	nmod	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
from	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
Cu2+	NN	nsubj	O
interferes	VBZ	ccomp	O
with	IN	case	O
the	DT	det	O
dissociation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B-I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

Neither	CC	cc:preconj	O
phosphorylation	NN	nsubjpass	O
nor	CC	cc	O
degradation	NN	conj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
was	VBD	auxpass	O
observed	VBN	ROOT	O
upon	IN	case	O
TNF-alpha	NN	compound	B-protein
stimulation	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
Cu2+	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Cu2+	NN	nsubj	O
inhibits	VBZ	ccomp	O
the	DT	det	O
release	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
by	IN	case	O
blockade	NN	nmod	O
of	IN	case	O
a	DT	det	O
signal	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

Cloning	VBG	ROOT	O
a	DT	det	O
cDNA	NN	dobj	B-DNA
from	IN	case	O
human	JJ	amod	O
NK/T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
which	WDT	nsubj	O
codes	VBZ	acl:relcl	O
for	IN	case	O
a	DT	det	O
protein	NN	nmod	O
with	IN	case	O
high	JJ	amod	O
proline	NN	compound	O
content	NN	nmod	O
.	.	punct	O

A	DT	det	O
cDNA	NN	compound	B-DNA
clone	NN	nsubjpass	I-DNA
,	,	punct	O
B4-2	NN	appos	B-DNA
,	,	punct	O
was	VBD	auxpass	O
isolated	VBN	ROOT	O
from	IN	case	O
a	DT	det	O
natural	JJ	amod	B-DNA
killer	NN	preconj	I-DNA
(	-LRB-	punct	I-DNA
NK	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
minus	CC	amod	I-DNA
T	NN	compound	I-DNA
cell	NN	compound	I-DNA
subtractive	JJ	amod	I-DNA
library	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
B4-2	NN	compound	B-DNA
clone	NN	nsubj	O
coded	VBD	ROOT	O
for	IN	case	O
an	DT	det	O
mRNA	NN	nmod	B-RNA
of	IN	case	O
2061	CD	nummod	O
bp	NN	nmod	O
in	IN	case	O
length	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
encodes	VBZ	ROOT	O
a	DT	det	O
deduced	VBN	amod	O
327	CD	nummod	B-protein
aa	NN	compound	I-protein
protein	NN	dobj	I-protein
with	IN	case	O
a	DT	det	O
calculated	VBN	amod	O
molecular	JJ	amod	O
mass	NN	nmod	O
of	IN	case	O
35.2	CD	nummod	O
kDa	NN	nmod	O
.	.	punct	O

Searching	NN	nsubj	O
of	IN	case	O
B4-2	NN	compound	B-DNA
DNA	NN	nmod	I-DNA
and	CC	cc	O
protein	NN	compound	O
sequences	NNS	conj	O
against	IN	case	O
various	JJ	amod	O
databases	NNS	nmod	O
revealed	VBD	ROOT	O
no	DT	neg	O
high	JJ	amod	O
homology	NN	dobj	O
to	TO	case	O
other	JJ	amod	O
sequences	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
B4-2	NN	nsubj	B-DNA
has	VBZ	ROOT	O
an	DT	det	O
unusually	RB	advmod	O
high	JJ	amod	O
proline	NN	compound	O
content	NN	dobj	O
(	-LRB-	punct	O
13	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
contains	VBZ	conj	O
a	DT	det	O
putative	JJ	amod	O
nuclear	JJ	amod	B-protein
targeting	NN	compound	I-protein
sequence	NN	dobj	I-protein
,	,	punct	O
and	CC	cc	O
has	VBZ	conj	O
several	JJ	amod	O
SPXX	NN	compound	B-protein
motifs	NNS	dobj	I-protein
which	WDT	nsubjpass	O
are	VBP	auxpass	O
frequently	RB	advmod	O
found	VBN	acl:relcl	O
in	IN	case	O
gene	NN	compound	B-protein
regulatory	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

One	CD	nsubj	O
of	IN	prep	O
the	DT	det	O
stretches	NNS	pobj	O
of	IN	case	O
prolines	NNS	nmod	O
in	IN	case	O
B4-2	NN	nmod	B-DNA
closely	RB	advmod	O
resembles	VBZ	ROOT	O
the	DT	det	O
ligand	NN	dobj	O
for	IN	case	O
proteins	NNS	nmod	O
with	IN	case	O
SH3	NN	compound	B-protein
domains	NNS	nmod	I-protein
.	.	punct	O

Northern	NN	compound	O
hybridization	NN	compound	O
data	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
B4-2	NN	nsubj	B-DNA
is	VBZ	cop	O
not	RB	neg	O
a	DT	det	O
lymphoid	JJ	amod	B-DNA
specific	JJ	amod	I-DNA
gene	NN	ccomp	I-DNA
and	CC	cc	O
is	VBZ	auxpass	O
expressed	VBN	conj	O
in	IN	case	O
a	DT	det	O
hepatoma	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
and	CC	cc	O
also	RB	advmod	O
weakly	RB	advmod	O
transcribed	VBN	conj	O
or	CC	cc	O
absent	JJ	conj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
other	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

A	DT	det	O
polyclonal	JJ	amod	O
antiserum	NN	nsubj	O
raised	VBN	acl	O
against	IN	case	O
recombinant	JJ	amod	B-protein
B4-2	NN	nmod	I-protein
recognizes	VBZ	ROOT	O
a	DT	det	O
32-34	CD	nummod	B-protein
kDa	NN	compound	I-protein
protein	NN	dobj	I-protein
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
JAK3	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
JAK1	NN	conj	B-protein
,	,	punct	O
is	VBZ	cop	O
critical	JJ	ROOT	O
for	IN	case	O
IL-2	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
proliferation	NN	nmod	O
and	CC	cc	O
STAT5	NN	compound	B-protein
recruitment	NN	conj	O
by	IN	case	O
a	DT	det	O
COOH-terminal	JJ	amod	B-protein
region	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-protein
receptor	NN	compound	I-protein
beta-chain	NN	nmod	I-protein
.	.	punct	O

A	DT	det	O
number	NN	nsubj	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
and	CC	cc	O
growth	NN	compound	B-protein
factors	NNS	conj	I-protein
use	VBP	ROOT	O
the	DT	det	O
JAK	NN	compound	B-protein
-STAT	JJ	amod	B-protein
pathway	NN	dobj	O
to	TO	case	O
signal	NN	nmod	O
from	IN	case	O
the	DT	det	O
cell	NN	compound	O
membrane	NN	nmod	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

While	IN	mark	O
homodimerizing	VBG	csubj	B-protein
cytokine	NN	compound	I-protein
receptors	NNS	nsubj	I-protein
may	MD	aux	O
transmit	VB	ROOT	O
signal	NN	dobj	O
via	IN	case	O
a	DT	det	O
single	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
JAK	NN	nmod	B-protein
(	-LRB-	punct	O
i.e	NN	dep	O
.	.	punct	O
growth	NN	compound	B-protein
hormone	NN	compound	I-protein
receptors	NNS	nsubjpass	I-protein
)	-RRB-	punct	O
,	,	punct	O
several	JJ	amod	O
multicomponent	JJ	amod	B-protein
cytokine	NN	compound	I-protein
receptors	NNS	nsubjpass	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
require	VB	xcomp	O
simultaneous	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
pairs	NNS	nmod	O
of	IN	case	O
different	JJ	amod	O
JAK	NN	compound	B-protein
kinases	NNS	nmod	I-protein
(	-LRB-	punct	O
i.e	NN	dep	O
.	.	punct	O
interferon	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
)	-RRB-	punct	O
.	.	punct	O

Recent	JJ	amod	O
evidence	NN	nsubj	O
for	IN	case	O
a	DT	det	O
preferential	JJ	amod	O
coupling	NN	nmod	O
of	IN	case	O
JAK3	NN	nmod	B-protein
to	TO	case	O
interleukin-2	NN	compound	B-protein
receptor-gamma	NN	nmod	I-protein
(	-LRB-	punct	O
IL-2R	NN	compound	B-protein
gamma	NN	appos	I-protein
)	-RRB-	punct	O
and	CC	cc	O
JAK1	NN	conj	B-protein
to	TO	case	O
IL-2R	NN	compound	B-protein
beta	NN	nmod	I-protein
supports	VBZ	ROOT	O
the	DT	det	O
concept	NN	dobj	O
of	IN	case	O
heterotrans-activation	NN	nmod	O
of	IN	case	O
JAK1	NN	nmod	B-protein
and	CC	cc	O
JAK3	NN	conj	B-protein
caused	VBN	acl	O
by	IN	case	O
IL-2	NN	compound	B-protein
-induced	JJ	amod	O
heterodimerization	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
receptor	NN	compound	O
partners	NNS	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
verified	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
to	TO	mark	O
cause	VB	acl	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
JAK1	NN	nmod	B-protein
and	CC	cc	O
JAK3	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
demonstrated	VBD	conj	O
that	IN	mark	O
IL-2	NN	nsubj	B-protein
stimulated	VBD	ccomp	O
JAK3	NN	dobj	B-protein
to	TO	case	O
a	DT	det	O
significantly	RB	advmod	O
larger	JJR	amod	O
extent	NN	nmod	O
than	IN	case	O
JAK1	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
the	DT	det	O
YT	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
.	.	punct	O

This	DT	det	O
conclusion	NN	nsubjpass	O
was	VBD	auxpass	O
based	VBN	ROOT	O
upon	IN	case	O
several	JJ	amod	O
independent	JJ	amod	O
criteria	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
more	RBR	advmod	O
vigorous	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
JAK3	NN	nmod	B-protein
,	,	punct	O
more	RBR	advmod	O
marked	JJ	amod	O
enzymatic	JJ	amod	O
activation	NN	appos	O
of	IN	case	O
JAK3	NN	nmod	B-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
higher	JJR	amod	O
abundance	NN	conj	O
of	IN	case	O
JAK3	NN	nmod	B-protein
in	IN	case	O
activated	VBN	amod	O
IL-2	NN	compound	B-protein
receptor	NN	compound	I-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
human	JJ	amod	B-protein
IL-2R	NN	compound	I-protein
beta	NN	nsubjpass	I-protein
was	VBD	auxpass	O
stably	RB	advmod	O
expressed	VBN	advcl	O
in	IN	case	O
murine	JJ	amod	B-cell_line
BA/F3	JJ	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
robust	JJ	amod	O
IL-2	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
proliferation	NN	nsubj	O
and	CC	cc	O
JAK3	NN	compound	B-protein
activation	NN	conj	O
occurred	VBD	ROOT	O
without	IN	case	O
detectable	JJ	amod	O
involvement	NN	nmod	O
of	IN	case	O
either	CC	cc:preconj	O
JAK1	NN	nmod	B-protein
,	,	punct	O
JAK2	NN	conj	B-protein
or	CC	cc	O
TYK2	NN	conj	B-protein
.	.	punct	O

We	PRP	nsubj	O
therefore	RB	advmod	O
propose	VBP	ROOT	O
that	IN	mark	O
IL-2	NN	compound	B-protein
receptor	NN	compound	I-protein
signal	NN	compound	O
transduction	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
depend	VB	ccomp	O
on	IN	case	O
equimolar	JJ	amod	O
heterodimerization	NN	nmod	O
of	IN	case	O
JAK1	NN	nmod	B-protein
and	CC	cc	O
JAK3	NN	conj	B-protein
following	VBG	case	O
IL-2	NN	compound	B-protein
-induced	JJ	amod	O
heterodimerization	NN	nmod	O
of	IN	case	O
IL-2R	NN	compound	B-protein
beta	NN	nmod	I-protein
and	CC	cc	O
IL-2R	NN	compound	B-protein
gamma	NN	conj	I-protein
.	.	punct	O

Nonetheless	RB	advmod	O
,	,	punct	O
a	DT	det	O
membrane-proximal	JJ	amod	B-protein
region	NN	nsubj	I-protein
of	IN	case	O
human	JJ	amod	O
IL-2R	NN	compound	B-protein
beta	NN	nmod	I-protein
(	-LRB-	punct	O
Asn240-Leu335	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	cop	O
critical	JJ	ROOT	O
for	IN	case	O
JAK3	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
amount	NN	nsubj	O
of	IN	case	O
JAK3	NN	nmod	B-protein
present	JJ	amod	O
in	IN	case	O
activated	VBN	amod	O
IL-2	NN	compound	B-protein
receptor	NN	compound	I-protein
complexes	NNS	nmod	I-protein
increased	VBD	conj	O
with	IN	case	O
time	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
stabilization	NN	nsubj	O
of	IN	case	O
JAK3	NN	nmod	B-protein
binding	NN	acl	O
to	TO	case	O
the	DT	det	O
receptor	NN	compound	B-protein
complex	NN	nmod	I-protein
relies	VBZ	ccomp	O
on	IN	case	O
both	CC	cc:preconj	O
IL-2R	NN	compound	B-protein
beta	NN	nmod	I-protein
and	CC	cc	O
IL-2R	NN	compound	B-protein
gamma	NN	conj	I-protein
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
STAT5	NN	nsubjpass	B-protein
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
predominant	JJ	amod	O
STAT	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	xcomp	I-protein
used	VBN	acl	O
by	IN	case	O
IL-2	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
specifically	RB	advmod	O
required	VBD	conj	O
a	DT	det	O
COOH-terminal	JJ	amod	B-protein
region	NN	dobj	I-protein
of	IN	case	O
IL-2R	NN	compound	B-protein
beta	NN	nmod	I-protein
(	-LRB-	punct	O
Ser386-Val525	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
STAT5	NN	compound	B-protein
recruitment	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	advcl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
IL-2R	NN	compound	B-protein
gamma	NN	nmod	I-protein
or	CC	cc	O
JAK3	NN	conj	B-protein
.	.	punct	O

Up-regulation	NN	ROOT	O
of	IN	case	O
high-affinity	JJ	amod	O
dehydroepiandrosterone	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
by	IN	case	O
dehydroepiandrosterone	NN	nmod	O
in	IN	case	O
activated	VBN	amod	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Although	IN	mark	O
evidence	NN	nsubj	O
indicates	VBZ	advcl	O
that	IN	mark	O
dehydroepiandrosterone	NN	nsubj	O
(	-LRB-	punct	O
DHEA	NN	appos	O
)	-RRB-	punct	O
exerts	VBZ	ccomp	O
direct	JJ	amod	O
physiological	JJ	amod	O
effects	NNS	dobj	O
,	,	punct	O
its	PRP$	nmod:poss	O
mechanism	NN	nsubj	O
of	IN	case	O
action	NN	nmod	O
remains	VBZ	ROOT	O
unknown	JJ	xcomp	O
.	.	punct	O

DHEA	NN	compound	O
binding	NN	compound	O
sites	NNS	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
whole-cell	JJ	amod	O
binding	NN	compound	O
assay	NN	dobj	O
in	IN	case	O
a	DT	det	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
lymphoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
PEER	NN	appos	B-cell_line
,	,	punct	O
revealing	VBG	xcomp	O
that	IN	mark	O
a	DT	det	O
single	JJ	amod	O
class	NN	nsubj	O
of	IN	case	O
high-affinity	JJ	amod	O
binding	VBG	amod	O
sites	NNS	nmod	O
for	IN	case	O
DHEA	NN	nmod	O
(	-LRB-	punct	O
dissociation	NN	compound	O
constant	NN	dep	O
=	JJ	amod	O
7.4	CD	nummod	O
+/-	CC	cc	O
0.53	CD	conj	O
nmol/L	NN	nmod	O
,	,	punct	O
mean	NN	conj	O
+/-	CC	cc	O
SE	NN	conj	O
,	,	punct	O
n	NN	nsubj	O
=	JJ	ccomp	O
4	CD	dobj	O
)	-RRB-	punct	O
was	VBD	auxpass	O
greatly	RB	advmod	O
increased	VBN	conj	O
when	WRB	advmod	O
treated	VBN	advcl	O
with	IN	case	O
DHEA	NN	nmod	O
,	,	punct	O
phorbol-12-myristate-13-acetate	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
Ca2+	NN	compound	O
ionophore	NN	compound	O
A23187	NN	conj	O
.	.	punct	O

Bound	VBN	ROOT	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
DHEA	NN	nsubjpass	O
was	VBD	auxpass	O
displaced	VBN	ccomp	O
sensitively	RB	advmod	O
by	IN	case	O
DHEA	NN	nmod	O
and	CC	cc	O
secondarily	RB	advmod	O
by	IN	case	O
dihydrotestosterone	NN	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
effectively	RB	conj	O
by	IN	case	O
other	JJ	amod	O
steroids	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
DHEA	NN	compound	O
sulfate	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
not	RB	neg	O
only	RB	cc:preconj	O
indicate	VBP	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
a	DT	det	O
DHEA	NN	compound	B-protein
receptor	NN	nmod	I-protein
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
suggest	VBP	conj	O
that	IN	mark	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
become	VBP	ccomp	O
susceptible	JJ	xcomp	O
to	TO	case	O
regulation	NN	nmod	O
by	IN	case	O
DHEA	NN	nmod	O
during	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
signal-induced	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

Ubiquitin-mediated	JJ	amod	O
processing	NN	ROOT	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcriptional	JJ	amod	B-protein
activator	NN	compound	I-protein
precursor	NN	nmod	I-protein
p105	NN	dep	B-protein
.	.	punct	O

Reconstitution	NN	ROOT	O
of	IN	case	O
a	DT	det	O
cell-free	JJ	amod	O
system	NN	nmod	O
and	CC	cc	O
identification	NN	conj	O
of	IN	case	O
the	DT	det	O
ubiquitin-carrier	JJ	amod	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
E2	NN	appos	B-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
novel	JJ	amod	O
ubiquitin-protein	NN	amod	B-protein
ligase	NN	conj	I-protein
,	,	punct	O
E3	NN	appos	B-protein
,	,	punct	O
involved	VBN	acl	O
in	IN	case	O
conjugation	NN	nmod	O
.	.	punct	O

In	IN	case	O
most	JJS	amod	O
cases	NNS	nmod	O
,	,	punct	O
the	DT	det	O
transcriptional	JJ	amod	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
heterodimer	NN	ROOT	B-protein
consisting	VBG	acl	O
of	IN	case	O
two	CD	nummod	O
subunits	NNS	nmod	O
,	,	punct	O
p50	NN	appos	B-protein
and	CC	cc	O
p65	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
encoded	VBN	acl:relcl	O
by	IN	case	O
two	CD	nummod	O
distinct	JJ	amod	O
genes	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Rel	NN	compound	B-DNA
family	NN	nmod	I-DNA
.	.	punct	O

p50	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
translated	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
precursor	NN	nmod	O
of	IN	case	O
105	CD	nummod	B-protein
kDa	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
C-terminal	JJ	amod	B-protein
domain	NN	nsubjpass	I-protein
of	IN	case	O
the	DT	det	O
precursor	NN	nmod	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
degraded	VBN	ROOT	O
,	,	punct	O
forming	VBG	xcomp	O
the	DT	det	O
mature	JJ	amod	B-protein
p50	NN	compound	I-protein
subunit	NN	dobj	I-protein
consisted	VBD	acl	O
of	IN	case	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
region	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
molecule	NN	nmod	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubjpass	O
of	IN	case	O
generation	NN	nmod	O
of	IN	case	O
p50	NN	nmod	B-protein
is	VBZ	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
ubiquitin	NN	compound	B-protein
-proteasome	JJ	amod	B-protein
system	NN	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
specific	JJ	amod	O
enzymes	NNS	nsubj	B-protein
involved	VBN	acl	O
and	CC	cc	O
the	DT	det	O
mechanism	NN	conj	O
of	IN	case	O
limited	JJ	amod	O
proteolysis	NN	nmod	O
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
half	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
molecule	NN	nmod	O
is	VBZ	auxpass	O
spared	VBN	acl:relcl	O
,	,	punct	O
have	VBP	aux	O
been	VBN	parataxis	O
obscure	JJ	acomp	O
.	.	punct	O

Palombella	NN	nsubj	O
and	CC	cc	O
colleagues	NNS	conj	O
(	-LRB-	punct	O
Palombella	NNP	nmod	O
,	,	punct	O
V.J.	NNP	appos	O
,	,	punct	O
Rando	NNP	conj	O
,	,	punct	O
O.J.	NNP	conj	O
,	,	punct	O
Goldberg	NNP	conj	O
,	,	punct	O
A.L.	NNP	conj	O
,	,	punct	O
and	CC	cc	O
Maniatis	NNP	compound	O
,	,	punct	O
T.	NNP	compound	O
(	-LRB-	punct	O
1994	CD	dep	O
)	-RRB-	punct	O
Cell	NNP	conj	O
78	CD	nummod	O
,	,	punct	O
773-785	CD	appos	O
)	-RRB-	punct	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
ubiquitin	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
the	DT	det	O
processing	NN	nmod	O
in	IN	case	O
a	DT	det	O
cell-free	JJ	amod	O
system	NN	nmod	O
of	IN	case	O
a	DT	det	O
truncated	VBN	amod	O
,	,	punct	O
artificially	RB	advmod	O
constructed	VBN	dep	O
,	,	punct	O
60-kDa	JJ	amod	B-protein
precursor	NN	nmod	I-protein
.	.	punct	O

They	PRP	nsubj	O
have	VBP	aux	O
also	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
proteasome	NN	compound	B-protein
inhibitors	NNS	nsubj	O
block	VBP	ccomp	O
the	DT	det	O
processing	NN	dobj	O
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
reconstitution	NN	dobj	O
of	IN	case	O
a	DT	det	O
cell-free	JJ	amod	O
processing	NN	compound	O
system	NN	nmod	O
and	CC	cc	O
demonstrate	VB	conj	O
directly	RB	advmod	O
that	DT	dobj	O
:	:	punct	O
(	-LRB-	punct	O
a	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
ubiquitin	NN	compound	B-protein
-proteasome	JJ	amod	B-protein
system	NN	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
processing	NN	nmod	O
of	IN	case	O
the	DT	det	O
intact	JJ	amod	O
p105	NN	compound	B-protein
precursor	NN	nmod	O
,	,	punct	O
(	-LRB-	punct	O
b	LS	appos	O
)	-RRB-	punct	O
conjugation	NN	nsubj	O
of	IN	case	O
ubiquitin	NN	nmod	B-protein
to	TO	case	O
the	DT	det	O
precursor	NN	nmod	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
intermediate	JJ	amod	O
step	NN	nmod	O
in	IN	case	O
the	DT	det	O
processing	NN	nmod	O
,	,	punct	O
(	-LRB-	punct	O
c	LS	appos	O
)	-RRB-	punct	O
the	DT	det	O
recently	RB	advmod	O
discovered	VBN	amod	O
novel	JJ	amod	O
species	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
ubiquitin-carrier	JJ	amod	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
E2-F1	NN	appos	B-protein
,	,	punct	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
conjugation	NN	nmod	O
and	CC	cc	O
degradation	NN	conj	O
of	IN	case	O
p53	NN	nmod	B-protein
,	,	punct	O
is	VBZ	auxpass	O
also	RB	advmod	O
required	VBN	conj	O
for	IN	case	O
the	DT	det	O
limited	JJ	amod	O
processing	NN	nmod	O
of	IN	case	O
the	DT	det	O
p105	NN	compound	B-protein
precursor	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
(	-LRB-	punct	O
d	LS	dep	O
)	-RRB-	punct	O
a	DT	det	O
novel	JJ	amod	O
,	,	punct	O
approximately	RB	advmod	O
320-kDa	JJ	dep	B-protein
species	NNS	conj	I-protein
of	IN	case	O
ubiquitin-protein	JJ	amod	B-protein
ligase	NN	nmod	I-protein
,	,	punct	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
.	.	punct	O

This	DT	det	O
novel	JJ	amod	O
enzyme	NN	nsubj	O
is	VBZ	cop	O
distinct	JJ	ROOT	O
from	IN	case	O
E6-AP	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
p53-conjugating	JJ	amod	B-protein
ligase	NN	appos	I-protein
,	,	punct	O
and	CC	cc	O
from	IN	case	O
E3	NN	compound	B-protein
alpha	NN	conj	I-protein
,	,	punct	O
the	DT	det	O
``	``	punct	B-protein
N-end	NN	compound	I-protein
rule	NN	compound	I-protein
''	''	punct	I-protein
ligase	NN	appos	I-protein
.	.	punct	O

Flutamide	NN	ROOT	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
hirsutism	NN	nmod	O
:	:	punct	O
long-term	JJ	amod	O
clinical	JJ	amod	O
effects	NNS	dep	O
,	,	punct	O
endocrine	JJ	amod	O
changes	NNS	conj	O
,	,	punct	O
and	CC	cc	O
androgen	NN	compound	B-protein
receptor	NN	compound	I-protein
behavior	NN	conj	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
long-term	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
low	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
flutamide	NN	nmod	O
on	IN	case	O
clinical	JJ	amod	O
and	CC	cc	O
hormonal	JJ	conj	O
parameters	NNS	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
on	IN	case	O
the	DT	det	O
androgen	NN	compound	B-protein
receptor	NN	compound	I-protein
status	NN	conj	O
,	,	punct	O
in	IN	case	O
hirsute	JJ	amod	O
women	NNS	nmod	O
.	.	punct	O

DESIGN	NN	dep	O
:	:	punct	O
Eighteen	CD	nummod	O
hirsute	JJ	amod	O
patients	NNS	nsubjpass	O
with	IN	case	O
regular	JJ	amod	O
menses	NNS	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
basally	RB	advmod	O
and	CC	advmod	O
during	IN	case	O
treatment	NN	conj	O
with	IN	case	O
125	CD	compound	O
mg	NN	nummod	O
flutamide	NN	nmod	O
,	,	punct	O
three	CD	nummod	O
times	NNS	conj	O
per	IN	prep	O
day	NN	pobj	O
for	IN	prep	O
12	CD	nummod	O
months	NNS	pobj	O
.	.	punct	O

Barrier	NN	amod	O
or	CC	cc	O
intrauterine	JJ	conj	O
contraception	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
during	IN	case	O
the	DT	det	O
study	NN	nmod	O
in	IN	case	O
sexually	RB	advmod	O
active	JJ	amod	O
women	NNS	nmod	O
.	.	punct	O

Safety	NN	compound	O
parameters	NNS	nsubjpass	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
throughout	IN	case	O
the	DT	det	O
study	NN	nmod	O
.	.	punct	O

Hirsutism	NN	nsubjpass	O
,	,	punct	O
graded	VBN	acl	O
by	IN	agent	O
the	DT	det	O
modified	VBN	amod	O
Ferriman-Gallwey	JJ	amod	O
score	NN	pobj	O
,	,	punct	O
and	CC	cc	O
hormonal	JJ	amod	O
parameters	NNS	nsubjpass	O
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
basally	RB	advmod	O
and	CC	advmod	O
at	IN	case	O
4-month	JJ	amod	O
intervals	NNS	conj	O
during	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

Gonadotropin-releasing	JJ	amod	O
hormone	NN	nsubjpass	O
and	CC	cc	O
ACTH	NN	compound	O
stimulation	NN	compound	O
tests	NNS	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
before	IN	nmod	O
and	CC	cc	O
after	IN	case	O
3	CD	compound	O
to	TO	dep	O
4	CD	nummod	O
months	NNS	nmod	O
of	IN	case	O
therapy	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
concentration	NN	nsubjpass	O
of	IN	case	O
androgen	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
was	VBD	auxpass	O
measured	VBN	ROOT	O
,	,	punct	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
follicular	JJ	nmod	O
and	CC	cc	O
luteal	JJ	conj	O
phases	NNS	dep	O
of	IN	case	O
the	DT	det	O
menstrual	JJ	amod	O
cycle	NN	nmod	O
,	,	punct	O
basally	RB	advmod	O
and	CC	cc	O
after	IN	case	O
4	CD	nummod	O
months	NNS	conj	O
of	IN	case	O
flutamide	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Flutamide	NN	nsubjpass	O
was	VBD	auxpass	O
well	RB	advmod	O
tolerated	VBN	dep	O
in	IN	case	O
all	DT	det	O
women	NNS	nmod	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
noticeable	JJ	amod	O
exception	NN	nmod	O
of	IN	case	O
one	CD	nummod	O
patient	NN	nmod	O
who	WP	nsubj	O
presented	VBD	acl:relcl	O
increased	VBN	amod	O
serum	NN	compound	B-protein
transaminase	NN	dobj	I-protein
after	IN	case	O
8	CD	nummod	O
months	NNS	nmod	O
of	IN	case	O
therapy	NN	nmod	O
.	.	punct	O

Hirsutism	NN	nsubj	O
markedly	RB	advmod	O
improved	VBD	ROOT	O
in	IN	case	O
all	DT	det	O
women	NNS	nmod	O
during	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
(	-LRB-	punct	O
Ferriman-Gallwey	JJ	amod	O
score	NN	dep	O
after	IN	case	O
1	CD	nummod	O
year	NN	nmod	O
:	:	punct	O
4.1	CD	dep	O
+/-	CC	cc	O
0.5	CD	conj	O
versus	CC	cc	O
14.1	CD	conj	O
+/-	CC	cc	O
0.9	CD	conj	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
reduction	NN	nsubjpass	O
of	IN	case	O
serum	NN	compound	O
androgens	NNS	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
,	,	punct	O
whereas	IN	dep	O
no	DT	neg	O
change	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	parataxis	O
in	IN	case	O
either	CC	cc:preconj	O
basal	JJ	nmod	O
or	CC	cc	O
GnRH-stimulated	JJ	conj	O
gonadotropins	NNS	dep	O
or	CC	cc	O
in	IN	case	O
the	DT	det	O
cortisol	NN	conj	O
and	CC	cc	O
17	CD	nummod	O
alpha-hydroxyprogesterone	NN	amod	O
response	NN	dep	O
to	TO	case	O
ACTH	NN	nmod	O
.	.	punct	O

Cycles	NNS	nsubj	O
remained	VBD	ROOT	O
ovulatory	JJ	xcomp	O
.	.	punct	O

Before	IN	case	O
treatment	NN	nmod	O
,	,	punct	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
androgen	NN	compound	B-protein
receptors	NNS	nmod	I-protein
was	VBD	cop	O
higher	JJR	ROOT	O
in	IN	case	O
the	DT	det	O
luteal	NN	nmod	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
follicular	JJ	amod	O
phase	NN	nmod	O
.	.	punct	O

This	DT	det	O
rhythmic	JJ	amod	O
differentiation	NN	nsubj	O
disappeared	VBD	ROOT	O
after	IN	mark	O
the	DT	det	O
patients	NNS	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
given	VBN	advcl	O
the	DT	det	O
antiandrogen	JJ	amod	O
drug	NN	dobj	O
.	.	punct	O

CONCLUSIONS	NNS	dep	O
:	:	punct	O
Flutamide	NN	nsubj	O
is	VBZ	cop	O
effective	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
hirsutism	NN	nmod	O
but	CC	cc	O
requires	VBZ	conj	O
constant	JJ	amod	O
surveillance	NN	dobj	O
of	IN	case	O
liver	NN	compound	O
function	NN	nmod	O
.	.	punct	O

Androgen	NN	compound	O
receptor	NN	compound	O
blockade	NN	nsubjpass	O
might	MD	aux	O
be	VB	auxpass	O
potentiated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
of	IN	case	O
serum	NN	compound	O
androgens	NNS	nmod	O
.	.	punct	O

Flutamide	NN	nsubj	O
affects	VBZ	ROOT	O
androgen	NN	compound	B-protein
receptor	NN	compound	I-protein
behavior	NN	dobj	O
during	IN	case	O
the	DT	det	O
menstrual	JJ	amod	O
cycle	NN	nmod	O
.	.	punct	O

The	DT	det	O
meaning	NN	nsubj	O
of	IN	case	O
this	DT	det	O
finding	NN	nmod	O
remains	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
elucidated	VBN	xcomp	O
.	.	punct	O

Constitutive	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
HIV-1	NN	compound	B-protein
tat	NN	compound	I-protein
protein	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
using	VBG	acl	O
a	DT	det	O
BK	NN	compound	O
virus	NN	compound	O
vector	NN	dobj	O
.	.	punct	O

The	DT	det	O
production	NN	nsubjpass	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
that	WDT	nsubj	O
constitutively	RB	advmod	O
express	VBP	acl:relcl	O
functional	JJ	amod	O
human	JJ	amod	B-protein
immune	JJ	amod	I-protein
deficiency	NN	compound	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	I-protein
HIV-1	NN	compound	I-protein
)	-RRB-	punct	I-protein
tat	NN	compound	I-protein
protein	NN	dobj	I-protein
,	,	punct	O
using	VBG	acl	O
a	DT	det	O
BK	NN	compound	O
virus	NN	compound	O
plasmid	NN	compound	O
expression	NN	compound	O
vector	NN	dobj	O
and	CC	cc	O
HIV-1	NN	compound	B-DNA
tat	NN	compound	I-DNA
cDNA	NN	conj	I-DNA
,	,	punct	O
is	VBZ	auxpass	O
described	VBN	ROOT	O
.	.	punct	O

An	DT	det	O
increased	VBN	amod	O
growth	NN	compound	O
rate	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
Jurkat-tat	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
as	IN	mark	O
compared	VBN	acl	O
with	IN	case	O
control	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

A	DT	det	O
PEBP2	NN	compound	B-protein
alpha/AML-1-related	JJ	amod	I-protein
factor	NN	nsubj	I-protein
increases	VBZ	ROOT	O
osteocalcin	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
through	IN	case	O
its	PRP$	nmod:poss	O
binding	NN	nmod	O
to	TO	case	O
an	DT	det	O
osteoblast-specific	JJ	amod	B-DNA
cis-acting	JJ	amod	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
osteoblast-specific	JJ	amod	B-DNA
cis-acting	JJ	amod	I-DNA
elements	NNS	dobj	I-DNA
and	CC	cc	O
trans-acting	JJ	amod	B-protein
factors	NNS	conj	I-protein
,	,	punct	O
we	PRP	nsubj	O
initiated	VBD	ROOT	O
an	DT	det	O
analysis	NN	dobj	O
of	IN	case	O
the	DT	det	O
promoter	NN	nmod	B-DNA
of	IN	case	O
a	DT	det	O
mouse	NN	compound	B-DNA
osteocalcin	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
an	DT	det	O
osteoblast-specific	JJ	amod	B-DNA
gene	NN	appos	I-DNA
.	.	punct	O

In	IN	case	O
this	DT	det	O
promoter	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
two	CD	nummod	O
osteoblast-specific	JJ	amod	B-DNA
cis-acting	JJ	amod	I-DNA
elements	NNS	dobj	I-DNA
(	-LRB-	punct	O
Ducy	NNP	dep	O
,	,	punct	O
P.and	NNP	compound	O
Karsenty	NNP	compound	O
,	,	punct	O
G.	NNP	conj	O
(	-LRB-	punct	O
1995	CD	appos	O
)	-RRB-	punct	O
Mol.Cell.Biol.15	NNP	dep	O
,	,	punct	O
1858-1869	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
sequence	NN	nsubj	O
of	IN	case	O
one	CD	nmod	O
of	IN	case	O
these	DT	det	O
elements	NNS	nmod	B-DNA
,	,	punct	O
OSE2	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
identical	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
DNA-binding	JJ	amod	B-DNA
site	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
PEBP2	NN	compound	B-protein
alpha/AML-1	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
the	DT	det	O
mammalian	JJ	amod	B-protein
homologues	NNS	dobj	I-protein
of	IN	case	O
the	DT	det	O
Drosophila	FW	compound	B-protein
Runt	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
,	,	punct	O
using	VBG	xcomp	O
nuclear	JJ	amod	O
extracts	NNS	dobj	O
,	,	punct	O
recombinant	JJ	amod	B-protein
protein	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
specific	JJ	amod	O
antiserum	NN	conj	O
against	IN	case	O
AML-1	NN	compound	B-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
DNA-binding	JJ	amod	O
assays	NNS	nmod	O
,	,	punct	O
that	IN	mark	O
one	CD	nummod	O
member	NN	nsubj	O
of	IN	case	O
this	DT	det	O
family	NN	nmod	O
,	,	punct	O
AML-1B	NN	appos	B-protein
,	,	punct	O
binds	VBZ	acl:relcl	O
specifically	RB	advmod	O
to	TO	case	O
OSE2	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
immunologically	RB	advmod	O
related	JJ	conj	O
to	TO	case	O
OSF2	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
factor	NN	appos	O
present	JJ	amod	O
in	IN	case	O
osteoblast	NN	compound	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
OSE2	NN	nmod	O
.	.	punct	O

By	IN	case	O
DNA	NN	compound	O
cotransfection	NN	compound	O
experiments	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
also	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
AML-1B	NN	nsubj	B-protein
can	MD	aux	O
increase	VB	ccomp	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
a	DT	det	O
short	JJ	amod	O
osteocalcin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
through	IN	case	O
its	PRP$	nmod:poss	O
binding	NN	nmod	O
to	TO	case	O
OSE2	NN	nmod	O
.	.	punct	O

Lastly	RB	advmod	O
,	,	punct	O
the	DT	det	O
different	JJ	amod	O
mobilities	NNS	nsubj	O
of	IN	case	O
osteoblast	NN	compound	B-protein
nuclear	JJ	amod	I-protein
extract-DNA	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
compared	VBN	case	O
with	IN	case	O
T-cell	NN	compound	B-protein
nuclear	JJ	amod	I-protein
extract-DNA	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
,	,	punct	O
along	IN	case	O
with	IN	case	O
the	DT	det	O
inability	NN	nmod	O
of	IN	case	O
OSF2	NN	nmod	B-protein
to	TO	mark	O
be	VB	auxpass	O
upregulated	VBN	acl	O
by	IN	case	O
retinoic	JJ	amod	O
acid	NN	nmod	O
,	,	punct	O
unlike	IN	case	O
the	DT	det	O
other	JJ	amod	O
PEBP2	NN	compound	B-protein
alpha	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
suggest	VBP	ROOT	O
that	IN	mark	O
OSF2	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
new	JJ	amod	O
member	NN	ccomp	O
of	IN	case	O
this	DT	det	O
family	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
AML-1B	NN	nsubj	B-protein
can	MD	aux	O
increase	VB	ccomp	O
gene	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
an	DT	det	O
osteoblast-specific	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
through	IN	case	O
its	PRP$	nmod:poss	O
binding	NN	nmod	O
to	TO	case	O
an	DT	det	O
osteoblast-specific	JJ	amod	B-DNA
cis-acting	JJ	amod	I-DNA
element	NN	nmod	I-DNA
and	CC	cc	O
presents	VBZ	conj	O
evidence	NN	dobj	O
that	IN	mark	O
OSF2	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
member	NN	ccomp	O
of	IN	case	O
the	DT	det	O
PEBP2	NN	compound	B-protein
alpha/AML-1	NN	compound	I-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Initiation	NN	compound	B-protein
binding	NN	compound	I-protein
repressor	NN	nsubj	I-protein
,	,	punct	O
a	DT	det	O
factor	NN	appos	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
histone	NN	compound	B-DNA
h5	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
glycosylated	VBN	amod	B-protein
member	NN	ROOT	I-protein
of	IN	case	O
a	DT	det	O
family	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-protein
growth	NN	compound	I-protein
regulators	NNS	nmod	I-protein
[	-LRB-	punct	O
corrected	VBN	dep	O
]	-RRB-	punct	O
[	-LRB-	punct	O
published	VBN	amod	O
erratum	NN	nsubj	O
appears	VBZ	dep	O
in	IN	case	O
Mol	NNP	compound	O
Cell	NNP	compound	O
Biol	NNP	compound	O
1996	CD	nummod	O
Feb	NNP	nmod	O
;	:	punct	O
16	CD	nummod	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
:	:	punct	O
735	CD	dep	O
]	-RRB-	punct	O

Initiation	NN	compound	B-protein
binding	NN	compound	I-protein
repressor	NN	nsubj	I-protein
[	-LRB-	punct	O
corrected	VBN	ROOT	O
]	-RRB-	punct	O
(	-LRB-	punct	O
IBR	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
chicken	NN	compound	B-protein
erythrocyte	NN	compound	I-protein
factor	NN	xcomp	I-protein
(	-LRB-	punct	O
apparent	JJ	amod	O
molecular	JJ	amod	O
mass	NN	dep	O
,	,	punct	O
70	CD	compound	O
to	TO	dep	O
73	CD	nummod	O
kDa	NN	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
sequences	NNS	nmod	O
spanning	VBG	acl	O
the	DT	det	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
site	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
histone	NN	compound	B-DNA
h5	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
repressing	VBG	xcomp	O
its	PRP$	nmod:poss	O
transcription	NN	dobj	O
.	.	punct	O

A	DT	det	O
variety	NN	nsubj	O
of	IN	case	O
other	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
transformed	VBN	amod	B-cell_type
erythroid	JJ	amod	I-cell_type
precursors	NNS	nmod	I-cell_type
,	,	punct	O
do	VBP	aux	O
not	RB	neg	O
have	VB	ROOT	O
IBR	NN	dobj	B-protein
but	CC	cc	O
a	DT	det	O
factor	NN	conj	O
referred	VBN	acl	O
to	TO	nmod	O
as	IN	case	O
IBF	NN	nmod	B-protein
(	-LRB-	punct	O
68	CD	compound	O
to	TO	dep	O
70	CD	nummod	O
kDa	NN	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
recognizes	VBZ	acl:relcl	O
the	DT	det	O
same	JJ	amod	O
IBR	NN	compound	B-protein
sites	NNS	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
cloned	VBN	ROOT	O
the	DT	det	O
IBR	NN	compound	B-DNA
cDNA	NN	dobj	I-DNA
and	CC	cc	O
studied	VBD	conj	O
the	DT	det	O
relationship	NN	dobj	O
of	IN	case	O
IBR	NN	nmod	B-protein
and	CC	cc	O
IBF	NN	conj	B-protein
.	.	punct	O

IBR	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
503-amino-acid-long	JJ	amod	B-protein
acidic	JJ	amod	I-protein
protein	NN	ROOT	I-protein
which	WDT	nsubj	O
is	VBZ	cop	O
99.0	CD	nummod	O
%	NN	nmod:npmod	O
identical	JJ	acl:relcl	O
to	TO	case	O
the	DT	det	O
recently	RB	advmod	O
reported	VBN	amod	O
human	JJ	amod	B-protein
NRF-1/alpha-Pal	NN	compound	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
highly	RB	advmod	O
related	JJ	conj	O
to	TO	case	O
the	DT	det	O
invertebrate	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
P3A2	NN	dep	B-protein
and	CC	cc	O
erected	JJ	amod	B-protein
wing	NN	compound	I-protein
gene	NN	compound	I-protein
product	NN	conj	I-protein
(	-LRB-	punct	O
EWG	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
present	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
IBR	NN	nsubj	B-protein
and	CC	cc	O
IBF	NN	conj	B-protein
are	VBP	cop	O
most	RBS	advmod	O
likely	RB	advmod	O
identical	JJ	amod	O
proteins	NNS	ccomp	O
,	,	punct	O
differing	VBG	acl	O
in	IN	case	O
their	PRP$	nmod:poss	O
degree	NN	nmod	O
of	IN	case	O
glycosylation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
analyzed	VBN	ROOT	O
several	JJ	amod	O
molecular	JJ	amod	O
aspects	NNS	dobj	O
of	IN	case	O
IBR/F	NN	nmod	B-protein
and	CC	cc	O
shown	VBN	conj	O
that	IN	mark	O
the	DT	det	O
factor	NN	nsubj	O
associates	VBZ	ccomp	O
as	IN	case	O
stable	JJ	amod	O
homodimers	NNS	nmod	B-protein
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
dimer	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
relevant	JJ	amod	B-protein
DNA-binding	JJ	amod	I-protein
species	NNS	conj	I-protein
.	.	punct	O

The	DT	det	O
evolutionarily	RB	advmod	O
conserved	VBN	amod	O
N-terminal	JJ	amod	B-protein
half	NN	nsubj	I-protein
of	IN	case	O
IBR/F	NN	nmod	B-protein
harbors	VBZ	ROOT	O
the	DT	det	O
DNA-binding/dimerization	JJ	amod	B-protein
domain	NN	dobj	I-protein
(	-LRB-	punct	O
outer	JJ	amod	O
limits	NNS	dep	O
,	,	punct	O
127	CD	compound	O
to	TO	dep	O
283	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
one	CD	nummod	O
or	CC	cc	O
several	JJ	conj	O
casein	NN	compound	B-protein
kinase	NN	compound	I-protein
II	CD	nummod	I-protein
sites	NNS	conj	I-protein
(	-LRB-	punct	O
37	CD	compound	O
to	TO	dep	O
67	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
bipartite	JJ	amod	B-protein
nuclear	JJ	amod	I-protein
localization	NN	compound	I-protein
signal	NN	conj	I-protein
(	-LRB-	punct	O
89	CD	nummod	O
to	TO	dep	O
106	CD	dep	O
)	-RRB-	punct	O
which	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
necessary	JJ	xcomp	O
for	IN	case	O
nuclear	JJ	amod	O
targeting	NN	nmod	O
.	.	punct	O

Binding	VBG	amod	O
site	NN	compound	O
selection	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
alternating	VBG	amod	B-protein
RCGCRYGCGY	NN	compound	I-protein
consensus	NN	nsubj	I-protein
constitutes	VBZ	ccomp	O
high-affinity	JJ	amod	O
IBR/F	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
direct-repeat	JJ	amod	B-DNA
palindrome	NN	nsubj	I-DNA
TGCGCATGCGCA	NN	dep	O
is	VBZ	cop	O
the	DT	det	O
optimal	JJ	amod	B-DNA
site	NN	conj	I-DNA
.	.	punct	O

A	DT	det	O
survey	NN	nsubj	O
of	IN	case	O
genes	NNS	nmod	B-DNA
potentially	RB	advmod	O
regulated	VBN	acl	O
by	IN	case	O
this	DT	det	O
family	NN	nmod	O
of	IN	case	O
factors	NNS	nmod	B-protein
primarily	RB	advmod	O
revealed	VBD	ROOT	O
genes	NNS	dobj	B-DNA
involved	VBN	acl	O
in	IN	case	O
growth-related	JJ	amod	O
metabolism	NN	nmod	O
.	.	punct	O

Triggering	NN	nsubj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
interleukin-6	NN	compound	O
gene	NN	nmod	O
by	IN	case	O
interferon-gamma	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	O
necrosis	NN	compound	O
factor-alpha	NN	conj	O
in	IN	case	O
monocytic	JJ	amod	O
cells	NNS	nmod	O
involves	VBZ	ROOT	O
cooperation	NN	dobj	O
between	IN	case	O
interferon	NN	compound	B-protein
regulatory	JJ	amod	I-protein
factor-1	NN	nmod	I-protein
,	,	punct	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
Sp1	NN	compound	B-protein
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
of	IN	case	O
the	DT	det	O
synergistic	JJ	amod	O
induction	NN	nmod	O
by	IN	case	O
interferon-gamma	NN	nmod	B-protein
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
/	:	punct	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	conj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
of	IN	case	O
human	JJ	amod	B-DNA
interleukin-6	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IL-6	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
THP-1	NN	compound	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
compared	VBD	conj	O
it	PRP	dobj	O
with	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
this	DT	det	O
induction	NN	nmod	O
by	IN	case	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Functional	JJ	amod	O
studies	NNS	nsubj	O
with	IN	case	O
IL-6	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
demonstrated	VBD	ROOT	O
that	IN	mark	O
three	CD	nummod	O
regions	NNS	nsubj	O
are	VBP	cop	O
the	DT	det	O
targets	NNS	ccomp	O
of	IN	case	O
the	DT	dep	O
IFN-gamma	NN	nmod	B-protein
and/or	CC	cc	O
TNF-alpha	NN	conj	B-protein
action	NN	dep	O
,	,	punct	O
whereas	IN	dep	O
only	RB	advmod	O
one	CD	nsubj	O
of	IN	case	O
these	DT	det	O
regions	NNS	nmod	O
seemed	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
implicated	VBN	xcomp	O
in	IN	case	O
LPS	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

The	DT	det	O
three	CD	nummod	O
regions	NNS	nsubj	O
concerned	VBN	acl	O
are	VBP	ROOT	O
:	:	punct	O
1	LS	dep	O
)	-RRB-	punct	O
a	DT	det	O
region	NN	attr	O
between	IN	case	O
-73	CD	nmod	O
and	CC	cc	O
-36	CD	conj	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
the	DT	det	O
minimal	JJ	amod	B-DNA
element	NN	acl:relcl	I-DNA
inducible	JJ	amod	O
by	IN	case	O
LPS	NN	nmod	O
or	CC	cc	O
TNF-alpha	NN	conj	B-protein
;	:	punct	O
2	LS	dep	O
)	-RRB-	punct	O
an	DT	det	O
element	NN	dep	O
located	JJ	amod	O
between	IN	case	O
-181	CD	nmod	O
and	CC	cc	O
-73	CD	conj	O
,	,	punct	O
which	WDT	nsubj	O
appeared	VBD	acl:relcl	O
to	TO	mark	O
regulate	VB	xcomp	O
the	DT	det	O
response	NN	dobj	O
to	TO	case	O
IFN-gamma	NN	nmod	B-protein
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
negatively	RB	advmod	O
;	:	punct	O
and	CC	cc	O
3	LS	conj	O
)	-RRB-	punct	O
a	DT	det	O
distal	JJ	amod	B-DNA
element	NN	appos	I-DNA
upstream	JJ	advmod	I-DNA
of	IN	case	O
-224	CD	nmod	O
,	,	punct	O
which	WDT	nsubj	O
was	VBD	cop	O
inducible	JJ	acl:relcl	O
by	IN	case	O
IFN-gamma	NN	nmod	B-protein
alone	RB	advmod	O
.	.	punct	O

LPS	NN	compound	O
signaling	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
activation	NN	dobj	O
by	IN	case	O
the	DT	det	O
p50/p65	NN	compound	B-protein
heterodimers	NNS	nmod	I-protein
.	.	punct	O

Synergistic	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
IL-6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
by	IN	case	O
IFN-gamma	NN	nmod	B-protein
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
involved	VBN	ROOT	O
cooperation	NN	dobj	O
between	IN	case	O
the	DT	dep	O
IRF-1	NN	nmod	B-protein
and	CC	cc	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
p65	NN	compound	I-protein
homodimers	NNS	conj	I-protein
with	IN	case	O
concomitant	JJ	amod	O
removal	NN	nmod	O
of	IN	case	O
the	DT	det	O
negative	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
the	DT	det	O
retinoblastoma	NN	compound	B-DNA
control	NN	compound	I-DNA
element	NN	nmod	I-DNA
present	JJ	amod	O
in	IN	case	O
the	DT	det	O
IL-6	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

This	DT	det	O
removal	NN	nsubj	O
occurred	VBD	ROOT	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
constitutive	JJ	amod	B-protein
Sp1	NN	compound	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
whose	WP$	nmod:poss	O
increased	VBN	amod	O
binding	NN	compound	O
activity	NN	nsubjpass	O
and	CC	cc	O
phosphorylation	NN	conj	O
were	VBD	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
IFN-gamma	NN	nmod	B-protein
.	.	punct	O

Mutation	NN	ROOT	O
of	IN	case	O
Jak3	NN	nmod	B-protein
in	IN	case	O
a	DT	det	O
patient	NN	nmod	O
with	IN	case	O
SCID	NN	nmod	O
:	:	punct	O
essential	JJ	amod	O
role	NN	dep	O
of	IN	case	O
Jak3	NN	nmod	B-protein
in	IN	case	O
lymphoid	JJ	amod	O
development	NN	nmod	O
.	.	punct	O

Males	NNS	nsubj	O
with	IN	case	O
X-linked	JJ	amod	O
severe	JJ	amod	O
combined	JJ	amod	O
immunodeficiency	NN	nmod	O
(	-LRB-	punct	O
XSCID	NN	appos	O
)	-RRB-	punct	O
have	VBP	ROOT	O
defects	NNS	dobj	O
in	IN	case	O
the	DT	det	O
common	JJ	amod	O
cytokine	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gamma	NN	compound	I-DNA
chain	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
gamma	NN	compound	I-DNA
c	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
that	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
a	DT	det	O
shared	JJ	amod	O
,	,	punct	O
essential	JJ	dep	O
component	NN	dobj	O
of	IN	case	O
the	DT	det	O
receptors	NNS	nmod	O
of	IN	case	O
interleukin-2	NN	nmod	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
IL-4	NN	conj	B-protein
,	,	punct	O
IL-7	NN	conj	B-protein
,	,	punct	O
IL-9	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-15	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
Janus	NN	compound	B-protein
family	NN	compound	I-protein
tyrosine	NN	compound	I-protein
kinase	NN	compound	I-protein
Jak3	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
only	JJ	amod	O
signaling	VBG	amod	O
molecule	NN	ROOT	O
known	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
gamma	NN	compound	B-protein
c	NN	nmod	I-protein
,	,	punct	O
so	CC	advmod	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
hypothesized	VBN	conj	O
that	IN	mark	O
defects	NNS	nsubj	O
in	IN	case	O
Jak3	NN	nmod	B-protein
might	MD	aux	O
cause	VB	ccomp	O
an	DT	det	O
XSCID-like	JJ	amod	O
phenotype	NN	dobj	O
.	.	punct	O

A	DT	det	O
girl	NN	nsubjpass	O
with	IN	case	O
immunological	JJ	amod	O
features	NNS	nmod	O
indistinguishable	JJ	amod	O
from	IN	case	O
those	DT	nmod	O
of	IN	case	O
XSCID	NN	nmod	O
was	VBD	auxpass	O
therefore	RB	advmod	O
selected	VBN	ROOT	O
for	IN	case	O
analysis	NN	nmod	O
.	.	punct	O

An	DT	det	O
Epstein-Barr	JJ	amod	B-cell_line
virus	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
EBV	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
-transformed	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nsubj	I-cell_line
derived	VBN	acl	O
from	IN	case	O
her	PRP$	nmod:poss	O
lymphocytes	NNS	nmod	B-cell_type
had	VBD	ROOT	O
normal	JJ	amod	O
gamma	NN	compound	B-protein
c	NN	compound	I-protein
expression	NN	dobj	O
but	CC	cc	O
lacked	VBD	conj	O
Jak3	NN	compound	B-protein
protein	NN	dobj	I-protein
and	CC	cc	O
had	VBD	aux	O
greatly	RB	advmod	O
diminished	VBN	conj	O
Jak3	NN	compound	B-RNA
messenger	NN	compound	I-RNA
RNA	NN	dobj	I-RNA
.	.	punct	O

Sequencing	NN	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
different	JJ	amod	O
mutation	NN	dobj	O
on	IN	case	O
each	DT	det	O
allele	NN	nmod	O
:	:	punct	O
a	DT	det	O
single	JJ	amod	O
nucleotide	NN	compound	O
insertion	NN	dep	O
resulting	VBG	acl	O
in	IN	case	O
a	DT	det	O
frame	NN	compound	O
shift	NN	nmod	O
and	CC	cc	O
premature	JJ	amod	O
termination	NN	conj	O
in	IN	case	O
the	DT	det	O
Jak3	NN	compound	B-protein
JH4	NN	compound	I-protein
domain	NN	nmod	I-protein
and	CC	cc	O
a	DT	det	O
nonsense	NN	compound	O
mutation	NN	conj	O
in	IN	case	O
the	DT	det	O
Jak3	NN	compound	B-protein
JH2	NN	compound	O
domain	NN	nmod	O
.	.	punct	O

The	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
Jak3	NN	compound	B-protein
expression	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
impaired	JJ	amod	O
B	NN	compound	O
cell	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
as	IN	mark	O
demonstrated	VBN	advcl	O
by	IN	case	O
the	DT	det	O
inability	NN	nmod	O
of	IN	case	O
IL-4	NN	nmod	B-protein
to	TO	mark	O
activate	VB	acl	O
Stat6	NN	dobj	B-protein
in	IN	case	O
the	DT	det	O
EBV-transformed	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
from	IN	case	O
the	DT	det	O
patient.	NN	nmod	O
These	DT	det	O
observations	NNS	nsubj	O
indicate	VBP	conj	O
that	IN	mark	O
the	DT	det	O
functions	NNS	nsubj	O
of	IN	case	O
gamma	NN	compound	B-protein
c	NN	nmod	I-protein
are	VBP	cop	O
dependent	JJ	ccomp	O
on	IN	case	O
Jak3	NN	nmod	B-protein
and	CC	cc	O
that	IN	mark	O
Jak3	NN	nsubj	B-protein
is	VBZ	cop	O
essential	JJ	conj	O
for	IN	case	O
lymphoid	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
signaling	NN	conj	O
.	.	punct	O

Constitutive	JJ	amod	O
overexpression	NN	ROOT	O
of	IN	case	O
the	DT	det	O
L-selectin	NN	compound	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
fresh	JJ	amod	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
adult	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	nmod	O
that	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
transactivated	VBN	acl:relcl	O
by	IN	case	O
human	JJ	amod	B-protein
T-cell	NN	compound	I-protein
lymphotropic	JJ	amod	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
Tax	NN	nmod	I-protein
.	.	punct	O

L-selectin	NN	nsubj	B-protein
is	VBZ	cop	O
an	DT	det	O
adhesion	NN	compound	O
molecule	NN	ROOT	O
of	IN	case	O
the	DT	det	O
selectin	NN	compound	O
family	NN	nmod	O
that	WDT	nsubj	O
mediates	VBZ	acl:relcl	O
the	DT	det	O
initial	JJ	amod	O
step	NN	dobj	O
of	IN	case	O
leukocyte	NN	compound	O
adhesion	NN	nmod	O
to	TO	case	O
vascular	JJ	amod	O
endothelium	NN	nmod	O
.	.	punct	O

Upon	IN	case	O
cellular	JJ	amod	O
activation	NN	nmod	O
,	,	punct	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
L-selectin	NN	compound	B-DNA
gene	NN	nmod	I-DNA
is	VBZ	auxpass	O
downregulated	VBN	ROOT	O
at	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
protein	NN	nmod	O
and	CC	cc	O
mRNA	NN	conj	O
levels	NNS	dep	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
leukemic	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
infiltration	NN	nmod	O
into	IN	case	O
organs	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
L-selectin	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
fresh	JJ	amod	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
adult	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
(	-LRB-	punct	O
ATL	NN	appos	O
)	-RRB-	punct	O
patients	NNS	nmod	O
and	CC	cc	O
investigated	VBD	conj	O
the	DT	det	O
response	NN	dobj	O
of	IN	case	O
the	DT	det	O
L-selectin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
to	TO	case	O
human	JJ	amod	B-protein
T-cell	NN	compound	I-protein
lymphotropic	JJ	amod	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	I-protein
HTLV-1	NN	compound	I-protein
)	-RRB-	punct	I-protein
Tax	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
viral	JJ	amod	B-protein
transcriptional	JJ	amod	I-protein
transactivator	NN	acl:relcl	I-protein
.	.	punct	O

Flow	NN	compound	O
cytometry	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
L-selectin	NN	nsubjpass	B-protein
was	VBD	auxpass	O
expressed	VBN	ccomp	O
on	IN	case	O
fresh	JJ	amod	O
ATL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
along	IN	case	O
with	IN	case	O
other	JJ	amod	O
activation	NN	compound	B-protein
antigens	NNS	nmod	I-protein
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
ATL	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
overexpressed	VBD	ccomp	O
that	IN	dobj	O
L-selectin	NN	compound	B-RNA
mRNA	NN	dep	I-RNA
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
level	NN	nsubjpass	O
was	VBD	auxpass	O
aberrantly	RB	advmod	O
upregulated	VBN	conj	O
after	IN	case	O
PMA	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Studies	NNS	nsubj	O
using	VBG	acl	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	dobj	O
showed	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
L-selectin	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
the	DT	det	O
infiltrating	VBG	amod	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
liver	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
ATL	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

Intravenous	JJ	amod	O
injection	NN	nsubj	O
of	IN	case	O
a	DT	det	O
rat	NN	compound	B-cell_line
T-cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
that	WDT	nsubj	O
overexpresses	VBZ	acl:relcl	O
L-selectin	NN	dobj	B-protein
showed	VBD	ROOT	O
increased	VBN	amod	O
organ	NN	compound	O
infiltration	NN	dobj	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
Tax	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
JPX9	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
resulted	VBD	ROOT	O
in	IN	case	O
about	RB	advmod	O
a	DT	det	O
twofold	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
mRNA	NN	compound	B-RNA
expression	NN	compound	O
levels	NNS	nmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
basal	JJ	amod	O
level	NN	advcl	O
.	.	punct	O

Chloramphenicol	NN	compound	B-protein
acetyltransferase	NN	compound	I-protein
(	-LRB-	punct	O
CAT	NN	appos	B-protein
)	-RRB-	punct	O
assay	NN	nsubj	O
after	IN	case	O
transient	JJ	amod	O
cotransfection	NN	nmod	O
showed	VBD	ROOT	O
about	IN	case	O
a	DT	det	O
fivefold	JJ	amod	O
transactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
L-selectin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
by	IN	case	O
Tax	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
serum	NN	compound	O
level	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
shed	NN	amod	O
form	NN	nmod	O
of	IN	case	O
L-selectin	NN	nmod	B-protein
was	VBD	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
ATL	NN	compound	O
patients	NNS	nmod	O
(	-LRB-	punct	O
mean	NN	dep	O
+/-	CC	cc	O
SD	NN	conj	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
215.4	CD	conj	O
+/-	CC	cc	O
4	CD	conj	O
,	,	punct	O
111	CD	nummod	O
ng/mL	NN	appos	O
)	-RRB-	punct	O
compared	VBN	case	O
with	IN	case	O
those	DT	nmod	O
of	IN	case	O
asymptomatic	JJ	amod	O
carriers	NNS	nmod	O
and	CC	cc	O
healthy	JJ	amod	O
blood	NN	compound	O
donors	NNS	conj	O
(	-LRB-	punct	O
mean	NN	dep	O
+/-	CC	cc	O
SD	NN	conj	O
,	,	punct	O
1	CD	conj	O
,	,	punct	O
148.0	CD	nummod	O
+/-	CC	cc	O
269.0	CD	conj	O
ng/mL	NN	dep	O
and	CC	cc	O
991.9	CD	nummod	O
+/-	CC	cc	O
224	CD	conj	O
ng/mL	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
ATL	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
constitutively	RB	advmod	O
overexpress	VBP	ccomp	O
the	DT	det	O
L-selectin	NN	compound	B-DNA
gene	NN	dobj	I-DNA
that	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
transactivated	VBN	acl:relcl	O
by	IN	case	O
HTLV-1	NN	compound	O
Tax	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
overexpression	NN	nsubj	O
of	IN	case	O
L-selectin	NN	nmod	B-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
of	IN	case	O
inflammatory	JJ	amod	B-protein
cytokines	NNS	conj	I-protein
,	,	punct	O
by	IN	case	O
ATL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
may	MD	aux	O
provide	VB	ROOT	O
a	DT	det	O
basis	NN	dobj	O
for	IN	case	O
ATL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
to	TO	mark	O
attach	VB	acl	O
the	DT	det	O
vascular	JJ	amod	O
endothelium	NN	dobj	O
,	,	punct	O
leading	VBG	advcl	O
to	TO	case	O
transmigration	NN	nmod	O
and	CC	cc	O
organ	NN	compound	O
infitration	NN	conj	O
.	.	punct	O

Human	JJ	amod	O
herpesvirus	NN	compound	O
6	CD	nummod	O
variant	JJ	amod	O
A	NN	nsubj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
variant	JJ	amod	O
B	NN	conj	O
,	,	punct	O
infects	VBZ	ROOT	O
EBV-positive	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
lymphoid	JJ	amod	I-cell_line
cells	NNS	dobj	I-cell_line
,	,	punct	O
activating	VBG	advcl	O
the	DT	det	O
latent	JJ	amod	B-DNA
EBV	NN	compound	I-DNA
genome	NN	dobj	I-DNA
through	IN	case	O
a	DT	det	O
BZLF-1	NN	compound	B-protein
-dependent	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

Human	JJ	amod	O
herpesvirus	NN	nsubjpass	O
6	CD	nummod	O
,	,	punct	O
a	DT	det	O
predominantly	RB	advmod	O
T	NN	compound	O
lymphotropic	JJ	amod	O
virus	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
recently	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
infect	VB	xcomp	O
some	DT	det	O
EBV-positive	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dobj	I-cell_line
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
in	IN	case	O
them	PRP	nmod	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
EBV	NN	compound	O
lytic	JJ	amod	O
cycle	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
have	VBP	aux	O
confirmed	VBN	ROOT	O
and	CC	cc	O
extended	VBD	conj	O
such	JJ	amod	O
observations	NNS	dobj	O
,	,	punct	O
showing	VBG	advcl	O
that	IN	mark	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
this	DT	det	O
phenomenon	NN	nsubj	O
is	VBZ	cop	O
restricted	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
variant	JJ	amod	O
A	NN	nmod	O
of	IN	case	O
HHV-6	NN	nmod	O
:	:	punct	O
in	IN	case	O
fact	NN	nmod	O
two	CD	nummod	O
isolates	NNS	nsubj	O
belonging	VBG	acl	O
to	TO	case	O
the	DT	det	O
HHV-6	NN	compound	O
variant	JJ	amod	O
B	NN	nmod	O
(	-LRB-	punct	O
BA92	NN	dep	O
and	CC	cc	O
Z29	NN	conj	O
)	-RRB-	punct	O
were	VBD	cop	O
neither	CC	cc:preconj	O
able	JJ	advcl	O
to	TO	mark	O
infect	VB	xcomp	O
any	DT	det	O
B	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	dobj	I-cell_line
,	,	punct	O
independently	RB	advmod	O
of	IN	case	O
the	DT	det	O
EBV	NN	compound	O
status	NN	nmod	O
,	,	punct	O
nor	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
the	DT	det	O
EBV	NN	compound	O
genome	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
only	JJ	amod	O
exception	NN	nsubjpass	O
is	VBZ	auxpass	O
represented	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
P3HR1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
infection	NN	nsubj	O
by	IN	case	O
the	DT	det	O
variant	JJ	amod	O
B	NN	nmod	O
does	VBZ	aux	O
not	RB	neg	O
determine	VB	acl:relcl	O
induction	NN	dobj	O
of	IN	case	O
EBV	NN	compound	B-protein
antigens	NNS	nmod	I-protein
;	:	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
the	DT	det	O
EBV	NN	compound	B-DNA
genome	NN	nmod	I-DNA
contributes	VBZ	parataxis	O
to	TO	case	O
the	DT	det	O
susceptibility	NN	nmod	O
of	IN	case	O
the	DT	det	O
B	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
to	TO	case	O
HHV-6	NN	compound	O
infection	NN	nmod	O
,	,	punct	O
increasing	VBG	xcomp	O
the	DT	det	O
binding	VBG	amod	O
sites	NNS	dobj	O
and	CC	cc	O
the	DT	det	O
percentage	NN	conj	O
of	IN	case	O
infectable	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
as	IN	mark	O
detected	VBN	advcl	O
by	IN	case	O
immunoelectron	NN	compound	O
microscopy	NN	nmod	O
;	:	punct	O
and	CC	cc	O
(	-LRB-	punct	O
3	LS	nummod	O
)	-RRB-	punct	O
HHV-6	NN	compound	B-cell_line
infected	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
,	,	punct	O
transfected	VBN	acl	O
with	IN	case	O
plasmids	NNS	nmod	B-DNA
bearing	VBG	acl	O
the	DT	det	O
promoter	NN	compound	B-DNA
regions	NNS	dobj	I-DNA
of	IN	case	O
the	DT	det	O
EBV	NN	compound	O
early	JJ	amod	O
genes	NNS	nmod	O
BZLF1	NN	dep	O
and	CC	cc	O
BMRF1	NN	conj	B-DNA
,	,	punct	O
show	VBP	conj	O
a	DT	det	O
strong	JJ	amod	O
transactivation	NN	dobj	O
of	IN	case	O
these	DT	det	O
promoters	NNS	nmod	B-DNA
.	.	punct	O

Evidence	NN	ROOT	O
for	IN	case	O
normal	JJ	amod	O
vitamin	NN	compound	B-RNA
D	NN	compound	I-RNA
receptor	NN	compound	I-RNA
messenger	NN	compound	I-RNA
ribonucleic	JJ	amod	I-RNA
acid	NN	nmod	I-RNA
and	CC	cc	O
genotype	NN	conj	O
in	IN	case	O
absorptive	JJ	amod	O
hypercalciuria	NN	nmod	O
.	.	punct	O

Absorptive	JJ	amod	O
hypercalciuria	NN	nsubjpass	O
(	-LRB-	punct	O
a	DT	det	O
stone-forming	JJ	amod	O
condition	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
gut	NN	compound	O
hyperabsorption	NN	nmod	O
of	IN	case	O
calcium	NN	nmod	O
,	,	punct	O
hypercalciuria	NN	conj	O
,	,	punct	O
and	CC	cc	O
reduced	VBN	amod	O
bone	NN	compound	O
density	NN	conj	O
.	.	punct	O

Inasmuch	RB	advmod	O
as	IN	mark	O
these	DT	det	O
features	NNS	nsubj	O
implicate	VBP	advcl	O
enhanced	VBN	amod	O
calcitriol	NN	compound	O
action	NN	dobj	O
in	IN	case	O
gut	NN	nmod	O
and	CC	cc	O
bone	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
vitamin	NN	compound	B-DNA
D	NN	compound	I-DNA
receptor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
VDR	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	dobj	I-DNA
to	TO	mark	O
ascertain	VB	advcl	O
whether	IN	mark	O
an	DT	det	O
abnormality	NN	nsubj	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
marks	VBZ	ccomp	O
patients	NNS	dobj	O
with	IN	case	O
intestinal	JJ	amod	O
hyperabsorption	NN	nmod	O
of	IN	case	O
calcium	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
compared	VBN	ROOT	O
the	DT	det	O
frequency	NN	dobj	O
of	IN	case	O
a	DT	det	O
restriction	NN	compound	B-DNA
fragment	NN	compound	I-DNA
length	NN	compound	I-DNA
polymorphism	NN	nmod	I-DNA
(	-LRB-	punct	O
Bsm	NN	compound	O
I	NN	appos	O
)	-RRB-	punct	O
associated	VBN	acl	O
with	IN	case	O
different	JJ	amod	O
alleles	NNS	nmod	O
of	IN	case	O
the	DT	det	O
VDR	NN	compound	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
a	DT	det	O
group	NN	nmod	O
of	IN	case	O
33	CD	nummod	O
well	RB	advmod	O
characterized	VBN	amod	O
absorptive	JJ	amod	O
hypercalciuric	NN	amod	O
patients	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
group	NN	conj	O
of	IN	case	O
36	CD	nummod	O
normal	JJ	amod	O
race-	NN	amod	O
and	CC	cc	O
age-matched	JJ	conj	O
control	JJ	compound	O
subjects	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
difference	NN	nsubj	O
between	IN	case	O
the	DT	det	O
distribution	NN	nmod	O
of	IN	case	O
the	DT	det	O
VDR	NN	compound	B-protein
alleles	NNS	nmod	O
in	IN	case	O
the	DT	det	O
patient	NN	compound	O
population	NN	nmod	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
the	DT	det	O
normal	JJ	amod	O
population	NN	nmod	O
.	.	punct	O

The	DT	det	O
coding	VBG	amod	O
region	NN	nsubj	O
of	IN	case	O
VDR	NN	compound	B-RNA
messenger	NN	compound	I-RNA
RNA	NN	nmod	I-RNA
was	VBD	cop	O
also	RB	advmod	O
normal	JJ	ROOT	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
both	CC	cc:preconj	O
DNA	NN	compound	B-DNA
sequence	NN	compound	I-DNA
analysis	NN	nmod	O
and	CC	cc	O
chemical	JJ	amod	O
mismatch	NN	compound	O
cleavage	NN	compound	O
analysis	NN	conj	O
of	IN	case	O
copy	NN	compound	O
DNA	NN	nmod	O
from	IN	case	O
11	CD	nummod	O
index	NN	nmod:npmod	O
absorptive	JJ	amod	O
hypercalciuric	NN	dep	O
patients	NNS	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
these	DT	det	O
results	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
enhanced	VBN	amod	O
intestinal	JJ	amod	O
calcium	NN	compound	O
absorption	NN	nsubj	O
invariably	RB	advmod	O
seen	VBN	acl	O
in	IN	case	O
absorptive	JJ	amod	O
hypercalciuria	NN	nmod	O
and	CC	cc	O
attendant	JJ	amod	O
symptoms	NNS	conj	O
of	IN	case	O
this	DT	det	O
disorder	NN	nmod	O
are	VBP	cop	O
not	RB	neg	O
attributable	JJ	ccomp	O
to	TO	case	O
mutations	NNS	nmod	O
of	IN	case	O
the	DT	det	O
VDR	NN	nmod	B-protein
and	CC	cc	O
are	VBP	auxpass	O
not	RB	neg	O
linked	VBN	conj	O
to	TO	case	O
a	DT	det	O
common	JJ	amod	O
VDR	NN	compound	B-DNA
genotype	NN	nmod	I-DNA
.	.	punct	O

Transcriptional	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
encoding	VBG	acl	O
the	DT	det	O
human	JJ	amod	B-protein
C-type	JJ	amod	I-protein
lectin	NN	compound	I-protein
leukocyte	NN	compound	I-protein
receptor	NN	dobj	I-protein
AIM/CD69	NN	dep	B-protein
and	CC	cc	O
functional	JJ	amod	O
characterization	NN	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
tumor	NN	compound	B-DNA
necrosis	NN	nmod:npmod	I-DNA
factor-alpha-responsive	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-protein
activation	NN	compound	I-protein
antigen	NN	nsubj	I-protein
CD69	NN	dep	B-protein
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
C-type	JJ	amod	B-protein
animal	NN	compound	I-protein
lectin	NN	compound	I-protein
superfamily	NN	nmod	I-protein
that	WDT	nsubj	O
functions	VBZ	acl:relcl	O
as	IN	case	O
a	DT	det	O
signal-transmitting	JJ	amod	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
CD69	NN	nmod	B-protein
can	MD	aux	O
be	VB	auxpass	O
induced	VBN	advcl	O
in	FW	compound	O
vitro	FW	advmod	O
on	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
most	JJS	advmod	O
hematopoietic	JJ	amod	O
lineages	NNS	nmod	O
with	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
stimuli	NNS	nmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
mainly	RB	advmod	O
expressed	VBN	ROOT	O
by	IN	case	O
T-lymphocytes	NNS	nmod	B-cell_type
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
infiltrates	NNS	nmod	O
of	IN	case	O
several	JJ	amod	O
human	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
the	DT	det	O
constitutive	JJ	amod	O
and	CC	cc	O
inducible	JJ	conj	O
expression	NN	dobj	O
of	IN	case	O
CD69	NN	nmod	B-protein
by	IN	case	O
leukocytes	NNS	nmod	B-cell_type
,	,	punct	O
we	PRP	nsubj	O
isolated	VBD	ROOT	O
the	DT	det	O
promoter	NN	compound	B-DNA
region	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
CD69	NN	compound	B-protein
gene	NN	nmod	O
and	CC	cc	O
carried	VBD	conj	O
out	RP	prt	O
its	PRP$	nmod:poss	O
functional	JJ	amod	O
characterization	NN	dobj	O
.	.	punct	O

Sequence	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
5'-flanking	JJ	amod	B-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
CD69	NN	compound	B-DNA
gene	NN	nmod	I-DNA
revealed	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
a	DT	det	O
potential	JJ	amod	O
TATA	NN	compound	B-DNA
element	NN	nmod	I-DNA
30	CD	nummod	B-DNA
base	NN	compound	I-DNA
pairs	NNS	dep	I-DNA
upstream	JJ	amod	I-DNA
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
several	JJ	amod	O
putative	JJ	amod	O
binding	NN	compound	O
sequences	NNS	conj	O
for	IN	case	O
inducible	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	dep	I-protein
,	,	punct	O
Egr-1	NN	conj	B-protein
,	,	punct	O
AP-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
might	MD	aux	O
mediate	VB	acl:relcl	O
the	DT	det	O
inducible	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
.	.	punct	O

Transient	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
CD69	NN	compound	B-DNA
promoter-based	JJ	amod	I-DNA
reporter	NN	compound	I-DNA
gene	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
in	IN	case	O
K562	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
proximal	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
region	NN	nsubj	I-DNA
spanning	VBG	acl	O
positions	NNS	dobj	O
-78	CD	dep	O
to	TO	case	O
+16	CD	nmod	O
contained	VBD	ccomp	O
the	DT	det	O
cis-acting	JJ	amod	B-DNA
sequences	NNS	dobj	I-DNA
necessary	JJ	amod	O
for	IN	case	O
basal	JJ	amod	O
and	CC	cc	O
phorbol	NN	nmod:npmod	O
12-myristate	NN	nmod:npmod	O
13-acetate-inducible	JJ	conj	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
CD69	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Removal	NN	nsubj	O
of	IN	case	O
the	DT	det	O
upstream	JJ	amod	O
sequences	NNS	nmod	O
located	JJ	amod	O
between	IN	case	O
positions	NNS	nmod	O
-78	CD	dep	O
and	CC	cc	O
-38	CD	conj	O
resulted	VBD	ROOT	O
in	IN	case	O
decreased	VBN	amod	O
promoter	NN	compound	O
strength	NN	nmod	O
and	CC	cc	O
abolished	VBD	conj	O
the	DT	det	O
response	NN	dobj	O
to	TO	case	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
found	VBD	ROOT	O
that	IN	mark	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nsubj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
inducing	VBG	advcl	O
the	DT	det	O
surface	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
CD69	NN	compound	B-protein
molecule	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
promoter	NN	compound	O
activity	NN	conj	O
of	IN	case	O
fusion	NN	compound	O
plasmids	NNS	nmod	O
that	WDT	nsubj	O
contain	VBP	acl:relcl	O
5'-flanking	JJ	amod	O
sequences	NNS	dobj	O
of	IN	case	O
the	DT	det	O
CD69	NN	compound	B-protein
gene	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
this	DT	det	O
cytokine	NN	nsubj	O
may	MD	aux	O
regulate	VB	ccomp	O
in	FW	compound	O
vivo	FW	advmod	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
CD69	NN	nmod	B-protein
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
end	NN	nmod	I-DNA
of	IN	case	I-DNA
human	JJ	amod	I-DNA
thromboxane	NN	compound	I-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Organizational	JJ	amod	O
analysis	NN	ROOT	O
and	CC	cc	O
mapping	NN	conj	O
of	IN	case	O
protein	NN	compound	B-DNA
kinase	NN	compound	I-DNA
C	NN	compound	I-DNA
--	:	punct	I-DNA
responsive	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
regulating	VBG	acl	O
expression	NN	dobj	O
in	IN	case	O
platelets	NNS	nmod	B-cell_type
.	.	punct	O

Platelet	NN	compound	B-protein
thromboxane	NN	compound	I-protein
receptors	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
acutely	RB	advmod	O
and	CC	advmod	O
reversibly	RB	advmod	O
upregulated	VBN	ROOT	O
after	IN	case	O
acute	JJ	amod	O
myocardial	JJ	amod	O
infarction	NN	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
if	IN	mark	O
platelet	NN	compound	O
thromboxane	NN	compound	B-protein
receptors	NNS	nsubj	I-protein
are	VBP	cop	O
under	IN	case	O
transcriptional	JJ	amod	O
control	NN	advcl	O
,	,	punct	O
we	PRP	nsubj	O
isolated	VBD	ROOT	O
and	CC	cc	O
characterized	VBN	conj	O
human	JJ	amod	B-DNA
genomic	JJ	amod	I-DNA
DNA	NN	compound	I-DNA
clones	NNS	dobj	I-DNA
containing	VBG	acl	O
the	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
region	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
exon-intron	JJ	amod	B-DNA
structure	NN	nsubjpass	I-DNA
of	IN	case	O
the	DT	det	O
5	CD	nummod	B-DNA
'	POS	punct	I-DNA
portion	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
determined	VBN	ROOT	O
initially	RB	advmod	O
by	IN	mark	O
comparing	VBG	advcl	O
the	DT	det	O
nucleotide	NN	compound	B-DNA
sequence	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
genomic	JJ	amod	I-DNA
clone	NN	nmod	I-DNA
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	B-DNA
human	JJ	amod	I-DNA
uterine	NN	amod	I-DNA
thromboxane	NN	compound	I-DNA
receptor	NN	compound	I-DNA
cDNA	NN	nmod	I-DNA
that	WDT	nsubj	O
extended	VBD	acl:relcl	O
the	DT	det	O
mRNA	NN	dobj	B-RNA
141	CD	nummod	B-DNA
bp	NN	dep	I-DNA
further	RB	advmod	I-DNA
upstream	RB	advmod	I-DNA
than	IN	case	O
the	DT	det	O
previously	RB	advmod	B-DNA
identified	VBN	amod	I-DNA
human	JJ	amod	I-DNA
placental	JJ	amod	I-DNA
cDNA	NN	nmod	I-DNA
.	.	punct	O

A	DT	det	O
major	JJ	amod	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
site	NN	nsubj	I-DNA
was	VBD	cop	O
located	JJ	ROOT	O
in	IN	case	O
three	CD	nummod	O
human	JJ	amod	O
tissues	NNS	nmod	O
approximately	RB	advmod	O
560	CD	nummod	B-DNA
bp	NN	nmod:npmod	I-DNA
upstream	RB	advmod	I-DNA
from	IN	case	O
the	DT	det	O
translation	NN	compound	B-DNA
initiation	NN	compound	I-DNA
codon	NN	nmod	I-DNA
and	CC	cc	O
380	CD	nummod	B-DNA
bp	NN	nmod:npmod	I-DNA
upstream	JJ	advmod	I-DNA
from	IN	case	O
any	DT	det	O
previously	RB	advmod	O
identified	VBN	amod	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nsubj	I-DNA
has	VBZ	ROOT	O
neither	CC	cc:preconj	O
a	DT	det	O
TATA	NN	dobj	B-DNA
nor	CC	cc	O
a	DT	det	O
CAAT	NN	compound	B-DNA
consensus	NN	compound	I-DNA
site	NN	conj	I-DNA
.	.	punct	O

Promoter	NN	compound	O
function	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	case	O
transfection	NN	nmod	O
of	IN	case	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter/chloramphenicol	NN	compound	I-DNA
acetyltransferase	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CAT	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
chimera	NN	compound	I-DNA
plasmids	NNS	nmod	I-DNA
into	IN	case	O
platelet-like	JJ	amod	O
K562	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Thromboxane	NN	compound	O
receptor	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nsubj	O
,	,	punct	O
as	IN	mark	O
assessed	VBN	advcl	O
by	IN	case	O
CAT	NN	compound	B-protein
expression	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
relatively	RB	advmod	O
weak	JJ	ROOT	O
but	CC	cc	O
was	VBD	auxpass	O
significantly	RB	advmod	O
enhanced	VBN	conj	O
by	IN	case	O
phorbol	NN	compound	O
ester	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Functional	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
deletion	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
in	IN	case	O
transfected	VBN	amod	O
K562	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
gel	NN	compound	O
mobility	NN	compound	O
shift	NN	conj	O
localized	VBD	ROOT	O
the	DT	det	O
major	JJ	amod	O
phorbol	NN	compound	O
ester-responsive	JJ	amod	O
motifs	NNS	dobj	O
in	IN	case	O
the	DT	det	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	O
to	TO	case	O
a	DT	det	O
cluster	NN	nmod	O
of	IN	case	O
activator	NN	compound	B-DNA
protein-2	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
AP-2	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
binding	NN	compound	I-DNA
consensus	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
located	JJ	amod	O
approximately	RB	advmod	O
1.8	CD	nummod	O
kb	NN	nmod	O
5	CD	nummod	O
'	''	punct	O
from	IN	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
are	VBP	cop	O
the	DT	det	O
first	JJ	ROOT	O
to	TO	mark	O
determine	VB	acl	O
the	DT	det	O
structure	NN	dobj	O
and	CC	cc	O
organization	NN	conj	O
of	IN	case	O
the	DT	det	O
5	CD	nummod	O
'	``	punct	O
end	NN	nmod	O
of	IN	case	O
the	DT	det	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
demonstrate	VBP	conj	O
that	IN	mark	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	compound	I-DNA
expression	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
regulated	VBN	ccomp	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
via	IN	case	O
induction	NN	nmod	O
of	IN	case	O
an	DT	det	O
AP-2-like	JJ	amod	B-protein
nuclear	JJ	amod	I-protein
factor	NN	nmod	I-protein
binding	VBG	acl	O
to	TO	case	O
upstream	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
strongly	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
mechanism	NN	nsubj	O
for	IN	case	O
previously	RB	advmod	O
described	VBN	amod	O
upregulation	NN	nmod	O
of	IN	case	O
platelet	NN	compound	B-protein
thromboxane	NN	compound	I-protein
receptors	NNS	nmod	I-protein
after	IN	case	O
acute	JJ	amod	O
myocardial	JJ	amod	O
infarction	NN	nmod	O
is	VBZ	cop	O
increased	VBN	amod	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	compound	I-DNA
transcription	NN	ccomp	O
in	IN	case	O
platelet-progenitor	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Estrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
concentration	NN	ROOT	O
and	CC	cc	O
social	JJ	amod	O
factors	NNS	conj	O
as	IN	case	O
predictors	NNS	nmod	O
of	IN	case	O
natural	JJ	amod	O
killer	NN	compound	O
cell	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
early-stage	JJ	amod	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

Confirmation	NN	ROOT	O
of	IN	prep	O
a	DT	det	O
model	NN	pobj	O
.	.	punct	O

Previous	JJ	amod	O
work	NN	nsubj	O
of	IN	case	O
ours	PRP	nmod	O
has	VBZ	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
a	DT	det	O
significant	JJ	amod	O
amount	NN	nsubjpass	O
of	IN	case	O
natural	JJ	amod	O
killer	NN	compound	O
(	-LRB-	punct	O
NK	NN	appos	O
)	-RRB-	punct	O
activity	NN	compound	O
variance	NN	nmod	O
after	IN	case	O
surgery	NN	nmod	O
in	IN	case	O
stage	NN	compound	O
I	CD	dep	O
and	CC	cc	O
II	CD	conj	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
could	MD	aux	O
be	VB	auxpass	O
accounted	VBN	ccomp	O
for	IN	case	O
by	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
estrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
ER	NN	appos	B-protein
)	-RRB-	punct	O
status	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	O
and	CC	cc	O
by	IN	case	O
social	JJ	amod	O
factors	NNS	conj	O
,	,	punct	O
namely	RB	advmod	O
,	,	punct	O
perceived	VBN	amod	O
social	JJ	amod	O
support	NN	conj	O
and	CC	cc	O
seeking	VBG	conj	O
social	JJ	amod	O
support	NN	dobj	O
as	IN	prep	O
a	DT	det	O
general	JJ	amod	O
coping	NN	compound	O
strategy	NN	pobj	O
.	.	punct	O

As	IN	mark	O
considerable	JJ	amod	O
evidence	NN	nsubj	O
has	VBZ	aux	O
accumulated	VBN	advcl	O
that	IN	mark	O
social	JJ	amod	O
support	NN	nsubj	O
in	IN	case	O
both	CC	cc:preconj	O
animal	NN	nmod	O
and	CC	cc	O
human	JJ	conj	O
populations	NNS	dep	O
may	MD	aux	O
have	VB	ccomp	O
survival	NN	compound	O
value	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
sought	VBD	ROOT	O
to	TO	mark	O
test	VB	xcomp	O
the	DT	det	O
reliability	NN	dobj	O
of	IN	case	O
this	DT	det	O
regression	NN	compound	O
model	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
coping	NN	dobj	O
and	CC	cc	O
perceived	VBN	amod	O
support	NN	compound	O
factor	NN	compound	O
values	NNS	conj	O
obtained	VBN	acl	O
at	IN	case	O
3	CD	nummod	O
months	NNS	nmod	O
after	IN	case	O
surgery	NN	nmod	O
to	TO	mark	O
account	VB	xcomp	O
for	IN	case	O
concurrent	JJ	amod	O
follow-up	JJ	dep	O
NK	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
this	DT	det	O
serially	RB	advmod	O
assessed	VBN	amod	O
group	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
most	RBS	advmod	O
significant	JJ	amod	O
variable	NN	nsubj	O
predicting	VBG	ccomp	O
NK	NN	compound	O
activity	NN	dobj	O
at	IN	case	O
follow-up	NN	nmod	O
was	VBD	cop	O
tumor	NN	compound	O
ER	NN	compound	B-protein
concentration	NN	dobj	O
,	,	punct	O
with	IN	case	O
higher	JJR	amod	O
NK	NN	compound	O
activity	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
ER	NN	compound	B-protein
-status	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
seeking	VBG	advcl	O
social	JJ	amod	O
support	NN	dobj	O
as	IN	case	O
a	DT	det	O
coping	NN	compound	O
strategy	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
perceived	VBN	amod	O
quality	NN	conj	O
of	IN	case	O
support	NN	nmod	O
,	,	punct	O
also	RB	advmod	O
entered	VBD	ROOT	O
the	DT	det	O
model	NN	dobj	O
to	TO	mark	O
account	VB	acl	O
for	IN	case	O
a	DT	det	O
significant	JJ	amod	O
amount	NN	nmod	O
of	IN	case	O
NK	NN	compound	O
activity	NN	compound	O
variance	NN	nmod	O
(	-LRB-	punct	O
multivariate	JJ	amod	O
F	NN	dep	O
=	JJ	amod	O
5.25	CD	dobj	O
,	,	punct	O
p	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

If	IN	mark	O
,	,	punct	O
as	IN	mark	O
the	DT	det	O
literature	NN	nsubj	O
suggests	VBZ	advcl	O
,	,	punct	O
NK	NN	compound	O
activity	NN	nsubj	O
is	VBZ	cop	O
relevant	JJ	advcl	O
to	TO	case	O
breast	NN	compound	O
cancer	NN	compound	O
control	NN	nmod	O
,	,	punct	O
and	CC	cc	O
since	IN	mark	O
ER	NN	compound	B-protein
-tumors	NNS	nsubj	O
have	VBP	conj	O
a	DT	det	O
worse	JJR	amod	O
prognosis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
suggest	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
perhaps	RB	advmod	O
such	JJ	amod	O
tumors	NNS	nsubj	O
are	VBP	cop	O
resistant	JJ	ccomp	O
to	TO	mark	O
control	VB	nmod	O
by	IN	case	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
because	IN	mark	O
they	PRP	nsubj	O
lack	VBP	advcl	O
the	DT	det	O
ability	NN	dobj	O
to	TO	mark	O
attract	VB	acl	O
an	DT	det	O
accumulation	NN	dobj	O
of	IN	case	O
effector	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
the	DT	det	O
tumor	NN	compound	O
site	NN	nmod	O
,	,	punct	O
or	CC	cc	O
because	IN	mark	O
blocking	VBG	csubj	O
factors	NNS	dobj	O
at	IN	case	O
the	DT	det	O
site	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	O
prevent	VBP	conj	O
local	JJ	amod	O
tumor	NN	compound	O
control	NN	dobj	O
at	IN	case	O
the	DT	det	O
site	NN	nmod	O
of	IN	case	O
action	NN	nmod	O
.	.	punct	O

The	DT	det	O
finding	NN	nsubj	O
related	JJ	amod	O
to	TO	prep	O
social	JJ	amod	O
support	NN	pobj	O
also	RB	advmod	O
replicates	VBZ	ROOT	O
results	NNS	dobj	O
from	IN	case	O
an	DT	det	O
independent	JJ	amod	O
sample	NN	nmod	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

This	DT	det	O
finding	NN	nsubj	O
,	,	punct	O
taken	VBN	acl	O
together	RB	advmod	O
with	IN	case	O
other	JJ	amod	O
evidence	NN	nmod	O
that	IN	mark	O
this	DT	det	O
social	JJ	amod	O
variable	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
longer	JJR	amod	O
survival	NN	nmod	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
populations	NNS	nmod	O
,	,	punct	O
underscores	VBZ	ROOT	O
the	DT	det	O
potential	JJ	amod	O
importance	NN	dobj	O
of	IN	case	O
this	DT	det	O
social	JJ	amod	O
support	NN	compound	O
variable	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
one	CD	nummod	O
possible	JJ	amod	O
immunological	JJ	amod	O
variable	NN	dobj	O
involved	JJ	acl	O
,	,	punct	O
with	IN	case	O
potential	JJ	amod	O
clinical	JJ	amod	O
significance	NN	nmod	O
,	,	punct	O
for	IN	case	O
this	DT	det	O
patient	NN	compound	O
population	NN	nmod	O
.	.	punct	O

Solution	NN	compound	O
structure	NN	ROOT	O
of	IN	case	O
the	DT	det	O
sequence-specific	JJ	amod	B-DNA
HMG	NN	compound	I-DNA
box	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
lymphocyte	NN	compound	B-protein
transcriptional	JJ	amod	I-protein
activator	NN	nmod	I-protein
Sox-4	NN	dep	B-protein
.	.	punct	O

Two	CD	nummod	O
groups	NNS	nsubjpass	O
of	IN	case	O
HMG	NN	compound	B-protein
box	NN	compound	I-protein
proteins	NNS	nmod	I-protein
are	VBP	auxpass	O
distinguished	VBN	ROOT	O
.	.	punct	O

Proteins	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
first	JJ	amod	O
group	NN	nmod	O
contain	VBP	ROOT	O
multiple	JJ	amod	O
HMG	NN	compound	B-protein
boxes	NNS	dobj	I-protein
,	,	punct	O
are	VBP	cop	O
non-sequence-specific	JJ	conj	O
,	,	punct	O
and	CC	cc	O
recognize	VBP	conj	O
structural	JJ	amod	O
features	NNS	dobj	O
as	IN	mark	O
found	VBN	advcl	O
in	IN	case	O
cruciform	JJ	compound	B-DNA
DNA	NN	nmod	I-DNA
and	CC	cc	O
cross-over	JJ	amod	B-DNA
DNA	NN	conj	I-DNA
.	.	punct	O

The	DT	det	O
abundant	JJ	amod	O
chromosomal	JJ	amod	B-protein
protein	NN	nsubj	I-protein
HMG-1	NN	dep	B-protein
belongs	VBZ	ROOT	O
to	TO	case	O
this	DT	det	O
subgroup	NN	nmod	O
.	.	punct	O

Proteins	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
second	JJ	amod	O
group	NN	nmod	O
carry	VBP	ROOT	O
a	DT	det	O
single	JJ	amod	B-protein
HMG	NN	compound	I-protein
box	NN	dobj	I-protein
with	IN	case	O
affinity	NN	nmod	O
for	IN	case	O
the	DT	det	O
minor	JJ	amod	O
groove	NN	nmod	O
of	IN	case	O
the	DT	det	O
heptamer	NN	compound	B-DNA
motif	NN	nmod	I-DNA
AACAAAG	NN	dep	O
or	CC	cc	O
variations	NNS	conj	O
thereof	RB	advmod	O
.	.	punct	O

A	DT	det	O
solution	NN	compound	O
structure	NN	nsubjpass	O
for	IN	case	O
the	DT	det	O
non-sequence-specific	JJ	amod	O
C-terminal	JJ	amod	B-protein
HMG	NN	compound	I-protein
box	NN	nmod	I-protein
of	IN	case	O
HMG-1	NN	nmod	B-protein
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
proposed	VBN	ROOT	O
.	.	punct	O

Now	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
solution	NN	compound	O
structure	NN	dobj	O
of	IN	case	O
the	DT	det	O
sequence-specific	JJ	amod	B-protein
HMG-box	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
SRY-related	JJ	amod	B-protein
protein	NN	nmod	I-protein
Sox-4	NN	dep	B-protein
.	.	punct	O

NMR	NN	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
three	CD	nummod	O
alpha-helices	NNS	nmod	B-protein
(	-LRB-	punct	O
Val10-Gln22	NN	dep	B-protein
,	,	punct	O
Glu30-Leu41	NN	conj	B-protein
and	CC	cc	O
Phe50-Tyr65	NN	conj	B-protein
)	-RRB-	punct	O
connected	VBN	acl	O
by	IN	case	O
loop	NN	compound	B-protein
regions	NNS	nmod	I-protein
(	-LRB-	punct	O
Ser23-Ala49	NN	dep	B-protein
and	CC	cc	O
Leu42-Pro49	NN	conj	B-protein
)	-RRB-	punct	O
.	.	punct	O

Helices	NNS	nsubjpass	B-protein
I	CD	nummod	I-protein
and	CC	cc	I-protein
II	CD	conj	I-protein
are	VBP	cop	O
positioned	JJ	ROOT	O
in	IN	case	O
an	DT	det	O
antiparallel	JJ	amod	B-protein
mode	NN	nmod	I-protein
and	CC	cc	O
form	VB	conj	O
one	CD	nummod	O
arm	NN	dobj	O
of	IN	case	O
the	DT	det	O
HMG	NN	compound	B-protein
box	NN	nmod	I-protein
.	.	punct	O

Helix	NN	nsubj	B-protein
III	CD	nummod	I-protein
is	VBZ	cop	O
less	RBR	advmod	O
rigid	JJ	ROOT	O
,	,	punct	O
makes	VBZ	conj	O
an	DT	det	O
average	JJ	amod	O
angle	NN	dobj	O
of	IN	case	O
about	RB	advmod	O
90	CD	nummod	O
degrees	NNS	nmod	O
with	IN	case	O
helices	NNS	nmod	B-protein
I	CD	dep	I-protein
and	CC	cc	I-protein
II	CD	conj	I-protein
,	,	punct	O
and	CC	cc	O
constitutes	VBZ	conj	O
the	DT	det	O
other	JJ	amod	O
arm	NN	dobj	O
of	IN	case	O
the	DT	det	O
molecule	NN	nmod	O
.	.	punct	O

As	IN	case	O
in	IN	case	O
HMG1B	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
overall	JJ	amod	O
structure	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Sox-4	NN	compound	B-protein
HMG	NN	compound	B-protein
box	NN	nmod	I-protein
is	VBZ	cop	O
L-shaped	JJ	ROOT	O
and	CC	cc	O
is	VBZ	auxpass	O
maintained	VBN	conj	O
by	IN	case	O
a	DT	det	O
cluster	NN	nmod	O
of	IN	case	O
conserved	VBN	amod	O
,	,	punct	O
mainly	RB	advmod	O
aromatic	JJ	amod	O
residues	NNS	nmod	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor-IL6	NN	nsubj	I-protein
activates	VBZ	ROOT	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-4	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Positive	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
element	NN	nsubj	I-DNA
I	NN	nummod	I-DNA
(	-LRB-	punct	O
PRE-I	NN	appos	B-DNA
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
strong	JJ	amod	O
enhancer	NN	compound	B-DNA
element	NN	ROOT	I-DNA
essential	JJ	amod	O
for	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-4	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
binding	VBG	acl	O
to	TO	case	O
PRE-I	NN	nmod	B-DNA
,	,	punct	O
we	PRP	nsubj	O
screened	VBD	ROOT	O
a	DT	det	O
cDNA	NN	compound	B-DNA
expression	NN	compound	I-DNA
library	NN	dobj	I-DNA
from	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
isolated	VBD	conj	O
a	DT	det	O
cDNA	NN	compound	B-DNA
encoding	VBG	amod	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	B-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-IL6	NN	dobj	I-protein
(	-LRB-	punct	O
also	RB	advmod	O
known	VBN	dep	O
as	IN	case	O
C/EBP	NN	compound	B-protein
beta	NN	nmod	I-protein
)	-RRB-	punct	O
.	.	punct	O

NF-IL6	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
in	IN	case	O
the	DT	det	O
mouse	NN	compound	B-cell_line
Th2	NN	compound	I-cell_line
clone	NN	conj	I-cell_line
D10	NN	dep	B-cell_line
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
Th1	NN	compound	B-cell_line
clone	NN	conj	I-cell_line
29	CD	nummod	I-cell_line
.	.	punct	O

rNF-IL6	NN	nsubjpass	B-protein
expressed	VBN	acl	O
in	IN	case	O
bacteria	NNS	nmod	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
specifically	RB	advmod	O
bind	VB	xcomp	O
to	TO	case	O
PRE-I	NN	nmod	B-DNA
.	.	punct	O

PRE-I	NN	nsubj	B-DNA
forms	VBZ	ROOT	O
multiple	JJ	amod	B-protein
DNA-protein	JJ	amod	I-protein
complexes	NNS	dobj	I-protein
with	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Some	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
complexes	NNS	nmod	O
were	VBD	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
contain	VB	xcomp	O
NF-IL6	NN	dobj	B-protein
by	IN	mark	O
using	VBG	advcl	O
anti-C/EBP	JJ	amod	B-protein
beta	NN	compound	I-protein
Abs	NNS	dobj	I-protein
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
NF-IL6	NN	nmod	B-protein
enhanced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyl	NN	compound	I-DNA
transferase	NN	compound	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
linked	VBN	acl	O
to	TO	case	O
the	DT	det	O
PRE-I-thymidine	NN	compound	B-protein
kinase	NN	nmod	I-protein
or	CC	cc	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-4	NN	compound	I-DNA
promoter	NN	conj	I-DNA
more	JJR	advmod	O
than	IN	mwe	O
10-fold	RB	advmod	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Promoter	NN	compound	O
deletion	NN	compound	O
studies	NNS	nsubj	O
revealed	VBD	ROOT	O
two	CD	nummod	O
additional	JJ	amod	O
NF-IL6	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
located	JJ	amod	O
at	IN	case	O
positions	NNS	nmod	O
-44	CD	compound	O
to	TO	dep	O
-36	CD	nummod	O
(	-LRB-	punct	O
C/EBP	NN	appos	B-protein
proximal	JJ	amod	I-protein
)	-RRB-	punct	O
and	CC	cc	O
-87	CD	compound	O
to	TO	dep	O
-79	CD	conj	O
(	-LRB-	punct	O
C/EBP	NN	appos	B-protein
medial	JJ	amod	I-protein
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
NF-IL6	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-4	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
an	DT	det	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod:npmod	I-protein
alpha-associated	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
in	IN	case	O
a	DT	det	O
human	JJ	amod	B-cell_line
monocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
and	CC	cc	O
determination	NN	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
phosphorylation	NN	compound	B-protein
sites	NNS	nmod	I-protein
on	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	nsubjpass	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
stored	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
as	IN	case	O
an	DT	det	O
inactive	JJ	amod	O
form	NN	nmod	O
through	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
rapid	JJ	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
presumed	VBN	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
important	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
subsequent	JJ	amod	O
degradation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
reported	VBN	ROOT	O
the	DT	det	O
establishment	NN	dobj	O
of	IN	case	O
a	DT	det	O
lipopolysaccharide	NN	compound	O
(	-LRB-	punct	O
LPS	NN	compound	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
cell-free	JJ	amod	O
activation	NN	compound	O
system	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
association	NN	nmod	O
with	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	I-protein
phosphorylation	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
kinase	NN	dobj	B-protein
in	IN	case	O
cell	NN	compound	O
extracts	NNS	nmod	O
from	IN	case	O
the	DT	det	O
LPS-stimulated	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
monocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
THP-1	NN	appos	B-cell_line
,	,	punct	O
that	WDT	nsubj	O
specifically	RB	advmod	O
binds	VBZ	acl:relcl	O
and	CC	cc	O
phosphorylates	VBZ	conj	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	dobj	I-protein
.	.	punct	O

LPS	NN	compound	O
stimulation	NN	nsubj	O
transiently	RB	advmod	O
enhanced	VBD	ROOT	O
the	DT	det	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	I-protein
-bound	JJ	amod	B-protein
kinase	NN	compound	I-protein
activity	NN	dobj	O
in	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Mutational	JJ	amod	O
analyses	NNS	nsubj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	O
and	CC	cc	O
competition	NN	conj	O
experiments	NNS	nmod	O
with	IN	case	O
the	DT	det	O
synthetic	JJ	amod	O
peptides	NNS	nmod	O
identified	VBD	ROOT	O
major	JJ	amod	O
phosphorylation	NN	compound	B-protein
sites	NNS	dobj	I-protein
by	IN	case	O
the	DT	det	O
bound	VBN	amod	O
kinase	NN	nmod	B-protein
as	IN	case	O
Ser	NN	compound	O
and	CC	cc	O
Thr	NN	conj	O
residues	NNS	nmod	O
in	IN	case	O
the	DT	det	O
C-terminal	JJ	amod	B-protein
acidic	JJ	amod	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
peptide	NN	nsubj	O
,	,	punct	O
corresponding	VBG	acl	O
to	TO	case	O
the	DT	det	O
C-terminal	JJ	amod	B-protein
acidic	JJ	amod	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
,	,	punct	O
blocked	VBD	ccomp	O
the	DT	det	O
LPS-induced	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	dobj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inducible	JJ	amod	O
phosphorylation	NN	conj	O
of	IN	case	O
endogenous	JJ	amod	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
in	IN	case	O
a	DT	det	O
cell-free	JJ	amod	O
system	NN	nmod	O
using	VBG	acl	O
THP-1	NN	compound	B-cell_line
cells	NNS	dobj	I-cell_line
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
bound	VBN	amod	B-protein
kinase	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
of	IN	case	O
LPS	NN	nmod	O
by	IN	mark	O
inducing	VBG	advcl	O
the	DT	det	O
phosphorylation	NN	dobj	O
of	IN	case	O
the	DT	det	O
C-terminal	JJ	amod	B-protein
region	NN	nmod	I-protein
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
subsequent	JJ	amod	O
dissociation	NN	conj	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	I-protein
complex	NN	ROOT	I-protein
.	.	punct	O

Bik	NN	nsubj	B-protein
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
death-inducing	JJ	amod	B-protein
protein	NN	nsubj	I-protein
shares	VBZ	ROOT	O
a	DT	det	O
distinct	JJ	amod	O
sequence	NN	compound	O
motif	NN	dobj	O
with	IN	case	O
Bcl-2	NN	compound	B-protein
family	NN	compound	I-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
interacts	VBZ	conj	O
with	IN	case	O
viral	JJ	amod	O
and	CC	cc	O
cellular	JJ	conj	B-protein
survival-promoting	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
survival-promoting	JJ	amod	O
activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Bcl-2	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
proteins	NNS	nmod	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
modulated	VBN	xcomp	O
by	IN	case	O
interactions	NNS	nmod	O
between	IN	case	O
various	JJ	amod	O
cellular	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
cellular	JJ	amod	B-protein
protein	NN	dobj	I-protein
,	,	punct	O
Bik	NN	appos	B-protein
,	,	punct	O
that	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-protein
survival-promoting	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
Bcl-2	NN	appos	B-protein
and	CC	cc	O
Bcl-xL	NN	conj	B-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
viral	JJ	amod	B-protein
survival-promoting	JJ	amod	I-protein
proteins	NNS	conj	I-protein
,	,	punct	O
Epstein	NN	compound	B-protein
Barr	NN	compound	I-protein
virus-BHRF1	NN	appos	I-protein
and	CC	cc	O
adenovirus	NN	compound	B-protein
E1B-19	NN	compound	I-protein
kDa	NN	conj	I-protein
.	.	punct	O

In	IN	case	O
transient	JJ	amod	O
transfection	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
Bik	NN	nsubj	B-protein
promotes	VBZ	ROOT	O
cell	NN	compound	O
death	NN	dobj	O
in	IN	case	O
a	DT	det	O
manner	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
the	DT	det	O
death-promoting	JJ	amod	B-protein
members	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
Bcl-2	NN	compound	B-protein
family	NN	nmod	I-protein
,	,	punct	O
Bax	NN	appos	B-protein
and	CC	cc	O
Bak	NN	conj	B-protein
.	.	punct	O

This	DT	det	O
death-promoting	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
Bik	NN	nmod	B-protein
can	MD	aux	O
be	VB	auxpass	O
suppressed	VBN	ROOT	O
by	IN	case	O
coexpression	NN	nmod	O
of	IN	case	O
Bcl-2	NN	compound	B-protein
,	,	punct	O
Bcl-XL	NN	conj	B-protein
,	,	punct	O
EBV-BHRF1	NN	conj	B-protein
and	CC	cc	O
E1B-19	NN	compound	B-protein
kDa	NN	conj	I-protein
proteins	NNS	nmod	O
suggesting	VBG	xcomp	O
that	IN	mark	O
Bik	NN	nsubj	B-protein
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
common	JJ	amod	O
target	NN	ccomp	O
for	IN	case	O
both	CC	cc:preconj	O
cellular	JJ	nmod	B-protein
and	CC	cc	I-protein
viral	JJ	conj	I-protein
anti-apoptotic	JJ	amod	I-protein
proteins	NNS	dep	I-protein
.	.	punct	O

While	IN	mark	O
Bik	NN	nsubj	B-protein
does	VBZ	aux	O
not	RB	neg	O
show	VB	advcl	O
overt	JJ	amod	O
homology	NN	dobj	O
to	TO	case	O
the	DT	det	O
BH1	NN	compound	B-protein
and	CC	cc	O
BH2	NN	conj	B-protein
conserved	JJ	amod	O
domains	NNS	nmod	O
characteristic	JJ	amod	O
of	IN	case	O
the	DT	det	O
Bcl-2	NN	compound	B-protein
family	NN	nmod	I-protein
,	,	punct	O
it	PRP	nsubj	O
does	VBZ	aux	O
share	VB	ROOT	O
a	DT	det	O
9	CD	nummod	O
amino	NN	compound	B-protein
acid	NN	compound	I-protein
domain	NN	dobj	I-protein
(	-LRB-	punct	O
BH3	NN	appos	B-protein
)	-RRB-	punct	O
with	IN	case	O
Bax	NN	nmod	B-protein
and	CC	cc	O
Bak	NN	conj	B-protein
which	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
critical	JJ	amod	O
determinant	NN	acl:relcl	O
for	IN	case	O
the	DT	det	O
death-promoting	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-DNA
TCF-1	NN	compound	I-DNA
gene	NN	nsubj	I-DNA
encodes	VBZ	ROOT	O
a	DT	det	O
nuclear	JJ	amod	B-protein
DNA-binding	JJ	amod	I-protein
protein	NN	dobj	I-protein
uniquely	RB	advmod	O
expressed	VBN	acl	O
in	IN	case	O
normal	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
neoplastic	JJ	conj	I-cell_line
T-lineage	JJ	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
TCF-1	NN	compound	B-DNA
gene	NN	nsubj	I-DNA
encodes	VBZ	ROOT	O
a	DT	det	O
putative	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	dobj	I-protein
with	IN	case	O
affinity	NN	nmod	O
for	IN	case	O
a	DT	det	O
sequence	NN	compound	O
motif	NN	nmod	O
occurring	VBG	acl	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
T-cell	NN	compound	B-DNA
enhancers	NNS	nmod	I-DNA
.	.	punct	O

TCF-1	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
originally	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
expressed	VBN	xcomp	O
in	IN	case	O
a	DT	det	O
T	NN	nmod:npmod	O
cell-specific	JJ	amod	O
fashion	NN	nmod	O
within	IN	case	O
a	DT	det	O
set	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
mouse	NN	conj	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
expression	NN	nsubj	O
reportedly	RB	advmod	O
occurs	VBZ	ROOT	O
in	IN	case	O
multiple	JJ	amod	O
nonlymphoid	JJ	amod	O
tissues	NNS	nmod	O
during	IN	case	O
murine	JJ	amod	O
embryogenesis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
now	RB	advmod	O
raised	VBN	ROOT	O
a	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	dobj	I-protein
to	TO	mark	O
document	VB	advcl	O
expression	NN	dobj	O
and	CC	cc	O
biochemistry	NN	conj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
TCF-1	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

As	IN	mark	O
expected	VBN	advcl	O
,	,	punct	O
the	DT	det	O
TCF-1	NN	compound	B-protein
protein	NN	nsubj	I-protein
was	VBD	cop	O
detectable	JJ	ROOT	O
only	RB	advmod	O
in	IN	case	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
of	IN	case	I-cell_line
T	NN	compound	I-cell_line
lineage	NN	nmod	I-cell_line
.	.	punct	O

Its	PRP$	nmod:poss	O
expression	NN	nsubj	O
was	VBD	cop	O
always	RB	advmod	O
restricted	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

Immunohistochemistry	NN	nsubj	O
on	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
tissues	NNS	nmod	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
TCF-1	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
found	VBN	ccomp	O
exclusively	RB	advmod	O
in	IN	case	O
thymocytes	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
CD3+	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
in	IN	case	O
peripheral	JJ	amod	O
lymphoid	JJ	amod	O
tissues	NNS	nmod	O
.	.	punct	O

Western	NN	compound	O
blotting	NN	nsubj	O
yielded	VBD	ROOT	O
a	DT	det	O
set	NN	dobj	O
of	IN	case	O
bands	NNS	nmod	O
ranging	VBG	acl	O
from	IN	case	O
25	CD	nummod	O
kD	NN	nmod	O
to	TO	case	O
55	CD	nummod	O
kD	NN	nmod	O
,	,	punct	O
resulting	VBG	advcl	O
from	IN	case	O
extensive	JJ	amod	O
alternative	JJ	amod	O
splicing	NN	nmod	O
.	.	punct	O

The	DT	det	O
TCF-1	NN	compound	B-protein
protein	NN	nsubj	O
was	VBD	cop	O
detectable	JJ	ROOT	O
in	IN	case	O
all	DT	det	O
samples	NNS	nmod	O
of	IN	case	O
a	DT	det	O
set	NN	nmod	O
of	IN	case	O
22	CD	nummod	O
T-cell	NN	compound	B-cell_type
malignancies	NNS	nmod	I-cell_type
of	IN	case	O
various	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
maturation	NN	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	cop	O
absent	JJ	conj	O
from	IN	case	O
a	DT	det	O
large	JJ	amod	O
number	NN	nmod	O
of	IN	case	O
other	JJ	amod	O
hematologic	JJ	amod	B-cell_type
neoplasms	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
imply	VBP	ROOT	O
a	DT	det	O
T	NN	nmod:npmod	O
cell-specific	JJ	amod	O
function	NN	dobj	O
for	IN	case	O
TCF-1	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
notion	NN	appos	O
corroborated	VBN	acl	O
by	IN	case	O
recent	JJ	amod	O
observations	NNS	nmod	O
on	IN	case	O
Tcf-1	NN	compound	O
knock-out	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
nuclear	JJ	amod	O
TCF-1	NN	compound	B-protein
expression	NN	nsubj	O
can	MD	aux	O
serve	VB	ccomp	O
as	IN	case	O
a	DT	det	O
pan-T-lineage	JJ	amod	O
marker	NN	nmod	O
in	IN	case	O
the	DT	det	O
diagnosis	NN	nmod	O
of	IN	case	O
lymphoid	JJ	amod	O
malignancies	NNS	nmod	O
.	.	punct	O

Cross-linking	NN	nsubj	O
of	IN	case	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
receptors	NNS	nmod	I-protein
activates	VBZ	ROOT	O
HIV-1	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod:npmod	I-DNA
-driven	JJ	amod	O
transcription	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

Elevation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
circulating	VBG	amod	B-protein
immune	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
frequently	RB	advmod	O
accompanies	VBZ	ROOT	O
HIV-1	NN	compound	O
infection	NN	dobj	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
prognostic	JJ	amod	O
indicator	NN	conj	O
of	IN	case	O
clinical	JJ	amod	O
progression	NN	nmod	O
from	IN	case	O
asymptomatic	JJ	amod	O
infection	NN	nmod	O
to	TO	case	O
AIDS	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
cross-linking	NN	nsubj	O
of	IN	case	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
RI	NN	nmod	I-protein
or	CC	cc	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
RII	NN	conj	I-protein
by	IN	case	O
adherent	JJ	amod	B-protein
human	JJ	amod	I-protein
IgG	NN	nmod	I-protein
or	CC	cc	O
by	IN	case	O
specific	JJ	amod	O
anti-Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
R	NN	compound	I-protein
mAb	NN	conj	I-protein
activates	VBZ	ccomp	O
HIV-1	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
monocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
BF24	NN	dep	B-cell_line
and	CC	cc	O
increased	VBN	conj	O
HIV	NN	compound	B-RNA
RNA	NN	compound	I-RNA
expression	NN	dobj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
from	IN	case	O
HIV	NN	compound	O
infected	JJ	amod	O
patients	NNS	nmod	O
as	IN	mark	O
assayed	VBN	advcl	O
by	IN	case	O
reverse	JJ	amod	O
transcription-PCR	NN	nmod	O
.	.	punct	O

In	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
R	NN	compound	I-protein
cross-linking	NN	nsubj	O
induced	VBD	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
the	DT	det	O
regulatory	JJ	amod	B-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
of	IN	case	O
HIV-1	NN	nmod	O
and	CC	cc	O
to	TO	mark	O
activate	VB	conj	O
HIV-1	NN	compound	O
transcription	NN	dobj	O
.	.	punct	O
Anti-TNF-alpha	NN	compound	B-protein
antibody	NN	nsubj	I-protein
but	CC	cc	O
not	RB	cc	O
anti-IL-1	NN	compound	B-protein
beta	NN	compound	I-protein
antibody	NN	conj	I-protein
strongly	RB	advmod	O
inhibited	VBD	ROOT	O
both	CC	cc:preconj	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
HIV-1-	NN	amod	O
LTR	NN	nmod:npmod	B-DNA
-driven	JJ	amod	O
transcription	NN	nmod	O
and	CC	cc	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
by	IN	case	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
R	NN	compound	I-protein
cross-linking	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
R	NN	nsubj	I-protein
can	MD	aux	O
mediate	VB	ccomp	O
a	DT	det	O
TNF-alpha	NN	compound	B-protein
-dependent	JJ	amod	O
induction	NN	dobj	O
of	IN	case	O
HIV-1	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
immune	JJ	amod	B-protein
complexes	NNS	nsubj	I-protein
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
the	DT	det	O
pathophysiology	NN	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
infection	NN	nmod	O
by	IN	mark	O
augmenting	VBG	advcl	O
viral	JJ	amod	O
replication	NN	dobj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Signalling	NN	ROOT	O
via	IN	case	O
CD28	NN	nmod	B-protein
of	IN	case	O
human	JJ	amod	B-cell_line
naive	JJ	amod	I-cell_line
neonatal	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

Accessory	NN	compound	O
molecules	NNS	nsubj	O
play	VBP	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
the	DT	det	O
T	NN	compound	O
cell	NN	compound	O
response	NN	nmod	O
to	TO	case	O
antigenic	JJ	amod	O
challenge	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
CD28	NN	nmod	B-protein
in	IN	mark	O
modulating	VBG	acl	O
the	DT	det	O
'naive	JJ	amod	O
'	``	punct	O
neonatal	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
response	NN	dobj	O
to	TO	case	O
anti-CD2	JJ	amod	B-protein
-mediated	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

To	TO	mark	O
compare	VB	advcl	O
the	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
CD28	NN	nmod	B-protein
,	,	punct	O
neonatal	JJ	amod	B-cell_type
and	CC	cc	O
adult	JJ	conj	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
pair	NN	nmod	O
of	IN	case	O
mitogenic	JJ	amod	B-protein
anti-CD2	JJ	amod	I-protein
antibodies	NNS	nmod	I-protein
in	IN	case	O
the	DT	dep	O
presence	NN	nmod	O
or	CC	cc	O
absence	NN	conj	O
of	IN	case	O
anti-CD28	JJ	amod	B-protein
MoAb	NN	nmod	I-protein
.	.	punct	O

With	IN	case	O
anti-CD2	NN	nmod	B-protein
alone	RB	advmod	O
,	,	punct	O
neonatal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
proliferated	VBD	ROOT	O
slightly	RB	advmod	O
but	CC	cc	O
produced	VBD	conj	O
no	DT	neg	O
detectable	JJ	amod	O
IL-2	NN	dobj	B-protein
,	,	punct	O
whereas	IN	dep	O
adult	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
proliferated	VBD	parataxis	O
vigorously	RB	advmod	O
,	,	punct	O
with	IN	case	O
significant	JJ	amod	O
IL-2	NN	compound	B-protein
production	NN	nmod	O
.	.	punct	O

Costimulation	NN	nsubj	O
with	IN	case	O
anti-CD28	JJ	amod	B-protein
MoAb	NN	nmod	I-protein
greatly	RB	advmod	O
enhanced	VBD	ROOT	O
the	DT	det	O
proliferative	JJ	amod	O
response	NN	dobj	O
of	IN	case	O
neonatal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
levels	NNS	nmod	O
equivalent	JJ	amod	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
adult	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
whereas	IN	dep	O
adult	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
showed	VBD	parataxis	O
only	RB	advmod	O
slight	JJ	amod	O
increases	NNS	dobj	O
.	.	punct	O

Although	IN	mark	O
IL-2	NN	compound	B-protein
secretion	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	advcl	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
anti-CD28	JJ	amod	B-protein
MoAb	NN	nmod	I-protein
,	,	punct	O
neonatal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
IL-2	NN	compound	B-protein
production	NN	nsubj	O
remained	VBD	ROOT	O
lower	JJR	xcomp	O
than	IN	case	O
in	IN	case	O
adults	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
enhancement	NN	nsubj	O
of	IN	case	O
IL-2	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nmod	O
in	IN	case	O
neonates	NNS	nmod	O
was	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
adult	JJ	amod	O
levels	NNS	nmod	O
.	.	punct	O

Anti-	JJ	amod	O
CD28	NN	compound	B-protein
MoAb	NN	compound	I-protein
costimulation	NN	nsubj	O
increased	VBD	ROOT	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
levels	NNS	dobj	O
in	IN	case	O
neonates	NNS	nmod	O
,	,	punct	O
albeit	IN	case	O
to	TO	case	O
levels	NNS	nmod	O
lower	JJR	amod	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
adults	NNS	nmod	O
.	.	punct	O

The	DT	det	O
cellular	JJ	amod	O
mechanism	NN	nsubj	O
governing	VBG	acl	O
the	DT	det	O
diminished	VBN	amod	O
proliferative	JJ	amod	O
response	NN	dobj	O
of	IN	case	O
neonatal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
to	TO	case	O
anti-CD2	NN	nmod	B-protein
may	MD	aux	O
therefore	RB	advmod	O
be	VB	cop	O
due	JJ	ROOT	O
to	TO	mark	O
decreased	VBN	xcomp	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
induction	NN	dobj	O
,	,	punct	O
reduced	VBD	amod	O
IL-2	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	conj	O
and	CC	cc	O
deficient	JJ	amod	O
IL-2	NN	compound	B-protein
production	NN	conj	O
.	.	punct	O

Although	IN	mark	O
anti-CD28	JJ	amod	B-protein
MoAb	NN	compound	I-protein
costimulation	NN	nsubj	O
enhances	VBZ	advcl	O
all	DT	dobj	O
of	IN	case	O
the	DT	det	O
above	JJ	amod	O
signals	NNS	nmod	O
,	,	punct	O
NF	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
and	CC	cc	O
IL-2	NN	conj	O
levels	NNS	nsubj	O
remain	VBP	ROOT	O
lower	JJR	xcomp	O
than	IN	case	O
in	IN	case	O
adults	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
the	DT	det	O
need	NN	dobj	O
for	IN	prep	O
further	JJ	amod	O
activation	NN	compound	O
requirements	NNS	pobj	O
in	IN	prep	O
the	DT	det	O
neonate	NN	pobj	O
.	.	punct	O

TCL1	NN	compound	O
oncogene	NN	compound	O
activation	NN	ROOT	O
in	IN	case	O
preleukemic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
a	DT	det	O
case	NN	nmod	O
of	IN	case	O
ataxia-telangiectasia	NN	nmod	O
.	.	punct	O

The	DT	det	O
TCL1	NN	compound	B-DNA
oncogene	NN	nsubjpass	I-DNA
on	IN	case	O
human	JJ	amod	B-DNA
chromosome	NN	compound	I-DNA
14q32.1	NN	nmod	B-DNA
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
chromosome	NN	compound	O
translocations	NNS	nmod	O
[	-LRB-	punct	O
t	NN	dep	B-DNA
(	-LRB-	punct	I-DNA
14	CD	nummod	I-DNA
;	:	punct	I-DNA
14	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
(	-LRB-	punct	I-DNA
q11	NN	compound	I-DNA
;	:	punct	I-DNA
q32.1	NN	conj	I-DNA
)	-RRB-	punct	I-DNA
and	CC	cc	O
t	NN	conj	B-DNA
(	-LRB-	punct	I-DNA
7	CD	dep	I-DNA
;	:	punct	I-DNA
14	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
(	-LRB-	punct	I-DNA
q35	NN	appos	I-DNA
;	:	punct	I-DNA
q32.1	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
]	-RRB-	punct	O
and	CC	cc	O
inversions	NNS	conj	O
[	-LRB-	punct	O
inv14	NN	dep	B-DNA
(	-LRB-	punct	I-DNA
q11	NN	compound	I-DNA
;	:	punct	I-DNA
q32.1	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
]	-RRB-	punct	O
with	IN	case	O
TCR	NN	compound	B-DNA
alpha/beta	NN	compound	I-DNA
loci	NNS	nmod	I-DNA
in	IN	case	O
T-cell	NN	compound	O
leukemias	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
T-prolymphocytic	JJ	nmod	O
(	-LRB-	punct	O
T-PLL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
involved	VBN	ROOT	O
in	IN	case	O
T-	NN	amod	O
acute	JJ	amod	O
and-	DT	amod	O
chronic	JJ	amod	O
leukemias	NNS	nmod	O
arising	VBG	acl	O
in	IN	case	O
cases	NNS	nmod	O
of	IN	case	O
ataxia-telangiectasia	JJ	nmod	O
(	-LRB-	punct	O
AT	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
immunodeficiency	NN	compound	O
syndrome	NN	appos	O
.	.	punct	O

Similar	JJ	amod	O
chromosomal	JJ	amod	O
rearrangements	NNS	nsubj	O
occur	VBP	ROOT	O
also	RB	advmod	O
in	IN	case	O
the	DT	det	O
clonally	RB	advmod	O
expanded	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
AT	IN	case	O
patients	NNS	nmod	O
before	IN	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
the	DT	det	O
overt	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
analyzed	VBN	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
TCL1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
and	CC	cc	O
protein	NN	conj	B-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBLs	NNS	appos	B-cell_type
)	-RRB-	punct	O
from	IN	case	O
four	CD	nummod	O
AT	IN	case	O
cases	NNS	nmod	O
and	CC	cc	O
from	IN	case	O
healthy	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
TCL1	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
overexpressed	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
PBLs	NNS	nmod	B-cell_type
of	IN	case	O
an	DT	det	O
AT	JJ	amod	O
patient	NN	nmod	O
with	IN	case	O
a	DT	det	O
large	JJ	amod	B-cell_line
clonal	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
population	NN	nmod	I-cell_line
exhibiting	VBG	acl	O
the	DT	det	O
t	NN	compound	O
(	-LRB-	punct	O
14	CD	nummod	O
;	:	punct	O
14	CD	dep	O
)	-RRB-	punct	O
translocation	NN	dobj	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
the	DT	det	O
lymphocytes	NNS	conj	B-cell_type
of	IN	case	O
the	DT	det	O
other	JJ	amod	O
cases	NNS	nmod	O
.	.	punct	O

Fluorescence	NN	compound	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nsubj	O
of	IN	case	O
the	DT	det	O
TCL1	NN	compound	B-DNA
genomic	JJ	amod	I-DNA
locus	NN	nmod	I-DNA
to	TO	case	O
lymphocyte	NN	compound	O
metaphases	NNS	nmod	O
from	IN	case	O
the	DT	det	O
AT	JJ	amod	O
patient	NN	nmod	O
with	IN	case	O
the	DT	det	O
T-cell	NN	compound	O
clonal	JJ	amod	O
expansion	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
breakpoint	NN	nsubj	O
of	IN	case	O
the	DT	det	O
t	NN	nmod	O
(	-LRB-	punct	O
14	CD	nummod	O
;	:	punct	O
14	CD	dep	O
)	-RRB-	punct	O
translocation	NN	nsubj	O
lies	VBZ	ccomp	O
within	IN	case	O
the	DT	det	O
TCL1	NN	compound	B-DNA
locus	NN	nmod	I-DNA
and	CC	cc	O
is	VBZ	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
an	DT	det	O
inverted	JJ	amod	O
duplication	NN	nmod	O
of	IN	case	O
the	DT	det	O
distal	JJ	amod	B-DNA
part	NN	nmod	I-DNA
of	IN	case	O
chromosome	NN	nmod	B-DNA
14	CD	nummod	I-DNA
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
TCL1	NN	nsubjpass	B-DNA
is	VBZ	auxpass	O
activated	VBN	ccomp	O
in	IN	case	O
preleukemic	JJ	amod	B-cell_line
clonal	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
as	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
of	IN	case	O
chromosome	NN	compound	O
translocation	NN	nmod	O
involving	VBG	acl	O
sequences	NNS	dobj	O
from	IN	case	O
the	DT	det	O
TCR	NN	compound	B-DNA
locus	NN	nmod	I-DNA
at	IN	case	O
14q11	NN	nmod	B-DNA
.	.	punct	O

Deregulation	NN	nsubj	O
of	IN	case	O
TCL1	NN	nmod	B-DNA
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
event	NN	ROOT	O
in	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
malignancy	NN	nmod	O
in	IN	case	O
these	DT	det	O
types	NNS	nmod	O
of	IN	case	O
leukemias	NNS	nmod	O
and	CC	cc	O
represents	VBZ	conj	O
a	DT	det	O
potential	JJ	amod	O
tool	NN	dobj	O
for	IN	case	O
clinical	JJ	amod	O
evaluation	NN	nmod	O
.	.	punct	O

C/EBP	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
activate	VBP	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1	CD	nummod	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
in	IN	case	O
macrophages/	JJ	amod	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Three	CD	nummod	O
binding	VBG	amod	O
sites	NNS	nsubjpass	O
for	IN	case	O
C/EBP	NN	compound	B-protein
proteins	NNS	nmod	I-protein
are	VBP	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
HIV-1	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
(	-LRB-	punct	O
V.M.	NNP	compound	O
Tesmer	NNP	dep	O
,	,	punct	O
A.Rajadhyaksha	NNP	conj	O
,	,	punct	O
J.Babin	NNP	conj	O
,	,	punct	O
and	CC	cc	O
M.Bina	NN	conj	O
,	,	punct	O
Proc.Natl.Acad.Sci.	JJ	compound	O
USA	NNP	appos	O
90	CD	nummod	O
:	:	punct	O
7298-7302	CD	dep	O
,	,	punct	O
1993	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
determined	VBN	ROOT	O
the	DT	det	O
functional	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
C/EBP	NN	compound	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
C/EBP	NN	compound	B-DNA
sites	NNS	conj	I-DNA
in	IN	mark	O
regulating	VBG	advcl	O
transcription	NN	dobj	O
from	IN	case	O
the	DT	det	O
HIV-	NN	compound	B-DNA
1	CD	nummod	I-DNA
LTR	NN	nmod	I-DNA
in	IN	case	O
monocytes/macrophages	NNS	nmod	B-cell_type
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
endogenous	JJ	amod	B-protein
C/EBP	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
using	VBG	acl	O
either	CC	cc:preconj	O
an	DT	det	O
excess	NN	dobj	O
of	IN	case	O
C/EBP	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
or	CC	cc	O
a	DT	det	O
trans-	JJ	amod	B-DNA
dominant	JJ	amod	I-DNA
negative	JJ	amod	I-DNA
inhibitor	NN	conj	I-DNA
,	,	punct	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
C/EBP	NN	compound	B-protein
proteins	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
basal	JJ	amod	O
and	CC	cc	O
activated	VBN	conj	O
levels	NNS	nmod	O
of	IN	case	O
HIV-1	NN	compound	B-DNA
LTR	NN	compound	I-DNA
transcription	NN	nmod	O
in	IN	case	O
the	DT	det	O
promonocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
U937	NN	nmod	I-cell_line
.	.	punct	O

Northern	NN	compound	O
(	-LRB-	punct	O
RNA	NN	appos	O
)	-RRB-	punct	O
blots	NNS	nsubj	O
and	CC	cc	O
binding	NN	compound	O
assays	NNS	conj	O
showed	VBD	ROOT	O
that	IN	mark	O
NF-IL6	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
only	RB	advmod	O
known	JJ	amod	O
C/EBP	NN	compound	B-protein
family	NN	compound	I-protein
member	NN	ccomp	I-protein
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
increased	VBN	acl:relcl	O
when	WRB	advmod	O
U937	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
are	VBP	auxpass	O
activated	VBN	advcl	O
.	.	punct	O

Mutational	JJ	amod	O
analyses	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
showed	VBD	ROOT	O
that	IN	mark	O
one	CD	nummod	O
C/EBP	NN	compound	B-DNA
site	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
normal	JJ	amod	O
LTR	NN	compound	B-DNA
transcription	NN	nmod	O
both	CC	cc:preconj	O
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
cellular	JJ	amod	O
activation	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
two	CD	nummod	O
3	CD	nummod	O
'	``	punct	O
C/EBP	NN	compound	B-DNA
sites	NNS	nsubj	I-DNA
are	VBP	cop	O
functionally	RB	advmod	O
equivalent	JJ	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
transcription	NN	nsubjpass	O
from	IN	case	O
crippled	JJ	amod	B-DNA
HIV-1	NN	compound	I-DNA
LTRs	NNS	nmod	I-DNA
lacking	VBG	acl	O
C/EBP	NN	compound	B-DNA
sites	NNS	dobj	I-DNA
can	MD	aux	O
still	RB	advmod	O
be	VB	auxpass	O
induced	VBN	ROOT	O
following	VBG	case	O
activation	NN	nmod	O
of	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Several	JJ	amod	O
models	NNS	nsubjpass	O
are	VBP	auxpass	O
suggested	VBN	ROOT	O
for	IN	mark	O
how	WRB	advmod	O
elevated	JJ	amod	O
NF-IL6	NN	nsubj	B-protein
may	MD	aux	O
participate	VB	advcl	O
in	IN	case	O
an	DT	det	O
autostimulatory	JJ	amod	O
loop	NN	nmod	O
involving	VBG	acl	O
HIV	NN	compound	O
infection	NN	dobj	O
,	,	punct	O
macrophage	NN	compound	O
activation	NN	conj	O
,	,	punct	O
cytokine	NN	compound	B-protein
expression	NN	conj	O
,	,	punct	O
and	CC	cc	O
HIV	NN	compound	O
replication	NN	conj	O
.	.	punct	O

Human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type-2	JJ	compound	O
gene	NN	compound	O
expression	NN	ROOT	O
:	:	punct	O
two	CD	nummod	O
enhancers	NNS	dep	B-DNA
and	CC	cc	O
their	PRP$	nmod:poss	O
activation	NN	conj	O
by	IN	case	O
T-cell	NN	compound	B-cell_type
activators	NNS	nmod	O
.	.	punct	O

The	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
viruses	NNS	nsubj	O
(	-LRB-	punct	O
HIVs	NNS	appos	O
)	-RRB-	punct	O
may	MD	aux	O
include	VB	ROOT	O
a	DT	det	O
spectrum	NN	dobj	O
of	IN	case	O
retroviruses	NNS	nmod	O
with	IN	case	O
varying	VBG	amod	O
potential	NN	nmod	O
to	TO	mark	O
infect	VB	acl	O
their	PRP$	nmod:poss	O
host	NN	dobj	O
,	,	punct	O
undergo	VB	conj	O
long	JJ	amod	O
periods	NNS	dobj	O
of	IN	case	O
latent	JJ	amod	O
infection	NN	nmod	O
,	,	punct	O
and	CC	cc	O
induce	VB	conj	O
pathology	NN	dobj	O
.	.	punct	O

Since	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
viruses	NNS	nmod	O
is	VBZ	cop	O
in	IN	case	O
large	JJ	amod	O
part	NN	nmod	O
regulated	VBN	advcl	O
by	IN	case	O
the	DT	det	O
sequence	NN	compound	B-DNA
elements	NNS	nmod	I-DNA
in	IN	case	O
their	PRP$	nmod:poss	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeats	NNS	nmod	I-DNA
(	-LRB-	punct	O
LTRs	NNS	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
this	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
directed	VBN	ROOT	O
to	TO	case	O
an	DT	det	O
analysis	NN	nmod	O
of	IN	case	O
the	DT	det	O
regulatory	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
HIV-2	NN	compound	B-DNA
LTR	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
contain	VB	xcomp	O
two	CD	nummod	O
enhancers	NNS	dobj	B-DNA
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
these	DT	det	O
enhancers	NNS	nmod	B-DNA
is	VBZ	cop	O
,	,	punct	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
identical	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

This	DT	det	O
enhancer	NN	nsubj	B-DNA
in	IN	case	O
HIV-1	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
T-cell	NN	compound	B-DNA
activation	NN	compound	I-DNA
response	NN	compound	I-DNA
element	NN	ROOT	I-DNA
;	:	punct	O
in	IN	case	O
HIV-2	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
the	DT	det	O
second	JJ	amod	B-DNA
enhancer	NN	appos	I-DNA
that	WDT	nsubj	O
is	VBZ	cop	O
mainly	RB	advmod	O
responsible	JJ	acl:relcl	O
for	IN	case	O
activation	NN	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
T-cell	NN	compound	O
activators	NNS	nmod	O
.	.	punct	O

The	DT	det	O
second	JJ	amod	O
enhancer	NN	nsubj	B-DNA
interacts	VBZ	ROOT	O
with	IN	case	O
two	CD	nummod	O
nuclear	JJ	amod	B-protein
binding	VBG	compound	I-protein
proteins	NNS	nmod	I-protein
(	-LRB-	punct	O
85	CD	nummod	O
kD	NN	dep	O
and	CC	cc	O
27	CD	nummod	O
kD	NN	amod	O
mobility	NN	conj	O
)	-RRB-	punct	O
that	WDT	nsubj	O
appear	VBP	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
for	IN	case	O
optimal	JJ	amod	O
enhancer	NN	compound	O
function	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
.	.	punct	O

Observations	NNS	nsubj	O
such	JJ	case	O
as	IN	mwe	O
these	DT	nsubj	O
encourage	VBP	ROOT	O
the	DT	det	O
speculation	NN	dobj	O
that	IN	mark	O
there	EX	expl	O
may	MD	aux	O
be	VB	cop	O
subtle	JJ	amod	O
differences	NNS	ccomp	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
HIV-1	NN	nmod	O
and	CC	cc	O
HIV-2	NN	conj	O
expression	NN	dep	O
that	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
relevant	JJ	acl:relcl	O
to	TO	case	O
the	DT	det	O
possible	JJ	amod	O
longer	JJR	dep	O
latency	NN	nmod	O
and	CC	cc	O
reduced	VBN	amod	O
pathogenicity	NN	conj	O
of	IN	case	O
HIV-2	NN	nmod	O
.	.	punct	O

NF-M	NN	nsubj	B-protein
(	-LRB-	punct	O
chicken	NN	compound	B-protein
C/EBP	NN	compound	I-protein
beta	NN	appos	I-protein
)	-RRB-	punct	O
induces	VBZ	ROOT	O
eosinophilic	JJ	amod	O
differentiation	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
a	DT	det	O
hematopoietic	JJ	amod	B-cell_line
progenitor	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

CAAT/enhancer	NN	compound	B-protein
binding	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
(	-LRB-	punct	O
C/EBPs	NNS	appos	B-protein
)	-RRB-	punct	O
are	VBP	cop	O
transcriptional	JJ	amod	O
activators	NNS	ROOT	O
implicated	VBN	acl	O
in	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
processes	NNS	nmod	O
of	IN	case	O
various	JJ	amod	O
cell	NN	compound	O
lineages	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
earlier	RBR	advmod	O
that	IN	mark	O
NF-M	NN	nsubjpass	B-protein
,	,	punct	O
the	DT	det	O
chicken	NN	compound	B-protein
homolog	NN	appos	I-protein
of	IN	case	O
C/EBP	NN	compound	B-protein
beta	NN	nmod	I-protein
,	,	punct	O
is	VBZ	auxpass	O
specifically	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
myelomonocytic	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
eosinophilic	JJ	conj	I-cell_type
cells	NNS	dep	I-cell_type
of	IN	case	O
the	DT	det	O
hematopoietic	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
NF-M	NN	nmod	B-protein
in	IN	case	O
hematopoietic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lineage	NN	compound	I-cell_line
commitment	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
a	DT	det	O
conditional	JJ	amod	O
form	NN	dobj	O
of	IN	case	O
the	DT	det	O
protein	NN	nmod	O
by	IN	mark	O
fusing	VBG	advcl	O
it	PRP	dobj	O
to	TO	case	O
the	DT	det	O
hormone	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
estrogen	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

This	DT	det	O
construct	NN	nsubjpass	O
was	VBD	auxpass	O
stably	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
multipotent	JJ	amod	B-cell_line
progenitor	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
transformed	VBN	acl	O
by	IN	case	O
the	DT	det	O
Myb-Ets	NN	compound	B-protein
oncoprotein	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
both	CC	cc:preconj	O
NF-M-dependent	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
constructs	NNS	nsubjpass	I-DNA
and	CC	cc	O
resident	JJ	amod	O
genes	NNS	conj	O
could	MD	aux	O
be	VB	auxpass	O
activated	VBN	ccomp	O
by	IN	case	O
addition	NN	nmod	O
of	IN	case	O
beta-estradiol	NN	nmod	O
to	TO	case	O
the	DT	det	O
NF-M-estrogen	NN	compound	B-cell_line
receptor	NN	compound	I-cell_line
expressing	VBG	compound	I-cell_line
progenitors	NNS	nmod	I-cell_line
.	.	punct	O

At	IN	prep	O
the	DT	det	O
same	JJ	amod	O
time	NN	pobj	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
a	DT	det	O
down-regulation	NN	dobj	O
of	IN	case	O
progenitor-specific	JJ	amod	B-protein
surface	NN	compound	I-protein
markers	NNS	nmod	I-protein
and	CC	cc	O
the	DT	det	O
up-regulation	NN	conj	O
of	IN	case	O
differentiation	NN	compound	B-protein
markers	NNS	nmod	I-protein
restricted	JJ	acl	O
to	TO	case	O
the	DT	det	O
eosinophil	NN	nmod	B-cell_type
and	CC	cc	O
myeloid	JJ	amod	B-cell_type
lineages	NNS	conj	I-cell_type
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
the	DT	det	O
onset	NN	nmod	O
of	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
cell	NN	compound	O
death	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
with	IN	case	O
typical	JJ	amod	O
apoptotic	JJ	amod	O
features	NNS	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
NF-M	NN	nsubj	B-protein
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
commitment	NN	nmod	O
along	IN	case	O
the	DT	det	O
eosinophil	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Prolactin	NN	compound	B-protein
and	CC	cc	O
interleukin-2	NN	conj	B-protein
receptors	NNS	nsubj	I-protein
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	compound	I-cell_type
signal	NN	ROOT	O
through	IN	case	O
a	DT	det	O
MGF-STAT5-like	JJ	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
cell	NN	compound	O
surface	NN	compound	O
receptors	NNS	nsubj	O
for	IN	case	O
PRL	NN	nmod	B-protein
and	CC	cc	O
interleukin-2	NN	conj	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
are	VBP	cop	O
structurally	RB	advmod	O
distinct	JJ	ROOT	O
,	,	punct	O
but	CC	cc	O
share	VBP	conj	O
regulatory	JJ	amod	O
tasks	NNS	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

They	PRP	nsubj	O
can	MD	aux	O
stimulate	VB	ROOT	O
proliferation	NN	dobj	O
and	CC	cc	O
activate	VBP	conj	O
transcription	NN	dobj	O
of	IN	case	O
over-lapping	JJ	amod	O
sets	NNS	nmod	O
of	IN	case	O
genes	NNS	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

PRL	NN	compound	B-protein
and	CC	cc	O
IL-2	NN	conj	B-protein
receptor	NN	compound	O
activation	NN	nsubjpass	O
are	VBP	auxpass	O
both	CC	dep	O
linked	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
Jak/Stat	NN	compound	B-protein
(	-LRB-	punct	O
signal	NN	compound	B-protein
transducer	NN	compound	I-protein
and	CC	cc	I-protein
activator	NN	compound	I-protein
of	IN	case	I-protein
transcription	NN	conj	I-protein
)	-RRB-	punct	O
pathway	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
PRL	NN	nmod	B-protein
and	CC	cc	O
IL-2	NN	conj	B-protein
to	TO	mark	O
activate	VB	acl	O
Stat	NN	compound	B-protein
proteins	NNS	dobj	I-protein
in	IN	case	O
different	JJ	amod	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
specificities	NNS	nsubjpass	O
,	,	punct	O
the	DT	det	O
reactivities	NNS	nsubjpass	O
toward	IN	case	O
Stat-specific	JJ	amod	O
antisera	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
mol	NN	conj	O
wt	IN	dep	O
of	IN	case	O
IL-2	NN	compound	B-protein
-and	NN	compound	O
PRL-induced	JJ	amod	B-protein
DNA-binding	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
Nb2	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
C196	NN	conj	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dep	I-cell_line
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

A	DT	det	O
comparison	NN	nsubjpass	O
with	IN	case	O
the	DT	det	O
Stat	NN	compound	B-protein
proteins	NNS	nmod	I-protein
induced	VBN	acl	O
by	IN	case	O
interferon-gamma	NN	nmod	B-protein
,	,	punct	O
PRL	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-6	NN	conj	B-protein
in	IN	case	O
T47D	NN	compound	B-cell_line
mammary	JJ	amod	I-cell_line
tumor	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
made	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
these	DT	det	O
parameters	NNS	nsubj	O
were	VBD	cop	O
indistinguishable	JJ	ccomp	O
for	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
PRL-	NN	amod	B-protein
and	CC	cc	I-protein
IL-2-induced	JJ	conj	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

A	DT	det	O
transcription	NN	compound	O
factor	NN	nsubjpass	O
closely	RB	advmod	O
related	JJ	amod	O
to	TO	case	O
mammary	JJ	amod	B-protein
gland	NN	compound	I-protein
factor-Stat5	NN	nmod	I-protein
is	VBZ	auxpass	O
rapidly	RB	advmod	O
activated	VBN	ROOT	O
upon	IN	case	O
interaction	NN	nmod	O
of	IN	case	O
IL-2	NN	nmod	B-protein
and	CC	cc	O
PRL	NN	conj	B-protein
with	IN	case	O
their	PRP$	nmod:poss	O
respective	JJ	amod	O
receptors	NNS	nmod	O
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
second	JJ	amod	O
protein	NN	nmod	O
related	JJ	amod	O
to	TO	case	O
Stat1	NN	nmod	B-protein
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
emphasize	VBP	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
PRL	NN	nmod	B-protein
as	IN	case	O
a	DT	det	O
regulator	NN	nmod	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
and	CC	cc	O
indicate	VBP	conj	O
that	IN	mark	O
the	DT	det	O
Stat	NN	compound	B-protein
factors	NNS	nsubj	I-protein
mammary	JJ	amod	B-protein
gland	NN	compound	I-protein
factor-Stat5	NN	dep	I-protein
and	CC	cc	O
Stat1	NN	conj	B-protein
play	VBP	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
during	IN	case	O
T	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

ETS1	NN	nsubj	B-protein
transactivates	VBZ	ROOT	O
the	DT	det	O
human	JJ	amod	B-DNA
GM-CSF	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
stimulated	VBN	acl	O
with	IN	case	O
PMA	NN	nmod	O
and	CC	cc	O
ionomycin	NN	conj	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
helper	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
results	VBZ	ROOT	O
in	IN	case	O
coordinate	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
involved	VBN	acl	O
in	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
proliferation	NN	conj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
haematopoietic	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	nsubj	I-protein
(	-LRB-	punct	O
GM-CSF	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
one	CD	nummod	O
such	JJ	amod	O
cytokine	NN	nsubj	B-protein
whose	WP$	nmod:poss	O
increased	VBN	amod	O
expression	NN	nsubj	O
results	VBZ	ROOT	O
partly	RB	advmod	O
from	IN	case	O
increases	NNS	nmod	O
in	IN	case	O
transcription	NN	nmod	O
.	.	punct	O

Cis-acting	JJ	amod	B-DNA
elements	NNS	nsubjpass	I-DNA
with	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
,	,	punct	O
AP-1	NN	conj	B-protein
and	CC	cc	O
ETS-like	JJ	amod	B-DNA
motifs	NNS	conj	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
promoter	NN	compound	O
region	NN	nmod	O
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
important	JJ	acl:relcl	O
for	IN	case	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
following	VBG	case	O
PMA	NN	compound	O
and	CC	cc	O
ionomycin	NN	conj	O
stimulation	NN	nmod	O
.	.	punct	O

A	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
ETS	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
are	VBP	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
including	VBG	case	O
ETS1	NN	nmod	B-protein
and	CC	cc	O
ELF1	NN	conj	B-protein
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
these	DT	det	O
factors	NNS	nmod	O
to	TO	mark	O
interact	VB	acl	O
with	IN	case	O
a	DT	det	O
site	NN	nmod	O
(	-LRB-	punct	O
GM5	NN	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
located	JJ	amod	O
within	IN	case	O
the	DT	det	O
CLE0	NN	compound	B-DNA
element	NN	nmod	I-DNA
,	,	punct	O
-47	CD	nummod	B-DNA
to	TO	dep	I-DNA
-40	CD	appos	I-DNA
upstream	RB	advmod	I-DNA
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
transcription	NN	compound	I-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Exogenous	JJ	amod	O
ETS1	NN	nsubj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
ELF1	NN	conj	B-protein
,	,	punct	O
can	MD	aux	O
transactivate	VB	ROOT	O
GM-CSF	NN	dobj	B-protein
,	,	punct	O
through	IN	case	O
the	DT	det	O
GM5	NN	compound	B-DNA
site	NN	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
PMA/ionomycin	NN	compound	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Other	JJ	amod	O
unidentified	JJ	amod	O
ETS-like	JJ	amod	B-protein
factors	NNS	nsubj	I-protein
present	JJ	amod	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
are	VBP	cop	O
also	RB	advmod	O
capable	JJ	ROOT	O
of	IN	mark	O
binding	VBG	advcl	O
GM5	NN	dobj	B-DNA
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
core	NN	compound	O
ETS	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
from	IN	case	O
-GGAA-	NN	compound	B-DNA
to	TO	dep	I-DNA
-GGAT-	NN	nmod	I-DNA
prevents	VBZ	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
ETS-like	JJ	amod	B-protein
factors	NNS	nmod	I-protein
with	IN	case	O
the	DT	det	O
exception	NN	nmod	O
of	IN	case	O
ETS1	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	nsubj	I-DNA
,	,	punct	O
modified	VBN	acl	O
in	IN	case	O
this	DT	det	O
way	NN	nmod	O
to	TO	mark	O
be	VB	cop	O
ETS1	NN	nmod:npmod	B-protein
specific	JJ	xcomp	O
,	,	punct	O
is	VBZ	cop	O
fully	RB	advmod	O
responsive	JJ	ROOT	O
to	TO	case	O
PMA/ionomycin	NN	compound	O
induction	NN	nmod	O
,	,	punct	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
ETS1	NN	compound	B-protein
transactivation	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
PMA	NN	nmod	O
and	CC	cc	O
ionomycin	NN	conj	O
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
ETS1	NN	nsubjpass	B-protein
may	MD	aux	O
be	VB	auxpass	O
involved	VBN	ccomp	O
in	IN	mark	O
mediating	VBG	advcl	O
the	DT	det	O
increased	VBN	amod	O
GM-CSF	NN	compound	B-protein
production	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
.	.	punct	O

Quantitation	NN	ROOT	O
of	IN	case	O
beta	NN	compound	B-RNA
1	CD	nummod	I-RNA
triiodothyronine	NN	compound	I-RNA
receptor	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
human	JJ	amod	O
tissues	NNS	nmod	O
by	IN	case	O
competitive	JJ	amod	O
reverse	JJ	amod	O
transcription	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
.	.	punct	O

Thyroid	NN	compound	O
hormones	NNS	nsubj	O
act	VBP	ROOT	O
by	IN	mark	O
binding	VBG	nmod	O
to	TO	case	O
nuclear	JJ	amod	B-protein
receptor	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
the	DT	det	O
thyroid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptors	NNS	appos	I-protein
(	-LRB-	punct	I-protein
TR	NN	compound	I-protein
)	-RRB-	punct	I-protein
alpha	NN	dep	I-protein
and	CC	cc	I-protein
beta	NN	conj	I-protein
.	.	punct	O

Data	NNS	nsubj	O
from	IN	case	O
cell	NN	compound	O
culture	NN	nmod	O
and	CC	cc	O
animal	NN	compound	O
studies	NNS	conj	O
indicate	VBP	ROOT	O
that	IN	mark	O
TR	NN	compound	B-protein
expression	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
regulated	VBN	ccomp	O
to	TO	mark	O
modulate	VB	xcomp	O
target	NN	compound	O
organ	NN	compound	O
responsiveness	NN	dobj	O
to	TO	case	O
thyroid	NN	compound	O
hormone	NN	nmod	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
whether	IN	mark	O
such	JJ	amod	O
adaptive	JJ	amod	O
changes	NNS	nsubj	O
in	IN	case	O
TR	NN	compound	B-protein
expression	NN	nmod	O
occur	VBP	ccomp	O
in	IN	case	O
humans	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
determined	VBD	ROOT	O
the	DT	det	O
mRNA	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
the	DT	det	O
hTR	NN	compound	B-protein
beta	NN	nmod	I-protein
1	CD	nummod	I-protein
in	IN	case	O
various	JJ	amod	O
thyroid	NN	compound	O
states	NNS	nmod	O
.	.	punct	O

Patients	NNS	nsubjpass	O
with	IN	case	O
overt	JJ	amod	O
hypo	RB	amod	O
-or	NN	compound	O
hyperthyroidism	NN	nmod	O
were	VBD	auxpass	O
enrolled	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
study	NN	nmod	O
.	.	punct	O

Total	JJ	amod	O
RNA	NN	nsubjpass	O
was	VBD	auxpass	O
isolated	VBN	ROOT	O
from	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
hTR	NN	compound	B-RNA
beta	NN	compound	I-RNA
1	CD	nummod	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	conj	O
determined	VBN	acl	O
by	IN	case	O
quantitative	JJ	amod	O
competitive	JJ	amod	O
reverse	JJ	amod	O
transcription	NN	compound	O
PCR	NN	nmod	O
.	.	punct	O

For	IN	case	O
comparison	NN	nmod	O
,	,	punct	O
hTR	NN	compound	B-RNA
beta	NN	compound	I-RNA
1	CD	nummod	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
and	CC	cc	O
normal	JJ	amod	O
thyroid	NN	compound	O
tissue	NN	conj	O
of	IN	case	O
euthyroid	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

Human	JJ	amod	B-RNA
TR	NN	compound	I-RNA
beta	NN	compound	I-RNA
1	CD	nummod	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nsubj	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
were	VBD	cop	O
1.8	CD	nummod	O
+/-	CC	cc	O
0.4	CD	conj	O
,	,	punct	O
1.9	CD	conj	O
+/-	CC	cc	O
0.5	CD	conj	O
,	,	punct	O
1.1	CD	conj	O
+/-	CC	cc	O
0.4	CD	conj	O
10	CD	conj	O
(	-LRB-	punct	O
-18	CD	appos	O
)	-RRB-	punct	O
mol/microgram	NN	compound	O
RNA	NN	ROOT	O
in	IN	case	O
hypo-	JJ	amod	O
,	,	punct	O
eu	IN	compound	O
-and	NN	compound	O
hyperthyroid	JJ	amod	O
patients	NNS	nmod	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
corresponding	VBG	acl	O
to	TO	case	O
an	DT	det	O
estimated	VBN	amod	O
0.5	CD	nummod	O
-2	CD	nummod	O
molecules	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
mean	JJ	amod	O
hTR	NN	compound	B-RNA
beta	NN	compound	I-RNA
1	CD	nummod	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nsubj	O
were	VBD	cop	O
40	CD	nummod	O
%	NN	nmod:npmod	O
lower	JJR	advcl	O
in	IN	case	O
hyperthyroid	JJ	nmod	O
than	IN	case	O
in	IN	case	O
euthyroid	JJ	amod	O
subjects	NNS	nmod	O
,	,	punct	O
this	DT	det	O
difference	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
reach	VB	ROOT	O
statistical	JJ	amod	O
significance	NN	dobj	O
.	.	punct	O

Similar	JJ	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
hTR	NN	compound	B-RNA
beta	NN	compound	I-RNA
1	CD	nummod	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nmod	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
thyroid	NN	compound	O
gland	NN	nmod	O
from	IN	case	O
euthyroid	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
developed	VBD	ROOT	O
an	DT	det	O
assay	NN	dobj	O
for	IN	case	O
the	DT	det	O
quantitative	JJ	amod	O
determination	NN	nmod	O
of	IN	case	O
hTR	NN	compound	B-RNA
beta	NN	compound	I-RNA
1	CD	nummod	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nmod	O
in	IN	case	O
small	JJ	amod	O
human	JJ	amod	O
tissue	NN	compound	O
samples	NNS	nmod	O
,	,	punct	O
containing	VBG	acl	O
as	RB	advmod	O
little	JJ	amod	O
as	IN	advmod	O
50	CD	nummod	O
ng	NN	dobj	O
of	IN	case	O
total	JJ	amod	O
RNA	NN	nmod	O
.	.	punct	O

Absolute	JJ	amod	O
hTR	NN	compound	B-RNA
beta	NN	compound	I-RNA
1	CD	nummod	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nsubj	O
are	VBP	cop	O
very	RB	advmod	O
low	JJ	ROOT	O
with	IN	case	O
an	DT	det	O
estimated	VBN	amod	O
one	CD	nummod	O
molecule	NN	nmod	O
of	IN	case	O
mRNA	NN	nmod	B-RNA
being	VBG	cop	O
present	JJ	xcomp	O
in	IN	case	O
a	DT	det	O
mononuclear	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
cell	NN	nmod	I-cell_type
or	CC	cc	O
thyrocyte	NN	conj	B-cell_type
.	.	punct	O

No	DT	neg	O
up-regulation	NN	nsubjpass	O
of	IN	case	O
hTR	NN	compound	B-protein
beta	NN	nmod	I-protein
1	CD	nummod	I-protein
was	VBD	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
hypothyroid	JJ	nmod	O
relative	JJ	xcomp	O
to	TO	case	O
euthyroid	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
a	DT	det	O
non-significant	JJ	amod	O
trend	NN	nsubj	O
towards	IN	case	O
a	DT	det	O
down-regulation	NN	nmod	O
of	IN	case	O
hTR	NN	compound	B-RNA
beta	NN	compound	I-RNA
1	CD	nummod	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nmod	O
in	IN	case	O
hyperthyroid	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

Multiple	JJ	amod	O
proteins	NNS	nsubj	O
interact	VBP	ROOT	O
with	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-DNA
inhibitory	JJ	amod	I-DNA
protein	NN	compound	I-DNA
repressor	NN	compound	I-DNA
element	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
interleukin-3	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

T	NN	compound	O
cell	NN	compound	O
expression	NN	nsubjpass	O
of	IN	case	O
interleukin	NN	nmod	B-protein
3	CD	nummod	I-protein
(	-LRB-	punct	O
IL-3	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
directed	VBN	ROOT	O
by	IN	case	O
positive	JJ	amod	B-DNA
and	CC	cc	I-DNA
negative	JJ	conj	I-DNA
cis-acting	JJ	amod	I-DNA
DNA	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
clustered	VBN	acl	O
within	IN	case	O
300	CD	nummod	O
base	NN	compound	O
pairs	NNS	nmod	O
of	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

A	DT	det	O
strong	JJ	amod	O
repressor	NN	compound	B-protein
element	NN	nsubjpass	I-protein
,	,	punct	O
termed	VBN	acl	O
nuclear	JJ	amod	B-protein
inhibitory	JJ	amod	I-protein
protein	NN	xcomp	I-protein
(	-LRB-	punct	O
NIP	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
previously	RB	advmod	O
mapped	VBN	ROOT	O
to	TO	case	O
a	DT	det	O
segment	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-3	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
between	IN	case	O
nucleotides	NNS	nmod	B-DNA
-271	CD	nummod	I-DNA
and	CC	cc	I-DNA
-250	CD	nummod	I-DNA
.	.	punct	O

Functional	JJ	amod	O
characterization	NN	nsubj	O
of	IN	case	O
this	DT	det	O
element	NN	nmod	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
it	PRP	nsubj	O
can	MD	aux	O
mediate	VB	ccomp	O
repression	NN	dobj	O
when	WRB	advmod	O
linked	VBN	advcl	O
in	IN	case	O
cis	NN	nmod	O
to	TO	case	O
a	DT	det	O
heterologous	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

DNA	NN	compound	O
binding	NN	compound	O
experiments	NNS	nsubjpass	O
were	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
to	TO	mark	O
characterize	VB	xcomp	O
the	DT	det	O
repressor	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

Using	VBG	advcl	O
varying	VBG	amod	O
conditions	NNS	dobj	O
,	,	punct	O
three	CD	nummod	O
distinct	JJ	amod	O
complexes	NNS	nsubjpass	O
were	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
interact	VB	xcomp	O
specifically	RB	advmod	O
with	IN	case	O
the	DT	det	O
NIP	NN	compound	B-DNA
region	NN	nmod	I-DNA
,	,	punct	O
although	IN	mark	O
only	RB	advmod	O
one	CD	nsubj	O
correlates	VBZ	advcl	O
with	IN	case	O
repressor	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

Complex	NN	nsubj	B-protein
1	CD	nummod	I-protein
results	VBZ	ROOT	O
from	IN	case	O
binding	NN	nmod	O
of	IN	case	O
a	DT	det	O
ubiquitous	JJ	amod	O
polypeptide	NN	nmod	O
that	WDT	nsubj	O
recognizes	VBZ	acl:relcl	O
the	DT	det	O
3	CD	nummod	B-DNA
'	POS	punct	I-DNA
portion	NN	dobj	I-DNA
of	IN	case	O
this	DT	det	O
sequence	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
not	RB	neg	O
required	VBN	conj	O
for	IN	case	O
repression	NN	nmod	O
.	.	punct	O

Complex	NN	nsubj	B-protein
2	CD	nummod	I-protein
corresponds	VBZ	ROOT	O
to	TO	case	O
binding	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
upstream	JJ	amod	B-protein
stimulatory	JJ	amod	I-protein
factor	NN	appos	I-protein
)	-RRB-	punct	O
to	TO	case	O
an	DT	det	O
E-box	NN	compound	B-DNA
motif	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
5	CD	nummod	B-DNA
'	POS	punct	I-DNA
portion	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
NIP	NN	compound	B-DNA
region	NN	nmod	I-DNA
.	.	punct	O

DNA	NN	compound	O
binding	NN	compound	O
specificity	NN	nsubj	O
of	IN	case	O
complex	NN	nmod	O
3	CD	nummod	O
overlaps	VBZ	ROOT	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
upstream	JJ	amod	B-protein
stimulatory	JJ	amod	I-protein
factor	NN	nmod	I-protein
but	CC	cc	O
is	VBZ	cop	O
clearly	RB	advmod	O
distinct	JJ	conj	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
which	WDT	nsubj	O
of	IN	case	O
the	DT	det	O
latter	JJ	amod	O
two	CD	nummod	O
complexes	NNS	nmod	O
represents	VBZ	ccomp	O
NIP	NN	compound	B-protein
activity	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
incorporated	VBD	ROOT	O
small	JJ	amod	O
alterations	NNS	dobj	O
into	IN	case	O
the	DT	det	O
NIP	NN	compound	B-DNA
site	NN	nmod	I-DNA
of	IN	case	O
an	DT	det	O
IL-3	NN	compound	B-DNA
promoter-linked	JJ	amod	I-DNA
reporter	NN	compound	I-DNA
construct	NN	nmod	I-DNA
and	CC	cc	O
examined	VBD	conj	O
their	PRP$	nmod:poss	O
effects	NNS	dobj	O
on	IN	case	O
NIP	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
repression	NN	nmod	O
.	.	punct	O

Functional	JJ	amod	O
specificity	NN	nsubj	O
for	IN	case	O
repression	NN	nmod	O
matches	VBZ	ROOT	O
the	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
specificity	NN	dobj	O
of	IN	case	O
complex	NN	nmod	B-protein
3	CD	nummod	I-protein
;	:	punct	O
both	CC	cc:preconj	O
repressor	NN	compound	O
activity	NN	nsubj	O
and	CC	cc	O
complex	NN	compound	B-protein
3	CD	nummod	I-protein
binding	NN	conj	O
require	VBP	parataxis	O
the	DT	det	O
consensus	NN	compound	B-DNA
sequence	NN	compound	I-DNA
CTCACNTNC	NN	dobj	O
.	.	punct	O

The	DT	det	O
hematopoietic	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
PU.1	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
downregulated	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_line
multiple	JJ	amod	I-cell_line
myeloma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

PU.1	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
hematopoietic	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	ROOT	I-protein
belonging	VBG	acl	O
to	TO	case	O
the	DT	det	O
Ets-family	NN	nmod	B-protein
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
identical	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
Spi-1	NN	compound	B-DNA
oncogene	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
spleen	NN	compound	O
focus-forming	JJ	amod	O
virus-induced	JJ	amod	O
murine	JJ	amod	O
erythroleukemias	NNS	nmod	O
.	.	punct	O

PU.1	NN	nsubj	B-protein
seems	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
for	IN	case	O
early	JJ	amod	O
development	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	B-cell_type
hematopoietic	JJ	amod	I-cell_type
lineages	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
expression	NN	nsubjpass	O
in	IN	case	O
mature	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
preferentially	RB	advmod	O
observed	VBN	conj	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
B-cell-and	NN	compound	B-cell_type
monocyte/macrophage-differentiation	NN	compound	I-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

It	PRP	nsubj	O
binds	VBZ	ROOT	O
the	DT	det	O
so-called	JJ	amod	O
Pu	NN	compound	B-DNA
box	NN	dobj	I-DNA
,	,	punct	O
an	DT	det	O
important	JJ	amod	O
tissue-specific	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
DNA	NN	compound	I-DNA
element	NN	appos	I-DNA
present	JJ	amod	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
expressed	VBN	acl	O
in	IN	case	O
these	DT	det	O
cell	NN	compound	B-cell_type
lineages	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
analyzed	VBN	ROOT	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
activity	NN	conj	O
of	IN	case	O
PU.1	NN	nmod	B-protein
during	IN	case	O
human	JJ	amod	O
B-cell	NN	compound	O
development	NN	nmod	O
using	VBG	xcomp	O
a	DT	det	O
panel	NN	dobj	O
of	IN	case	O
B-cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
representing	VBG	acl	O
different	JJ	amod	O
stages	NNS	dobj	O
of	IN	case	O
maturation	NN	nmod	O
,	,	punct	O
from	IN	case	O
early	JJ	amod	B-cell_line
precursors	NNS	nmod	I-cell_line
to	TO	case	O
differentiated	VBN	amod	B-cell_line
plasma	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

PU.1	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nsubj	O
and	CC	cc	O
PU.1	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	conj	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
were	VBD	cop	O
evident	JJ	ROOT	O
in	IN	case	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
representing	VBG	acl	O
pro-B	JJ	amod	B-cell_line
,	,	punct	I-cell_line
pre-B	JJ	conj	I-cell_line
,	,	punct	I-cell_line
and	CC	cc	I-cell_line
mature	JJ	conj	I-cell_line
B	NN	compound	I-cell_line
cells	NNS	dobj	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
could	MD	aux	O
also	RB	advmod	O
show	VB	ROOT	O
Pu	NN	nmod:npmod	B-DNA
box	NN	nmod:npmod	I-DNA
-dependent	JJ	amod	O
transactivation	NN	dobj	O
of	IN	case	O
a	DT	det	O
reporter	NN	compound	O
gene	NN	nmod	O
in	IN	case	O
transient	JJ	amod	O
transfections	NNS	nmod	O
in	IN	case	O
these	DT	det	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	B-cell_line
myeloma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
representing	VBG	acl	O
differentiated	VBN	amod	B-cell_type
,	,	punct	I-cell_type
plasma	NN	compound	I-cell_type
cell-like	JJ	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
,	,	punct	O
PU.1	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	conj	O
,	,	punct	O
mRNA	NN	compound	O
expression	NN	conj	O
,	,	punct	O
and	CC	cc	O
Pu	NN	nmod:npmod	B-DNA
box	NN	nmod:npmod	I-DNA
-dependent	JJ	amod	O
transactivation	NN	conj	O
were	VBD	cop	O
absent	JJ	ROOT	O
or	CC	cc	O
detectable	JJ	conj	O
at	IN	case	O
a	DT	det	O
very	RB	advmod	O
low	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

In	IN	case	O
lymphoblastoid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
which	WDT	nsubj	O
exemplify	VBP	acl:relcl	O
an	DT	det	O
intermediate	JJ	amod	O
stage	NN	dobj	O
of	IN	case	O
B-cell	NN	compound	O
differentiation	NN	nmod	O
,	,	punct	O
a	DT	det	O
reduced	VBN	amod	O
expression	NN	nsubjpass	O
and	CC	cc	O
activity	NN	conj	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
findings	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
multiple	JJ	amod	I-cell_line
myeloma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
represent	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
examples	NNS	dobj	O
of	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
downregulated	VBN	amod	O
PU.1	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
apparently	RB	advmod	O
contradict	VBP	amod	O
observations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
murine	JJ	amod	O
system	NN	nmod	O
in	IN	case	O
which	WDT	nmod	O
PU.1	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
and	CC	cc	O
active	JJ	conj	O
in	IN	case	O
plasmacytoma	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

At	IN	prep	O
present	JJ	pobj	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	ROOT	O
whether	IN	mark	O
the	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
PU.1	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
activity	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_line
multiple	JJ	amod	I-cell_line
myeloma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
represents	VBZ	ccomp	O
a	DT	det	O
malignancy-associated	JJ	amod	O
defect	NN	dobj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
or	CC	cc	O
exemplifies	VBZ	conj	O
a	DT	det	O
normal	JJ	amod	O
developmental	JJ	amod	O
regulation	NN	dobj	O
in	IN	case	O
terminally	RB	advmod	B-cell_type
differentiated	VBN	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
E-selectin	NN	compound	B-protein
expression	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
and	CC	cc	O
the	DT	det	O
T-cell	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
NFAT	NN	conj	B-protein
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nsubjpass	I-protein
(	-LRB-	punct	O
NFAT	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
originally	RB	advmod	O
described	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
T-cell-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
athat	WDT	nsubj	O
supported	VBD	acl:relcl	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
cytokine	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
mediated	VBD	conj	O
the	DT	det	O
immunoregulatory	JJ	amod	B-protein
effects	NNS	dobj	O
of	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
(	-LRB-	punct	O
CsA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

As	IN	mark	O
we	PRP	nsubj	O
observed	VBD	advcl	O
that	IN	mark	O
activated	VBN	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
also	RB	advmod	O
expressed	VBD	ccomp	O
NFAT	NN	dobj	B-protein
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
antiinflammatory	JJ	amod	O
properties	NNS	dobj	O
of	IN	case	O
CsA	NN	nmod	O
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Significantly	RB	advmod	O
,	,	punct	O
CsA	NN	nsubj	O
completely	RB	advmod	O
suppressed	VBD	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
NFAT	NN	nmod	B-protein
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
inhibited	VBD	conj	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
granulocyte-macrophage	JJ	amod	B-DNA
colony-stimulating	JJ	amod	I-DNA
factor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
GM-CSF	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	compound	I-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
that	WDT	nsubj	O
use	VBP	acl:relcl	O
NFAT	NN	dobj	B-protein
by	IN	case	O
60	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

CsA	NN	nsubj	O
similarly	RB	advmod	O
mediated	VBD	ROOT	O
a	DT	det	O
reduction	NN	dobj	O
of	IN	case	O
up	RB	advmod	O
to	TO	dep	O
65	CD	nummod	O
%	NN	nmod	O
in	IN	case	O
GM-CSF	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
and	CC	cc	O
protein	NN	compound	O
expression	NN	conj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

CsA	NN	nsubj	O
also	RB	advmod	O
suppressed	VBD	ROOT	O
E-selectin	NN	compound	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
vascular	JJ	amod	B-protein
cell	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	compound	I-protein
(	-LRB-	punct	O
VCAM-1	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	dobj	O
in	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
even	RB	advmod	O
though	IN	mark	O
the	DT	det	O
E-selectin	NN	compound	B-DNA
promoter	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
activated	VBN	advcl	O
by	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
rather	RB	cc	O
than	IN	mwe	O
NFAT	NN	conj	B-protein
.	.	punct	O

Hence	RB	advmod	O
,	,	punct	O
induction	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	O
surface	NN	compound	O
expression	NN	nmod	O
of	IN	case	O
this	DT	det	O
leukocyte	NN	compound	B-protein
adhesion	NN	compound	I-protein
molecule	NN	nmod	I-protein
by	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TNF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-alpha	NN	nmod	I-protein
was	VBD	auxpass	O
reduced	VBN	ROOT	O
by	IN	case	O
40	CD	nummod	O
%	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
CsA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
this	DT	nsubjpass	O
was	VBD	auxpass	O
reflected	VBN	conj	O
by	IN	case	O
a	DT	det	O
29	CD	compound	O
%	NN	amod	O
decrease	NN	nmod	O
in	IN	case	O
neutrophil	NN	compound	B-cell_type
adhesion	NN	nmod	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
CsA	NN	nmod	O
on	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	auxpass	O
also	RB	advmod	O
detected	VBN	ROOT	O
at	IN	case	O
the	DT	det	O
chromatin	NN	compound	B-DNA
structure	NN	compound	O
level	NN	nmod	O
,	,	punct	O
as	IN	mark	O
DNasel	NN	compound	B-DNA
hypersensitive	JJ	amod	I-DNA
sites	NNS	nsubjpass	I-DNA
within	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
GM-CSF	NN	compound	B-protein
enhancer	NN	nmod	O
and	CC	cc	O
the	DT	det	O
E-selectin	NN	compound	B-DNA
promoter	NN	conj	I-DNA
were	VBD	auxpass	O
suppressed	VBN	advcl	O
by	IN	case	O
CsA	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
represents	VBZ	ROOT	O
the	DT	det	O
first	JJ	amod	O
report	NN	dobj	O
of	IN	case	O
NFAT	NN	nmod	B-protein
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
suggests	VBZ	conj	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
CsA	NN	nsubj	O
could	MD	aux	O
function	VB	acl:relcl	O
as	IN	case	O
an	DT	det	O
antiinflammatory	JJ	amod	O
agent	NN	nmod	O
.	.	punct	O

Costimulation	NN	compound	O
requirement	NN	ROOT	O
for	IN	case	O
AP-1	NN	nmod	B-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	O
factor	NN	compound	O
activation	NN	conj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
transcriptional	JJ	amod	O
activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
requires	VBZ	ROOT	O
T-cell	NN	compound	B-cell_type
costimulation	NN	dobj	O
delivered	VBN	acl	O
by	IN	case	O
the	DT	det	O
TCR	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
auxiliary	JJ	amod	B-protein
receptor	NN	compound	I-protein
CD28	NN	conj	I-protein
.	.	punct	O

Several	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
participate	VBP	ROOT	O
in	IN	case	O
IL-2	NN	compound	B-protein
promoter	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
among	IN	case	O
which	WDT	nmod	O
are	VBP	cop	O
AP-1-like	JJ	amod	B-protein
factors	NNS	nmod	I-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
.	.	punct	O

Protein	NN	compound	O
phosphorylation	NN	nsubj	O
has	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
these	DT	det	O
two	CD	nummod	O
factors	NNS	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
it	PRP	nsubj	O
induces	VBZ	parataxis	O
the	DT	det	O
transactivating	VBG	amod	O
capacity	NN	dobj	O
of	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-protein
protein	NN	compound	I-protein
c-Jun	NN	nmod	B-protein
;	:	punct	O
and	CC	cc	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	conj	O
in	IN	case	O
the	DT	det	O
release	NN	nmod	O
of	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
inhibitor	NN	nmod	I-protein
,	,	punct	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	appos	I-protein
,	,	punct	O
from	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
allowing	VBG	xcomp	O
translocation	NN	dobj	O
of	IN	case	O
the	DT	det	O
latter	JJ	nmod	O
into	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
both	CC	det	O
phosphorylation	NN	compound	O
processes	NNS	nsubj	O
require	VBP	ccomp	O
T-cell	NN	compound	O
costimulation	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
in	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
the	DT	det	O
kinetics	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
phosphorylation	NN	compound	O
events	NNS	nmod	O
are	VBP	cop	O
essentially	RB	advmod	O
similar	JJ	ROOT	O
.	.	punct	O

According	VBG	ROOT	O
to	IN	prep	O
our	PRP$	poss	O
results	NNS	pobj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
kinases	NNS	nsubj	O
responsible	JJ	amod	O
for	IN	case	O
the	DT	det	O
two	CD	nummod	O
processes	NNS	nmod	O
are	VBP	cop	O
distinct	JJ	amod	O
entities	NNS	pobj	O
.	.	punct	O

Whereas	IN	mark	O
TPCK	NN	nsubj	B-protein
inhibits	VBZ	advcl	O
phosphorylation	NN	dobj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
,	,	punct	O
consequently	RB	advmod	O
,	,	punct	O
activation	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
it	PRP	nsubj	O
markedly	RB	advmod	O
enhances	VBZ	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
JNK	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
MAP	NN	compound	B-protein
kinase-related	JJ	amod	I-protein
kinase	NN	appos	I-protein
that	WDT	nsubj	O
phosphorylates	VBZ	acl:relcl	O
the	DT	det	O
transactivation	NN	compound	B-protein
domain	NN	dobj	I-protein
of	IN	case	O
c-Jun	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
propose	VBP	ROOT	O
the	DT	det	O
activation	NN	compound	O
scheme	NN	dobj	O
presented	VBN	acl	O
in	IN	case	O
FIGURE	NN	nmod	O
3	CD	nummod	O
for	IN	case	O
T-cell	NN	compound	O
costimulation	NN	nmod	O
.	.	punct	O

Costimulation	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
a	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
that	WDT	nsubj	O
leads	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
simultaneous	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
AP-1	NN	appos	B-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
.	.	punct	O

Integration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
signals	NNS	nmod	O
generated	VBN	acl	O
by	IN	case	O
TCR	NN	compound	B-protein
and	CC	cc	O
CD28	NN	conj	B-protein
engagement	NN	nmod	O
occurs	VBZ	ROOT	O
along	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
then	RB	advmod	O
bifurcates	VBZ	acl:relcl	O
to	TO	mark	O
induce	VB	xcomp	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
phosphorylation	NN	dobj	O
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	conj	O
on	IN	case	O
the	DT	det	O
one	CD	nummod	O
hand	NN	nmod	O
,	,	punct	O
and	CC	cc	O
JNK	NN	compound	B-protein
activation	NN	conj	O
and	CC	cc	O
c-Jun	NN	compound	B-protein
phosphorylation	NN	conj	O
on	IN	case	O
the	DT	det	O
other	JJ	nmod	O
.	.	punct	O

We	PRP	nsubjpass	O
are	VBP	auxpass	O
currently	RB	advmod	O
engaged	VBN	ROOT	O
in	IN	mark	O
defining	VBG	advcl	O
where	WRB	advmod	O
the	DT	det	O
two	CD	nummod	O
signals	NNS	nsubj	O
integrate	VBP	ccomp	O
along	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-protein
/	:	punct	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
pathway	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
and	CC	cc	O
cytokine	NN	conj	O
gene	NN	compound	O
expression	NN	dep	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
NF-kappa	NN	compound	B-protein
B/Rel	NN	compound	I-protein
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

CD4+	JJ	amod	B-cell_line
macrophages	NNS	nsubj	I-cell_line
in	IN	case	O
tissues	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
lung	NN	nmod	O
,	,	punct	O
skin	NN	conj	O
,	,	punct	O
and	CC	cc	O
lymph	NN	compound	O
nodes	NNS	conj	O
,	,	punct	O
promyelocytic	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
in	IN	case	O
bone	NN	compound	O
marrow	NN	nmod	O
,	,	punct	O
and	CC	cc	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	conj	I-cell_type
serve	VBP	ROOT	O
as	IN	case	O
important	JJ	amod	O
targets	NNS	nmod	O
and	CC	cc	O
reservoirs	NNS	conj	O
for	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
replication	NN	nmod	O
.	.	punct	O

HIV-1-infected	JJ	amod	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
often	RB	advmod	O
diminished	VBN	ROOT	O
in	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
participate	VB	acl	O
in	IN	case	O
chemotaxis	NN	nmod	O
,	,	punct	O
phagocytosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
intracellular	JJ	amod	O
killing	NN	conj	O
.	.	punct	O

HIV-1	NN	compound	O
infection	NN	nsubj	O
of	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
can	MD	aux	O
lead	VB	ROOT	O
to	TO	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
surface	NN	compound	B-protein
receptors	NNS	nmod	I-protein
associated	VBN	acl	O
with	IN	case	O
cellular	JJ	amod	O
activation	NN	nmod	O
and/or	CC	cc	O
differentiation	NN	conj	O
that	WDT	nsubj	O
increase	VBP	acl:relcl	O
the	DT	det	O
responsiveness	NN	dobj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
to	TO	case	O
cytokines	NNS	nmod	B-protein
secreted	VBN	acl	O
by	IN	case	O
neighboring	VBG	amod	O
cells	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
to	IN	case	O
bacteria	NNS	conj	O
or	CC	cc	O
other	JJ	amod	O
pathogens	NNS	conj	O
.	.	punct	O

Enhancement	NN	nsubj	O
of	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
is	VBZ	cop	O
related	JJ	ROOT	O
in	IN	case	O
part	NN	nmod	O
to	TO	case	O
increased	VBN	amod	O
DNA-binding	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
such	JJ	case	O
as	IN	mwe	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
binds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
region	NN	nmod	O
of	IN	case	O
the	DT	det	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
and	CC	cc	O
contributes	VBZ	conj	O
to	TO	case	O
the	DT	det	O
inducibility	NN	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
multiple	JJ	amod	O
activating	VBG	amod	O
agents	NNS	nmod	O
.	.	punct	O

Phosphorylation	NN	nsubj	O
and	CC	cc	O
degradation	NN	conj	O
of	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
inhibitor	NN	compound	I-protein
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	O
are	VBP	cop	O
crucial	JJ	amod	O
regulatory	JJ	amod	O
events	NNS	ROOT	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
DNA-binding	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
N-	NN	nsubjpass	O
and	CC	cc	O
C-terminal	JJ	conj	O
residues	NNS	dep	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	O
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
inducer-mediated	JJ	amod	O
degradation	NN	nmod	O
.	.	punct	O

Chronic	JJ	amod	O
HIV-1	NN	compound	O
infection	NN	nsubj	O
of	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
leads	VBZ	ROOT	O
to	TO	case	O
constitutive	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
DNA-binding	JJ	amod	O
activity	NN	nmod	O
and	CC	cc	O
provides	VBZ	conj	O
an	DT	det	O
intranuclear	JJ	amod	O
environment	NN	dobj	O
capable	JJ	amod	O
of	IN	mark	O
perpetuating	VBG	advcl	O
HIV-1	NN	compound	O
replication	NN	dobj	O
.	.	punct	O

Increased	VBN	amod	O
intracellular	JJ	amod	O
stores	NNS	nsubj	O
of	IN	case	O
latent	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
may	MD	aux	O
also	RB	advmod	O
result	VB	ROOT	O
in	IN	case	O
rapid	JJ	amod	O
inducibility	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
-dependent	JJ	amod	O
cytokine	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
response	NN	dep	O
to	TO	case	O
secondary	JJ	amod	O
pathogenic	JJ	amod	O
infections	NNS	nmod	O
or	CC	cc	O
antigenic	JJ	amod	O
challenge	NN	conj	O
,	,	punct	O
cytokine	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
induced	VBN	ROOT	O
,	,	punct	O
enhanced	VBN	conj	O
,	,	punct	O
and	CC	cc	O
sustained	JJ	conj	O
over	IN	case	O
prolonged	JJ	amod	O
periods	NNS	nmod	O
in	IN	case	O
HIV-1-infected	JJ	amod	B-cell_line
myeloid	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
compared	VBN	case	O
with	IN	case	O
uninfected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Elevated	JJ	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
several	JJ	amod	O
inflammatory	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
sera	NN	nmod	O
of	IN	case	O
HIV-1-infected	JJ	amod	O
individuals	NNS	nmod	O
.	.	punct	O

Secretion	NN	nsubj	O
of	IN	case	O
myeloid	JJ	amod	B-protein
cell-derived	JJ	amod	I-protein
cytokines	NNS	nmod	I-protein
may	MD	aux	O
both	DT	cc:preconj	O
increase	VB	ROOT	O
virus	NN	compound	O
production	NN	dobj	O
and	CC	cc	O
contribute	VBP	conj	O
to	TO	case	O
AIDS-associated	JJ	amod	O
disorders	NNS	nmod	O
.	.	punct	O

Steroid	NN	compound	O
mediated	JJ	amod	O
lysis	NN	nsubj	O
of	IN	case	O
lymphoblasts	NNS	nmod	B-cell_type
requires	VBZ	ROOT	O
the	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
region	NN	dobj	O
of	IN	case	O
the	DT	det	O
steroid	NN	compound	O
hormone	NN	compound	O
receptor	NN	nmod	O
.	.	punct	O

Glucocorticoids	NNS	nsubj	O
kill	VBP	ROOT	O
certain	JJ	amod	O
types	NNS	dobj	O
of	IN	case	O
lymphoblasts	NNS	nmod	B-cell_type
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanisms	NNS	nsubj	O
are	VBP	cop	O
unknown	JJ	conj	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
clear	JJ	ROOT	O
that	IN	mark	O
sufficient	JJ	amod	O
numbers	NNS	nsubjpass	O
of	IN	case	O
functional	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
are	VBP	auxpass	O
required	VBN	ccomp	O
to	TO	mark	O
mediate	VB	xcomp	O
lysis	NN	dobj	O
,	,	punct	O
but	CC	cc	O
whether	IN	mark	O
they	PRP	nsubj	O
do	VBP	advcl	O
so	RB	advmod	O
through	IN	case	O
the	DT	det	O
classical	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
steroid	NN	compound	O
hormone	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
modulation	NN	conj	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
established	VBN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
asked	VBN	ROOT	O
which	WDT	mark	O
region	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
steroid	NN	compound	B-protein
receptor	NN	nmod	I-protein
are	VBP	cop	O
important	JJ	ccomp	O
for	IN	mark	O
mediating	VBG	advcl	O
lysis	NN	dobj	O
in	IN	case	O
leukemic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
.	.	punct	O

CEM-ICR	NN	compound	B-cell_line
27	CD	nummod	I-cell_line
leukemic	JJ	amod	I-cell_line
lymphoblasts	NNS	nsubjpass	I-cell_line
,	,	punct	O
a	DT	det	O
clone	NN	appos	O
of	IN	case	O
CEM	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
which	WDT	nsubj	O
lack	VBP	acl:relcl	O
functional	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	dobj	I-protein
and	CC	cc	O
therefore	RB	advmod	O
are	VBP	auxpass	O
neither	CC	cc:preconj	O
lysed	VBN	conj	O
by	IN	case	O
dexamethasone	NN	nmod	O
nor	CC	cc	O
capable	JJ	conj	O
of	IN	mark	O
showing	VBG	advcl	O
glutamine	NN	compound	B-protein
synthetase	NN	compound	I-protein
induction	NN	dobj	O
,	,	punct	O
were	VBD	auxpass	O
provided	VBN	ROOT	O
with	IN	case	O
steroid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
by	IN	case	O
DNA	NN	compound	O
transfections	NNS	nmod	O
of	IN	case	O
various	JJ	amod	O
receptor	NN	compound	O
gene	NN	compound	O
constructs	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
measured	VBD	ROOT	O
steroid	NN	compound	O
mediated	JJ	amod	O
lysis	NN	dobj	O
,	,	punct	O
receptor	NN	compound	O
number	NN	conj	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
glutamine	NN	compound	B-protein
synthetase	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
transfected	VBN	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
the	DT	det	O
lysis	NN	compound	O
mechanism	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
ICR27	NN	compound	B-cell_line
lymphoblasts	NNS	nmod	I-cell_line
is	VBZ	auxpass	O
restored	VBN	ccomp	O
when	WRB	advmod	O
functional	JJ	amod	O
receptor	NN	compound	O
number	NN	nsubjpass	O
is	VBZ	auxpass	O
restored	VBN	advcl	O
.	.	punct	O

The	DT	det	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
region	NN	nsubjpass	I-protein
specifying	VBG	acl	O
high	JJ	amod	O
affinity	NN	dobj	O
for	IN	case	O
GRE	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
is	VBZ	auxpass	O
required	VBN	ROOT	O
.	.	punct	O

Lysis	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
any	DT	det	O
steroid	NN	nmod	O
that	WDT	nsubj	O
allows	VBZ	acl:relcl	O
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
containing	VBG	acl	O
such	PDT	amod	O
a	DT	det	O
region	NN	dobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
view	NN	dobj	O
that	IN	mark	O
steroid-mediated	JJ	amod	O
cell	NN	compound	O
death	NN	nsubj	O
occurs	VBZ	acl	O
by	IN	case	O
a	DT	det	O
process	NN	nmod	O
requiring	VBG	acl	O
direct	JJ	amod	O
interaction	NN	dobj	O
of	IN	case	O
steroid-receptor	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
with	IN	case	O
the	DT	det	O
genome	NN	nmod	O
.	.	punct	O

Functional	JJ	amod	O
characterization	NN	ROOT	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	B-protein
homolog	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
B	NN	compound	B-protein
cell-specific	JJ	amod	I-protein
coactivator	NN	compound	I-protein
BOB.1/OBF.1	NN	nmod	B-protein
.	.	punct	O

B	NN	nmod:npmod	O
cell-specific	JJ	amod	O
transcriptional	JJ	amod	O
promoter	NN	compound	O
activity	NN	nsubj	O
mediated	VBN	acl	O
by	IN	case	O
the	DT	det	O
octamer	NN	compound	B-DNA
motif	NN	nmod	I-DNA
requires	VBZ	ROOT	O
the	DT	det	O
Oct1	NN	compound	B-protein
or	CC	cc	O
Oct2	NN	conj	B-protein
protein	NN	dobj	I-protein
and	CC	cc	O
additional	JJ	amod	O
B	NN	nmod:npmod	B-protein
cell-restricted	JJ	amod	I-protein
cofactors	NNS	conj	I-protein
.	.	punct	O

One	CD	nummod	O
such	JJ	amod	O
cofactor	NN	nsubjpass	B-protein
,	,	punct	O
BOB.1/OBF.1	NN	appos	B-protein
,	,	punct	O
was	VBD	auxpass	O
recently	RB	advmod	O
isolated	VBN	ROOT	O
from	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
the	DT	det	O
isolation	NN	dobj	O
and	CC	cc	O
detailed	JJ	amod	O
characterization	NN	conj	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	B-protein
homolog	NN	nmod	I-protein
.	.	punct	O

Full-length	JJ	amod	O
cDNAs	NNS	nsubjpass	B-DNA
and	CC	cc	O
genomic	JJ	amod	B-DNA
clones	NNS	conj	I-DNA
were	VBD	auxpass	O
isolated	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
gene	NN	compound	O
structure	NN	nsubj	O
was	VBD	cop	O
determined.	NN	compound	O
Comparison	NN	nsubj	O
of	IN	case	O
the	DT	det	O
deduced	VBN	amod	O
amino	NN	compound	O
acids	NNS	nmod	O
shows	VBZ	conj	O
88	CD	nummod	O
%	NN	compound	O
sequence	NN	compound	O
identity	NN	dobj	O
between	IN	case	O
mouse	NN	compound	B-protein
and	CC	cc	I-protein
human	JJ	conj	I-protein
BOB.1/OBF.1	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
NH2-terminal	JJ	amod	B-protein
126	CD	nummod	I-protein
amino	NN	compound	I-protein
acids	NNS	nsubj	I-protein
of	IN	case	O
BOB.1/OBF.1	NN	nmod	B-protein
are	VBP	cop	O
both	CC	cc:preconj	O
essential	JJ	ROOT	O
and	CC	cc	O
sufficient	JJ	conj	O
for	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
the	DT	det	O
POU	NN	compound	B-protein
domains	NNS	nmod	I-protein
of	IN	case	O
either	CC	cc:preconj	O
Oct1	NN	nmod	B-protein
or	CC	cc	O
Oct2	NN	conj	B-protein
.	.	punct	O

This	DT	det	O
protein-protein	JJ	amod	O
interaction	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
require	VB	ROOT	O
the	DT	det	O
simultaneous	JJ	amod	O
binding	NN	dobj	O
of	IN	case	O
Oct	NN	compound	B-protein
proteins	NNS	nmod	I-protein
to	TO	case	O
DNA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
high	JJ	amod	O
resolution	NN	compound	O
footprinting	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Oct	NN	compound	B-DNA
-DNA	NN	compound	O
interaction	NN	nmod	O
reveals	VBZ	conj	O
that	IN	mark	O
binding	NN	nsubj	O
of	IN	case	O
BOB.1/OBF.1	NN	nmod	B-protein
to	TO	case	O
Oct1	NN	nmod	B-protein
or	CC	cc	O
Oct2	NN	conj	B-protein
does	VBZ	aux	O
not	RB	neg	O
alter	VB	ccomp	O
the	DT	det	O
interaction	NN	dobj	O
with	IN	case	O
DNA	NN	nmod	O
.	.	punct	O

BOB.1/OBF.1	NN	nsubj	B-protein
can	MD	aux	O
efficiently	RB	advmod	O
activate	VB	ROOT	O
octamer-dependent	JJ	amod	O
promoters	NNS	dobj	O
in	IN	case	O
fibroblasts	NNS	nmod	B-cell_type
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
fails	VBZ	parataxis	O
to	TO	mark	O
stimulate	VB	xcomp	O
octamer-dependent	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
activity	NN	dobj	O
.	.	punct	O

Fusion	NN	nsubj	O
of	IN	case	O
subdomains	NNS	nmod	O
of	IN	case	O
BOB.1/OBF.1	NN	nmod	B-protein
with	IN	case	O
the	DT	det	O
GAL4	NN	compound	B-protein
DNA	NN	compound	I-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
reveals	VBZ	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
NH2-	NN	nsubj	B-protein
and	CC	cc	I-protein
COOH-terminal	JJ	conj	I-protein
domains	NNS	dep	I-protein
of	IN	case	O
BOB.1/OBF.1	NN	nmod	B-protein
contribute	VBP	ccomp	O
to	TO	case	O
full	JJ	amod	O
transactivation	NN	compound	O
function	NN	nmod	O
,	,	punct	O
the	DT	det	O
COOH-terminal	JJ	amod	B-protein
domain	NN	nsubj	I-protein
is	VBZ	cop	O
more	RBR	advmod	O
efficient	JJ	parataxis	O
in	IN	case	O
this	DT	det	O
transactivation	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
the	DT	det	O
failure	NN	nmod	O
of	IN	case	O
full-length	JJ	amod	B-protein
BOB.1/OBF.1	NN	nmod	I-protein
to	TO	mark	O
stimulate	VB	acl	O
octamer-dependent	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
elements	NNS	dobj	I-DNA
in	IN	case	O
non	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
the	DT	det	O
GAL4	NN	compound	B-protein
fusions	NNS	nsubj	I-protein
likewise	RB	ROOT	O
only	RB	advmod	O
stimulate	VBP	dobj	O
from	IN	case	O
a	DT	det	O
promoter-proximal	JJ	amod	O
position	NN	nmod	O
.	.	punct	O

Anti-immunoglobulin	NN	compound	B-protein
M	NN	nsubj	I-protein
activates	VBZ	ROOT	O
nuclear	JJ	amod	B-protein
calcium/calmodulin-dependent	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	dobj	I-protein
II	CD	nummod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
and	CC	cc	O
others	NNS	conj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
nuclear	JJ	amod	B-protein
protein	NN	nsubjpass	I-protein
,	,	punct	O
Ets-1	NN	appos	B-protein
,	,	punct	O
is	VBZ	auxpass	O
phosphorylated	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
calcium-dependent	JJ	amod	O
manner	NN	nmod	O
after	IN	case	O
ligation	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	O
(	-LRB-	punct	O
Ig	NN	compound	O
)	-RRB-	punct	O
M	NN	nmod	O
on	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

As	IN	mark	O
this	DT	det	O
phosphorylation	NN	nsubj	O
was	VBD	cop	O
independent	JJ	advcl	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
activity	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
whether	IN	mark	O
a	DT	det	O
calcium/calmodulin-dependent	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	nsubj	I-protein
(	-LRB-	punct	O
CaM	NN	compound	B-protein
kinase	NN	appos	I-protein
)	-RRB-	punct	O
might	MD	aux	O
phosphorylate	VB	ccomp	O
the	DT	det	O
Ets-1	NN	compound	B-protein
protein	NN	dobj	I-protein
after	IN	case	O
elevation	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	O
free	JJ	amod	O
calcium	NN	compound	O
concentrations	NNS	nmod	O
.	.	punct	O

The	DT	det	O
dephosphorylated	JJ	amod	O
form	NN	nsubjpass	O
of	IN	case	O
Ets-1	NN	nmod	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
chromatin	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
operative	JJ	amod	B-protein
kinase	NN	nsubj	I-protein
should	MD	aux	O
be	VB	cop	O
detectable	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
prepared	VBD	ROOT	O
nuclear	JJ	amod	O
extracts	NNS	dobj	O
from	IN	case	O
two	CD	nummod	O
human	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
in	IN	case	O
which	WDT	nmod	O
increased	VBN	amod	O
intracellular	JJ	amod	O
free	JJ	dep	O
calcium	NN	compound	O
levels	NNS	nsubj	O
correlated	VBD	acl:relcl	O
with	IN	case	O
increased	VBN	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
Ets-1	NN	compound	B-protein
protein	NN	nmod	O
.	.	punct	O

Activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
CaM	NN	compound	B-protein
kinases	NNS	nmod	I-protein
was	VBD	auxpass	O
determined	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
synthetic	JJ	amod	O
peptide	NN	compound	O
substrate	NN	dobj	O
both	CC	cc:preconj	O
in	IN	case	O
the	DT	dep	O
absence	NN	nmod	O
and	CC	cc	O
presence	NN	conj	O
of	IN	case	O
an	DT	det	O
inhibitor	NN	nmod	O
specific	JJ	amod	O
for	IN	case	O
the	DT	det	O
CaM	NN	compound	B-protein
kinase	NN	compound	I-protein
family	NN	nmod	I-protein
,	,	punct	O
KN-62	NN	appos	O
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	O
with	IN	case	O
anti-IgM	NN	nmod	B-protein
led	VBD	ROOT	O
to	TO	case	O
increased	VBN	amod	O
activity	NN	nmod	O
of	IN	case	O
a	DT	det	O
nuclear	JJ	amod	B-protein
kinase	NN	nmod	I-protein
that	WDT	nsubj	O
could	MD	aux	O
phosphorylate	VB	acl:relcl	O
the	DT	det	O
peptide	NN	dobj	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
reduced	VBN	conj	O
by	IN	case	O
10	CD	compound	O
microM	NN	amod	O
KN-62	NN	nmod	O
.	.	punct	O

Kinase	NN	compound	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
lysates	NNS	nmod	O
preadsorbed	VBN	acl	O
using	VBG	xcomp	O
an	DT	det	O
antibody	NN	dobj	B-protein
specific	JJ	amod	O
for	IN	case	O
CaM	NN	compound	B-protein
kinase	NN	nmod	I-protein
II	CD	nummod	I-protein
.	.	punct	O

Two-dimensional	JJ	amod	O
phosphopeptide	NN	compound	O
maps	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
Ets-1	NN	compound	B-protein
protein	NN	nmod	O
from	IN	case	O
cells	NNS	nmod	O
incubated	VBN	acl	O
with	IN	case	O
ionomycin	NN	nmod	O
or	CC	cc	O
anti-IgM	NN	conj	B-protein
contained	VBD	ROOT	O
two	CD	nummod	O
unique	JJ	amod	O
phosphopeptides	NNS	dobj	O
that	WDT	nsubj	O
were	VBD	cop	O
absent	JJ	acl:relcl	O
in	IN	case	O
untreated	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

Incubation	NN	nsubj	O
of	IN	case	O
isolated	VBN	amod	B-protein
Ets-1	NN	compound	I-protein
protein	NN	nmod	I-protein
with	IN	case	O
purified	VBN	amod	O
CaM	NN	compound	B-protein
kinase	NN	nmod	I-protein
II	CD	nummod	I-protein
produced	VBD	ROOT	O
phosphorylation	NN	dobj	O
of	IN	case	O
peptides	NNS	nmod	O
that	WDT	nsubj	O
migrated	VBD	acl:relcl	O
identically	RB	advmod	O
to	TO	case	O
those	DT	nmod	O
found	VBN	acl	O
in	IN	case	O
cells	NNS	nmod	O
incubated	VBN	acl	O
with	IN	case	O
either	CC	cc:preconj	O
anti-IgM	NN	nmod	B-protein
or	CC	cc	O
ionomycin	NN	conj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
model	NN	dobj	O
of	IN	case	O
signal	NN	compound	O
transduction	NN	nmod	O
by	IN	case	O
the	DT	det	O
antigen	NN	compound	B-protein
receptor	NN	nmod	I-protein
on	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
which	WDT	nmod	O
increased	VBN	amod	O
intracellular	JJ	amod	O
free	JJ	dep	O
calcium	NN	nsubj	O
can	MD	aux	O
rapidly	RB	advmod	O
activate	VB	acl:relcl	O
nuclear	JJ	amod	B-protein
CaM	NN	compound	I-protein
kinase	NN	dobj	I-protein
II	CD	nummod	I-protein
,	,	punct	O
potentially	RB	advmod	O
resulting	VBG	acl	O
in	IN	case	O
phosphorylation	NN	nmod	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
DNA-binding	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

Transcriptional	JJ	amod	O
activation	NN	ROOT	O
and	CC	cc	O
repression	NN	conj	O
,	,	punct	O
two	CD	nummod	O
properties	NNS	appos	O
of	IN	case	O
the	DT	det	O
lymphoid-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
Oct-2a	NN	dep	B-protein
.	.	punct	O

The	DT	det	O
lymphoid-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nsubj	I-protein
Oct-2a	NN	dep	B-protein
contains	VBZ	ROOT	O
two	CD	nummod	O
transcriptional	JJ	amod	B-protein
activation	NN	compound	I-protein
domains	NNS	dobj	I-protein
which	WDT	nsubj	O
are	VBP	cop	O
located	JJ	acl:relcl	O
within	IN	case	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
and	CC	cc	O
C-terminal	JJ	conj	B-protein
regions	NNS	nmod	I-protein
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
their	PRP$	nmod:poss	O
differential	JJ	amod	O
activation	NN	compound	O
properties	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
linked	VBD	ROOT	O
the	DT	det	O
isolated	VBN	amod	O
effector	NN	compound	B-protein
domains	NNS	dobj	I-protein
to	TO	case	O
the	DT	det	O
GAL4	NN	compound	B-protein
DNA-binding	JJ	amod	I-protein
domain	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
both	DT	det	O
activating	VBG	amod	O
regions	NNS	nsubj	O
of	IN	case	O
Oct-2a	NN	nmod	B-protein
,	,	punct	O
isolated	VBN	acl	O
from	IN	case	O
their	PRP$	nmod:poss	O
natural	JJ	amod	O
context	NN	nmod	O
,	,	punct	O
can	MD	aux	O
activate	VB	ccomp	O
transcription	NN	dobj	O
as	IN	case	O
promoter	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
to	TO	case	O
the	DT	det	O
C-terminus	NN	nmod	B-protein
,	,	punct	O
activation	NN	nsubj	O
by	IN	case	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
domain	NN	nmod	I-protein
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
a	DT	det	O
yet	RB	advmod	O
unidentified	JJ	amod	O
factor	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
binding	VBG	acl	O
to	TO	case	O
the	DT	det	O
simian	JJ	amod	B-DNA
virus	NN	compound	I-DNA
40	CD	nummod	I-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
obtained	VBN	acl	O
by	IN	case	O
duplication	NN	nmod	O
of	IN	case	O
activation	NN	compound	B-protein
domains	NNS	nmod	I-protein
or	CC	cc	O
their	PRP$	nmod:poss	O
mixed	JJ	amod	O
combination	NN	conj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
domains	NNS	nsubj	O
are	VBP	cop	O
functionally	RB	advmod	O
independent	JJ	ccomp	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
activation	NN	nsubjpass	O
from	IN	case	O
a	DT	det	O
remote	JJ	amod	O
position	NN	nmod	O
could	MD	aux	O
only	RB	advmod	O
be	VB	auxpass	O
achieved	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
C-terminus	NN	nmod	B-protein
of	IN	case	O
Oct-2a	NN	nmod	B-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
higher	JJR	amod	O
activation	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
distinct	JJ	amod	O
B-cell-specific	JJ	amod	B-protein
cofactors	NNS	nsubjpass	I-protein
in	IN	case	O
concert	NN	nmod	O
with	IN	case	O
the	DT	det	O
effector	NN	compound	B-protein
domains	NNS	nmod	I-protein
of	IN	case	O
Oct-2a	NN	nmod	B-protein
might	MD	aux	O
be	VB	auxpass	O
involved	VBN	ccomp	O
in	IN	mark	O
mediating	VBG	advcl	O
transcription	NN	dobj	O
from	IN	case	O
proximal	JJ	amod	O
and	CC	cc	O
remote	JJ	conj	O
positions	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
a	DT	det	O
repression	NN	compound	O
domain	NN	dobj	O
at	IN	case	O
the	DT	det	O
N-terminus	NN	nmod	O
of	IN	case	O
Oct-2a	NN	nmod	B-protein
.	.	punct	O

When	WRB	advmod	O
transferred	VBN	advcl	O
to	TO	case	O
a	DT	det	O
potent	JJ	amod	O
activator	NN	nmod	O
,	,	punct	O
transcriptional	JJ	amod	O
stimulation	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
efficiently	RB	advmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
underscore	VBP	ROOT	O
the	DT	det	O
modular	JJ	amod	O
structure	NN	dobj	O
of	IN	case	O
Oct-2a	NN	nmod	B-protein
with	IN	case	O
separable	JJ	amod	O
domains	NNS	nmod	O
for	IN	case	O
activation	NN	nmod	O
and	CC	cc	O
repression	NN	conj	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
Oct-2a	NN	nsubj	B-protein
might	MD	aux	O
have	VB	ccomp	O
complex	JJ	amod	O
regulatory	JJ	amod	O
functions	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Nonopsonic	JJ	amod	O
phagocytosis	NN	nsubj	O
of	IN	case	O
Pseudomonas	FW	compound	O
aeruginosa	FW	nmod	O
by	IN	case	O
macrophages	NNS	nmod	B-cell_type
and	CC	cc	O
polymorphonuclear	JJ	amod	B-cell_type
leukocytes	NNS	conj	I-cell_type
requires	VBZ	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
the	DT	det	O
bacterial	JJ	amod	O
flagellum	NN	nmod	O
.	.	punct	O

Whereas	IN	mark	O
the	DT	det	O
mechanism	NN	nsubjpass	O
of	IN	case	O
nonopsonic	JJ	amod	O
phagocytosis	NN	nmod	O
of	IN	case	O
Pseudomonas	FW	compound	O
aeruginosa	FW	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
described	VBN	advcl	O
,	,	punct	O
the	DT	det	O
bacterial	JJ	amod	O
ligands	NNS	nsubjpass	O
required	VBN	acl	O
are	VBP	auxpass	O
poorly	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O

To	TO	mark	O
identify	VB	ROOT	O
the	DT	det	O
requisite	JJ	amod	O
bacterial	JJ	amod	O
ligands	NNS	dobj	O
,	,	punct	O
studies	NNS	nsubjpass	O
with	IN	case	O
isogenic	JJ	amod	O
mutants	NNS	nmod	O
of	IN	case	O
P.	FW	compound	O
aeruginosa	FW	nmod	O
PAK	NN	dep	O
lacking	VBG	acl	O
pili	NNS	dobj	O
,	,	punct	O
flagella	NNS	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
RpoN	NN	compound	B-protein
sigma	NN	compound	I-protein
factor	NN	conj	I-protein
were	VBD	auxpass	O
undertaken	VBN	parataxis	O
.	.	punct	O

The	DT	det	O
RpoN	NN	compound	O
mutant	NN	nsubj	O
,	,	punct	O
lacking	VBG	acl	O
pili	NNS	dobj	O
,	,	punct	O
flagella	NNS	conj	O
,	,	punct	O
and	CC	cc	O
nonpilus	JJ	amod	B-protein
adhesins	NNS	conj	I-protein
,	,	punct	O
bound	VBD	ROOT	O
poorly	RB	advmod	O
and	CC	cc	O
was	VBD	cop	O
resistant	JJ	conj	O
to	TO	case	O
ingestion	NN	nmod	O
by	IN	case	O
both	CC	cc:preconj	O
macrophages	NNS	nmod	B-cell_type
and	CC	cc	O
neutrophils	NNS	conj	B-cell_type
.	.	punct	O

Pili	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
absolutely	RB	advmod	O
required	VBN	ROOT	O
for	IN	case	O
binding	NN	nmod	O
or	CC	cc	O
phagocytosis	NN	conj	O
of	IN	case	O
P.	FW	compound	O
aeruginosa	FW	nmod	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
flagellum	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
required	VBN	ROOT	O
for	IN	case	O
binding	NN	nmod	O
of	IN	case	O
P.	FW	compound	O
aeruginosa	FW	nmod	O
to	TO	case	O
macrophages	NNS	nmod	B-cell_type
but	CC	cc	O
was	VBD	cop	O
critical	JJ	conj	O
for	IN	case	O
the	DT	det	O
subsequent	JJ	amod	O
internalization	NN	nmod	O
of	IN	case	O
the	DT	det	O
bacterium	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
this	DT	det	O
factor	NN	nsubj	O
or	CC	cc	O
a	DT	det	O
surface	NN	compound	O
ligand	NN	conj	O
associated	VBN	acl	O
with	IN	case	O
its	PRP$	nmod:poss	O
assembly	NN	nmod	O
was	VBD	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
nonopsonic	JJ	amod	O
phagocytosis	NN	nmod	O
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
essential	JJ	amod	O
GATA	NN	nmod	B-DNA
and	CC	cc	O
Ets	NN	compound	B-DNA
binding	NN	compound	I-DNA
motifs	NNS	conj	I-DNA
within	IN	case	O
the	DT	det	O
promoter	NN	nmod	O
of	IN	case	O
the	DT	det	O
platelet	NN	compound	B-DNA
glycoprotein	NN	compound	I-DNA
Ib	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Platelet	NN	compound	B-protein
glycoprotein	NN	compound	I-protein
(	-LRB-	punct	O
GP	NN	appos	B-protein
)	-RRB-	punct	O
Ib-IX-V	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
multisubunit	JJ	amod	B-protein
adhesion	NN	compound	I-protein
receptor	NN	ROOT	I-protein
that	WDT	nsubj	O
supports	VBZ	acl:relcl	O
platelet	NN	compound	O
attachment	NN	dobj	O
to	TO	case	O
thrombogenic	JJ	amod	O
surfaces	NNS	nmod	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
vascular	JJ	amod	O
injury	NN	nmod	O
.	.	punct	O

The	DT	det	O
congenital	JJ	amod	O
absence	NN	nsubj	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
a	DT	det	O
bleeding	JJ	amod	O
disorder	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
``	``	punct	B-cell_type
giant	JJ	amod	I-cell_type
''	''	punct	I-cell_type
platelets	NNS	nmod	I-cell_type
,	,	punct	O
a	DT	det	O
condition	NN	appos	O
linking	VBG	acl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
complex	NN	nmod	O
to	TO	case	O
platelet	NN	compound	O
morphogenesis	NN	nmod	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
better	JJR	advmod	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
GP	NN	compound	B-protein
Ib-IX-V	NN	compound	I-protein
complex	NN	nmod	I-protein
,	,	punct	O
studies	NNS	nsubjpass	O
were	VBD	auxpass	O
undertaken	VBN	ROOT	O
to	TO	mark	O
define	VB	xcomp	O
the	DT	det	O
essential	JJ	amod	O
genetic	JJ	amod	B-DNA
elements	NNS	dobj	I-DNA
supporting	VBG	acl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
alpha-subunit	NN	nmod	B-protein
of	IN	case	O
the	DT	det	O
complex	NN	nmod	O
(	-LRB-	punct	O
GP	NN	compound	B-protein
Ib	NN	compound	I-protein
alpha	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

GP	NN	compound	B-DNA
Ib	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
activity	NN	nsubjpass	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	case	O
transfection	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
erythroleukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
reporter	NN	compound	O
plasmids	NNS	nmod	O
coding	VBG	acl	O
for	IN	case	O
the	DT	det	O
enzyme	NN	nmod	B-protein
,	,	punct	O
luciferase	NN	appos	B-protein
.	.	punct	O

Studies	NNS	nsubjpass	O
were	VBD	auxpass	O
initiated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
fragment	NN	nmod	O
extending	VBG	acl	O
2	CD	nummod	O
,	,	punct	O
738	CD	nummod	O
nucleotides	NNS	dobj	O
5	CD	nummod	O
'	''	punct	O
to	TO	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
lead	VB	conj	O
to	TO	case	O
the	DT	det	O
identification	NN	nmod	O
of	IN	case	O
253	CD	nummod	O
nucleotides	NNS	nmod	O
retaining	VBG	acl	O
full	JJ	amod	O
promoter	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
erythroleukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
nonhematopoietic	JJ	amod	B-cell_type
lineage	NN	nmod	I-cell_type
,	,	punct	O
human	JJ	amod	B-cell_type
endothelial	JJ	conj	I-cell_type
and	CC	cc	O
HeLa	NN	conj	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
the	DT	det	O
GP	NN	compound	B-DNA
Ib	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
activity	NN	nsubj	O
was	VBD	cop	O
no	RB	neg	O
greater	JJR	ROOT	O
than	IN	case	O
background	NN	compound	O
levels	NNS	nmod	O
obtained	VBN	acl	O
with	IN	case	O
promoterless	JJ	compound	B-DNA
constructs	NNS	nmod	I-DNA
.	.	punct	O

Gel	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
and	CC	cc	O
site-directed	JJ	amod	O
mutagenesis	NN	compound	O
studies	NNS	conj	O
defined	VBD	ROOT	O
essential	JJ	amod	O
GATA	NN	dobj	B-DNA
and	CC	cc	O
Ets	NN	compound	B-DNA
binding	NN	compound	I-DNA
motifs	NNS	conj	I-DNA
93	CD	dep	B-DNA
and	CC	cc	I-DNA
150	CD	conj	I-DNA
nucleotides	NNS	conj	I-DNA
upstream	JJ	amod	I-DNA
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
,	,	punct	O
a	DT	det	O
finding	NN	appos	O
which	WDT	nsubj	O
further	RB	advmod	O
substantiates	VBZ	acl:relcl	O
these	DT	det	O
elements	NNS	dobj	O
as	IN	case	O
important	JJ	amod	O
determinants	NNS	nmod	O
of	IN	case	O
megakaryocytic	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
define	VBP	ROOT	O
essential	JJ	amod	O
cis-acting	JJ	amod	B-DNA
elements	NNS	dobj	I-DNA
responsible	JJ	amod	O
for	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
GP	NN	compound	B-protein
Ib	NN	compound	I-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
provide	VBP	conj	O
insights	NNS	dobj	O
into	IN	case	O
molecular	JJ	amod	O
events	NNS	nmod	O
coinciding	VBG	acl	O
with	IN	case	O
the	DT	det	O
release	NN	nmod	O
of	IN	case	O
normal	JJ	amod	B-cell_type
platelets	NNS	nmod	I-cell_type
into	IN	case	O
the	DT	det	O
bloodstream	NN	nmod	O
.	.	punct	O

CD30	NN	compound	B-protein
ligation	NN	nsubj	O
induces	VBZ	ROOT	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	compound	I-protein
activation	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

CD30	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
recently	RB	advmod	O
described	VBN	amod	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor/nerve	NN	compound	I-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
receptor	NN	compound	I-protein
superfamily	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
following	VBG	case	O
incubation	NN	nmod	O
of	IN	case	O
L540	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
Hodgkin	NN	nmod:npmod	B-cell_line
's	POS	case	I-cell_line
disease-derived	JJ	dep	I-cell_line
,	,	punct	I-cell_line
T	NN	nmod:npmod	I-cell_line
cell-like	JJ	amod	I-cell_line
,	,	punct	I-cell_line
CD30+	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
)	-RRB-	punct	O
with	IN	case	O
the	DT	det	O
agonistic	JJ	amod	B-protein
anti-CD30	JJ	amod	I-protein
monoclonal	JJ	amod	I-protein
antibodies	NNS	nmod	I-protein
(	-LRB-	punct	O
mAb	NN	appos	B-protein
)	-RRB-	punct	O
M44	NN	dep	B-protein
and	CC	cc	O
M67	NN	conj	B-protein
,	,	punct	O
two	CD	nummod	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappa	NN	compound	I-protein
B	NN	compound	I-protein
DNA	NN	compound	O
binding	NN	compound	O
activities	NNS	nsubjpass	O
were	VBD	auxpass	O
induced	VBN	ccomp	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
in	IN	case	O
gel	NN	compound	O
retardation	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mAb	NN	nmod	B-protein
towards	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
was	VBD	cop	O
rapid	JJ	ROOT	O
,	,	punct	O
as	IN	mark	O
it	PRP	nsubj	O
occurred	VBD	advcl	O
within	IN	case	O
20	CD	nummod	O
min	NN	nmod	O
,	,	punct	O
and	CC	cc	O
was	VBD	cop	O
sustained	JJ	conj	O
for	IN	case	O
up	RB	advmod	O
to	TO	dep	O
6	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

By	IN	case	O
comparison	NN	nmod	O
,	,	punct	O
an	DT	det	O
isotype-matched	JJ	amod	B-protein
antibody	NN	nsubj	I-protein
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
in	IN	case	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
helper	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
Th	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
clones	NNS	nsubj	I-cell_line
functionally	RB	advmod	O
characterized	VBN	advcl	O
as	IN	mark	O
being	VBG	pcomp	O
of	IN	case	O
the	DT	det	O
type	NN	nmod	O
0	CD	nummod	O
,	,	punct	O
type	NN	conj	O
1	CD	nummod	O
and	CC	cc	O
type	NN	conj	O
2	CD	nummod	O
(	-LRB-	punct	O
28	CD	nummod	O
%	NN	dep	O
,	,	punct	O
<	:	appos	O
1	CD	nummod	O
%	NN	npadvmod	O
und	JJ	advcl	O
93	CD	nummod	O
%	NN	nmod:npmod	O
CD30+	JJ	dobj	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
extent	NN	nsubj	O
of	IN	case	O
CD30	NN	compound	B-protein
-mediated	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
proportion	NN	nmod	O
of	IN	case	O
CD30+	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
all	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
investigated	VBN	acl	O
,	,	punct	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
complexes	NNS	nsubjpass	I-protein
induced	VBN	acl	O
following	VBG	case	O
CD30	NN	compound	B-protein
engagement	NN	nmod	O
were	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
contain	VB	xcomp	O
p50	NN	compound	B-protein
NF-kappa	NN	compound	I-protein
B1	NN	dobj	I-protein
,	,	punct	O
p65	NN	compound	B-protein
RelA	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
possibly	RB	advmod	O
other	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	dobj	O
nuclear	JJ	amod	O
translocation	NN	dep	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
rank	NN	nmod	O
among	IN	case	O
the	DT	det	O
short-term	JJ	amod	O
cellular	JJ	amod	O
responses	NNS	nmod	O
elicited	VBN	acl	O
following	VBG	case	O
CD30	NN	compound	B-protein
ligation	NN	nmod	O
.	.	punct	O

Pathogenesis	NN	ROOT	O
of	IN	case	O
atherosclerosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
earliest	JJS	amod	O
lesion	NN	nsubj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
an	DT	det	O
atherosclerotic	JJ	amod	O
plaque	NN	nmod	O
is	VBZ	ROOT	O
the	DT	det	O
fatty	JJ	amod	O
streak	NN	attr	O
.	.	punct	O

This	DT	det	O
chronic	JJ	amod	O
inflammatory	JJ	amod	O
reaction	NN	nsubj	O
results	VBZ	ROOT	O
from	IN	case	O
a	DT	det	O
sequence	NN	nmod	O
of	IN	case	O
events	NNS	nmod	O
that	WDT	nsubj	O
begins	VBZ	acl:relcl	O
with	IN	case	O
the	DT	det	O
trapping	NN	nmod	O
of	IN	case	O
low	JJ	amod	O
density	NN	compound	O
lipoprotein	NN	nmod	O
(	-LRB-	punct	O
LDL	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
subendothelial	JJ	amod	O
space	NN	nmod	O
of	IN	prep	O
the	DT	det	O
artery	NN	compound	O
wall	NN	pobj	O
.	.	punct	O

The	DT	det	O
trapped	VBN	amod	O
LDL	NN	nsubjpass	O
is	VBZ	auxpass	O
seeded	VBN	ROOT	O
with	IN	case	O
oxidative	JJ	amod	O
species	NNS	nmod	O
released	VBN	acl	O
by	IN	case	O
the	DT	det	O
overlying	VBG	amod	O
endothelium	NN	nmod	O
,	,	punct	O
and	CC	cc	O
lipid	NN	compound	O
oxidation	NN	nsubjpass	O
is	VBZ	auxpass	O
initiated	VBN	conj	O
within	IN	case	O
the	DT	det	O
LDL	NN	nmod	O
particle.	VB	compound	O
Some	DT	dep	O
of	IN	case	O
the	DT	det	O
lipids	NNS	nmod	O
that	WDT	nsubj	O
result	VBP	acl:relcl	O
lead	VBP	xcomp	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NFkB-like	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
cause	VBP	acl:relcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
whose	WP$	nmod:poss	O
protein	NN	compound	B-protein
products	NNS	nsubj	I-protein
mediate	VBP	conj	O
monocyte	NN	compound	O
binding	NN	dobj	O
,	,	punct	O
monocyte	NN	compound	B-cell_type
chemotaxis	NN	conj	O
into	IN	case	O
the	DT	det	O
subendothelial	JJ	amod	O
space	NN	nmod	O
,	,	punct	O
and	CC	cc	O
conversion	NN	conj	O
into	IN	case	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

At	IN	case	O
least	JJS	nmod:npmod	O
1	CD	nummod	O
major	JJ	amod	B-DNA
gene	NN	nsubj	I-DNA
modulates	VBZ	ROOT	O
the	DT	det	O
oxidation	NN	dobj	O
of	IN	case	O
LDL	NN	compound	O
lipids	NNS	nmod	O
and/or	CC	cc	O
the	DT	det	O
biologic	JJ	amod	O
response	NN	conj	O
to	TO	case	O
these	DT	det	O
lipids	NNS	nmod	O
.	.	punct	O

The	DT	det	O
inverse	JJ	amod	O
relation	NN	nsubj	O
between	IN	case	O
high	JJ	amod	O
density	NN	compound	O
lipoprotein	NN	nmod	O
(	-LRB-	punct	O
HDL	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
atherosclerotic	JJ	amod	O
events	NNS	conj	O
may	MD	aux	O
in	IN	case	O
part	NN	nmod	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
enzymes	NNS	ROOT	B-protein
associated	VBN	acl	O
with	IN	case	O
HDL	NNP	nmod	O
that	WDT	nsubj	O
destroy	VBP	acl:relcl	O
the	DT	det	O
biologically	RB	advmod	O
active	JJ	amod	O
lipids	NNS	dobj	O
generated	VBN	acl	O
in	IN	case	O
LDL	NN	nmod	O
.	.	punct	O

Estrogen	NN	compound	B-protein
and	CC	cc	O
progesterone	NN	conj	B-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
vernal	JJ	amod	O
keratoconjunctivitis	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Sex-related	JJ	amod	O
influences	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	dep	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
vernal	JJ	amod	O
keratoconjunctivitis	NN	nmod	O
(	-LRB-	punct	O
VKC	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
allergic	JJ	amod	O
eosinophilic	JJ	amod	O
disease	NN	appos	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
authors	NNS	nsubj	O
evaluated	VBD	appos	O
tarsal	NN	amod	O
and	CC	cc	O
bulbar	JJ	conj	O
conjunctival	JJ	compound	O
biopsies	NNS	dobj	O
from	IN	case	O
seven	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
severe	JJ	amod	O
and	CC	cc	O
symptomatic	JJ	conj	O
VKC	NN	nmod	O
for	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
estrogen	NN	compound	B-protein
and	CC	cc	O
progesterone	NN	conj	B-protein
receptors	NNS	nmod	I-protein
by	IN	mark	O
using	VBG	advcl	O
monoclonal	JJ	amod	B-protein
antibodies	NNS	dobj	I-protein
with	IN	case	O
a	DT	det	O
peroxidase-antiperoxidase	NN	amod	O
technique	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
the	DT	det	O
epithelium	NN	nsubj	O
and	CC	cc	O
subepithelium	NN	conj	O
of	IN	case	O
the	DT	dep	O
tarsal	NN	amod	O
and	CC	cc	O
bulbar	JJ	conj	O
conjunctiva	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
VKC	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
those	DT	conj	O
of	IN	case	O
four	CD	nummod	O
nonatopic	JJ	amod	O
control	JJ	compound	O
subjects	NNS	nmod	O
,	,	punct	O
showed	VBD	dep	O
intense	JJ	amod	O
positive	JJ	amod	O
staining	NN	dobj	O
for	IN	case	O
estrogen	NN	compound	O
and	CC	cc	O
progesterone	NN	conj	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Immunofluorescence	NN	compound	O
colocalization	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
estrogen	NN	compound	B-protein
and	CC	cc	O
progesterone	NN	conj	B-protein
receptors	NNS	nmod	I-protein
with	IN	case	O
eosinophil	NN	compound	B-protein
cationic	JJ	amod	I-protein
protein	NN	nmod	I-protein
showed	VBD	ROOT	O
that	IN	mark	O
approximately	RB	advmod	O
70	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
positive	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	cop	O
eosinophils	NNS	ccomp	B-cell_type
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Sexual	JJ	amod	O
hormones	NNS	nsubj	O
,	,	punct	O
through	IN	case	O
their	PRP$	nmod:poss	O
receptors	NNS	nmod	B-protein
,	,	punct	O
may	MD	aux	O
influence	VB	dep	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
eosinophils	NNS	nmod	B-cell_type
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
VKC	NN	nmod	O
.	.	punct	O

CIITA	NN	nsubj	B-protein
activates	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
MHC	NN	compound	B-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
mouse	NN	compound	O
T	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

It	PRP	nsubj	O
has	VBZ	aux	O
long	RB	advmod	O
been	VBN	ROOT	O
a	DT	det	O
puzzle	NN	attr	O
that	IN	mark	O
MHC	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
molecules	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
after	IN	case	O
activation	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
mouse	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
;	:	punct	O
this	DT	det	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	parataxis	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
mediated	JJ	amod	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Recently	RB	advmod	O
the	DT	det	O
MHC	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
transactivator	NN	nsubjpass	I-protein
(	-LRB-	punct	O
CIITA	NN	appos	B-protein
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
major	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
factor	NN	xcomp	I-protein
for	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
constitutive	JJ	nmod	O
and	CC	cc	O
IFN	NN	nmod:npmod	O
inducible	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
MHC	NN	compound	B-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
expressing	VBG	acl	O
MHC	NN	compound	O
class	NN	dobj	O
II	CD	nummod	O
have	VBP	ccomp	O
CIITA	NN	compound	B-protein
transcripts	NNS	dobj	O
while	IN	mark	O
MHC	NN	compound	O
class	NN	nmod:npmod	O
II-negative	JJ	amod	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
and	CC	cc	O
mouse	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
do	VBP	advcl	O
not	RB	neg	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
MHC	NN	compound	B-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
mouse	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
can	MD	aux	O
be	VB	auxpass	O
reconstituted	VBN	ROOT	O
upon	IN	case	O
transfection	NN	nmod	O
with	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
CIITA	NN	compound	I-DNA
cDNA	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
CIITA	NN	nmod	B-protein
explains	VBZ	ccomp	O
the	DT	det	O
expression	NN	dobj	O
or	CC	cc	O
lack	NN	conj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
MHC	NN	compound	B-protein
class	NN	nmod	I-protein
II	CD	nummod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
and	CC	cc	O
mouse	NN	conj	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
respectively	RB	advmod	O
.	.	punct	O

Anti-Ro	NN	compound	B-protein
(	-LRB-	punct	I-protein
SSA	NN	appos	I-protein
)	-RRB-	punct	I-protein
autoantibodies	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
T	NN	compound	B-DNA
cell	NN	compound	I-DNA
receptor	NN	compound	I-DNA
beta	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
systemic	JJ	amod	O
lupus	NN	compound	O
erythematosus	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

Several	JJ	nsubjpass	O
of	IN	case	O
the	DT	det	O
heterogeneous	JJ	amod	O
clinical	JJ	amod	O
manifestations	NNS	nmod	O
of	IN	case	O
systemic	JJ	amod	O
lupus	NN	compound	O
erythematosus	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
specific	JJ	amod	O
autoantibodies	NNS	nmod	B-protein
.	.	punct	O

Associations	NNS	nsubjpass	O
between	IN	case	O
HLA	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
antigens	NNS	nmod	I-protein
and	CC	cc	O
autoantibodies	NNS	conj	B-protein
to	TO	case	O
the	DT	det	O
ribonucleoproteins	NNS	nmod	B-protein
Ro	NN	dep	B-protein
(	-LRB-	punct	I-protein
SSA	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
La	NN	conj	B-protein
(	-LRB-	punct	I-protein
SSB	NN	appos	I-protein
)	-RRB-	punct	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
in	IN	case	O
these	DT	det	O
patients	NNS	nmod	O
.	.	punct	O

Because	IN	mark	O
HLA	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
molecules	NNS	nsubj	I-protein
present	VBP	advcl	O
antigen	NN	dobj	O
to	TO	case	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
TCRs	NNS	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
searched	VBN	ROOT	O
for	IN	case	O
a	DT	det	O
TCR	NN	compound	B-DNA
gene	NN	nmod	I-DNA
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
anti-Ro	NNS	compound	B-protein
(	-LRB-	punct	I-protein
SSA	NN	appos	I-protein
)	-RRB-	punct	I-protein
antibodies	NNS	nmod	I-protein
.	.	punct	O

A	DT	det	O
pair	NN	nsubjpass	O
of	IN	case	O
restriction	NN	compound	B-DNA
fragment	NN	compound	I-DNA
length	NN	compound	I-DNA
polymorphisms	NNS	nmod	I-DNA
(	-LRB-	punct	O
RFLPs	NNS	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
one	CD	nsubj	O
of	IN	case	O
which	WDT	nmod	O
hybridizes	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
TCR	NN	compound	B-DNA
constant	JJ	amod	I-DNA
region	NN	compound	I-DNA
C	NN	compound	I-DNA
beta	NN	nmod	I-DNA
1	CD	nummod	I-DNA
and	CC	cc	O
the	DT	det	O
other	JJ	conj	O
to	TO	case	O
the	DT	det	O
C	NN	compound	B-DNA
beta	NN	compound	I-DNA
2	CD	nummod	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
,	,	punct	O
suggesting	VBG	advcl	O
these	DT	nsubj	O
may	MD	aux	O
be	VB	cop	O
genotypic	JJ	amod	O
markers	NNS	dobj	O
for	IN	case	O
an	DT	det	O
extended	VBN	amod	O
region	NN	nmod	O
of	IN	case	O
the	DT	det	O
TCR	NN	compound	B-DNA
beta	NN	compound	I-DNA
locus	NN	nmod	I-DNA
.	.	punct	O

This	DT	det	O
RFLP	NN	compound	B-DNA
pair	NN	nsubj	I-DNA
occurs	VBZ	ROOT	O
in	IN	case	O
76	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
Ro	NN	compound	B-protein
(	-LRB-	punct	I-protein
SSA	NN	appos	I-protein
)	-RRB-	punct	I-protein
precipitins	NNS	nmod	O
,	,	punct	O
84	CD	nummod	O
%	NN	appos	O
of	IN	case	O
anti-	NN	amod	O
Ro	NN	compound	B-protein
(	-LRB-	punct	I-protein
SSA	NN	compound	I-protein
)	-RRB-	punct	I-protein
-positive	JJ	amod	O
patients	NNS	nmod	O
lacking	VBG	acl	O
La	NN	compound	B-protein
(	-LRB-	punct	I-protein
SSB	NN	appos	I-protein
)	-RRB-	punct	I-protein
precipitins	NNS	dobj	B-protein
,	,	punct	O
but	CC	cc	O
only	RB	advmod	O
41	CD	nummod	O
%	NN	conj	O
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
lacking	VBG	acl	O
both	DT	det	O
precipitins	NNS	dobj	B-protein
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0.0004	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
disproportionate	JJ	amod	O
occurrence	NN	nsubj	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
lupus	NN	compound	O
patients	NNS	nmod	O
indicates	VBZ	ROOT	O
that	IN	mark	O
these	DT	det	O
RFLPs	NNS	nsubj	B-DNA
are	VBP	cop	O
not	RB	neg	O
disease	NN	compound	O
susceptibility	NN	compound	O
markers	NNS	ccomp	O
,	,	punct	O
but	CC	cc	O
rather	RB	cc	O
are	VBP	cop	O
important	JJ	amod	O
markers	NNS	conj	O
for	IN	case	O
TCR	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
whose	WP$	nmod:poss	O
products	NNS	nsubjpass	O
are	VBP	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
anti-Ro	NNS	compound	B-protein
(	-LRB-	punct	I-protein
SSA	NN	appos	I-protein
)	-RRB-	punct	I-protein
antibodies	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
majority	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	O
who	WP	nsubj	O
have	VBP	acl:relcl	O
these	DT	det	O
RFLPs	NNS	dobj	B-DNA
and	CC	cc	O
HLA	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
antigens	NNS	conj	I-protein
previously	RB	advmod	O
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
anti-	NN	compound	O
Ro	NN	compound	B-protein
(	-LRB-	punct	I-protein
SSA	NN	appos	I-protein
)	-RRB-	punct	I-protein
response	NN	nmod	O
make	VBP	ROOT	O
this	DT	det	O
antibody	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
interactions	NNS	nsubj	O
between	IN	case	O
products	NNS	nmod	O
of	IN	case	O
these	DT	det	O
loci	NNS	nmod	B-DNA
occur	VBP	ccomp	I-DNA
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
Ro	NN	nmod	B-protein
(	-LRB-	punct	I-protein
SSA	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

Inhibition	NN	ROOT	O
of	IN	case	O
NF-AT	NN	compound	B-protein
-dependent	JJ	amod	O
transcription	NN	nmod	O
by	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
:	:	punct	O
implications	NNS	dep	O
for	IN	case	O
differential	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
helper	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
subsets	NNS	nmod	I-cell_type
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
individual	JJ	amod	O
CD4+	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
results	VBZ	ROOT	O
in	IN	case	O
differential	JJ	amod	O
lymphokine	NN	compound	B-protein
expression	NN	nmod	O
:	:	punct	O
interleukin	NN	nsubjpass	B-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
preferentially	RB	advmod	O
produced	VBN	parataxis	O
by	IN	case	O
T	NN	compound	B-cell_line
helper	NN	compound	I-cell_line
type	NN	compound	I-cell_line
1	CD	nummod	I-cell_line
(	-LRB-	punct	I-cell_line
TH1	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
cell-mediated	JJ	amod	O
immune	JJ	amod	O
responses	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
IL-4	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
synthesized	VBN	parataxis	O
by	IN	case	O
TH2	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
essential	JJ	acl:relcl	O
for	IN	case	O
humoral	JJ	amod	O
immunity	NN	nmod	O
.	.	punct	O

The	DT	det	O
Ca	NN	compound	B-protein
(	-LRB-	punct	I-protein
2+	NN	amod	I-protein
)	-RRB-	punct	I-protein
-dependent	JJ	amod	I-protein
factor	NN	compound	I-protein
NF-ATp	NN	nsubj	B-protein
plays	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
inducible	JJ	amod	O
transcription	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
these	DT	det	O
lymphokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
while	IN	mark	O
IL2	NN	compound	B-protein
expression	NN	nsubj	O
requires	VBZ	advcl	O
the	DT	det	O
contribution	NN	dobj	O
of	IN	case	O
Ca	NN	intj	O
(	-LRB-	punct	O
2+	NN	intj	O
)	-RRB-	punct	O
-	:	punct	O
and	CC	cc	O
protein	NN	nmod:npmod	B-protein
kinase	NN	nmod:npmod	I-protein
C	NN	nmod:npmod	I-protein
-dependent	JJ	amod	O
signals	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
activation	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	B-protein
IL4	NN	compound	I-protein
transcription	NN	nmod	O
through	IN	case	O
the	DT	det	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	amod	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
pathway	NN	nmod	O
is	VBZ	auxpass	O
diminished	VBN	ccomp	O
by	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
stimulation	NN	nmod	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

This	DT	det	O
phenomenon	NN	nsubj	O
is	VBZ	cop	O
due	JJ	case	O
to	TO	mwe	O
mutually	RB	advmod	O
exclusive	JJ	amod	O
binding	NN	ROOT	O
of	IN	case	O
NF-ATp	NN	nmod	B-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
to	TO	case	O
the	DT	det	O
P	NN	compound	B-DNA
sequence	NN	nmod	I-DNA
,	,	punct	O
an	DT	det	O
element	NN	appos	O
located	JJ	amod	O
69	CD	nummod	B-DNA
bp	NN	nmod:npmod	I-DNA
upstream	RB	advmod	I-DNA
of	IN	case	O
the	DT	det	O
IL4	NN	compound	B-DNA
transcription	NN	compound	I-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Human	JJ	amod	B-DNA
IL4	NN	compound	I-DNA
promoter	NN	nmod:npmod	I-DNA
-mediated	JJ	amod	O
transcription	NN	nsubjpass	O
is	VBZ	auxpass	O
downregulated	VBN	ROOT	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
stimulated	VBN	acl	O
with	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B-activating	JJ	amod	I-protein
cytokine	NN	compound	I-protein
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
suppressed	VBD	conj	O
in	IN	case	O
RelA-overexpressing	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
stimulation	NN	nsubj	O
or	CC	cc	O
RelA	NN	compound	B-protein
overexpression	NN	conj	O
does	VBZ	aux	O
not	RB	neg	O
affect	VB	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-DNA
IL4	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
containing	VBG	acl	O
a	DT	det	O
mouse	NN	compound	B-DNA
P	NN	compound	I-DNA
sequence	NN	dobj	I-DNA
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
higher-affinity	JJ	amod	B-DNA
site	NN	acl:relcl	I-DNA
for	IN	case	O
NF-ATp	NN	nmod	B-protein
and	CC	cc	O
a	DT	det	O
lower-affinity	JJ	amod	B-DNA
site	NN	conj	I-DNA
for	IN	case	O
RelA	NN	nmod	B-protein
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
competition	NN	nsubj	O
between	IN	case	O
two	CD	nummod	O
general	JJ	amod	O
transcriptional	JJ	amod	B-protein
activators	NNS	nmod	I-protein
,	,	punct	O
RelA	NN	appos	B-protein
and	CC	cc	O
NF-ATp	NN	conj	B-protein
,	,	punct	O
mediates	VBZ	ROOT	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
stimulation	NN	nmod	O
on	IN	case	O
IL4	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
contribute	VB	conj	O
to	TO	case	O
differential	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
TH	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
balance	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
and	CC	cc	O
the	DT	det	O
signal	NN	compound	O
transducer	NN	compound	O
and	CC	cc	O
activator	NN	conj	O
of	IN	amod	O
transcription	NN	dep	O
(	-LRB-	punct	O
STAT	NN	compound	B-protein
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	compound	O
activity	NN	nmod	O
by	IN	case	O
cytokines	NNS	nmod	B-protein
and	CC	cc	O
inflammatory	JJ	amod	O
synovial	JJ	amod	O
fluids	NNS	conj	O
.	.	punct	O

The	DT	det	O
balance	NN	nsubj	O
between	IN	case	O
type	NN	nmod	O
1	CD	nummod	O
and	CC	cc	O
2	CD	conj	O
T	NN	compound	O
helper	NN	compound	O
cell	NN	compound	O
cytokine	NN	compound	O
production	NN	dep	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
several	JJ	amod	O
animal	NN	compound	O
models	NNS	nmod	O
of	IN	case	O
autoimmunity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
skewed	JJ	amod	O
patterns	NNS	nsubjpass	O
of	IN	case	O
cytokine	NN	compound	B-protein
expression	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	conj	O
in	IN	case	O
human	JJ	amod	O
inflammatory	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

Many	JJ	amod	O
cytokines	NNS	nsubj	B-protein
activate	VBP	ROOT	O
signal	NN	compound	B-protein
transducer	NN	dobj	I-protein
and	CC	cc	I-protein
activation	NN	conj	I-protein
of	IN	case	I-protein
transcription	NN	compound	I-protein
(	-LRB-	punct	I-protein
STAT	NN	compound	I-protein
)	-RRB-	punct	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
,	,	punct	O
in	IN	case	O
turn	NN	nmod	O
,	,	punct	O
activate	VBP	acl:relcl	O
transcription	NN	dobj	O
of	IN	case	O
inflammatory	JJ	amod	O
effector	NN	compound	O
genes	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
used	VBD	ROOT	O
mononuclear	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
priming	NN	compound	I-cell_line
cultures	NNS	dobj	I-cell_line
and	CC	cc	O
inflammatory	JJ	amod	B-cell_type
synovial	JJ	amod	I-cell_type
fluids	NNS	conj	I-cell_type
(	-LRB-	punct	O
SFs	NNS	appos	B-cell_type
)	-RRB-	punct	O
derived	VBN	acl	O
from	IN	case	O
arthritis	NN	compound	O
patients	NNS	nmod	O
to	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
and	CC	cc	O
STAT	NN	compound	B-protein
activity	NN	conj	O
by	IN	case	O
an	DT	det	O
inflammatory	JJ	amod	O
synovial	JJ	amod	O
microenvironment	NN	nmod	O
.	.	punct	O

Exposure	NN	nsubj	O
to	TO	case	O
SFs	NNS	nmod	B-cell_type
during	IN	case	O
priming	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
an	DT	det	O
81	CD	compound	O
%	NN	amod	O
inhibition	NN	nmod	O
of	IN	case	O
interferon	NN	compound	B-protein
(	-LRB-	punct	I-protein
IFN	NN	compound	I-protein
)	-RRB-	punct	I-protein
-gamma	NN	nmod	I-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	conj	I-protein
)	-RRB-	punct	I-protein
4	CD	nummod	I-protein
,	,	punct	O
production	NN	conj	O
by	IN	case	O
effector	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
generated	VBN	acl	O
in	IN	case	O
priming	JJ	amod	O
cultures	NNS	nmod	O
.	.	punct	O

SF	NN	compound	O
suppression	NN	nsubjpass	O
was	VBD	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
IL-4	NN	nmod	B-protein
and	CC	cc	O
IL-10	NN	conj	B-protein
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
IL-12	NN	compound	B-protein
expression	NN	nmod	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
reversed	VBN	conj	O
in	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
fashion	NN	nmod	O
by	IN	case	O
exogenous	JJ	amod	O
IL-12	NN	nmod	O
.	.	punct	O

SFs	NNS	nsubj	B-cell_type
blocked	VBD	ROOT	O
the	DT	det	O
sustained	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
Stat1	NN	nmod	I-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
Stat3	NN	conj	B-protein
,	,	punct	O
during	IN	case	O
the	DT	det	O
priming	NN	compound	O
period	NN	nmod	O
,	,	punct	O
and	CC	cc	O
Stat1	NN	compound	B-protein
activity	NN	nsubjpass	O
was	VBD	auxpass	O
differentially	RB	advmod	O
regulated	VBN	conj	O
by	IN	case	O
cytokines	NNS	nmod	B-protein
in	IN	case	O
parallel	NN	nmod	O
with	IN	case	O
their	PRP$	nmod:poss	O
positive	JJ	nmod	O
or	CC	cc	O
negative	JJ	conj	O
regulation	NN	dep	O
of	IN	case	O
IFN-gamma	NN	compound	B-protein
production	NN	nmod	O
.	.	punct	O

Active	JJ	amod	O
Stat3	NN	nsubjpass	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
Stat1	NN	conj	B-protein
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
cells	NNS	nmod	O
from	IN	case	O
inflamed	JJ	amod	O
joints	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
altered	JJ	amod	O
balance	NN	nmod	O
of	IN	case	O
Stat1	NN	compound	O
and	CC	cc	O
Stat3	NN	conj	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
differentiation	NN	nmod	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	conj	O
of	IN	case	O
inflammatory	JJ	amod	O
synovitis	NN	nmod	O
.	.	punct	O

Triggering	NN	nsubj	O
of	IN	case	O
complement	NN	compound	B-protein
receptors	NNS	nmod	I-protein
CR1	NN	dep	B-protein
(	-LRB-	punct	O
CD35	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
CR3	NN	conj	B-protein
(	-LRB-	punct	O
CD11b/CD18	NN	appos	B-protein
)	-RRB-	punct	O
induces	VBZ	ROOT	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
p50/p65	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
and	CC	cc	O
enhances	VBZ	conj	O
viral	JJ	amod	O
replication	NN	dobj	O
in	IN	case	O
HIV-infected	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Monocyte/macrophages	NNS	nsubj	B-cell_type
may	MD	aux	O
harbor	VB	ROOT	O
HIV	NN	dobj	O
in	IN	case	O
a	DT	det	O
nonproductive	JJ	amod	O
fashion	NN	nmod	O
for	IN	case	O
prolonged	JJ	amod	O
periods	NNS	nmod	O
of	IN	prep	O
time	NN	pobj	O
.	.	punct	O

Viral	JJ	amod	O
gene	NN	compound	O
expression	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
reactivated	VBN	ROOT	O
by	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
LPS	NN	nmod	O
or	CC	cc	O
cytokines	NNS	conj	B-protein
such	JJ	case	O
as	IN	mwe	O
TNF-alpha	NN	nmod	B-protein
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
LPS	NN	nmod	O
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
induce	VB	acl	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
the	DT	det	O
DNA-binding	JJ	amod	B-protein
heterodimer	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
p50/p65	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
a	DT	det	O
specific	JJ	amod	O
sequence	NN	nmod	O
in	IN	case	O
the	DT	det	O
HIV-long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
triggering	NN	nsubj	O
of	IN	case	O
complement	NN	compound	B-protein
receptors	NNS	nmod	I-protein
CR1	NN	dep	B-protein
(	-LRB-	punct	O
CD35	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
CR3	NN	conj	B-protein
(	-LRB-	punct	O
CD11b/CD18	NN	appos	B-protein
)	-RRB-	punct	O
enhances	VBZ	ccomp	O
viral	JJ	amod	O
replication	NN	dobj	O
in	IN	case	O
HIV-infected	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
monocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Monocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubjpass	I-cell_line
and	CC	cc	O
normal	JJ	amod	O
peripheral	JJ	amod	O
blood	NN	compound	O
monocytes	NNS	conj	O
were	VBD	auxpass	O
infected	VBN	ROOT	O
with	IN	case	O
HIV-1	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
cultured	VBN	conj	O
in	IN	case	O
the	DT	dep	O
presence	NN	nmod	O
or	CC	cc	O
absence	NN	conj	O
of	IN	case	O
F	NN	nmod	B-protein
(	-LRB-	punct	I-protein
ab	NN	dep	I-protein
'	''	punct	I-protein
)	-RRB-	punct	I-protein
2	CD	nummod	I-protein
fragments	NNS	dep	I-protein
of	IN	case	O
monoclonal	JJ	amod	B-protein
anti-CR1	JJ	nmod	I-protein
or	CC	cc	O
anti-CR3	JJ	conj	B-protein
Abs	NNS	dep	I-protein
or	CC	cc	O
with	IN	case	O
C3	NN	compound	B-protein
fragments	NNS	conj	I-protein
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
CR1	NN	nmod	B-protein
or	CC	cc	O
CR3	NN	conj	B-protein
induces	VBZ	ROOT	O
a	DT	det	O
two-	CD	amod	O
to	TO	dep	O
fourfold	JJ	dep	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
amount	NN	nmod	O
of	IN	case	O
cell-associated	JJ	amod	O
and	CC	cc	O
released	VBN	conj	O
p24	NN	compound	B-protein
Ag	NN	nmod	I-protein
in	IN	case	O
cell	NN	compound	B-cell_line
cultures	NNS	nmod	I-cell_line
that	WDT	nsubj	O
was	VBD	cop	O
equivalent	JJ	acl:relcl	O
to	TO	case	O
that	DT	nmod	O
observed	VBN	acl	O
in	IN	case	O
control	JJ	amod	B-cell_line
cultures	NNS	nmod	I-cell_line
triggered	VBN	acl	O
with	IN	case	O
LPS	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
observed	VBD	ROOT	O
that	IN	mark	O
stimulation	NN	nsubj	O
of	IN	case	O
CR1	NN	nmod	B-protein
or	CC	cc	O
CR3	NN	conj	B-protein
induces	VBZ	ccomp	O
the	DT	det	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
p50/p65	NN	nmod	B-protein
in	IN	case	O
infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Translocation	NN	nsubjpass	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
p50/p65	NN	nmod	B-protein
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
following	VBG	case	O
stimulation	NN	nmod	O
of	IN	case	O
CR1	NN	nmod	B-protein
or	CC	cc	O
CR3	NN	conj	B-protein
of	IN	case	O
uninfected	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
from	IN	case	O
HIV-seronegative	JJ	amod	O
donors	NNS	nmod	O
.	.	punct	O

The	DT	det	O
amount	NN	nsubj	O
of	IN	case	O
protein	NN	nmod	O
translocated	VBN	acl	O
was	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
observed	VBN	acl	O
when	WRB	advmod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
stimulated	VBN	advcl	O
with	IN	case	O
rhTNF-alpha	NN	nmod	B-protein
.	.	punct	O

TNF-alpha	NN	nsubj	B-protein
did	VBD	aux	O
not	RB	neg	O
mediate	VB	ROOT	O
the	DT	det	O
translocation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
p50/p65	NN	nmod	B-protein
induced	VBN	acl	O
by	IN	case	O
triggering	NN	nmod	O
of	IN	case	O
complement	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
HIV	NN	compound	O
gene	NN	compound	O
expression	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
activated	VBN	ccomp	O
in	IN	case	O
infected	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
through	IN	case	O
interaction	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
complement-opsonized	JJ	amod	B-protein
particles	NNS	nmod	I-protein
and	CC	cc	O
that	IN	mark	O
enhanced	VBD	amod	O
viral	JJ	amod	O
replication	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
C3	NN	nmod:npmod	B-protein
receptor	NN	nmod:npmod	I-protein
-mediated	JJ	amod	O
nuclear	JJ	amod	O
translocation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

Attenuation	NN	nsubj	O
of	IN	case	O
gamma	NN	nmod:npmod	B-protein
interferon	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
phagocytes	NNS	nmod	I-cell_type
infected	VBN	acl	O
with	IN	case	O
Leishmania	NN	nmod	O
donovani	NN	ROOT	O
:	:	punct	O
selective	JJ	amod	O
inhibition	NN	dep	O
of	IN	case	O
signaling	NN	nmod	O
through	IN	case	O
Janus	NN	compound	B-protein
kinases	NNS	nmod	I-protein
and	CC	cc	O
Stat1	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
gamma	NN	compound	B-protein
interferon	NN	nmod	I-protein
is	VBZ	cop	O
impaired	JJ	ROOT	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
phagocytes	NNS	nmod	I-cell_type
infected	VBN	acl	O
with	IN	case	O
Leishmania	NN	compound	O
donovani	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
mechanisms	NNS	nsubjpass	O
involved	VBN	acl	O
are	VBP	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	conj	O
.	.	punct	O

The	DT	det	O
changes	NNS	nsubj	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
brought	VBN	ROOT	O
about	RP	advmod	O
by	IN	case	O
gamma	NN	compound	B-protein
interferon	NN	nmod	I-protein
are	VBP	auxpass	O
thought	VBN	conj	O
to	TO	mark	O
involve	VB	xcomp	O
transient	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
the	DT	det	O
activities	NNS	nmod	O
of	IN	case	O
cellular	JJ	amod	B-protein
protein	NN	compound	I-protein
tyrosine	NN	compound	I-protein
kinases	NNS	nmod	I-protein
,	,	punct	O
including	VBG	case	O
the	DT	det	O
Janus	NN	compound	B-protein
kinases	NNS	nmod	I-protein
Jak1	NN	dep	B-protein
and	CC	cc	O
Jak2	NN	conj	B-protein
,	,	punct	O
leading	VBG	xcomp	O
to	TO	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
Stat1	NN	nmod	I-protein
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
accounting	VBG	acl	O
for	IN	case	O
the	DT	det	O
impaired	JJ	amod	O
responses	NNS	nmod	O
to	TO	case	O
gamma	NN	compound	B-protein
interferon	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
model	NN	compound	O
system	NN	appos	O
for	IN	mark	O
examining	VBG	acl	O
overall	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
protein	NN	compound	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
,	,	punct	O
activation	NN	nsubjpass	O
of	IN	case	O
Jak1	NN	nmod	B-protein
and	CC	cc	O
Jak2	NN	conj	B-protein
and	CC	cc	O
phosphorylation	NN	conj	O
of	IN	case	O
Stat1	NN	nmod	B-protein
was	VBD	auxpass	O
developed	VBN	ROOT	O
in	IN	case	O
phorbol	NN	nmod:npmod	B-cell_line
12-myristate	NN	nmod:npmod	I-cell_line
13-acetate-differentiated	JJ	amod	I-cell_line
U-937	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
whole-cell	JJ	amod	O
lysates	NNS	nmod	O
by	IN	case	O
antiphosphotyrosine	NN	compound	O
immunoblotting	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
incubation	NN	nsubj	O
with	IN	case	O
gamma	NN	compound	B-protein
interferon	NN	nmod	I-protein
brought	VBN	ccomp	O
about	IN	case	O
specific	JJ	amod	O
increases	NNS	nmod	O
in	IN	case	O
phosphotyrosine	NN	compound	O
labeling	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
proteins	NNS	nmod	O
.	.	punct	O

Increased	VBN	amod	O
labeling	NN	nsubj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
occurred	VBD	ROOT	O
to	TO	case	O
similar	JJ	amod	O
extents	NNS	nmod	O
in	IN	case	O
control	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
cells	NNS	conj	O
that	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
infected	VBN	acl:relcl	O
with	IN	case	O
L.	FW	nmod	O
donovani	NN	xcomp	O
for	IN	case	O
16	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Jak1	NN	nsubjpass	B-protein
,	,	punct	O
Jak2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Stat1	NN	nsubjpass	B-protein
were	VBD	auxpass	O
immunoprecipitated	VBN	conj	O
from	IN	case	O
control	NN	amod	O
and	CC	cc	O
interferon-treated	JJ	conj	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
and	CC	cc	O
tyrosine	NN	compound	O
phosphorylation	NN	conj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
,	,	punct	O
detected	VBN	advcl	O
by	IN	case	O
antiphosphotyrosine	NN	compound	O
immunoblotting	NN	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
measured	VBN	xcomp	O
their	PRP$	nmod:poss	O
activation	NN	dobj	O
.	.	punct	O

Tyrosine	NN	compound	O
phosphorylation	NN	nsubj	O
of	IN	case	O
Jak1	NN	nmod	B-protein
,	,	punct	O
Jak2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Stat1	NN	conj	B-protein
increased	VBD	ROOT	O
markedly	RB	advmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
manner	NN	nmod	O
,	,	punct	O
in	IN	case	O
U-937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
incubated	VBN	acl	O
with	IN	case	O
gamma	NN	compound	B-protein
interferon	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
in	IN	case	O
cells	NNS	nmod	O
infected	VBN	acl	O
with	IN	case	O
L.	FW	compound	O
donovani	NN	nmod	O
,	,	punct	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubj	O
of	IN	case	O
Jak1	NN	nmod	B-protein
,	,	punct	O
Jak2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Stat1	NN	conj	B-protein
was	VBD	auxpass	O
markedly	RB	advmod	O
impaired	JJ	ROOT	O
.	.	punct	O

This	DT	det	O
effect	NN	nsubj	O
was	VBD	cop	O
dependent	JJ	ROOT	O
upon	IN	case	O
the	DT	det	O
duration	NN	nmod	O
of	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
L.	FW	nmod	O
donovani	NN	nmod	O
and	CC	cc	O
was	VBD	cop	O
maximal	JJ	conj	O
and	CC	cc	O
complete	JJ	conj	O
at	IN	case	O
16	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Results	NNS	nsubjpass	O
similar	JJ	amod	O
to	TO	case	O
those	DT	nmod	O
observed	VBN	acl	O
with	IN	case	O
U-937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
were	VBD	auxpass	O
also	RB	advmod	O
obtained	VBN	ROOT	O
with	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
infection	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
phagocytes	NNS	nmod	I-cell_type
with	IN	case	O
L.	FW	compound	O
donovani	NN	nmod	O
leads	VBZ	ccomp	O
to	TO	case	O
impaired	JJ	amod	O
gamma	NN	nmod:npmod	B-protein
interferon	NN	nmod:npmod	I-protein
-mediated	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
and	CC	cc	O
selective	JJ	amod	O
effects	NNS	conj	O
on	IN	case	O
the	DT	det	O
Jak-	NN	amod	O
Stat1	NN	compound	B-protein
pathway	NN	nmod	O
.	.	punct	O

Unresponsiveness	NN	nsubj	O
to	TO	case	O
gamma	VB	compound	B-protein
interferon	NN	nmod	I-protein
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
may	MD	aux	O
explain	VB	ROOT	O
impaired	JJ	amod	O
transcriptional	JJ	amod	O
responses	NNS	dobj	O
in	IN	case	O
leishmania-infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Mutually	RB	advmod	O
exclusive	JJ	amod	O
interaction	NN	ROOT	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	O
matrix	NN	compound	B-protein
attachment	NN	compound	I-protein
region	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
NF-muNR	NN	compound	B-protein
enhancer	NN	compound	I-protein
repressor	NN	conj	I-protein
.	.	punct	O

Implications	NNS	ROOT	O
for	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-protein
heavy	JJ	amod	I-protein
chain	NN	compound	I-protein
expression	NN	nmod	O
.	.	punct	O

The	DT	det	O
immunoglobulin	NN	compound	B-protein
heavy	JJ	amod	I-protein
chain	NN	compound	I-protein
(	-LRB-	punct	O
IgH	NN	appos	B-protein
)	-RRB-	punct	O
intronic	JJ	amod	O
enhancer	NN	nsubj	O
stimulates	VBZ	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
functional	JJ	amod	O
promoters	NNS	nmod	O
in	IN	case	O
B	NN	compound	O
lymphocytes	NNS	nmod	O
but	CC	cc	O
not	RB	cc	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	conj	O
.	.	punct	O

The	DT	det	O
observation	NN	nsubj	O
that	IN	mark	O
binding	VBG	amod	O
sites	NNS	nsubj	O
for	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor-mu	NN	amod	I-protein
negative	JJ	amod	I-protein
regulator	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF-muNR	NN	compound	I-protein
)	-RRB-	punct	I-protein
enhancer	NN	compound	I-protein
repressor	NN	nmod	I-protein
overlap	NN	ccomp	I-protein
nuclear	JJ	amod	I-protein
matrix	NN	compound	I-protein
attachment	NN	compound	I-protein
regions	NNS	dobj	I-protein
(	-LRB-	punct	O
MARs	NNS	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
this	DT	det	O
enhancer	NN	nmod	B-DNA
has	VBZ	aux	O
lead	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
the	DT	det	O
cell	NN	compound	O
type	NN	compound	O
specificity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
enhancer	NN	nmod	B-DNA
might	MD	aux	O
be	VB	auxpass	O
controlled	VBN	ccomp	O
by	IN	mark	O
regulating	VBG	advcl	O
nuclear	JJ	amod	O
matrix	NN	compound	O
attachment	NN	dobj	O
(	-LRB-	punct	O
Scheuermann	NNP	compound	O
,	,	punct	O
R.	NNP	appos	O
H.	NNP	dep	O
,	,	punct	O
and	CC	cc	O
Chen	NNP	compound	O
,	,	punct	O
U.	NNP	compound	O
(	-LRB-	punct	O
1989	CD	appos	O
)	-RRB-	punct	O
Genes	NNP	conj	O
&	CC	cc	O
Dev.	NNP	conj	O
3	CD	nummod	O
,	,	punct	O
1255-1266	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
MARs	NNS	nmod	B-protein
in	IN	case	O
IgH	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
regulation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
MAR-binding	JJ	amod	B-protein
protein	NN	dobj	I-protein
,	,	punct	O
MAR-BP1	NN	appos	B-protein
,	,	punct	O
from	IN	case	O
soluble	JJ	amod	O
nuclear	JJ	amod	O
matrix	NN	compound	O
preparations	NNS	nmod	O
based	VBN	case	O
on	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
bind	VB	acl	O
to	TO	case	O
the	DT	det	O
MARs	NNP	nmod	B-protein
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

Purified	VBN	amod	O
MAR-BP1	NN	compound	B-protein
migrates	NNS	ROOT	O
as	IN	case	O
a	DT	det	O
33-kDa	JJ	amod	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
found	VBN	conj	O
in	IN	case	O
nuclear	JJ	amod	O
matrix	NN	compound	O
preparations	NNS	nmod	O
from	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
lymphoid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Although	IN	mark	O
specific	JJ	amod	O
binding	VBG	amod	O
sites	NNS	nsubj	O
have	VBP	aux	O
been	VBN	cop	O
difficult	JJ	advcl	O
to	TO	mark	O
localize	VB	xcomp	O
by	IN	case	O
chemical	JJ	amod	O
or	CC	cc	O
enzymatic	JJ	conj	O
footprinting	NN	compound	O
procedures	NNS	nmod	O
,	,	punct	O
NF-muNR	NN	compound	B-protein
binding	NN	compound	O
sites	NNS	nsubj	O
are	VBP	cop	O
critical	JJ	ROOT	O
for	IN	case	O
efficient	JJ	amod	O
MAR-BP1	NN	compound	B-protein
binding	NN	nmod	O
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
binding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
to	TO	case	O
either	CC	cc:preconj	O
intact	JJ	amod	O
nuclear	JJ	amod	O
matrix	NN	compound	O
preparations	NNS	nmod	O
or	CC	cc	O
to	TO	case	O
MAR-BP1	NN	conj	B-protein
is	VBZ	cop	O
mutually	RB	advmod	O
exclusive	JJ	ROOT	O
to	TO	case	O
NF-muNR	NN	compound	B-protein
binding	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
are	VBP	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
a	DT	det	O
model	NN	nmod	O
for	IN	case	O
cell-type	JJ	amod	O
specific	JJ	amod	O
regulation	NN	nmod	O
in	IN	case	O
which	WDT	nmod	O
binding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NF-muNR	NN	compound	B-protein
repressor	NN	nmod	I-protein
to	TO	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
prevents	VBZ	acl:relcl	O
nuclear	JJ	amod	O
matrix	NN	compound	O
attachment	NN	dobj	O
in	IN	case	O
inappropriate	JJ	amod	O
cells	NNS	nmod	O
by	IN	mark	O
interfering	VBG	advcl	O
with	IN	case	O
MAR-BP1	NN	compound	B-protein
/enhancer	NN	compound	B-DNA
interaction	NN	nmod	O
.	.	punct	O

PU.1	NN	nsubj	B-protein
(	-LRB-	punct	O
Spi-1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
C/EBP	NN	compound	B-protein
alpha	NN	conj	I-protein
regulate	VBP	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
granulocyte-macrophage	JJ	amod	B-DNA
colony-stimulating	JJ	amod	I-DNA
factor	NN	compound	I-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Growth	NN	compound	B-protein
factor	NN	compound	I-protein
receptors	NNS	nsubj	I-protein
play	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
hematopoiesis	NN	nmod	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	dep	O
further	RB	advmod	O
understand	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
directing	VBG	acl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
these	DT	det	O
key	JJ	amod	O
regulators	NNS	nmod	O
of	IN	case	O
hematopoiesis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
initiated	VBD	ROOT	O
a	DT	det	O
study	NN	dobj	O
investigating	VBG	acl	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
activating	VBG	acl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
granulocyte-macrophage	JJ	amod	B-DNA
colony-stimulating	JJ	amod	I-DNA
factor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
GM-CSF	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
human	JJ	amod	B-DNA
GM-CSF	NN	compound	I-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	nsubj	I-DNA
directs	VBZ	ccomp	O
reporter	NN	compound	B-DNA
gene	NN	compound	I-DNA
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
tissue-specific	JJ	amod	O
fashion	NN	nmod	O
in	IN	case	O
myelomonocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
correlates	VBZ	acl:relcl	O
with	IN	case	O
its	PRP$	nmod:poss	O
expression	NN	compound	O
pattern	NN	nmod	O
as	IN	mark	O
analyzed	VBN	advcl	O
by	IN	case	O
reverse	JJ	amod	O
transcription	NN	compound	O
PCR	NN	nmod	O
.	.	punct	O

The	DT	det	O
GM-CSF	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
functional	JJ	amod	O
site	NN	dobj	O
between	IN	case	O
positions	NNS	nmod	O
-53	CD	nummod	O
and	CC	cc	O
-41	CD	conj	O
as	IN	mark	O
identified	VBN	advcl	O
by	IN	case	O
deletion	NN	compound	O
analysis	NN	nmod	O
of	IN	case	O
reporter	NN	compound	B-DNA
constructs	NNS	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	dep	O
myeloid	JJ	nsubj	O
and	CC	cc	O
B	NN	conj	B-protein
cell	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
PU.1	NN	dep	B-protein
binds	VBZ	ccomp	O
specifically	RB	advmod	O
to	TO	case	O
this	DT	det	O
site	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
CCAAT	NN	compound	B-DNA
site	NN	nsubjpass	I-DNA
located	JJ	amod	O
upstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
PU.1	NN	compound	B-DNA
site	NN	nmod	I-DNA
between	IN	case	O
positions	NNS	nmod	O
-70	CD	nummod	O
and	CC	cc	O
-54	CD	conj	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
positive-negative	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
.	.	punct	O

C/EBP	NN	compound	B-protein
alpha	NN	nsubj	I-protein
is	VBZ	cop	O
the	DT	det	O
major	JJ	amod	O
CCAAT/enhancer-binding	JJ	amod	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	O
C/EBP	NN	appos	B-protein
)	-RRB-	punct	O
form	NN	ROOT	O
binding	VBG	acl	O
to	TO	case	O
this	DT	det	O
site	NN	nmod	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Point	NN	compound	O
mutations	NNS	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
PU.1	NN	compound	B-DNA
site	NN	nmod	I-DNA
or	CC	cc	O
the	DT	det	O
C/EBP	NN	compound	B-DNA
site	NN	conj	I-DNA
that	WDT	nsubj	O
abolish	VBP	acl:relcl	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
the	DT	det	O
respective	JJ	amod	O
factors	NNS	nmod	O
result	VBP	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	nmod	O
of	IN	case	O
GM-CSF	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
in	IN	case	O
myelomonocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
only	RB	advmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
myeloid	JJ	nmod	O
and	CC	cc	O
B	NN	conj	O
cell	NN	compound	O
extracts	NNS	dep	O
,	,	punct	O
PU.1	NN	nsubj	B-protein
forms	VBZ	ccomp	O
a	DT	det	O
novel	JJ	amod	O
,	,	punct	O
specific	JJ	dep	O
,	,	punct	O
more	RBR	advmod	O
slowly	RB	advmod	O
migrating	VBG	dep	O
complex	NN	dobj	O
(	-LRB-	punct	O
PU-SF	NN	appos	B-protein
)	-RRB-	punct	O
when	WRB	advmod	O
binding	VBG	advcl	O
the	DT	det	O
GM-CSF	NN	compound	B-protein
receptor	NN	compound	I-protein
alpha	NN	compound	I-protein
promoter	NN	compound	O
PU.1	NN	compound	B-DNA
site	NN	dobj	I-DNA
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
first	JJ	amod	O
demonstration	NN	attr	O
of	IN	case	O
a	DT	det	O
specific	JJ	amod	O
interaction	NN	nmod	O
with	IN	case	O
PU.1	NN	nmod	B-protein
on	IN	case	O
a	DT	det	O
myeloid	JJ	amod	B-DNA
PU.1	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
novel	JJ	amod	O
complex	NN	nsubj	O
is	VBZ	cop	O
distinct	JJ	ROOT	O
from	IN	case	O
that	DT	nmod	O
described	VBN	acl	O
previously	RB	advmod	O
as	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
B	NN	compound	B-DNA
cell	NN	compound	I-DNA
enhancer	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
and	CC	cc	O
can	MD	aux	O
be	VB	auxpass	O
formed	VBN	conj	O
by	IN	case	O
addition	NN	nmod	O
of	IN	case	O
PU.1	NN	nmod	B-protein
to	TO	case	O
extracts	NNS	nmod	O
from	IN	case	O
certain	JJ	amod	O
nonmyeloid	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
types	NNS	nmod	I-cell_type
which	WDT	nsubj	O
do	VBP	aux	O
not	RB	neg	O
express	VB	acl:relcl	O
PU.1	NN	dobj	B-protein
,	,	punct	O
including	VBG	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
epithelial	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
from	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
PU-SF	NN	compound	B-protein
complex	NN	nsubj	I-protein
binds	VBZ	ccomp	O
to	TO	case	O
PU.1	NN	compound	B-protein
sites	NNS	nmod	O
found	VBN	acl	O
on	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
myeloid	JJ	amod	B-DNA
promoters	NNS	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
formation	NN	nsubj	O
requires	VBZ	conj	O
an	DT	det	O
intact	JJ	amod	O
PU.1	NN	compound	B-DNA
site	NN	dobj	I-DNA
adjacent	JJ	amod	O
to	TO	case	O
a	DT	det	O
single-stranded	JJ	amod	O
region	NN	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
PU.1	NN	nmod	B-protein
in	IN	case	O
nonmyeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
can	MD	aux	O
activate	VB	ROOT	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

Deletion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
amino-terminal	JJ	amod	B-protein
region	NN	nmod	I-protein
of	IN	case	O
PU.1	NN	nmod	B-protein
results	VBZ	ROOT	O
in	IN	case	O
a	DT	det	O
failure	NN	nmod	O
to	TO	mark	O
form	VB	acl	O
the	DT	det	O
PU-SF	NN	compound	B-protein
complex	NN	dobj	O
and	CC	cc	O
in	IN	case	O
a	DT	det	O
concomitant	JJ	amod	O
loss	NN	conj	O
of	IN	case	O
transactivation	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
formation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
PU-SF	NN	compound	B-protein
complex	NN	nmod	I-protein
is	VBZ	cop	O
of	IN	case	O
functional	JJ	amod	O
importance	NN	ccomp	O
for	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
C/EBP	NN	compound	B-protein
alpha	NN	nsubj	I-protein
can	MD	aux	O
also	RB	advmod	O
active	JJ	ccomp	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
in	IN	case	O
nonmyeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
400	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

HMG-I	NN	nsubj	B-protein
binds	VBZ	ROOT	O
to	TO	case	O
GATA	NN	compound	B-DNA
motifs	NNS	nmod	I-DNA
:	:	punct	O
implications	NNS	dep	O
for	IN	case	O
an	DT	det	O
HPFH	NN	compound	O
syndrome	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
binding	NN	dobj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
protein	NN	nmod	I-protein
HMG-I	NN	dep	B-protein
to	TO	case	O
the	DT	det	O
human	JJ	amod	B-DNA
gamma-globin	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
HMG-I	NN	nsubj	B-protein
binds	VBZ	ccomp	O
preferentially	RB	advmod	O
to	TO	case	O
the	DT	det	O
more	JJR	advmod	O
3	CD	nmod	O
'	''	punct	O
of	IN	case	O
a	DT	det	O
pair	NN	nmod	O
of	IN	case	O
GATA	NN	compound	B-DNA
motifs	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
gamma-globin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
;	:	punct	O
this	DT	det	O
paired	JJ	amod	O
motif	NN	nsubjpass	O
is	VBZ	auxpass	O
bound	VBN	parataxis	O
by	IN	case	O
the	DT	det	O
erythroid	JJ	amod	B-protein
factor	NN	compound	I-protein
GATA-1	NN	nmod	I-protein
.	.	punct	O

A	DT	det	O
naturally	RB	advmod	O
occurring	VBG	amod	O
mutation	NN	nsubj	O
(	-LRB-	punct	O
-175	CD	nummod	O
T-C	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
area	NN	nmod	O
bound	VBN	acl	O
by	IN	case	O
HMG-I	NN	nmod	B-protein
results	VBZ	ROOT	O
in	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
gamma-globin	NN	nmod	B-protein
in	IN	case	O
adult	JJ	amod	B-cell_type
red	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
HPFH	NN	appos	B-cell_type
)	-RRB-	punct	O
and	CC	cc	O
up-regulation	NN	conj	O
of	IN	case	O
the	DT	det	O
gamma-globin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
expression	NN	compound	O
assays	NNS	nmod	O
;	:	punct	O
HMG-I	NN	nsubj	B-protein
does	VBZ	aux	O
not	RB	neg	O
bind	VB	parataxis	O
to	TO	case	O
this	DT	det	O
mutant	JJ	amod	B-DNA
sequence	NN	nmod	I-DNA
.	.	punct	O

A	DT	det	O
survey	NN	nsubj	O
of	IN	case	O
GATA	NN	compound	B-DNA
motifs	NNS	nmod	I-DNA
from	IN	case	O
other	JJ	amod	O
globin	NN	compound	B-DNA
cis-elements	NNS	nmod	I-DNA
demonstrates	VBZ	ROOT	O
HMG-I	NN	compound	B-protein
binding	NN	dobj	O
to	TO	case	O
most	JJS	nmod	O
of	IN	case	O
them	PRP	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
implicate	VBP	ROOT	O
HMG-I	NN	dobj	B-protein
in	IN	case	O
the	DT	det	O
HPFH	NN	compound	B-cell_type
phenotype	NN	nmod	O
;	:	punct	O
we	PRP	nsubj	O
speculate	VBP	parataxis	O
that	IN	mark	O
it	PRP	nsubj	O
may	MD	aux	O
participate	VB	ccomp	O
in	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
multiprotein	JJ	compound	B-protein
complexes	NNS	nmod	I-protein
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
globin	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Constitutive	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
different	JJ	amod	O
Jak	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinases	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-protein
T	NN	compound	I-protein
cell	NN	compound	I-protein
leukemia	NN	compound	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	I-protein
HTLV-1	NN	compound	I-protein
)	-RRB-	punct	I-protein
tax	NN	compound	I-protein
protein	NN	nmod	I-protein
or	CC	cc	O
virus-transformed	JJ	amod	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

HTLV-1	NN	compound	O
infection	NN	nsubj	O
causes	VBZ	ROOT	O
an	DT	det	O
adult	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	dobj	O
in	IN	case	O
humans	NNS	nmod	O
.	.	punct	O

The	DT	det	O
viral	JJ	amod	B-protein
encoded	VBN	amod	I-protein
protein	NN	compound	I-protein
tax	NN	nsubjpass	B-protein
,	,	punct	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
oncogenesis	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
previous	JJ	amod	O
data	NNS	nsubj	O
obtained	VBN	acl	O
from	IN	case	O
a	DT	det	O
tax	NN	compound	B-protein
transgenic	JJ	amod	O
mouse	NN	compound	O
model	NN	nmod	O
revealed	VBD	ROOT	O
that	IN	mark	O
tax	NN	nsubj	B-protein
transforms	VBZ	ccomp	O
mouse	NN	compound	B-cell_type
fibroblasts	NNS	dobj	I-cell_type
but	CC	cc	O
not	RB	cc	O
thymocytes	NNS	conj	B-cell_type
,	,	punct	O
despite	IN	case	O
comparable	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
tax	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
both	DT	det	O
tissues	NNS	nmod	O
.	.	punct	O

Constitutive	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
130-kD	JJ	amod	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
tax	NN	nmod:npmod	B-protein
transformed	JJ	amod	B-cell_line
fibroblast	NN	compound	I-cell_line
B	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
and	CC	cc	O
in	IN	case	O
HTLV-1	NN	compound	B-cell_line
transformed	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
lymphoid	JJ	amod	I-cell_line
lines	NNS	conj	I-cell_line
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
thymocytes	NNS	conj	B-cell_type
from	IN	case	O
Thy-tax	NN	compound	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Phosphotyrosine	NN	compound	O
immunoprecipitation	NN	nsubj	O
followed	VBN	acl	O
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
with	IN	case	O
a	DT	det	O
set	NN	nmod	O
of	IN	case	O
Jak	NN	nmod:npmod	B-protein
kinase	NN	nmod:npmod	I-protein
specific	JJ	amod	I-protein
antibodies	NNS	nmod	I-protein
,	,	punct	O
identified	VBD	ROOT	O
p130	NN	dobj	O
as	IN	case	O
Jak2	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
tax	NN	nmod	B-protein
transformed	JJ	amod	O
mouse	NN	compound	B-cell_line
fibroblastic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	dep	I-cell_line
and	CC	cc	O
Jak3	NN	conj	B-protein
in	IN	case	O
HTLV-1	NN	compound	B-cell_line
transformed	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Phosphorylation	NN	nsubj	O
of	IN	case	O
Jak2	NN	nmod	B-protein
in	IN	case	O
tax	NN	compound	B-cell_line
transformed	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
resulted	VBD	ROOT	O
from	IN	case	O
high	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
IL-6	NN	nmod	O
.	.	punct	O

Tyrosine	NN	compound	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
could	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
Balb/c3T3	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
using	VBG	xcomp	O
a	DT	det	O
supernatant	NN	dobj	O
from	IN	case	O
the	DT	det	O
B	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
induction	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
phosphorylation	NN	nsubjpass	O
and	CC	cc	O
proliferation	NN	conj	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
IL-6	NN	compound	B-protein
neutralizing	NN	compound	I-protein
antibodies	NNS	nmod	I-protein
.	.	punct	O

Constitutive	JJ	amod	O
phosphorylation	NN	nsubj	O
of	IN	case	O
Jak	NN	compound	B-protein
kinases	NNS	nmod	I-protein
may	MD	aux	O
facilitate	VB	ROOT	O
tumor	NN	compound	O
growth	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
HTLV-1	NN	compound	B-cell_type
infected	JJ	amod	I-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
the	DT	det	O
transgenic	JJ	amod	O
mouse	NN	compound	O
model	NN	conj	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
c-jun	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nmod	O
by	IN	case	O
hydroxyurea	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_line
K562	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
during	IN	case	O
erythroid	JJ	amod	O
differentiation	NN	nmod	O
[	-LRB-	punct	O
published	VBN	amod	O
erratum	NN	nsubj	O
appears	VBZ	dep	O
in	IN	case	O
Biochim	NNP	compound	O
Biophys	NNP	compound	O
Acta	NNP	compound	O
1995	CD	nummod	O
Dec	NNP	nmod	O
27	CD	nummod	O
;	:	punct	O
1264	CD	dep	O
(	-LRB-	punct	O
3	CD	appos	O
)	-RRB-	punct	O
:	:	punct	O
409	CD	nummod	O
]	-RRB-	punct	O

Hydroxyurea	NN	nsubj	O
(	-LRB-	punct	O
HU	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
antitumor	JJ	amod	O
agent	NN	ROOT	O
which	WDT	nsubj	O
also	RB	advmod	O
induces	VBZ	acl:relcl	O
hemoglobinization	NN	dobj	O
during	IN	case	O
erythroid	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
HU	NN	nsubj	O
stimulates	VBZ	ROOT	O
the	DT	det	O
synthesis	NN	dobj	O
of	IN	case	O
fetal	JJ	amod	B-protein
hemoglobin	NN	nmod	I-protein
in	IN	case	O
sickle	JJ	amod	O
cell	NN	compound	O
anemia	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
understand	VB	advcl	O
its	PRP$	nmod:poss	O
mechanism	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
HU	NN	nmod	O
on	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
c-jun	NN	compound	B-DNA
expression	NN	nmod	O
prior	RB	case	O
to	TO	case	O
the	DT	det	O
onset	NN	nmod	O
of	IN	case	O
erythroid	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
K562	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

HU	NN	nsubj	O
induced	VBD	ROOT	O
a	DT	det	O
dose-dependent	JJ	amod	O
stimulation	NN	dobj	O
of	IN	case	O
c-jun	NN	compound	B-DNA
synthesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
c-jun	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
was	VBD	cop	O
elevated	JJ	ROOT	O
4	CD	dobj	O
to	TO	dep	O
7.5-fold	RB	nmod	O
by	IN	case	O
HU	NN	nmod	O
within	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
gradual	JJ	amod	O
decline	NN	nmod	O
to	TO	case	O
the	DT	det	O
basal	JJ	amod	O
level	NN	nmod	O
by	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
nuclear	JJ	amod	O
run-on	JJ	amod	O
and	CC	cc	O
actinomycin	NN	compound	O
D	NN	compound	O
pulse	NN	compound	O
experiments	NNS	nsubj	O
strongly	RB	advmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
HU	NN	nsubj	O
regulates	VBZ	ccomp	O
c-jun	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	dobj	O
by	IN	mark	O
increasing	VBG	advcl	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
synthesis	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
stabilizing	VBG	conj	O
the	DT	det	O
c-jun	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
jun	NN	compound	B-protein
protein	NN	nmod	I-protein
was	VBD	auxpass	O
elevated	VBN	ROOT	O
by	IN	case	O
2	CD	compound	O
to	TO	dep	O
5-fold	RB	nmod	O
within	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
in	IN	case	O
HU	NN	nmod:npmod	B-cell_line
treated	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
concentrations	NNS	nsubj	O
of	IN	case	O
HU	NN	nmod	O
below	IN	case	O
250	CD	nummod	O
microM	NN	nmod	O
slightly	RB	advmod	O
increased	VBD	ROOT	O
the	DT	det	O
5X	NN	compound	O
AP-1	NN	compound	B-protein
/CAT	NN	compound	B-protein
activity	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
strongly	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
HU	NN	nsubj	O
induces	VBZ	ccomp	O
both	CC	cc:preconj	O
transcriptional	JJ	amod	O
and	CC	cc	O
post-transcription	JJ	conj	O
regulation	NN	dobj	O
of	IN	case	O
c-jun	NN	nmod	B-DNA
during	IN	case	O
erythroid	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
and	CC	ROOT	O
in	FW	amod	O
vitro	FW	dep	O
effects	NNS	dobj	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
on	IN	case	O
lymphocyte	NN	compound	O
proliferation	NN	nmod	O
in	IN	case	O
man	NN	nmod	O
:	:	punct	O
relationship	NN	dep	O
to	TO	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Interrelations	NNS	nsubj	O
between	IN	case	O
the	DT	det	O
hypothalamic-pituitary-adrenal	JJ	amod	O
system	NN	nmod	O
(	-LRB-	punct	O
HPA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
immune	JJ	amod	O
system	NN	conj	O
represent	VBP	ROOT	O
a	DT	det	O
well-documented	JJ	amod	O
biological	JJ	amod	O
phenomenon	NN	dobj	O
.	.	punct	O

While	IN	mark	O
in	FW	amod	O
vitro	FW	dep	O
administration	NN	nsubj	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
may	MD	aux	O
inhibit	VB	advcl	O
concanavalin	NN	compound	O
A	NN	dobj	O
(	-LRB-	punct	O
Con	NN	compound	O
A	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
and	CC	cc	O
phytohemagglutinin	NN	compound	O
(	-LRB-	punct	O
PHA	NN	nmod:npmod	O
)	-RRB-	punct	O
-induced	JJ	amod	O
T-cell	NN	compound	O
proliferation	NN	conj	O
,	,	punct	O
pokeweed	NN	compound	B-protein
mitogen	NN	compound	I-protein
(	-LRB-	punct	O
PWM	NN	compound	B-protein
)	-RRB-	punct	O
-driven	JJ	amod	O
B-cell	NN	compound	O
mitogenesis	NN	nsubj	O
is	VBZ	cop	O
relatively	RB	advmod	O
resistant	JJ	ROOT	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
explore	VB	advcl	O
the	DT	det	O
link	NN	dobj	O
between	IN	case	O
the	DT	det	O
HPA	NN	nmod	O
and	CC	cc	O
the	DT	det	O
immune	JJ	amod	O
system	NN	conj	O
in	IN	case	O
relation	NN	nmod	O
to	TO	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
function	NN	nmod	O
,	,	punct	O
dose-response	JJ	amod	O
curves	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
for	IN	case	O
Con	NN	compound	O
A	NN	compound	O
-and	NN	compound	O
PHA	NN	compound	B-protein
-induced	JJ	amod	O
T-cell	NN	compound	O
mitogenesis	NN	nmod	O
,	,	punct	O
PWM	NN	compound	B-protein
-generated	JJ	amod	O
B-cell	NN	compound	O
mitogenesis	NN	conj	O
and	CC	cc	O
spontaneous	JJ	amod	O
lymphocyte	NN	compound	O
proliferation	NN	conj	O
in	IN	case	O
13	CD	nummod	O
healthy	JJ	amod	O
controls	NNS	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	case	O
depletion	NN	nmod	O
of	IN	case	O
endogenous	JJ	amod	O
glucocorticoids	NNS	nmod	O
after	IN	case	O
oral	JJ	amod	O
administration	NN	nmod	O
of	IN	case	O
1.5	CD	nummod	O
g	NN	compound	O
metyrapone	NN	nmod	O
(	-LRB-	punct	O
MET	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
subsequent	JJ	amod	O
glucocorticoid	NN	compound	O
replacement	NN	conj	O
,	,	punct	O
and	CC	cc	O
in	FW	compound	O
vitro	FW	conj	O
by	IN	case	O
incubation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
different	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
DEX	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	nsubj	O
in	IN	case	O
PWM	NN	compound	B-protein
-induced	JJ	amod	O
B-cell	NN	compound	O
mitogenesis	NN	nmod	O
and	CC	cc	O
a	DT	det	O
more	RBR	advmod	O
pronounced	JJ	amod	O
effect	NN	conj	O
of	IN	case	O
DEX	NN	nmod	O
administered	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
on	IN	case	O
spontaneous	JJ	amod	O
lymphocyte	NN	compound	O
proliferation	NN	nmod	O
after	IN	case	O
MET	NN	compound	O
treatment	NN	nmod	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
the	DT	det	O
DEX	NN	compound	O
plus	CC	cc	O
MET	NN	conj	O
pretreated	JJ	amod	O
condition	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
spontaneous	JJ	amod	O
lymphocyte	NN	compound	O
proliferation	NN	nmod	O
by	IN	case	O
glucocorticoids	NNS	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
is	VBZ	cop	O
related	JJ	ccomp	O
to	TO	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
function	NN	nmod	O
.	.	punct	O

The	DT	det	O
decrease	NN	nsubjpass	O
in	IN	case	O
PWM	NN	compound	B-protein
-generated	JJ	amod	O
B-cell	NN	compound	O
proliferation	NN	nmod	O
following	VBG	case	O
cortisol	NN	compound	O
depletion	NN	nmod	O
by	IN	case	O
MET	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
connection	NN	nmod	O
with	IN	case	O
impaired	JJ	amod	O
glucocorticoid-mediated	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
interleukin-1	NN	compound	B-protein
receptor	NN	compound	I-protein
synthesis	NN	nmod	O
.	.	punct	O

Transcription	NN	compound	O
specific	JJ	amod	O
differences	NNS	ROOT	O
visualized	VBN	acl	O
by	IN	case	O
fluorescence	NN	compound	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	compound	O
pattern	NN	nmod	O
on	IN	case	O
interphase	JJ	compound	O
nuclei	NNS	nmod	O
of	IN	case	O
different	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

Application	NN	nsubj	O
of	IN	case	O
a	DT	det	O
``	``	punct	O
formamide	NN	advmod	O
free	JJ	nmod	O
''	''	punct	O
and	CC	cc	O
thus	RB	advmod	O
``	``	punct	O
material	JJ	amod	O
preserving	NN	conj	O
''	''	punct	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	compound	O
technique	NN	nmod	O
using	VBG	acl	O
the	DT	det	O
cDNA	NN	dobj	B-DNA
of	IN	case	O
the	DT	det	O
myf3	NN	compound	B-DNA
gene	NN	nmod	I-DNA
revealed	VBD	ROOT	O
the	DT	det	O
following	JJ	amod	O
results	NNS	dobj	O
:	:	punct	O
Human	JJ	amod	B-cell_type
rhabdomyosarcoma	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
,	,	punct	O
characterized	VBN	acl	O
by	IN	case	O
a	DT	det	O
high	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
myf3	NN	nmod	B-DNA
show	VBP	parataxis	O
intensive	JJ	amod	O
hybridization	NN	compound	O
signals	NNS	dobj	O
in	IN	case	O
their	PRP$	nmod:poss	O
interphase	NN	nmod	O
.	.	punct	O

RNase	NN	compound	B-protein
treatment	NN	nsubj	O
prior	JJ	case	O
to	TO	case	O
hybridization	NN	nmod	O
considerably	RB	advmod	O
reduces	VBZ	ROOT	O
the	DT	det	O
size	NN	dobj	O
of	IN	case	O
this	DT	det	O
signals	NNS	nmod	O
.	.	punct	O

In	IN	case	O
comparison	NN	nmod	O
,	,	punct	O
isolated	VBN	amod	O
nuclei	NNS	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
which	WDT	nmod	O
no	DT	neg	O
need	NN	nsubj	O
for	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
exists	VBZ	acl:relcl	O
,	,	punct	O
show	VBP	ROOT	O
barely	RB	advmod	O
hybridization	NN	compound	O
signals	NNS	dobj	O
.	.	punct	O

Correspondingly	RB	advmod	O
,	,	punct	O
RNase	NN	compound	B-protein
treatment	NN	nsubj	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
hybridization	NN	compound	O
pattern	NN	nmod	O
at	IN	case	O
all	RB	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
an	DT	det	O
increased	VBN	amod	O
transcription	NN	compound	O
efficiency	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
cell	NN	compound	O
type	NN	compound	O
specific	JJ	amod	O
gene	NN	nmod	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
higher	JJR	amod	O
hybridization	NN	compound	O
accessibility	NN	nmod	O
in	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
cell	NN	compound	O
nuclei	NNS	nmod	O
.	.	punct	O

Oncogenicity	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_line
papillomavirus-	NN	amod	I-cell_line
or	CC	cc	I-cell_line
adenovirus-transformed	JJ	conj	I-cell_line
cells	NNS	nmod	I-cell_line
correlates	VBZ	ROOT	O
with	IN	case	O
resistance	NN	nmod	O
to	TO	case	O
lysis	NN	nmod	O
by	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
reasons	NNS	nsubj	O
for	IN	case	O
the	DT	det	O
dissimilar	JJ	amod	O
oncogenicities	NNS	nmod	O
of	IN	case	O
human	JJ	amod	O
adenoviruses	NNS	nmod	O
and	CC	cc	O
human	JJ	amod	O
papillomaviruses	NNS	conj	O
(	-LRB-	punct	O
HPV	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
humans	NNS	nmod	O
are	VBP	cop	O
unknown	JJ	ROOT	O
but	CC	cc	O
may	MD	aux	O
relate	VB	conj	O
to	TO	case	O
differences	NNS	nmod	O
in	IN	case	O
the	DT	det	O
capacities	NNS	nmod	O
of	IN	case	O
the	DT	det	O
E1A	NN	compound	B-protein
and	CC	cc	O
E7	NN	conj	B-protein
proteins	NNS	nmod	I-protein
to	TO	case	O
target	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
for	IN	case	O
rejection	NN	nmod	O
by	IN	case	O
the	DT	det	O
host	NN	compound	B-cell_type
natural	JJ	amod	I-cell_type
killer	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NK	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cell	NN	compound	I-cell_type
response	NN	nmod	O
.	.	punct	O

As	IN	prep	O
one	CD	nummod	O
test	NN	pobj	O
of	IN	case	O
this	DT	det	O
hypothesis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
compared	VBD	ROOT	O
the	DT	det	O
abilities	NNS	dobj	O
of	IN	case	O
E1A	NN	compound	B-protein
-and	NN	compound	O
E7	NN	compound	B-protein
-expressing	JJ	amod	O
human	JJ	amod	B-cell_line
fibroblastic	JJ	amod	I-cell_line
or	CC	cc	I-cell_line
keratinocyte-derived	JJ	conj	I-cell_line
human	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
to	TO	mark	O
be	VB	auxpass	O
selectively	RB	advmod	O
killed	VBN	acl	O
by	IN	case	O
either	CC	cc:preconj	O
unstimulated	JJ	nmod	B-cell_type
or	CC	cc	O
interferon	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
IFN	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
-activated	JJ	amod	I-cell_line
NK	NN	compound	I-cell_line
cells	NNS	dep	I-cell_line
.	.	punct	O

Cells	NNS	nsubjpass	O
expressing	VBG	acl	O
the	DT	det	O
E1A	NN	compound	B-protein
oncoprotein	NN	dobj	I-protein
were	VBD	auxpass	O
selectively	RB	advmod	O
killed	VBN	ROOT	O
by	IN	case	O
unstimulated	JJ	amod	B-cell_line
NK	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
while	IN	mark	O
the	DT	det	O
same	JJ	amod	O
parental	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
but	CC	cc	O
expressing	VBG	conj	O
the	DT	det	O
HPV	NN	compound	O
type	NN	dobj	O
16	CD	nummod	O
(	-LRB-	punct	O
HPV-16	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
HPV-18	NN	compound	O
E7	NN	compound	B-protein
oncoprotein	NN	conj	I-protein
were	VBD	cop	O
resistant	JJ	advcl	O
to	TO	case	O
NK	NN	compound	O
cell	NN	compound	O
lysis	NN	nmod	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
IFN-activated	JJ	amod	B-cell_line
NK	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
to	TO	mark	O
selectively	RB	advmod	O
kill	VB	acl	O
virally	RB	advmod	O
transformed	VBN	amod	O
cells	NNS	dobj	O
depends	VBZ	ROOT	O
on	IN	case	O
IFN	NN	nmod:poss	B-protein
's	POS	case	O
ability	NN	nmod	O
to	TO	mark	O
induce	VB	acl	O
resistance	NN	dobj	O
to	TO	case	O
NK	NN	compound	O
cell	NN	compound	O
lysis	NN	nmod	O
in	IN	case	O
normal	JJ	amod	O
(	-LRB-	punct	O
i.e.	FW	dep	O
,	,	punct	O
non-viral	JJ	amod	B-cell_line
oncogene-expressing	JJ	dep	I-cell_line
)	-RRB-	punct	O
but	CC	cc	O
not	RB	neg	O
virally	RB	advmod	B-cell_line
transformed	VBN	amod	I-cell_line
cells	NNS	dobj	I-cell_line
.	.	punct	O

E1A	NN	nsubj	B-protein
blocked	VBD	ROOT	O
IFN	NN	nmod:poss	B-protein
's	POS	case	O
induction	NN	dobj	O
of	IN	case	O
cytolytic	JJ	amod	O
resistance	NN	nmod	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
the	DT	det	O
selective	JJ	amod	O
lysis	NN	nmod	O
of	IN	case	O
adenovirus-transformed	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
by	IN	case	O
IFN-activated	JJ	amod	B-cell_line
NK	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
extent	NN	nsubj	O
of	IN	case	O
IFN	NN	compound	B-protein
-induced	JJ	amod	O
NK	NN	compound	O
cell	NN	compound	O
killing	NN	nmod	O
of	IN	case	O
E1A-expressing	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	cop	O
proportional	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
E1A	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
E1A	NN	nmod	B-protein
to	TO	mark	O
block	VB	acl	O
IFN	NN	nmod:npmod	B-protein
-stimulated	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
target	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
E7	NN	nsubj	B-protein
blocked	VBD	ROOT	O
neither	CC	cc:preconj	O
IFN	NN	nmod:npmod	B-protein
-stimulated	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
nor	CC	cc	O
IFN	NN	nmod:poss	B-protein
's	POS	case	O
induction	NN	conj	O
of	IN	case	O
cytolytic	JJ	amod	O
resistance	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
precluding	VBG	advcl	O
the	DT	det	O
selective	JJ	amod	O
lysis	NN	dobj	O
of	IN	case	O
HPV-transformed	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
by	IN	case	O
IFN-activated	JJ	amod	B-cell_line
NK	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
E1A	NN	compound	B-protein
expression	NN	nsubj	O
marks	VBZ	ROOT	O
cells	NNS	dobj	O
for	IN	case	O
destruction	NN	nmod	O
by	IN	case	O
the	DT	det	O
host	NN	compound	O
NK	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
response	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
E7	NN	compound	B-protein
oncoprotein	NN	nsubj	I-protein
lacks	VBZ	parataxis	O
this	DT	det	O
activity	NN	dobj	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
IkB	NN	compound	B-protein
alpha	NN	compound	I-protein
phosphorylation	NN	nmod	O
by	IN	case	O
PKC-	NN	nmod	O
and	CC	cc	O
Ca	NN	conj	O
(	-LRB-	punct	O
2+	NN	dep	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	dep	O
.	.	punct	O

The	DT	det	O
Ca	NN	compound	B-protein
(	-LRB-	punct	I-protein
2+	NN	appos	I-protein
)	-RRB-	punct	I-protein
-dependent	JJ	amod	I-protein
phosphatase	NN	compound	I-protein
calcineurin	NN	nsubj	B-protein
,	,	punct	O
a	DT	det	O
target	NN	appos	O
of	IN	case	O
FK506	NN	nmod	O
and	CC	cc	O
CsA	NN	conj	O
,	,	punct	O
synergizes	VBZ	ROOT	O
with	IN	case	O
PKC	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
in	IN	case	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
whether	IN	mark	O
this	DT	det	O
synergy	NN	nsubj	O
is	VBZ	cop	O
present	JJ	ccomp	O
in	IN	case	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	conj	O
)	-RRB-	punct	O
by	IN	case	O
which	WDT	nmod	O
these	DT	det	O
two	CD	nummod	O
pathways	NNS	nsubj	O
lead	VBP	acl:relcl	O
to	TO	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
.	.	punct	O

While	IN	mark	O
this	DT	det	O
synergy	NN	nsubj	O
is	VBZ	cop	O
present	JJ	advcl	O
in	IN	case	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
monocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
U937	NN	compound	I-cell_line
calcineurin	NN	nsubj	B-protein
is	VBZ	cop	O
also	RB	advmod	O
sufficient	JJ	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
.	.	punct	O

Having	VBG	aux	O
previously	RB	advmod	O
shown	VBN	advcl	O
that	IN	mark	O
Ca	NN	nsubj	O
(	-LRB-	punct	O
2+	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
and	CC	cc	O
PKC-dependent	JJ	amod	O
pathways	NNS	conj	O
synergize	VBP	ccomp	O
by	IN	mark	O
accelerating	VBG	advcl	O
the	DT	det	O
degradation	NN	dobj	O
of	IN	case	O
IkB	NN	compound	B-protein
alpha	NN	nmod	I-protein
,	,	punct	O
we	PRP	nsubj	O
focused	VBD	ROOT	O
on	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
IkB	NN	compound	B-protein
alpha	NN	compound	I-protein
phosphorylation	NN	nmod	O
.	.	punct	O

While	IN	mark	O
PKC	NN	compound	B-protein
-dependent	JJ	amod	O
pathways	NNS	nsubj	O
sequentially	RB	advmod	O
result	VBP	advcl	O
in	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
and	CC	cc	O
in	IN	case	O
an	DT	det	O
incomplete	JJ	amod	O
degradation	NN	conj	O
of	IN	case	O
IkB	NN	compound	B-protein
alpha	NN	nmod	I-protein
in	IN	case	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
co-activation	NN	nsubj	O
of	IN	case	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	amod	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
pathways	NNS	nmod	O
accelerates	VBZ	ROOT	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
IkB	NN	compound	B-protein
alpha	NN	compound	I-protein
phosphorylation	NN	nmod	O
and	CC	cc	O
results	VBZ	conj	O
in	IN	case	O
its	PRP$	nmod:poss	O
complete	JJ	amod	O
degradation	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	amod	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
pathways	NNS	nmod	O
alone	RB	advmod	O
do	VBP	aux	O
not	RB	neg	O
result	VB	ROOT	O
in	IN	case	O
the	DT	dep	O
phosphorylation	NN	nmod	O
and/or	CC	cc	O
degradation	NN	conj	O
of	IN	case	O
IkB	NN	compound	B-protein
alpha	NN	nmod	I-protein
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	nmod	I-cell_line
or	CC	cc	O
in	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
the	DT	det	O
selective	JJ	amod	O
PKC	NN	compound	B-protein
inhibitor	NN	compound	O
GF109203X	NN	nmod	O
abrogates	VBZ	ROOT	O
the	DT	det	O
PMA-induced	JJ	amod	O
IkB	NN	compound	B-protein
alpha	NN	compound	I-protein
phosphorylation/degradation	NN	dobj	O
irrespective	JJ	amod	O
of	IN	case	O
activation	NN	nmod	O
of	IN	case	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	amod	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
pathways	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
phosphorylation	NN	conj	O
and	CC	cc	O
degradation	NN	conj	O
of	IN	case	O
IkB	NN	compound	B-protein
alpha	NN	nmod	I-protein
induced	VBN	acl	O
by	IN	case	O
TNF-alpha	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
PKC	NN	compound	B-protein
-independent	JJ	amod	O
stimulus	NN	appos	O
.	.	punct	O

Contrary	JJ	advmod	O
to	TO	case	O
the	DT	det	O
interaction	NN	nmod	O
with	IN	case	O
PKC	NN	nmod	B-protein
,	,	punct	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	amod	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
pathways	NNS	nsubj	O
synergize	VBP	ROOT	O
with	IN	case	O
TNF-alpha	NN	nmod	B-protein
not	RB	neg	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
IkB	NN	compound	B-protein
alpha	NN	compound	I-protein
phosphorylation	NN	nmod	O
,	,	punct	O
but	CC	cc	O
at	IN	case	O
the	DT	det	O
level	NN	conj	O
of	IN	case	O
its	PRP$	poss	O
degradation	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	amod	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
pathways	NNS	nsubj	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
phosphatase	NN	compound	B-protein
calcineurin	NN	nmod	B-protein
,	,	punct	O
participate	VBP	ccomp	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
a	DT	det	O
cell	NN	compound	O
specific	JJ	amod	O
fashion	NN	nmod	O
and	CC	cc	O
synergize	VB	conj	O
with	IN	case	O
PKC	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
and	CC	cc	O
-independent	JJ	conj	O
pathways	NNS	nmod	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
IkB	NN	compound	B-protein
alpha	NN	compound	I-protein
phosphorylation	NN	nmod	O
and	CC	cc	O
degradation	NN	conj	O
.	.	punct	O

Vitamin	NN	compound	O
E	NN	compound	O
therapy	NN	nsubjpass	O
of	IN	case	O
acute	JJ	amod	O
CCl4-induced	JJ	amod	O
hepatic	JJ	amod	O
injury	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
binding	NN	nmod	O
.	.	punct	O

Oxidative	JJ	amod	O
stress	NN	nsubj	O
,	,	punct	O
with	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
intermediate	JJ	amod	O
formation	NN	nmod	O
,	,	punct	O
may	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
common	JJ	amod	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
liver	NN	compound	O
injury	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	acl:relcl	O
by	IN	case	O
diverse	JJ	amod	O
etiologies	NNS	nmod	O
.	.	punct	O

Oxidative	JJ	amod	O
stress	NN	nsubj	O
enhances	VBZ	ROOT	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	conj	O
to	TO	mark	O
enhance	VB	xcomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
cytotoxic	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
.	.	punct	O

Acute	JJ	amod	O
hepatic	JJ	amod	O
injury	NN	nsubjpass	O
caused	VBN	acl	O
by	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
intermediate	JJ	amod	O
production	NN	nmod	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
intraperitoneal	JJ	amod	O
injection	NN	nmod	O
of	IN	case	O
CCl4	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	O
.	.	punct	O

This	DT	det	O
injury	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
intravenous	JJ	amod	O
pretreatment	NN	nmod	O
of	IN	case	O
the	DT	det	O
mice	NNS	nmod	O
with	IN	case	O
a	DT	det	O
water-soluble	JJ	amod	O
emulsion	NN	nmod	O
of	IN	case	O
alpha-tocopherol	NN	nmod	O
.	.	punct	O

Alpha-tocopherol	NN	compound	O
treatment	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mice	NNS	nmod	O
given	VBN	acl	O
the	DT	det	O
CCl4	NN	dobj	O
also	RB	advmod	O
reduced	VBD	ROOT	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	dobj	O
to	TO	case	O
levels	NNS	nmod	O
approaching	VBG	acl	O
those	DT	dobj	O
found	VBN	acl	O
in	IN	case	O
normal	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
treatment	NN	nsubj	O
of	IN	case	O
a	DT	det	O
monocyte/macrophage	NN	compound	O
cell	NN	compound	O
line	NN	nmod	O
with	IN	case	O
CCl4	NN	nmod	O
led	VBD	ROOT	O
to	TO	case	O
enhanced	VBN	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	nmod	O
and	CC	cc	O
an	DT	det	O
increase	NN	conj	O
in	IN	case	O
tumor	NN	compound	B-RNA
necrosis	NN	compound	I-RNA
factor-alpha	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
TNF-alpha	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
messenger	NN	compound	I-RNA
RNA	NN	compound	I-RNA
levels	NNS	nmod	O
.	.	punct	O

Liver	NN	compound	O
specimens	NNS	nsubj	O
taken	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
fulminant	JJ	amod	O
hepatitis	NN	nmod	O
had	VBD	aux	O
markedly	RB	advmod	O
increased	VBN	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
the	DT	det	O
binding	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
livers	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
abolishing	VBG	csubj	O
acute	JJ	amod	O
hepatic	JJ	amod	O
injury	NN	dobj	O
with	IN	case	O
alpha-tocopherol	NN	nmod	O
,	,	punct	O
a	DT	det	O
free	JJ	amod	O
radical	NN	amod	O
scavenger	NN	appos	O
,	,	punct	O
also	RB	advmod	O
eliminated	VBD	ccomp	O
increased	VBN	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	dobj	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
tempting	JJ	ROOT	O
to	TO	mark	O
speculate	VB	xcomp	O
that	IN	mark	O
enhanced	VBN	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
expression	NN	nsubj	O
caused	VBN	acl	O
by	IN	case	O
free	JJ	amod	O
radical	JJ	amod	O
production/oxidative	JJ	amod	O
stress	NN	nmod	O
may	MD	aux	O
modulate	VB	ccomp	O
liver	NN	compound	O
injury	NN	dobj	O
,	,	punct	O
perhaps	RB	advmod	O
through	IN	case	O
an	DT	det	O
effect	NN	nmod	O
on	IN	case	O
cytotoxic	JJ	amod	B-protein
cytokine	NN	compound	I-protein
synthesis	NN	nmod	O
.	.	punct	O

Immunosuppression	NN	ROOT	O
by	IN	case	O
glucocorticoids	NNS	nmod	O
:	:	punct	O
inhibition	NN	dep	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
through	IN	case	O
induction	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
synthesis	NN	nmod	O
[	-LRB-	punct	O
see	VB	dep	O
comments	NNS	dobj	O
]	-RRB-	punct	O

Glucocorticoids	NNS	nsubj	O
are	VBP	cop	O
among	IN	case	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	amod	O
anti-inflammatory	JJ	amod	O
and	CC	cc	O
immunosuppressive	JJ	conj	O
agents	NNS	ROOT	O
.	.	punct	O

They	PRP	nsubj	O
inhibit	VBP	ROOT	O
synthesis	NN	dobj	O
of	IN	case	O
almost	RB	advmod	O
all	DT	amod	O
known	JJ	amod	O
cytokines	NNS	nmod	B-protein
and	CC	cc	O
of	IN	case	O
several	JJ	amod	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
molecules	NNS	conj	I-protein
required	VBN	acl	O
for	IN	case	O
immune	JJ	amod	O
function	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	nsubjpass	O
underlying	VBG	acl	O
this	DT	det	O
activity	NN	dobj	O
has	VBZ	aux	O
been	VBN	auxpass	O
unclear.	NN	advmod	O
Here	RB	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
shown	VBN	conj	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
are	VBP	cop	O
potent	JJ	amod	O
inhibitors	NNS	ccomp	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
activation	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	O
and	CC	cc	O
cultured	VBN	amod	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

This	DT	det	O
inhibition	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	O
inhibitory	JJ	amod	O
protein	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
traps	VBZ	acl:relcl	O
activated	VBD	amod	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
in	IN	case	O
inactive	JJ	amod	B-protein
cytoplasmic	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

Because	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
activates	VBZ	advcl	O
many	JJ	amod	O
immunoregulatory	JJ	amod	B-DNA
genes	NNS	dobj	I-DNA
in	IN	case	O
response	NN	dep	O
to	TO	case	O
pro-inflammatory	JJ	amod	O
stimuli	NNS	nmod	O
,	,	punct	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
its	PRP$	nmod:poss	O
activity	NN	nmod	O
can	MD	aux	O
be	VB	cop	O
a	DT	det	O
major	JJ	amod	O
component	NN	ROOT	O
of	IN	case	O
the	DT	det	O
anti-inflammatory	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

Transcriptional	JJ	amod	O
repression	NN	ROOT	O
of	IN	case	O
the	DT	det	O
interleukin-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
by	IN	case	O
vitamin	NN	compound	O
D3	NN	nmod	O
:	:	punct	O
direct	JJ	amod	O
inhibition	NN	dep	O
of	IN	case	O
NFATp/AP-1	NN	compound	B-protein
complex	NN	compound	I-protein
formation	NN	nmod	O
by	IN	case	O
a	DT	det	O
nuclear	JJ	amod	B-protein
hormone	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

T-lymphocyte	NN	compound	O
proliferation	NN	nsubjpass	O
is	VBZ	auxpass	O
suppressed	VBN	ROOT	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
[	-LRB-	punct	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	appos	O
]	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
active	JJ	amod	O
metabolite	NN	nmod	O
of	IN	case	O
vitamin	NN	compound	O
D3	NN	nmod	O
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
interleukin	NN	nmod	O
2	CD	nummod	O
(	-LRB-	punct	O
IL-2	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
gamma	NN	compound	O
interferon	NN	conj	O
,	,	punct	O
and	CC	cc	O
granulocyte-macrophage	JJ	amod	O
colony-stimulating	JJ	amod	O
factor	NN	compound	O
mRNA	NN	compound	O
levels	NNS	conj	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	nmod:npmod	O
)	-RRB-	punct	O
2D3-mediated	JJ	dep	O
repression	NN	nsubj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	cop	O
cycloheximide	NN	nmod:npmod	O
resistant	JJ	ccomp	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
it	PRP	nsubj	O
is	VBZ	cop	O
a	DT	det	O
direct	JJ	amod	O
transcriptional	JJ	amod	O
repressive	JJ	amod	O
effect	NN	ccomp	O
on	IN	case	O
IL-2	NN	compound	B-protein
expression	NN	nmod	O
by	IN	case	O
the	DT	det	O
vitamin	NN	compound	B-protein
D3	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
VDR	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
therefore	RB	advmod	O
examined	VBD	ROOT	O
vitamin	NN	compound	O
D3-mediated	JJ	amod	O
repression	NN	dobj	O
of	IN	case	O
activated	VBN	amod	O
IL-2	NN	compound	B-protein
expression	NN	nmod	O
by	IN	mark	O
cotransfecting	VBG	advcl	O
Jurkat	NN	compound	B-cell_line
cells	NNS	dobj	I-cell_line
with	IN	case	O
IL-2	NN	compound	B-DNA
promoter/reporter	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
and	CC	cc	O
a	DT	det	O
VDR	NN	compound	B-DNA
overexpression	NN	compound	I-DNA
vector	NN	conj	I-DNA
and	CC	cc	O
by	IN	case	O
DNA	NN	compound	O
binding	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
delineated	VBD	ROOT	O
an	DT	det	O
element	NN	dobj	O
conferring	VBG	acl	O
both	CC	det	O
DNA	NN	compound	O
binding	NN	dobj	O
by	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	nmod:npmod	O
)	-RRB-	punct	O
2D3-mediated	JJ	amod	O
repression	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
to	TO	case	O
a	DT	det	O
short	JJ	amod	O
40-bp	JJ	amod	B-DNA
region	NN	nmod	I-DNA
encompassing	VBG	acl	O
an	DT	det	O
important	JJ	amod	O
positive	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
element	NN	dobj	I-DNA
,	,	punct	O
NF-AT-1	NN	appos	B-DNA
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
bound	VBN	acl:relcl	O
by	IN	case	O
a	DT	det	O
T-cell-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
NFATp	NN	appos	B-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
by	IN	case	O
AP-1	NN	conj	B-protein
.	.	punct	O

VDR	NN	compound	B-protein
DNA-binding	JJ	amod	I-protein
mutants	NNS	nsubj	I-protein
were	VBD	cop	O
unable	JJ	ROOT	O
to	TO	case	O
either	DT	dep	O
bind	VB	xcomp	O
to	TO	case	O
this	DT	det	O
element	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
or	CC	cc	O
repress	VB	conj	O
in	FW	compound	O
vivo	FW	advmod	O
;	:	punct	O
the	DT	det	O
VDR	NN	compound	B-protein
DNA-binding	JJ	amod	I-protein
domain	NN	dep	I-protein
alone	RB	advmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
bound	VBD	parataxis	O
the	DT	det	O
element	NN	dobj	O
but	CC	cc	O
also	RB	advmod	O
could	MD	aux	O
not	RB	neg	O
repress	VB	conj	O
IL-2	NN	compound	B-protein
expression	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
DNA	NN	compound	O
binding	NN	nsubj	O
by	IN	case	O
VDR	NN	nmod	B-protein
is	VBZ	cop	O
necessary	JJ	ccomp	O
but	CC	cc	O
not	RB	neg	O
sufficient	JJ	conj	O
to	TO	mark	O
mediate	VB	xcomp	O
IL-2	NN	compound	B-protein
repression	NN	dobj	O
.	.	punct	O

By	IN	prep	O
combining	VBG	pcomp	O
partially	RB	advmod	B-protein
purified	VBN	amod	I-protein
proteins	NNS	dobj	I-protein
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
the	DT	det	O
loss	NN	dobj	O
of	IN	case	O
the	DT	det	O
bound	VBN	amod	O
NFATp/AP-1-DNA	NN	compound	B-protein
complex	NN	nmod	I-protein
upon	IN	case	O
inclusion	NN	nmod	O
of	IN	case	O
VDR	NN	nmod	B-protein
or	CC	cc	O
VDR-retinoid	NN	compound	B-protein
X	NN	compound	I-protein
receptor	NN	conj	I-protein
.	.	punct	O

Order	NN	nsubj	O
of	IN	case	O
addition	NN	nmod	O
and	CC	cc	O
off-rate	JJ	amod	O
experiments	NNS	conj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
VDR-retinoid	NN	compound	B-protein
X	NN	compound	I-protein
receptor	NN	compound	I-protein
heterodimer	NN	nsubj	I-protein
blocks	VBZ	ccomp	O
NFATp/AP-1	NN	compound	B-protein
complex	NN	compound	I-protein
formation	NN	dobj	O
and	CC	cc	O
then	RB	advmod	O
stably	RB	advmod	O
associates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
NF-AT-1	NN	compound	B-DNA
element	NN	nmod	I-DNA
.	.	punct	O

This	DT	det	O
direct	JJ	amod	O
inhibition	NN	nsubj	O
by	IN	case	O
a	DT	det	O
nuclear	JJ	amod	O
hormone	NN	compound	O
receptor	NN	nmod	O
of	IN	case	O
transcriptional	JJ	amod	B-protein
activators	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
may	MD	aux	O
provide	VB	ROOT	O
a	DT	det	O
mechanistic	JJ	amod	O
explanation	NN	dobj	O
of	IN	mark	O
how	WRB	advmod	O
vitamin	NN	compound	O
derivatives	NNS	nsubj	O
can	MD	aux	O
act	VB	nmod	O
as	IN	case	O
potent	JJ	amod	O
immunosuppressive	JJ	amod	O
agents	NNS	nmod	O
.	.	punct	O

Tissue-specific	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
rabbit	NN	compound	B-DNA
15-lipoxygenase	NN	compound	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	B-DNA
silencer	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
15-lipoxygenase	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
lox	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
tissue-specific	JJ	amod	O
manner	NN	nmod	O
,	,	punct	O
predominantly	RB	advmod	O
in	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
also	RB	advmod	O
in	IN	case	O
airway	NN	compound	B-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
and	CC	cc	O
eosinophils	NNS	conj	B-cell_type
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
in	IN	case	O
this	DT	det	O
report	NN	nmod	O
that	IN	mark	O
the	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
DNA	NN	nsubj	I-DNA
of	IN	case	O
the	DT	det	O
15-lox	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
contains	VBZ	ccomp	O
sequences	NNS	dobj	O
which	WDT	nsubj	O
down-regulate	VBP	acl:relcl	O
its	PRP$	nmod:poss	O
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
non-erythroid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
two	CD	nummod	O
erythroid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

The	DT	det	O
element	NN	nsubj	O
has	VBZ	ROOT	O
characteristics	NNS	dobj	O
of	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	B-DNA
'silencer	NN	nmod	I-DNA
'	''	punct	I-DNA
since	IN	mark	O
it	PRP	nsubj	O
functions	VBZ	advcl	O
in	IN	prep	O
both	DT	det	O
orientations	NNS	pobj	O
.	.	punct	O

The	DT	det	O
main	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
silencer	NN	nmod	B-DNA
has	VBZ	aux	O
been	VBN	auxpass	O
mapped	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
first	JJ	amod	O
900	CD	nummod	O
bp	NN	nmod	O
of	IN	case	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
DNA	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
nine	CD	nummod	O
binding	VBG	amod	O
sites	NNS	dobj	O
for	IN	case	O
a	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	nmod	I-protein
present	JJ	amod	O
in	IN	case	O
non-	JJ	amod	O
erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

These	DT	det	O
binding	VBG	compound	O
sites	NNS	nsubj	O
have	VBP	ROOT	O
similar	JJ	amod	O
sequences	NNS	dobj	O
and	CC	cc	O
multiple	JJ	amod	O
copies	NNS	conj	O
of	IN	case	O
the	DT	det	O
binding	VBG	amod	B-DNA
sites	NNS	nmod	I-DNA
confer	VBP	conj	O
tissue-specific	JJ	amod	O
down-regulation	NN	dobj	O
when	WRB	advmod	O
attached	VBN	advcl	O
to	TO	case	O
a	DT	det	O
minimal	JJ	amod	B-DNA
lox	JJ	amod	I-DNA
promoter	NN	compound	I-DNA
fragment	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
DNA	NN	nsubj	I-DNA
also	RB	advmod	O
contains	VBZ	ROOT	O
a	DT	det	O
cluster	NN	dobj	O
of	IN	case	O
three	CD	nummod	O
binding	VBG	amod	B-DNA
sites	NNS	nmod	I-DNA
for	IN	case	O
the	DT	det	O
GATA	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Phosphorylation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
NFATp	NN	dep	B-protein
inhibits	VBZ	ROOT	O
its	PRP$	nmod:poss	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
cyclosporin	NN	compound	B-cell_line
A-treated	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
B	NN	compound	I-cell_line
and	CC	cc	O
T	NN	conj	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Cyclosporin	NN	compound	O
A	NN	nsubj	O
(	-LRB-	punct	O
CsA	NN	appos	O
)	-RRB-	punct	O
exerts	VBZ	ROOT	O
its	PRP$	nmod:poss	O
immunosuppressive	JJ	amod	O
effect	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
NFAT	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
thus	RB	advmod	O
preventing	VBG	advcl	O
transcriptional	JJ	amod	O
induction	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
cytokine	NN	compound	O
genes	NNS	nmod	O
.	.	punct	O

This	DT	det	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
largely	RB	advmod	O
mediated	VBN	xcomp	O
through	IN	case	O
inactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
phosphatase	NN	compound	O
calcineurin	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
inhibits	VBZ	acl:relcl	O
translocation	NN	dobj	O
of	IN	case	O
an	DT	det	O
NFAT	NN	compound	B-protein
component	NN	nmod	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
CsA	NN	compound	O
treatment	NN	nsubj	O
of	IN	case	O
Raji	NN	compound	B-cell_line
B	NN	nmod	I-cell_line
and	CC	cc	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
yields	VBZ	ccomp	O
a	DT	det	O
phosphorylated	JJ	amod	O
form	NN	dobj	O
of	IN	case	O
NFATp	NN	nmod	B-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
inhibited	VBN	acl:relcl	O
in	IN	case	O
DNA-binding	JJ	nmod	O
and	CC	cc	O
in	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	conj	O
to	TO	mark	O
form	VB	acl	O
an	DT	det	O
NFAT	NN	compound	B-protein
complex	NN	dobj	I-protein
with	IN	case	O
Fos	NN	nmod	B-protein
and	CC	cc	O
Jun	NN	conj	B-protein
.	.	punct	O

Immunoblot	NN	compound	O
analyses	NNS	nsubj	O
and	CC	cc	O
metabolic	JJ	amod	O
labeling	NN	conj	O
with	IN	prep	O
[	-LRB-	punct	O
32P	NN	pobj	O
]	-RRB-	punct	O
orthophosphate	NN	dep	O
show	VBP	ROOT	O
that	IN	mark	O
CsA	NN	nsubj	O
alters	VBZ	ccomp	O
NFATp	NN	compound	B-protein
migration	NN	dobj	O
on	IN	case	O
SDS-polyacrylamide	NN	compound	O
gel	NN	compound	O
electrophoresis	NN	nmod	O
by	IN	mark	O
increasing	VBG	advcl	O
its	PRP$	nmod:poss	O
phosphorylation	NN	compound	O
level	NN	dobj	O
without	IN	mark	O
affecting	VBG	advcl	O
subcellular	JJ	amod	O
distribution	NN	dobj	O
.	.	punct	O

Dephosphorylation	NN	nsubj	O
by	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
treatment	NN	nmod	O
with	IN	case	O
calcineurin	NN	nmod	B-protein
or	CC	cc	O
alkaline	NN	compound	B-protein
phosphatase	NN	conj	I-protein
restores	VBZ	ROOT	O
NFATp	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
and	CC	cc	O
its	PRP$	nmod:poss	O
ability	NN	conj	O
to	TO	mark	O
reconstitute	VB	acl	O
an	DT	det	O
NFAT	NN	compound	B-protein
complex	NN	dobj	I-protein
with	IN	case	O
Fos	NN	compound	B-protein
and	CC	cc	O
Jun	NN	conj	B-protein
proteins	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
point	VBP	ROOT	O
to	TO	case	O
a	DT	det	O
new	JJ	amod	O
mechanism	NN	nmod	O
for	IN	case	O
CsA-sensitive	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
NFATp	NN	nmod	B-protein
in	IN	case	O
which	WDT	nmod	O
dephosphorylation	NN	nsubj	O
is	VBZ	cop	O
critical	JJ	acl:relcl	O
for	IN	case	O
DNA	NN	compound	O
binding	NN	nmod	O
.	.	punct	O

Transcription	NN	compound	B-protein
factors	NNS	ROOT	I-protein
as	IN	case	O
targets	NNS	nmod	O
for	IN	case	O
oxidative	JJ	amod	O
signalling	NN	nmod	O
during	IN	case	O
lymphocyte	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
a	DT	det	O
requirement	NN	dobj	O
for	IN	case	O
oxidative	JJ	amod	O
events	NNS	nmod	O
during	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
entry	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
have	VBP	aux	O
hypothesised	VBN	conj	O
that	IN	mark	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	nsubj	O
may	MD	aux	O
act	VB	ccomp	O
as	IN	case	O
intracellular	JJ	amod	O
signalling	NN	amod	O
agents	NNS	nmod	O
during	IN	case	O
lymphocyte	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
cysteamine	NN	nsubjpass	O
,	,	punct	O
an	DT	det	O
aminothiol	NN	compound	O
compound	NN	appos	O
with	IN	case	O
antioxidant	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
further	RB	advmod	O
investigate	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
oxidative	JJ	amod	O
signalling	NN	nmod	O
during	IN	case	O
lymphocyte	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubjpass	O
of	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
with	IN	case	O
cysteamine	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
proliferation	NN	dobj	O
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
manner	NN	nmod	O
,	,	punct	O
with	IN	case	O
essentially	RB	advmod	O
complete	JJ	amod	O
inhibition	NN	nmod	O
occurring	VBG	acl	O
at	IN	case	O
a	DT	det	O
dose	NN	nmod	O
of	IN	case	O
400	CD	nummod	O
microM	NN	nmod	O
.	.	punct	O

This	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
limited	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
first	JJ	amod	O
2	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
mitogenic	JJ	amod	O
activation	NN	nmod	O
,	,	punct	O
localizing	VBG	xcomp	O
the	DT	det	O
time-frame	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
cysteamine	NN	nmod	O
to	TO	case	O
within	IN	case	O
the	DT	det	O
commitment	NN	compound	O
period	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
therefore	RB	advmod	O
was	VBD	ROOT	O
of	IN	prep	O
interest	NN	pobj	O
to	TO	aux	O
establish	VB	xcomp	O
which	WDT	mark	O
,	,	punct	O
if	IN	mark	O
any	DT	dep	O
,	,	punct	O
commitment	NN	compound	O
events	NNS	nsubjpass	O
were	VBD	auxpass	O
affected	VBN	ccomp	O
by	IN	case	O
oxidative	JJ	amod	O
signalling	NN	nmod	O
during	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
entry	NN	nmod	O
.	.	punct	O

Taking	VBG	advcl	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	dobj	I-DNA
as	IN	case	O
a	DT	det	O
candidate	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
cysteamine	NN	compound	O
treatment	NN	nmod	O
on	IN	case	O
early	JJ	amod	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
during	IN	case	O
lymphocyte	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
on	IN	case	O
the	DT	det	O
activity	NN	conj	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
AP-1	NN	dep	B-protein
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
,	,	punct	O
NF-AT	NN	conj	B-protein
and	CC	cc	O
Oct1	NN	conj	B-protein
,	,	punct	O
whose	WP$	nmod:poss	O
functions	NNS	nsubjpass	O
are	VBP	auxpass	O
required	VBN	acl:relcl	O
for	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-protein
mRNA	NN	nmod	O
.	.	punct	O

Cysteamine	NN	compound	O
treatment	NN	nsubj	O
inhibited	VBD	ROOT	O
both	CC	cc:preconj	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
and	CC	cc	O
secretion	NN	conj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
into	IN	case	O
the	DT	det	O
culture	NN	compound	O
medium	NN	nmod	O
.	.	punct	O

The	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
cysteamine	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
mediated	VBN	ROOT	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
by	IN	case	O
an	DT	det	O
effect	NN	nmod	O
on	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
function	NN	nmod	O
,	,	punct	O
as	IN	mark	O
the	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
activities	NNS	nsubjpass	O
of	IN	case	O
AP-1	NN	nmod	B-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
extracted	VBN	acl	O
from	IN	case	O
mitogen-stimulated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	auxpass	O
significantly	RB	advmod	O
inhibited	VBN	advcl	O
by	IN	case	O
cysteamine	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
Oct1	NN	compound	O
and	CC	cc	O
NF-AT	NN	conj	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
affected	VBN	ROOT	O
by	IN	case	O
cysteamine	NN	compound	O
treatment	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
oxidative	JJ	amod	O
signalling	NN	amod	O
processes	NNS	nsubj	O
operate	VBP	ccomp	O
in	IN	case	O
a	DT	det	O
selective	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

The	DT	det	O
identification	NN	nsubj	O
of	IN	case	O
regulatory	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
as	IN	case	O
molecular	JJ	amod	O
targets	NNS	nmod	O
for	IN	case	O
oxidative	JJ	amod	O
signalling	NN	nmod	O
provides	VBZ	ROOT	O
further	JJ	amod	O
evidence	NN	dobj	O
to	TO	mark	O
implicate	VB	acl	O
oxidative	JJ	amod	O
signalling	NN	dobj	O
as	IN	mark	O
being	VBG	auxpass	O
intimately	RB	advmod	O
involved	VBN	advcl	O
in	IN	case	O
the	DT	det	O
G0	NN	compound	O
to	TO	case	O
G1	NN	compound	O
phase	NN	compound	O
transition	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Sex	NN	compound	O
and	CC	cc	O
age	NN	conj	O
distribution	NN	ROOT	O
of	IN	case	O
1	CD	nummod	B-protein
,	,	punct	I-protein
25	CD	conj	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
normal	JJ	amod	O
human	JJ	amod	O
subjects	NNS	nmod	O
.	.	punct	O

Specific	JJ	amod	O
receptors	NNS	nsubjpass	O
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
Dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
tried	VBN	ROOT	O
to	TO	aux	O
find	VB	xcomp	O
out	RP	prt	O
whether	IN	mark	O
these	DT	det	O
receptors	NNS	nsubj	O
could	MD	aux	O
show	VB	ccomp	O
any	DT	det	O
difference	NN	dobj	O
in	IN	case	O
sex	NN	intj	O
or	CC	cc	O
age	NN	conj	O
distribution	NN	nmod	O
.	.	punct	O

Twenty	CD	nummod	O
two	CD	nummod	O
healthy	JJ	amod	O
men	NNS	nsubjpass	O
aged	JJ	amod	O
21-66	CD	nummod	O
yr	NN	dep	O
(	-LRB-	punct	O
mean	NN	dep	O
+/-	CC	cc	O
SD	NN	conj	O
41.0	CD	dep	O
+/-	CC	cc	O
13.6	CD	conj	O
)	-RRB-	punct	O
and	CC	cc	O
nineteen	CD	nummod	O
healthy	JJ	amod	O
women	NNS	conj	O
aged	JJ	amod	O
22-60	CD	nummod	O
yr	NN	dep	O
(	-LRB-	punct	O
38.9	CD	dep	O
+/-	CC	cc	O
13.9	CD	conj	O
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
mean	NN	compound	O
dissociation	NN	compound	O
constant	NN	nsubj	O
(	-LRB-	punct	O
Kd	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
both	DT	det	O
sexes	NNS	nmod	O
(	-LRB-	punct	O
1.35	CD	nummod	O
+/-	CC	cc	O
0.70	CD	conj	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-10	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
in	IN	case	O
males	NNS	nmod	O
,	,	punct	O
1.13	CD	nummod	O
+/-	CC	cc	O
0.66	CD	conj	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-10	CD	dep	O
)	-RRB-	punct	O
M	NN	nmod	O
in	IN	case	O
females	NNS	nmod	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
concentration	NN	nsubj	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
(	-LRB-	punct	O
Nmax	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	conj	O
in	IN	case	O
females	NNS	nmod	O
(	-LRB-	punct	O
2.32	CD	nummod	O
+/-	CC	cc	O
0.92	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	dep	O
)	-RRB-	punct	O
PBMC	NN	dep	B-cell_type
vs	CC	cc	O
4.43	CD	nummod	O
+/-	CC	cc	O
1.38	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	appos	O
)	-RRB-	punct	O
PBMC	NN	conj	B-cell_type
in	IN	case	O
males	NNS	nmod	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0.0001	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Neither	CC	cc:preconj	O
Kd	NN	nsubjpass	O
nor	CC	cc	O
Nmax	NN	conj	O
were	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
age	NN	nmod	O
.	.	punct	O

No	DT	neg	O
difference	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
pre	JJ	nmod	O
and	CC	cc	O
postmenopausal	JJ	conj	O
women	NNS	dep	O
.	.	punct	O

Further	JJ	amod	O
studies	NNS	nsubjpass	O
are	VBP	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
elucidate	VB	xcomp	O
if	IN	mark	O
this	DT	det	O
sex	NN	compound	O
difference	NN	nsubj	O
in	IN	case	O
PBMC	NN	compound	B-protein
receptors	NNS	nmod	I-protein
for	IN	case	O
1.25	CD	nummod	O
Dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
is	VBZ	cop	O
of	IN	case	O
any	DT	det	O
pathophysiological	JJ	amod	O
relevance	NN	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
Id2	NN	compound	O
and	CC	cc	O
Id3	NN	conj	O
mRNA	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Helix-loop-helix	JJ	amod	B-protein
(	-LRB-	punct	I-protein
HLH	JJ	appos	I-protein
)	-RRB-	punct	I-protein
transcription	NN	compound	I-protein
factors	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
cellular	JJ	amod	O
growth	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

The	DT	det	O
Id	NN	compound	B-protein
(	-LRB-	punct	O
inhibitor	NN	nsubj	O
of	IN	case	O
DNA	NN	compound	O
binding	NN	compound	O
and	CC	cc	O
differentiation	NN	conj	O
)	-RRB-	punct	O
HLH	JJ	compound	B-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
in	IN	case	O
a	DT	det	O
dominantly	RB	advmod	O
negative	JJ	amod	O
fashion	NN	nmod	O
,	,	punct	O
regulate	VBP	ROOT	O
transcriptional	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
basic	JJ	amod	B-protein
HLH	JJ	compound	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
by	IN	case	O
northern	JJ	amod	O
hybridization	NN	nmod	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
Id2	NN	compound	B-RNA
and	CC	cc	I-RNA
Id3	NN	conj	I-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
human	JJ	amod	B-cell_line
leukemia/lymphoma	JJ	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
patient	NN	compound	O
samples	NNS	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
resting	VBG	amod	O
and	CC	cc	O
activated	VBN	conj	B-cell_line
normal	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
lymphocytes	NNS	conj	I-cell_line
from	IN	case	O
peripheral	JJ	amod	O
blood	NN	nmod	O
(	-LRB-	punct	O
PBL	NN	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
Id2	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
abundantly	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
5/12	CD	compound	B-cell_line
T-cell	NN	nmod	I-cell_line
and	CC	cc	O
3/4	CD	nummod	B-cell_line
B-cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
,	,	punct	O
and	CC	cc	O
Id3	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
detected	VBN	conj	O
in	IN	case	O
4/12	CD	nummod	B-cell_line
T-cell	NN	nmod	I-cell_line
and	CC	cc	O
3/4	CD	nummod	B-cell_line
B-cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
Id2	NN	nsubjpass	B-RNA
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
Id3	NN	conj	B-RNA
,	,	punct	O
mRNA	NN	nsubjpass	O
was	VBD	auxpass	O
strongly	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
4/5	CD	nummod	B-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
infected	VBN	acl	O
with	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
(	-LRB-	punct	O
HTLV-I	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
ATL-1k	NN	dep	B-cell_line
,	,	punct	O
MT-2	NN	conj	B-cell_line
,	,	punct	O
S-LB1	NN	appos	B-cell_line
)	-RRB-	punct	O
and	CC	cc	O
type	NN	conj	O
II	CD	nummod	O
(	-LRB-	punct	O
Mo	NN	appos	B-cell_line
)	-RRB-	punct	O
.	.	punct	O

Another	DT	det	O
unexpected	JJ	amod	O
finding	NN	nsubj	O
was	VBD	ROOT	O
that	IN	mark	O
T-cell	NN	compound	O
leukemias	NNS	nsubj	O
and	CC	cc	O
T-cell	NN	compound	B-cell_line
lines	NNS	conj	I-cell_line
often	RB	advmod	O
expressed	VBD	ccomp	O
either	CC	cc:preconj	O
Id2	NN	compound	B-RNA
or	CC	cc	O
Id3	NN	conj	B-RNA
mRNA	NN	dobj	I-RNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
resting	VBG	amod	B-cell_type
PBL	NN	nsubj	I-cell_type
constitutively	RB	advmod	O
expressed	VBD	ROOT	O
prominent	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
Id2	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
Id3	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
.	.	punct	O

Upon	IN	case	O
PHA	NN	compound	B-protein
-stimulation	NN	nmod	O
,	,	punct	O
Id2	NN	compound	B-protein
expression	NN	nsubj	O
decreased	VBD	ROOT	O
and	CC	cc	O
Id3	NN	conj	B-protein
levels	NNS	nsubj	O
increased	VBD	conj	O
with	IN	case	O
biphasic	JJ	amod	O
kinetics	NNS	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
revealed	VBD	ROOT	O
three	CD	nummod	O
unexpected	JJ	amod	O
findings	NNS	dobj	O
which	WDT	nsubj	O
require	VBP	acl:relcl	O
further	JJ	amod	O
analysis	NN	dobj	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
expression	NN	nsubjpass	O
of	IN	case	O
Id2	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
is	VBZ	auxpass	O
often	RB	advmod	O
associated	VBN	parataxis	O
with	IN	case	O
lymphocytic	JJ	amod	O
transformation	NN	nmod	O
by	IN	case	O
HTLV-I	NN	nmod	O
or	CC	cc	O
-II	NN	conj	O
;	:	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
T-cells	NNS	nsubj	O
usually	RB	advmod	O
express	VBP	parataxis	O
either	CC	cc:preconj	O
Id2	NN	compound	B-protein
or	CC	cc	O
Id3	NN	conj	B-RNA
mRNA	NN	dobj	I-RNA
,	,	punct	O
but	CC	cc	O
B-cells	NNS	nsubj	O
often	RB	advmod	O
express	VBP	conj	O
both	CC	advmod	O
simultaneously	RB	advmod	O
;	:	punct	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
non-dividing	JJ	amod	O
,	,	punct	O
normal	JJ	dep	O
PBL	NN	nsubj	B-cell_type
express	VBP	parataxis	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
Id2	NN	nmod	B-protein
and	CC	cc	O
no	DT	neg	O
Id3	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
;	:	punct	O
and	CC	cc	O
with	IN	case	O
the	DT	det	O
onset	NN	conj	O
of	IN	case	O
cellular	JJ	amod	O
proliferation	NN	nmod	O
,	,	punct	O
levels	NNS	dep	O
of	IN	case	O
Id2	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
decrease	VBP	nmod	O
while	IN	mark	O
levels	NNS	nsubj	O
of	IN	case	O
Id3	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
increase	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
regulation	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
these	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
genes	NNS	nmod	B-DNA
is	VBZ	cop	O
disparate	JJ	ccomp	O
.	.	punct	O

Salicylates	NNS	nsubj	O
inhibit	VBP	ROOT	O
lipopolysaccharide-induced	JJ	amod	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
tissue	NN	compound	O
factor	NN	compound	O
gene	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Binding	NN	nsubj	O
of	IN	case	O
plasma	NN	compound	B-protein
Factor	NN	compound	I-protein
VII/VIIa	NN	nmod	I-protein
to	TO	case	O
the	DT	det	O
tissue	NN	compound	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TF	NN	compound	I-protein
)	-RRB-	punct	I-protein
receptor	NN	nmod	I-protein
initiates	VBZ	ROOT	O
the	DT	det	O
coagulation	NN	compound	B-protein
protease	NN	compound	I-protein
cascades	NNS	dobj	O
.	.	punct	O

TF	NN	compound	O
expression	NN	nsubjpass	O
by	IN	case	O
circulating	VBG	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
thrombotic	JJ	amod	O
and	CC	cc	O
inflammatory	JJ	conj	O
complications	NNS	nmod	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
diseases	NNS	nmod	O
.	.	punct	O

Transcriptional	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
TF	NN	compound	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
exposed	VBN	acl	O
to	TO	case	O
bacterial	JJ	amod	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
binding	NN	nmod	O
of	IN	case	O
c-Rel/p65	NN	compound	B-protein
heterodimers	NNS	nmod	I-protein
to	TO	case	O
a	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
site	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
TF	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
family	NN	nsubj	O
of	IN	case	O
anti-inflammatory	JJ	amod	O
agents	NNS	nmod	O
,	,	punct	O
known	VBN	acl	O
as	IN	case	O
the	DT	det	O
salicylates	NNS	nmod	O
,	,	punct	O
inhibited	VBD	ccomp	O
LPS	NN	compound	O
induction	NN	dobj	O
of	IN	case	O
TF	NN	compound	O
activity	NN	nmod	O
and	CC	cc	O
TF	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
and	CC	cc	O
monocytic	JJ	amod	B-cell_line
THP-1	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
at	IN	case	O
clinically	RB	advmod	O
relevant	JJ	amod	O
doses	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
sodium	NN	compound	O
salicylate	NN	nsubj	O
blocked	VBD	ROOT	O
the	DT	det	O
LPS-induced	JJ	amod	O
proteolytic	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
prevented	VBD	acl:relcl	O
the	DT	det	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
c-Rel/p65	NN	compound	B-protein
heterodimers	NNS	nmod	I-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
two	CD	nummod	O
other	JJ	amod	O
nonsteroidal	JJ	amod	O
anti-inflammatory	JJ	amod	O
drugs	NNS	nsubj	O
,	,	punct	O
ibuprofen	NN	appos	O
and	CC	cc	O
indomethacin	NN	conj	O
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
inhibit	VB	ROOT	O
LPS	NN	compound	O
induction	NN	dobj	O
of	IN	case	O
the	DT	det	O
TF	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
salicylates	NNS	nsubj	O
inhibited	VBD	ccomp	O
LPS	NN	compound	O
induction	NN	dobj	O
of	IN	case	O
TF	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	mark	O
preventing	VBG	advcl	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
c-Rel/p65	NN	compound	B-protein
heterodimers	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
benefits	NNS	nsubj	O
of	IN	case	O
salicylates	NNS	nmod	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
diseases	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
atherosclerosis	NN	nmod	O
and	CC	cc	O
rheumatoid	JJ	amod	O
arthritis	NN	conj	O
,	,	punct	O
may	MD	aux	O
be	VB	cop	O
related	JJ	ROOT	O
to	TO	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
reduce	VB	acl	O
monocyte	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
signal	NN	compound	O
transducer	NN	nmod	O
and	CC	cc	O
transcription	NN	compound	O
(	-LRB-	punct	O
STAT	NN	appos	B-protein
)	-RRB-	punct	O
signaling	NN	compound	O
pathway	NN	conj	O
in	IN	case	O
a	DT	det	O
primary	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
response	NN	nmod	O
.	.	punct	O

Critical	JJ	amod	O
role	NN	ROOT	O
for	IN	case	O
IL-6	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nsubjpass	O
is	VBZ	auxpass	O
initiated	VBN	ROOT	O
by	IN	case	O
interaction	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
Ags	NNS	nmod	B-protein
with	IN	case	O
TCR	NN	nmod	B-protein
,	,	punct	O
followed	VBN	advcl	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	O
biochemical	JJ	amod	O
events	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

The	DT	det	O
activation	NN	nsubjpass	O
of	IN	case	O
signal	NN	compound	O
transducer	NN	compound	O
and	CC	cc	O
activator	NN	compound	O
of	IN	amod	O
transcription	NN	compound	B-protein
(	-LRB-	punct	I-protein
STAT	NN	appos	I-protein
)	-RRB-	punct	I-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
a	DT	det	O
primary	JJ	amod	O
TCR	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
have	VBP	aux	O
been	VBN	auxpass	O
explored	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
purified	VBN	amod	B-cell_type
human	JJ	amod	I-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
nuclear	JJ	amod	B-protein
STAT	NN	compound	I-protein
proteins	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
activated	VBN	ROOT	O
approximately	RB	advmod	O
3	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
activation	NN	nmod	O
by	IN	case	O
cross-linked	JJ	amod	O
anti-CD3	JJ	amod	B-protein
Abs	NNS	nmod	I-protein
.	.	punct	O

These	DT	det	O
STAT	NN	compound	B-protein
proteins	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	mark	O
using	VBG	advcl	O
the	DT	det	O
IFN-gamma-activated	JJ	amod	B-DNA
sequence	NN	dobj	I-DNA
(	-LRB-	punct	O
GAS	NN	appos	B-DNA
)	-RRB-	punct	O
and	CC	cc	O
related	JJ	amod	O
oligonucleotides	NNS	conj	O
as	IN	case	O
probes	NNS	nmod	O
in	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
with	IN	case	O
anti-STAT	NN	compound	B-protein
Abs	NNS	nmod	I-protein
indicated	VBD	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
contained	VBD	ccomp	O
STAT-3	NN	dobj	B-protein
and	CC	cc	O
additional	JJ	amod	O
proteins	NNS	conj	O
crossreactive	JJ	amod	O
with	IN	case	O
the	DT	det	O
STAT	NN	compound	B-protein
family	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
STAT	NN	compound	B-protein
activity	NN	nmod	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
completely	RB	advmod	O
by	IN	case	O
pretreatment	NN	nmod	O
with	IN	case	O
either	CC	cc:preconj	O
cycloheximide	NN	nmod	O
or	CC	cc	O
cyclosporin	NN	compound	O
A	NN	conj	O
,	,	punct	O
thus	RB	advmod	O
indicating	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
induction	NN	nsubj	O
was	VBD	cop	O
due	JJ	case	O
to	TO	case	O
a	DT	det	O
secondary	JJ	amod	B-protein
factor	NN	ccomp	I-protein
produced	VBN	acl	O
by	IN	case	O
the	DT	det	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

As	IN	mark	O
neutralizing	VBG	csubj	B-protein
anti-IL-6	JJ	amod	I-protein
Abs	NNS	dobj	I-protein
effectively	RB	advmod	O
down-regulated	VBD	advcl	O
the	DT	det	O
early	JJ	amod	O
induction	NN	dobj	O
of	IN	case	O
STAT	NN	compound	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
as	IN	advmod	O
exogenously	RB	advmod	O
added	VBN	amod	O
IL-6	NN	nsubj	B-protein
rapidly	RB	advmod	O
activated	VBD	conj	O
DNA	NN	compound	O
binding	NN	dobj	O
similar	JJ	amod	O
to	TO	case	O
TCR	NN	compound	B-protein
-mediated	JJ	amod	O
bindings	NNS	nmod	O
,	,	punct	O
it	PRP	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
IL-6	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
factor	NN	ccomp	O
responsible	JJ	amod	O
for	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
STAT	NN	compound	B-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
a	DT	det	O
primary	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
response	NN	nmod	O
.	.	punct	O

The	DT	det	O
normal	JJ	amod	O
cell	NN	compound	O
cycle	NN	compound	O
activation	NN	compound	O
program	NN	nsubjpass	O
is	VBZ	auxpass	O
exploited	VBN	ROOT	O
during	IN	case	O
the	DT	det	O
infection	NN	nmod	O
of	IN	case	O
quiescent	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
by	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
.	.	punct	O

B	NN	compound	B-cell_type
lymphocytes	NNS	nsubjpass	I-cell_type
in	IN	case	O
the	DT	det	O
peripheral	JJ	amod	O
circulation	NN	nmod	O
are	VBP	auxpass	O
maintained	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
non-proliferative	JJ	amod	O
state	NN	nmod	O
.	.	punct	O

Antigen	NN	compound	O
recognition	NN	nsubj	O
stimulates	VBZ	ROOT	O
limited	JJ	amod	O
proliferation	NN	dobj	O
,	,	punct	O
whereas	IN	mark	O
infection	NN	nsubj	O
with	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
results	VBZ	advcl	O
in	IN	case	O
continual	JJ	amod	O
proliferation	NN	nmod	O
and	CC	cc	O
the	DT	det	O
outgrowth	NN	conj	O
of	IN	case	O
immortal	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Because	IN	mark	O
it	PRP	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
clear	JJ	advcl	O
at	IN	case	O
which	WDT	det	O
point	NN	dep	O
in	IN	case	O
cell	NN	compound	O
cycle	NN	nmod	O
the	DT	det	O
peripheral	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
arrested	VBN	advcl	O
,	,	punct	O
we	PRP	nsubj	O
characterized	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
cell	NN	compound	B-DNA
cycle-associated	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
quiescent	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
stimulated	VBN	conj	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
four	CD	nummod	O
cell	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
cdc-2	NN	appos	B-DNA
,	,	punct	O
cyclin	NN	compound	B-DNA
E	NN	conj	I-DNA
,	,	punct	O
CD23	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
cyclin	NN	compound	B-DNA
D2	NN	conj	I-DNA
,	,	punct	O
are	VBP	auxpass	O
up-regulated	VBN	ccomp	O
approximately	RB	advmod	O
100-fold	RB	advmod	O
as	IN	case	O
a	DT	det	O
result	NN	nmod	O
of	IN	case	O
EBV-mediated	JJ	amod	O
immortalization	NN	nmod	O
.	.	punct	O

Because	IN	mark	O
these	DT	det	O
genes	NNS	nsubj	O
play	VBP	advcl	O
a	DT	det	O
positive	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
regulatory	JJ	amod	O
switch	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	mark	O
controlling	VBG	xcomp	O
entry	NN	dobj	O
into	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
.	.	punct	O

Transient	JJ	amod	O
stimulation	NN	nsubj	O
of	IN	case	O
quiescent	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
with	IN	case	O
either	CC	cc:preconj	O
a	DT	det	O
cocktail	NN	nmod	O
of	IN	case	O
anti-CD40	NN	nmod	B-protein
,	,	punct	O
anti-IgM	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL4	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
EBV	NN	conj	O
results	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
rapid	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
same	JJ	amod	O
four	CD	nummod	O
genes	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
,	,	punct	O
after	IN	case	O
infection	NN	nmod	O
,	,	punct	O
EBV	NN	nsubj	O
exploits	VBZ	ccomp	O
the	DT	det	O
normal	JJ	amod	O
program	NN	dobj	O
of	IN	case	O
B-lymphocyte	NN	compound	B-cell_type
cell	NN	compound	O
cycle	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
chemokine	NN	compound	B-protein
receptor	NN	nmod	I-protein
BLR2/EBI1	NN	dep	B-protein
is	VBZ	auxpass	O
specifically	RB	advmod	O
transactivated	VBN	ROOT	O
by	IN	case	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
nuclear	JJ	amod	I-protein
antigen	NN	nmod	I-protein
2	CD	nummod	I-protein
.	.	punct	O

In	IN	case	O
our	PRP$	nmod:poss	O
attempt	NN	nmod	O
to	TO	mark	O
identify	VB	acl	O
chemokine	NN	compound	B-protein
receptors	NNS	dobj	I-protein
that	WDT	nsubj	O
are	VBP	cop	O
related	JJ	acl:relcl	O
to	TO	case	O
Burkitt	NN	nmod:poss	B-protein
's	POS	case	I-protein
lymphoma	NN	compound	I-protein
receptor	NN	nmod	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
BLR1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
are	VBP	auxpass	O
expressed	VBN	conj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
we	PRP	nsubj	O
used	VBD	ROOT	O
RT-PCR	NN	dobj	O
resulting	VBG	acl	O
in	IN	case	O
the	DT	det	O
isolation	NN	nmod	O
of	IN	case	O
a	DT	det	O
cDNA	NN	nmod	O
encoding	VBG	acl	O
a	DT	det	O
seven	CD	nummod	B-protein
transmembrane	NN	compound	I-protein
receptor	NN	dobj	I-protein
termed	VBN	acl	O
BLR2	NN	xcomp	B-protein
.	.	punct	O

The	DT	det	O
protein	NN	nsubj	O
shows	VBZ	ROOT	O
significant	JJ	amod	O
sequence	NN	compound	O
similarities	NNS	dobj	O
to	TO	case	O
the	DT	det	O
family	NN	nmod	O
of	IN	case	O
G-protein	NN	compound	B-protein
coupled	JJ	amod	I-protein
chemokine	NN	compound	I-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
turned	VBD	conj	O
out	RP	advmod	O
to	TO	mark	O
be	VB	cop	O
identical	JJ	xcomp	O
to	TO	case	O
the	DT	det	O
recently	RB	advmod	O
described	VBN	amod	O
receptor	NN	compound	B-protein
EBI1	NN	nmod	I-protein
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
BLR2	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
could	MD	aux	O
be	VB	auxpass	O
highly	RB	advmod	O
stimulated	VBN	ccomp	O
in	IN	case	O
mitogen-	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
anti-CD3-treated	JJ	conj	I-cell_line
peripheral	JJ	amod	I-cell_line
blood	NN	compound	I-cell_line
lymphocytes	NNS	dep	I-cell_line
.	.	punct	O

BLR2-specific	JJ	amod	B-RNA
mRNA	NN	nsubjpass	I-RNA
could	MD	aux	O
be	VB	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
Epstein-Barr	JJ	amod	B-cell_line
virus	NN	compound	I-cell_line
positive	JJ	amod	I-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
transcription	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
BLR2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
could	MD	aux	O
be	VB	auxpass	O
specifically	RB	advmod	O
induced	VBN	ccomp	O
in	IN	case	O
Epstein-Barr	JJ	amod	B-cell_line
virus	NN	compound	I-cell_line
negative	JJ	amod	I-cell_line
BL	NN	compound	I-cell_line
41	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
via	IN	case	O
estrogen-mediated	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
nuclear	JJ	amod	I-protein
antigen	NN	nmod	I-protein
2	CD	nummod	I-protein
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	appos	O
of	IN	case	O
viral	JJ	amod	B-DNA
and	CC	cc	I-DNA
cellular	JJ	conj	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
immortalized	VBN	amod	B-cell_line
B	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
an	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
BLR2	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
migration	NN	nmod	O
in	IN	case	O
activated	VBN	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
viral	JJ	amod	O
pathogenesis	NN	conj	O
.	.	punct	O

A	DT	det	O
central	JJ	amod	O
role	NN	ROOT	O
for	IN	case	O
a	DT	det	O
single	JJ	amod	B-DNA
c-Myb	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
in	IN	case	O
a	DT	det	O
thymic	JJ	amod	B-DNA
locus	NN	compound	I-DNA
control	NN	compound	I-DNA
region	NN	nmod	I-DNA
.	.	punct	O

Locus	NN	compound	B-DNA
control	NN	compound	I-DNA
regions	NNS	nsubj	I-DNA
(	-LRB-	punct	O
LCRs	NNS	appos	B-DNA
)	-RRB-	punct	O
are	VBP	cop	O
powerful	JJ	amod	O
assemblies	NNS	ROOT	O
of	IN	case	O
cis	NN	compound	B-DNA
elements	NNS	nmod	I-DNA
that	WDT	nsubj	O
organize	VBP	acl:relcl	O
the	DT	det	O
actions	NNS	dobj	O
of	IN	case	O
cell-type-specific	JJ	amod	B-protein
trans-acting	JJ	amod	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

A	DT	det	O
2.3-kb	JJ	amod	B-protein
LCR	NN	nsubjpass	I-protein
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
adenosine	NN	compound	I-DNA
deaminase	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
ADA	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	compound	I-DNA
first	JJ	amod	I-DNA
intron	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
controls	VBZ	acl:relcl	O
expression	NN	dobj	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
,	,	punct	O
is	VBZ	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
a	DT	det	O
200-bp	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
domain	NN	nmod	I-DNA
and	CC	cc	O
extended	VBD	conj	O
flanking	JJ	amod	O
sequences	NNS	dobj	O
that	WDT	nsubj	O
facilitate	VBP	acl:relcl	O
activation	NN	dobj	O
from	IN	case	O
within	IN	case	O
chromatin	NN	nmod	B-DNA
.	.	punct	O

Prior	JJ	amod	O
analyses	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
enhancer	NN	nsubj	B-DNA
contains	VBZ	ccomp	O
a	DT	det	O
28-bp	JJ	amod	B-DNA
core	NN	compound	I-DNA
region	NN	dobj	I-DNA
and	CC	cc	O
local	JJ	amod	O
adjacent	JJ	amod	O
augmentative	JJ	amod	O
cis	NN	compound	B-DNA
elements	NNS	conj	I-DNA
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
core	NN	nsubj	O
contains	VBZ	ccomp	O
a	DT	det	O
single	JJ	amod	O
critical	JJ	amod	O
c-Myb	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
.	.	punct	O

In	IN	case	O
both	DT	cc:preconj	O
transiently	RB	advmod	B-cell_line
cotransfected	VBN	amod	I-cell_line
human	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
stable	JJ	amod	O
chromatin-integrated	JJ	amod	B-cell_line
yeast	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
c-Myb	NN	nsubj	B-protein
strongly	RB	advmod	O
transactivated	VBD	ROOT	B-DNA
reporter	NN	compound	I-DNA
constructs	NNS	dobj	I-DNA
that	WDT	nsubj	O
contained	VBD	acl:relcl	O
polymerized	VBN	amod	B-DNA
core	NN	compound	I-DNA
sequences	NNS	dobj	I-DNA
.	.	punct	O

c-Myb	NN	compound	B-protein
protein	NN	nsubj	I-protein
was	VBD	cop	O
strongly	RB	advmod	O
evident	JJ	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphoblasts	NNS	nmod	I-cell_type
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
enhancer	NN	nsubj	B-DNA
was	VBD	cop	O
active	JJ	acl:relcl	O
and	CC	cc	O
was	VBD	aux	O
localized	JJ	conj	O
within	IN	case	O
discrete	JJ	amod	O
nuclear	JJ	amod	O
structures	NNS	nmod	O
.	.	punct	O

Fetal	JJ	amod	O
murine	JJ	amod	O
thymus	NN	nsubj	O
exhibited	VBD	ROOT	O
a	DT	det	O
striking	JJ	amod	O
concordance	NN	dobj	O
of	IN	case	O
endogenous	JJ	amod	O
c-myb	NN	compound	B-DNA
expression	NN	nmod	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
mouse	NN	compound	B-DNA
ADA	NN	nmod	I-DNA
and	CC	cc	O
human	JJ	amod	B-DNA
ADA	NN	compound	I-DNA
LCR	NN	compound	I-DNA
-directed	JJ	amod	O
transgene	NN	compound	O
expression	NN	conj	O
.	.	punct	O

Point	NN	compound	O
mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
c-Myb	NN	compound	B-DNA
site	NN	nmod	I-DNA
within	IN	case	O
the	DT	det	O
intact	JJ	amod	O
2.3-kb	JJ	amod	B-protein
LCR	NN	nmod	I-protein
severely	RB	advmod	O
attenuated	VBD	ROOT	O
enhancer	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
transfections	NNS	nmod	O
and	CC	cc	O
LCR	NN	compound	B-DNA
activity	NN	conj	O
in	IN	case	O
transgenic	JJ	amod	B-cell_line
thymocytes	NNS	nmod	I-cell_line
.	.	punct	O

Within	IN	case	O
the	DT	det	O
context	NN	nmod	O
of	IN	case	O
a	DT	det	O
complex	JJ	amod	B-DNA
enhancer	NN	nmod	I-DNA
and	CC	cc	O
LCR	NN	conj	B-DNA
,	,	punct	O
c-Myb	NN	nsubj	B-protein
can	MD	aux	O
act	VB	ROOT	O
as	IN	case	O
an	DT	det	O
organizer	NN	nmod	O
of	IN	case	O
thymocyte-specific	JJ	amod	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
via	IN	case	O
a	DT	det	O
single	JJ	amod	O
binding	VBG	amod	O
site	NN	nmod	O
.	.	punct	O

A	DT	det	O
regulatory	JJ	amod	B-DNA
element	NN	nsubj	I-DNA
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
interleukin	NN	compound	I-DNA
2	CD	nummod	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
is	VBZ	cop	O
a	DT	det	O
binding	VBG	amod	B-DNA
site	NN	ROOT	I-DNA
for	IN	case	O
the	DT	det	O
zinc	NN	compound	B-protein
finger	NN	compound	I-protein
proteins	NNS	nmod	I-protein
Sp1	NN	dep	B-protein
and	CC	cc	O
EGR-1	NN	conj	B-protein
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
interleukin	NN	compound	B-DNA
2	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
IL-2	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
after	IN	case	O
antigen	NN	compound	O
recognition	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	O
event	NN	ROOT	O
for	IN	case	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	nmod	O
and	CC	cc	O
effector	NN	compound	O
function	NN	conj	O
.	.	punct	O

Prior	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
several	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
stimulated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
regulatory	JJ	amod	B-DNA
element	NN	dobj	I-DNA
within	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
located	JJ	amod	O
immediately	RB	advmod	O
upstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-DNA
factor	NN	compound	I-DNA
of	IN	amod	I-DNA
activated	VBN	amod	I-DNA
T	NN	compound	I-DNA
cell	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
NFAT	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
domain	NN	nmod	I-DNA
.	.	punct	O

This	DT	det	O
region	NN	nsubj	O
(	-LRB-	punct	O
termed	VBN	acl	O
the	DT	det	O
zinc	NN	compound	B-DNA
finger	NN	compound	I-DNA
protein	NN	compound	I-DNA
binding	NN	compound	I-DNA
region	NN	xcomp	I-DNA
(	-LRB-	punct	O
ZIP	NN	appos	B-DNA
)	-RRB-	punct	O
)	-RRB-	punct	O
serves	VBZ	ROOT	O
as	IN	case	O
binding	VBG	amod	O
site	NN	nmod	O
for	IN	case	O
two	CD	nummod	O
differently	RB	advmod	O
regulated	VBN	amod	O
zinc	NN	compound	B-protein
finger	NN	compound	I-protein
proteins	NNS	nmod	I-protein
:	:	punct	O
the	DT	det	O
constitutively	RB	advmod	B-protein
expressed	VBN	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
Sp1	NN	dep	B-protein
and	CC	cc	O
the	DT	det	O
inducible	JJ	amod	B-protein
early	JJ	amod	I-protein
growth	NN	compound	I-protein
response	NN	compound	I-protein
protein	NN	compound	I-protein
EGR-1	NN	conj	B-protein
.	.	punct	O

In	IN	case	O
unstimulated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
which	WDT	nsubj	O
do	VBP	aux	O
not	RB	neg	O
secrete	VB	acl:relcl	O
IL-2	NN	dobj	B-protein
,	,	punct	O
only	RB	advmod	O
Sp1	NN	nsubj	B-protein
binds	VBZ	ROOT	O
to	TO	case	O
this	DT	det	O
region	NN	nmod	O
,	,	punct	O
while	IN	mark	O
in	IN	case	O
stimulated	VBN	amod	B-cell_line
IL-2	NN	compound	I-cell_line
secreting	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
the	DT	det	O
inducible	JJ	amod	B-protein
EGR-1	NN	compound	I-protein
protein	NN	nsubj	I-protein
recognizes	VBZ	advcl	O
this	DT	det	O
element	NN	dobj	O
.	.	punct	O

In	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
the	DT	det	O
ZIP	NN	compound	B-DNA
site	NN	nsubj	I-DNA
serves	VBZ	ROOT	O
as	IN	case	O
an	DT	det	O
activator	NN	nmod	O
for	IN	case	O
IL-2	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
combination	NN	nsubjpass	O
of	IN	case	O
ZIP	NN	nmod	B-DNA
and	CC	cc	O
NFAT	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	conj	I-DNA
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
maximal	JJ	amod	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
ZIP	NN	compound	B-DNA
site	NN	nmod	I-DNA
for	IN	case	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
by	IN	case	O
the	DT	det	O
LEF-1	NN	compound	B-protein
HMG	NN	compound	I-protein
protein	NN	nmod	I-protein
on	IN	case	O
nucleosome-assembled	JJ	amod	B-DNA
DNA	NN	nmod	I-DNA
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Lymphoid	JJ	amod	B-protein
enhancer-binding	JJ	amod	I-protein
factor	NN	nsubj	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
LEF-1	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
regulatory	JJ	amod	B-protein
high	JJ	amod	I-protein
mobility	NN	compound	I-protein
group	NN	compound	I-protein
(	-LRB-	punct	I-protein
HMG	NN	compound	I-protein
)	-RRB-	punct	I-protein
protein	NN	ROOT	I-protein
that	WDT	nsubj	O
activates	VBZ	acl:relcl	O
the	DT	det	O
T	NN	compound	B-DNA
cell	NN	compound	I-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
TCR	NN	compound	I-DNA
alpha	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
enhancer	NN	dobj	I-DNA
in	IN	case	O
a	DT	det	O
context-restricted	JJ	amod	O
manner	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
paper	NN	nmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
distal	JJ	amod	O
region	NN	nsubj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus-1	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
HIV-1	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
enhancer	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
DNA-binding	JJ	amod	B-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
LEF-1	NN	nmod	B-protein
and	CC	cc	O
Ets-1	NN	conj	O
,	,	punct	O
also	RB	advmod	O
provides	VBZ	ccomp	O
a	DT	det	O
functional	JJ	amod	O
context	NN	dobj	O
for	IN	case	O
activation	NN	nmod	O
by	IN	case	O
LEF-1	NN	nmod	B-protein
.	.	punct	O

First	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
mutations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
LEF-1-binding	JJ	amod	B-DNA
site	NN	nmod	I-DNA
inhibit	VBP	ccomp	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
multimerized	JJ	amod	B-DNA
copies	NNS	nmod	I-DNA
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
LEF-1/GAL4	NN	nsubj	B-protein
can	MD	aux	O
activate	VB	conj	O
a	DT	det	O
GAL4-substituted	JJ	amod	B-DNA
HIV-1	NN	compound	I-DNA
enhancer	NN	compound	I-DNA
80-	CD	dobj	O
to	TO	dep	O
100-fold	RB	dep	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Second	RB	advmod	O
,	,	punct	O
recombinant	JJ	amod	B-protein
LEF-1	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
HIV-1	NN	compound	O
transcription	NN	dobj	O
on	IN	case	O
chromatin-assembled	JJ	amod	B-DNA
DNA	NN	nmod	I-DNA
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
nucleosome	JJ	amod	B-protein
-assembly	JJ	amod	O
system	NN	dobj	O
derived	VBN	acl	O
from	IN	case	O
Drosophila	FW	compound	O
embryos	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
packaging	NN	nsubj	O
of	IN	case	O
DNA	NN	nmod	O
into	IN	case	O
chromatin	NN	nmod	B-DNA
in	FW	compound	O
vitro	FW	advmod	O
strongly	RB	advmod	O
represses	VBZ	ccomp	O
HIV-1	NN	compound	O
transcription	NN	dobj	O
and	CC	cc	O
that	IN	mark	O
repression	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
counteracted	VBN	conj	O
efficiently	RB	advmod	O
by	IN	case	O
preincubation	NN	nmod	O
of	IN	case	O
the	DT	det	O
DNA	NN	nmod	O
with	IN	case	O
LEF-1	NN	nmod	B-protein
(	-LRB-	punct	O
or	CC	cc	O
LEF-1	NN	conj	B-protein
and	CC	cc	O
Ets-1	NN	conj	B-protein
)	-RRB-	punct	O
supplemented	VBN	acl	O
with	IN	case	O
fractions	NNS	nmod	O
containing	VBG	acl	O
the	DT	det	O
promoter-binding	JJ	amod	B-protein
protein	NN	dobj	I-protein
,	,	punct	O
Sp1	NN	appos	B-protein
.	.	punct	O

Addition	NN	nsubj	O
of	IN	case	O
TFE-3	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
an	DT	det	O
E-box	NN	compound	B-DNA
motif	NN	nmod	I-DNA
upstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
LEF-1	NN	compound	B-DNA
and	CC	cc	I-DNA
Ets-1	NN	conj	I-DNA
sites	NNS	nmod	I-DNA
,	,	punct	O
further	RB	advmod	O
augments	VBZ	ROOT	O
transcription	NN	dobj	O
in	IN	case	O
this	DT	det	O
system	NN	nmod	O
.	.	punct	O

Individually	RB	advmod	O
or	CC	advmod	O
collectively	RB	advmod	O
,	,	punct	O
none	NN	nsubj	O
of	IN	case	O
the	DT	det	O
three	CD	nummod	O
enhancer-binding	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
(	-LRB-	punct	O
LEF-1	NN	dep	B-protein
,	,	punct	O
Ets-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
TFE-3	NN	conj	B-protein
)	-RRB-	punct	O
could	MD	aux	O
activate	VB	ROOT	O
transcription	NN	dobj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
Sp1	NN	nmod	B-protein
.	.	punct	O

A	DT	det	O
truncation	NN	compound	B-protein
mutant	NN	nsubj	I-protein
of	IN	case	O
LEF-1	NN	nmod	B-protein
(	-LRB-	punct	O
HMG-88	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
the	DT	det	O
HMG	NN	compound	B-protein
box	NN	dobj	I-protein
but	CC	cc	O
lacks	VBZ	conj	O
the	DT	det	O
trans-activation	NN	compound	B-protein
domain	NN	dobj	I-protein
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
activate	VB	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
nucleosomal	JJ	amod	B-DNA
DNA	NN	nmod	I-DNA
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
bending	NN	nsubj	O
of	IN	case	O
DNA	NN	nmod	O
by	IN	case	O
the	DT	det	O
HMG	NN	compound	B-protein
domain	NN	nmod	I-protein
is	VBZ	cop	O
not	RB	neg	O
sufficient	JJ	ccomp	O
to	TO	mark	O
activate	VB	xcomp	O
transcription	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
transcription	NN	compound	O
activation	NN	nsubj	O
by	IN	case	O
LEF-1	NN	nmod	B-protein
in	FW	compound	O
vitro	FW	advmod	O
is	VBZ	cop	O
a	DT	det	O
chromatin	NN	compound	B-DNA
-dependent	JJ	amod	O
process	NN	ccomp	O
that	WDT	nsubj	O
requires	VBZ	acl:relcl	O
a	DT	det	O
functional	JJ	amod	O
trans-activation	NN	compound	B-protein
domain	NN	dobj	I-protein
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
the	DT	det	O
HMG	NN	compound	B-protein
domain	NN	nmod	I-protein
.	.	punct	O

HIV-1	NN	compound	B-protein
envelope	NN	compound	I-protein
glycoproteins	NNS	nsubj	I-protein
induce	VBP	ROOT	O
activation	NN	dobj	O
of	IN	case	O
activated	VBN	amod	O
protein-1	NN	nmod	B-protein
in	IN	case	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
[	-LRB-	punct	O
published	VBN	amod	O
erratum	NN	nsubj	O
appears	VBZ	ccomp	O
in	IN	case	O
J	NNP	compound	O
Biol	NNP	compound	O
Chem	NNP	compound	O
1995	CD	nummod	O
Dec	NNP	nmod	O
1	CD	nummod	O
;	:	punct	O
270	CD	nummod	O
(	-LRB-	punct	O
48	CD	appos	O
)	-RRB-	punct	O
:	:	punct	O
29038	CD	nummod	O
]	-RRB-	punct	O

Activation	NN	nsubj	O
of	IN	case	O
CD4	NN	compound	B-cell_type
positive	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
a	DT	det	O
primary	JJ	amod	O
requirement	NN	ROOT	O
for	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
HIV	NN	appos	O
)	-RRB-	punct	O
entry	NN	nmod	O
,	,	punct	O
efficient	JJ	amod	O
HIV	NN	compound	O
replication	NN	conj	O
,	,	punct	O
and	CC	cc	O
progression	NN	conj	O
to	TO	case	O
AIDS	NN	nmod	O
,	,	punct	O
Utilizing	VBG	amod	O
CD4	NN	compound	B-cell_line
positive	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
purified	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
from	IN	case	O
normal	JJ	amod	O
individuals	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	parataxis	O
that	IN	mark	O
native	JJ	amod	B-protein
envelope	NN	compound	I-protein
glycoproteins	NNS	nsubj	I-protein
of	IN	case	O
HIV	NN	nmod	O
,	,	punct	O
gp	NN	appos	B-protein
160	CD	nummod	I-protein
,	,	punct	O
can	MD	aux	O
induce	VB	ccomp	O
activation	NN	dobj	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
,	,	punct	I-protein
activated	VBN	amod	I-protein
protein-1	NN	appos	I-protein
(	-LRB-	punct	O
AP-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
stimulatory	JJ	amod	O
effects	NNS	nsubjpass	O
of	IN	case	O
gp160	NN	nmod	B-protein
are	VBP	auxpass	O
mediated	VBN	ROOT	O
through	IN	case	O
the	DT	det	O
CD4	NN	compound	B-protein
molecule	NN	nmod	I-protein
,	,	punct	O
since	IN	mark	O
treatment	NN	nsubj	O
of	IN	case	O
gp160	NN	nmod	B-protein
with	IN	case	O
soluble	JJ	amod	O
CD4-IgG	NN	nmod	B-protein
abrogates	VBZ	advcl	O
its	PRP$	nmod:poss	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
CD4	NN	compound	B-cell_line
negative	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubj	I-cell_line
fail	VBP	conj	O
to	TO	mark	O
be	VB	auxpass	O
stimulated	VBN	xcomp	O
with	IN	case	O
gp160	NN	nmod	B-protein
.	.	punct	O

Immunoprecipitation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
gp	NN	compound	B-protein
160	CD	nummod	I-protein
-induced	JJ	amod	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
with	IN	case	O
polyclonal	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
to	TO	case	O
Fos	NN	compound	B-protein
and	CC	cc	O
Jun	NN	conj	B-protein
proteins	NNS	nmod	I-protein
indicates	VBZ	ROOT	O
that	IN	mark	O
AP-1	NN	compound	B-protein
complex	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
comprised	VBN	ccomp	O
of	IN	case	O
members	NNS	nmod	O
of	IN	case	O
these	DT	det	O
family	NN	nmod	O
of	IN	case	O
proteins	NNS	nmod	O
.	.	punct	O

The	DT	det	O
gp160-induced	JJ	amod	B-protein
AP-1	NN	compound	I-protein
complex	NN	nsubj	I-protein
is	VBZ	cop	O
dependent	JJ	ROOT	O
upon	IN	case	O
protein	NN	compound	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
protein	NN	nmod:npmod	O
synthesis-independent	JJ	conj	O
.	.	punct	O

This	DT	det	O
stimulation	NN	nsubjpass	O
can	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
abolished	VBN	ROOT	O
by	IN	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
,	,	punct	O
but	CC	cc	O
it	PRP	nsubj	O
is	VBZ	cop	O
unaffected	JJ	conj	O
by	IN	case	O
calcium	NN	compound	O
channel	NN	compound	O
blocker	NN	nmod	O
or	CC	cc	O
cyclosporine	NN	compound	O
A	NN	conj	O
.	.	punct	O

This	DT	det	O
gp160	NN	compound	B-protein
treatment	NN	nsubj	O
adversely	RB	advmod	O
affects	VBZ	ROOT	O
the	DT	det	O
functional	JJ	amod	O
capabilities	NNS	dobj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
pre-treatment	NN	nsubj	O
of	IN	case	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
gp160	NN	nmod	B-protein
for	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
inhibited	VBD	parataxis	O
anti-CD3	JJ	amod	B-protein
-induced	JJ	amod	O
interleukin-2	NN	compound	B-protein
secretion	NN	dobj	O
.	.	punct	O

Effects	NNS	nsubjpass	O
similar	JJ	amod	O
to	TO	case	O
gp160	NN	nmod	B-protein
were	VBD	auxpass	O
seen	VBN	ROOT	O
with	IN	case	O
anti-CD4	JJ	amod	B-protein
mAb	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
aberrant	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
AP-1	NN	nmod	B-protein
by	IN	case	O
gp160	NN	nmod	B-protein
in	IN	case	O
CD4	NN	compound	B-cell_type
positive	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
could	MD	aux	O
result	VB	ROOT	O
in	IN	case	O
up-regulation	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
containing	VBG	acl	O
AP-1	NN	compound	B-DNA
sites	NNS	dobj	I-DNA
,	,	punct	O
e.g	NN	appos	O
.	.	punct	O
interleukin-3	NN	ROOT	B-protein
and	CC	cc	O
granulocyte	NN	compound	B-protein
macrophage	NN	nmod:npmod	I-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
concurrently	RB	advmod	O
lead	VBP	conj	O
to	TO	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
unresponsiveness	NN	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
interleukin-2	NN	compound	B-protein
secretion	NN	dobj	O
.	.	punct	O

